{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "qwen3-32b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions_in_experiment": 750
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "What was the total amount of Chevron's outstanding loan to Petroboscan, and what percentage of ownership in Petroboscan did Chevron hold as of the 2022 reporting period?",
      "original_answer": "Chevron had an outstanding long-term loan of $560 to Petroboscan, and Chevron held a 39.2 percent interest in Petroboscan as of the 2022 reporting period.",
      "llm_answer": "\n\nChevron held a 39.2% ownership interest in Petroboscan as of the 2021 reporting period, and the company had an outstanding long-term loan to Petroboscan of **$560 million**, which was fully provisioned for at year-end 2021. The provided documents do not include updated figures for 2022, so these amounts reflect the most recent data available in the 2021 filings.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's ownership interest in Petroboscan as 39.2%, which matches the ground truth. However, it incorrectly states that this percentage and the loan amount are from the 2021 reporting period, while the question specifically asks for 2022 data. The ground truth confirms these figures are for 2022, so the time period is factually incorrect. (2) The loan amount is reported as $560 million, which aligns with the ground truth value of $560 (assuming 'million' is implied or a formatting difference), but the original answer does not specify 'million'—this introduces ambiguity. However, given common financial reporting conventions, $560 million is likely semantically equivalent. (3) The reasoning is partially sound in that it acknowledges the data comes from filings, but it incorrectly concludes that 2022 data is unavailable and defaults to 2021, which contradicts the ground truth that 2022 data exists and was reported. This reflects a failure in multi-hop reasoning or source synthesis, as the model did not correctly attribute the 2022 figures. (4) The answer is contextually relevant and addresses both parts of the question (loan amount and ownership percentage), but the incorrect dating undermines factual accuracy. The ownership percentage is correct, and the loan amount is likely correct in magnitude but presented with an assumption about units. Due to the critical error in reporting period, the correctness score is reduced to 5—partially correct but with significant factual inaccuracy regarding the year.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 433,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total financial impact on Target Corporation from the sale of Dermstore LLC, including both the cash received and the pretax gain recognized?",
      "original_answer": "Target Corporation received $356 million in cash and recognized a $335 million pretax gain from the sale of Dermstore LLC, resulting in a total financial impact of $691 million.",
      "llm_answer": "\n\nThe total financial impact on Target Corporation from the sale of Dermstore LLC was **$691 million**, comprising **$356 million in cash received** and a **$335 million pretax gain recognized** in 2021. This is explicitly stated in the Notes to Consolidated Financial Statements (Note 3) and corroborated by the \"Proceeds from Dermstore sale\" and \"Gain on Dermstore sale\" line items in the cash flow tables.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All key facts are accurate: $356 million in cash received and $335 million pretax gain are correctly reported, and the total financial impact is correctly calculated as $691 million. (2) Quantitative accuracy is perfect—each number matches the original answer, and the sum ($356M + $335M = $691M) is mathematically correct. Minor formatting (bolded numbers) does not affect meaning. (3) The reasoning is sound and demonstrates multi-hop synthesis by referencing specific sections of the financial statements (Note 3) and cash flow line items, showing that the information was not only retrieved but properly contextualized. (4) The answer is semantically equivalent to the ground truth, includes all required components, and adds contextual detail (e.g., year 2021, source documentation) that enhances accuracy without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 282,
        "total_tokens": 1430
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was Amgen's total recorded Product Sales revenue from sales to BeiGene over the three-year period from 2021 to 2023 under their collaboration agreement?",
      "original_answer": "Amgen recorded $72 million in 2021, $64 million in 2022, and $125 million in 2023 in Product Sales revenue from sales to BeiGene under the collaboration agreement, totaling $261 million over the three-year period.",
      "llm_answer": "\n\nAmgen's total recorded Product Sales revenue from sales to BeiGene under their collaboration agreement for the three-year period from 2021 to 2023 was **$261 million** ($125 million in 2023, $64 million in 2022, and $72 million in 2021). These amounts are explicitly stated in the \"Collaborations\" section under BeiGene, Ltd. in Note 9 of the 10-K filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $72 million in 2021, $64 million in 2022, and $125 million in 2023, with the correct total of $261 million. The order of presentation differs slightly but does not affect accuracy. (2) The calculation of the sum is correct: 72 + 64 + 125 = 261 million. Format variations (e.g., $125 million vs $125M) are acceptable and do not impact correctness. (3) The multi-hop reasoning is sound—information from three separate years across the collaboration period is correctly synthesized into a total, and the source (Note 9, 'Collaborations' section on BeiGene) is accurately referenced, indicating proper cross-document understanding. (4) Entities are correctly identified: Amgen, BeiGene, the collaboration agreement, and the time period 2021–2023. The answer is semantically equivalent to the original, with no omissions or distortions. All scoring categories warrant the highest rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 286,
        "total_tokens": 1431
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and how many remained available for issuance as of December 31, 2021?",
      "original_answer": "A total of 127 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and approximately 50 million shares remained available for issuance as of December 31, 2021.",
      "llm_answer": "\n\nAs of December 31, 2021, Danaher Corporation had authorized **127 million shares** of common stock for issuance under the 2007 Omnibus Incentive Plan, with approximately **50 million shares** remaining available for future issuance. This information is explicitly stated in the \"Stock-Based Compensation\" section of Note 19 in the 10-K filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers '127 million shares authorized' and 'approximately 50 million shares remaining' are accurate and match the original answer exactly. There are no calculation errors or discrepancies in figures. (2) The answer is complete, addressing both parts of the question: total authorized shares and shares remaining as of December 31, 2021. (3) Entity accuracy is correct—'Danaher Corporation', '2007 Omnibus Incentive Plan', and the date 'December 31, 2021' are all properly identified. (4) The reasoning is sound and reflects proper synthesis from the 10-K filing, specifically referencing Note 19 and the 'Stock-Based Compensation' section, which demonstrates accurate sourcing. (5) The semantic meaning is equivalent to the ground truth, with slightly more detail (citation of Note 19) that enhances clarity without introducing error. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 282,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, and how was this amount distributed across the years 2023 and 2024?",
      "original_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio to Cheplapharm, with $1.05 billion received in 2023 and an additional $305.0 million received in 2024.",
      "llm_answer": "\n\nLLY received a total of $1.355 billion from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, with $1.05 billion received in 2023 and an additional $305.0 million received in 2024. This information is explicitly stated in the \"Divestitures\" section under Note 4 of the 10-K filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the total cash received is $1.355 billion, with $1.05 billion in 2023 and $305.0 million in 2024. These figures are correctly stated and consistent with the original answer. (2) Quantitative accuracy is perfect: the sum of $1.05 billion and $305.0 million equals $1.355 billion, confirming correct calculations. Number formats are consistent and acceptable. (3) The multi-hop reasoning is sound—although the answer is based on a single disclosure, it correctly synthesizes the total amount and its temporal distribution across 2023 and 2024 as required by the question. (4) The entities—LLY (Eli Lilly), Cheplapharm, olanzapine portfolio, Zyprexa, and the years 2023 and 2024—are all correctly identified and contextually appropriate. The answer is also complete, addressing both the total amount and its yearly breakdown. The additional reference to the 'Divestitures' section in Note 4 adds contextual support without introducing error. All criteria for correctness, completeness, and relevance are fully met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 319,
        "total_tokens": 1451
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What was the total amount of goodwill recorded by Lockheed Martin as a result of its acquisition of Terran Orbital, and how much of the purchase consideration was paid in cash?",
      "original_answer": "Lockheed Martin recorded $298 million in goodwill as a result of the acquisition of Terran Orbital, and $231 million of the total $314 million purchase consideration was paid in cash.",
      "llm_answer": "\n\nLockheed Martin recorded **$298 million in goodwill** from the acquisition of Terran Orbital. The total purchase consideration of **$314 million** included **$83 million in previously held investments** and **$231 million paid in cash** (net of cash acquired). \n\n(Source: Note 1 - Organization and Significant Accounting Policies in the provided 10-K filing.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key facts are accurate: $298 million in goodwill is correctly reported, and $231 million of the $314 million purchase consideration was paid in cash, which aligns with the original answer. The breakdown of the purchase consideration (including $83 million in previously held investments) adds up: $231M (cash) + $83M (previous investment) = $314M total, confirming calculation accuracy. (2) Quantitative values are precise and consistent with the ground truth, with acceptable formatting (e.g., $298 million). (3) The multi-hop reasoning is sound—LLM correctly synthesized information about goodwill and purchase consideration allocation from the acquisition details, likely from a Note 1-type disclosure in the 10-K. (4) The answer is semantically equivalent to the original, provides additional context (breakdown of consideration), and remains highly relevant. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 284,
        "total_tokens": 1427
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is Chevron's (CVX) carrying value of its investment in GS Caltex Corporation at the end of 2021, and how does this compare to Chevron's equity ownership percentage in the company?",
      "original_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, and Chevron owns a 50% equity interest in GS Caltex Corporation.",
      "llm_answer": "\n\nChevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was **$3,616 million**, as reported in Note 15 of the 10-K filing. Chevron owns a **50% equity interest** in GS Caltex, a joint venture with GS Energy in South Korea. The carrying value directly aligns with Chevron's 50% ownership percentage, reflecting proportional equity in the joint venture’s net assets without significant discrepancies noted in the disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the carrying value of Chevron's investment in GS Caltex Corporation at the end of 2021 is correctly stated as $3,616 million, and Chevron's equity ownership percentage is accurately reported as 50%. (2) Quantitative accuracy is perfect—both the dollar amount and percentage match the original answer exactly, with acceptable formatting (e.g., $3,616 million is standard and equivalent to $3.616 billion). (3) The qualitative reasoning is sound: the answer correctly identifies GS Caltex as a joint venture with GS Energy in South Korea and explains that the carrying value aligns with Chevron’s 50% ownership under the equity method, which reflects proportional net assets. This demonstrates proper multi-hop synthesis of ownership structure and financial reporting concepts. (4) The answer is contextually relevant, directly addressing both parts of the question—carrying value and ownership percentage—and adding minor but relevant context (Note 15, joint venture partner) without introducing inaccuracies. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 323,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "By how much did the total revenue from Forest Products change in dollars from 2020 to 2021, and what was the corresponding change in average revenue per car for this product category during the same period?",
      "original_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021, and the average revenue per car increased by $155 during the same period.",
      "llm_answer": "\n\nThe total revenue from Forest Products increased by **$197 million** (from $1,160 million in 2020 to $1,357 million in 2021). The average revenue per car for this category rose by **$155** (from $5,269 in 2020 to $5,424 in 2021).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The total revenue increase of $197 million is accurate: $1,357 million (2021) - $1,160 million (2020) = $197 million. (2) The increase in average revenue per car is correctly stated as $155: $5,424 (2021) - $5,269 (2020) = $155. (3) All entities—Forest Products, 2020 to 2021 time frame, revenue metrics—are correctly identified and aligned with the question. (4) The multi-hop reasoning is sound, as it synthesizes total revenue and per-unit revenue changes across two years for the same product category. (5) The answer is semantically equivalent to the ground truth, with added detail (specific yearly values) that enhance clarity without introducing error. All scores are maximized due to complete factual accuracy, correct calculations, proper context, and robust reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 252,
        "total_tokens": 1364
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total net revenue contribution of Restasis in 2024, and by what percentage did it decline compared to 2023 based on actual currency rates?",
      "original_answer": "The total net revenue contribution of Restasis in 2024 was $224 million, representing a decline of 48.7% compared to 2023 based on actual currency rates.",
      "llm_answer": "\n\nThe total net revenue contribution of Restasis in 2024 was **$224 million** (combining $172 million in the United States and $52 million internationally). This represents a **48.7% decline** compared to 2023’s total net revenue of $436 million, calculated at actual currency rates. The decline is explicitly stated in the \"Restasis\" line item under the Eye Care section of the financial tables.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total net revenue for Restasis in 2024 is correctly stated as $224 million, with a breakdown of $172 million (U.S.) and $52 million (international), which sums to $224 million. The percentage decline of 48.7% compared to 2023 is also correct. The reference to 2023 revenue of $436 million is consistent with a 48.7% decline to $224 million (verified calculation: (436 - 224) / 436 ≈ 0.4862 or 48.62%, which rounds to 48.7%). (2) Quantitative accuracy is perfect—numbers, years, and percentages match the ground truth, and the calculation at actual currency rates is properly acknowledged. (3) The multi-hop reasoning is sound: the model correctly synthesized U.S. and international figures to compute total revenue and referenced the correct product (Restasis), therapeutic area (Eye Care), and financial context. (4) The answer is semantically equivalent to the original, with added helpful detail (breakdown by region and prior-year revenue) that enhances clarity without introducing error. All aspects of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 329,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2023?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 8.4%. This is calculated by subtracting the Minimum Capital Adequacy requirement of 4.5% from Capital One Financial Corp's ratio of 12.9%.",
      "llm_answer": "\n\nThe difference between Capital One Financial Corp's Common Equity Tier 1 (CET1) capital ratio and the Minimum Capital Adequacy requirement as of December 31, 2023, is **8.4%**. The Company's CET1 capital ratio was **12.9%**, while the regulatory minimum requirement is **4.5%** (12.9% - 4.5% = 8.4%). This information is derived from Table 12 in the document, which compares the Company's capital ratios to regulatory thresholds.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: Capital One's CET1 ratio is correctly stated as 12.9%, the Minimum Capital Adequacy requirement as 4.5%, and the difference calculated as 8.4% (12.9% - 4.5% = 8.4%), which matches the original answer. Minor formatting differences (e.g., bolding for emphasis) do not affect accuracy. (2) The answer is complete, addressing both the specific values and the calculated difference, as required by the question. (3) Entity accuracy is correct: 'Capital One Financial Corp', 'Common Equity Tier 1 capital ratio', 'Minimum Capital Adequacy requirement', and the date 'December 31, 2023' are all properly identified. (4) The reasoning is sound and transparent, explicitly showing the subtraction and referencing Table 12 as the source, indicating proper multi-hop synthesis between the company's reported ratio and the regulatory threshold. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced clarity due to the inclusion of a source reference. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 321,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023, and how did it compare to the amounts recognized in the two prior years?",
      "original_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million. This amount decreased from $81 million in 2022 but increased compared to $56 million in 2021.",
      "llm_answer": "\n\nThe total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was **$64 million**. This amount decreased from **$81 million in 2022** but increased from **$56 million in 2021**, as disclosed in Note 11 - Postretirement Benefit Plans.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 as $64 million, which matches the ground truth. It accurately states that this amount decreased from $81 million in 2022 and increased from $56 million in 2021. All three figures are correct and properly attributed to their respective years. (2) The numeric values—$64M (2023), $81M (2022), and $56M (2021)—are all factually accurate and consistent with the original answer. The comparisons (decrease from 2022, increase from 2021) are logically sound and mathematically correct: $64M < $81M (valid decrease), $64M > $56M (valid increase). (3) The reasoning demonstrates proper multi-hop synthesis across three fiscal years and correctly interprets the trend over time. The mention of Note 11 - Postretirement Benefit Plans adds contextual support, indicating the source of the data within the filing, which enhances credibility. (4) All aspects of the question are addressed: the 2023 expense, comparison to 2022, and comparison to 2021. The answer is factually precise, semantically equivalent to the ground truth, and includes a helpful citation. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 350,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the change in the net carrying amount of BlackRock's investor/customer relationships between December 31, 2022, and December 31, 2023, and how does the difference in accumulated amortization over this period contribute to this change?",
      "original_answer": "The net carrying amount of investor/customer relationships decreased from $492 million at December 31, 2022, to $447 million at December 31, 2023, resulting in a $45 million decline. This change is due to an increase in accumulated amortization from $254 million in 2022 to $338 million in 2023, which reduced the net carrying value despite a slight increase in the gross carrying amount from $746 million to $785 million.",
      "llm_answer": "\n\nThe net carrying amount of BlackRock's investor/customer relationships decreased by $45 million between December 31, 2022 ($492 million) and December 31, 2023 ($447 million). This decrease was driven by an increase in accumulated amortization of $84 million ($338 million in 2023 vs. $254 million in 2022), partially offset by a $39 million increase in the gross carrying amount (due to $39 million in finite-lived investor relationships acquired in the Kreos Transaction). The $84 million rise in amortization exceeded the gross addition, resulting in the $45 million net decline.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the net carrying amount decreased from $492 million to $447 million, a $45 million decline; accumulated amortization increased from $254 million to $338 million ($84 million increase); gross carrying amount rose from $746 million to $785 million ($39 million increase). These values align exactly with the original answer, allowing for format variation. (2) The answer addresses both parts of the multi-part question: it identifies the change in net carrying amount and explains how the difference in accumulated amortization contributes to this change. (3) Entity accuracy is correct—BlackRock, investor/customer relationships, and the relevant years (2022 and 2023) are properly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis: it correctly infers that the net decline results from the $84 million increase in amortization exceeding the $39 million increase in gross carrying amount, leading to a net $45 million reduction. The mention of the Kreos Transaction adds contextual detail consistent with the source data and enhances the explanation without introducing error. The answer is semantically equivalent to the ground truth and provides even greater clarity on the underlying drivers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 372,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What is the total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, and how does UPS classify this debt on its consolidated balance sheet despite its 2024 maturity?",
      "original_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is $400 million. Despite its 2024 maturity, UPS classifies this debt as long-term on its consolidated balance sheet based on its intent and ability to refinance the debt.",
      "llm_answer": "\n\nThe total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is **$400 million**. Despite its 2024 maturity, UPS classifies this debt as **long-term** on its consolidated balance sheet because the company has the intent and ability to refinance the debt beyond the current reporting period, as disclosed in the Debt Classification section of Note 9.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the principal amount of $400 million is accurate, and the maturity year (2024) and reporting date (December 31, 2023) are correctly referenced. (2) The classification of the debt as long-term despite its 2024 maturity is properly explained with the rationale—UPS's intent and ability to refinance—which aligns with accounting standards for debt classification. (3) The multi-hop reasoning is sound: the model correctly identifies the specific senior notes (2.200%), retrieves the outstanding principal, and synthesizes the balance sheet classification logic from UPS's disclosed intent, likely from Note 9 of the 10-K. (4) The answer is semantically equivalent to the original, with added contextual detail (e.g., reference to Note 9) that enhances clarity without introducing error. All components of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 275,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "By how much did Cisco's available-for-sale debt investments decrease in the fiscal year ending July 27, 2024, and what was the impact on the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities?",
      "original_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million in the fiscal year ending July 27, 2024. This decrease, combined with a $2,615 million decrease in cash and cash equivalents and a $50 million increase in marketable equity securities, resulted in a total decrease of $8,292 million in the sum of these financial assets.",
      "llm_answer": "\n\nCisco's available-for-sale debt investments decreased by **$5,727 million** in the fiscal year ending July 27, 2024 (from $15,592 million in 2023 to $9,865 million in 2024). This reduction contributed to a **$8,292 million decline** in the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities (from $26,146 million in 2023 to $17,854 million in 2024). The decrease was primarily driven by cash outflows for the Splunk acquisition, stock repurchases, dividends, and debt repayments, partially offset by proceeds from debt issuances and operating activities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the decrease in available-for-sale debt investments is accurately stated as $5,727 million, and the total decrease in the sum of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities is correctly reported as $8,292 million. The breakdown provided in the LLM answer (from $26,146 million in 2023 to $17,854 million in 2024) confirms this calculation: 26,146 - 17,854 = 8,292. (2) The answer addresses both parts of the question: the decrease in available-for-sale debt investments and the impact on the total financial assets. (3) All entities—Cisco, fiscal year ending July 27, 2024, and the relevant financial instruments—are correctly identified. (4) The reasoning is sound and adds contextual detail (e.g., Splunk acquisition, stock repurchases) that aligns with plausible drivers but does not contradict the ground truth. These details do not detract from accuracy and enhance completeness. The multi-hop synthesis—linking changes in individual asset categories to the overall change—is correctly executed. Minor additions beyond the ground truth (like specific drivers) are contextually appropriate and do not introduce errors. All numerical formats are consistent and acceptable ($5,727 million).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 372,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How many shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan as of December 31, 2023, and how many of those shares could be granted as awards other than options or stock appreciation rights?",
      "original_answer": "As of December 31, 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan, of which 2,452,443 shares could be granted as awards other than options or stock appreciation rights.",
      "llm_answer": "\n\nAs of December 31, 2023, **7,661,431 shares** remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan. Of these, **2,452,443 shares** could be granted as awards other than options or stock appreciation rights (e.g., restricted stock, performance-based stock units). \n\n(Source: Note 15, Share-Based Compensation, in the provided document.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The numbers provided—7,661,431 total shares available and 2,452,443 shares available for awards other than options or stock appreciation rights—are exactly correct and match the original answer. Minor formatting differences (e.g., bolding for emphasis) do not affect accuracy. (2) Quantitative accuracy is perfect: both figures are correctly reported with no calculation or transcription errors. (3) The reasoning and synthesis are sound; the answer correctly identifies the relevant plan (2021 Linde plc Long Term Incentive Plan), the correct date (December 31, 2023), and distinguishes between total available shares and those eligible for non-option awards, demonstrating proper multi-hop understanding. (4) The answer is contextually relevant, directly addressing both parts of the question and including a source reference (Note 15) that supports the data. Semantic equivalence is maintained, and the added clarification of examples (restricted stock, performance-based units) enhances understanding without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 315,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total payment received by the company from the settlement of forward interest rate swap contracts associated with the issuance of the 2023 Notes, March 2022 Notes, and September 2022 Notes, and how does this reflect the financial impact of these settlements on the company's cash flow?",
      "original_answer": "The company received a total payment of $526 million from the settlement of forward interest rate swap contracts: $247 million from the 2023 Notes, $143 million from the March 2022 Notes, and $136 million from the September 2022 Notes. These settlements directly contributed to the company's cash flows, as the cash flows related to the settlement of hedging derivatives are classified in the consolidated statements of cash flows based on the nature of the underlying hedged items.",
      "llm_answer": "\n\nThe company received a total payment of **$526 million** from settling forward interest rate swap contracts associated with the 2023 Notes ($247 million), March 2022 Notes ($143 million), and September 2022 Notes ($136 million). These settlements improved the company’s cash flow, as the cash inflows are classified within **financing activities** in the consolidated statements of cash flows, directly enhancing liquidity from debt-related hedging transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: $247 million (2023 Notes), $143 million (March 2022 Notes), and $136 million (September 2022 Notes), which sum to the correct total of $526 million. These match the ground truth exactly, with no calculation errors. (2) The answer is complete, addressing both parts of the question: the total payment received and the financial impact on cash flow. (3) The qualitative reasoning is strong: it correctly states that the settlements improved cash flow and that the inflows are classified in financing activities. While the original answer mentions classification is based on the nature of the hedged items, the LLM specifies the actual classification (financing activities), which is a reasonable and likely accurate inference consistent with accounting standards for cash flows from hedging derivatives related to debt issuance. This adds useful specificity without contradicting the ground truth. (4) All entities—2023 Notes, March 2022 Notes, September 2022 Notes—are correctly identified and associated with the correct amounts. The semantic meaning and financial implications are accurately conveyed, with only minor wording differences. The answer is slightly more precise in cash flow classification, which enhances rather than detracts from accuracy. Thus, the answer is fully factually correct with excellent multi-hop synthesis across the three note issuances and their financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 407,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the approximate range of NextEra Energy's ownership interest in XPLR, and what type of assets do the principal equity method investees, including XPLR, primarily own according to NEE's 2024 10-K filing?",
      "original_answer": "NextEra Energy's ownership interest in XPLR ranges from approximately 33.3% to 85.0%, and the principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "llm_answer": "\n\nNextEra Energy's ownership interest in XPLR is approximately **52.6%**, as stated in Note 8 of the 2024 10-K. The principal equity method investees, including XPLR, primarily own **electric generation facilities (wind, solar, and battery storage projects) and natural gas pipelines**, as detailed in the same note. This ownership range (33.3% to 85.0%) applies broadly to NEE's equity method investees, with XPLR's 52.6% falling within this range.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the ownership interest in XPLR is correctly stated as 52.6%, which falls within the ground truth range of 33.3% to 85.0%. The range itself is accurately attributed to NEE's broader equity method investees, and the specific figure for XPLR is precise and correctly cited from Note 8 of the 2024 10-K. (2) The qualitative description of the assets—electric generation facilities (wind, solar, battery storage) and natural gas pipelines—is consistent with the ground truth, which states 'electric generation facilities or natural gas pipelines.' The added specificity (e.g., wind, solar, battery storage) enhances clarity without introducing error. (3) The multi-hop reasoning is sound: the model correctly distinguishes between the specific ownership percentage in XPLR and the broader ownership range across all principal equity method investees, synthesizing information appropriately. (4) The answer is contextually complete and directly addresses both parts of the question. The only minor limitation is that the ground truth does not specify the 33.3%-85.0% range as applying to 'principal' equity method investees broadly—this inference, while reasonable, slightly extends beyond the explicit statement. However, since XPLR's 52.6% clearly falls within that range and the core facts are correct, this does not constitute a significant error. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 415,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total fair value of Corporate notes and obligations as reported in the fair value hierarchy table, and how does this compare to their amortized cost in terms of unrealized losses?",
      "original_answer": "The total fair value of Corporate notes and obligations is $3,354 million as reported in the fair value hierarchy table. This is $92 million less than their amortized cost of $3,442 million, indicating an unrealized loss of $92 million.",
      "llm_answer": "\n\nThe total fair value of Corporate notes and obligations as reported in the fair value hierarchy table is **$2,978 million** as of January 31, 2024. This fair value is **$45 million lower** than their amortized cost of $3,014 million, reflecting unrealized losses of $45 million for the period. \n\nIn comparison, as of January 31, 2023, the fair value was $3,354 million (amortized cost: $3,442 million), with unrealized losses of $92 million, indicating a larger decline in fair value relative to amortized cost in the prior year.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the key numbers. The ground truth states that the total fair value of Corporate notes and obligations is $3,354 million with an amortized cost of $3,442 million, resulting in an unrealized loss of $92 million. However, the LLM reports a fair value of $2,978 million and amortized cost of $3,014 million, yielding a $45 million unrealized loss — all of which are incorrect for the current period in question. The LLM appears to have used data from a different time period (possibly 2024) not referenced in the original question or ground truth. (2) While the LLM correctly calculates the difference between fair value and amortized cost as an unrealized loss (e.g., $3,014M - $2,978M = $36M, though stated as $45M — even this internal calculation is inconsistent), the core numbers do not match the ground truth. The mention of $3,354 million and $3,442 million aligns with the ground truth but is incorrectly presented as prior-year (2023) data rather than the current value being asked for. (3) The multi-hop reasoning is partially sound — the model understands it needs to extract fair value and amortized cost, compute the difference, and interpret it as an unrealized loss. It also attempts comparative analysis across years, which shows good qualitative intent, but fails in entity and time-period alignment. (4) The contextual relevance is high because the structure and intent of the answer match the question, and it addresses both parts: total fair value and comparison to amortized cost. However, due to major quantitative errors in the primary data, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate due to correct reasoning framework but incorrect data sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 487,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total number of locomotives operated by UNP in 2024, and how does the combination of owned and leased locomotives contribute to this figure?",
      "original_answer": "The total number of locomotives operated by UNP in 2024 is 7,026. This total is derived from 6,106 owned locomotives and 920 leased locomotives.",
      "llm_answer": "\n\nThe total number of locomotives operated by Union Pacific Railroad (UNP) in 2024 was **7,026**, comprising **6,106 owned locomotives** and **920 leased locomotives**. This figure is derived directly from the breakdown in the \"RAIL EQUIPMENT\" section of the 10-K filing, where owned and leased locomotives are aggregated to reflect the total operational fleet. Owned locomotives constitute the majority (87%), while leased units account for 13% of the total.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total number of locomotives (7,026), owned (6,106), and leased (920) figures are exactly correct. (2) Quantitative accuracy is perfect — the sum of 6,106 + 920 equals 7,026, and the percentages (87% owned, 13% leased) are correctly calculated approximations. (3) The reasoning is sound and reflects proper synthesis from the 10-K filing, correctly identifying that the total operational fleet is the sum of owned and leased units. (4) The answer addresses both parts of the question: the total number and the contribution of owned vs. leased locomotives. Semantic equivalence is maintained with added contextual clarity (percentages), which enhances understanding without introducing error. All entities (UNP, 2024, locomotives) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 252,
        "total_tokens": 1404
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the net change in the value of Brands/Tradenames for LIN in 2024, and how did foreign currency translation and amortization expense specifically contribute to this change?",
      "original_answer": "The net value of Brands/Tradenames for LIN decreased from $2,609 million in 2023 to $2,239 million in 2024, a reduction of $370 million. This decrease was primarily driven by a foreign currency translation reduction of $107 million and an amortization expense of $36 million. Together, these two factors contributed a total decline of $143 million, which is more than the total additions (which were $0 million) and partially offset by a small positive adjustment of $4 million under 'Other'.",
      "llm_answer": "\n\nThe net change in the value of Brands/Tradenames for Linde (LIN) in 2024 was a decrease of **$137 million** (from $2,376 million in 2023 to $2,239 million in 2024). Foreign currency translation contributed **$112 million** to this decline, primarily due to a $107 million reduction in the asset’s cost and a $5 million increase in accumulated amortization from currency effects. Amortization expense further reduced the net value by **$36 million** through increased accumulated amortization. Together, these factors accounted for the majority of the net decrease.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. It reports the 2023 value as $2,376 million, whereas the ground truth states $2,609 million. This leads to an incorrect net change of $137 million instead of the correct $370 million reduction. The foreign currency translation is reported as $112 million (attributed to $107M in cost reduction and $5M in amortization), but the ground truth specifies a direct $107 million reduction from foreign currency translation, not $112 million. While the amortization expense of $36 million is correct, the LLM incorrectly frames the foreign currency impact as split across cost and amortization without supporting evidence from the original answer. (2) Calculations are flawed: $2,376M to $2,239M is indeed a $137M drop, but this is based on incorrect starting values. The correct drop is $2,609M to $2,239M = $370M. The LLM also fails to mention that additions were $0 and there was a $4M positive 'Other' adjustment, which are important for completeness. (3) The multi-hop reasoning is partially sound—LLM correctly identifies that foreign exchange and amortization reduce the net value and attempts to break down components—but it misattributes the magnitude and structure of the foreign currency effect, undermining the synthesis. (4) Scores reflect major quantitative errors (especially the net change and initial value), partial qualitative accuracy in identifying relevant factors, and high contextual relevance as it addresses the right entities and general direction of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 430,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities at the end of 2021 and how did it compare to the previous year in terms of dollar value change?",
      "original_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities was $1,023 million at the end of 2021. This represents a decrease of $19 million compared to the previous year's value of $1,042 million.",
      "llm_answer": "\n\nThe total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities (i.e., its own long-term debt) at the end of 2021 was **$40,311 million**, compared to **$43,218 million** at the end of 2020. This represents a **decrease of $2,907 million** over the period. The figures are derived from the fair value disclosures of long-term debt in the \"Other Fair Value Disclosures\" section of the 10-K filing.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both magnitude and reasoning. (1) The reported fair value of Coca-Cola's Corporate Bonds and Debt Securities at the end of 2021 is stated as $40,311 million, which is drastically different from the ground truth of $1,023 million. Similarly, the 2020 value is reported as $43,218 million versus the correct $1,042 million. These numbers are off by an order of magnitude, suggesting confusion between total long-term debt and the specific subset of Corporate Bonds and Debt Securities. (2) The calculated dollar change is $2,907 million decrease, whereas the correct change is a $19 million decrease. This large discrepancy confirms a failure in quantitative accuracy. (3) The multi-hop reasoning is flawed: the model likely extracted the total fair value of long-term debt (which includes various instruments) instead of isolating Corporate Bonds and Debt Securities, which are a specific component. The original answer refers to a much smaller portfolio of securities, not the company's total debt obligations. (4) While the answer addresses the structure of the question (value in 2021, comparison to 2020, dollar change), it does so with entirely incorrect data, making it contextually relevant in format but not in substance. The citation to 'Other Fair Value Disclosures' may be accurate in location, but the interpretation of the data is wrong. Thus, the correctness score is very low due to complete factual inaccuracy despite proper framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 409,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program, and why are these units not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023?",
      "original_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is $42.5 million. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because, although LTIP units are potentially dilutive securities, they have not yet met the performance conditions necessary to be considered earned, and no securities had a material dilutive effect during the reporting period.",
      "llm_answer": "\n\nThe maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is **$42.5 million**, as stated in the 2023 LTI Program description. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because their vesting is contingent on future performance conditions (e.g., FFO and objective criteria goals) and a market condition (TSR modifier) that have not yet been satisfied. Since the awards are not yet probable of being earned (with the measurement period ending in 2026), they are excluded from diluted earnings per share calculations for 2023. Additionally, the compensation expense for these awards is being amortized over the three-year performance period, but no dilutive shares are recognized until the awards are earned and vest.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns with the ground truth. (1) The maximum potential fair value at grant date is accurately stated as $42.5 million, matching the original answer. (2) The explanation for why these units are not reflected as a material dilutive effect is comprehensive and factually sound: the performance and market conditions (e.g., FFO goals, TSR modifier) have not been satisfied, and the measurement period extends to 2026, making the awards not probable of being earned as of December 31, 2023. This correctly explains their exclusion from diluted EPS calculations. (3) The multi-hop reasoning is strong—synthesizing the grant date fair value, vesting conditions, performance period, and accounting treatment for dilutive securities. (4) The answer adds contextual detail (e.g., three-year performance period, amortization of compensation expense) that enhances accuracy without introducing error. All entities (2023 LTI Program, LTIP units, net income attributable to common stockholders, December 31, 2023) are correctly identified and used. Minor wording differences do not affect semantic equivalence; in fact, the LLM provides a more detailed and equally accurate rationale.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 338,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the difference between the amortized cost and fair value of Covered Bonds held by CRM in 2023, and what is the unrealized loss on these bonds?",
      "original_answer": "The amortized cost of Covered Bonds held by CRM in 2023 is $105 million, while the fair value is $101 million, resulting in an unrealized loss of $4 million.",
      "llm_answer": "\n\nThe difference between the amortized cost and fair value of Covered Bonds held by CRM in 2023 is **$4 million** ($105 million amortized cost minus $101 million fair value). The unrealized loss on these bonds is also **$4 million**, as explicitly stated in the \"Unrealized Losses\" column for 2023. \n\n(Source: \"Marketable Securities\" table under \"3. Investments\" for January 31, 2023.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the amortized cost ($105 million), fair value ($101 million), and unrealized loss ($4 million) are correctly reported. (2) The calculation of the difference ($105M - $101M = $4M) is accurate and aligns with the definition of unrealized loss. (3) The reasoning is sound and reflects proper multi-hop synthesis—linking the amortized cost and fair value to compute the unrealized loss, and confirming it with the reported 'Unrealized Losses' column. (4) The entities—CRM, Covered Bonds, and the year 2023—are correctly identified. The answer is semantically equivalent to the original, with clear, precise, and relevant explanation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 235,
        "total_tokens": 1372
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What percentage of Union Pacific's Multiple Purpose locomotives are leased rather than owned, and how does this compare to the proportion of leased locomotives in the 'Switching' and 'Other' categories combined?",
      "original_answer": "13.35% of Union Pacific's Multiple Purpose locomotives are leased. Since there are no leased locomotives in the 'Switching' and 'Other' categories, the percentage of leased locomotives in these categories combined is 0%.",
      "llm_answer": "\n\nUnion Pacific's Multiple Purpose locomotives have 920 leased units out of 6,893 total, representing **13.3%** leased (920 ÷ 6,893). In contrast, the 'Switching' and 'Other' categories combined have **0%** leased locomotives, as both categories are entirely owned (122 Switching + 11 Other = 133 total, all owned). Thus, the proportion of leased locomotives is significantly higher in the Multiple Purpose category compared to the combined Switching and Other categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth. (1) The percentage of leased Multiple Purpose locomotives is correctly calculated as 13.3% (920 ÷ 6,893 ≈ 0.13345, which rounds to 13.3%), while the ground truth states 13.35%. This minor difference is due to rounding and does not affect factual correctness—both values are acceptably close. (2) The answer correctly identifies that there are no leased locomotives in the 'Switching' and 'Other' categories, accurately stating the combined leased percentage as 0%, matching the ground truth. (3) The multi-hop reasoning is sound: it correctly separates locomotive categories, aggregates Switching and Other, and compares leasing proportions across categories. (4) All entities (Union Pacific, Multiple Purpose, Switching, Other) are correctly identified, and the response addresses both parts of the question. The only minor issue is the rounding of 13.35% to 13.3%, which is acceptable in most contexts but slightly less precise. Hence, full marks are justified except for a small deduction in quantitative accuracy due to rounding precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 319,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "By how much did the combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 increase compared to the end of 2020, and what was the total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023?",
      "original_answer": "The natural gas liquids (NGLs) volume in the Lower 48 increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, a difference of 567 million barrels. In 2023, the total depreciation, depletion, amortization, and impairments for the Lower 48 was $5,729 million.",
      "llm_answer": "\n\nThe combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 was **797 million barrels**, compared to **230 million barrels** at the end of 2020, reflecting an **increase of 567 million barrels**. The total depreciation, depletion, amortization, and impairments (DD&A) for the Lower 48 in 2023 amounted to **$5,729 million**. \n\nThese figures are derived from the \"Natural Gas Liquids\" tables (showing developed and undeveloped reserves) and the \"Depreciation, Depletion, Amortization and Impairments\" section in the segment disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the NGLs volume increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, resulting in an increase of 567 million barrels (797 - 230 = 567), which is correctly calculated. The total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023 is accurately reported as $5,729 million. (2) Quantitative accuracy is perfect—numbers, dates, and calculations are correct, with acceptable formatting (e.g., $5,729 million). (3) The multi-hop reasoning is sound: the model correctly synthesized data across time periods (2020 to 2023) and across different financial and operational metrics (volumes and DD&A), demonstrating proper integration of information from distinct parts of the filings. (4) The answer is semantically equivalent to the original, includes all required components, and adds minor contextual sourcing without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 303,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How much total cash did Walmart spend in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation, and what was the subsequent financial treatment of Alert Innovation in fiscal 2025 as reflected in the consolidated financial statements?",
      "original_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation ($0.4 billion for each). Alert Innovation was subsequently sold and deconsolidated in fiscal 2025.",
      "llm_answer": "\n\nWalmart spent a total of **$0.8 billion** in fiscal 2023 to acquire full ownership of Massmart ($0.4 billion) and Alert Innovation ($0.4 billion). In fiscal 2025, Alert Innovation was **sold and deconsolidated**, meaning it was no longer included in Walmart’s consolidated financial statements following the transaction. \n\n(Source: \"Purchase and Sale of Subsidiary Stock\" section in the document, specifically the fiscal 2023 and 2025 disclosures.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total cash spent ($0.8 billion), broken down into $0.4 billion for Massmart and $0.4 billion for Alert Innovation, is accurate and matches the original answer. The fiscal years (2023 for acquisition, 2025 for deconsolidation) are correctly stated. (2) The answer is complete, addressing both parts of the question: the total acquisition cost in fiscal 2023 and the subsequent financial treatment of Alert Innovation in fiscal 2025. (3) Entity accuracy is perfect—Walmart, Massmart, and Alert Innovation are correctly identified, and the financial events are attributed to the correct fiscal years. (4) The reasoning is sound: the model correctly synthesizes that Walmart acquired full ownership of two entities in 2023 with equal $0.4 billion payments, totaling $0.8 billion, and that Alert Innovation was later sold and deconsolidated in 2025, which aligns with proper financial reporting treatment. The mention of deconsolidation correctly reflects that the subsidiary was removed from the consolidated financial statements. Semantic equivalence is maintained, with clear, precise wording that conveys the same factual content as the ground truth. Minor formatting (bold text) does not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 363,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total revenue generated from Metals & minerals shipments for UNP in 2021, combining the number of carloads with the average revenue per car for that category?",
      "original_answer": "$1,810,806,000",
      "llm_answer": "\n\nThe total revenue from Metals & Minerals shipments in 2021 was calculated by multiplying **697,000 carloads** (from the \"Revenue Carloads\" table) by the **average revenue per car of $2,598** (from the \"Average Revenue per Car\" table). This results in **$1,810.8 million** (697,000 × $2,598). The reported freight revenue for Metals & Minerals in the 2021 table is **$1,811 million**, which aligns closely with this calculation, accounting for rounding differences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key numbers: 697,000 carloads and $2,598 average revenue per car, both of which are accurate for UNP's 2021 Metals & Minerals shipments. The multiplication (697,000 × $2,598) yields $1,810,806,000, which matches the ground truth exactly. The LLM reports this as $1,810.8 million, a valid rounding and format variation. It further notes alignment with the reported $1,811 million, acknowledging minor rounding—this adds contextual accuracy. (2) All numeric values are correct and calculations are accurate. The final value is within rounding tolerance of the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two separate tables (carloads and average revenue per car), performs the necessary calculation, and validates against reported revenue—demonstrating strong qualitative reasoning. (4) The answer is fully relevant, addressing the exact question with correct entities (UNP, 2021, Metals & Minerals, revenue calculation). The only minor deduction is for not explicitly stating the exact dollar figure $1,810,806,000, instead using rounded forms, but this does not affect correctness due to semantic equivalence in financial reporting contexts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 350,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization, and how does this compare to the amount of the Series 2013-2A Securities that were repaid in March 2023?",
      "original_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization is $1.3 billion. This matches the amount of the Series 2013-2A Securities that were repaid in March 2023, indicating a direct refinancing of the older securities with the new issuance.",
      "llm_answer": "\n\nThe total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization was **$1.3 billion**. This amount is **equal** to the **$1.3 billion** aggregate principal amount of the Series 2013-2A Securities that were repaid in March 2023. \n\n(Source: Document pages detail the 2023 Securitization issuance of $1.3 billion in Series 2023-1A Securities and the repayment of the full $1.3 billion outstanding under the Series 2013-2A Securities in March 2023.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1.3 billion principal amount for both the Series 2023-1A Securities and the repaid Series 2013-2A Securities is accurately reported, with no discrepancies in numbers or dates. The comparison correctly states that the amounts are equal. (2) The answer is complete, addressing both parts of the question: the amount issued in 2023 and the amount repaid in March 2023. (3) Entity accuracy is correct—both security series (2023-1A and 2013-2A), the year of securitization (2023), and the repayment timing (March 2023) are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that the issuance and repayment amounts being equal suggests a refinancing, which aligns with the ground truth's interpretation. The semantic meaning is equivalent to the original answer, with clear, precise wording and proper contextual support. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 292,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the facility's total borrowing capacity?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. This compares to a total borrowing capacity of $6.0 billion under the facility as of December 31, 2023.",
      "llm_answer": "\n\nDuring the year ended December 31, 2023, American Tower Corporation borrowed **$3.0 billion** and repaid **$6.1 billion** (including €842.6 million, equivalent to $919.1 million at repayment) under the 2021 Multicurrency Credit Facility. The facility’s total borrowing capacity as of December 31, 2023, was **$6.0 billion**, with an outstanding principal balance of **$723.4 million** at year-end. Thus, while repayments during the year exceeded the facility’s capacity (due to revolving nature and multiple drawdowns/repayments), the outstanding balance at year-end remained well below the $6.0 billion limit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that $3.0 billion was borrowed and $6.1 billion was repaid during the year ended December 31, 2023, under the 2021 Multicurrency Credit Facility, matching the ground truth exactly. The total borrowing capacity of $6.0 billion is also accurately reported. (2) All numeric values are correct: $3.0 billion borrowed, $6.1 billion repaid (including the €842.6 million converted to $919.1 million, which is consistent with disclosed amounts in filings), and $6.0 billion capacity. The additional detail about the year-end outstanding balance of $723.4 million is factually accurate and provides useful context, though not requested in the question. (3) The reasoning is sound: the LLM correctly interprets the revolving nature of the facility to explain how repayments can exceed total capacity due to multiple cycles of borrowing and repayment. This demonstrates strong multi-hop synthesis and understanding of credit facility mechanics. (4) The answer exceeds the original in contextual depth without introducing errors. The only reason for not scoring a 10 is that the original answer did not include the breakdown of euro repayments or the year-end balance, so while accurate, those additions slightly extend beyond the scope of the question. However, they do not detract from correctness. All core facts are present and correctly synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 386,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "By how much did the total Intermodal revenue increase for UNP in 2021 compared to 2020, and how did this growth compare to the increase in average revenue per car for Intermodal during the same period?",
      "original_answer": "The total Intermodal revenue for UNP increased by $515 million in 2021 compared to 2020, and the average revenue per car for Intermodal increased by $136 during the same period.",
      "llm_answer": "\n\nThe total Intermodal revenue for UNP increased by **13%** in 2021 compared to 2020 (from $3,989 million to $4,504 million). The average revenue per car for Intermodal rose by **11%** during the same period (from $1,267 to $1,403). Thus, the growth in total Intermodal revenue (13%) outpaced the increase in average revenue per car (11%), reflecting a 2% rise in Intermodal carloads (from 3,149 thousand to 3,211 thousand).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides percentage changes and absolute revenue values not present in the ground truth, but fails to report the actual dollar increase in total Intermodal revenue ($515 million) and the exact increase in average revenue per car ($136), which are the core requirements of the question. Instead, it reports percentage increases (13% and 11%) and derived figures (e.g., average revenue per car rising from $1,267 to $1,403), which are not confirmed by the ground truth. (2) While the LLM's calculation of a $515 million revenue increase (from $3,989M to $4,504M) is mathematically correct (4,504 - 3,989 = 515), this specific dollar figure aligns with the ground truth by coincidence, but the method differs — the ground truth directly states the $515M increase without providing base values. However, the $136 increase in average revenue per car is misrepresented: the LLM calculates 1,403 - 1,267 = 136, which matches numerically, but the ground truth does not confirm these base values or the metric being reported in those terms. (3) The multi-hop reasoning is logically sound — the model infers that revenue growth outpaced per-unit growth, implying volume growth — but this level of analysis goes beyond the original answer, which only states the two absolute increases. While insightful, it introduces unverified intermediate data. (4) The contextual relevance is high because the answer addresses both parts of the question and adds useful context. However, the quantitative accuracy is low because the answer relies on unstated assumptions (the base revenue and per-car values) not found in the ground truth, even if the final differences align. Thus, the correctness score is moderate due to alignment on the $515M and implied $136 figures, but penalized for introducing unverified granular data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 497,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021, and how does this compare to the net gain or loss reported from operations in the same region for the same year?",
      "original_answer": "The total capital expenditure in the EMENA region in 2021 was $534 million, while the net loss reported from operations in the same region was $24 million. This indicates that despite significant investment in the region, operations resulted in a net loss.",
      "llm_answer": "\n\nThe total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021 was **$534 million**. For the same year, the EMENA region reported a **net gain of $24 million** from operations, primarily due to decreased asset retirement obligation (ARO) estimates on fields in Norway. Thus, the capital expenditure ($534 million) significantly exceeded the net operational gain ($24 million) in the region. \n\nSource: Capital expenditures are detailed in the \"Capital Requirements\" section (table under \"Capital Program\"), and the net gain is derived from the \"Note 7—Impairments\" section (2021 EMENA credit of $24 million).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the capital expenditure amount ($534 million) and the year (2021), which matches the ground truth. However, it incorrectly states that the EMENA region reported a 'net gain of $24 million' from operations, while the original answer clearly states a 'net loss of $24 million.' This is a critical factual error that reverses the financial outcome. (2) The quantitative accuracy is partially correct: $534 million in capital expenditures is accurate, but the $24 million figure is mischaracterized as a gain instead of a loss. The source cited (Note 7—Impairments) mentioning a 'credit of $224 million' may have been misinterpreted; a credit in impairment context does not equate to a net operational gain. (3) The multi-hop reasoning is flawed: while the model attempts to synthesize data from different sections of the filing, it fails to correctly interpret the nature of the $24 million item. The original answer indicates a net loss, meaning expenses exceeded revenues, despite the impairment credit. The LLM incorrectly concludes a net gain, likely due to misreading the financial statement impact. (4) Contextual relevance is high—the answer addresses both parts of the question, cites appropriate sections, and discusses the comparison. However, the reversal of loss to gain severely undermines factual correctness, warranting a moderate score of 4 for overall correctness, 5 for quantitative and qualitative accuracy due to partial data correctness but major interpretation error, and 9 for relevance as the structure and intent align well with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 440,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Microsoft position Copilot Pro within its AI-driven productivity strategy as described in its strategic ambitions, and in which specific revenue category is Copilot Pro classified in the financial reporting?",
      "original_answer": "Microsoft positions Copilot Pro as a consumer subscription service that offers faster and more powerful AI assistance in Microsoft 365 apps and on the web, aligning with its ambition to reinvent productivity and business processes. In the financial reporting, Copilot Pro is classified under 'Office Consumer products and cloud services revenue,' which includes Microsoft 365 Consumer and Copilot Pro subscriptions, Office licensed on-premises, and other Office services.",
      "llm_answer": "\n\nMicrosoft positions **Copilot Pro** as a consumer subscription service that enhances productivity by providing \"faster and more powerful AI assistance in Microsoft 365 apps and on the web,\" aligning with its ambition to \"reinvent productivity and business processes\" through AI-driven tools. In financial reporting, Copilot Pro is classified under the **Office Consumer products and cloud services revenue growth** category within the **Productivity and Business Processes** segment, as explicitly stated in the document's segment results and revenue breakdowns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Microsoft's positioning of Copilot Pro as a consumer subscription service offering faster and more powerful AI assistance in Microsoft 365 apps and on the web, which supports the strategic ambition to reinvent productivity and business processes—this matches the original answer verbatim in substance. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised. (3) The classification of Copilot Pro in financial reporting is stated as 'Office Consumer products and cloud services revenue growth'—this is semantically equivalent to the ground truth's 'Office Consumer products and cloud services revenue.' The slight addition of 'growth' may reflect phrasing from the source document and does not distort meaning. The mention of the broader 'Productivity and Business Processes' segment adds contextual clarity and is consistent with Microsoft’s segment reporting structure, even if not explicitly required. (4) The reasoning is sound, and the multi-hop synthesis—linking strategic ambition with financial categorization—is correctly executed. The answer is fully relevant and conveys the same information as the original, with only minor, inconsequential wording differences. Hence, a score of 9 is appropriate—excellent but not perfect due to slight imprecision in the revenue category label.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 405,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment, and how was this increase determined based on the Nasdaq stock price movement?",
      "original_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan was 128,000. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan in response to the 2024 special dividend, which was calculated using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the Nasdaq opening price of $662.70 on December 27, 2023 (the ex-dividend date), resulting in an adjustment factor of 1.018.",
      "llm_answer": "\n\nThe total increase in RSU shares available under the 2019 Incentive Plan due to the 2024 special dividend adjustment was **128,000 shares**. This increase was determined by applying a **1.018 adjustment factor**, calculated as the ratio of the Nasdaq closing price ($674.62) on the day before the ex-dividend date (December 26, 2023) to the opening price ($662.70) on the ex-dividend date (December 27, 2023). The adjustment proportionally increased the maximum shares issuable under the plan to preserve the value of outstanding RSUs after the special dividend.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the increase of 128,000 RSU shares, the Nasdaq closing price of $674.62 on December 26, 2023, the opening price of $662.70 on December 27, 2023 (ex-dividend date), and the resulting adjustment factor of 1.018 are all correctly stated. The calculation of the adjustment factor (674.62 / 662.70 ≈ 1.018) is accurate. (2) The answer is complete, addressing both parts of the question: the total increase in shares and how it was determined based on Nasdaq stock price movement. (3) Entity accuracy is correct: the 2019 Incentive Plan, 2024 special dividend, and relevant dates and prices are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it explains that the adjustment was applied proportionally to preserve the value of RSUs post-dividend, linking the stock price movement to the adjustment mechanism. (5) The semantic meaning is equivalent to the original answer, with clear, concise restatement without loss of factual content. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 321,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the headwinds from PFAS manufactured products quantitatively affect the 2024 sales performance of 3M's Transportation and Electronics segment when comparing reported sales to non-GAAP adjusted sales?",
      "original_answer": "The headwinds from PFAS manufactured products caused a 4.5 percentage point difference in the 2024 sales performance of 3M's Transportation and Electronics segment. Reported sales decreased by 1.4%, but when adjusted for PFAS-related special items, sales increased by 3.1%. This implies that the PFAS-related headwinds reduced sales growth by 4.5 percentage points (from +3.1% to -1.4%).",
      "llm_answer": "\n\nThe headwinds from PFAS manufactured products quantitatively reduced the Transportation and Electronics segment's 2024 sales performance by $945 million, as reflected in the difference between reported sales ($8.38 billion) and non-GAAP adjusted sales ($7.435 billion). This adjustment excluded PFAS-related sales, which negatively impacted the segment's reported growth, dragging the sales change from a -1.4% decline (GAAP) to a 3.1% increase (non-GAAP), representing a 4.5 percentage point drag on growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in dollar amounts and misrepresents the relationship between reported and adjusted sales. The ground truth states that PFAS headwinds caused a 4.5 percentage point reduction in sales growth (from +3.1% non-GAAP to -1.4% reported), but the LLM incorrectly introduces absolute sales figures of $8.38 billion (reported) and $7.435 billion (adjusted), which are not in the original answer and contradict the implied direction of adjustment. Adjusted sales should be higher than reported if PFAS items are excluded as headwinds, but the LLM shows adjusted sales as lower, which is illogical. (2) The calculation of a 4.5 percentage point drag is correctly stated and matches the ground truth, which is a key quantitative element. However, the $945 million difference is fabricated and not supported by the original answer, which does not provide any dollar amounts. This severely undermines quantitative accuracy. (3) The reasoning partially captures the multi-hop nature of the question—linking PFAS headwinds to the difference between GAAP and non-GAAP sales performance—but fails in financial logic by reversing the magnitude and direction of the adjustment. The model correctly identifies the segment and year and understands that non-GAAP adjustments remove PFAS impacts, but misapplies the numerical implications. (4) Contextual relevance is high because the answer addresses the right segment, company, year, and concept (PFAS impact on sales via GAAP vs non-GAAP). However, the incorrect dollar figures and misstated sales values result in a low correctness and quantitative accuracy score despite capturing the 4.5 percentage point effect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 466,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the total recognized gain on equity method investment contracts in 2021, and what was the fair value of these contracts as of December 31, 2021?",
      "original_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31, 2021, was $(3) million.",
      "llm_answer": "\n\nThe total recognized gain on equity method investment contracts in 2021 was **$2 million**, as disclosed in the \"Economic Hedges\" section under pre-tax gains/losses recorded in net earnings. The fair value of these contracts as of December 31, 2021, was **$(3) million (liability)**, based on the \"Fair values of derivative instruments\" table under Level 2 inputs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the recognized gain of $2 million in 2021 and the fair value of $(3) million as of December 31, 2021, are accurately reported with correct signs and units. The negative fair value correctly indicates a liability, which aligns with the ground truth's $(3) million. (2) The answer is complete, addressing both parts of the question: the total gain in 2021 and the fair value at year-end. (3) Entity and metric accuracy is sound—'equity method investment contracts' are correctly identified, and the years (2021 and December 31, 2021) are precise. (4) The reasoning is strong, with appropriate references to the 'Economic Hedges' section and 'Fair values of derivative instruments' table under Level 2 inputs, indicating correct synthesis from relevant sections of the filing. The additional context about where the data was sourced enhances credibility without introducing error. Semantic equivalence is maintained, and all information matches the original answer exactly in meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 306,
        "total_tokens": 1441
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does Abbott Laboratories' use of interest rate hedge contracts with a total notional value of $2.2 billion as of December 31, 2024, impact the fair value of its long-term debt, which stood at $13.7 billion on that date?",
      "original_answer": "Abbott Laboratories uses interest rate hedge contracts totaling $2.2 billion to convert fixed-rate debt into variable-rate debt, directly affecting the fair value of its long-term debt. This hedging strategy reduces the volatility in the fair value of the $13.7 billion long-term debt caused by changes in long-term benchmark interest rates. Without these hedges, the fair value of the debt would fluctuate more significantly with market interest rate changes, potentially impacting Abbott's financial position and earnings.",
      "llm_answer": "\n\nAbbott Laboratories uses interest rate hedge contracts with a notional value of $2.2 billion to manage its exposure to interest rate fluctuations on fixed-rate debt. These contracts are designated as **fair value hedges**, converting a portion of fixed-rate debt to variable-rate debt. By doing so, changes in the fair value of the hedged debt caused by benchmark interest rate movements are offset by inverse changes in the fair value of the derivative contracts. \n\nAs of December 31, 2024, the **fair value of Abbott’s long-term debt was $13.7 billion**, reflecting adjustments from these hedges. The hedging strategy ensures that the debt’s reported fair value accounts for interest rate risks, stabilizing the net exposure. Specifically, the $2.2 billion in hedges reduces volatility in the debt’s fair value by economically converting fixed-rate obligations to variable rates, aligning the debt’s value with prevailing market rates. This offsetting mechanism is explicitly described in Note 12, which states that hedged debt is marked to market with adjustments to the carrying amount of the debt. Thus, the $13.7 billion fair value incorporates the impact of these hedging activities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately stated: the $2.2 billion notional value of interest rate hedges and the $13.7 billion fair value of long-term debt as of December 31, 2024, match the original answer exactly. Number formats are consistent and precise. (2) The explanation correctly identifies that Abbott uses fair value hedges to convert fixed-rate debt to variable-rate debt, which directly reduces the volatility in the fair value of its long-term debt due to interest rate changes. This aligns with the ground truth's claim that the hedges stabilize the debt’s fair value. (3) The multi-hop reasoning is sound: the model connects the use of hedges with their accounting treatment (fair value hedges), explains the offsetting mechanism between debt and derivative values, and correctly references the impact on the reported fair value of debt. The mention of Note 12 adds contextual support, demonstrating synthesis of detailed financial reporting knowledge. (4) The answer is contextually rich, complete, and directly addresses how the hedges impact the fair value of debt—answering both the quantitative and qualitative aspects of the question. Minor wording differences (e.g., 'reduces volatility' vs 'stabilizing the net exposure') do not affect factual equivalence. No errors in entities, dates, or financial concepts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 388,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the total oil-equivalent proved reserves (in million barrels) for equity companies in Asia, and how does this compare to the total proved reserves for consolidated subsidiaries in Asia, based on the data from ExxonMobil's 2024 10-K filing?",
      "original_answer": "The total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 2,286 million barrels. This means that the consolidated subsidiaries in Asia hold approximately 1.8 times more oil-equivalent reserves than the equity companies in the same region.",
      "llm_answer": "\n\nThe total oil-equivalent proved reserves for equity companies in Asia, as reported in ExxonMobil's 2024 10-K filing, are **1,276 million barrels (developed)** and **1,503 million barrels (undeveloped)**, summing to **2,779 million barrels**. For consolidated subsidiaries in Asia, the reserves are **2,286 million barrels (developed)** and **1,315 million barrels (undeveloped)**, totaling **3,601 million barrels**. Thus, equity companies in Asia hold approximately **2,779 million barrels**, which is **lower** than the **3,601 million barrels** held by consolidated subsidiaries in the same region.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and calculations. The original answer states that equity companies in Asia have 1,276 million barrels of oil-equivalent proved reserves, while the LLM incorrectly reports this as a sum of developed (1,276M) and undeveloped (1,503M) reserves, totaling 2,779M. This is a critical error—1,276M is the total proved reserves for equity companies, not just developed. Similarly, for consolidated subsidiaries, the original answer gives 2,286 million barrels as the total, but the LLM incorrectly adds 2,286M (developed) and 1,315M (undeveloped) to reach 3,601M, again misrepresenting the total. The correct totals are 1,276M (equity) and 2,286M (consolidated), not the inflated figures provided. (2) The comparison in the LLM answer—that equity companies hold less than consolidated—is technically correct in direction but based on wrong magnitudes. The correct ratio is ~1.8x (2,286 / 1,276), but the LLM’s implied ratio (~1.3x) is inaccurate due to incorrect totals. (3) The multi-hop reasoning fails because the model misinterprets the structure of the data: it treats the 1,276M and 2,286M as developed reserves only, when in fact those are the total proved reserves for each category as reported in the filing. There is no indication in the original answer that these numbers are broken down into developed/undeveloped components. (4) The contextual relevance is high—the answer addresses the right region (Asia), entities (equity companies vs. consolidated subsidiaries), and metric (oil-equivalent proved reserves). However, the quantitative inaccuracy severely undermines the correctness. Despite correct sourcing context, the factual and calculation errors result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 480,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the Swiss Tax Reform impact Mondelēz International's effective tax rate in 2019, and what was the net financial benefit recorded in that year as a result of this reform?",
      "original_answer": "The Swiss Tax Reform reduced Mondelēz International's effective tax rate in 2019 by 22.3 percentage points, contributing to a net financial benefit of $767 million recorded during that year.",
      "llm_answer": "\n\nThe Swiss Tax Reform in 2019 resulted in a **net financial benefit of $767 million** for Mondelēz International, primarily from a $769 million reduction in deferred tax expense due to a step-up of intangible assets and remeasurement of deferred tax balances, partially offset by a $2 million indirect tax impact. This one-time benefit caused the company’s **effective tax rate for 2019 to drop to 0.1%**, significantly lower than the normalized rate of 22.4% excluding this impact. The reform’s ongoing effects became effective January 1, 2020.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net financial benefit as $767 million, matching the ground truth. It also accurately describes the impact on the effective tax rate by stating it dropped to 0.1% in 2019, which reflects a reduction of approximately 22.3 percentage points from the normalized rate of 22.4%, aligning with the ground truth's claim of a 22.3 percentage point reduction. The breakdown of the benefit ($769M reduction in deferred tax expense minus $2M indirect tax impact) is consistent with the net $767M benefit. (2) All numeric values—$767 million net benefit, $769 million deferred tax reduction, $2 million offset, 0.1% effective tax rate, and 22.4% normalized rate—are factually correct and support the conclusion. The calculation 769 - 2 = 767 is accurate. (3) The multi-hop reasoning is sound: the model synthesizes the effect of the Swiss Tax Reform on deferred taxes, intangible asset revaluation, and the resulting impact on the effective tax rate. It correctly attributes the rate drop to the one-time benefit and notes that ongoing effects began in 2020, which adds context beyond the question but does not contradict it. (4) The only minor deviation from the original answer is that the LLM expresses the tax rate impact indirectly (by stating the resulting rate and normalized rate) rather than explicitly saying 'reduced by 22.3 percentage points,' though the quantitative implication is identical. This does not affect factual accuracy but slightly reduces qualitative precision. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 438,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What was the total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG?",
      "original_answer": "The total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG was $665 million.",
      "llm_answer": "\n\nThe total financial impact on PepsiCo in 2022 from the pension obligation transfer to TBG and the gain from remeasuring its 39% ownership stake in TBG was a net gain of **$375 million**. This includes a **$145 million outflow** related to transferring pension and retiree medical obligations to TBG (as disclosed in Note 7) and a **$520 million pre-tax gain** recognized from remeasuring the 39% ownership stake at fair value (as detailed in Note 13). The net effect combines these two components.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final result. The ground truth states the total financial impact was $665 million, but the LLM reports a net gain of $375 million, which is significantly off. While the LLM identifies two components—$145 million outflow and $520 million gain—their sum ($520M - $145M = $375M) contradicts the correct total of $665 million. This indicates a critical error in either the component values or the logic of combination. (2) Quantitatively, the $520 million gain and $145 million outflow do not align with the ground truth; the correct figures should sum to $665 million, suggesting that at least one of these numbers is inaccurate or misattributed. There is no indication in the original answer that these specific sub-components exist, and their presence in the LLM response appears fabricated or misextracted. (3) The reasoning is partially sound in structure—attempting to net an outflow against a gain—but fails in multi-hop synthesis because it does not reflect the actual reported total from the correct documents. The model introduces specific footnote references (Note 7, Note 13) not present in the original answer, raising concerns about hallucination. (4) Despite incorrect numbers and flawed calculation, the answer is contextually relevant: it addresses the right entities (PepsiCo, TBG, pension transfer, remeasurement gain), time frame (2022), and financial concepts. However, the severe quantitative discrepancy results in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 419,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total amount of sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and how does this compare to the accrued but unpaid sales-based milestone payments as of December 31, 2021?",
      "original_answer": "Merck made $200 million in sales-based milestone payments to Eisai for Lenvima in 2021. As of December 31, 2021, $600 million in sales-based milestone payments were accrued but not yet paid. This indicates that the accrued but unpaid amount was three times the amount paid in 2021.",
      "llm_answer": "\n\nThe total sales-based milestone payments made by Merck to Eisai for Lenvima in 2021 were **$200 million**. As of December 31, 2021, the accrued but unpaid sales-based milestone payments totaled **$600 million**, indicating that the accrued unpaid amount was three times higher than the 2021 payments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the $200 million in sales-based milestone payments made by Merck to Eisai for Lenvima in 2021 is correctly stated, and the $600 million in accrued but unpaid sales-based milestone payments as of December 31, 2021 is also correct. (2) The quantitative comparison — that the accrued unpaid amount was three times the amount paid in 2021 — is accurately conveyed. There are no calculation errors, and the numbers match the original answer exactly, with acceptable formatting (bolded for emphasis but semantically equivalent). (3) The multi-hop reasoning is sound: the model correctly synthesizes two distinct pieces of financial data (payments made in 2021 vs. accrued but unpaid as of year-end) from what would be different sections of financial disclosures. (4) Entities (Merck, Eisai, Lenvima, 2021, December 31, 2021) are correctly identified and contextualized. The answer is complete, factually precise, and semantically equivalent to the original answer, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 313,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How much cash did PepsiCo receive from the sale of the Naked brand and other juice brands to PAI Partners, and what percentage ownership interest in TBG did PepsiCo retain as part of the transaction?",
      "original_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and retained a 39% noncontrolling ownership interest in TBG.",
      "llm_answer": "\n\nPepsiCo received approximately **$3.5 billion in cash** from the sale of the Tropicana, Naked, and other select juice brands to PAI Partners in 2022 and retained a **39% noncontrolling interest** in The Beverage Group (TBG), as detailed in Note 13 to the consolidated financial statements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the cash amount of $3.5 billion and the retained ownership interest of 39% are accurately reported, with no calculation or numerical errors. Minor expansion on included brands (Tropicana, 'other select juice brands') does not contradict the original answer, which specifies 'Naked brand and other juice brands'. (2) The answer is complete, addressing both parts of the question: the cash received and the percentage ownership retained. (3) Entity accuracy is correct: PepsiCo, PAI Partners, and TBG (The Beverage Group) are properly identified, and the reference to Note 13 adds contextual support without introducing error. (4) The reasoning is sound and reflects proper multi-hop synthesis—connecting the sale transaction to the financial proceeds and retained stake. (5) Semantic equivalence is maintained: although the LLM includes slightly more detail (e.g., '2022', 'Note 13'), all added information is factually consistent with the ground truth. No inaccuracies or omissions affect the correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 312,
        "total_tokens": 1444
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does Southern Company's adoption of the fair value approach for liability-hedging securities, as opposed to the calculated value approach, affect the recognition of changes in the market value of plan assets in relation to the measurement of net periodic pension cost?",
      "original_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities results in the immediate recognition of changes in the market value of these plan assets, as opposed to amortizing these changes over five years under the calculated value approach. This change leads to a more current reflection of asset value changes in the measurement of net periodic pension cost, aligning it more closely with the changes in the related pension obligations.",
      "llm_answer": "\n\nSouthern Company's adoption of the fair value approach for liability-hedging securities, effective January 1, 2020, results in **immediate recognition of changes in the market value of these plan assets** in the expected return on plan assets component of net periodic pension cost. This contrasts with the prior calculated value approach, which amortized gains and losses over five years, smoothing returns. By using fair value for liability-hedging securities, market fluctuations in these assets directly impact the expected return calculation in the same period, increasing the volatility of net periodic pension cost and aligning it more closely with the timing of changes in related obligations. The remaining plan assets (return-seeking) still use the calculated value approach, maintaining a mix of immediate and smoothed recognition.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in both factual content and reasoning. (1) All key facts are accurate: Southern Company adopted the fair value approach for liability-hedging securities, resulting in immediate recognition of market value changes in net periodic pension cost, as opposed to the prior five-year amortization under the calculated value approach. The answer correctly notes that this leads to greater alignment with changes in pension obligations and increased volatility. (2) The date 'January 1, 2020' is an additional detail not in the original answer but does not contradict it and is contextually plausible; no numeric inaccuracies exist. The five-year amortization period is correctly stated. (3) The multi-hop reasoning is sound: the answer synthesizes the impact of the accounting method change on asset valuation, cost recognition timing, and its differential application (liability-hedging vs. return-seeking assets), demonstrating accurate understanding across concepts. (4) The LLM adds contextual clarity by specifying that only liability-hedging securities use fair value while return-seeking assets still use calculated value, which enhances completeness without deviating from the truth. Semantic equivalence is strong, with precise financial terminology and correct cause-effect logic. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 388,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total increase in Netflix's content spending from 2019 to 2021, and how did the growth in produced content compare to the growth in licensed content over this period?",
      "original_answer": "Netflix's total content spending increased by $3,014,120,000 from 2019 to 2021. During this period, produced content spending grew by $2,201,108,000, which was a significantly faster rate of growth compared to the $813,012,000 increase in licensed content spending.",
      "llm_answer": "\n\nThe total increase in Netflix's content spending from 2019 to 2021 was **$3.01 billion** (from $9.22 billion in 2019 to $12.23 billion in 2021). Produced content spending grew significantly faster than licensed content: **produced content increased by $2.20 billion (111.6%)**, while licensed content rose by **$813 million (11.2%)** over the same period. This reflects Netflix's strategic shift toward investing heavily in original content relative to licensed content.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total content spending increase is accurately reported as $3.01 billion, which aligns with the ground truth increase of $3,014,120,000 (rounded appropriately). The breakdown into produced content growth ($2.20 billion vs. $2,201,108,000) and licensed content growth ($813 million vs. $813,012,000) is precise, with only negligible rounding differences that are acceptable under format variation rules. (2) The percentages provided (111.6% for produced, 11.2% for licensed) are consistent with the growth implied by the source data, indicating correct multi-hop calculation across years and categories. (3) The reasoning correctly identifies the strategic shift toward original content, which is a valid qualitative inference supported by the disproportionate growth rates. (4) All entities—Netflix, content spending, produced vs. licensed content, and the 2019–2021 timeframe—are accurately identified and synthesized from the knowledge graph. The answer addresses both parts of the question: total spending increase and comparative growth. Semantic equivalence is maintained, with clear, concise, and factually accurate communication. No errors in logic, numbers, or synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 356,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total pre-tax impairment charge recorded by PepsiCo in 2023 related to its 39% noncontrolling interest in TBG, and how does this compare to the gain recognized in 2022 from the remeasurement of the same investment?",
      "original_answer": "PepsiCo recorded a pre-tax impairment charge of $321 million in 2023 related to its 39% noncontrolling interest in TBG. In contrast, in 2022, the company recognized a gain of $520 million from the remeasurement of this investment at fair value. This results in a net pre-tax difference of -$199 million over the two-year period.",
      "llm_answer": "\n\nIn 2023, PepsiCo recorded a **pre-tax impairment charge of $321 million** related to its 39% noncontrolling interest in TBG, driven by an other-than-temporary impairment of the investment and TBG's indefinite-lived intangible assets. This contrasts with a **$520 million pre-tax gain in 2022** from remeasuring the same investment at fair value upon the sale of its juice brands to PAI Partners. The 2022 gain reflected the initial fair value adjustment using discounted cash flows and an option pricing model, while the 2023 charge indicates a subsequent decline in TBG's value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $321 million pre-tax impairment charge in 2023 and the $520 million gain in 2022 are accurately reported, with no calculation or numerical errors. The net difference of -$199 million implied by the two values is mathematically correct (321M - 520M = -199M), though not explicitly stated, the individual figures are precise. (2) The answer addresses both parts of the question: the 2023 impairment charge and the 2022 gain from remeasurement. (3) Entity accuracy is perfect: PepsiCo, TBG, the 39% noncontrolling interest, and the relevant years (2022 and 2023) are correctly identified. (4) The reasoning is sound and enhances the answer by explaining the causes—remeasurement at fair value in 2022 using discounted cash flows and option pricing, and an other-than-temporary impairment in 2023. This demonstrates proper multi-hop synthesis across time and financial events. (5) The semantic meaning fully aligns with the original answer, with added context that improves clarity without introducing inaccuracies. All criteria for a top score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 324,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Netflix's increased investment in original programming in 2021 affect content amortization and cost of revenues as a percentage of revenue?",
      "original_answer": "Netflix's increased investment in original programming in 2021 led to a $1,423 million increase in content amortization. Despite this rise in amortization, the cost of revenues as a percentage of revenue decreased from 61% to 58%, primarily due to delays in content releases caused by the COVID-19 pandemic, which slowed the rate of amortization growth relative to revenue growth.",
      "llm_answer": "\n\nNetflix's increased investment in original programming in 2021 led to a $1.423 billion rise in content amortization (absolute terms) due to new and exclusive content. However, **cost of revenues as a percentage of revenue decreased from 61% in 2020 to 58% in 2021**. This decline occurred because revenue growth (19%) outpaced the growth in content amortization, partly due to pandemic-related delays in content releases slowing the rate of amortization relative to revenue expansion. Thus, while absolute amortization costs rose, their proportional impact on revenue was mitigated by stronger top-line growth.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1.423 billion increase in content amortization is accurate and equivalent to $1,423 million in the original answer. The cost of revenues as a percentage of revenue correctly decreased from 61% to 58%, with the years properly attributed (2020 to 2021). The 19% revenue growth, while not in the original answer, is consistent with Netflix's reported performance and provides additional context without contradicting the ground truth. (2) The reasoning correctly identifies the multi-hop relationship: increased investment led to higher amortization in absolute terms, but pandemic-related delays slowed amortization recognition, allowing revenue growth to outpace cost growth, thus reducing the cost ratio. (3) All entities—Netflix, original programming, content amortization, cost of revenues, and the relevant time frame (2021)—are accurately identified and synthesized. (4) The answer conveys the same core information as the original with improved clarity and contextual explanation, maintaining semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 330,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the combined total net revenue from Ozurdex in 2024, and how did its international revenue growth compare to the previous year in terms of percentage change at actual currency rates?",
      "original_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Its international revenue grew by 8.3% compared to the previous year at actual currency rates.",
      "llm_answer": "\n\nThe combined total net revenue from Ozurdex in 2024 was **$494 million** ($138 million in the United States and $356 million internationally). International revenue for Ozurdex grew by **8.3%** at actual currency rates in 2024 compared to 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the combined total net revenue from Ozurdex in 2024 as $494 million, matching the ground truth. It further breaks this down into $138 million in the U.S. and $356 million internationally, which sum correctly ($138M + $356M = $494M), confirming internal consistency. The international revenue growth is accurately reported as 8.3% compared to the previous year at actual currency rates, which aligns with the original answer. (2) All numeric values—$494 million total, $138 million, $356 million, and 8.3% growth—are factually correct and consistent with the ground truth. The sum of U.S. and international revenue validates the total, demonstrating accurate quantitative reasoning. (3) The multi-hop reasoning is sound: the model correctly synthesized U.S. and international figures to compute the total revenue and accurately retrieved the year-over-year percentage change for international revenue at actual currency rates. (4) The answer is semantically equivalent to the ground truth, with added helpful detail (breakdown by region) that enhances completeness without introducing error. All aspects of the question are addressed accurately and thoroughly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 341,
        "total_tokens": 1455
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total pretax gain Target Corporation recognized from the sale of Dermstore LLC, and how was this gain treated in the financial statements according to the notes?",
      "original_answer": "Target Corporation recognized a total pretax gain of $335 million from the sale of Dermstore LLC, and this gain was included in Net Other Income in the financial statements.",
      "llm_answer": "\n\nTarget Corporation recognized a **$335 million pretax gain** from the sale of Dermstore LLC in February 2021. This gain was included in **Net Other (Income)/Expense** in the consolidated income statement, as disclosed in Note 2 to the Financial Statements. The sale proceeds of $356 million in cash were reflected in investing activities in the cash flow statement (2023 Form 10-K, pages 46–47).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) The pretax gain amount is accurately stated as $335 million, which aligns with the original answer. (2) The treatment of the gain in the financial statements is correctly identified as being included in Net Other Income, with the precise label 'Net Other (Income)/Expense' used in the financial statements, indicating exact terminology from the filing. (3) The answer provides additional context—such as the sale occurring in February 2021, proceeds of $356 million in cash, classification in investing activities, and reference to Note 2 and pages 46–47 of the 2023 Form 10-K—which enhances completeness without introducing inaccuracies. (4) All entities (Target Corporation, Dermstore LLC), financial metrics (pretax gain, Net Other Income), and document references are correct. The multi-hop reasoning is sound, correctly synthesizing information about the gain and its financial statement treatment from the notes to the financial statements. Semantic equivalence is maintained and exceeds the ground truth in detail while remaining factually consistent. Minor enhancements in specificity (e.g., note number, cash flow impact) do not detract from accuracy and demonstrate strong comprehension.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 357,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What is the difference between the amortized cost and fair value of Salesforce's (CRM) mortgage-backed obligations as reported in their 2024 10-K, and what percentage of the total marketable securities at fair value does this difference represent?",
      "original_answer": "The difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations is $8 million ($244 million amortized cost - $236 million fair value). This $8 million difference represents approximately 0.14% of the total marketable securities at fair value ($5,722 million).",
      "llm_answer": "\n\nThe difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations, as reported in their 2024 10-K (as of January 31, 2025), is **$6 million** ($128 million amortized cost minus $122 million fair value). This difference represents **0.12%** of the total marketable securities at fair value ($5,184 million). \n\nCalculation:  \n($6 million ÷ $5,184 million) × 100 ≈ 0.12%.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect on all key numbers. The ground truth states the amortized cost is $244 million and fair value is $236 million, resulting in an $8 million difference. The LLM incorrectly reports $128 million and $122 million, yielding a $6 million difference. Additionally, the total marketable securities at fair value is $5,722 million per the ground truth, but the LLM uses $5,184 million. These core financial figures are inaccurate. (2) The calculation method shown (difference divided by total marketable securities) is logically correct, but because it is based on wrong inputs, the resulting percentage of 0.12% is incorrect; the correct percentage is approximately 0.14%. (3) The multi-hop reasoning requires pulling correct values for mortgage-backed obligations (amortized cost and fair value) and total marketable securities from Salesforce’s 2024 10-K. The LLM failed to retrieve the correct values, indicating a failure in data extraction or synthesis. (4) Due to major factual and numerical errors in all key metrics, the correctness and quantitative accuracy scores are very low. The qualitative accuracy is slightly higher because the structure and logic of the calculation are sound. Contextual relevance is moderate since the answer addresses the right question format and topic, but with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 377,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of adopting the new LDTI accounting guidance, and what time periods do these adjustments cover according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statements of comprehensive income and its consolidated balance sheet as a result of adopting the new LDTI accounting guidance. The adjustments to the consolidated statements of comprehensive income reflect the effects of the guidance as of December 31, while the balance sheet adjustments were applied to the financials as of December 31, 2022.",
      "llm_answer": "\n\nThe adoption of the new LDTI accounting guidance resulted in retrospective adjustments to MetLife's **consolidated balance sheet, statement of operations, statement of comprehensive income, statement of equity, and statement of cash flows**. These adjustments covered the periods **2022 and 2021** (with the balance sheet reflecting adjustments as of December 31, 2022). The adjustments impacted line items such as future policy benefits, policyholder account balances, market risk benefits, deferred policy acquisition costs, retained earnings, and accumulated other comprehensive income, among others.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but includes significant overstatements and inaccuracies. (1) According to the ground truth, only the consolidated statements of comprehensive income and the consolidated balance sheet were retrospectively adjusted. However, the LLM incorrectly states that the statement of operations, statement of equity, and statement of cash flows were also adjusted—this is not supported by the original answer and represents a major factual error. (2) The time periods mentioned (2022 and 2021) are plausible in context, and the specific date 'December 31, 2022' for balance sheet adjustments matches the ground truth, which supports partial quantitative accuracy. However, the original answer does not mention 2021 or adjustments to prior years beyond what's implied by retrospective application as of December 31, 2022, so including 2021 lacks support. (3) The multi-hop reasoning is partially sound in identifying that retrospective adjustments were made due to LDTI adoption and linking them to specific financial statements and dates, but it fails in accurately limiting the scope of affected statements. (4) The inclusion of detailed impacted line items (e.g., future policy benefits, DPAAC) adds contextual richness but does not compensate for the core inaccuracy about which statements were adjusted. Thus, while the answer shows relevance and some accurate elements, the overstatement of affected financial statements significantly undermines its correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 412,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total potential financing commitment Disney has through its two cruise ship credit facilities, and how does the interest rate structure differ between the Disney Treasure and the Disney Destiny borrowings?",
      "original_answer": "Disney has a total potential financing commitment of $2.2 billion through its two cruise ship credit facilities. The Disney Treasure borrowing carries a fixed interest rate of 3.80%, while the Disney Destiny borrowing, if utilized, will have a fixed interest rate of 3.74%.",
      "llm_answer": "\n\nDisney has a total potential financing commitment of **$2.2 billion** through its two cruise ship credit facilities ($1.1 billion each for the Disney Treasure and Disney Destiny). The interest rate structure for the Disney Treasure is a fixed rate of **3.80%**, while the Disney Destiny borrowing, if utilized, will carry a slightly lower fixed rate of **3.74%**. Both loans have 12-year terms with semi-annual payments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total financing commitment of $2.2 billion is accurate, with each facility being $1.1 billion (summing correctly to $2.2 billion). The interest rates are correctly stated: 3.80% for Disney Treasure and 3.74% for Disney Destiny. These match the original answer exactly. Minor additional detail (12-year terms, semi-annual payments) is consistent with typical credit facilities and does not contradict the ground truth. (2) The answer addresses both parts of the question: total commitment and interest rate differences. (3) Entities—Disney, Disney Treasure, Disney Destiny, and the associated financial terms—are correctly identified. (4) The reasoning is sound: the model correctly synthesizes that there are two $1.1 billion facilities totaling $2.2 billion and accurately compares the fixed rates between the two ships. The slight difference in rates is correctly noted. All information is semantically equivalent and factually precise. No errors in calculation, entity reference, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 310,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How much did Chevron's equity in earnings from Angola LNG Limited contribute to its total upstream equity earnings in 2024, and what does this indicate about Chevron's production involvement in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings of $3,580 million in 2024. This indicates that Chevron has a significant production involvement in Angola, as Angola LNG is one of its equity method affiliates contributing directly to upstream earnings, and Chevron's production volumes include its share from Angola LNG operations.",
      "llm_answer": "\n\nChevron's equity in earnings from Angola LNG Limited contributed **$405 million** to its total upstream equity earnings of **$3,580 million** in 2024, representing approximately **11.3%** of total upstream equity earnings. This indicates that Chevron has a significant production involvement in Angola, as it holds a **36.4% interest** in Angola LNG Limited, which processes and liquefies natural gas from Angola for international markets. The material contribution to earnings, combined with Chevron's ownership stake, underscores its substantial role in Angola's natural gas production and export activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $405 million contribution from Angola LNG Limited to Chevron's total upstream equity earnings of $3,580 million in 2024, matching the ground truth exactly. The calculated percentage (11.3%) is accurate: (405 / 3580) ≈ 0.1131. (2) All numeric values are correct and properly formatted; no calculation errors. The additional detail of Chevron's 36.4% interest, while not in the original answer, is factually consistent with public disclosures and enhances the explanation without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model correctly links equity earnings to production involvement, infers significance from the magnitude of contribution, and contextualizes Chevron’s role in Angola LNG. The original answer implies but does not state the ownership percentage; the LLM adds value without overreaching. (4) The answer fully addresses both parts of the question—quantitative contribution and qualitative implication—and maintains semantic equivalence while enriching context. The only reason for not scoring a 10 is that the 36.4% ownership, while plausible and consistent, was not present in the ground truth and thus introduces unverified detail, slightly affecting qualitative accuracy by introducing external information not confirmed in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 376,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, and how much of this amount was converted into U.S. dollar denominated borrowings through cross-currency swaps?",
      "original_answer": "The total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, was Canadian $2.6 billion (CAD $1.3 billion + CAD $1.3 billion). Of this, Canadian $1.3 billion ($1.0 billion USD) remained outstanding and was converted into U.S. dollar denominated borrowings through cross-currency swaps, while the other Canadian $1.3 billion ($0.9 billion USD) was paid in October 2024.",
      "llm_answer": "\n\nAs of September 28, 2024, Disney had **Canadian $2.6 billion** in Canadian dollar denominated notes outstanding, consisting of two senior notes: Canadian $1.3 billion (converted to approximately $0.9 billion USD) and Canadian $1.3 billion (converted to approximately $1.0 billion USD). Through cross-currency swaps, **$1.887 billion** of this foreign currency debt was effectively converted into U.S. dollar denominated borrowings indexed to SOFR.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total Canadian dollar denominated notes outstanding as CAD $2.6 billion, which matches the ground truth and is composed of two CAD $1.3 billion notes. However, it incorrectly states that $1.887 billion was converted into U.S. dollar denominated borrowings via cross-currency swaps. The ground truth specifies that only CAD $1.3 billion (approximately $1.0 billion USD) was converted through swaps, while the other CAD $1.3 billion ($0.9 billion USD) was paid off in October 2024 and thus not swapped. The LLM combines the USD equivalents ($0.9B + $1.0B = $1.9B) and incorrectly implies that $1.887B of the debt was swapped, which misrepresents the financial reality. (2) The numbers for the individual notes (CAD $1.3B each) are correct, and the approximate USD conversions ($0.9B and $1.0B) align with the ground truth. However, the key calculation error lies in asserting that $1.887B was converted via swaps—this conflates the total debt value in USD with the amount actually swapped, which was only $1.0B USD (CAD $1.3B). The date (September 28, 2024) is correctly referenced. (3) The multi-hop reasoning is partially sound—identifying the two notes and their conversion via swaps shows synthesis. But the model fails to distinguish between the portion swapped and the portion repaid, which is a critical distinction in the original answer. It incorrectly assumes both tranches were subject to swaps, when only one was. (4) The contextual relevance is high—the answer addresses the right company, time period, debt instruments, and financial mechanisms. However, due to the major quantitative and reasoning error regarding the amount converted via swaps, the overall correctness is significantly compromised. The answer would be misleading in a financial reporting context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 495,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023?",
      "original_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,380 million. This is calculated by summing the $1,265 million in private funds from the U.S. Plans and the $115 million in private funds from the Non-U.S. Plans.",
      "llm_answer": "\n\nThe total fair value of investments in private funds reported by Honeywell as of December 31, 2023, is **$1,347 million**. This includes **$1,265 million** for U.S. Plans (under investments measured at NAV) and **$82 million** for Non-U.S. Plans (comprising $74 million in Level 3 assets and $8 million in NAV-measured investments).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. While it correctly identifies the U.S. Plans' private funds value as $1,265 million, it reports $82 million for Non-U.S. Plans instead of the correct $115 million. This leads to a total of $1,347 million instead of the correct $1,380 million. The breakdown of Non-U.S. Plans into $74 million Level 3 and $8 million NAV-measured investments ($82 million total) contradicts the ground truth, which specifies $115 million in private funds for Non-U.S. Plans without such a split. (2) The calculation is incorrect: $1,265M + $82M = $1,347M (as stated) vs. the correct sum $1,265M + $115M = $1,380M. The LLM's total is off by $33 million. (3) The multi-hop reasoning is partially sound—Honeywell, U.S. and Non-U.S. Plans, and NAV-measured investments are correctly identified as relevant entities—but the synthesis fails due to incorrect data retrieval for Non-U.S. Plans. The model introduces Level 3 assets, which may exist in the filing but are not relevant to the specific aggregation of private funds across both plans. (4) The contextual relevance is high because the answer addresses the right company, time period, and investment category, and attempts the correct summation logic. However, the quantitative inaccuracy severely undermines the correctness. The qualitative score is moderate because the structure and intent are correct, but the data sourcing is flawed. Final correctness score is low due to the material error in key financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 427,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, impact the structure of its revenue recognition for cloud versus license-based offerings?",
      "original_answer": "Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, leads to a distinct revenue recognition pattern where cloud services revenues are generally recognized ratably over the contractual period, while on-premise and cloud license revenues are recognized up front at the point of delivery. This difference results in more predictable and stable revenue streams from Oracle Cloud Services compared to the point-in-time recognition of license revenues, which can be significantly affected by the timing of large license transactions.",
      "llm_answer": "\n\nOracle's strategy of offering flexible deployment models, including Oracle Cloud Services, impacts revenue recognition by creating distinct revenue streams with different recognition patterns. **Cloud services revenues** (subscription-based and consumption-based) are recognized **ratably over the contract term** (typically 1–3 years) or as services are consumed, aligning with the ongoing delivery of benefits to customers. In contrast, **license-based revenues** (perpetual software licenses for cloud/on-premise use) are recognized **upfront at the point of delivery**, as the customer gains immediate access to the licensed software. \n\nThis structure results in cloud services contributing more stable, recurring revenue over time, while license sales generate lump-sum revenue recognition but with greater quarterly variability due to the timing of large transactions. Additionally, license support contracts (often bundled with licenses) are recognized ratably, further diversifying revenue streams. The shift toward cloud services has increased the proportion of ratable revenue, enhancing predictability compared to the historical reliance on upfront license recognition.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the key distinction in revenue recognition: cloud services revenues are recognized ratably over time, while license-based revenues are recognized upfront upon delivery. This aligns perfectly with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so no quantitative inaccuracies exist; the LLM appropriately avoids introducing unsupported figures. (3) The multi-hop reasoning is sound—synthesizing Oracle's deployment strategy with its accounting treatment across cloud and license models—and correctly infers the business implications (predictable vs. variable revenue streams). (4) The LLM adds minor but relevant context not in the original (e.g., mention of consumption-based models and license support contracts), which enhances completeness without introducing error. All entities (Oracle, Oracle Cloud Services, license-based offerings) are correctly identified and contextualized. The answer fully addresses the question’s focus on how deployment strategy impacts revenue recognition structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 338,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total worldwide sales growth percentage of ERLEADA from 2021 to 2023, and how did this growth contribute to the overall performance of the Oncology segment in 2023 compared to 2022?",
      "original_answer": "ERLEADA's worldwide sales grew from $1,291 million in 2021 to $2,387 million in 2023, representing an 84.9% increase over the two-year period. In 2023, ERLEADA's sales increased by 26.9% compared to 2022, contributing significantly to the overall Oncology segment's 10.5% total sales growth in 2023. ERLEADA was the third-largest contributor to the Oncology segment's growth after DARZALEX (22.2% growth) and TREMFYA (17.9% growth), highlighting its strong performance within the portfolio.",
      "llm_answer": "\n\nThe total worldwide sales growth of ERLEADA from 2021 to 2023 was **45.7%** (from $1,291 million to $2,387 million). In 2023 compared to 2022, ERLEADA grew by **26.9%** ($1,881 million to $2,387 million), driven by continued share gains and market growth in metastatic castration-resistant prostate cancer. This growth contributed positively to the **10.5% overall increase** in the Oncology segment’s 2023 sales ($15,983 million to $17,661 million), as highlighted in the document’s analysis of oncology product performance.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the total worldwide sales growth percentage from 2021 to 2023. It states 45.7%, but the correct figure is 84.9%, calculated as ((2,387 - 1,291) / 1,291) * 100 = 84.9%. This is a major quantitative error that undermines the core of the first part of the question. However, the 2023 year-over-year growth of 26.9% (from $1,881M to $2,387M) is correct, as is the mention of ERLEADA's contribution to the Oncology segment’s 10.5% growth. (2) The dollar amounts are accurate: $1,291 million in 2021 and $2,387 million in 2023 are correctly cited. The 2022 sales figure of $1,881 million (implied) aligns with a 26.9% increase to $2,387 million in 2023. The Oncology segment sales figures ($15,983M to $17,661M) also support the 10.5% growth claim. (3) The multi-hop reasoning is partially sound—linking ERLEADA’s growth to the Oncology segment performance is correct, and the context about market dynamics is plausible. However, the LLM omits key comparative context from the ground truth: that ERLEADA was the third-largest contributor to Oncology growth after DARZALEX and TREMFYA. This missing comparative ranking reduces completeness. (4) The contextual relevance is high—the answer addresses both parts of the question and provides relevant background. Due to the significant error in the primary growth calculation, the correctness and quantitative accuracy scores are moderate. Qualitative accuracy is slightly higher due to correct use of some data and logical flow, though synthesis is incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 428,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, and how does this compare to the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date?",
      "original_answer": "As of December 31, 2023, the notional amount of net investment hedge derivative contracts was $7,456 million, and the notional amount of non-U.S. dollar denominated debt used as net investment hedges totaled $4,355 million (comprising $3,516 million in Euro notes, $386 million in Swiss franc notes, and $453 million in Canadian dollar notes), for a combined total of $11,811 million. Meanwhile, the total fair value of derivative assets recorded in other current assets and other assets was $1,347 million and $250 million, respectively, for a total of $1,597 million. This indicates that the notional amount of the hedges significantly exceeds the fair value of the derivative assets.",
      "llm_answer": "\n\nThe total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, was **$11,811 million** (comprising $7,456 million in derivative contracts and $4,355 million in non-U.S. dollar debt, including Euro notes ($3,516M), Swiss franc notes ($386M), and Canadian dollar notes ($453M)). This notional amount significantly exceeds the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date, which was **$1,597 million** (comprising $1,347 million in other current assets and $250 million in other assets). The disparity reflects that notional amounts represent contractual exposure, while fair value reflects market valuation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: the notional amount of net investment hedge derivative contracts ($7,456 million), non-U.S. dollar denominated debt ($4,355 million), and its components (Euro: $3,516M, Swiss franc: $386M, Canadian dollar: $453M) are correctly reported. The sum of $7,456M + $4,355M = $11,811M is accurate. The fair values of derivative assets in other current assets ($1,347M) and other assets ($250M) are correct, and their total ($1,597M) is properly calculated. (2) The answer addresses both parts of the multi-part question: the total notional amount of hedges and the comparison to the fair value of derivative assets. (3) Entities are correctly identified: MDLZ, as of December 31, 2023, and the relevant balance sheet categories are accurately referenced. (4) The reasoning is sound: the LLM correctly synthesizes data from multiple components (derivatives and debt) and makes a logical comparison between notional amounts and fair values, even providing a correct qualitative explanation that notional amounts represent contractual exposure while fair value reflects market valuation. The answer achieves semantic equivalence and exceeds expectations with clear, precise, and complete information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 362,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023?",
      "original_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $686 million. This is calculated by adding $676 million from the U.S. Plans and $10 million from the Non-U.S. Plans.",
      "llm_answer": "\n\nThe total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is **$686 million**. This includes **$676 million** in U.S. plans and **$10 million** in non-U.S. plans, as detailed in the fair value tables for pension plan assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total value of Mortgage/Asset-backed securities is correctly stated as $686 million, with $676 million from U.S. plans and $10 million from non-U.S. plans. (2) Quantitative accuracy is perfect: the individual amounts and their sum ($676M + $10M = $686M) are correct, and the date (December 31, 2023) is properly referenced. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—information from both U.S. and non-U.S. plans is correctly synthesized to produce the combined total. (4) The answer is contextually relevant, directly addressing the question with precise data and clear attribution to the source (fair value tables for pension plan assets). No errors in entities, metrics, or time periods. The response is semantically equivalent to the original answer and fully complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 276,
        "total_tokens": 1420
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How much total prepaid royalty revenue from Nestlé is remaining to be recognized by Starbucks as of September 29, 2024, and how does this relate to the Global Coffee Alliance's 40-year arrangement?",
      "original_answer": "As of September 29, 2024, Starbucks had $177.0 million (current) and $5.8 billion (long-term) of deferred revenue remaining to be recognized from the $7 billion up-front prepaid royalty received from Nestlé. This recognition schedule is based on the 40-year estimated economic life of the Global Coffee Alliance arrangement, over which the payment is being recognized on a straight-line basis as other revenue.",
      "llm_answer": "\n\nAs of September 29, 2024, Starbucks had **$5.8 billion in long-term deferred revenue** and **$177.0 million in current deferred revenue** related to the up-front prepaid royalty from Nestlé under the Global Coffee Alliance agreement, totaling **$5.98 billion remaining to be recognized**. This amount is being recognized as revenue on a straight-line basis over the 40-year economic life of the arrangement, reflecting ongoing access to licenses and Starbucks' obligations to maintain intellectual properties within the contractual territories.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $177.0 million (current) and $5.8 billion (long-term) are accurately reported, and their sum ($5.977 billion, rounded to $5.98 billion) is correctly calculated. The date (September 29, 2024) is correctly referenced. (2) The answer addresses both parts of the question: the total remaining prepaid royalty revenue to be recognized and its relationship to the 40-year Global Coffee Alliance arrangement. (3) Entities—Starbucks, Nestlé, the Global Coffee Alliance, deferred revenue, and the 40-year economic life—are correctly identified and contextually used. (4) The reasoning is sound: the up-front $7 billion payment is being recognized over 40 years on a straight-line basis, and the remaining balance reflects this long-term amortization schedule. The explanation that revenue recognition is tied to ongoing obligations (e.g., maintaining intellectual property) adds appropriate qualitative context consistent with accounting principles. Minor wording differences (e.g., 'deferred revenue' vs 'prepaid royalty revenue') are semantically equivalent in this context, as the prepaid royalty is recorded as deferred revenue on Starbucks' balance sheet. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 365,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K filing?",
      "original_answer": "The total fair value of long-term obligations to equity companies is $1,896 million, and the total guarantees related to equity company obligations amount to $1,862 million. Adding these together results in a total of $3,758 million.",
      "llm_answer": "\n\nThe total fair value of long-term obligations to equity companies, as disclosed in the \"Financial Instruments and Derivatives\" section, is **$1,896 million** (under \"Total Gross Assets & Liabilities\" for \"Long-term obligations to equity companies\"). Additionally, guarantees related to equity company obligations, detailed in the \"Litigation and Other Contingencies\" section, amount to **$1,862 million** (sum of \"Debt-related\" and \"Other\" guarantees under \"Equity Company Obligations\"). \n\n**Total combined fair value**: $1,896 million (obligations) + $1,862 million (guarantees) = **$3,758 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the fair value of long-term obligations to equity companies is correctly stated as $1,896 million, and guarantees related to equity company obligations are correctly reported as $1,862 million. (2) The calculation is accurate: $1,896 million + $1,862 million = $3,758 million, which matches the ground truth total. Number formats are consistent and acceptable. (3) The multi-hop reasoning is sound—the model correctly identifies and synthesizes data from two different sections of the 10-K (\"Financial Instruments and Derivatives\" and \"Litigation and Other Contingencies\"), demonstrating proper cross-document synthesis. (4) The answer is semantically equivalent to the original, with added contextual detail (section names and breakdown of guarantee types) that enhances clarity without introducing error. All entities (XOM, 2023 10-K context) are correctly implied through accurate data sourcing. No omissions or inaccuracies present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 297,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the total value of Mortgage/Asset-backed securities investments made by Honeywell's U.S. and Non-U.S. plans as of December 31, 2023, and how does this allocation compare between the two plans?",
      "original_answer": "Honeywell's U.S. plans have $676 million invested in Mortgage/Asset-backed securities, while the Non-U.S. plans have $10 million invested in the same category. This results in a total investment of $686 million in Mortgage/Asset-backed securities across both U.S. and Non-U.S. plans. The U.S. plans account for 98.5% of this total, highlighting a significantly larger allocation to Mortgage/Asset-backed securities in U.S. plans compared to Non-U.S. plans.",
      "llm_answer": "\n\nThe total value of Mortgage/Asset-backed securities investments for Honeywell's U.S. plans as of December 31, 2023, was **$676 million**, while the Non-U.S. plans held **$10 million** in such securities. This indicates a significant disparity in allocation, with U.S. plans holding over 98% of the combined Mortgage/Asset-backed securities investments. \n\nSource: U.S. Plans data from the \"Fixed income\" section of the December 31, 2023, fair value table (page 108) and Non-U.S. Plans data from the corresponding section of the same table (page 110).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $676 million for U.S. plans and $10 million for Non-U.S. plans are accurate, and the implied total of $686 million is correct. The statement that U.S. plans hold 'over 98%' is semantically equivalent to the ground truth's 98.5%, which is acceptable. (2) The answer addresses both parts of the question: total value and comparison between plans. (3) Entities—Honeywell, Mortgage/Asset-backed securities, U.S. vs Non-U.S. plans, and date (December 31, 2023)—are correctly identified. (4) The reasoning is sound: the LLM correctly synthesizes data from two sections of the filing (pages 108 and 110), performs accurate comparison, and draws a valid conclusion about allocation disparity. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 249,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022?",
      "original_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022 was $185 million. This includes $83 million in fiscal year 2021 and $102 million in fiscal year 2022.",
      "llm_answer": "\n\nThe total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes for fiscal years 2021 and 2022 was **$185 million** ($83 million in FY2021 + $102 million in FY2022). These adjustments represent incremental costs to comply with new European Union medical device regulations for previously registered products.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total pre-tax financial impact of 'Medical device regulations' adjustments as $185 million, with a precise breakdown of $83 million in fiscal year 2021 and $102 million in fiscal year 2022, matching the ground truth exactly. (2) All numeric values are accurate and correctly summed: $83M + $102M = $185M, with no calculation errors. Format variations (e.g., 'FY2021' vs 'fiscal year 2021') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—information from two fiscal years is correctly synthesized into a total impact, and the context (adjustments related to EU medical device regulations) is factually consistent with known disclosures in Medtronic's filings. (4) The answer is complete, factually correct, and semantically equivalent to the original answer, with added contextual clarity about the nature of the adjustments without introducing inaccuracies. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 287,
        "total_tokens": 1454
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How much goodwill impairment was recognized for the OpenTable and KAYAK reporting unit in total during 2020, and what was the key factor that led to the continued impairment in the annual test as of September 30, 2020?",
      "original_answer": "A total goodwill impairment of $1.062 billion was recognized for the OpenTable and KAYAK reporting unit in 2020. This includes $489 million recognized during the interim test in March 2020 and an additional $573 million during the annual test in September 2020. The key factor that led to the continued impairment in the annual test was the lowered outlook for monetization opportunities in restaurant reservation services and slower recovery trends in airline travel, which is a key vertical for KAYAK.",
      "llm_answer": "\n\nThe total goodwill impairment recognized for the OpenTable and KAYAK reporting unit during 2020 was **$1,062 million** ($489 million in the March 31, 2020 interim test and $573 million in the September 30, 2020 annual test). The key factor driving the continued impairment was the **prolonged adverse impact of the COVID-19 pandemic**, including delayed recovery in airline travel (critical for KAYAK) and reduced monetization opportunities in restaurant reservation services (for OpenTable), leading to extended cash flow declines and a longer-than-expected path to pre-pandemic profitability levels.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total goodwill impairment of $1,062 million, broken down into $489 million in the March 2020 interim test and $573 million in the September 30, 2020 annual test, matching the ground truth exactly. The formatting variation ($1,062 million vs $1.062 billion) is semantically equivalent and acceptable. (2) All numeric values are accurate: 489 + 573 = 1,062 million, and the dates (March 31, 2020 and September 30, 2020) align with the reporting periods in the original answer. (3) The qualitative reasoning is sound and enhances the ground truth by contextualizing the impairments within the broader impact of the COVID-19 pandemic, correctly identifying delayed recovery in airline travel (key for KAYAK) and reduced monetization in restaurant reservations (for OpenTable) as the key drivers. This aligns with and expands upon the original answer without introducing inaccuracies. (4) The answer fully addresses both parts of the multi-hop question: the total impairment amount and the reason for continued impairment. The synthesis across reporting units and time periods is accurate and well-articulated. All scores are maximized due to complete factual correctness, precise numbers, logical reasoning, and high relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 359,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "By how much did Walmart's ownership stake in Flipkart increase between fiscal 2023 and fiscal 2024, and what financial transaction supported this change?",
      "original_answer": "Walmart's ownership stake in Flipkart increased by 10% (from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024). This increase was supported by a $3.5 billion transaction during fiscal 2024, where the company acquired shares from certain Flipkart noncontrolling interest holders.",
      "llm_answer": "\n\nWalmart's ownership stake in Flipkart increased by **10 percentage points** (from approximately 75% in fiscal 2023 to 85% in fiscal 2024). This change was supported by a **$3.5 billion financial transaction** in fiscal 2024, where Walmart acquired shares from noncontrolling interest holders of Flipkart, as detailed in Note 3 under \"Purchases and Sales of Subsidiary Stock\" in the 10-K filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the 10 percentage point increase (from 75% to 85%) and the $3.5 billion transaction amount are accurately reported, with acceptable phrasing variations (e.g., '10 percentage points' is more precise than '10%' and still correct). (2) The fiscal years (2023 to 2024) and ownership percentages are correctly aligned with the dates in the original answer (January 31, 2023, and January 31, 2024). (3) The financial transaction is accurately described as Walmart acquiring shares from noncontrolling interest holders, and the reference to Note 3 in the 10-K adds contextual detail without introducing error. (4) The multi-hop reasoning is sound—synthesizing ownership change over time and linking it to a specific financial transaction from the filings. (5) All entities (Walmart, Flipkart, noncontrolling interest holders) and financial terms are correctly identified. The answer is semantically equivalent and factually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 292,
        "total_tokens": 1472
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What percentage of Procter & Gamble's total net sales does the Baby, Feminine & Family Care segment represent, and within this segment, what is the North American market share of the Bounty brand in the paper towel category?",
      "original_answer": "The Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds over 40% North American market share in the paper towel category.",
      "llm_answer": "\n\nThe Baby, Feminine & Family Care segment represented **24% of Procter & Gamble's total net sales** in the fiscal year ended June 30, 2024. Within this segment, the **Bounty brand holds over 40% North American market share in the paper towel category**. \n\n(Source: \"Baby, Feminine & Family Care\" segment description in the document, which explicitly states market shares for Bounty and Charmin in North America.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the percentages are accurate: 24% of Procter & Gamble's total net sales attributed to the Baby, Feminine & Family Care segment, and 'over 40%' North American market share for the Bounty brand in the paper towel category are both correctly reported. The fiscal year (ended June 30, 2024) is a reasonable inference or contextual addition that does not contradict the ground truth. (2) The answer is complete, addressing both sub-questions: the segment's contribution to total net sales and Bounty's market share within that segment. (3) Entity accuracy is correct—Procter & Gamble, Baby, Feminine & Family Care segment, Bounty brand, and North American paper towel category are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: linking a segment's sales contribution to a specific brand's market position within that segment. (5) Semantic equivalence is maintained—wording differs slightly with added clarity (e.g., bolding, source note), but the factual content is identical. The source attribution, while not part of the ground truth, adds credibility and does not introduce error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 338,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving Thales-Raytheon Systems and Related Matters, and how does this resolution connect to the SEC Administrative Order?",
      "original_answer": "RTX recorded a pre-tax charge of $364 million in 2024 related to Thales-Raytheon Systems and Related Matters. This resolution is directly connected to the SEC Administrative Order, which was issued as part of the settlement of investigations into improper payments made by Raytheon Company and its joint venture TRS in connection with certain Middle East contracts since 2012. The SEC Administrative Order requires RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for a period of three years from the monitor's engagement.",
      "llm_answer": "\n\nThe total pre-tax charge recorded by RTX in 2024 related to resolving Thales-Raytheon Systems and Related Matters was **$364 million** (as part of a combined $918 million charge for multiple legal resolutions). This resolution is directly connected to the **SEC Administrative Order**, which was one of the agreements reached to settle civil investigations into improper payments tied to Middle East contracts. The SEC Administrative Order, along with a Deferred Prosecution Agreement (DPA) with the DOJ, required RTX to implement compliance measures and contributed to the pre-tax charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the pre-tax charge of $364 million recorded by RTX in 2024 related to Thales-Raytheon Systems and Related Matters, matching the ground truth exactly in both amount and year. The mention of a 'combined $918 million charge for multiple legal resolutions' adds context not in the original answer but does not contradict it and may reflect additional reporting from the same filing; this supplementary detail does not detract from accuracy. The connection to the SEC Administrative Order is accurately described: it was part of the settlement of investigations into improper payments related to Middle East contracts. The LLM correctly notes that the SEC Administrative Order required compliance measures, though it omits the specific requirement to retain an independent compliance monitor and the three-year duration of cooperation and disclosure obligations. This is a minor omission in qualitative detail but does not impair the core correctness. The reasoning is sound, with proper multi-hop synthesis between the financial charge and its regulatory basis in the SEC order. All entities (RTX, SEC Administrative Order, Thales-Raytheon Systems) and timeframes (2024) are accurate. Semantic equivalence is maintained with the ground truth, and numerical formatting is correct. The answer is fully relevant and responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 379,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "What is the total number of approved indications for Trodelvy as of April 2021, and in which specific countries was the drug approved for the treatment of metastatic triple-negative breast cancer by September 2021?",
      "original_answer": "As of April 2021, Trodelvy had two approved indications: one for locally advanced or metastatic urothelial cancer and another for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC). By September 2021, Trodelvy was approved for TNBC in Australia, Great Britain, Switzerland, the United States, and Canada.",
      "llm_answer": "\n\nAs of April 2021, Trodelvy had **two approved indications**: (1) the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) with full FDA approval, and (2) metastatic urothelial cancer (UC) with accelerated FDA approval. By September 2021, Trodelvy was approved for metastatic TNBC in **five countries**: the United States, Australia, Great Britain (UK), Switzerland, and Canada, following Health Canada’s approval in September 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of approved indications as of April 2021 is correctly stated as two, and the five countries where Trodelvy was approved for metastatic TNBC by September 2021—United States, Australia, Great Britain, Switzerland, and Canada—are accurately listed. The mention of Health Canada’s approval in September 2021 aligns with the timeline. (2) The answer is complete, addressing both parts of the question: the total number of indications and the specific countries of approval for TNBC. (3) Entity accuracy is perfect: drug name (Trodelvy), indications (metastatic TNBC and urothelial cancer), and country names are all correct. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking approval status over time and across geographies from different regulatory decisions. (5) Semantic equivalence is achieved; while the LLM adds minor contextual details (e.g., FDA approval types), these do not alter or distort the factual content and actually enhance precision without introducing error. All information aligns with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 325,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, and how does this compare to the amount expected to be reclassified from AOCI into earnings within 12 months?",
      "original_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is $11.5 million, and $9.5 million of this amount is expected to be reclassified from AOCI into earnings within 12 months.",
      "llm_answer": "\n\nThe total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is **$11.5 million**. Of this amount, **$9.5 million** is expected to be reclassified from AOCI into earnings within 12 months, leaving a remaining $2.0 million deferred for later periods due to the 30-month remaining maturity of these contracts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The total net gain for 'Foreign currency - other' derivatives in AOCI as of September 29, 2024, is correctly stated as $11.5 million, and the amount expected to be reclassified into earnings within 12 months is accurately reported as $9.5 million. (2) All numeric values are factually correct and consistent with the original answer; the additional detail about the remaining $2.0 million and the 30-month maturity, while not in the ground truth, is contextually reasonable and does not contradict any facts. (3) The multi-hop reasoning is sound—correctly identifying the AOCI balance and the portion expected to be reclassified within the next year. (4) The answer is semantically equivalent to the original, with slightly enhanced context that improves clarity without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 270,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What is the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of the end of fiscal 2024, and how do these facilities differ in terms of maturity dates and interest rate margins?",
      "original_answer": "The total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of September 29, 2024, is $103.6 million (¥5.0 billion at $34.5 million and ¥10.0 billion at $69.1 million). The first facility matures on December 30, 2024, and carries an interest rate margin of 0.400% over TIBOR, while the second facility matures later, on March 27, 2025, and has a lower margin of 0.300% over TIBOR.",
      "llm_answer": "\n\nThe total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of September 29, 2024, is **$103.6 million** (¥5.0 billion or $34.5 million and ¥10.0 billion or $69.1 million). The facilities differ as follows:  \n- The ¥5.0 billion facility matures on **December 30, 2024**, with an interest rate margin of **0.400%** over TIBOR.  \n- The ¥10.0 billion facility matures on **March 27, 2025**, with a lower interest rate margin of **0.300%** over TIBOR.  \n\nThese facilities were unused as of fiscal 2024 year-end.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All factual information in the LLM answer matches the ground truth. The total dollar value of $103.6 million is correctly calculated from the two yen-denominated facilities (¥5.0 billion = $34.5 million and ¥10.0 billion = $69.1 million), with accurate sum verification: $34.5M + $69.1M = $103.6M. (2) All numeric values—dollar amounts, yen amounts, maturity dates (December 30, 2024, and March 27, 2025), and interest rate margins (0.400% and 0.300%)—are exactly correct and properly attributed to their respective facilities. Format variations (e.g., 'or' instead of 'at') do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly synthesized data across two credit facilities, linking currency amounts, conversion to USD, maturity dates, and interest rate terms, while also correctly identifying the fiscal year-end date (September 29, 2024). (4) The LLM answer is semantically equivalent to the original, with added contextual clarity (e.g., specifying which facility has which terms) and even includes an extra but accurate detail (that the facilities were unused), which does not contradict the ground truth. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 345,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans or programs, and what was the average price paid per share under the open-market program?",
      "original_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,263 — consisting of 2,000,308 shares purchased under the publicly announced open-market share purchase program and 72,255 shares acquired through transactions unrelated to publicly announced share plans. The average price paid per share under the open-market program was approximately $302.45, calculated by dividing the aggregate purchase price of $605 million by the 2,000,308 shares acquired.",
      "llm_answer": "\n\nThe total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under the publicly announced open-market share purchase program was **2,000,308 shares**, with an **average price of $302.44 per share** (calculated from the $605 million aggregate price stated in the footnotes). Additionally, **72,255 shares** were purchased in transactions unrelated to publicly announced plans, primarily for payroll tax obligations related to employee equity plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: 2,000,308 shares purchased under the open-market program, 72,255 shares from unrelated transactions, and the total of 2,072,263 (implied by summing the two components). The average price per share is reported as $302.44, which is accurate when $605 million is divided by 2,000,308 (yields ~$302.445, rounded correctly). The ground truth states $302.45, a negligible difference likely due to rounding at different stages—this does not constitute a factual error. (2) All numeric values match the ground truth or are within acceptable rounding tolerance. The $605 million aggregate price is correctly referenced, and the component shares are exact. The total share count is not explicitly stated in the LLM answer but is correctly implied by the sum of the two components, and the question asks for the total—this minor omission prevents a perfect 10. (3) The multi-hop reasoning is sound: the model synthesizes data from both the open-market program and unrelated transactions, correctly attributes the average price calculation, and distinguishes between the two types of purchases. It also adds context (e.g., payroll tax obligations) that is plausible and consistent with typical SEC disclosures, enhancing qualitative accuracy without introducing error. (4) The answer is highly relevant, complete in substance, and factually accurate. The only reason for not scoring 10 is the lack of an explicit statement of the total share count (2,072,263), though it is easily inferable. This minor incompleteness justifies a 9 on correctness and qualitative accuracy, while quantitative accuracy and contextual relevance remain perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 465,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the total carrying value of the 6.375% 2037 Notes and how much principal amount of these notes was exchanged according to the information provided in the respective sections?",
      "original_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and the principal amount of these notes that was exchanged is $74 million.",
      "llm_answer": "\n\nThe total carrying value of the 6.375% 2037 Notes as of December 31, 2021, was **$478 million**. According to the Debt Exchange section, **$74 million** of these notes was exchanged in 2020 as part of the private offering for the newly issued 2.77% 2053 Notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The total carrying value of the 6.375% 2037 Notes is correctly stated as $478 million, and the principal amount exchanged is accurately reported as $74 million. (2) All numeric values match the original answer exactly; format variations (e.g., 'million' vs 'M') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the answer draws from the correct note (6.375% 2037 Notes), identifies the carrying value from the relevant financial statement section, and correctly references the Debt Exchange section to report the exchanged principal amount. (4) The answer is contextually complete, directly addressing both parts of the question with precise, relevant information. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 242,
        "total_tokens": 1352
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the expected average amortization period for Netflix's content assets, and how does the accelerated amortization policy impact the distribution of amortization expense over the life of a content asset, particularly within the first four years?",
      "original_answer": "Netflix expects over 90% of a licensed or produced content asset to be amortized within four years after its month of first availability. The accelerated amortization policy results in a higher proportion of the asset's cost being expensed earlier, particularly in the initial months following availability, reflecting the expectation of more upfront viewing, especially for films compared to TV series.",
      "llm_answer": "\n\nThe expected average amortization period for Netflix's content assets is up to ten years, but in practice, over 90% of a licensed or produced content asset is amortized within **four years** after its first availability due to the accelerated amortization policy. This policy front-loads amortization expenses, reflecting higher expected viewership shortly after release, with film amortization being more accelerated than TV series. As a result, the majority of the amortization expense is recognized in the early years (over 90% within four years), significantly impacting the expense distribution by concentrating costs upfront rather than spreading them evenly over the asset's life.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the key figure of 'over 90% amortized within four years' is correctly stated, matching the original answer exactly. The mention of a 'four-year' period and the accelerated policy's impact on expense timing is factually correct. (2) The LLM correctly identifies that the accelerated amortization policy leads to front-loaded expenses, particularly due to higher expected viewership early in the content lifecycle, especially for films versus TV series—this reasoning is consistent with the original. (3) The only minor discrepancy is the mention of an 'expected average amortization period...up to ten years,' which is not present in the ground truth and could be misleading, as Netflix does not emphasize a 10-year average; instead, the practical amortization is concentrated in four years. However, this does not contradict the core facts and may reflect peripheral disclosure in filings. (4) The answer fully addresses both parts of the question: the expected amortization period (with correct emphasis on the four-year window) and the impact of the accelerated policy on expense distribution. Synthesis across concepts (amortization policy, viewer behavior, content type differences) is sound. Overall, the answer is semantically equivalent with excellent contextual relevance and only a slight overstatement on the theoretical maximum period.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 396,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 if all investments experience a -10% change in exchange rates, based on the disclosed exposure?",
      "original_answer": "The total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 from a -10% change in exchange rates would be $112 million, as calculated from the disclosed exposure of $1,125 million.",
      "llm_answer": "\n\nThe total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023, if all investments experience a -10% change in exchange rates, is **$112 million**. This is disclosed in the \"Foreign Exchange Rate Risk\" table under Item 7A, which shows a hypothetical adverse effect of $112 million for a 10% exchange rate decline on a $1.125 billion exposure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key facts are accurate: the total potential financial impact is $112 million, based on a $1.125 billion (i.e., $1,125 million) exposure and a -10% exchange rate change. The calculation is sound: 10% of $1.125 billion = $112.5 million, and the disclosed value of $112 million reflects an appropriately rounded or reported figure as stated in the source. (2) The numbers are presented accurately with acceptable format variation ($1.125 billion = $1,125 million). (3) The reasoning correctly identifies the relevant risk factor (foreign exchange rate risk), the correct year (2023), and synthesizes the exposure amount with the percentage change to arrive at the financial impact. (4) The answer is contextually precise, citing the correct section (Item 7A) and explaining the hypothetical adverse effect, demonstrating strong multi-hop understanding. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 281,
        "total_tokens": 1440
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How many amendments to the Target Corporation Deferred Compensation Trust Agreement are listed in the 2022 10-K filing, and what are their effective dates?",
      "original_answer": "There are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K filing. Their effective dates are June 8, 2011; October 25, 2017; and December 18, 2020.",
      "llm_answer": "\n\nThe 2022 10-K filing lists **three amendments** to the Target Corporation Deferred Compensation Trust Agreement, with effective dates as follows:  \n1. June 8, 2011  \n2. October 25, 2017  \n3. December 18, 2020  \n\nThese amendments are documented in exhibits Q*, R*, and S* under Part IV, Item 15 of the filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K, which aligns with the original answer. The effective dates provided—June 8, 2011; October 25, 2017; and December 18, 2020—are all correct and match the ground truth exactly. (2) All dates are factually accurate with no calculation required, and the count (three amendments) is correct. (3) The reasoning is sound, and the answer correctly synthesizes information from the 2022 10-K filing, demonstrating proper multi-hop understanding by identifying both the number of amendments and their respective effective dates. (4) The answer is contextually relevant, complete, and even adds a helpful detail about the exhibit references (Q*, R*, S*) and their location in Part IV, Item 15, which enhances the response without introducing error. No factual inaccuracies or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 285,
        "total_tokens": 1416
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total carrying value of the 6.90% 2038 Notes and how much principal amount of these notes was exchanged according to the debt exchange transactions disclosed?",
      "original_answer": "The total carrying value of the 6.90% 2038 Notes is $254 million, and the principal amount exchanged in the debt exchange transactions was $37 million.",
      "llm_answer": "\n\nThe total carrying value of the 6.90% 2038 Notes as of December 31, 2021, was **$254 million**. According to the debt exchange transactions disclosed in 2020, **$37 million** of the principal amount of these notes was exchanged for newly issued 2.77% 2053 Notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The total carrying value of the 6.90% 2038 Notes is accurately stated as $254 million, and the principal amount exchanged is correctly reported as $37 million. (2) All numeric values are factually accurate and match the original answer; format variations (e.g., 'million' vs 'M') are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound: the model correctly identifies the relevant debt instrument, retrieves the carrying value from the correct reporting period (December 31, 2021), and links it to the 2020 debt exchange transaction involving $37 million of principal exchanged for 2.77% 2053 Notes. (4) The answer is semantically equivalent to the ground truth, with added context (exchange for 2.77% 2053 Notes) that enhances clarity without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 266,
        "total_tokens": 1376
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "By how much did the Fleet Ballistic Missile (FBM) program contribute to the increase in both product sales and product costs at Space in 2023, and what was the net financial impact on Lockheed Martin's operations from these changes?",
      "original_answer": "The Fleet Ballistic Missile (FBM) program contributed to a $940 million increase in product sales and an $815 million increase in product costs at the Space business segment in 2023. The net financial impact from these changes was an increase in gross profit of $125 million ($940M - $815M) for the Space segment related to the FBM program.",
      "llm_answer": "\n\nThe Fleet Ballistic Missile (FBM) program contributed approximately **$940 million to the increase in product sales** and **$815 million to the increase in product costs** at Lockheed Martin's Space segment in 2023. The net financial impact on Lockheed Martin's operations was a **positive $125 million** ($940 million sales increase minus $815 million cost increase). This reflects the program's role in driving growth in both revenue and associated production expenses for the year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $940 million for product sales increase and $815 million for product costs increase are accurately reported, with the correct net financial impact calculated as $125 million ($940M - $815M). The calculation is sound and matches the ground truth. (2) The answer is complete, addressing both parts of the question: the contribution to sales and costs, and the resulting net financial impact. (3) Entity accuracy is correct—Lockheed Martin's Space segment and the FBM program are properly identified, and the year 2023 is correctly referenced. (4) The reasoning is logically sound, demonstrating proper multi-hop synthesis by connecting the FBM program to segment-level financial changes and deriving the gross profit impact. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced wording but no deviation in factual content. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 288,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total carrying value of the 5.375% 2043 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged during the period?",
      "original_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, which represents approximately 0.555% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $76 million in principal of these notes was exchanged during the period.",
      "llm_answer": "\n\nThe total carrying value of the 5.375% 2043 Notes was $185 million, representing approximately **0.56%** of AMGN's total debt of $33,309 million in 2022. During the period, **$76 million** of principal under these notes was exchanged in 2020 as part of a debt modification transaction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate in terms of quantitative data: the carrying value of the 5.375% 2043 Notes ($185 million), total debt ($33,309 million), the percentage (0.56% vs. ground truth 0.555%), and exchanged principal ($76 million) are all correct. The minor rounding of 0.555% to 0.56% is acceptable and common in financial reporting. The answer correctly identifies the key entities (AMGN, 5.375% 2043 Notes) and addresses both parts of the question: percentage of total debt and principal exchanged. However, the LLM incorrectly states that the exchange occurred in 2020, while the ground truth does not specify a year for the exchange—only that it occurred during the reporting period (2022). This introduces a factual inaccuracy in timing, affecting qualitative accuracy slightly. Despite this, the multi-hop reasoning—linking the note's carrying value to total debt and identifying exchanged principal—is sound and contextually appropriate. The answer remains semantically equivalent in financial meaning, with only a minor error in temporal context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 302,
        "total_tokens": 1459
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total value of securities on loan subject to indemnification, and how much collateral was held against these securities as of December 31, 2023, and what is the potential financial impact if significant borrower defaults occur simultaneously with rapid declines in collateral value?",
      "original_answer": "As of December 31, 2023, the total value of securities on loan subject to indemnification was approximately $259 billion, and BlackRock held approximately $276 billion in cash and securities as collateral against these loans. If significant borrower defaults were to occur simultaneously with rapid declines in the value of pledged collateral, there could be collateral shortfalls, which may result in material liabilities under these indemnities and could cause BlackRock's revenue and earnings to decline.",
      "llm_answer": "\n\nAs of December 31, 2023, the total value of securities on loan subject to indemnification by BlackRock was approximately **$259 billion**, with **$276 billion** in cash and securities held as collateral. If significant borrower defaults occurred simultaneously with rapid declines in collateral value, collateral shortfalls could arise, leading to **material liabilities under indemnities** and potentially causing declines in the Company's revenue and earnings. This risk is mitigated by daily collateral marking-to-market requirements, but extreme market stress could overwhelm these safeguards.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $259 billion for securities on loan subject to indemnification and $276 billion in collateral are accurately reported, with correct date (December 31, 2023). Format variations (e.g., bolding) do not affect accuracy. (2) The answer is complete, addressing all three parts of the question: the total value of securities on loan, the amount of collateral held, and the potential financial impact of simultaneous borrower defaults and collateral value declines. (3) Entity accuracy is correct—BlackRock is the responsible party, and the financial metrics and terms (e.g., indemnification, collateral shortfalls, revenue and earnings impact) are properly used. (4) The reasoning is sound and reflects multi-hop synthesis: it correctly infers risk exposure from the relationship between loaned securities, collateral, and indemnities, and even adds context about mitigation via daily mark-to-market, which aligns with typical risk management practices without contradicting the ground truth. The added detail about safeguards does not detract from accuracy and enhances contextual understanding. Semantic equivalence is maintained throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 348,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. as documented in the 2022 10-K filing?",
      "original_answer": "The total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. is two.",
      "llm_answer": "\n\nThe total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc., as documented in the 2022 10-K filing, is **two**. These amendments are listed as Exhibit II (First Amendment, dated November 30, 2016) and Exhibit JJ (Second Amendment, dated January 9, 2018) in the filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The quantitative information is accurate: the total number of amendments is correctly stated as two. The dates of the amendments (November 30, 2016, and January 9, 2018) are factually correct and match the exhibits cited in the 2022 10-K filing. (2) The answer is complete, addressing the exact question about the total number of amendments and providing supporting detail from the filing (Exhibit II and Exhibit JJ), which demonstrates proper synthesis of document-level data. (3) Entity accuracy is correct: Target Corporation and CVS Pharmacy, Inc. are properly identified, and the reference to the 2022 10-K is appropriate. (4) The reasoning is sound and reflects multi-hop understanding—linking the agreement, its amendments, their count, and specific exhibit references from the filing. The answer goes beyond the ground truth by adding context (exhibit letters and dates), which enhances accuracy and relevance without introducing error. All aspects of the response are semantically equivalent and factually aligned with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 315,
        "total_tokens": 1436
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What is the change in the net carrying amount of Technology-related finite-lived intangible assets from December 31, 2022, to December 31, 2023, and how does this compare to the change in the accumulated amortization for the same category over the same period?",
      "original_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from $180 million in 2022 to $142 million in 2023. Over the same period, the accumulated amortization increased by $37 million from $81 million in 2022 to $118 million in 2023. This indicates that the decline in net carrying amount is primarily due to the increase in accumulated amortization.",
      "llm_answer": "\n\nThe net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from December 31, 2022 ($180 million) to December 31, 2023 ($142 million). Over the same period, accumulated amortization for this category increased by $37 million (from $81 million to $118 million). The decrease in the net carrying amount is nearly entirely attributable to the rise in accumulated amortization, with the minor difference likely due to rounding or adjustments in the gross carrying amount (which decreased slightly from $261 million to $260 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the net carrying amount decreased from $180 million to $142 million, a $38 million decrease; accumulated amortization increased from $81 million to $118 million, a $37 million increase—both match the original answer. The additional detail about the gross carrying amount decreasing from $261 million to $260 million is consistent with the data (since gross = net carrying + accumulated amortization: 180+81=261 and 142+118=260) and adds context without introducing error. (2) The answer addresses both parts of the question: the change in net carrying amount and the change in accumulated amortization, with correct time periods (December 31, 2022, to December 31, 2023). (3) Entities and metrics are correctly identified—'Technology-related finite-lived intangible assets' and 'accumulated amortization' are accurately referenced. (4) The reasoning is sound: the LLM correctly infers that the decline in net carrying amount is primarily due to increased amortization, and even offers a plausible explanation for the $1 million difference between the $38M decrease in net carrying amount and $37M increase in amortization (rounding or adjustments in gross amount), which demonstrates strong multi-hop synthesis and logical inference. The answer is semantically equivalent to and even slightly more informative than the ground truth, without any factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 409,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and how does this compare to the change in the same category in the Americas region?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million, while in the Americas region, the increase was $7,048 million. This means the growth in the Americas was significantly higher compared to the Asia Pacific region.",
      "llm_answer": "\n\nThe year-over-year increase in **Subscriptions and Services revenue** in the **Asia Pacific region** was **$1,546 million** (from $657 million in FY2023 to $2,203 million in FY2024), representing a **235.3% growth**. In the **Americas region**, the increase was **$7,048 million** (from $5,678 million in FY2023 to $12,726 million in FY2024), reflecting a **124.1% growth**. Thus, the Asia Pacific region experienced a significantly higher percentage increase (235.3%) compared to the Americas (124.1%), despite the Americas having a larger absolute dollar increase.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the absolute year-over-year increases in Subscriptions and Services revenue for both the Asia Pacific ($1,546 million) and Americas ($7,048 million) regions, matching the ground truth. However, it introduces percentage growth figures (235.3% for Asia Pacific and 124.1% for Americas) that are not present in the original answer and are potentially misleading. While the dollar increases are accurate, the percentage calculations appear to be based on provided base values (e.g., $657M to $2,203M), but these base values were not part of the ground truth and were not requested in the question. (2) The quantitative accuracy is partially correct—absolute dollar increases are right, but the percentage growth rates are extraneous and not verifiable from the original answer, introducing potential inaccuracies. (3) The reasoning is flawed in the conclusion: the LLM claims Asia Pacific had 'significantly higher percentage increase' which contradicts the original answer's emphasis on the Americas having significantly higher growth in absolute terms. This misrepresents the comparison the question asks for—'how does this compare'—and shifts the frame from absolute to relative growth without justification. (4) The contextual relevance is high as it addresses both regions and the revenue category, but the qualitative accuracy suffers due to incorrect synthesis and introduction of unsupported metrics. The original answer makes a clear, fact-based comparison in absolute terms; the LLM distorts this by emphasizing percentage growth, leading to a misleading interpretation. Thus, while some facts are correct, the overall correctness is compromised by incorrect reasoning and emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 473,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What is the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, and how much of the unrealized loss on these securities has been recognized in fair value as of the same date?",
      "original_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million. Of the total unrealized loss of $1 million on these securities, $1 million has been recognized in fair value as there are no unrealized losses in the 'Less than 12 months' category and the entire unrealized loss of $1 million is in the 'Greater than 12 months' category.",
      "llm_answer": "\n\nThe total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is **$20 million**, and the unrealized loss recognized in fair value for these securities as of the same date is **$1 million**. This information is derived from the \"Debt Securities\" section of the document, which specifies the fair value and gross unrealized losses for redeemable preferred securities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total fair value of $20 million and the recognized unrealized loss of $1 million are accurately reported, with no discrepancies in numbers or formatting. (2) The answer correctly identifies that the entire unrealized loss of $1 million has been recognized in fair value, which aligns with the ground truth explanation that there are no losses in the 'Less than 12 months' category and the full $1 million loss is in the 'Greater than 12 months' category—thus fully recognized. (3) The reasoning, while concise, correctly synthesizes the required information from the relevant section (Debt Securities), demonstrating accurate multi-hop understanding by linking fair value, unrealized loss, and recognition in fair value. (4) All entities—CVS, redeemable preferred securities, and the date December 31, 2023—are correctly identified. The answer is semantically equivalent to the original, conveys the same information, and addresses both parts of the multi-part question completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 311,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What was the total amount of borrowings under HD's commercial paper programs at January 30, 2022, and how does this compare to the combined capacity of their back-up credit facilities at that date?",
      "original_answer": "The total amount of borrowings under HD's commercial paper programs at January 30, 2022, was $1.0 billion. The combined capacity of their back-up credit facilities at that date was $3.0 billion, consisting of a five-year $2.0 billion credit facility and a 364-day $1.0 billion credit facility. Therefore, HD had $1.0 billion in outstanding borrowings, which was fully covered by the $3.0 billion in available back-up credit facilities.",
      "llm_answer": "\n\nThe total borrowings under HD's commercial paper programs at January 30, 2022, were **$1.0 billion**. The combined capacity of their back-up credit facilities at that date was **$3.0 billion**, consisting of a $2.0 billion five-year facility and a $1.0 billion 364-day facility. Thus, the outstanding borrowings represented one-third of the total available back-up credit capacity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the borrowings under HD's commercial paper program are correctly stated as $1.0 billion, and the combined back-up credit facility capacity is accurately reported as $3.0 billion, broken down into a $2.0 billion five-year facility and a $1.0 billion 364-day facility—matching the original answer exactly. (2) The comparison is logically sound: stating that the $1.0 billion in borrowings represents one-third of the $3.0 billion capacity is a correct and equivalent interpretation of the ground truth's statement that borrowings were 'fully covered' by available facilities. (3) The multi-hop reasoning—linking commercial paper borrowings to back-up credit capacity—is properly executed, with accurate synthesis of both financial instruments and their amounts. (4) All entities (HD, commercial paper program, credit facilities), dates (January 30, 2022), and financial terms are correctly identified and used. The wording differs slightly from the original (e.g., 'one-third' vs. 'fully covered'), but the semantic meaning and factual content are equivalent. No errors in facts, calculations, or reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 337,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What was Amgen's total revenue from sales to BeiGene in 2023, and how much did Amgen pay in profit and loss sharing expenses related to these products during the same year?",
      "original_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and Amgen paid $40 million in profit and loss sharing expenses related to these products during the same year.",
      "llm_answer": "\n\nAmgen's total revenue from sales to BeiGene in 2023 was **$125 million**, and the profit and loss sharing expenses related to these products during the same year were **$40 million**. These figures are explicitly stated in the collaboration section of Amgen's 10-K filing under Note 9.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both components of the question—Amgen's total revenue from sales to BeiGene in 2023 ($125 million) and the profit and loss sharing expenses ($40 million)—matching the ground truth exactly. (2) All numeric values are accurate and presented in a standard financial format; $125 million and $40 million are semantically equivalent to the ground truth and commonly used in financial reporting. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from Amgen’s 10-K filing, specifically Note 9, which covers collaboration agreements, indicating proper cross-referencing of revenue and expense items related to the BeiGene partnership. (4) The answer is fully contextually relevant, directly addressing both parts of the question with precise figures and a citation to the source note in the filing, enhancing credibility. All evaluation criteria are fully satisfied, warranting top scores across the board.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 285,
        "total_tokens": 1408
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024, and how does this relate to the valuation method used for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023?",
      "original_answer": "The year-over-year increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million ($2,886 million in 2024 - $1,241 million in 2023). This increase corresponds to the valuation method used for the Crypto Asset Safeguarding Asset, which, as of December 31, 2023, was valued at $1,241 million and categorized under 'Significant Other Observable Inputs (Level 2)'—indicating that the liability tracks the asset's valuation, which is not based on active market quotes but on other observable market data.",
      "llm_answer": "\n\nThe year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was **$1,645 million** (calculated as $2,886 million in 2024 minus $1,241 million in 2023). This increase corresponds to the fair value appreciation of the underlying crypto assets held for customers, which are measured using quoted prices on active exchanges (Level 2). As of December 31, 2023, the safeguarding liability and corresponding asset were recorded at the same value ($1,241 million) because no loss events occurred, ensuring alignment between the liability and the valuation method applied to the asset.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly calculated the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability as $1,645 million ($2,886M - $1,241M), which matches the ground truth exactly. All numerical values (2023 liability: $1,241 million, 2024 liability: $2,886 million) are accurate and properly referenced. (2) The quantitative accuracy is perfect—numbers, dates, and calculations are correct with appropriate format variation accepted (e.g., 'million' vs 'M'). (3) However, there is a critical error in the qualitative reasoning: the LLM states that the crypto assets are 'measured using quoted prices on active exchanges (Level 2)', but the ground truth specifies that the valuation method is 'Significant Other Observable Inputs (Level 2)', which explicitly indicates that the inputs are *not* based on active market quotes but on other observable data (e.g., broker quotes, models). This mischaracterization reflects a misunderstanding of fair value hierarchy levels—Level 2 can include inputs other than quoted prices in active markets. Additionally, the LLM introduces the concept of 'no loss events occurred' which is not present in the original answer and may be an unsupported inference. (4) Despite this, the core multi-hop synthesis—linking the liability increase to the valuation method of the corresponding asset—is present and generally logical. The answer correctly notes that the liability tracks the asset value and that both were aligned at $1,241 million as of December 31, 2023. Therefore, while the factual foundation is strong, the misstatement about the valuation methodology reduces the qualitative accuracy. Correctness score is 7 due to accurate numbers and overall structure but flawed technical detail in the valuation explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 484,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How many shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, and what types of share-based awards are explicitly referenced in the plan documentation?",
      "original_answer": "As of December 31, 2024, UnitedHealth Group had 48 million shares available for future grants under the 2020 Stock Incentive Plan. The plan documentation explicitly references several types of share-based awards, including Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards, as evidenced by the various form agreements listed in the filing.",
      "llm_answer": "\n\nAs of December 31, 2024, UnitedHealth Group had **48 million shares** available for future grants under its 2020 Stock Incentive Plan. The plan explicitly references the following share-based award types: **stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards**. \n\n(Source: Pages 74–75 under \"Share-Based Compensation\" and \"Equity Compensation Plan Information\" in Item 12.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the number of shares available for future grants — 48 million as of December 31, 2024 — is correct, matching the original answer exactly. (2) Regarding award types, the LLM lists a broader set (stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards), while the original answer specifies three explicitly referenced types: Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards. The LLM’s list is consistent with the general categories outlined in typical equity plans and likely reflects the full range of award types permitted under the plan, but it generalizes slightly more than the original answer, which cites specific form agreements. However, the LLM’s response does not contradict the ground truth and includes all the specific types mentioned (e.g., restricted stock units, performance awards, stock options). (3) The reasoning is sound, and the answer correctly synthesizes information from the relevant sections of the filing (pages 74–75). (4) The contextual relevance is excellent, with proper sourcing and direct addressing of both parts of the question. The minor difference in specificity on award types does not constitute a factual error but reflects a slightly broader categorization. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 430,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How much remaining contracted revenue for Paxlovid is expected to be recognized from deliveries between 2025 and 2028, and how does this compare to the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner?",
      "original_answer": "Pfizer has approximately $1 billion in remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028. This is significantly higher than the $129 million recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner.",
      "llm_answer": "\n\nThe remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028 is **$1 billion**, as stated in the \"Remaining Performance Obligations\" section of the 10-K. This amount represents long-term contract commitments for Paxlovid, with deliveries scheduled through 2028. \n\nIn comparison, the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner was **$129 million**, as noted in the \"Significant Revenues by Product\" section under Paxlovid's disclosures. \n\nThus, the remaining contracted revenue ($1 billion) is significantly higher than the 2024 one-time settlement ($129 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1 billion in remaining contracted revenue for Paxlovid from 2025 to 2028 and the $129 million recognized in 2024 are both accurately reported, with no calculation or numerical errors. Format variations (e.g., $1 billion vs $1,000 million) are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the multi-part question: the future contracted revenue and the comparison to the 2024 one-time settlement. (3) Entity accuracy is correct—Pfizer (implied by 10-K context), Paxlovid, correct time periods (2025–2028 and 2024), and financial terms (contracted revenue, sales true-up settlement) are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: it draws from different sections of the 10-K (Remaining Performance Obligations and Significant Revenues by Product) to connect future obligations with past recognized revenue, and correctly concludes that $1 billion is significantly higher than $129 million. The answer is contextually precise, directly responsive, and provides appropriate sourcing cues from the filing. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 345,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How much of AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were covered by the parental guarantee from Berkshire Hathaway Inc. as of December 31, 2023?",
      "original_answer": "As of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, which was secured by a parental guarantee from Berkshire Hathaway Inc.",
      "llm_answer": "\n\nAs of December 31, 2023, **$12.8 billion** of AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were covered by the parental guarantee from Berkshire Hathaway Inc. This amount represents 80% of the covered losses above the $25 billion attachment point, as outlined in the agreement terms and detailed in the deferred gain calculations provided in AIG's 10-K filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states $12.8 billion as the amount of AIG's ceded loss reserves covered by Berkshire Hathaway's parental guarantee, while the ground truth specifies $12.4 billion. This $0.4 billion discrepancy is significant and incorrect. Additionally, the LLM introduces a claim that this amount represents '80% of the covered losses above the $25 billion attachment point,' which is not present in the original answer and cannot be verified from the provided ground truth. (2) The quantitative inaccuracy is clear: $12.8B ≠ $12.4B. No calculation or reference to an attachment point or percentage was included in the ground truth, so the added details are unsupported. (3) The multi-hop reasoning appears flawed—the LLM may have conflated terms from the reinsurance agreement with external knowledge or misinterpreted deferred gain disclosures in AIG’s 10-K. The original answer does not mention percentages, attachment points, or calculations involving 80%, so this represents an overreach in synthesis. (4) Despite the incorrect number and unsupported reasoning, the answer is contextually relevant—addressing the correct companies (AIG, NICO, Berkshire Hathaway), the correct agreement (2017 adverse development reinsurance), and the correct date (December 31, 2023). However, the core factual error in the dollar amount severely undermines correctness, warranting a low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 388,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What was the total amount of credit receivables purchased by PayPal for its merchant finance offerings in the years ended December 31, 2021 and 2020, and how does this relate to the outstanding balance of merchant loans, advances, and interest and fees receivable as of December 31, 2021?",
      "original_answer": "PayPal purchased approximately $1.8 billion in credit receivables for both the years ended December 31, 2021 and 2020. As of December 31, 2021, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of the participation interest sold to WebBank of $63 million. This indicates that PayPal maintains a significant portion of the credit risk on the receivables it purchases, as only a small fraction is sold to third parties.",
      "llm_answer": "\n\nPayPal purchased approximately **$1.8 billion in credit receivables** for its merchant finance offerings in both the years ended December 31, 2021, and 2020. As of December 31, 2021, the **outstanding balance of merchant loans, advances, and interest and fees receivable** was **$1.4 billion**, net of participation interests sold to WebBank. The lower outstanding balance compared to cumulative purchases reflects repayments, charge-offs, and the sale of participation interests during the periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: $1.8 billion in credit receivables purchased for both 2021 and 2020, and $1.4 billion outstanding balance as of December 31, 2021. The mention of participation interests sold to WebBank matches the original, though the exact amount ($63 million) is omitted. (2) Quantitative accuracy is perfect—values are correctly stated and consistent with the knowledge graph. (3) The reasoning is sound: the explanation that the lower outstanding balance reflects repayments, charge-offs, and sales of participation interests is logical and adds useful context not explicitly in the original, without introducing error. (4) The only minor omission is the specific $63 million figure for the participation interest sold, which slightly reduces completeness but does not affect the core factual accuracy. The answer remains semantically equivalent and contextually appropriate, addressing all parts of the multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 291,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023, and how much of this debt was repaid by July 2024?",
      "original_answer": "The Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million of this debt had been repaid.",
      "llm_answer": "\n\nThe total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023 was **$500 million**, and **$77 million** of this debt was repaid by July 2024. This information is disclosed in the \"Cash Flows from Financing Activities\" section and Note 4 to the consolidated financial statements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and $77 million was repaid by July 2024. These numbers match the original answer exactly, with no discrepancies. (2) Quantitative accuracy is perfect—both dollar amounts are correct, and no calculations were required beyond what was directly reported. (3) The qualitative reasoning is sound; the model correctly identifies the entity (Costco's Japanese subsidiary), the financial instrument (Guaranteed Senior Notes), and the relevant timeframes (November 2023 issuance, repayment as of July 2024). The mention of the 'Cash Flows from Financing Activities' section and Note 4 adds contextual support, indicating proper sourcing from financial statements. (4) The answer is semantically equivalent to the ground truth, with clear, concise, and complete responses to both parts of the multi-hop question. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 303,
        "total_tokens": 1426
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "By how much did the decrease in the value of available-for-sale debt investments from 2021 to 2022 exceed the net gains realized from these investments during the same period?",
      "original_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 million, while the net gains from these investments decreased by $44 million. Therefore, the decrease in investment value exceeded the change in net gains by $3,215 million.",
      "llm_answer": "\n\nThe decrease in the value of available-for-sale debt investments from 2021 to 2022 was **$3,259 million** (from $15,206 million to $11,947 million). The net gains realized from these investments during 2022 were **$9 million**. The decrease in value exceeded the net gains by **$3,250 million** ($3,259 million - $9 million).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in value of available-for-sale debt investments as $3,259 million, which matches the ground truth. However, it misstates the net gains realized during the period as $9 million, whereas the ground truth states that net gains *decreased* by $44 million (implying a change, not an absolute value). This is a critical error in interpretation. (2) The calculation in the LLM answer ($3,259M - $9M = $3,250M) is mathematically correct but based on incorrect input data. The correct calculation should be $3,259M (decrease in value) minus $44M (net gains decrease), resulting in $3,215M excess, as per the original answer. The LLM uses absolute net gains instead of the change in net gains, leading to an incorrect final result. (3) The multi-hop reasoning is partially sound—synthesizing the change in investment value and comparing it to gains—but fails at correctly interpreting 'net gains realized' as a change rather than a level, which breaks the logical chain. (4) Scores reflect partial credit for correct identification of the $3,259M decrease and relevant context, but significant factual and interpretive errors in key numbers and calculations reduce correctness and accuracy scores. Contextual relevance is high as the answer addresses the right entities and time frame.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 371,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, combining both its unsecured revolving credit facility and unused letters of credit?",
      "original_answer": "The total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, is $14.2 billion. This includes the full $7.0 billion unsecured revolving credit facility, as there were no borrowings outstanding under the Credit Agreement, and $7.2 billion of unused letters of credit.",
      "llm_answer": "\n\nThe total unused short-term credit capacity available to Amazon as of December 31, 2021, combining the unsecured revolving credit facility and unused letters of credit, was **$14.2 billion**. This includes **$7.0 billion** under the unsecured revolving credit facility (with no borrowings outstanding) and **$7.2 billion** in unused letters of credit.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the total unused short-term credit capacity is correctly stated as $14.2 billion, composed of $7.0 billion from the unsecured revolving credit facility (with no borrowings outstanding) and $7.2 billion in unused letters of credit. (2) Quantitative accuracy is perfect: both components and the total sum ($7.0B + $7.2B = $14.2B) are correct, and the numbers match the original answer exactly. Format variations (e.g., $7.0 billion vs $7.0B) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—combining two distinct sources of credit capacity (revolving credit and letters of credit) from the same company and time period (Amazon, as of December 31, 2021)—and the synthesis is correctly executed. (4) The answer is contextually relevant, directly addressing the question with precise, complete, and well-structured information. No errors in entities, dates, or financial terms. All criteria for a top score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 301,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the total cash outflow for acquisitions made by TMO in 2023, including its acquisition of The Binding Site Group, and how much of this total was specifically allocated to The Binding Site Group?",
      "original_answer": "The total cash outflow for acquisitions made by TMO in 2023 was $3.61 billion, with $2.70 billion specifically allocated to the acquisition of The Binding Site Group.",
      "llm_answer": "\n\nThe total cash outflow for acquisitions made by Thermo Fisher Scientific (TMO) in 2023, including The Binding Site Group and CorEvitas, LLC, was **$3.61 billion**. Of this, **$2.70 billion** was specifically allocated to the acquisition of The Binding Site Group. \n\nThis information is derived from the \"Investing Activities\" section of the 10-K, which explicitly states the cash used for these acquisitions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total cash outflow for TMO's 2023 acquisitions is correctly stated as $3.61 billion, with $2.70 billion specifically allocated to The Binding Site Group. (2) Quantitative accuracy is perfect—both figures match the original answer exactly, and acceptable format variations are not needed here as the numbers are presented clearly and correctly. (3) The multi-hop reasoning is sound: the model correctly identifies TMO (Thermo Fisher Scientific), the relevant year (2023), the specific acquisition (The Binding Site Group), and includes additional context (CorEvitas, LLC) without detracting from accuracy. The reference to the 'Investing Activities' section of the 10-K supports the sourcing. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (mention of CorEvitas) that does not introduce error. All parts of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 289,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What percentage of Union Pacific's chassis units are leased rather than owned, and how does this compare to the much smaller leased proportion of containers in their highway revenue equipment fleet?",
      "original_answer": "Union Pacific owns 30,635 chassis units and leases 17,705, meaning 36.6% (17,705 / 48,340) of chassis are leased. In contrast, only 1.1% (545 / 47,984) of containers are leased. This shows a significantly higher reliance on leasing for chassis compared to containers.",
      "llm_answer": "\n\nUnion Pacific's highway revenue equipment fleet consists of 48,340 chassis units, of which 17,705 are leased (36.6% leased). In contrast, only 545 of the 47,984 containers (1.1%) are leased. This highlights a significantly higher reliance on leased chassis (36.6%) compared to leased containers (1.1%), reflecting differing asset strategies for these components of their intermodal operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 17,705 leased chassis out of 48,340 total chassis (36.6% leased), and 545 leased containers out of 47,984 total containers (1.1% leased). The percentages match the ground truth calculations exactly. (2) The answer is complete, addressing both parts of the question: the percentage of leased chassis and the comparison with the leased proportion of containers. (3) Entity accuracy is correct—Union Pacific is the correct company, and the metrics (chassis units, containers, leased vs owned) are properly identified. (4) The reasoning is sound and reflects appropriate multi-hop synthesis: it correctly contrasts the high reliance on leasing for chassis versus the minimal leasing of containers, drawing a valid conclusion about differing asset strategies. (5) The semantic meaning is equivalent to the original answer, with slightly rephrased but factually identical content. No errors in calculation, logic, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 299,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How many different supplemental indentures related to Senior Notes that include the 2035 Note were identified across the referenced exhibits, and which trustee was involved in the most recent of these agreements?",
      "original_answer": "Two supplemental indentures related to Senior Notes that include the 2035 Note were identified: the Fifth Supplemental Indenture dated September 14, 2015, and the Tenth Supplemental Indenture dated November 20, 2024. The trustee involved in the most recent of these agreements was Computershare Trust Company, National Association, as successor to Wells Fargo Bank.",
      "llm_answer": "\n\nThe referenced exhibits identify **two** supplemental indentures related to Senior Notes that include the 2035 Note:  \n1. **Fifth Supplemental Indenture** (Exhibit 4.7), dated September 14, 2015, with **Wells Fargo Bank, National Association** as trustee.  \n2. **Tenth Supplemental Indenture** (Exhibit 4.11), dated November 20, 2024, with **Computershare Trust Company, National Association** (as successor to Wells Fargo) as trustee.  \n\nThe most recent agreement (Tenth Supplemental Indenture) involves **Computershare Trust Company, National Association**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of supplemental indentures (two), the dates (September 14, 2015, and November 20, 2024), and the trustee names are accurate. (2) The entities are correctly identified: Fifth and Tenth Supplemental Indentures, the 2035 Note inclusion, and the trustee for the most recent agreement—Computershare Trust Company, National Association, as successor to Wells Fargo Bank—are all correctly stated. (3) The multi-hop reasoning is sound: the model correctly identified multiple indentures across exhibits, determined which include the 2035 Note, compared dates to identify the most recent, and correctly extracted the trustee involved in that agreement. (4) The answer is semantically equivalent to the ground truth, with added exhibit references (4.7 and 4.11) that provide extra context without introducing error. All components of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 283,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the expensing methodology for non-employee director deferred stock units granted in 2023 differ from those granted prior to 2022, and what is the vesting timeline for the 2023 awards?",
      "original_answer": "Deferred stock units granted to non-employee directors in 2023 are expensed on a straight-line basis over the requisite service period, whereas awards granted prior to 2022 were expensed in full on the grant date because they vested immediately. The 2023 awards vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "llm_answer": "\n\nThe expensing methodology for non-employee director deferred stock units (DSUs) granted in 2023 differs from prior-to-2022 grants in that **2023 awards are expensed on a straight-line basis over the requisite service period** (aligned with their vesting timeline), whereas awards granted prior to 2022 **vested immediately upon grant and were fully expensed on the grant date**. For 2023 awards, the vesting timeline is **one year from the grant date or the day immediately preceding the next Annual Meeting of Shareholders**, whichever occurs first, subject to potential acceleration under certain circumstances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the expensing methodology for 2023 DSUs is correctly described as straight-line over the service period, contrasting with immediate expensing for pre-2022 awards due to immediate vesting. (2) The vesting timeline for 2023 awards is accurately stated as the earlier of one year from grant or the day before the next Annual Meeting, with mention of acceleration under certain circumstances. (3) Multi-hop reasoning is sound—LLM correctly synthesizes differences in accounting treatment across time periods and links vesting conditions to expensing methodology. (4) No numerical inaccuracies; no entities (years, awards, directors) are misstated. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 256,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, and what percentage of the total identifiable assets in that same region and business unit did this profit represent?",
      "original_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million. The identifiable assets in that same region and business unit were $698 million. Therefore, the operating profit represented approximately 36.4% of the identifiable assets.",
      "llm_answer": "\n\nThe total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was **$254 million**. However, the document pages provided do not include data on total identifiable assets for the Africa/Eurasia region or its business units, making it impossible to calculate the requested percentage based on the available information.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM correctly identified the operating profit of $254 million for the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, which matches the ground truth. This earns full points for quantitative accuracy. However, the LLM incorrectly claims that identifiable assets data is unavailable, when the ground truth explicitly states it was $698 million in the same region and business unit. This failure to retrieve or synthesize the second key data point prevents the calculation of the requested percentage (36.4%), which is a critical part of the question. As a result, the answer is incomplete and the multi-hop reasoning fails at the second step. While the first part is accurate, the refusal to provide the percentage—despite the data being available in the knowledge base—represents a significant factual and reasoning gap. The contextual relevance remains high because the response addresses the correct entities and metric, but the refusal to compute a straightforward percentage based on available data undermines completeness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 307,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "What was the total amount of AMD's purchases from and resales to the ATMP JV in fiscal year 2024, and how does this compare to the amount of the loan AMD provided to the ATMP JV during the same year?",
      "original_answer": "In fiscal year 2024, AMD's purchases from the ATMP JV amounted to $1.7 billion, and its resales to the ATMP JV totaled $121 million, resulting in a combined total of $1.821 billion. This is significantly higher than the $100 million loan AMD provided to one of the ATMP JVs in October 2024.",
      "llm_answer": "\n\nIn fiscal year 2024, AMD's purchases from the ATMP JV totaled **$1.7 billion**, and resales to the ATMP JV amounted to **$121 million**. The loan provided to the ATMP JV during the same year was **$100 million**, which is significantly lower than the purchase amount and slightly lower than the resale amount.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key numerical values: AMD's purchases from the ATMP JV ($1.7 billion), resales to the ATMP JV ($121 million), and the loan amount ($100 million), matching the ground truth exactly. These figures are reported accurately with acceptable formatting. (2) Quantitative accuracy is perfect—each dollar amount is correct, and while the LLM does not explicitly calculate the combined total of $1.821 billion, it reports both components needed to derive it. However, the statement that the $100 million loan is 'slightly lower than the resale amount' is factually incorrect—the resale amount is $121 million, so the loan is actually lower than the resale, but not 'slightly' in relative terms (it's about 17% less); more importantly, this misstatement inverts the comparison logic. The loan is much lower than the purchase amount but also lower than the resale, not higher. (3) The multi-hop reasoning is mostly sound—the model retrieves correct figures from different parts of the knowledge graph (purchases, resales, loan) and attempts a comparison. However, the qualitative error in interpreting the resale vs. loan comparison indicates a flaw in reasoning. (4) Scores reflect high factual accuracy and completeness, with a moderate deduction in qualitative accuracy due to the incorrect comparative statement, though contextual relevance remains strong as all parts of the question are addressed with relevant data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 403,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021, and how does this growth compare to the increase in the Research and medical products segment over the same period?",
      "original_answer": "The revenue for the Analytical and physical instrumentation product line increased by $156 million from 2019 to 2021 ($2,620 million in 2021 vs. $2,464 million in 2019). The Research and medical products segment increased by $11,290 million over the same period ($24,802 million in 2021 vs. $13,512 million in 2019). The increase in Analytical and physical instrumentation revenue was relatively modest compared to the significant growth in Research and medical products.",
      "llm_answer": "\n\nThe total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021 was **$156 million** (from $2,464 million to $2,620 million). For the Research and medical products segment, the increase was **$11,290 million** (from $13,512 million to $24,802 million). This indicates that the Research and medical products segment grew significantly faster in both absolute terms and as a percentage of its base revenue compared to the Analytical and physical instrumentation segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the increase in Analytical and physical instrumentation revenue is correctly calculated as $156 million ($2,620M - $2,464M), and the increase in Research and medical products is correctly stated as $11,290 million ($24,802M - $13,512M). These values match the original answer exactly. (2) The answer is complete, addressing both parts of the question: the revenue increase for each segment and a valid comparison between them. (3) Entity accuracy is perfect—both product lines and the years 2019 and 2021 are correctly identified. (4) The reasoning is sound: the LLM correctly performs the multi-hop synthesis across time and segments, and the conclusion about the relative growth (with Research and medical products growing much faster) is logically supported by the data. The addition of 'percentage of its base revenue' enhances the comparison without contradicting the original answer. All formatting (e.g., $156 million) is acceptable and semantically equivalent. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 323,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Microsoft's SQL Server product line contribute to its Intelligent Cloud segment's financial performance, given the segment's reported structure and revenue drivers?",
      "original_answer": "Microsoft's SQL Server is a core component of the Intelligent Cloud segment, which includes server products and cloud services. SQL Server contributes to the segment's revenue through volume licensing programs, OEM licenses, and retail packaged products. As part of the server products category, SQL Server also drives revenue through Client Access Licenses (CALs), which provide access rights to the server product and are reported alongside the associated server product revenue. This aligns with the Intelligent Cloud segment's primary revenue drivers, which include server product licensing and cloud services like Azure.",
      "llm_answer": "\n\nMicrosoft's SQL Server contributes to the Intelligent Cloud segment's financial performance by generating revenue through licensing (volume, OEM, and retail) and Client Access Licenses (CALs), which are reported within the Server Products and Cloud Services category. As part of the Intelligent Cloud segment, SQL Server's sales are influenced by enterprise demand for on-premises and cloud-based database solutions, with revenue driven by the number of licenses sold and average revenue per user. The segment's growth in server products and cloud services (which grew to $67.3 billion in 2022) reflects SQL Server's role alongside Azure and other cloud services, though its contribution is more tied to traditional licensing than consumption-based cloud models. Competitive positioning against databases from Oracle, IBM, and SAP further underscores its importance in maintaining the segment's revenue streams.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies SQL Server's contribution to the Intelligent Cloud segment through licensing models (volume, OEM, retail) and Client Access Licenses (CALs), aligning with the ground truth. It accurately places SQL Server within the Server Products and Cloud Services category and notes its role alongside Azure. However, the inclusion of a specific revenue figure—'$67.3 billion in 2022'—is problematic. The ground truth does not provide any numerical revenue data for the segment or for SQL Server specifically, so this figure cannot be verified and appears to be hallucinated or incorrectly sourced. This significantly impacts quantitative accuracy. (2) The number '$67.3 billion in 2022' is not present in the original answer and was not part of the provided knowledge graph ground truth. Without confirmation from the source, this introduces a factual error, especially since the year 2022 and that specific figure are not referenced in the original. Even if accurate in reality, within the context of evaluation against the provided ground truth, it is unsupported. (3) The multi-hop reasoning is generally sound: the model connects SQL Server to licensing revenue, CALs, the Intelligent Cloud segment, and contrasts it with cloud consumption models like Azure. It also appropriately contextualizes SQL Server’s competitive landscape. However, the addition of unverified quantitative data weakens the reasoning chain by introducing unsupported claims. (4) The correctness score is 7 because the core qualitative facts—licensing models, CALs, segment structure—are correct and the answer addresses the question’s intent. The qualitative accuracy is high (8) due to correct entity identification and logical synthesis. Quantitative accuracy is lower (6) due to the unsupported revenue figure. Contextual relevance is strong (9) as the response stays focused and adds relevant context about enterprise demand and competition.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 529,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What is the total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, and how does this reflect in both the 2023 and 2024 year-end balances?",
      "original_answer": "The value of Insurance Buy-in Contracts increased from $950 million at December 31, 2022, to $1,605 million at December 31, 2023, and then decreased to $1,390 million at December 31, 2024. This results in a net increase of $440 million over the two-year period ($1,390 million - $950 million = $440 million).",
      "llm_answer": "\n\nThe total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, is an **increase of $440 million** (from $950 million in 2022 to $1,390 million in 2024). This reflects a **$655 million increase in 2023** (from $950 million in 2022 to $1,605 million in 2023) and a **$215 million decrease in 2024** (from $1,605 million in 2023 to $1,390 million in 2024). The decline in 2024 was driven by a negative actual return on plan assets of $(215) million for Insurance Buy-in Contracts, as detailed in the Level 3 asset fair value changes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key values: $950 million (2022), $1,605 million (2023), and $1,390 million (2024), matching the ground truth. The total change is accurately calculated as $440 million ($1,390M - $950M), the 2023 increase as $655 million ($1,605M - $950M), and the 2024 decrease as $215 million ($1,605M - $1,390M), all of which are factually correct. (2) All calculations are accurate and properly contextualized across years. The explanation of the 2024 decline referencing the negative return on plan assets of $(215) million adds relevant qualitative detail consistent with the data. (3) The multi-hop reasoning is sound: the model correctly synthesizes year-over-year changes across three time points, computes net change, and explains annual movements. (4) The answer is fully complete, addressing both the total change and the reflection in 2023 and 2024 balances. All entities (Insurance Buy-in Contracts, correct dates, financial values) are accurate. Wording differs slightly from the original but maintains full semantic equivalence with added contextual insight. All scores are maximized due to perfect factual accuracy, correct calculations, logical reasoning, and comprehensive coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 349,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and how much in dividends was paid on those shares during 2024?",
      "original_answer": "$886 million was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and $26 million in dividends was paid on those shares during 2024.",
      "llm_answer": "\n\nThe total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, was **$886 million** ($852 million in U.S. plans and $34 million in non-U.S. plans). Dividends paid on these shares during 2024 totaled **$26 million** (material for U.S. plans and immaterial for non-U.S. plans).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total value of TI common stock is correctly stated as $886 million, with a valid breakdown of $852 million in U.S. plans and $34 million in non-U.S. plans (852 + 34 = 886). The dividends paid during 2024 are accurately reported as $26 million. (2) The answer is complete, addressing both parts of the question: the total stock value as of December 31, 2024, and the dividends paid during 2024. (3) Entity accuracy is correct—TI common stock, U.S. and non-U.S. defined contribution plans, and the year 2024 are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis, as it combines data from both U.S. and non-U.S. plans and correctly aggregates the total value and dividends. The additional context about materiality of dividends (material for U.S., immaterial for non-U.S.) adds clarity without contradicting the ground truth. (5) The semantic meaning is equivalent to the original answer, with slightly more detail but no factual deviation. All scores are maximized due to full factual accuracy, completeness, and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 330,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What was the principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in their 2022 10-K, and how does this amount compare to the combined principal of their 3.900%, 4.450%, and 5.200% Senior Notes from the same filing?",
      "original_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 was $1,250 million. The combined principal of their 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes totals $2,250 million. Therefore, the 5.300% Senior Notes due 2050 represent approximately 55.6% of the combined principal of the other three notes.",
      "llm_answer": "\n\nThe principal amount of UPS's 5.300% Senior Notes due 2050, as disclosed in the 2022 10-K, was **$1,250 million**. This amount is **less than** the combined principal of the 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes, which totaled **$2,250 million** in the same filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the principal amount of the 5.300% Senior Notes due 2050 as $1,250 million, matching the ground truth. It accurately reports the individual principal amounts of the 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes and correctly calculates their combined total as $2,250 million. The comparison stating that $1,250 million is less than $2,250 million is factually correct. However, while the LLM conveys that the 5.300% note amount is less than the combined total, it omits the specific percentage comparison (approximately 55.6%) explicitly mentioned in the original answer. This is a minor omission in completeness but does not detract from the core factual accuracy. All numbers and calculations are correct, and the multi-hop reasoning—aggregating principals across multiple notes and comparing—is sound. The answer is contextually relevant and semantically equivalent in all key aspects except the missing percentage, which slightly affects qualitative completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 297,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What is the total weighted-average grant-date fair value of all Service-Based RSUs that were both outstanding at the beginning of the year and still outstanding at the end of 2024, after accounting for grants, vesting, and forfeitures?",
      "original_answer": "The total weighted-average grant-date fair value of Service-Based RSUs that remained outstanding throughout 2024 is $183.41 million.",
      "llm_answer": "\n\nThe total weighted-average grant-date fair value of Service-Based RSUs outstanding at both the beginning and end of 2024, after accounting for grants, vesting, and forfeitures, is **$183.41 per RSU**. This figure is derived from Table 10.1, which reports the weighted-average grant-date fair value of Service-Based RSUs outstanding as of December 31, 2024, following adjustments for activity during the year.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the unit of the value as '$183.41 per RSU', whereas the ground truth specifies the total value as '$183.41 million'—a critical error in magnitude and interpretation. The model confuses per-unit value with total value, which are fundamentally different financial metrics. (2) The number '183.41' is numerically correct but is misapplied: it should represent millions of dollars in total, not dollars per RSU. This undermines quantitative accuracy despite matching the digits. (3) The reasoning appears to reference a source (Table 10.1) and acknowledges the need to account for grants, vesting, and forfeitures, showing some understanding of multi-hop logic. However, it fails to correctly interpret the output of that process—synthesizing activity to arrive at a total value rather than a per-unit value. (4) Contextually, the answer is relevant and addresses the right time frame (2024), the correct type of RSUs (Service-Based), and the requirement to adjust for year-long activity. But due to the severe misinterpretation of the metric, the correctness score is low. Quantitative accuracy is penalized heavily because financial values must be both numerically and dimensionally correct. Qualitative accuracy is moderate due to correct contextual framing but flawed synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 370,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does UPS's estimation process for uncertain tax positions, as described in both the notes to the financial statements and the management discussion section, influence the potential recognition of tax benefits or additional charges to the tax provision, and what specific criteria determine the measurement of these benefits?",
      "original_answer": "UPS evaluates uncertain tax positions using a two-step process that directly affects the recognition of tax benefits or additional charges to the tax provision. First, it determines whether a tax position is more likely than not to be sustained on audit, based on available evidence. Second, it measures the largest amount of tax benefit that is more likely than not to be realized upon settlement. The difference between this recognizable benefit and the total benefit claimed or to be claimed is recorded as a liability. This process, detailed in both the financial statement notes and the management discussion, leads to quarterly reevaluations based on changes in facts, tax law, audit outcomes, or new activity, which can result in either recognizing a tax benefit or recording an additional charge to the tax provision.",
      "llm_answer": "\n\nUPS's estimation process for uncertain tax positions involves a two-step approach: first, assessing whether the position is more likely than not to be sustained on audit (qualitative recognition threshold), and second, measuring the largest amount of tax benefit that is more likely than not to be realized upon settlement (quantitative measurement). This process directly influences the tax provision, as changes in recognition (e.g., new audit activity, tax law changes) or measurement (e.g., revised probability assessments) can result in either recognizing tax benefits or recording additional charges. The criteria for measurement hinge on the \"more likely than not\" standard for sustainability and the maximum probable benefit expected under settlement scenarios, with quarterly reevaluations ensuring adjustments to the tax provision based on updated facts, legal developments, or audit outcomes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All key factual elements are accurately captured: the two-step process (recognition and measurement), the 'more likely than not' standard for both recognition and measurement, the impact on the tax provision through recognition of benefits or additional charges, and the requirement for quarterly reevaluations based on new facts, tax law changes, audit outcomes, or other developments. (2) There are no numeric values in the question or ground truth that require verification; the answer appropriately avoids introducing any incorrect figures and correctly describes qualitative thresholds. (3) The multi-hop reasoning is sound—information from both the notes to the financial statements and the management discussion is synthesized correctly, and the causal chain from estimation process to financial impact is logically presented. (4) The wording differs slightly but preserves precise technical meaning (e.g., 'qualitative recognition threshold' and 'quantitative measurement' are valid paraphrases). No omissions or inaccuracies are present. All scoring categories warrant the highest rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 337,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What was the total capital expenditure in Africa/Eurasia in 2021, and by what percentage did organic sales in this region increase during the same year?",
      "original_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0% during the same year.",
      "llm_answer": "\n\nThe total capital expenditure in Africa/Eurasia in 2021 was **$33 million**, and organic sales in this region increased by **7.0%** during the same year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Both numeric values are accurate: the total capital expenditure in Africa/Eurasia in 2021 is correctly stated as $33 million, and the organic sales increase is exactly 7.0%. (2) All numbers are factually correct with no calculation or formatting issues—$33 million is presented clearly and 7.0% matches the reported percentage. (3) The reasoning, while not explicitly shown, is sound in the final output, as it correctly synthesizes two distinct financial metrics (capital expenditure and organic sales growth) for the correct region (Africa/Eurasia) and correct year (2021). (4) The answer is semantically equivalent to the original, complete, and directly addresses both parts of the multi-part question. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1076,
        "completion_tokens": 245,
        "total_tokens": 1322
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What was the increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021, and how did this growth contribute to the overall increase in Vision segment sales during the same period?",
      "original_answer": "Johnson & Johnson's Contact Lenses/Other sales increased by $446 million (from $2,994 million in 2020 to $3,440 million in 2021). Vision segment sales grew by $769 million (from $3,919 million in 2020 to $4,688 million in 2021). Therefore, the increase in Contact Lenses/Other sales accounted for approximately 58% of the total growth in Vision segment sales from 2020 to 2021.",
      "llm_answer": "\n\nThe increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021 was $446 million (14.9%), rising from $2.994 billion to $3.440 billion. This growth, driven by market recovery and market share gains from new products, contributed to the Vision segment's overall 19.6% sales increase (from $3.919 billion to $4.688 billion). The Vision segment's growth was further supported by Surgical Vision's recovery and uptake of recently launched products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: Contact Lenses/Other sales increased by $446 million (from $2,994 million to $3,440 million), and Vision segment sales grew from $3,919 million to $4,688 million, a $769 million increase. These figures match the ground truth exactly, with acceptable format variation ($2.994 billion = $2,994 million). (2) The percentage increases (14.9% for Contact Lenses/Other and 19.6% for Vision segment) are accurate based on the provided numbers, though not explicitly required in the original answer. The core calculation of the contribution ($446M / $769M ≈ 58%) is implied through context even though the exact percentage (58%) is not stated. (3) The multi-hop reasoning is sound: the model correctly links Contact Lenses/Other sales growth to the overall Vision segment growth, and adds relevant qualitative context (market recovery, new product launches, Surgical Vision recovery). (4) The only minor omission is the explicit statement that Contact Lenses/Other accounted for approximately 58% of the total Vision segment sales growth, which was part of the original answer. However, all data needed to derive this is present and correct. Thus, the answer is factually complete and highly accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 388,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What was the impact of AspenTech's consolidation into Emerson's financial statements on the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022?",
      "original_answer": "The consolidation of AspenTech into Emerson's financial statements significantly reduced the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022. In 2022, AspenTech contributed $12 million in earnings, but in 2023, it reported a loss of $107 million. This $119 million deterioration directly impacted the overall segment earnings, which remained flat at $529 million in 2023 despite revenue growth, compared to $437 million in 2022. Additionally, the segment margin declined from 14.7% in 2022 to 11.6% in 2023, a 3.1 percentage point decrease, largely driven by AspenTech's poor performance.",
      "llm_answer": "\n\nThe consolidation of AspenTech into Emerson's financial statements in 2023 did not directly impact the **Control Systems & Software segment's earnings or margins**. For 2023 compared to 2022, the Control Systems & Software segment reported **earnings of $529 million (up 21% from $437 million)** and a **margin of 20.3% (up from 18.2%)**, driven by higher sales and operational leverage. The negative impact of AspenTech’s consolidation (e.g., $249 million in incremental intangibles amortization) affected the broader **Software and Control segment’s overall performance**, causing its earnings to decline by 6% and margins to drop by 3.1 percentage points. However, the Control Systems & Software segment itself remained unaffected and showed strong growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The LLM claims the Control Systems & Software segment's earnings increased from $437M to $529M (21% growth), which contradicts the ground truth stating earnings were flat at $529M in 2023 vs $437M in 2022 — a $92M increase, not flat as claimed in the original answer. However, the original answer states earnings were flat at $529M in 2023 despite revenue growth, compared to $437M in 2022 — this is a contradiction within the ground truth itself, but the LLM incorrectly interprets 'flat' as no change when it should be $529M in both years. More critically, the LLM reports a margin of 20.3% in 2023 (up from 18.2%), while the ground truth states margins declined from 14.7% to 11.6% — a 3.1 percentage point drop. These numbers are completely wrong. (2) The LLM invents a 'Software and Control segment' that is not mentioned in the original, and attributes AspenTech's negative impact to that segment, whereas the ground truth explicitly states the Control Systems & Software segment was directly impacted. (3) Qualitative Accuracy: The reasoning is flawed — the LLM claims AspenTech’s consolidation did not affect the Control Systems & Software segment, directly contradicting the ground truth that states the $119M deterioration from AspenTech (from +$12M to -$107M) 'directly impacted' the segment. The LLM also introduces 'incremental intangibles amortization of $249M' not present in the original, which appears fabricated. (4) Contextual Relevance: While the answer addresses the question's structure and attempts to discuss AspenTech’s impact, it misattributes effects to a different segment and fabricates data, making it largely irrelevant to the actual financial reality. The core conclusion — that the segment was 'unaffected and showed strong growth' — is the opposite of the truth: the segment’s earnings growth was suppressed and margins declined significantly due to AspenTech. Thus, the answer fails on all key dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 549,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How much total monetary liability did Visa record in fiscal 2022 for U.S. covered litigation, and how is this liability recovered under the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of class B common stock to class A common stock.",
      "llm_answer": "\n\nVisa recorded a total monetary liability of **$861 million** in fiscal 2022 for U.S. covered litigation, specifically related to the interchange multidistrict litigation. Under the **U.S. Retrospective Responsibility Plan**, this liability is recovered through a **downward adjustment to the conversion rate** at which shares of Visa’s Class B common stock convert into Class A common stock. This mechanism allows Visa to offset litigation costs by reducing the number of Class A shares issued upon conversion of Class B shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $861 million liability for fiscal 2022 is accurately reported, with no calculation or numerical errors. (2) The answer completely addresses both parts of the question: the total monetary liability and the recovery mechanism under the U.S. Retrospective Responsibility Plan. (3) Entity accuracy is perfect—'Visa', 'fiscal 2022', 'U.S. covered litigation', 'Class B common stock', and 'Class A common stock' are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it correctly links the recorded liability to the specific recovery mechanism involving the conversion rate adjustment. The added context about interchange multidistrict litigation and the effect on share conversion enhances clarity without introducing inaccuracies. The semantic meaning is equivalent to the original answer, with slightly more detail that improves understanding without deviating from the truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 291,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "What was the total financial impact on Pfizer from its historical ownership of Meridian in 2021, including both operational results and post-closing adjustments?",
      "original_answer": "The total financial impact on Pfizer from its historical ownership of Meridian in 2021 was a $512 million negative impact, which includes a $345 million pre-tax legal charge in the second quarter and an after-tax loss of $167 million related to the sale of Meridian in the fourth quarter.",
      "llm_answer": "\n\nThe total financial impact on Pfizer from its historical ownership of Meridian in 2021, including operational results and post-closing adjustments, was a **net loss of $435 million**. This includes operational results of Meridian prior to its sale (reflected in discontinued operations) and adjustments such as a pre-tax $345 million legal charge in Q2 and an after-tax $167 million loss on the sale in Q4. The full impact is summarized in the 2021 Discontinued Operations line, net of tax, totaling $(187 + 236 + 13 - 1) = $435 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the final reported total financial impact. The ground truth states a $512 million negative impact, while the LLM reports a $435 million net loss, which is incorrect. The LLM incorrectly calculates a total from arbitrary numbers (187 + 236 + 13 - 1) that do not appear in the original answer or align with disclosed figures. (2) While the LLM correctly identifies the $345 million pre-tax legal charge in Q2 and the $167 million after-tax loss on sale in Q4, it fails to properly combine them. The correct total impact of $512 million is the sum of $345 million (pre-tax charge) and $167 million (after-tax loss), but the LLM does not reflect this correctly and instead introduces an unsupported calculation. Additionally, the $345 million is pre-tax and the $167 million is after-tax, so direct summation requires tax adjustment—this complexity is not addressed. (3) The multi-hop reasoning is partially sound in identifying relevant events (Q2 charge, Q4 loss), but the synthesis is flawed due to the invented calculation and misaggregation of tax treatments. The model attempts to tie the impact to discontinued operations, which is contextually appropriate, but fabricates line-item values. (4) The contextual relevance is high as the answer addresses operational results and post-closing adjustments as required. However, the quantitative inaccuracy in the final figure and the incorrect calculation undermine the correctness. The qualitative accuracy is moderate due to correct identification of key components but flawed integration. Final score reflects major error in total impact figure despite partial factual recognition.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 465,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "What is the minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, and how does this requirement differ from the SLR requirement for its insured depository institution subsidiaries?",
      "original_answer": "Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of 3.0 percent plus a leverage buffer of 2.0 percent, totaling 5.0 percent, to avoid restrictions on capital distributions and discretionary bonus payments. In contrast, its insured depository institution subsidiaries are required to maintain a higher minimum SLR of 6.0 percent to be considered well capitalized under the PCA framework.",
      "llm_answer": "\n\nBank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of **5.0%** under Basel 3, calculated as a base requirement of **3.0%** plus a **2.0% leverage buffer** to avoid restrictions on capital distributions and executive bonuses. In contrast, its **insured depository institution subsidiaries** (e.g., Bank of America, N.A.) are required to maintain a **6.0% SLR** to be considered \"well capitalized\" under the Prompt Corrective Action (PCA) framework. The key difference is that the Corporation’s SLR includes a separate 2.0% buffer added to a 3.0% base, while the subsidiaries’ 6.0% SLR already incorporates the buffer as part of the PCA well-capitalized threshold.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all percentages are accurate: the 3.0% base SLR and 2.0% leverage buffer correctly sum to 5.0% for Bank of America Corporation, and the 6.0% SLR for its insured depository subsidiaries is correctly stated. These values align exactly with the original answer. (2) The answer is complete, addressing both parts of the multi-hop question: the SLR requirement for the parent corporation under Basel 3 (including buffer) and the higher requirement for its subsidiaries under the PCA framework. (3) Entities are accurately identified—'Bank of America Corporation' as the parent and 'insured depository institution subsidiaries' (with example Bank of America, N.A.) are correctly distinguished. (4) The reasoning is sound and adds value by clarifying that the subsidiary’s 6.0% threshold already incorporates the buffer within the PCA well-capitalized standard, which is a correct interpretation and enhances understanding. The semantic meaning, factual accuracy, and synthesis across regulatory frameworks (Basel 3 and PCA) are fully aligned with the ground truth. Minor wording differences (e.g., 'executive bonuses' vs 'discretionary bonus payments') do not affect factual equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 356,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact MetLife's accounting treatment for mortgage loans, specifically in terms of the allowance for credit losses and the timing of credit loss recognition?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed MetLife's accounting treatment for mortgage loans by requiring the establishment of an allowance for credit losses (ACL) at the time of purchase based on expected lifetime credit losses, rather than recognizing credit loss only when it was probable that amounts due would not be collected. This shift moved the company from an incurred loss model to an expected loss model, resulting in earlier recognition of credit losses and presenting mortgage loans at the net amount expected to be collected.",
      "llm_answer": "\n\nThe adoption of the credit loss guidance on January 1, 2020, required MetLife to recognize an **allowance for credit losses (ACL)** for mortgage loans based on **expected lifetime credit losses** at the time of purchase, rather than waiting for losses to be incurred. This replaced the prior **incurred loss model** (used in 2019), where credit losses were recognized only when it was probable all contractual payments would not be collected. Under the new guidance, MetLife estimates expected credit losses over the entire life of the loans, incorporating forward-looking economic forecasts and adjusting for prepayments/extensions. This resulted in earlier recognition of credit losses and presentation of mortgage loans at the net amount expected to be collected, increasing the ACL and reducing reported loan values compared to the prior standard.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that the adoption of the credit loss guidance on January 1, 2020, required MetLife to establish an allowance for credit losses (ACL) based on expected lifetime credit losses at the time of purchase, replacing the incurred loss model. This correctly captures the shift from recognizing losses only when probable to recognizing expected losses upfront. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the date 'January 1, 2020' is correct and consistently referenced. The description of incorporating forward-looking economic forecasts and adjusting for prepayments/extensions adds appropriate detail not contradicted by the ground truth. (3) The multi-hop reasoning is sound: the answer synthesizes the change in accounting standard, its impact on mortgage loans, the shift in timing of loss recognition, and the effect on financial presentation (i.e., loans presented at net amount expected to be collected). (4) The LLM answer is semantically equivalent to the original answer, with enhanced clarity and context (e.g., mentioning use of forecasts and adjustments), without introducing any factual errors. All entities—MetLife, mortgage loans, ACL, incurred vs. expected loss models—are correctly identified and used. The answer fully addresses both parts of the question: impact on allowance for credit losses and timing of credit loss recognition.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 412,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, change the timing and methodology of recognizing credit losses on leveraged lease receivables and mortgage loans, and what specific models and inputs were used under the new guidance?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition of credit losses from an incurred loss model to an expected lifetime credit loss model for both leveraged lease receivables and mortgage loans. For leveraged lease receivables, the Company now uses a probability of default and loss given default model to estimate expected lifetime credit loss, incorporating third-party credit ratings and historical default data. For mortgage loans, the Company applies significant judgment to estimate expected lifetime credit loss over the contractual term adjusted for prepayments and extensions, considering past events and current and forecasted economic conditions. This represents a shift from recognizing credit losses only when incurred to proactively accounting for expected losses over the life of the asset.",
      "llm_answer": "\n\nThe adoption of the credit loss guidance effective January 1, 2020, shifted the recognition of credit losses from an **incurred loss model** (recognizing losses only when deemed probable of non-collection) to an **expected credit loss model** (recognizing allowances for lifetime expected losses over the asset’s contractual term). For **leveraged lease receivables**, the Company uses a **probability of default (PD) and loss given default (LGD) model**, incorporating third-party credit ratings of lessees and historical default data. For **mortgage loans**, the methodology aligns with commercial mortgage practices, estimating expected losses by considering past events, current conditions, and forecasts, with inputs including economic scenarios, prepayment assumptions, and collateral valuations. Both approaches require forward-looking judgments about economic conditions and risk factors, resulting in earlier and more proactive recognition of credit losses compared to the prior incurred loss model.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) All key facts are correct: the shift from incurred loss to expected lifetime credit loss model on January 1, 2020, is correctly identified. The use of a probability of default (PD) and loss given default (LGD) model for leveraged lease receivables, incorporating third-party credit ratings and historical default data, matches the ground truth. For mortgage loans, the answer correctly states that expected lifetime credit losses are estimated over the contractual term adjusted for prepayments and extensions, using judgment and forward-looking information such as economic conditions, prepayment assumptions, and collateral valuations. (2) There are no numeric values requiring calculation, but the date 'January 1, 2020' is correctly cited. (3) Multi-hop reasoning is sound: the answer synthesizes changes in both timing (earlier recognition) and methodology (model shift) across two asset types, correctly attributing distinct models and inputs to each. (4) The LLM response captures all elements of the original answer with slightly enhanced clarity (e.g., explaining 'incurred loss' vs 'expected credit loss'), without introducing inaccuracies. Wording differences do not affect meaning—semantic equivalence is maintained. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 379,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does Texas Instruments' (TXN) structural cost advantage in manufacturing analog products using 300-millimeter wafers contribute to its ability to generate and return significant amounts of cash, as highlighted in its business model and competitive advantages?",
      "original_answer": "Texas Instruments achieves a 40% cost reduction per unpackaged chip by using 300-millimeter wafers instead of 200-millimeter wafers, which directly supports its competitive advantage in manufacturing and technology. This cost advantage enables greater control over the supply chain and lowers production costs, contributing to higher gross margins. As a result, TI is positioned to generate significant free cash flow, which aligns with its stated objective of maximizing long-term free cash flow per share growth and returning substantial amounts of cash to shareholders.",
      "llm_answer": "\n\nTexas Instruments' use of 300-millimeter wafers in manufacturing analog products provides a structural cost advantage, reducing the cost of an unpackaged chip by approximately 40% compared to 200-millimeter wafers. This efficiency, highlighted in the Manufacturing section, enhances gross margins (67.5% in 2021) by lowering production costs and improving supply chain control. The cost savings directly contribute to strong cash flow generation, with $8.76 billion in operating cash flow and $6.29 billion in free cash flow in 2021. This robust cash flow enables significant returns to shareholders, such as $4.41 billion in dividends and stock repurchases, as outlined in the business model and competitive advantages section, reinforcing TI's focus on long-term free cash flow per share growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 40% cost reduction in unpackaged chip cost using 300mm vs 200mm wafers, which is a key factual point from the original answer. (2) The LLM adds specific financial figures—$8.76 billion in operating cash flow, $6.29 billion in free cash flow, and $4.41 billion returned to shareholders in 2021—which are factually correct and enhance completeness, though these specific numbers were not in the original answer. Since they are accurate and contextually appropriate, their inclusion improves the response without introducing error. The gross margin of 67.5% in 2021 is also correctly cited. (3) The reasoning correctly traces the multi-hop logic: larger wafers → lower unit cost → higher gross margins → strong cash flow → shareholder returns, which reflects sound synthesis of manufacturing advantage into financial outcomes. (4) All entities (Texas Instruments, 300mm wafers, analog products, free cash flow, shareholder returns) are correctly identified and logically connected. The only minor limitation is that the original answer emphasizes the strategic objective of maximizing long-term free cash flow per share, which the LLM mentions but could have highlighted more centrally. However, the core causal chain and all quantitative data are correct, and the added details improve rather than detract. Thus, the answer earns a 9 for correctness—excellent but not perfect—due to slight over-enrichment beyond the original without altering accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 425,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What is the total value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes issued by TMO as of December 31, 2021, and how does this compare to the value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of the same date?",
      "original_answer": "The total value of the Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes issued by TMO as of December 31, 2021, is $1,000 million. The value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of December 31, 2021, is $500 million. Therefore, the 1.5-Year Senior Notes are valued at twice the amount of the 2-Year Senior Notes as of December 31, 2021.",
      "llm_answer": "\n\nAs of December 31, 2021, the total value of the **1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes** issued by TMO was **$1,000 million**, and the value of the **Floating Rate (SOFR + 0.39%) 2-Year Senior Notes** due on October 18, 2023, was **$500 million**. The 1.5-Year notes had twice the value of the 2-Year notes as of that date. \n\n(Source: Note 10, Debt and Other Financing Arrangements, TMO 10-K 2022.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $1,000 million for the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes and $500 million for the 2-Year Floating Rate (SOFR + 0.39%) Senior Notes are accurate as of December 31, 2021. The comparison stating that the 1.5-Year notes are valued at twice the amount of the 2-Year notes is mathematically correct (1,000 / 500 = 2). (2) The answer is complete, addressing both parts of the question: the total value of each note and their comparative valuation. (3) Entity accuracy is correct—TMO is properly identified, the interest rate spreads (SOFR + 0.35% and SOFR + 0.39%), maturities (1.5-Year and 2-Year), and the due date (October 18, 2023) are all accurately referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly extracted and compared two distinct debt instruments from the same issuer and reporting date. (5) The semantic meaning is equivalent to the original answer, with clear, concise restatement and even added source citation (Note 10, TMO 10-K 2022), enhancing credibility without introducing error. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 340,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How many shares of UnitedHealth Group common stock were available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, and which plan had more shares available?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan and 17 million shares were available under the ESPP, making a total of 70 million shares available for future issuance combined. The 2020 Stock Incentive Plan had more shares available than the ESPP.",
      "llm_answer": "\n\nAs of December 31, 2023, UnitedHealth Group had **70 million shares** of common stock available for future issuance under both the 2020 Stock Incentive Plan (53 million shares) and the 1993 Employee Stock Purchase Plan (17 million shares) combined. The **2020 Stock Incentive Plan** had significantly more shares available than the ESPP. \n\nThis information is detailed in the \"Equity Compensation Plan Information\" table under Item 12 of the 10-K filing, with specific breakdowns provided in footnotes (3).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 53 million shares under the 2020 Stock Incentive Plan and 17 million under the ESPP, summing to 70 million total shares available as of December 31, 2023. The calculation (53M + 17M = 70M) is correct. (2) The answer is complete, addressing both parts of the question: the total number of shares available and which plan had more shares. It correctly identifies that the 2020 Stock Incentive Plan had more shares than the ESPP. (3) Entity accuracy is perfect: correct plan names, correct date, and correct company (implied by context). (4) The reasoning is sound and reflects proper multi-hop synthesis—combining data from two different plans and comparing them. The mention of Item 12 and footnotes adds contextual support, indicating accurate sourcing from the 10-K. (5) Semantic equivalence is maintained: although the wording differs slightly from the original answer, the meaning and factual content are identical. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 308,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "What was the total liability for postemployment benefits reported by CAT in 2023, and how did the pension benefits freeze impact the assumptions used in their financial reporting?",
      "original_answer": "The total liability for postemployment benefits reported by CAT in 2023 was $621 million, which includes $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans. The pension benefits freeze, which became effective December 31, 2019, resulted in the elimination of service cost and rendered certain actuarial assumptions no longer applicable to the pension reporting.",
      "llm_answer": "\n\nThe total liability for postemployment benefits reported by Caterpillar (CAT) in 2023 was **$701 million**. This includes liabilities for other postretirement benefits ($56 million) and non-qualified deferred compensation plans ($565 million). \n\nThe freeze of U.S. pension benefits, effective December 31, 2019, eliminated **service cost** and rendered certain assumptions, such as the **rate of compensation increase**, no longer applicable. This removed the need to account for future service accruals, simplifying actuarial calculations. Additionally, the freeze reduced volatility in pension obligations by decoupling liabilities from future salary growth assumptions, though discount rates and market performance of plan assets still impact the overall liability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a significant factual error in the total liability amount: it reports $701 million instead of the correct $621 million. While it correctly identifies the $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation, the sum of these ($56M + $565M = $621M) contradicts the stated total of $701M, indicating a calculation or reporting error. (2) The date of the pension freeze (December 31, 2019) is accurate, and the impact on service cost and actuarial assumptions (e.g., rate of compensation increase) is correctly described and aligns with the ground truth. However, the incorrect total liability undermines quantitative accuracy. (3) The reasoning around the pension freeze’s effect on assumptions is sound and reflects proper multi-hop synthesis between the freeze event and its implications for financial reporting. The explanation of reduced volatility and simplified actuarial calculations adds context beyond the ground truth but remains plausible. (4) Despite strong qualitative reasoning and relevance, the major numerical discrepancy in the total liability—especially since it’s the first and most critical piece of information requested—severely impacts correctness. The answer is partially correct but fails on a key factual element.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 365,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "What was the total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans, and how does this compare to the prior year?",
      "original_answer": "The total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was $2,555 million for investment funds and $2,171 million for equity securities, totaling $4,726 million. In 2023, the fair value was $2,797 million for investment funds and $2,071 million for equity securities, totaling $4,868 million. This represents a decrease of $142 million from 2023 to 2024.",
      "llm_answer": "\n\nThe total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was **$4.726 billion** ($2.555 billion in investment funds and $2.171 billion in equity securities). This represents a **decrease of $142 million** compared to 2023, which totaled **$4.868 billion** ($2.797 billion in investment funds and $2.071 billion in equity securities). The decline reflects lower values in both investment funds (down $242 million) partially offset by higher equity securities (up $100 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: $2,555 million ($2.555 billion) for investment funds and $2,171 million ($2.171 billion) for equity securities in 2024; $2,797 million ($2.797 billion) and $2,071 million ($2.071 billion) in 2023. The totals are correctly calculated: $4,726 million ($4.726 billion) in 2024 and $4,868 million ($4.868 billion) in 2023. The year-over-year decrease is correctly computed as $142 million. (2) The quantitative accuracy is perfect—minor formatting differences (e.g., billion vs. million) are semantically equivalent and acceptable. The breakdown and comparison are precise. (3) The multi-hop reasoning is sound: the model correctly synthesized data across two asset categories (investment funds and equity securities) and two years (2024 and 2023), computed totals and the change, and correctly identified the directional movement in each component (down $242M in funds, up $100M in securities). (4) The answer is contextually complete and directly addresses both parts of the question: the 2024 total fair value and the comparison to the prior year. No irrelevant or extraneous information is included. All entities (Merck, U.S. Pension Plans, developed markets equities, 2024 vs. 2023) are correctly identified and used. Therefore, all scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 375,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and how many remain available for issuance as of December 31, 2024, considering the plan's role in issuing stock options, RSUs, and PSUs as stated in the plan documentation and stock-based compensation disclosures?",
      "original_answer": "A total of 135 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and approximately 47 million shares remain available for issuance as of December 31, 2024, after accounting for shares issued through stock options, RSUs, and PSUs under the plan.",
      "llm_answer": "\n\nAs of December 31, 2024, a total of **135 million shares** of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception. Of these, **approximately 47 million shares** remained available for future issuance as of December 31, 2024, after excluding shares underlying outstanding awards (such as unvested RSUs, PSUs, and unexercised stock options). This availability reflects the plan’s use for issuing equity awards, including stock options, restricted stock units (RSUs), and performance-based stock units (PSUs), as disclosed in the stock-based compensation section.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers '135 million shares authorized' and 'approximately 47 million shares remaining' are accurate and match the original answer exactly; minor phrasing differences (e.g., 'remain available' vs 'remained available') do not affect meaning. (2) The answer addresses both parts of the multi-part question: total shares authorized since inception and shares remaining as of December 31, 2024. (3) Entities are correctly identified: Danaher, 2007 Omnibus Incentive Plan, stock options, RSUs, and PSUs. (4) The reasoning is sound and reflects proper multi-hop synthesis—connecting plan authorization, historical usage, and current availability based on disclosures about equity awards. The mention of 'outstanding awards such as unvested RSUs, PSUs, and unexercised stock options' correctly explains how availability is calculated, aligning with standard stock-based compensation disclosures. (5) The semantic meaning is equivalent to the ground truth, with slightly enhanced clarity in explaining what reduces available shares. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 331,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the growth in Google Play's revenue contribution, as part of non-advertising revenues, potentially affect Google's overall profit margins, given the differing margin profiles between advertising and non-advertising revenue streams?",
      "original_answer": "Google Play generates revenues from app sales, in-app purchases, and digital content, and is a growing component of Google's non-advertising revenues. According to the 2022 10-K filing, non-advertising revenues—including those from Google Play, hardware, and Google Cloud—are increasing and may adversely affect overall profit margins because the margins on these revenues vary significantly and may be lower than those on advertising revenues. As Google Play's revenue contribution grows, if its margins remain lower than those of advertising, the overall profit margin of Google could decrease unless offset by efficiencies or higher-margin offerings.",
      "llm_answer": "\n\nThe growth in Google Play's revenue contribution, as part of non-advertising streams, may **negatively impact Alphabet's overall profit margins** due to the inherently lower margin profiles of non-advertising revenue compared to advertising. The 10-K explicitly states that non-advertising revenues (including Google Play, hardware, and YouTube subscriptions) \"may adversely affect margins,\" as these segments face higher costs of goods sold (e.g., content acquisition, inventory, and hardware production) relative to advertising, which has lower direct costs. While non-advertising growth diversifies revenue, its expansion could dilute overall profitability if advertising (higher-margin) growth stagnates or declines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Google Play is part of non-advertising revenues and that growth in this segment may negatively impact overall profit margins due to lower margins compared to advertising. The core factual claim—that non-advertising revenues may adversely affect margins—is directly supported by the 2022 10-K, as stated in the original answer. (2) There are no specific numerical values (e.g., percentages, dollar amounts) in either the question or the original answer, so quantitative accuracy is not applicable in a strict sense; however, the LLM does not introduce any incorrect numbers, preserving accuracy. (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects Google Play to non-advertising revenue, recognizes the margin differential, and infers the dilutive effect on overall profitability—consistent with the original answer. The only minor deviation is that the LLM mentions 'YouTube subscriptions' as part of non-advertising revenue, which is not in the original answer (which cites Google Cloud and hardware); this is not factually incorrect but adds a detail not present in the ground truth, slightly affecting qualitative precision. (4) The answer is fully contextually relevant, directly addressing how Google Play's revenue growth affects overall margins through margin profile differences. Wording differs but semantic meaning matches. No critical omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 411,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What specific financial instruments does CVS use to hedge against credit quality risk, and how does the company expect these instruments to impact its overall risk exposure?",
      "original_answer": "CVS uses derivative financial instruments such as interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps to hedge against credit quality risk. The company expects these instruments, when used for hedging, to reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately.",
      "llm_answer": "\n\nCVS uses derivative financial instruments such as **interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps** to hedge against credit quality risk. The company expects these instruments, when used for hedging purposes, to **reduce overall risk exposure** by mitigating potential adverse effects from fluctuations in interest rates, credit ratings, and market spreads, thereby aligning with its risk management objectives of maintaining high credit quality and diversified sector exposure in its debt securities portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all the derivative financial instruments used by CVS to hedge against credit quality risk—interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps—matching the original answer exactly. The core claim that these instruments reduce overall risk exposure when used for hedging is also accurately reflected. The LLM adds contextual detail about mitigating fluctuations in interest rates, credit ratings, and market spreads, and mentions risk management objectives like maintaining high credit quality and diversified sector exposure. While these additions are not in the original answer, they are reasonable elaborations consistent with the stated purpose of hedging and do not introduce inaccuracies. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense; however, all qualitative financial terms are used correctly, warranting a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes that CVS uses specific derivatives for hedging credit quality risk and that the net effect is a reduction in overall risk, despite introducing other risks (interest rate, equity price, credit risk), which is implied in the original answer. The LLM slightly expands the explanation but maintains logical consistency. (4) The correctness score is 9 because the answer is factually accurate and complete, with only minor, non-material elaboration. Quantitative accuracy is 10 as there are no numerical errors. Qualitative accuracy is 9 due to the slight expansion beyond the original answer without contradiction. Contextual relevance is 10 as the response directly and fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 495,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021?",
      "original_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $691 million. This is calculated by summing $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans.",
      "llm_answer": "\n\nThe total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was **$691 million**. This includes **$682 million** in U.S. Pension Plans and **$9 million** in Other Postretirement Benefit Plans, as detailed in the respective asset class tables.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total investment in Hedge funds/limited partnerships in 2021 is correctly stated as $691 million, with $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans. (2) Quantitative accuracy is perfect: the numbers match exactly, and the sum ($682M + $9M = $691M) is correct. Format variations (e.g., $691 million vs $691M) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—information from two distinct plans is correctly synthesized to arrive at the total. (4) The answer is contextually relevant, directly addressing the question with precise data and clear attribution. No errors in entities, years, or metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 233,
        "total_tokens": 1384
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total number of freight cars UNP both owns and leases as of 2024, and how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?",
      "original_answer": "UNP owns or leases a total of 56,176 freight cars as of 2024. Based on the capital plan and lease buyout figures, they spent $143 million on acquiring freight cars in 2024.",
      "llm_answer": "\n\nAs of 2024, **Union Pacific (UNP)** owns **33,704 freight cars** and leases **22,472 freight cars**, totaling **56,176 freight cars**. In 2024, the company spent **$788 million** on acquiring freight cars, which includes **$143 million in lease buyouts**, as detailed in the capital plan and cash capital investments table.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the total number of freight cars owned and leased by UNP as 56,176, which matches the ground truth. It accurately breaks this down into 33,704 owned and 22,472 leased, demonstrating proper synthesis of components. However, there is a significant error in the reported spending on acquiring freight cars: the LLM states $788 million, while the ground truth is $143 million. Although the LLM correctly notes that $143 million was spent on lease buyouts, it incorrectly presents this as a subset of a much larger $788 million acquisition expenditure, which contradicts the original answer. This suggests confusion between total capital spending and freight-car-specific spending. The entities (UNP, 2024), time frame, and metric types are correct, and the reasoning shows multi-hop capability—just flawed data mapping. The contextual relevance is perfect as all parts of the question are addressed with appropriate detail, but the major quantitative discrepancy in the spending figure limits correctness. Semantic equivalence fails on the key financial figure despite structural accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 316,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "By how much did changes in non-marketable equity securities contribute to the overall increase in other income (expense), net, from 2020 to 2021, given the role of these investments in Google's equity portfolio?",
      "original_answer": "The changes in non-marketable equity securities contributed $6.9 billion to the overall increase in other income (expense), net, from 2020 to 2021. This was the primary driver behind the $5.2 billion net increase in other income, despite being partially offset by a $1.3 billion increase in accrued performance fees.",
      "llm_answer": "\n\nChanges in non-marketable equity securities contributed **$8.3 billion** to the increase in other income (expense), net, from 2020 to 2021. This is calculated from the total unrealized gains on non-marketable equity securities, which rose from $1.5 billion in 2020 to $9.8 billion in 2021, reflecting a $8.3 billion increase. This amount is part of the $6.9 billion total increase in unrealized gains from both marketable and non-marketable equity securities, which drove the overall $5.2 billion rise in other income (expense), net, after accounting for offsets like accrued performance fees.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that changes in non-marketable equity securities contributed $8.3 billion to the increase in other income (expense), net, which is incorrect. The ground truth specifies a contribution of $6.9 billion. This $1.4 billion overstatement is a major factual error. (2) The calculation provided—$9.8 billion (2021 gains) minus $1.5 billion (2020 gains)—results in $8.3 billion, which may be arithmetically correct, but this figure does not align with the ground truth and misrepresents the actual contribution. Additionally, the claim that $8.3 billion is part of a $6.9 billion total increase in unrealized gains is logically inconsistent (a part cannot exceed the whole), indicating a fundamental error in reasoning or data sourcing. (3) The multi-hop reasoning fails: the model incorrectly identifies the contribution of non-marketable securities, misstates the relationship between marketable and non-marketable gains, and does not accurately reflect the offsetting impact of accrued performance fees. The original answer identifies $6.9 billion as the contribution from non-marketable securities being partially offset by $1.3 billion in fees to result in a $5.2 billion net increase—this logic is coherent and supported. The LLM reverses or distorts this causal chain. (4) Despite the incorrect numbers and flawed logic, the answer is contextually relevant—it addresses the right metric (non-marketable equity securities), time period (2020 to 2021), and financial statement line (other income, net)—and attempts to explain the role of these investments in Google's portfolio. Hence, moderate relevance but low accuracy in both quantitative and qualitative dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 464,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023, and how were these contracts classified in the company's financial statements upon final settlement?",
      "original_answer": "The total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 was $0.7 billion ($0.3 billion in 2022 and $0.4 billion in 2023). These forward contracts were initially classified as equity instruments and recorded within capital surplus. Upon final settlement, the forward contracts were reclassified from capital surplus to treasury stock.",
      "llm_answer": "\n\nThe total value of the forward contracts associated with CVS's ASR transactions in 2022 and 2023 was **$700 million** ($300 million in 2022 and $400 million in 2023). These contracts were classified as **equity instruments** and initially recorded within **capital surplus**. Upon final settlement, they were **reclassified from capital surplus to treasury stock**. \n\n**Details:**  \n- **2022 ASR (Barclays Bank PLC):** $1.5 billion notional amount, with a $300 million forward contract.  \n- **2023 ASR (Citibank, N.A.):** $2.0 billion notional amount, with a $400 million forward contract.  \nThe classification and reclassification are explicitly described in the \"Share Repurchase Programs\" section of the 10-K.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total value of $700 million ($300 million in 2022 and $400 million in 2023) is accurate and equivalent to $0.7 billion ($0.3 billion and $0.4 billion), with acceptable formatting variations. (2) The classification of the forward contracts as equity instruments, initial recording in capital surplus, and reclassification to treasury stock upon settlement are correctly stated and align with the original answer. (3) The multi-hop reasoning is sound: the answer synthesizes data from two separate ASR transactions across 2022 and 2023, correctly identifying the associated forward contract values and their accounting treatment. (4) Additional details (notional amounts and counterparties) are factually consistent and enhance completeness without introducing errors. All entities (CVS, ASR transactions, years, financial classifications) are accurate. The answer is semantically equivalent and fully addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 296,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, relate to the defined contribution retirement plan in terms of addressing restrictions under the Internal Revenue Code of 1986 for eligible employees?",
      "original_answer": "The Benefit Restoration Plan supplements benefits provided under the defined contribution retirement plan (401(k) Plan) for participants whose benefits are restricted due to provisions in the Internal Revenue Code of 1986. The Company Match under the 401(k) Plan varies up to a maximum of 4.25% of eligible compensation, and this matching contribution is mirrored in the Benefit Restoration Plan for affected participants.",
      "llm_answer": "\n\nThe Lowe's Companies Benefit Restoration Plan, as amended, supplements the defined contribution retirement plan (401(k) Plan) by addressing restrictions under the Internal Revenue Code of 1986. Specifically, it provides additional benefits to eligible employees whose 401(k) Plan contributions or employer matches are limited by IRS regulations, such as compensation or contribution caps. The Benefit Restoration Plan allows these employees to defer salary and receive employer contributions (e.g., Company Match) that would otherwise be restricted under the qualified 401(k) Plan, ensuring they retain the full intended benefits under Lowe's retirement programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies that the Benefit Restoration Plan supplements the 401(k) Plan for employees affected by IRS restrictions under the Internal Revenue Code of 1986. The explanation of how the plan restores benefits limited by compensation or contribution caps is factually sound and contextually appropriate. Quantitatively, while the ground truth specifies a maximum Company Match of 4.25% of eligible compensation that is mirrored in the Benefit Restoration Plan, the LLM answer does not include this exact percentage. However, it correctly conveys the concept of matching contributions being restored, which constitutes a minor omission rather than an error. The multi-hop reasoning—linking the Benefit Restoration Plan to the 401(k) Plan and IRS limitations—is logically sound and synthesizes the required information accurately. The entities (Lowe's Companies, Benefit Restoration Plan, 401(k) Plan, Internal Revenue Code) are correctly identified and related. The answer is semantically equivalent to the original, with slightly less specificity on the numerical match cap. Thus, the correctness and qualitative accuracy are slightly reduced due to the missing 4.25% figure, but all other aspects are fully accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 364,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, including both CS&Co and TDAC, and how does this compare to the total borrowing capacity under these facilities?",
      "original_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, which includes $950 million outstanding under CS&Co's secured uncommitted lines of credit and $700 million outstanding under TDAC's secured uncommitted lines of credit. This represents a utilization rate of approximately 91.7% of the total borrowing capacity of $1.8 billion.",
      "llm_answer": "\n\nThe total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was **$1.65 billion** ($950 million for CS&Co and $700 million for TDAC). The total borrowing capacity for these secured uncommitted lines is not explicitly disclosed in the provided text, but the Company’s uncommitted lines of credit with external banks (unsecured) had a combined capacity of **$1.8 billion**, with no amounts outstanding. The secured lines’ specific borrowing capacity is not separately stated in the document.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM correctly identifies the total amount outstanding ($1.65 billion) and its components ($950 million for CS&Co and $700 million for TDAC), which matches the ground truth. However, it fails to state the total borrowing capacity under the *secured* uncommitted lines of credit, which is $1.8 billion according to the original answer. Instead, it incorrectly states that the secured capacity is not disclosed and conflates it with unsecured lines, which have the same total capacity but are a different facility. (2) The quantitative accuracy is partially correct: the $1.65 billion outstanding is accurate, and the $1.8 billion total capacity is mentioned in the LLM answer but misattributed to unsecured lines. The utilization rate of ~91.7% (1.65/1.8) is omitted entirely, which is a key comparative metric in the ground truth. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize that the $1.8 billion capacity refers to the secured uncommitted lines (not unsecured), which is essential for answering the comparison part of the question. This indicates a misunderstanding of the document structure or entity types. (4) While the answer contains relevant numbers and entities, the misclassification of the borrowing capacity as unsecured undermines the core of the question, which asks for a comparison between outstanding amounts and capacity under the *secured* facilities. Hence, the correctness score is reduced significantly despite partial factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 410,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021, and how does this compare to the total value of hedge funds/limited partnerships and real estate investments combined in the same year?",
      "original_answer": "The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87. This is greater than the combined total of hedge funds/limited partnerships ($9) and real estate investments ($5), which together amounted to $14. Thus, mutual, pooled, and commingled funds represented a significantly larger portion of the investment portfolio than the other two categories combined.",
      "llm_answer": "\n\nThe total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was **$850 million**. The combined total value of hedge funds/limited partnerships ($720 million) and real estate investments ($389 million) was **$1,109 million**. Thus, the combined value of hedge funds and real estate investments exceeded the mutual/pooled/commingled funds by **$259 million** in 2021.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 were $87 (likely $87 million, though units are ambiguous but internally consistent), while the LLM reports $850 million—off by nearly 10x. Similarly, the LLM reports hedge funds/limited partnerships as $720 million and real estate as $389 million (combined $1,109 million), whereas the ground truth reports $9 and $5 respectively (combined $14). These numbers are completely inconsistent with the source data. (2) Calculations in the LLM answer are mathematically correct (e.g., $720M + $389M = $1,109M), but they are based on fabricated inputs, rendering the results invalid. The comparison conclusion—that hedge funds and real estate exceed mutual/pooled/commingled funds—is the opposite of the ground truth, which states that $87 > $14. (3) The multi-hop reasoning fails because the model did not retrieve or synthesize the correct data points from the knowledge base. It appears to have hallucinated figures for each investment category without alignment to the actual filing data. (4) The contextual structure of the answer is appropriate—it addresses both parts of the question and attempts a comparison—but due to severe factual and quantitative errors, the overall correctness score is very low. Minor credit is given for attempting the right comparison framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 406,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the treatment of LTIP units as participating securities impact Simon Property Group's earnings per share calculation, based on the disclosure regarding distributions equal to 10% of the regular quarterly distributions on Operating Partnership units?",
      "original_answer": "LTIP units are treated as participating securities under the two-class method of computing earnings per share because they entitle participants to receive distributions equal to 10% of the regular quarterly distributions paid on a unit of the Operating Partnership. This impacts earnings per share because participating securities must be included in the computation of earnings per share using the two-class method, which allocates earnings to both common shares and participating securities. Although the LTIP units do not have full parity with common units in terms of distributions, their participation in a portion of the distributions affects the allocation of earnings and thus the resulting earnings per share figure.",
      "llm_answer": "\n\nThe treatment of LTIP units as participating securities impacts Simon Property Group's earnings per share (EPS) calculation by requiring earnings to be allocated between common stockholders and the LTIP units under the two-class method. Since LTIP units receive distributions equal to 10% of the regular quarterly distributions on Operating Partnership (OP) units, they are entitled to a share of net income proportional to their distribution rights. This allocation reduces the amount of earnings available to common shareholders, thereby lowering basic EPS. For 2023, this allocation is reflected in Simon’s EPS computation, though the document notes that LTIP units did not have a material dilutive effect on diluted EPS. The two-class method ensures that participating securities like LTIP units are accounted for in basic EPS, directly reducing the numerator (net income attributable to common shareholders) compared to a scenario where they were not participating.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: LTIP units are treated as participating securities due to receiving distributions equal to 10% of regular quarterly OP unit distributions, triggering the two-class method for EPS calculation. The explanation that this reduces earnings available to common shareholders and thus lowers basic EPS is correct and consistent with accounting standards (ASC 260). (2) Quantitative accuracy is perfect: the 10% distribution right is correctly cited, and no erroneous numbers or calculations are present. The mention of '2023' is contextually appropriate and does not contradict the ground truth, even if not explicitly in the original answer, as it reflects current practice. (3) Reasoning is sound and demonstrates proper multi-hop synthesis: the model connects the distribution feature of LTIP units → classification as participating securities → application of the two-class method → impact on EPS by allocating earnings to both classes. The note about no material dilutive effect on diluted EPS adds value and reflects typical disclosure patterns, though not in the original answer; however, it does not detract from accuracy. (4) The only reason for not scoring a 10 is minor: the original answer emphasizes that LTIP units do not have full parity, which the LLM omits, slightly reducing completeness in characterizing the limited nature of participation. Otherwise, the answer is semantically equivalent, contextually relevant, and correctly reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 426,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, and how is this entity classified in NEE's financial reporting structure based on its control and governance characteristics?",
      "original_answer": "NEE's noncontrolling interest investment in XPLR OpCo totaled $3,315 million as of December 31, 2024. XPLR OpCo is classified as a variable interest entity (VIE) in which NEE is not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest, and therefore it is accounted for under the equity method.",
      "llm_answer": "\n\nThe total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, is not explicitly stated in the provided pages. However, NEE holds a 52.6% interest in XPLR through its limited partner interest in XPLR OpCo, which is classified as an **equity method investment** in NEE's financial reporting structure. This classification reflects that NEE has significant influence over XPLR OpCo but does not have full control, as the entity is structured as a limited partnership where limited partners (including NEE) do not have substantive rights over significant activities. The equity method is applied because NEE’s ownership (52.6%) and governance role fall short of consolidation criteria under GAAP.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect on the key quantitative fact—the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, is stated in the ground truth as $3,315 million, but the LLM claims this amount is 'not explicitly stated.' This is a major factual omission and contradicts the ground truth. (2) The percentage ownership (52.6%) is plausible and may be contextually accurate, but it does not compensate for the failure to report the required dollar amount. The answer incorrectly frames the investment as merely 'equity method' without acknowledging that this is due to XPLR OpCo being a VIE in which NEE is not the primary beneficiary—a key governance and control rationale specified in the original answer. (3) The reasoning partially reflects multi-hop understanding by connecting ownership percentage and accounting treatment, but it fails to correctly synthesize the control and governance characteristics (lack of substantive rights, not being primary beneficiary) that justify the equity method under GAAP for VIEs. (4) The contextual relevance is moderate because the answer addresses the classification and method of accounting, but the absence of the core financial figure and misrepresentation of the rationale for equity method treatment severely undermine correctness. Quantitative accuracy is very low due to missing the $3,315 million figure; qualitative accuracy is mid-range due to partial reasoning; contextual relevance is acceptable as the discussion aligns thematically with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 433,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the total number of distribution methods Linde uses to supply process gases, and how does the company's on-site delivery method differ from the other methods in terms of contract duration and customer volume requirements?",
      "original_answer": "Linde uses three distribution methods to supply process gases: on-site, merchant, and packaged. The on-site delivery method differs significantly from the others in that it serves customers with the largest volume requirements and typically involves contracts ranging from 10 to 20 years in duration, often containing minimum purchase requirements. In contrast, merchant and packaged gas contracts are generally shorter, ranging from three to seven years and one to three years respectively, and do not typically include minimum purchase requirements or volume commitments.",
      "llm_answer": "\n\nLinde uses **three** primary distribution methods to supply process gases: **on-site (tonnage)**, **merchant (bulk liquid)**, and **packaged (cylinder gases)**. The **on-site delivery method** differs from the others in two key ways:  \n1. **Contract Duration**: On-site contracts are typically **10–20 years**, whereas merchant and packaged gas contracts are shorter (3–7 years and 1–3 years, respectively).  \n2. **Customer Volume Requirements**: On-site supply requires **large, consistent volumes** (often the largest customer volumes) with **minimum purchase commitments**, while merchant and packaged gas methods serve smaller volumes without minimum purchase requirements.  \n\nThis structure reflects on-site’s focus on long-term, high-volume industrial customers versus the more flexible, shorter-term arrangements of the other methods.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that Linde uses three distribution methods: on-site, merchant, and packaged—using equivalent terminology (on-site/tonnage, merchant/bulk liquid, packaged/cylinder gases). (2) Quantitative accuracy is perfect: contract durations of 10–20 years (on-site), 3–7 years (merchant), and 1–3 years (packaged) are correctly reported with exact alignment to the original answer. Volume requirements and the presence of minimum purchase commitments for on-site versus the others are correctly contrasted. (3) The multi-hop reasoning is sound—differences in contract duration and volume requirements across methods are synthesized correctly and compared meaningfully. (4) The answer is contextually complete, addressing both parts of the question: total number of methods and the specific differences in contract duration and volume requirements. Wording differs slightly but maintains full semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 301,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relate to the Board of Directors' prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock, and what condition was required for the stock split to proceed?",
      "original_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relates to the prior $50.0 billion Class C stock repurchase authorization from April 2021 because the stock split required an increase in the number of authorized shares of Class C stock to accommodate the split. This condition was necessary to ensure that the company had enough authorized shares post-split for both ongoing operations and the repurchase program. The stock split was subject to stockholder approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A, Class B, and Class C stock.",
      "llm_answer": "\n\nThe 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, and the April 2021 Board authorization for repurchasing up to $50.0 billion of Class C stock are both corporate actions related to capital structure management but are not directly linked. The stock split required **stockholder approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares** of Class A, B, and C stock to accommodate the split. The repurchase authorization, which was amended in July 2021 to include Class A and C shares, remained a separate initiative to return capital to shareholders. The split's approval was conditional solely on the charter amendment, not on the repurchase program.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key condition for the stock split—stockholder approval of an amendment to increase authorized shares of Class A, B, and C stock—which matches the ground truth. It also accurately references the April 2021 $50.0 billion repurchase authorization and the February 2022 announcement of the 20-for-one stock split. All dates, dollar amounts, and percentages are correct. (2) Quantitative accuracy is perfect: $50.0 billion, April 2021, February 2022, and 20-for-one split are all correctly stated with no calculation errors. (3) However, the reasoning on the relationship between the stock split and the repurchase program diverges from the ground truth. The original answer states that the split required an increase in authorized shares *to accommodate both the split and the ongoing repurchase program*, implying a direct operational link. The LLM answer downplays this connection, calling the two actions 'not directly linked' and describing them as 'separate initiatives', which understates the interdependence highlighted in the ground truth. This is a significant qualitative shortcoming in multi-hop synthesis. (4) Despite accurate facts and context, the incorrect characterization of the relationship between the split and repurchase authorization reduces the correctness score. The answer is factually sound but misses a key nuance in corporate rationale, warranting a 7 for correctness and qualitative accuracy. Contextual relevance remains high as all information is pertinent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 423,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023, and how much in committed capital contributions did GM have outstanding to the same entity as of December 31, 2023?",
      "original_answer": "GM's equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, and GM had $0.8 billion in committed capital contributions outstanding to the same entity as of December 31, 2023.",
      "llm_answer": "\n\nGM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023 was **$293 million**. As of December 31, 2023, GM had **$800 million** in committed capital contributions outstanding to Ultium Cells Holdings LLC. \n\n**Source References**:  \n- **Equity earnings**: Explicitly stated in *Note 23 (Segment Reporting)* under the note labeled \"(b)\" for 2023.  \n- **Committed capital contributions**: Disclosed in *Note 11 (Variable Interest Entities)* under \"Nonconsolidated VIEs,\" specifying $0.8 billion in committed capital contributions for 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the equity earnings contribution of $293 million and the committed capital contributions of $800 million (equivalent to $0.8 billion) are accurate and correctly formatted. Minor variation in presentation ($800 million vs $0.8 billion) is semantically equivalent and acceptable. (2) The answer is complete, addressing both parts of the multi-part question: the 2023 equity earnings and the outstanding committed capital as of December 31, 2023. (3) Entity accuracy is correct—Ultium Cells Holdings LLC and GM are properly identified, and the time frame (2023, as of December 31, 2023) is precise. (4) The reasoning is sound and reflects proper multi-hop synthesis: pulling equity earnings from Note 23 (Segment Reporting) and committed capital from Note 11 (Variable Interest Entities), which demonstrates correct cross-referencing of financial disclosures. The source references further validate the accuracy and traceability of the information. All criteria for correctness, completeness, and contextual relevance are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 320,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 as reported in both its consolidated financial statements and its other postretirement benefit plan assets, and how does this dual reporting reflect the company's overall exposure to such investment vehicles?",
      "original_answer": "The Coca-Cola Company reported $720 million in hedge funds and limited partnerships within its consolidated financial statements and $9 million in such investments within its other postretirement benefit plan assets for 2021. This totals $729 million in exposure to hedge funds and limited partnerships across both reporting categories.",
      "llm_answer": "\n\nThe total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 was **$729 million**, comprising **$720 million** in pension plan assets and **$9 million** in other postretirement benefit plan assets. This dual reporting reflects the company's strategic allocation to alternative investments as part of its broader retirement benefit plan management, aiming to diversify risk and enhance returns. The significant allocation to hedge funds/limited partnerships in pension assets (primarily through illiquid, long-term vehicles) underscores exposure to non-traditional, potentially higher-yield investments, while the smaller postretirement allocation aligns with liquidity needs for shorter-term obligations. Together, they highlight a balanced approach to managing retirement liabilities through diversified asset classes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the total value of $729 million, with $720 million in hedge funds and limited partnerships in consolidated financial statements (specifically pension plan assets) and $9 million in other postretirement benefit plan assets, matching the ground truth exactly. The total exposure calculation ($720M + $9M = $729M) is accurate. (2) All numeric values are correct and properly formatted; the breakdown and sum are factually sound. (3) The multi-hop reasoning is strong: the model correctly synthesizes data from two distinct reporting categories—consolidated financial statements (where the $720M is reported in pension assets) and other postretirement benefit plan assets ($9M)—and combines them to reflect total exposure. While the LLM slightly rephrases 'consolidated financial statements' as 'pension plan assets', this is contextually acceptable since the $720M figure originates from pension-related disclosures within those statements. (4) The qualitative interpretation about strategic allocation, risk diversification, and liquidity considerations is reasonable and adds relevant context without overreaching. The only minor issue is the conflation of 'consolidated financial statements' with 'pension plan assets'—while the investment is reported within the consolidated statements, specifying it as part of pension assets is more precise. However, this does not undermine factual correctness. Overall, the answer is factually accurate, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 417,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the increased use of e-commerce by retail tenants, as mentioned in the risk factors, contribute to the difficulty Simon Property Group (SPG) faces in leasing spaces and maintaining rental rates at its properties?",
      "original_answer": "The increased use of e-commerce by retail tenants has led to lower demand for physical retail space, which directly contributes to higher vacancy rates at SPG's properties. This oversupply of vacant space, combined with the increased bargaining power of creditworthy retail tenants, results in downward pressure on rental rates and occupancy levels. Additionally, SPG may need to increase spending on tenant improvements and offer more lease modifications to attract or retain tenants, all of which materially and adversely affect SPG's financial performance and leasing strategy.",
      "llm_answer": "\n\nThe increased use of e-commerce by retail tenants contributes to Simon Property Group's (SPG) challenges in leasing spaces and maintaining rental rates by reducing demand for physical retail footprints. As retailers shift sales to online platforms, tenants require smaller or fewer physical locations, leading to higher vacancy rates at SPG properties. This shift also strengthens tenants' bargaining power, forcing SPG to offer concessions (e.g., reduced rents, tenant improvements) to secure leases, thereby pressuring rental rates. Additionally, e-commerce growth accelerates store closures, particularly for anchor tenants, further exacerbating vacancies and reducing customer traffic, which diminishes the appeal of SPG properties and complicates re-leasing efforts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core causal mechanisms described in the ground truth. It correctly identifies that e-commerce adoption reduces demand for physical retail space, leading to higher vacancy rates and downward pressure on rental rates due to increased tenant bargaining power. It also accurately notes SPG's need to offer concessions like reduced rents and tenant improvements, which aligns with the original answer. The LLM adds contextual detail about anchor tenant closures and reduced customer traffic, which, while not explicitly stated in the ground truth, are reasonable and relevant inferences consistent with the broader implications of e-commerce disruption. There are no numerical inaccuracies (quantitative accuracy is 10), and all entities (SPG, retail tenants, e-commerce) are correctly identified. The reasoning is sound and reflects proper multi-hop synthesis: e-commerce growth → reduced physical footprint → higher vacancies → weaker leasing power for SPG → financial pressure. The only minor gap is that the original answer explicitly mentions 'materially and adversely affect SPG's financial performance and leasing strategy,' which the LLM implies but does not directly state—hence a qualitative accuracy of 9. Overall, the answer is semantically equivalent and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 372,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the cumulative impact on UNP's deferred tax expense in 2024 and 2023 from corporate income tax legislation enacted in Arkansas, and how does this compare to the 2022 impact from Arkansas legislation?",
      "original_answer": "The cumulative impact on UNP's deferred tax expense from Arkansas tax legislation was $34 million in 2024 and $114 million in 2023, totaling $148 million over the two years. In 2022, Arkansas legislation contributed to a $95 million reduction in deferred tax expense. Therefore, the reduction in 2024 and 2023 was greater than the 2022 impact by $53 million.",
      "llm_answer": "\n\nThe cumulative impact on UNP's deferred tax expense from Arkansas legislation was **$34 million in 2024** (combined with Louisiana) and **$114 million in 2023** (combined with Nebraska, Iowa, and Kansas). In 2022, Arkansas legislation contributed to a **$95 million reduction** (combined with Nebraska, Iowa, and Idaho). The document does not specify the exact portion attributable to Arkansas alone in each year, as the totals include multiple states. Thus, the 2023 impact from Arkansas legislation was higher than in 2024 and 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $34 million impact in 2024 and $114 million in 2023, matching the ground truth. It also correctly states the $95 million reduction in 2022. However, it introduces significant confusion by claiming these figures are 'combined with' other states (Louisiana, Nebraska, Iowa, Kansas, Idaho), which contradicts the ground truth that these are Arkansas-specific impacts. This undermines the accuracy of the synthesis. (2) Quantitatively, the individual year amounts are correct, but the LLM fails to compute the cumulative $148 million or the $53 million difference ($148M - $95M) as required by the question. The absence of this key comparison calculation results in a partial quantitative score. (3) The multi-hop reasoning is flawed: instead of comparing the total 2023–2024 impact to 2022, the LLM incorrectly suggests the 2023 impact alone was higher than both 2024 and 2022, which misrepresents the comparison. It also injects unsupported claims about multi-state aggregations not present in the ground truth, indicating a failure in entity attribution. (4) Contextual relevance is moderate—the answer addresses the right years, company (UNP), and metric (deferred tax expense), but the added noise about other states and lack of proper cumulative comparison reduce its usefulness. The core numbers are right, but the reasoning and synthesis are significantly compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 394,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does NEE's limited partner interest in XPLR OpCo potentially impact its financial obligations and liquidity, particularly if XPLR is unable to access capital on commercially reasonable terms?",
      "original_answer": "NEE's limited partner interest in XPLR OpCo could negatively affect its liquidity and financial obligations if XPLR is unable to access capital on commercially reasonable terms. This is because XPLR's inability to secure capital would hinder its ability to complete acquisitions or meet growth opportunities, reducing its cash distributions to unitholders, including NEE. Additionally, if XPLR issues more common units or converts existing securities into common units, NEE's share of future distributions could be diluted. This directly impacts NEE’s cash flows, which are crucial for meeting its financial obligations and paying dividends.",
      "llm_answer": "\n\nNEE's limited partner interest in XPLR OpCo exposes it to financial risks if XPLR cannot access capital on favorable terms. Specifically, XPLR's inability to secure capital could hinder its ability to pursue acquisitions or growth opportunities, reducing cash distributions to NEE and diminishing the value of its investment. Additionally, XPLR issuing new securities (e.g., common units) to address capital needs could dilute NEE's ownership, further lowering its share of future cash flows. These constraints could adversely affect NEE's liquidity, particularly if NEE relies on distributions from XPLR OpCo to meet its financial obligations or dividend payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the risk to NEE's liquidity and financial obligations due to XPLR OpCo's limited access to capital, reduced cash distributions, and potential dilution from issuance of common units are all correctly identified. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly links XPLR's capital constraints → hindered growth/acquisitions → lower cash distributions → reduced cash flows to NEE → impact on NEE's liquidity and ability to meet obligations/dividends. It also correctly identifies dilution risk from new unit issuances. (4) The only minor shortcoming is a slightly less explicit connection between NEE’s dividend funding and reliance on XPLR distributions compared to the original, but this is implied. Wording differs but semantic meaning and factual content are equivalent. All entities (NEE, XPLR OpCo) and financial relationships are accurately represented.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 316,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the difference between the fair value of mortgage-backed obligations reported in the 'Marketable securities' section and the 'Fair Value' column of the marketable securities table?",
      "original_answer": "The difference between the fair value of mortgage-backed obligations reported in the two sections is $58. In the 'Marketable securities' section, the fair value is $178, while in the 'Fair Value' column of the marketable securities table, it is $236.",
      "llm_answer": "\n\nThe fair value of mortgage-backed obligations reported in the \"Marketable securities\" section and the \"Fair Value\" column of the marketable securities table is the same. For January 31, 2024, mortgage-backed obligations have a fair value of **$236 million** in both sections. The apparent difference arises from the presentation of data: the \"Marketable securities\" table shows the fair value as part of the security breakdown, while the \"Fair Value Measurement\" table categorizes it within Level 2 of the fair value hierarchy. The numerical value remains consistent across both sections.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) According to the ground truth, there is a $58 difference between the fair values reported in the two sections: $178 in the 'Marketable securities' section and $236 in the 'Fair Value' column of the marketable securities table. The LLM incorrectly claims both values are $236 million and that there is no difference. (2) The quantitative accuracy is severely flawed—both the individual values and the difference are wrong. The correct difference is $236 - $178 = $58, but the model fails to report this. (3) The reasoning is unsound: the model asserts consistency between sections due to presentation differences, but this contradicts the ground truth, which explicitly states a numerical discrepancy. It fails the multi-hop requirement to compare two reported values across sections. (4) While the answer addresses the right context (fair value of mortgage-backed obligations), it conveys the opposite of the true relationship—claiming equivalence instead of a $58 difference—making it mostly irrelevant factually despite topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 307,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the revenue recognition method for Google Play impact the financial reporting of non-advertising revenues, given the increasing portion of these revenues and their effect on margins?",
      "original_answer": "Google Play's revenue is reported on a net basis because Google's performance obligation is to facilitate a transaction between app developers and end users, for which it earns a service fee. This method reduces the total revenue amount reported for Google Play sales. As non-advertising revenues, which include Google Play, are increasing and have varying margins that may be lower than advertising revenues, this trend could adversely affect overall margins.",
      "llm_answer": "\n\nThe revenue recognition method for Google Play, which reports app sales and in-app purchases on a **net basis** (as a service fee rather than gross revenue), reduces the reported amount of non-advertising revenues. This approach impacts financial reporting by lowering top-line revenue growth metrics for non-advertising segments, as Google retains only a portion (e.g., a service fee) of the transaction value, with the remainder paid to developers. However, this method also avoids recognizing the full cost of these transactions as a separate line item in cost of revenues, potentially improving reported gross margins for Google Play specifically. Despite this, the **overall margin pressure** from non-advertising revenues (which inherently carry lower margins than advertising) persists as these revenues grow, as highlighted in Management’s Discussion and Analysis. The increasing proportion of lower-margin non-advertising revenues, including Google Play, thus negatively affects Alphabet’s consolidated margins over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Google Play revenue is recognized on a net basis because Google acts as an intermediary, earning a service fee—this reduces reported non-advertising revenue, which matches the original answer. (2) There are no specific numerical values (e.g., percentages or dollar amounts) in the ground truth, so the absence of numbers in the LLM response does not constitute an error; thus, quantitative accuracy is full. (3) The reasoning correctly synthesizes the impact of net reporting on financials: lower top-line revenue, avoidance of gross cost recognition, and the margin pressure from growing lower-margin non-advertising revenues. The mention of 'Management’s Discussion and Analysis' adds contextual support, though not explicitly in the ground truth, it is a reasonable inference. (4) The only minor gap is that the LLM slightly expands on the margin effect by suggesting net reporting could improve gross margins for Google Play specifically—while logically sound, the original answer emphasizes the adverse effect on *overall* margins due to the mix shift, without commenting on segment-level margin presentation. This nuance is not incorrect but adds a layer not in the original. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 385,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023, and how does this compare to the previous year's commitment?",
      "original_answer": "General Motors committed $0.8 billion to Ultium Cells Holdings LLC in 2023, which is a decrease from $1.4 billion in 2022. This indicates a reduction in GM's capital commitment to the joint venture by $0.6 billion year-over-year.",
      "llm_answer": "\n\nThe total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023 was **$800 million**. This represents a decrease from the previous year's commitment of **$1.4 billion** in 2022, reflecting a reduction of **$600 million** in GM's committed capital contributions to the entity. \n\n(Source: Note 11 under \"Nonconsolidated VIEs\" in the provided 10-K document.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the committed capital contributions are accurately reported: $800 million (i.e., $0.8 billion) in 2023 and $1.4 billion in 2022, with a correct year-over-year reduction of $600 million ($0.6 billion). The formatting variation ($800 million vs. $0.8 billion) is semantically equivalent and acceptable. (2) The answer is complete, addressing both parts of the question: the 2023 commitment and the comparison to the previous year. (3) Entity accuracy is correct—General Motors, Ultium Cells Holdings LLC, and the relevant years (2023 and 2022) are properly identified. (4) The reasoning is sound: the LLM correctly synthesizes data across years, computes the difference accurately, and draws the correct conclusion about the reduction in commitment. The source citation (Note 11 under 'Nonconsolidated VIEs') adds contextual support. Overall, the answer demonstrates precise multi-hop reasoning and factual fidelity to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 294,
        "total_tokens": 1460
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total cash consideration paid by Mastercard in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc., and how much of this amount was attributed to goodwill?",
      "original_answer": "Mastercard paid a total cash consideration of $2.8 billion in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc. Out of this, $1.7 billion was attributed to goodwill.",
      "llm_answer": "\n\nMastercard paid a total cash consideration of **$2.8 billion** for all acquisitions in 2024, including the acquisition of RF UlEmate Parent, Inc. (Recorded Future) for **$2.7 billion**. Of the total cash consideration, **$1.736 billion** was attributed to goodwill, as detailed in the purchase price allocation table under Note 2 of the 10-K filing.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total cash consideration as $2.8 billion, which matches the ground truth. However, it states that $1.736 billion was attributed to goodwill, whereas the ground truth specifies $1.7 billion. While this is close, the discrepancy in the goodwill amount—especially in a financial context where precision matters—counts as a factual inaccuracy. The mention of RF UlEmate Parent, Inc. being acquired for $2.7 billion is additional detail not present in the ground truth and could imply a breakdown not confirmed in the original answer, potentially causing confusion. (2) The total cash consideration ($2.8B) is accurate, but the goodwill attribution is off by $36 million. This affects quantitative accuracy despite being directionally correct. (3) The reasoning is sound: the model correctly synthesizes the total acquisition cost and links it to goodwill, referencing Note 2 of the 10-K filing, which indicates proper multi-hop reasoning from acquisition to financial impact. (4) The answer is contextually complete and relevant, addressing both parts of the question—total cash paid and goodwill attributed—though with a minor numerical inaccuracy in the goodwill figure. Wording and structure enhance clarity, but the extra $2.7 billion detail, while possibly true, is not part of the verified ground truth and introduces unverified specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 386,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total amount spent by UNP on freight car lease buyouts over the three-year period from 2022 to 2024, and how does this relate to the company's capital plan for acquiring freight cars in 2025?",
      "original_answer": "UNP spent a total of $270 million on freight car lease buyouts from 2022 to 2024 ($70 million in 2022, $57 million in 2023, and $143 million in 2024). This spending trend aligns with the company's 2025 capital plan, which includes acquiring freight cars to support asset replacement and growth opportunities, as part of a broader $3.4 billion investment strategy.",
      "llm_answer": "\n\nThe total amount spent by UNP on freight car lease buyouts from 2022 to 2024 was **$270 million** ($70 million in 2022, $57 million in 2023, and $143 million in 2024), as disclosed in the \"Investing Activities\" section of the document. This relates to the company's 2025 capital plan, which includes acquiring freight cars to support asset replacement and growth opportunities, with the 2025 capital plan estimated at approximately **$3.4 billion**, consistent with prior years. The prior lease buyouts align with UNP's ongoing strategy to modernize its fleet and enhance operational efficiency.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total spend of $270 million is accurate, with correct yearly breakdowns: $70M (2022), $57M (2023), and $143M (2024); the sum of these values is correct ($70M + $57M + $143M = $270M). The 2025 capital plan amount of $3.4 billion is also accurately reported. (2) The answer is complete, addressing both parts of the question: total lease buyout spending over 2022–2024 and its relation to the 2025 capital plan. (3) All entities—UNP, freight car lease buyouts, capital plan, and correct years—are accurately identified and used. (4) The reasoning is sound and reflects multi-hop synthesis: it connects past spending behavior to future strategic intent, correctly inferring alignment with fleet modernization and operational efficiency goals, which is consistent with the original answer’s assertion of supporting asset replacement and growth. Minor additional context (e.g., 'modernize its fleet') enhances clarity without introducing inaccuracies. The answer is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 314,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023?",
      "original_answer": "The total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $3.5 billion. This is calculated by summing the $2.0 billion notional amount from the ASR disclosed in the 2023 transaction and the $1.5 billion notional amount from the ASR disclosed in the 2022 transaction.",
      "llm_answer": "\n\nThe total notional amount of accelerated share repurchase (ASR) agreements under the 2021 Repurchase Program, based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023, was **$3.5 billion**. This includes a $1.5 billion ASR in 2022 (with Barclays Bank PLC) and a $2.0 billion ASR in 2023 (with Citibank, N.A.). The 2024 ASR ($3.0 billion) is excluded as its initial transaction occurred in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total notional amount as $3.5 billion, which matches the ground truth. It accurately breaks this down into a $1.5 billion ASR in 2022 and a $2.0 billion ASR in 2023, with correct attribution to the respective years and counterparties (Barclays Bank PLC and Citibank, N.A.), which aligns with disclosed forward contracts and treasury transactions. (2) All numeric values are correct: $1.5B (2022) + $2.0B (2023) = $3.5B total, and the exclusion of the 2024 ASR is appropriate per the question’s scope. Number formats are consistent and acceptable. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data across two years, identifies relevant ASR agreements under the 2021 Repurchase Program, and excludes transactions outside the specified period. (4) The answer is fully complete, factually accurate, and semantically equivalent to the original answer, with added contextual detail (counterparties) that enhances clarity without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 308,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Given GM's dependency on full-size ICE pickup trucks for near-term profitability and the risks outlined in the forward-looking statements, how does the company's reliance on these vehicles interact with its strategic shift toward electric vehicles (EVs) to impact long-term financial stability?",
      "original_answer": "GM's near-term profitability is heavily dependent on the success of its full-size ICE pickup trucks, which currently generate the highest profit margins and fund the company's strategic shift toward EVs. However, the forward-looking statements highlight that any shift in consumer preferences toward smaller, more fuel-efficient vehicles could weaken demand for these high-margin ICE vehicles. This would reduce the cash flow available to invest in EV development, which is critical to GM's long-term strategy. Therefore, a decline in ICE truck sales could jeopardize both short-term financial performance and the funding necessary to transition to an all-electric future, creating a dual risk that threatens both immediate and long-term financial stability.",
      "llm_answer": "\n\nGM's reliance on high-margin full-size ICE pickup trucks for near-term profitability creates both financial support and strategic risk as it transitions to EVs. The cash flow from ICE vehicles funds EV development, but this dependency exposes the company to volatility if consumer demand for ICE trucks wanes due to regulatory pressures, fuel price shifts, or changing preferences. Simultaneously, GM's EV strategy faces risks including high development costs, scaling manufacturing, securing battery materials, and achieving consumer adoption—compounded by uncertainties around charging infrastructure and government incentives like the Inflation Reduction Act. The forward-looking statements highlight that missteps in balancing these priorities (e.g., over-investment in EVs amid declining ICE sales or delayed EV profitability) could strain liquidity, reduce margins, and undermine long-term financial stability. Additionally, regulatory scrutiny of AV operations (e.g., Cruise's pause following an accident) and fixed-cost structures further complicate the transition, creating a delicate interplay between short-term profitability and long-term transformation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies GM's dependency on high-margin ICE pickup trucks to fund its EV transition, a core element of the original answer. The response accurately captures the dual risk: near-term financial stability relies on sustained ICE truck demand, while long-term success depends on EV investment funded by that same cash flow. It expands on the original with additional relevant risks (regulatory pressures, fuel prices, battery materials, charging infrastructure, Inflation Reduction Act incentives, Cruise AV issues), which are contextually appropriate and consistent with forward-looking statements in SEC filings, even if not explicitly in the ground truth. There are no numerical inaccuracies (quantitative accuracy is 10), and while the original answer does not mention AV operations or fixed costs, their inclusion does not detract from correctness and reflects plausible multi-hop reasoning from GM’s broader strategic risks. The core logic — that declining ICE sales could impair EV funding and thus long-term stability — is preserved and well-reasoned. One minor point: the original emphasizes the risk of shifting consumer preferences toward *smaller, more fuel-efficient vehicles* as a specific threat, which the LLM generalizes to 'changing preferences' — still correct but slightly less precise in causal mechanism. This justifies a 9 instead of 10 in qualitative accuracy. Overall, the answer is factually sound, comprehensive, and contextually rich without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 429,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the uncertainty around the pace of the energy transition, as influenced by changing commodity prices and regulatory developments, affect Chevron's asset impairment assessments and upstream investment decisions?",
      "original_answer": "Chevron evaluates the pace of the energy transition as a key factor in its commodity price forecasting and asset impairment assessments. Due to the uncertainty around the energy transition, Chevron may face reduced demand for traditional oil and gas products, which directly affects upstream earnings, cash flows, and capital expenditure programs. This uncertainty complicates impairment evaluations, as future cash flows from upstream assets depend on long-term assumptions about commodity prices, carbon costs, production profiles, and regulatory changes. If the energy transition accelerates or commodity prices remain low, Chevron may be forced to impair upstream assets, particularly those tied to crude oil, which could negatively impact its financial condition and reduce its ability to invest in new business lines such as lower-carbon energy solutions.",
      "llm_answer": "\n\nChevron's asset impairment assessments and upstream investment decisions are significantly influenced by uncertainty in the energy transition's pace, driven by volatile commodity prices and evolving regulations. **Changing commodity prices** directly impact future cash flow projections used in impairment evaluations; prolonged low prices or accelerated demand shifts toward lower-carbon energy could reduce the recoverability of upstream assets, triggering impairments. **Regulatory developments**, such as stricter emissions policies or restrictions on fossil fuel projects, may further pressure reserves estimates and asset valuations by altering the economic viability of existing operations. \n\nIn response, Chevron adjusts its upstream investment strategy, prioritizing projects with lower carbon intensity and diversifying into emerging opportunities like hydrogen and carbon capture (via Chevron New Energies). However, regulatory and market uncertainties complicate long-term planning, potentially delaying or scaling back traditional upstream projects while increasing focus on transitional technologies. The company also emphasizes flexibility in capital allocation to align with evolving energy dynamics, as outlined in its risk management and impairment assessment frameworks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the influence of commodity prices and regulatory developments on impairment assessments and upstream investments is properly described. The connection between energy transition uncertainty, long-term cash flow projections, and potential asset impairments—especially for crude oil-linked assets—is accurately conveyed. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable; however, the absence of incorrect numbers or miscalculations supports a score of 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how external factors (commodity prices, regulation) affect internal financial assessments (impairments) and strategic decisions (investment shifts toward lower-carbon projects like hydrogen and carbon capture). It also correctly identifies Chevron’s adaptive capital allocation strategy, which reflects the original answer’s emphasis on flexibility. (4) The only minor gap is that the LLM answer does not explicitly mention the impact of impairments on Chevron’s financial condition and its resulting reduced ability to invest in new business lines—a point emphasized in the original. However, this is implied through discussion of capital allocation shifts. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 402,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Mastercard's provision of Consumer Engagement Services, as part of its broader payment solutions, support its global payments network operations and financial performance?",
      "original_answer": "Mastercard's provision of Consumer Engagement Services enhances its global payments network by drawing on the company's principled and responsible use of secure data, which helps attract and retain consumers and merchants. This, in turn, strengthens the network's utility and drives additional payment flows, contributing to the company's financial performance. These services are part of a suite of offerings that are fundamentally interdependent and support the overall efficiency and attractiveness of Mastercard's global payments network.",
      "llm_answer": "\n\nMastercard's Consumer Engagement Services enhance its global payments network by driving customer acquisition, retention, and transaction volume growth, which directly boosts revenue from Gross Dollar Volume (GDV) fees. These services, integrated with Mastercard's payment network, offer value-added solutions like security, data insights, and digital tools that improve user experiences, increase approval rates, and expand acceptance of Mastercard's payment rails (e.g., cards, real-time payments). By differentiating its offerings and fostering deeper customer relationships, Mastercard strengthens network adoption, captures incremental payment flows, and diversifies revenue streams, contributing to higher net income and financial performance. For example, growth in GDV (up 11% in 2024) and net revenue ($28.2B, up 12%) reflects the effectiveness of these strategies in expanding transaction volumes and customer engagement.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the qualitative role of Mastercard's Consumer Engagement Services in enhancing the global payments network by driving customer acquisition, retention, and transaction volume, which supports network effects and financial performance. It accurately describes the integration of data insights, security, and digital tools as value-added services that improve user experience and expand payment rail adoption—aligning well with the ground truth's emphasis on secure data use and network utility. However, the quantitative claims introduce specific figures not present in the original answer: 'GDV up 11% in 2024' and 'net revenue $28.2B, up 12%' are unsupported by the provided ground truth, which contains no financial metrics or timeframes. Since the original answer does not include any numbers, the LLM fabricates metrics that may be factually incorrect or misaligned with actual filings, significantly reducing quantitative accuracy. While the reasoning is logically sound and contextually relevant—correctly synthesizing how consumer engagement drives network effects and revenue—the inclusion of unverified data undermines factual correctness. The answer is semantically aligned in intent and structure but fails on strict factual fidelity due to unsupported numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 364,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025, considering the initial acquisition cost and the deconsolidation in the final year?",
      "original_answer": "The total net cash outflow impact from Walmart's acquisition and deconsolidation of Alert Innovation was $0.4 billion, as the company initially spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no net cash inflow from its deconsolidation in fiscal 2025.",
      "llm_answer": "\n\nThe total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025 was **$0.4 billion**. Walmart acquired Alert Innovation for $0.4 billion in fiscal 2023, and while the entity was deconsolidated in fiscal 2025, the document does not specify any additional cash outflow or inflow related to the sale, implying the net impact remains limited to the initial acquisition cost.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total net cash outflow as $0.4 billion, matching the ground truth. The acquisition cost of $0.4 billion in fiscal 2023 is accurately stated, and the absence of any cash inflow from deconsolidation in fiscal 2025 is correctly inferred, leading to the correct net impact. (2) All numeric values are accurate: $0.4 billion acquisition cost, no additional cash flow on deconsolidation. The time periods (fiscal 2023 acquisition, fiscal 2025 deconsolidation) align with the ground truth. (3) The multi-hop reasoning is sound—correctly synthesizing the initial outflow and the lack of recovery on sale to conclude net outflow equals initial cost. The only minor limitation is the use of 'does not specify' rather than affirming no net cash inflow, which slightly weakens the confidence in the reasoning but does not affect factual correctness. (4) The answer is fully relevant, addressing both the acquisition and deconsolidation impact across the specified fiscal years. Overall, the answer is factually correct and well-reasoned, warranting a high score with only a slight deduction in qualitative accuracy due to phrasing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 332,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Considering the information provided about LTIP Units in both disclosures, what is the combined total of potentially dilutive securities for the year ended December 31, 2023, and why was no adjustment made to net income attributable to common stockholders?",
      "original_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes units exchangeable for common stock and LTIP Units. No adjustment was made to net income attributable to common stockholders because these securities had no material dilutive effect during the reporting period.",
      "llm_answer": "\n\nThe combined total of potentially dilutive securities for the year ended December 31, 2023, related to LTIP Units is not explicitly quantified in the disclosures, as the company states **no securities had a material dilutive effect** for 2023, 2022, or 2021. The company did not adjust net income attributable to common stockholders because **the inclusion of LTIP Units and exchangeable units would have no dilutive impact** on earnings per share or unit calculations. This is due to the fact that income allocable to limited partners or units, including dividends on these securities, is already accounted for in the basic earnings metrics, and their conversion would not reduce earnings per share/unit (as they are antidilutive or immaterial). \n\n**Answer:** The combined total of potentially dilutive securities (LTIP Units) is not material, and no adjustment to net income was required because these securities had no dilutive effect on earnings per share/unit for 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that the combined total of potentially dilutive securities (LTIP Units and exchangeable units) had no material dilutive effect for the year ended December 31, 2023, which aligns with the ground truth. While the exact numerical total is not provided in either the original or LLM answer—because it is immaterial and thus not quantified—the LLM accurately reflects that these securities are considered but not material. The reasoning for no adjustment to net income attributable to common stockholders is sound: no dilutive effect due to immateriality and because income allocable to these units is already accounted for in basic earnings metrics. The answer correctly synthesizes the multi-hop concept that despite the existence of potentially dilutive securities, they do not require adjustment because of antidilution or immateriality. All entities (LTIP Units, exchangeable units, net income attributable to common stockholders), time period (2023), and financial logic are accurate. The only minor shortcoming is a slight lack of emphasis on the 'combined total' being implicitly zero or negligible due to immateriality, but this is reasonably inferred. No numeric inaccuracies; format and semantics match ground truth in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 354,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ, and how does this compare to the total investments at fair value in each category?",
      "original_answer": "The total value of Investments measured at NAV across both asset categories in the 2023 10-K filing for VZ is $14 million ($9 million from the first category and $5 million from the second). This represents 3.1% of the total investments at fair value, which sum to $902 million ($441 million in the first category and $461 million in the second).",
      "llm_answer": "\n\nThe total value of Investments measured at NAV in the 2023 10-K for VZ is **$4,437 million** ($4,432 million for Pension Plans + $5 million for Health Care and Life Plans). \n\nFor comparison:  \n- **Pension Plans**: Investments at NAV ($4,432 million) represent approximately 48.7% of total investments at fair value ($9,104 million).  \n- **Health Care and Life Plans**: Investments at NAV ($5 million) account for just 1.1% of total investments at fair value ($461 million).  \n\nThis highlights a significant reliance on NAV valuation for Pension assets versus minimal use for Health Care and Life Plans.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitative Accuracy: The total value of Investments measured at NAV is stated as $4,437 million ($4,432M + $5M), whereas the ground truth reports only $14 million ($9M + $5M). This is a massive overstatement by over $4.4 billion. The LLM incorrectly reports $4,432 million for Pension Plans at NAV, which does not align with the ground truth. Additionally, the total investments at fair value are reported as $9,104 million and $461 million (summing to $9,565 million), while the ground truth states a total of $902 million ($441M + $461M). These numbers are completely inconsistent with the source data. (2) Calculations: The percentages derived by the LLM (48.7% and 1.1%) are based on incorrect inputs and thus invalid. The ground truth states that NAV investments represent 3.1% of total fair value investments, which the LLM fails to compute or mention. (3) Multi-hop reasoning: The question requires synthesizing values across two asset categories from the 2023 VZ 10-K. The LLM appears to have pulled data from unrelated or misidentified disclosures, possibly confusing total investment values with NAV-measured portions. It introduces 'Pension Plans' and 'Health Care and Life Plans' as categories, but the ground truth does not specify these as the two disclosed asset categories in this context. (4) Entity and Context Accuracy: While the company (VZ) and year (2023) are correct, the financial metrics and their values are fundamentally wrong. The LLM answer discusses a scale of investments (billions) that contradicts the ground truth (millions). (5) Semantic Equivalence: The answer does not convey the same information—on the contrary, it presents a completely different financial picture. The only partially correct element is the $5 million in one category, which matches one component of the ground truth, though its context may still be inaccurate. Overall, the answer reflects a severe failure in data retrieval, quantitative accuracy, and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 555,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much in equity earnings did GM report from Ultium Cells Holdings LLC in 2023, and in what financial statement category were these earnings disclosed?",
      "original_answer": "General Motors reported $293 million in equity earnings from Ultium Cells Holdings LLC in the year ended December 31, 2023, and these earnings were disclosed under 'Automotive and other cost of sales' in the financial statements.",
      "llm_answer": "\n\nGM reported equity earnings of **$293 million** from Ultium Cells Holdings LLC in 2023. These earnings were disclosed in the **Automotive and other cost of sales** category, as noted in **Note 8 (Equity in Net Assets of Nonconsolidated Affiliates)** and reiterated in **Note 23 (Segment Reporting)**. The document explicitly states that equity earnings from Ultium Cells Holdings LLC are presented in this line item due to the entity's role in supplying battery cells for GM's electric vehicles.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the equity earnings amount of $293 million for 2023 is accurate and correctly attributed to Ultium Cells Holdings LLC. The year (2023) and entity name are correct. (2) The financial statement category 'Automotive and other cost of sales' is correctly identified, which aligns with the ground truth. The LLM provides additional context by citing Note 8 and Note 23 from the financial statements, which enhances accuracy and traceability, even though these notes were not required in the original answer. (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects the equity earnings to the correct accounting treatment based on Ultium's role in the supply chain, demonstrating understanding beyond rote recall. (4) The answer is semantically equivalent to the original and adds value through supporting documentation references without introducing any factual errors. All components of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 297,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the change in equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) from 2023 to 2024, and how does this shift reflect in the overall ownership structure of MA?",
      "original_answer": "The equity ownership of Principal or Affiliate Customers (Class B stockholders) decreased from 0.8% in 2023 to 0.7% in 2024, a reduction of 0.1 percentage points. This shift indicates a minor decline in the relative ownership stake of this group within MA's overall ownership structure.",
      "llm_answer": "\n\nThe equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) decreased from **0.8% in 2023 to 0.7% in 2024**, a reduction of **0.1 percentage points**. This decline aligns with the conversion of Class B shares to Class A shares (as detailed in the \"Common Stock Activity\" table, showing Class B shares falling from 7.2 million to 6.8 million) and the subsequent requirement for Class B stockholders to sell converted Class A shares. \n\nThis shift reflects a marginal reduction in the influence of Principal or Affiliate Customers in MA’s ownership structure, with the majority equity (89.9%) now held by Public Investors (Class A stockholders) and the Mastercard Foundation (9.3%). Class B stockholders retain minimal non-voting equity, while voting power remains concentrated in Class A shares. The decrease underscores a gradual transition toward broader public ownership and reduced stakeholder control by MA’s principal customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the change in equity ownership of Principal or Affiliate Customers (Class B stockholders) from 0.8% in 2023 to 0.7% in 2024, a reduction of 0.1 percentage points, matching the ground truth exactly. All quantitative values are accurate, including the share count decline from 7.2 million to 6.8 million, which supports the percentage change. 2) Calculations are correct: the 0.1 percentage point decrease is accurate, and the share count difference (0.4 million) aligns with the ownership drop. Number formats are consistent and acceptable. 3) The reasoning is sound and reflects multi-hop synthesis: the LLM connects the ownership percentage change to the Class B to Class A conversion, references specific data (e.g., share counts), and contextualizes the shift within MA's broader ownership structure, including Public Investors (89.9%) and the Mastercard Foundation (9.3%). This goes beyond the ground truth but adds relevant context without introducing errors. 4) The answer is semantically equivalent to the ground truth and addresses both parts of the question: the numerical change and its implication on ownership structure. The only reason for not scoring a 10 is that the original answer did not include the additional details about voting power and the Mastercard Foundation, so while the LLM's elaboration is accurate, it slightly exceeds the scope of the verified ground truth. However, no inaccuracies are present, and all added context is factually sound and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 417,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total financial impact on Walmart (WMT) in terms of cash outflows related to Alert Innovation during fiscal 2023, and what happened to this entity in the following fiscal year?",
      "original_answer": "Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023, and then subsequently sold and deconsolidated the entity in fiscal 2025.",
      "llm_answer": "\n\nThe total cash outflow related to Alert Innovation in fiscal 2023 was **$0.4 billion**, as Walmart acquired the remaining interest to become a 100% owner. In the following fiscal year (2024), there is no mention of activity related to Alert Innovation; however, the entity was **sold and deconsolidated in fiscal 2025** (the year after 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion cash outflow in fiscal 2023 related to Walmart's acquisition of Alert Innovation, which matches the ground truth. It also accurately states that the entity was sold and deconsolidated in fiscal 2025. However, the LLM refers to 'the following fiscal year (2024)' and notes no activity then, which is factually consistent but slightly misaligns with the question's phrasing—'what happened to this entity in the following fiscal year?' The ground truth specifies the event occurred in fiscal 2025, not 2024, so the answer correctly clarifies that nothing notable happened in 2024 and correctly places the sale in 2025. (2) Quantitatively, the $0.4 billion figure is accurate and properly formatted; no calculations are required. (3) The multi-hop reasoning is sound: the model synthesizes acquisition in 2023 and disposition in 2025 across time points, correctly inferring that no intermediate event occurred in 2024. (4) The answer is contextually relevant and semantically equivalent to the ground truth, with only a minor nuance in framing the 'following fiscal year' as 2024 (which is correct from a 2023 perspective), but correctly clarifies the actual event timing in 2025.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 348,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much total principal was repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024, and what was the impact on the facility's remaining borrowing capacity as of December 31, 2023?",
      "original_answer": "The company repaid a total principal of $1.5 billion using borrowings from the 2021 Multicurrency Credit Facility in early 2024 ($500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes). As of December 31, 2023, the company still had the ability to borrow up to $6.0 billion under the facility, which includes a $3.5 billion sublimit for multicurrency borrowings, a $200.0 million sublimit for letters of credit, and a $50.0 million sublimit for swingline loans.",
      "llm_answer": "\n\nThe total principal repaid using the 2021 Multicurrency Credit Facility in early 2024 was **$1.5 billion**, consisting of $500 million for the 0.600% Senior Notes (January 12, 2024) and $1.0 billion for the 5.00% Senior Notes (February 14, 2024). As of December 31, 2023, the facility’s remaining borrowing capacity was **$5,276.6 million**, calculated as the $6.0 billion total capacity minus the $723.4 million outstanding principal balance reported for that date. The repayments in early 2024 occurred after year-end and thus did not affect the December 31, 2023, capacity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total principal repaid ($1.5 billion) and its components ($500 million and $1.0 billion), which matches the ground truth. However, it introduces a critical error in stating the remaining borrowing capacity as $5,276.6 million due to subtracting an outstanding balance of $723.4 million from the $6.0 billion capacity. This calculation and the figure of $723.4 million are not present in the original answer and contradict the ground truth, which explicitly states the full $6.0 billion remained available as of December 31, 2023, without any reduction. (2) The dates (January 12 and February 14, 2024) are plausible but not specified in the ground truth, so their inclusion adds unsupported detail. The core error lies in the quantitative miscalculation of remaining capacity, which undermines the answer's factual accuracy. (3) The multi-hop reasoning fails because the model incorrectly assumes that outstanding balances reduce available capacity, whereas the original answer affirms the full $6.0 billion was still accessible as of year-end 2023, implying no such drawdown had occurred. The model fabricates a liability not present in the source. (4) While the first part of the answer is correct and contextually relevant, the incorrect calculation and unsupported assumption about utilization severely reduce correctness and quantitative accuracy. The reasoning is partially sound but based on false premises, leading to a significant factual deviation in a key part of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 422,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Intel's use of EUV in its Intel 4 and Intel 3 process nodes relate to its broader roadmap for advanced transistor architectures, and what future node is expected to introduce High Numerical Aperture EUV as part of this progression?",
      "original_answer": "Intel uses EUV in its Intel 4 process node to print small features using ultra-short wavelength light, which is critical for improving performance-per-watt and enabling future client processors like Meteor Lake. Intel 3 builds on this by leveraging further FinFET optimizations and increased EUV usage to deliver additional area and efficiency improvements. This progression sets the stage for Intel 20A, which will introduce RibbonFET (Intel's implementation of gate-all-around transistor architecture) and PowerVia (backside power delivery). Beyond Intel 20A, Intel is developing Intel 18A, which will refine RibbonFET performance and incorporate next-generation High Numerical Aperture EUV in its process technology roadmap.",
      "llm_answer": "\n\nIntel's use of EUV in its Intel 4 and Intel 3 process nodes represents a critical step in advancing transistor density and performance, enabling the transition to more complex architectures like FinFET optimizations and preparing for gate-all-around (GAA) transistors. This progression supports Intel's broader roadmap toward leadership in process performance-per-watt and advanced packaging. The next major node, **Intel 18A**, is expected to introduce **High Numerical Aperture (HNA) EUV** as part of its continued refinement of RibbonFET technology and further advancements in manufacturing precision beyond the Intel 20A node.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: EUV is used in Intel 4 and Intel 3 for improved performance-per-watt and transistor density, with Intel 3 building on Intel 4 via increased EUV and FinFET optimizations. The progression to Intel 20A (RibbonFET and PowerVia) is correctly implied as a precursor to Intel 18A. (2) The future node expected to introduce High Numerical Aperture (HNA) EUV is correctly identified as Intel 18A—this matches the original answer exactly. There are no numeric values requiring calculation, but all technical terms (EUV, HNA EUV, RibbonFET) are used accurately. (3) Multi-hop reasoning is sound: the answer connects EUV usage in Intel 4/3 to the broader roadmap, including the transition to GAA transistors (RibbonFET), and correctly positions Intel 18A as the next step after Intel 20A with HNA EUV. (4) The only minor shortcoming is that the LLM omits explicit mention of Intel 20A introducing RibbonFET and PowerVia—though it references 'beyond Intel 20A' and refinement of RibbonFET, the specific innovations at Intel 20A are slightly under-articulated. However, since the question primarily asks about the node introducing HNA EUV (Intel 18A), this omission does not undermine the core correctness. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 408,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in the 2023 10-K filing by VZ, and how does this compare to the total cash and cash equivalents?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies is $239 million ($101 million + $138 million). This amount is significantly higher than the total cash and cash equivalents, which sum to $57 million ($30 million + $27 million).",
      "llm_answer": "\n\nThe total combined value of investments in U.S. Treasuries and agencies across both pension and health care/retirement plans in VZ's 2023 10-K is **$1,550 million** ($1,412 million in pension plans + $138 million in health care and life plans). This is **$433 million less** than the total cash and cash equivalents of **$1,983 million** ($1,956 million in pension plans + $27 million in health care and life plans). Cash and cash equivalents significantly exceed the value of U.S. Treasuries and agencies investments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) The reported values for U.S. Treasuries and agencies ($1,412M + $138M = $1,550M) and cash and cash equivalents ($1,956M + $27M = $1,983M) are completely wrong and do not match the ground truth. The correct values are $101M + $138M = $239M for U.S. Treasuries and agencies and $30M + $27M = $57M for cash and cash equivalents. (2) The calculation comparing the two totals is therefore also incorrect: the LLM claims Treasuries are $433M less than cash, but in reality, Treasuries ($239M) are significantly higher than cash ($57M). (3) The multi-hop reasoning failed—while the model correctly identified that two categories (pension and health care/retirement) should be summed, it used entirely incorrect base numbers, suggesting a failure to extract the correct data from the 10-K. (4) The conclusion that 'cash and cash equivalents significantly exceed' Treasuries is the opposite of the truth. The only partially correct element is the mention of two plan types (pension and health care/life), which shows some contextual awareness, but all critical financial data is wrong. Hence, the correctness score is very low due to total factual inaccuracy despite structurally attempting the right operations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 359,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021, and how much of the total goodwill from these acquisitions was attributed specifically to Aldevron?",
      "original_answer": "DHR paid a total net cash consideration of $9,561 million for Aldevron and $1,340 million for the other 11 businesses acquired in 2021, totaling $10,901 million. Of the total goodwill of $7,187 million recorded for these acquisitions, $6,149 million was attributed specifically to Aldevron.",
      "llm_answer": "\n\nThe total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021 was **$10.9 billion** ($9.6 billion for Aldevron and $1.3 billion for the other 11 businesses). Of the total goodwill of **$7.187 billion** from these acquisitions, **$6.149 billion** was specifically attributed to Aldevron.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only minor formatting differences in number presentation. (1) Quantitatively: The total net cash consideration is correctly stated as $10.9 billion, which matches the sum of $9,561 million (Aldevron) and $1,340 million (other 11 businesses) = $10,901 million (~$10.9 billion when rounded). The individual components are approximated as $9.6 billion and $1.3 billion, which are acceptable rounding of $9,561M and $1,340M respectively. The goodwill figures are exact: $7.187 billion and $6.149 billion match the original values. (2) Completeness: The answer addresses both parts of the question—total cash consideration and Aldevron-attributed goodwill—and includes the necessary breakdown. (3) Entity and metric accuracy: DHR, Aldevron, 2021 acquisitions, goodwill, and net cash consideration are all correctly identified. (4) Reasoning: The synthesis across the 12 acquisitions and attribution of goodwill to Aldevron reflects correct multi-hop logic. The only minor shortcoming is the rounding of individual cash components without explicit indication, which could slightly affect precision but does not mislead. Overall, the semantic meaning and factual content are preserved with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 358,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was GM's total committed capital contribution to Ultium Cells Holdings LLC as of December 31, 2023, and how does this compare to the carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date?",
      "original_answer": "GM had a committed capital contribution of $0.8 billion to Ultium Cells Holdings LLC as of December 31, 2023, while the carrying amount of its investment in Ultium Cells Holdings LLC was $2,268 million on the same date. This indicates that GM had not fully funded its committed capital contribution as of year-end.",
      "llm_answer": "\n\nAs of December 31, 2023, GM's total committed capital contribution to Ultium Cells Holdings LLC was **$800 million**, as disclosed in Note 11 under nonconsolidated variable interest entities. The carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date was **$2,268 million** (from Note 8). This means the carrying amount significantly exceeds the committed capital contribution, reflecting additional contributions or earnings allocations integral to the joint venture's operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects. (1) The committed capital contribution is correctly stated as $800 million (equivalent to $0.8 billion in the original answer), and the carrying amount is accurately reported as $2,268 million. These figures are correctly attributed to Note 11 and Note 8, respectively, showing proper sourcing. (2) All numbers are factually correct and presented in acceptable format variations (e.g., $800 million = $0.8 billion). There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly identifies and synthesizes two distinct pieces of information—committed capital vs. carrying amount—from different parts of the financial statements. (4) The qualitative interpretation is mostly correct; however, the original answer emphasizes that GM had *not fully funded* its commitment, while the LLM suggests the carrying amount exceeds the commitment due to 'additional contributions or earnings allocations.' While plausible, this interpretation slightly mischaracterizes the relationship—the carrying amount typically reflects cumulative equity method adjustments (including earnings, losses, and contributions), but stating it 'significantly exceeds' the commitment may imply overfunding, which contradicts the original point that the commitment was not yet fully funded. Despite this minor interpretive discrepancy, the core facts and synthesis are correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 410,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total amount of depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023, and how does it compare to the net book value of proved and unproved properties in that region as of December 31, 2023?",
      "original_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 was $5,729 million. The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, was $37,185 million. This means that the accumulated depreciation, depletion, and amortization for the Lower 48 region, which was $36,829 million, when added to the 2023 depreciation, depletion, amortization, and impairments of $5,729 million, results in a total accumulated value of $42,558 million. This represents a significant portion of the original total property value of $74,014 million for the Lower 48 region.",
      "llm_answer": "\n\nThe total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 were **$5,729 million**. The net book value of proved and unproved properties in the Lower 48 as of December 31, 2023, was **$37,185 million** (calculated as $70,621 million proved properties + $3,393 million unproved properties - $36,829 million accumulated depreciation, depletion, and amortization). Thus, the 2023 expenses represented approximately **15.4%** of the region’s net book value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 as $5,729 million and the net book value of proved and unproved properties as $37,185 million, matching the ground truth. The calculation of net book value ($70,621M + $3,393M - $36,829M = $37,185M) is accurate and aligns with the knowledge graph. The derived percentage (15.4%) of 2023 expenses relative to net book value is correct: ($5,729 / $37,185) ≈ 15.4%. (2) All numeric values are factually accurate and properly formatted. The LLM correctly used the accumulated depreciation figure ($36,829 million) in its net book value calculation, confirming access to and correct use of multi-hop data. (3) The reasoning is sound: the LLM synthesized data across proved properties, unproved properties, and accumulated depreciation to compute net book value, then compared it to 2023 expenses. However, it omitted the broader context from the original answer about the total original property value ($74,014 million) and the resulting total accumulated value ($42,558 million), which provides deeper insight into asset lifecycle. While not strictly required, this contextual synthesis was present in the ground truth and partially missing here. (4) Scores reflect full quantitative accuracy, excellent contextual relevance, and strong qualitative reasoning, with a minor deduction in qualitative accuracy due to incomplete synthesis of the full asset valuation narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 416,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total amount repaid under the 2021 Multicurrency Credit Facility in 2023, including both USD and EUR-denominated repayments, and how did this repayment activity affect the company's overall revolving indebtedness under this facility?",
      "original_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which included $919.1 million from the repayment of 842.6 million EUR. This significant repayment activity reduced the company's revolving indebtedness under the facility, contributing to a net decrease despite borrowing $3.0 billion during the year for purposes such as repaying the 2021 USD Two Year Delayed-Draw Term Loan and for general corporate purposes.",
      "llm_answer": "\n\nThe total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was **$6.1 billion**, which included **842.6 million EUR** (equivalent to $919.1 million at the repayment date). This repayment activity significantly reduced the company’s revolving indebtedness under the facility, lowering the outstanding principal balance to **$723.4 million** as of December 31, 2023, despite $3.0 billion in new borrowings during the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key numbers are correct: the total repayment of $6.1 billion, the EUR-denominated repayment of 842.6 million EUR (converted to $919.1 million), and the $3.0 billion in new borrowings during 2023 are all factually consistent with the original answer. Number formats are acceptable and semantically equivalent. (2) The quantitative accuracy is perfect—conversion from EUR to USD is correctly stated, and no calculation errors are present. (3) The qualitative reasoning is sound: the answer correctly identifies that the repayment reduced revolving indebtedness and notes the counteracting effect of new borrowings. It adds a specific detail—the outstanding balance of $723.4 million as of December 31, 2023—which is not in the original answer but does not contradict it and may reflect additional context from the filing. However, since this specific balance figure is not in the ground truth and was not asked for in the question, it slightly extends beyond the required synthesis, but not inaccurately. (4) The answer fully addresses both parts of the question: the total repayment amount (with USD and EUR components) and the effect on revolving indebtedness. The multi-hop reasoning—linking repayments, currency components, and net impact on debt—is logically and factually sound. The contextual relevance is excellent, directly addressing the question with precise, relevant information. The score is 9 instead of 10 only because the original answer does not mention the $723.4 million balance, so including it introduces a detail not verified by the ground truth, though it does not appear incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 457,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014, as referenced in both the glossary and the business section, impact its operational costs and closure activities at coal ash impoundments?",
      "original_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 directly impacts its operational costs and closure activities at coal ash impoundments. According to the business section, Duke Energy has completed excavation of coal ash at three of the four high-priority North Carolina sites and has begun closure activities at all of its jurisdictions. These activities involve moving coal combustion residuals (CCR) to engineered landfills or for reuse, which requires significant planning, permitting, and execution. The costs associated with these closure activities are included in rate proceedings and partially recovered through amended wholesale contracts approved by FERC in 2017. Additionally, the glossary explicitly defines the Coal Ash Act, indicating its regulatory significance and the necessity for Duke Energy to factor compliance into its financial planning and operational timelines.",
      "llm_answer": "\n\nDuke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 involves closure activities at coal ash impoundments, including excavation and relocation of coal combustion residuals (CCR) to lined landfills or beneficial reuse. These activities, initiated in 2015 at high-priority sites (with three of four North Carolina sites completed), have increased operational costs due to remediation, transportation, and regulatory permitting. However, Duke Energy has secured cost recovery mechanisms through state regulatory proceedings and amended wholesale contracts, allowing recovery of asset retirement obligation (ARO) expenses via retail and wholesale rates. This regulatory approval mitigates the financial impact by aligning closure costs with customer rate structures, ensuring compliance while managing cash flow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 involves closure activities including excavation and relocation of coal combustion residuals (CCR), three of four high-priority sites in North Carolina have been completed, and activities include moving CCR to lined landfills or for beneficial reuse. (2) Quantitative accuracy is perfect: the mention of 2015 as the start year for activities is consistent with the timeline implied in the original (post-2014 Act), and the completion of three of four sites matches exactly. No dollar amounts are in dispute. (3) The reasoning is sound and multi-hop: the LLM correctly links regulatory compliance (from the Act) to operational actions (excavation, closure), cost impacts (remediation, permitting, transport), and financial mitigation via cost recovery through rate proceedings and FERC-approved wholesale contracts. It correctly identifies the role of state and federal regulatory mechanisms in managing financial exposure. (4) The only minor omission is that the original specifies FERC approval occurred in 2017, while the LLM mentions 'amended wholesale contracts' without specifying the year. This is a small detail that slightly affects completeness but does not undermine the overall correctness. The glossary reference to the Coal Ash Act’s definition is implicitly acknowledged through discussion of compliance. Wording differs but semantic equivalence is strong. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 460,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Intel's FPGA technology, specifically the Agilex family, contribute to its IPU platforms and what role does the Intel eASIC N5X play in this context?",
      "original_answer": "Intel's Agilex FPGA family, built on Intel 10nm SuperFin technology, plays a critical role in its IPU platforms by enabling cloud and communications service providers to reduce overhead and free up CPU performance. The Agilex FPGA is already being deployed in IPU platforms at multiple cloud service providers. Additionally, the Intel eASIC N5X, as the next-generation Intel eASIC device, complements this ecosystem by offering a structured ASIC solution that provides lower unit cost and lower power compared to FPGAs, while still enabling fast time-to-market and reduced non-recurring engineering costs. This combination allows Intel to offer scalable, high-performance, and power-efficient solutions tailored for evolving infrastructure demands in cloud and communications.",
      "llm_answer": "\n\nIntel's Agilex FPGA family contributes to its IPU (Infrastructure Processing Unit) platforms by providing high-performance, reconfigurable hardware acceleration, enabling cloud and communication service providers to offload infrastructure tasks from CPUs, thereby improving efficiency and reducing overhead. The Agilex FPGAs, built on Intel 10nm SuperFin technology, offer low-latency processing and adaptability for dynamic workloads, as seen in the Oak Springs Canyon IPU reference platform combining Agilex with the Intel Xeon D processor. \n\nThe Intel eASIC N5X, a structured ASIC, complements this ecosystem by offering a cost-effective, power-efficient alternative for specific applications like 5G network acceleration, cloud storage, and edge computing. Positioned between FPGAs and ASICs, the N5X provides faster time-to-market and lower non-recurring costs, supporting Intel's strategy to address diverse market needs across IPU deployments and network infrastructure. Together, Agilex and eASIC N5X strengthen Intel's programmable solutions portfolio for scalable, flexible data center and edge architectures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Agilex FPGAs are built on Intel 10nm SuperFin technology and used in IPU platforms to offload CPU tasks, reduce overhead, and improve efficiency. The mention of the Oak Springs Canyon IPU reference platform (though not in the original answer) is contextually relevant and factually accurate, enhancing rather than detracting. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10. (3) The role of the Intel eASIC N5X is correctly described as a structured ASIC that offers lower power and cost than FPGAs, with faster time-to-market and reduced NRE costs—matching the original answer's intent. The LLM slightly reframes the benefit in terms of 5G, cloud storage, and edge computing, which are valid applications but not explicitly mentioned in the ground truth; this is acceptable as elaboration, not error. (4) Multi-hop reasoning is sound: the answer synthesizes the relationship between Agilex FPGAs and eASIC N5X within Intel’s broader IPU and infrastructure strategy. The only minor shortcoming is that the original emphasizes the 'next-generation' status of eASIC N5X more explicitly, which the LLM implies but doesn’t state verbatim. Overall, the answer is semantically equivalent, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 387,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How many employees does Danaher have in Other Developed Markets compared to North America, and what percentage of the total global workforce do these regions collectively represent?",
      "original_answer": "Danaher has 3,000 employees in Other Developed Markets and 24,000 employees in North America, collectively representing approximately 42.86% of the company's total global workforce of 63,000 employees.",
      "llm_answer": "\n\nDanaher has approximately **24,000 employees in North America** and **3,000 employees in Other Developed Markets** (as of December 31, 2023). Collectively, these regions represent **43% of the total global workforce** (27,000 employees out of 63,000 total associates).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively: The employee counts for North America (24,000) and Other Developed Markets (3,000) are correct. The total global workforce (63,000) is accurate. The combined workforce from these regions is correctly calculated as 27,000 (24,000 + 3,000), and the percentage is correctly computed as approximately 42.86%, which the LLM rounds to 43%—an acceptable and common rounding in reporting. (2) Completeness: The answer addresses both parts of the question—employee counts in the two regions and their collective percentage of the global workforce. (3) Entity Accuracy: Danaher is correctly identified, and the data aligns with the correct time frame (implied as of the latest available filing, consistent with ground truth). (4) Reasoning: The multi-hop synthesis—aggregating two regional headcounts and calculating their proportion of the global total—is sound and correctly executed. (5) Semantic Equivalence: The answer conveys the same information as the ground truth, with only minor rounding in the percentage (43% vs 42.86%), which does not affect factual correctness. The use of 'associates' instead of 'employees' is semantically equivalent in this context. The only reason for not scoring a 10 is the slight rounding without specifying it's approximate, though this is minor and common practice.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 386,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, and how does this compare to the total derivative assets reported on the balance sheet for the same year?",
      "original_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million. This matches the total derivative assets reported on the balance sheet for the same year, indicating that all derivative assets were composed of foreign exchange forwards and options.",
      "llm_answer": "\n\nThe total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, was **$557 million**. This amount matches the total derivative assets reported on the balance sheet for the same year, as all derivative assets listed ($557 million) consist of foreign exchange forwards and options (both designated and undesignated as hedging instruments). \n\n**Answer:** The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, was $557 million, which equals the total derivative assets reported on the balance sheet for that year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the value of $557 million is accurate and correctly attributed to the fair value of Nike's foreign exchange forwards and options as of May 31, 2023. This matches the total derivative assets on the balance sheet for the same period. (2) The answer is complete, addressing both parts of the question: the total fair value and its comparison to reported derivative assets. (3) Entity accuracy is correct—Nike, the instrument types (forwards and options), and the date (May 31, 2023) are all accurate. (4) The reasoning is sound: the LLM correctly infers that the matching amounts imply all derivative assets are composed of these instruments, which aligns with the multi-hop logic required. Minor additional detail (e.g., designation as hedging instruments) adds context without introducing error. The answer is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 271,
        "total_tokens": 1500
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much did the depreciation, depletion, amortization, and impairments expense in the Lower 48 region increase from 2021 to 2023, and what was the corresponding change in the number of productive wells in that region over the same period?",
      "original_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased by $1,662 million from 2021 ($4,067 million) to 2023 ($5,729 million). Over the same period, the number of productive wells in the Lower 48 region decreased by 49, from 87 in 2021 to 38 in 2023.",
      "llm_answer": "\n\nThe depreciation, depletion, amortization, and impairments (D&D&A) expense in the Lower 48 region increased by **$1,662 million** from 2021 ($4,067 million) to 2023 ($5,729 million). Over the same period, the number of productive wells in the Lower 48 region increased by **106 wells**, rising from 426 productive wells in 2021 (87 exploratory + 339 development) to 532 productive wells in 2023 (38 exploratory + 494 development).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in depreciation, depletion, amortization, and impairments (D&D&A) expense as $1,662 million, with accurate base values of $4,067 million in 2021 and $5,729 million in 2023. This part is factually correct. However, the LLM incorrectly states that the number of productive wells increased by 106, from 426 in 2021 to 532 in 2023. According to the ground truth, the number of productive wells actually decreased from 87 in 2021 to 38 in 2023—a reduction of 49 wells. The LLM appears to have misinterpreted 'exploratory' and 'development' wells as components of 'productive wells,' but in the context of the question and ground truth, 'productive wells' refers to the total number of producing wells, not a sum of exploratory and development categories. (2) The D&D&A calculation is accurate: $5,729M - $4,067M = $1,662M. However, the productive well count is fundamentally wrong—both the starting and ending values are incorrect, leading to an erroneous conclusion about the direction and magnitude of change. (3) The multi-hop reasoning fails in the second part: while the model attempts to synthesize data across years and categories, it uses an invalid formula (summing exploratory and development wells) rather than retrieving the actual reported number of productive wells. This reflects a failure in entity and metric interpretation. (4) The correctness score is 4 due to one major factual error in a key part of the answer. Quantitative accuracy is 5 because half the numbers (the D&D&A figures) are correct, but the well count is completely off. Qualitative accuracy is 4 due to flawed reasoning in interpreting what constitutes 'productive wells.' Contextual relevance is 8 because the answer addresses both parts of the question and uses appropriate structure, despite factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 502,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both tables from Verizon's 2023 10-K filing, and how does this allocation compare between the two different categorizations of investments at fair value?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies from both tables is $2,953 million. In the first table, U.S. Treasuries and agencies are valued at $1,412 million and are categorized under fixed income securities with $1,274 million in Level 1 and $138 million in Level 2. In the second table, U.S. Treasuries and agencies are valued at $1,541 million, with $1,312 million in Level 1 and $229 million in Level 2. This indicates a slight increase in the value of U.S. Treasuries and agencies between the two categorizations, with a corresponding shift in the distribution between Level 1 and Level 2 assets.",
      "llm_answer": "\n\nThe total combined value of investments in U.S. Treasuries and agencies reported in Verizon's 2023 10-K is **$1.55 billion** ($1,412 million in pension plans + $138 million in health care and life plans). \n\nThe allocation differs significantly between the two categorizations: **pension plans hold 97.5%** of the total ($1,412 million out of $1.55 billion) in U.S. Treasuries and agencies, while **health care and life plans account for only 2.5%** ($138 million). This reflects the pension plans' focus on liability-hedging fixed-income assets, whereas the health care plans have a smaller, more diversified allocation.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The total combined value is stated as $1.55 billion, but the ground truth is $2,953 million ($2.953 billion), derived from summing $1,412 million from the first table and $1,541 million from the second. The LLM incorrectly adds $1,412 million (correct) and $138 million (which is actually the Level 2 portion of the first table, not a separate plan), leading to a major miscalculation. (2) The allocation breakdown is fundamentally wrong: the two tables do not represent 'pension plans' vs 'health care and life plans'—they represent two different fair value hierarchy categorizations (e.g., by investment type and level within fair value hierarchy), not different benefit plans. The LLM misidentifies the nature of the tables, leading to incorrect interpretation. (3) Multi-hop reasoning fails: the model does not correctly synthesize that both tables report U.S. Treasuries and agencies with different level breakdowns (Level 1/Level 2), and instead invents a plan-based categorization not present in the ground truth. (4) While the answer attempts to address the question and uses plausible financial reasoning, the core numbers, entities, and logic are incorrect, warranting low scores in correctness, quantitative accuracy, and qualitative reasoning. Contextual relevance is moderate as it discusses the right topic and filing but with wrong structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 394,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "By how much did Nike's timed deposits classified as cash and equivalents decrease from fiscal year 2023 to 2024?",
      "original_answer": "Nike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 to 2024.",
      "llm_answer": "\n\nNike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 ($502 million) to 2024 ($347 million), as reported in Note 4 - Fair Value Measurements of the 10-K filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The quantitative decrease of $155 million is accurate: $502 million (FY2023) - $347 million (FY2024) = $155 million, which aligns with the original answer. Minor formatting differences (e.g., inclusion of exact values) add clarity without affecting correctness. (2) The answer is complete, addressing the exact decrease, the two fiscal years involved, and even citing the relevant note (Note 4 - Fair Value Measurements) from the 10-K filing, which enhances credibility. (3) Entity accuracy is correct: Nike is the subject, the metric 'timed deposits classified as cash and equivalents' is properly identified, and fiscal years 2023 and 2024 are correctly referenced. (4) The reasoning is sound and demonstrates multi-hop synthesis by pulling data from two different fiscal years and computing the difference, while also attributing the source. The semantic meaning fully matches the ground truth, with added detail that improves clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1073,
        "completion_tokens": 294,
        "total_tokens": 1367
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much did the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations total in 2023, and how does this compare to the combined total from 2022?",
      "original_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled $6,790 million in 2023, compared to $5,795 million in 2022. This represents an increase of $995 million.",
      "llm_answer": "\n\nThe combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled **$6,790 million in 2023** ($1,061 million for Alaska + $5,729 million for Lower 48). In 2022, the combined total was **$5,795 million** ($941 million for Alaska + $4,854 million for Lower 48). This represents an increase of **$995 million** in 2023 compared to 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: $6,790 million for 2023 and $5,795 million for 2022, with a correct difference of $995 million. The breakdowns by region (Alaska and Lower 48) are also factually correct and sum to the correct totals: 2023: $1,061M + $5,729M = $6,790M; 2022: $941M + $4,854M = $5,795M. (2) The answer is complete, addressing both the 2023 total, the 2022 total, and the year-over-year comparison (increase of $995M). (3) Entities (Alaska, Lower 48, depreciation/depletion/amortization/impairments, years 2022 and 2023) are correctly identified and used. (4) The multi-hop reasoning—aggregating across two regions and two years, then computing the difference—is sound and accurately executed. The answer provides additional detail (regional breakdowns) not in the original ground truth but does not introduce any errors. Semantic equivalence is maintained, and the extra detail enhances clarity without deviating from correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 291,
        "total_tokens": 1451
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total fair value of the crypto asset safeguarding liability and corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022, and how is this reflected in the fair value measurement disclosures?",
      "original_answer": "PayPal Holdings, Inc. reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022. This is disclosed in both the financial assets and liabilities table and the related notes to consolidated financial statements, where the crypto asset safeguarding liability is listed under financial liabilities and the safeguarding asset is listed under financial assets, with both categorized under 'Significant Other Observable Inputs (Level 2)' for fair value measurement.",
      "llm_answer": "\n\nAs of December 31, 2022, PayPal Holdings, Inc. reported a **crypto asset safeguarding asset and corresponding safeguarding liability of $604 million each**, as disclosed in Note 9 to the consolidated financial statements. These amounts are classified under **Level 2** of the fair value hierarchy, reflecting their valuation using quoted prices on active exchanges identified as the principal market for the underlying crypto assets. The disclosures specify that these items are recorded within \"prepaid expenses and other current assets\" and \"accrued expenses and other current liabilities\" on the consolidated balance sheets, with no significant unobservable inputs (Level 3) involved.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $604 million figure for both the crypto asset safeguarding asset and liability as of December 31, 2022, is accurate and correctly attributed to PayPal Holdings, Inc. The date and dollar amount are consistent with the original answer, with acceptable formatting. (2) The answer correctly identifies that both the asset and liability are reported at $604 million and are classified under Level 2 (Significant Other Observable Inputs) of the fair value hierarchy, which aligns with the ground truth. (3) The qualitative reasoning is sound: the LLM correctly synthesizes information by referencing Note 9 to the financial statements, specifying the balance sheet line items ('prepaid expenses and other current assets' and 'accrued expenses and other current liabilities'), and explaining the use of observable inputs from active exchanges. This reflects accurate multi-hop understanding across disclosures and accounting classifications. (4) The answer is contextually complete, addressing both the total fair value and how it is reflected in fair value measurement disclosures, including hierarchy level and absence of Level 3 inputs. Minor additional details (e.g., principal market) enhance clarity without introducing error. All elements match the original answer semantically and factually.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 385,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024, considering both the cash outflow to increase ownership and the cash inflow from new equity funding?",
      "original_answer": "Walmart paid $0.9 billion to former noncontrolling interest holders of PhonePe to increase its ownership during fiscal 2024, while also receiving $0.7 billion from new equity funding rounds in PhonePe, which resulted in a net cash outflow of $0.2 billion.",
      "llm_answer": "\n\nThe net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024 was a **$2.8 billion cash outflow**. This reflects $3.5 billion paid to increase ownership in Flipkart (which indirectly affected PhonePe through structural changes) and $0.7 billion received from new equity funding in PhonePe, resulting in a net outflow of $2.8 billion ($3.5B outflow – $0.7B inflow). The ownership in PhonePe decreased slightly from 89% to 84% due to the equity funding dilution. \n\n(Source: Note 3. Shareholders’ Equity, \"Purchases and Sales of Subsidiary Stock\" section.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states Walmart paid $0.9 billion to increase its ownership in PhonePe, but the LLM claims Walmart paid $3.5 billion related to Flipkart, which is incorrect and conflates two different transactions. The $0.7 billion inflow from new equity funding in PhonePe is correctly identified. However, the net outflow is stated as $2.8 billion, which is wrong; the correct net outflow is $0.2 billion ($0.9B out - $0.7B in). (2) Quantitative accuracy is very low: $3.5B outflow is not supported by the ground truth and appears to misattribute a Flipkart-related transaction to PhonePe. The $0.7B inflow is correct. The resulting calculation of $2.8B net outflow is therefore incorrect. (3) The reasoning is flawed: the LLM incorrectly introduces Flipkart as part of the ownership change in PhonePe, despite the question focusing solely on PhonePe. It also mentions a decrease in ownership from 89% to 84%, which is not mentioned in the ground truth and introduces unverified information. The multi-hop synthesis fails because it does not correctly identify the entities or transactions involved. (4) Contextual relevance is moderate because the answer addresses ownership changes and cash flows in PhonePe, but the incorrect linkage to Flipkart and erroneous figures severely undermine the response. The cited source reference (Note 3) may be plausible, but the content does not align with the ground truth. Overall, the answer is mostly incorrect with significant factual and logical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 430,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net change in total wholesale revenues (both affiliate and non-affiliate sales) for Southern Company in 2024 compared to 2023, and how did the IIC-approved affiliate sales mechanism influence this outcome?",
      "original_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $69 million. This is calculated by combining the $77 million increase in affiliate and non-affiliate wholesale revenues from one segment and the $79 million increase in affiliate sales offset by the $87 million decrease in non-affiliate sales from another segment. Specifically, affiliate sales increased by $79 million due to a 165.5% rise in the volume of KWH sales, which were conducted in accordance with the IIC-approved FERC pricing mechanism, ensuring energy was sold at marginal cost and stabilizing the financial impact of these internal transactions.",
      "llm_answer": "\n\nThe net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an **increase of $69 million**. This was driven by a **$77 million increase at Georgia Power** (due to higher market demand and capacity contracts) and a **$8 million net decrease at Alabama Power** (offsetting non-affiliate declines with a $79 million rise in affiliate sales). The IIC-approved affiliate sales mechanism influenced this outcome by enabling Alabama Power to increase affiliate sales by 165.5% in volume (due to affiliated company energy needs), as these sales are transacted at marginal cost under FERC-approved rules, stabilizing wholesale revenues without significant earnings impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net change in total wholesale revenues as a $69 million increase, matching the ground truth. It breaks this down into a $77 million increase (attributed to Georgia Power) and a net $8 million decrease at Alabama Power, which aligns with the calculation in the original answer: $77M + ($79M affiliate increase - $87M non-affiliate decrease) = $69M. All numeric values—$77M, $79M, $87M, 165.5% volume increase—are accurate and consistent with the ground truth. (2) Quantitative accuracy is perfect: all dollar amounts and percentages are correct, and the net change calculation is sound. The $8 million net decrease at Alabama Power (from +$79M affiliate and -$87M non-affiliate) is mathematically accurate and correctly inferred. (3) The multi-hop reasoning is strong: the model synthesizes data across segments (Georgia Power and Alabama Power), correctly attributes the affiliate sales increase to the IIC-approved FERC mechanism, and explains that sales at marginal cost stabilize revenues without significant earnings impact—consistent with the original answer’s emphasis on financial stabilization. The only minor gap is that the LLM attributes the $77M increase specifically to Georgia Power, which is plausible but not explicitly stated in the ground truth; the original answer refers to 'one segment' without naming it. This is a reasonable inference but introduces a slight assumption. (4) Contextual relevance is excellent: the answer addresses both parts of the question—net change and the role of the IIC-approved mechanism—and provides a coherent, focused explanation. The reasoning is logically structured and semantically equivalent to the ground truth, with only minor entity-level specificity not present in the original. Overall, this is a highly accurate, well-reasoned response with full quantitative fidelity and strong qualitative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 518,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total amount Intel plans to invest in manufacturing expansion under the IDM 2.0 strategy, based on the investments announced for Arizona, Ohio, and the global packaging sites?",
      "original_answer": "Intel plans to invest a total of $50.5 billion in manufacturing expansion under the IDM 2.0 strategy. This includes $20 billion for two new fabs in Arizona, more than $20 billion for two leading-edge fabs in Ohio, and $10.5 billion to equip the Rio Rancho, New Mexico and Malaysia sites for advanced packaging manufacturing.",
      "llm_answer": "\n\nIntel plans to invest a total of **$50.5 billion** in manufacturing expansion under the IDM 2.0 strategy. This includes **$20 billion for two new fabs in Arizona**, **over $20 billion for two leading-edge fabs in Ohio**, and **approximately $10.5 billion to equip global packaging sites in Rio Rancho, New Mexico, and Malaysia**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dollar amounts are accurate: $20 billion for Arizona, over $20 billion for Ohio, and $10.5 billion for packaging sites in Rio Rancho, New Mexico, and Malaysia. The total investment of $50.5 billion is correctly stated and aligns with the sum of the components. Minor wording differences such as 'over $20 billion' instead of 'more than $20 billion' and 'approximately $10.5 billion' instead of the exact figure do not affect factual accuracy, as they are semantically equivalent and reflect the original intent. (2) The answer is complete, addressing all three components of the investment (Arizona, Ohio, and global packaging sites) as required by the multi-hop question. (3) Entity accuracy is perfect: Intel, IDM 2.0 strategy, correct locations, and proper characterization of the investments (fabs vs. packaging) are all correct. (4) The reasoning is sound, demonstrating proper synthesis across multiple investment announcements and locations. The LLM correctly aggregates the total without double-counting or omission. (5) The semantic meaning is equivalent to the original answer, with only stylistic improvements (e.g., bold formatting for emphasis). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 365,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total goodwill did Danaher record from the acquisition of Abcam and what was the impact of the Veralto separation on Danaher's cash position prior to the distribution date?",
      "original_answer": "Danaher preliminarily recorded approximately $3.9 billion of goodwill related to the acquisition of Abcam. Additionally, Danaher received net cash distributions of approximately $2.6 billion from Veralto prior to the distribution date, which was partially used to redeem $1.0 billion of commercial paper.",
      "llm_answer": "\n\nDanaher recorded **$3.9 billion in goodwill** from the acquisition of Abcam. The Veralto separation impacted Danaher's cash position by **increasing cash by $2.6 billion** through proceeds from Veralto's debt issuance prior to the distribution date. Danaher used a portion of these proceeds to **redeem $1.0 billion in commercial paper**, with the remainder allocated to bond maturities and quarterly dividends. Thus, the net cash impact prior to the distribution was a **$1.6 billion increase** ($2.6 billion received minus $1.0 billion redeployed).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3.9 billion goodwill from the Abcam acquisition, matching the ground truth. It also correctly states that Danaher received $2.6 billion in net cash from Veralto prior to the distribution date. However, the LLM introduces a calculation not present in the original answer—claiming a 'net cash impact' of $1.6 billion after redeeming $1.0 billion in commercial paper. While the individual numbers are accurate, the original answer does not state or imply that the net impact was $1.6 billion; it only states the $2.6 billion was 'partially used' for the $1.0 billion redemption, without specifying the net increase in cash position. Thus, the inference of a $1.6 billion net increase goes beyond the provided information and adds unsupported precision. (2) All numeric values ($3.9 billion, $2.6 billion, $1.0 billion) are factually correct and match the ground truth. The calculation of $2.6B - $1.0B = $1.6B is mathematically accurate but not explicitly supported in the original answer, which avoids quantifying the net cash position change. (3) The multi-hop reasoning is mostly sound—linking Abcam goodwill and Veralto cash distributions—but overreaches by calculating a net cash impact that wasn't requested or stated in the ground truth. The original answer reports facts without aggregating them into a net figure, so the LLM's synthesis adds interpretation. (4) Scores reflect high factual accuracy and relevance, but docking for introducing a derived metric not in the source, which risks misrepresenting the completeness of the information. Contextual relevance is perfect as all content directly addresses the question parts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 459,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024, and how does this compare to the fair value of these derivatives assets and liabilities reported at year-end?",
      "original_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million. At year-end, the fair value of these derivatives was $557 million in assets and $180 million in liabilities. This indicates that while Nike held significant foreign exchange derivative positions, the net gain recognized during the year was relatively small compared to the overall fair value of these instruments.",
      "llm_answer": "\n\nThe total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was **$24 million**, as reported in the \"Derivatives not designated as hedging instruments\" section of the Consolidated Statements of Income. At year-end May 31, 2024, the fair value of these derivatives was **$343 million in assets** (primarily in prepaid expenses and deferred tax assets) and **$151 million in liabilities** (primarily in accrued liabilities). The net gain recognized in income is significantly lower than the year-end fair value amounts, as the gain reflects the cumulative income effect for the fiscal year, while the fair value represents the ending balance sheet positions of derivative assets and liabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 as $24 million, which matches the ground truth. However, the fair value of derivative assets and liabilities at year-end is incorrect: the LLM reports $343 million in assets and $151 million in liabilities, whereas the ground truth states $557 million in assets and $180 million in liabilities. These discrepancies are significant and affect the validity of the comparison. (2) The numbers for year-end fair values are quantitatively inaccurate—$343M vs $557M (asset) and $151M vs $180M (liability)—representing material deviations that cannot be attributed to rounding or formatting. The net gain figure is accurate. (3) The reasoning and multi-hop synthesis are partially sound: the model correctly distinguishes between income statement gains and balance sheet fair values, and explains the conceptual difference appropriately. However, because it uses incorrect balance sheet figures, the synthesis is based on flawed data. (4) The contextual relevance is high—the answer addresses both parts of the question and provides meaningful interpretation. Qualitative accuracy is moderate due to correct logic but incorrect data sourcing for fair values. Quantitative accuracy is low due to major errors in key financial figures. Correctness score is 5 due to partial correctness: one major component (net gain) is accurate, but the second (fair value amounts) is not, undermining the overall reliability of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 429,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates, and how does this compare to the 2022 depreciation, depletion, amortization, and impairments for the same region?",
      "original_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million, as equity affiliates contributed no discounted future net cash flows from the Lower 48. This is significantly higher than the 2022 depreciation, depletion, amortization, and impairments for the Lower 48, which amounted to $4,854 million. This indicates that the future cash flow potential of the Lower 48 region is much greater than the costs recognized during 2022.",
      "llm_answer": "\n\nThe combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is **$55,912 million** (with equity affiliates showing $0 for Lower 48). This is significantly higher than the 2022 depreciation, depletion, amortization, and impairments for the Lower 48 region, which totaled **$4,854 million**. The discounted cash flows reflect future net revenue projections, while the DD&A represents historical cost allocations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key figures—$55,912 million for the combined discounted future net cash flows and $4,854 million for depreciation, depletion, amortization, and impairments—are accurately reported with correct units and year (2022). The note that equity affiliates contributed $0 to the Lower 48 cash flows aligns with the original answer. (2) The comparison between future cash flows and DD&A is correctly framed as a significant difference, emphasizing that future cash flow potential far exceeds 2022 costs. (3) The multi-hop reasoning is sound: the model correctly synthesized data from both consolidated operations and equity affiliates for the Lower 48 region, and contrasted forward-looking cash flow projections with historical cost allocations. (4) The answer is semantically equivalent to the ground truth, with slightly more concise wording but no loss of meaning. Minor stylistic differences (e.g., bold formatting, omission of 'this indicates that...') do not affect factual accuracy or completeness. All entities—Lower 48 region, 2022 time frame, consolidated operations, equity affiliates—are correctly identified and used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 342,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023, and how does this compare to the fair value of these receivables based on the level of unobservable inputs?",
      "original_answer": "PayPal reported a total value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023. This entire amount was measured using significant unobservable inputs (Level 3), indicating that the fair value of these receivables is entirely based on Level 3 inputs.",
      "llm_answer": "\n\nThe total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023 was **$563 million**. This amount is entirely classified as **Level 3** in the fair value hierarchy, as the fair value is determined using significant unobservable inputs. Specifically, the fair value is based on the price at which PayPal expects to sell the loans under its agreement with a global investment firm, calculated at **$0.99 per $1.00 par value** (weighted average). Since no observable market inputs are used, the reported value and fair value are equivalent, both relying on internal risk classifications and contractual terms.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023, is accurate. The mention of Level 3 classification (significant unobservable inputs) aligns with the ground truth. The additional detail about the $0.99 per $1.00 par value (weighted average) is consistent with Level 3 valuation and provides context without contradicting the original answer. (2) The answer addresses both parts of the question: the total value and its comparison to fair value based on unobservable inputs. (3) Entities are correct: PayPal, December 2023 (implied as of December 31, 2023), and the financial metric are all accurately identified. (4) The reasoning is sound and enhances the ground truth by explaining *why* the fair value is based on Level 3 inputs—due to reliance on internal pricing models and contractual terms with a global investment firm, with no observable market data. This demonstrates proper multi-hop synthesis across financial reporting and fair value hierarchy concepts. (5) Semantic equivalence is maintained: while the LLM provides more detail than the original answer, all added information supports and elaborates on the ground truth without introducing inaccuracies. Therefore, the answer deserves the highest score across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 386,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the amounts borrowed and repaid under the 2021 Credit Facility in the same period?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. Under the 2021 Credit Facility, $3.1 billion was borrowed and $2.6 billion was repaid during the same period. This results in a net repayment of $3.1 billion for the 2021 Multicurrency Credit Facility and a net borrowing of $0.5 billion for the 2021 Credit Facility.",
      "llm_answer": "\n\nDuring the year ended December 31, 2023, under the **2021 Multicurrency Credit Facility**, the company borrowed **$3.0 billion** and repaid **$6.1 billion** (including €842.6 million, equivalent to $919.1 million at repayment). Under the **2021 Credit Facility**, the company borrowed **$3.1 billion** and repaid **$2.6 billion** during the same period. \n\nThus, the Multicurrency Credit Facility saw significantly higher repayments ($6.1B vs. $2.6B) compared to the Credit Facility, while borrowings were slightly lower under the Multicurrency Facility ($3.0B vs. $3.1B).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key numerical values: $3.0 billion borrowed and $6.1 billion repaid under the 2021 Multicurrency Credit Facility, and $3.1 billion borrowed and $2.6 billion repaid under the 2021 Credit Facility. The inclusion of €842.6 million (converted to $919.1 million) as part of the $6.1 billion repayment is an additional detail not contradicted by the ground truth and may reflect a breakdown of the total repayment amount; it does not introduce error since the total repayment figure remains consistent at $6.1 billion. All calculations and comparisons are correct: higher repayments in the Multicurrency Facility, slightly lower borrowings. The answer fully addresses both parts of the question—amounts borrowed and repaid for each facility—and provides a valid comparison. The reasoning is sound and entities (facilities, time period) are correctly identified. The only minor point reducing qualitative accuracy slightly is the introduction of a foreign currency conversion detail not present in the original answer, which, while potentially accurate, adds complexity without clarification of how it integrates into the total. However, since it doesn't contradict the total and may provide helpful context, it does not warrant a larger deduction. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 384,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What specific audit procedures were applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs, and how do these procedures reflect the subjectivity involved in assessing future regulatory orders?",
      "original_answer": "Both Georgia Power and Mississippi Power underwent similar audit procedures to evaluate the impact of regulatory rate changes on incurred costs. These procedures included testing the effectiveness of management's controls over the evaluation of the likelihood of recovery in future rates of certain incurred costs, refunds, or future reductions in rates. Auditors also reviewed regulatory orders and publicly available information to assess precedents for similar cost treatments. These procedures reflect the high degree of subjectivity involved in assessing the potential impact of future regulatory orders on incurred costs, as management must make significant judgments regarding the likelihood of recovery, disallowance, or refund obligations.",
      "llm_answer": "\n\nThe audit procedures applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs included: (1) testing management’s controls over assessing recovery likelihood of costs and refunds, (2) reviewing regulatory orders and precedents to evaluate recovery assumptions, (3) testing the completeness/accuracy of regulatory asset/liability recordings, (4) obtaining management representations on cost recoverability and rate adjustments, and (5) evaluating disclosures around regulatory uncertainties. These procedures reflect subjectivity by requiring judgments about future regulatory outcomes (e.g., recovery of costs, disallowed plant costs, or rate refunds), which depend on unpredictable commission decisions. Auditors addressed this by analyzing historical precedents, validating management’s assumptions, and ensuring disclosures highlighted the inherent uncertainties in regulatory assessments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the core audit procedures applied to both Georgia Power and Mississippi Power: testing management's controls over recovery likelihood, reviewing regulatory orders and precedents, and evaluating disclosures. The LLM expands slightly beyond the original answer by including additional procedures such as testing completeness/accuracy of regulatory asset/liability recordings and obtaining management representations—while these are not explicitly mentioned in the ground truth, they are reasonable and contextually appropriate audit steps that do not contradict the original answer. The explanation of subjectivity is strong and semantically equivalent: it emphasizes judgment in predicting future regulatory outcomes, reliance on historical precedents, and the uncertainty inherent in commission decisions. There are no numeric values in the question or answers, so quantitative accuracy is scored based on absence of errors (N/A but treated as correct by default). The multi-hop reasoning is sound—linking audit procedures to subjectivity in regulatory assessments across two companies. The only minor gap is that the original answer emphasizes the 'high degree of subjectivity' tied specifically to management’s judgments, while the LLM attributes some of this to auditors’ evaluations, slightly shifting focus. However, this does not undermine factual correctness. Overall, the answer is complete, factually accurate, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 423,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the decline in Comirnaty's global revenue in 2023 and the collaboration agreement terms with BioNTech impact Pfizer's operational results and future financial obligations?",
      "original_answer": "The decline in Comirnaty's global revenue from $37,806 million in 2022 to $11,220 million in 2023, a 70% drop, significantly affected Pfizer's operational results, driven by lower contracted deliveries and demand in international markets and the transition to traditional U.S. commercial market sales. This decline was compounded by Pfizer's ongoing collaboration agreement with BioNTech, under which Pfizer agreed to pay BioNTech tiered royalties and share gross profits from Comirnaty sales globally, excluding certain regions. Despite the revenue drop, Pfizer retained global commercialization rights (excluding Germany, Turkey, and certain Asian regions) and continued to share development and commercialization profits with BioNTech, creating ongoing financial obligations even as revenue declined.",
      "llm_answer": "\n\nThe decline in Comirnaty's global revenue in 2023, which fell 70% to $11.2 billion from $37.8 billion in 2022, significantly reduced Pfizer's total revenues and profitability. This decline, driven by lower international deliveries and the transition to traditional U.S. commercial sales, contributed to a **$40.8 billion net operational decline in total revenues** for 2023. The collaboration agreement with BioNTech further impacted Pfizer’s results by requiring shared development costs for Comirnaty and profit-sharing on sales in Germany and Turkey (recorded as Alliance revenues). Additionally, non-cash charges for inventory write-offs ($6.2 billion, including $1.2 billion for Comirnaty) exacerbated the decline in operational performance. Future financial obligations under the BioNTech agreement include ongoing cost-sharing for development and potential profit-sharing, though reduced sales volumes may temper these costs. The collaboration terms do not impose new material obligations beyond these existing commitments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies, particularly in quantitative claims. While it correctly identifies the 70% decline in Comirnaty revenue from $37.8 billion in 2022 to $11.2 billion in 2023 (matching the ground truth of $37,806M to $11,220M), it introduces a major error by claiming a '$40.8 billion net operational decline in total revenues' for Pfizer in 2023. This figure is not supported by the original answer or public filings and appears to be a miscalculation or misattribution. Additionally, the LLM mentions '$6.2 billion in inventory write-offs, including $1.2 billion for Comirnaty'—this specific breakdown is not present in the ground truth and cannot be verified from the provided information, making it an unsupported addition. 2) The revenue figures are correctly stated with acceptable formatting ($11.2 billion = $11,220 million), and the 70% drop is accurate. However, the $40.8 billion operational decline is incorrect: the difference between Comirnaty's 2022 and 2023 revenues is ~$26.6 billion, not $40.8 billion, and this should not be equated to Pfizer's total operational decline. The inventory write-off numbers are unverified and likely fabricated. 3) The reasoning partially captures the multi-hop relationship: it acknowledges the revenue drop and the BioNTech collaboration's financial impact. However, it misrepresents the profit-sharing structure—ground truth states Pfizer shares gross profits globally (excluding certain regions), while the LLM incorrectly limits it to Germany and Turkey and refers to 'Alliance revenues', which is not mentioned in the original. It also fails to mention Pfizer's retention of global commercialization rights outside specific regions, a key point in future obligations. 4) Despite these issues, the answer is contextually relevant, addressing both the revenue decline and collaboration impact. It correctly identifies lower international demand and U.S. market transition as drivers. The future obligations are reasonably interpreted, though incomplete. Overall, the answer is partially correct but undermined by significant quantitative errors and misrepresentation of the collaboration terms, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 589,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023?",
      "original_answer": "The value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024.",
      "llm_answer": "\n\nThe value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024. This information is derived from Note 4 - Fair Value Measurements in the 10-K filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the year-over-year decrease of $11 million, the starting value of $46 million as of May 31, 2023, and the ending value of $35 million as of May 31, 2024, are all correctly reported. (2) Quantitative accuracy is perfect: the difference ($46M - $35M = $11M) is accurate, and the dates and dollar amounts match exactly. (3) The qualitative reasoning is sound—although the LLM added a reference to 'Note 4 - Fair Value Measurements in the 10-K filing,' this is plausible context and does not detract from accuracy; it may enhance traceability. (4) The answer is semantically equivalent to the original and fully addresses the multi-hop nature of the question by identifying the correct company (NKE), security type (U.S. Agency securities), asset classification (short-term investments), and time points for comparison. No errors in entities, metrics, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 280,
        "total_tokens": 1398
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024, considering both new issuances and repayments?",
      "original_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was an increase of $423 million.",
      "llm_answer": "\n\nThe net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was **+$423 million**. This was calculated by subtracting the $77 million repaid in July 2024 from the $500 million in new issuances in November 2023 (both amounts stated in the document). No other transactions related to these notes were reported for 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net change as +$423 million, which matches the ground truth. The calculation is accurate: $500 million issued minus $77 million repaid equals $423 million increase. All numeric values are correct and properly formatted. (2) Quantitative accuracy is perfect: $500M issuance and $77M repayment are correctly cited, and the arithmetic is sound. The net change is correctly computed. (3) The reasoning is mostly sound, correctly synthesizing the issuance and repayment events. However, the issuance occurred in November 2023, not 2024, and while the question asks about the net change in 2024, the issuance in late 2023 would still affect the outstanding principal during 2024 if no repayment occurred until 2024. The repayment in July 2024 is within the correct timeframe. The model assumes the 2023 issuance is relevant to the 2024 net change, which may depend on whether the note was outstanding during 2024 — this is a subtle point, but in practice, such notes are typically considered in the principal balance unless retired. Thus, including it is reasonable. (4) The answer is contextually relevant, complete, and conveys the same information as the ground truth. The minor issue with the issuance date (2023 vs 2024) does not invalidate the financial impact in 2024, so the score is reduced by only one point for qualitative accuracy due to slightly imprecise temporal framing, but the core multi-hop logic and conclusion are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 412,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments, and how does this compare to the amount of cash, cash equivalents, and marketable securities held by the company in the U.S. as of December 31, 2024?",
      "original_answer": "3M had $0.5 billion in stand-alone letters of credit, bank guarantees, and other similar instruments issued and outstanding as of December 31, 2024. At the same date, the company held $4.2 billion in cash, cash equivalents, and marketable securities in the United States. Therefore, the stand-alone instruments represent approximately 11.9% of the U.S.-held liquidity.",
      "llm_answer": "\n\nThe total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments as of December 31, 2024, was **$500 million**. This amount is significantly lower than the **$4.2 billion** in cash, cash equivalents, and marketable securities held by the company in the U.S. as of the same date. The U.S. holdings represent the majority (approximately 55%) of 3M's total $7.7 billion in global cash, cash equivalents, and marketable securities.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $500 million in stand-alone letters of credit, bank guarantees, and similar instruments (equivalent to $0.5 billion in the ground truth), and accurately states the $4.2 billion in U.S. cash, cash equivalents, and marketable securities. These core numbers are correct. However, the LLM introduces additional information—namely that U.S. holdings represent approximately 55% of $7.7 billion in global liquidity—which is not present in the original answer and cannot be verified from the provided ground truth. This extra detail may be factually accurate but goes beyond the scope of the known truth and distracts from the required comparison. (2) The quantitative values for the instruments ($500M = $0.5B) and U.S. liquidity ($4.2B) are correct and match the ground truth. The calculation of the percentage (11.9%) is missing in the LLM answer, which was explicitly required in the original answer to compare the two figures. While the statement that the $500M is 'significantly lower' is qualitatively reasonable, the absence of the precise percentage (11.9%) constitutes a partial omission. (3) The multi-hop reasoning is partially sound: the model correctly retrieves two key figures from different parts of the financial data (instruments vs. U.S. liquidity). However, it fails to compute or report the exact percentage comparison (0.5 / 4.2 ≈ 11.9%), which is a core component of the original answer’s reasoning. Instead, it introduces an unverified global liquidity context. (4) The contextual relevance is high as the answer addresses the main question directly and uses appropriate financial terminology. The qualitative accuracy is reduced due to the missing percentage calculation and the introduction of unverified external data. Quantitative accuracy is high because all stated numbers are correct or appropriately formatted equivalents. Correctness score is 7 because the key facts are accurate but the answer omits a critical analytical component (the 11.9% comparison) and adds unsupported context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 553,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What percentage of Meta's worldwide MAUs were estimated to be duplicate accounts in Q4 2023, and how does this compare to the percentage of false accounts during the same period?",
      "original_answer": "In Q4 2023, duplicate accounts were estimated to represent approximately 10% of Meta's worldwide MAUs, while false accounts were estimated at approximately 4% of worldwide MAUs. This means duplicate accounts were more than twice as prevalent as false accounts during the same period.",
      "llm_answer": "\n\nIn Q4 2023, Meta estimated that **10% of its worldwide Monthly Active Users (MAUs)** were duplicate accounts, while **4% were false accounts**. Duplicate accounts were higher in developing markets (e.g., the Philippines and Vietnam), whereas false accounts showed episodic spikes in countries like Indonesia, Vietnam, and Nigeria. This indicates duplicate accounts represented double the share of false accounts during the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the percentages are accurate: 10% for duplicate accounts and 4% for false accounts in Q4 2023, with no calculation or number errors. (2) The answer correctly addresses both parts of the question: the percentage of duplicate accounts and how it compares to false accounts. It accurately states that duplicate accounts were double the share of false accounts, which aligns with the ground truth's 'more than twice as prevalent' (10% vs 4% is exactly 2.5 times, so 'double' is a reasonable approximation). (3) Entity accuracy is correct: Meta, Q4 2023, MAUs, duplicate accounts, and false accounts are all properly identified. (4) The reasoning is sound and includes additional context (geographic distribution) that enhances the answer without contradicting the core facts. The multi-hop synthesis—comparing two distinct metrics from the same period and drawing a comparative conclusion—is correctly executed. (5) Semantic equivalence is maintained: the core information and conclusion match the original answer, even with slightly different phrasing. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 338,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How much did Pfizer pay upfront in cash to BioNTech for the shingles mRNA vaccine collaboration, and how does this compare to the upfront payment made to Biohaven for migraine treatment rights outside the U.S.?",
      "original_answer": "Pfizer paid $75 million upfront in cash to BioNTech for the shingles mRNA vaccine collaboration and $150 million upfront to Biohaven for migraine treatment rights outside the U.S., resulting in a $75 million difference in favor of the Biohaven deal.",
      "llm_answer": "\n\nPfizer paid an upfront cash payment of **$75 million** to BioNTech for the shingles mRNA vaccine collaboration. In comparison, the upfront payment made to Biohaven for migraine treatment rights outside the U.S. was **$150 million**. Thus, the upfront payment to Biohaven was **double** the amount paid to BioNTech for the shingles vaccine collaboration. \n\nThese figures are derived from the collaboration agreements detailed in the Notes to Consolidated Financial Statements (pages 70–71) of Pfizer's 2023 10-K filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the upfront payments of $75 million to BioNTech and $150 million to Biohaven are accurately reported, with the correct comparison (double) that aligns with the $75 million difference stated in the original answer. (2) The numbers are factually accurate and consistent with the knowledge graph, and the calculation (150M = 2 × 75M) is sound. (3) The multi-hop reasoning is correct—information is synthesized across two distinct collaborations (BioNTech and Biohaven), and the comparison is logically drawn. (4) The answer is contextually relevant, complete, and includes a citation to the source (Pfizer's 2023 10-K, Notes to Consolidated Financial Statements), enhancing credibility. Semantic equivalence is maintained, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 248,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging instruments and non-hedging instruments?",
      "original_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is $115 million. This includes $110 million from derivatives designated as hedging instruments and $5 million from derivatives not designated as hedging instruments.",
      "llm_answer": "\n\nThe total liabilities related to foreign exchange forwards and options as of May 31, 2024, are **$120 million**. This includes **$115 million** for hedging instruments (split between $110 million in Accrued liabilities and $5 million in Deferred income taxes and other liabilities) and **$5 million** for non-hedging instruments (recorded in Accrued liabilities).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the total liabilities as $120 million, while the ground truth is $115 million. It also misallocates the hedging instrument amount as $115 million (split between $110M and $5M), which conflates the correct hedging ($110M) and non-hedging ($5M) amounts. The non-hedging amount is correctly identified as $5 million, but the total is wrong due to double-counting or mislabeling. (2) The calculation is flawed: $115M (hedging) + $5M (non-hedging) = $120M is incorrect because the ground truth states that hedging is $110M and non-hedging is $5M, totaling $115M. The LLM incorrectly inflates the hedging portion by including the $5M non-hedging amount within it. (3) The multi-hop reasoning is partially sound—information about hedging and non-hedging instruments is addressed, and the distinction between balance sheet classifications (Accrued liabilities, Deferred income taxes) is added detail—but the synthesis is incorrect due to misattribution of values. (4) Scores reflect major quantitative error (total and component amounts wrong), partial qualitative accuracy (correct structure and entities, but flawed logic), and high contextual relevance (addresses the right instruments, date, and categories).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 352,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does PayPal's recognition of a crypto asset safeguarding liability connect to its disclosure of risk concentrations, and what does this imply about the company's exposure to credit risk in relation to customer-held crypto assets?",
      "original_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard cryptocurrencies held on behalf of customers, and it discloses that its cash, cash equivalents, customer accounts, and other financial assets are subject to concentration of credit risk. Since crypto assets held for customers are not PayPal's assets but are safeguarded through a liability mechanism, the company's exposure to credit risk arises not from the crypto assets themselves but from the financial institutions where these customer funds are held. PayPal places these funds in high-quality financial institutions but acknowledges that balances may exceed FDIC insurance limits, creating a credit risk concentration that could impact the company if those institutions fail.",
      "llm_answer": "\n\nPayPal's recognition of a crypto asset safeguarding liability reflects its obligation to protect customer-held cryptocurrencies, which are not recorded as company assets but are legally safeguarded. This connects to its risk concentration disclosures, as the company emphasizes credit risk management for customer funds held in regulated accounts (e.g., high-quality financial institutions). However, customer-held crypto assets are distinct: they are not subject to the same credit risk frameworks (e.g., allowance for credit losses) because PayPal does not own or extend credit against them. Instead, the safeguarding liability underscores operational/custodial risks, implying limited direct credit risk exposure, as the company’s role is custodial rather than financial, and these assets are not integrated into its credit risk concentration metrics.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and synthesis compared to the ground truth. (1) It correctly identifies that PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard customer-held crypto assets and that these are not company assets. This aligns with the original answer. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) However, the key error lies in the reasoning about credit risk: the LLM incorrectly states that customer-held crypto assets are not subject to credit risk frameworks and implies PayPal has limited direct credit risk exposure due to its custodial role. This contradicts the ground truth, which clarifies that while the crypto assets themselves are not exposed to credit risk, the *funds used to safeguard them*—held in financial institutions—*are* subject to credit risk concentration. PayPal’s exposure arises because these funds may exceed FDIC insurance limits at high-quality institutions, creating a material credit risk if those institutions fail. The LLM fails to make this critical multi-hop connection between the safeguarding liability, the placement of funds in third-party institutions, and the resulting concentration of credit risk. (4) The answer is contextually relevant and well-structured, but the flawed reasoning downgrades qualitative accuracy. Correctness is moderate because core concepts (liability, custodial role) are right, but the implication about credit risk exposure is misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 438,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How many LTIP units were issued net of forfeitures under the 2019 Plan, and what was the impact of these units on potential stock dilution for the year ended December 31, 2024?",
      "original_answer": "689,202 LTIP units were issued net of forfeitures under the 2019 Plan, and these units were considered potentially dilutive securities. However, they did not have a material dilutive effect on the company's stock for the year ended December 31, 2024.",
      "llm_answer": "\n\nUnder the 2019 Plan, **689,202 LTIP units** were issued net of forfeitures for the year ended December 31, 2024. These units are included in the calculation of diluted earnings per share and unit, but the document explicitly states that **no securities (including LTIP units) had a material dilutive effect** for the year ended December 31, 2024. Thus, while the units exist as potential dilutive instruments, their impact on stock dilution was immaterial in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of LTIP units issued net of forfeitures—689,202—is accurate, and the time period (year ended December 31, 2024) is correctly identified. (2) The answer correctly states that these units are considered potentially dilutive but had no material dilutive effect, which aligns with the original answer’s assertion of immaterial impact. (3) The reasoning is sound: it acknowledges that LTIP units are included in diluted EPS calculations (a standard accounting treatment) but emphasizes the explicit disclosure of no material effect, demonstrating proper synthesis of financial reporting concepts. (4) The response addresses both parts of the multi-hop question—quantity of units and their dilutive impact—with precise, semantically equivalent information. Minor wording differences (e.g., 'no securities had a material dilutive effect' vs. 'did not have a material dilutive effect') do not affect factual accuracy. All entities (2019 Plan, LTIP units, December 31, 2024) are correctly referenced. No errors in logic, calculation, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 324,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products, and how did this compare to the impact in 2022?",
      "original_answer": "The total financial impact on 3M's earnings per diluted share from manufactured PFAS products was a reduction of $0.20 in 2024 and a reduction of $0.90 in 2022, resulting in a total combined impact of $1.10 over the two years.",
      "llm_answer": "\n\nThe total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products was **$0.28**, compared to **$0.90** in 2022. This represents a significant reduction in the negative impact on earnings per share from PFAS products between 2022 and 2024. \n\nThis information is derived from the \"Earnings (loss) from continuing operations per diluted share\" table in the MD&A section, where the \"Manufactured PFAS products\" line item shows $0.28 for 2024 and $0.90 for 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 impact as $0.90, which matches the ground truth. However, it incorrectly states the 2024 impact as $0.28 instead of $0.20, which is a significant factual error. The comparison between 2022 and 2024 is directionally correct (noting a reduction), but the magnitude is based on incorrect data. (2) The quantitative accuracy is compromised: the 2024 figure is off by $0.08, and the answer fails to mention the combined total impact of $1.10 over the two years, which is a key part of the original answer. No calculation of the total or difference is provided. (3) The reasoning shows partial multi-hop capability—comparing two years and identifying the trend—but fails to synthesize the full scope (combined impact). The citation to the MD&A table adds contextual support but does not compensate for factual inaccuracy. (4) Scores reflect that core entities (3M, PFAS, EPS, years) are correct and the response is relevant, but the incorrect 2024 number and missing combined total reduce correctness and quantitative accuracy significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 312,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the volume changes in KWH sales to affiliates and non-affiliates in 2024, governed by the Intercompany Interchange Contract (IIC), impact the overall wholesale revenue performance for the Southern Company system?",
      "original_answer": "The Southern Company system experienced a $87 million (20.5%) decrease in wholesale revenues from non-affiliate sales due to a 30.8% drop in KWH volume after power agreements ended in May 2023. This was partially offset by a $79 million (131.7%) increase in affiliate sales driven by a 165.5% rise in KWH volume, largely due to increased affiliated energy demand. These affiliate sales were conducted under the IIC approved by FERC, showing that while external market conditions reduced non-affiliate revenue, internal energy transfers under the IIC helped mitigate some of the overall revenue decline.",
      "llm_answer": "\n\nThe volume changes in KWH sales to affiliates and non-affiliates under the IIC in 2024 had contrasting impacts on Southern Company's wholesale revenue. **Sales to non-affiliates decreased by 30.8% in volume**, leading to a $87 million decline in revenue (20.5% drop) due to expiring power sales agreements. Conversely, **sales to affiliates surged 165.5% in volume**, driving a $79 million revenue increase (131.7% growth) as affiliated companies met higher energy needs. While these transactions are governed by the IIC and priced at marginal cost, their net impact on earnings is minimal, as associated expenses are offset by cost recovery mechanisms. Overall, the Southern Company system shifted wholesale activity toward internal sales, reflecting operational coordination but limited net income effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 30.8% drop in non-affiliate KWH volume leading to a $87M (20.5%) revenue decrease, and the 165.5% increase in affiliate volume driving a $79M (131.7%) revenue increase are all accurately reported. These numbers match the original answer exactly, and formatting is consistent. (2) Quantitative accuracy is perfect—values, percentages, and directions of change are all correct and consistent with the source. (3) The reasoning is sound: the LLM correctly identifies the cause (expiring agreements for non-affiliates, increased demand for affiliates) and notes the role of the FERC-approved IIC. However, it adds a nuance not in the original—that affiliate sales are priced at marginal cost and have minimal net income impact due to cost recovery. While plausible and contextually reasonable, this detail was not in the ground truth and slightly extends beyond the provided information, slightly reducing qualitative accuracy. (4) The answer fully addresses the question about volume changes under the IIC and their impact on wholesale revenue. It synthesizes multi-hop information (volume changes, revenue impacts, causes, and contractual framework) correctly. The added commentary on earnings impact does not contradict the original but introduces an inference. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only minor deduction for the slight over-extension in reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 424,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total financial penalty imposed by the Irish Data Protection Commission alongside the corrective orders related to unlawful data transfers, and how might compliance with these orders affect Meta's operational costs in Europe?",
      "original_answer": "The Irish Data Protection Commission imposed a financial penalty of €1.2 billion alongside the corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and cease the processing of EEA Facebook user data in the United States. Compliance with these corrective orders could increase the cost and complexity of delivering Meta's products and services in Europe, as the company may be required to take additional steps to align its data processing operations with Chapter V of the GDPR.",
      "llm_answer": "\n\nThe Irish Data Protection Commission (IDPC) imposed a **€1.2 billion administrative fine** alongside corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and comply with GDPR by ceasing the storage of EEA user data in the United States. Compliance with these orders could **increase Meta's operational costs in Europe** by necessitating structural changes to data processing systems, implementing alternative lawful transfer mechanisms (e.g., adhering to the EU-U.S. Data Privacy Framework), and incurring ongoing compliance and legal expenses. Additionally, operational complexity may rise due to stricter data localization requirements or reduced efficiency in cross-border data flows, potentially impacting service delivery and advertising targeting capabilities in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the €1.2 billion fine is correctly stated, matching the original answer exactly. (2) The LLM correctly identifies the corrective orders related to suspending unlawful data transfers and ceasing processing of EEA user data in the U.S., though it slightly rephrases 'processing' as 'storage'—a minor imprecision but not factually incorrect in context. (3) The reasoning about increased operational costs is sound and expands appropriately on the original answer by specifying potential measures like adopting the EU-U.S. Data Privacy Framework, which is a valid and relevant example of a lawful transfer mechanism under GDPR Chapter V. The mention of structural changes, compliance costs, and impact on advertising targeting adds valuable context without introducing inaccuracies. (4) All entities—Irish Data Protection Commission, Meta Platforms Ireland, EEA user data, GDPR—are correctly identified and used. The answer fully addresses both parts of the question: the penalty amount and the operational cost implications. The only reason for not scoring a 10 is that the original answer specifically references 'Chapter V of the GDPR' and the need to align with it, which the LLM implies but does not explicitly mention. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 386,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does The Home Depot's emphasis on product depth and job lot quantities specifically support its strategy to meet the needs of professional customers (Pros), and what risks are highlighted in the document if this aspect of competitiveness is not effectively maintained?",
      "original_answer": "The Home Depot emphasizes product depth and job lot quantities to meet the complex purchase needs of professional customers (Pros), who require larger volumes and dedicated sales support. If the company fails to maintain these offerings alongside competitive delivery and pickup options, it could negatively impact demand for products and services and reduce profit margins.",
      "llm_answer": "\n\nThe Home Depot emphasizes product depth (approximately 30,000–40,000 items per store) and job-lot quantities to meet the complex needs of professional customers (Pros), such as contractors and tradespeople, who require specialized products in bulk for large projects. This strategy supports their focus on providing a \"broad assortment of Pro-focused products,\" dedicated fulfillment options, and the ability to serve urgent or large-scale purchase demands, as highlighted in the document. \n\nThe risks associated with failing to maintain this competitiveness include **loss of market share** and **reduced demand for products/services**, as Pros may seek alternatives if Home Depot cannot consistently offer product availability, job-lot quantities, or timely delivery. The document explicitly notes that failure to maintain these capabilities could negatively impact profit margins and customer loyalty, particularly in a highly competitive market where Pros prioritize product depth, credit options, and efficient fulfillment (as outlined in the \"Competition and Seasonality\" and \"Risk Factors\" sections).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies The Home Depot's emphasis on product depth and job lot quantities to serve professional customers (Pros), explaining that these offerings meet the bulk and specialized needs of contractors and tradespeople. The inclusion of '30,000–40,000 items per store' is a reasonable estimate consistent with public knowledge, though this specific number is not in the original ground truth; however, since the ground truth does not specify a number, the LLM's addition is contextually appropriate and not factually incorrect. (2) Quantitatively, no specific figures (e.g., dollar amounts, exact dates) are misstated; the range provided is plausible and does not contradict the source. (3) The reasoning is sound: the LLM correctly synthesizes the strategic rationale (meeting complex Pro needs) and links it to risks like reduced demand and margin pressure if competitiveness erodes. It appropriately references 'Competition and Seasonality' and 'Risk Factors' sections, indicating correct multi-hop reasoning. (4) The risks highlighted—loss of market share, reduced demand, lower profit margins, and customer attrition—are consistent with the original answer, with added contextual detail (e.g., credit options, fulfillment efficiency) that enriches but does not distort the meaning. The only minor deviation is the expanded risk discussion beyond the original scope, but this reflects plausible inference from the domain. Overall, the answer is factually correct, comprehensive, and contextually grounded.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 439,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures, and what might this exclusion indicate about the complexity of valuing these specific investments?",
      "original_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $177 million ($94 million + $83 million). The exclusion of these interests indicates that the valuation of these specific investments is complex and not easily categorized within the standard fair value hierarchy, likely due to the lack of observable market data or the presence of restrictions that limit the company’s ability to readily redeem these investments.",
      "llm_answer": "\n\nThe total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy was **$83 million in 2021** and **$94 million in 2020**. This exclusion indicates that these investments are classified as Level 3 in the fair value hierarchy, requiring complex valuations based on unobservable inputs, such as actuarial present value computations and internal models, rather than relying on observable market prices or transactions. The use of Level 3 methods reflects the significant judgment and subjectivity involved in estimating their fair value.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies the two values ($94 million and $83 million) from the two disclosures, and although it reverses the years (stating $83M in 2021 and $94M in 2020), the total sum of $177 million is implied through listing both figures. However, the LLM does not explicitly calculate or state the total value of $177 million, which is a key part of the question. 2) Quantitatively, the numbers are accurate with only a possible year reversal—$94M and $83M are correct amounts. The sum is not explicitly computed, but both components are present. 3) The reasoning is partially correct: the exclusion from the fair value hierarchy is due to complexity, but the LLM incorrectly states that these are classified as Level 3 within the hierarchy. The ground truth emphasizes that they are *excluded from* the fair value hierarchy entirely, not classified within it (even at Level 3). This is a significant conceptual error in financial reporting terminology—excluded means not reported in the hierarchy at all, not that they are Level 3. 4) Contextually, the answer is relevant and addresses valuation complexity, citing unobservable inputs and internal models, which aligns with the intent of the original answer. However, the mischaracterization of the classification undermines the qualitative accuracy. The explanation of complexity is sound but misapplied due to the incorrect framing within the hierarchy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 390,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does PayPal's use of loss curves in conjunction with macroeconomic forecasts impact its allowance for credit losses on both merchant and consumer receivables, and what specific macroeconomic factors are applied in each category?",
      "original_answer": "PayPal applies loss curves to both merchant and consumer receivables to estimate the allowance for credit losses, incorporating macroeconomic forecasts. For merchant receivables, the loss curves are applied by geography, delinquency, and origination period, and the macroeconomic factors include forecasted trends in unemployment rates and retail e-commerce sales. For consumer revolving credit receivables, the loss curves are also used, and macroeconomic factors such as forecasted trends in household disposable income and retail e-commerce sales are applied. These macroeconomic inputs directly influence the projected loss rates, which are then applied to the principal amounts of receivables to determine the allowance for credit losses, ensuring that economic conditions are factored into the financial estimates.",
      "llm_answer": "\n\nPayPal uses loss curves in conjunction with macroeconomic forecasts to estimate current expected credit losses for both merchant and consumer receivables. For **merchant receivables**, the allowance incorporates historical loss data and macroeconomic factors such as **unemployment rates** and **retail e-commerce sales trends**, with forecasts applied over a 2.5–3.5 year horizon. For **consumer receivables** (primarily revolving credit products), macroeconomic factors include **household disposable income** and **retail e-commerce sales** (unemployment rates were previously included but are no longer explicitly cited post-2023), with a longer forecast period of approximately 5 years. These factors are sourced externally and integrated into loss models to adjust allowances based on economic scenarios, ensuring the allowances reflect potential credit risks across varying economic conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies that PayPal uses loss curves with macroeconomic forecasts for both merchant and consumer receivables. For merchant receivables, it accurately lists unemployment rates and retail e-commerce sales as key macroeconomic factors, consistent with the original answer. For consumer receivables, it correctly identifies household disposable income and retail e-commerce sales, noting the exclusion of unemployment rates post-2023—an additional detail not in the ground truth but not contradictory (possibly reflecting updated disclosures). The answer adds value by specifying forecast horizons (2.5–3.5 years for merchants, ~5 years for consumers), which are not in the original answer but are plausible and contextually relevant. These additions do not detract from accuracy but enhance completeness. All entities (PayPal, receivables types, macroeconomic variables) are correct. The reasoning is sound, demonstrating multi-hop synthesis across receivable types and macroeconomic inputs. Quantitative elements (forecast periods) are presented accurately, with no calculation errors. The only minor deviation is the claim about unemployment rates no longer being used for consumer receivables post-2023, which is not in the ground truth and cannot be verified from the provided data—this prevents a perfect 10 but does not constitute a factual error given possible updates. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 424,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does Costco's investment in the development and protection of Kirkland Signature, as well as its reliance on manufacturing and distribution facilities for private-label items, expose the company to risks that could affect both brand loyalty and gross margin performance?",
      "original_answer": "Costco has invested significantly in the development and protection of its private-label brand, Kirkland Signature, which contributes to higher margins and helps differentiate its merchandise offerings. However, the company relies on processing, packaging, and manufacturing facilities to produce these private-label items, and any disruptions in these operations—such as extreme weather, pandemics, or labor issues—could delay production and delivery. If such disruptions occur, Costco risks inconsistent product availability and quality, which could reduce member acceptance of Kirkland Signature products. Since these products represent a growing portion of overall sales and carry higher margins, any loss of member confidence could negatively impact both brand loyalty and gross margin performance.",
      "llm_answer": "\n\nCostco's investment in Kirkland Signature and reliance on private-label manufacturing/distribution exposes it to risks that could undermine brand loyalty and gross margins. First, disruptions in manufacturing, packaging, or distribution facilities (due to labor issues, extreme weather, or supply chain challenges) could delay product availability or compromise quality, reducing member satisfaction and eroding trust in the Kirkland brand. Second, if Kirkland Signature products fail to maintain perceived quality or value relative to national brands, members may lose confidence, shifting purchases to lower-margin alternatives. Since private-label items already carry higher margins than national brands, any decline in their sales penetration or margin performance would directly reduce overall gross profits. Additionally, over-reliance on internal production could amplify vulnerabilities compared to diversified suppliers, increasing operational risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Costco's investment in Kirkland Signature supports higher margins and differentiation; reliance on manufacturing and distribution facilities introduces operational risks from disruptions like labor issues or extreme weather; such disruptions could affect product availability and quality, undermining member trust and brand loyalty. The link between Kirkland Signature's margin contribution and overall gross margin performance is correctly emphasized. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the model correctly synthesizes the connection between operational dependencies (manufacturing facilities), brand perception (quality and availability), and financial outcomes (gross margins and loyalty). The addition of 'over-reliance on internal production' and comparison to 'diversified suppliers' extends the original slightly but does not introduce inaccuracy—it adds reasonable context. (4) The LLM answer is semantically equivalent to the original, with slightly expanded reasoning that remains factually consistent. One minor point preventing a perfect 10 is that the original emphasizes the 'growing portion of overall sales' as a reason for heightened risk, which the LLM mentions implicitly but not explicitly. Otherwise, the response is complete, relevant, and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 416,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total grant date fair value of the performance-based LTIP units across the 2021 and 2022 LTI Programs, and how does this compare to the time-based restricted stock units granted in those same years?",
      "original_answer": "The total grant date fair value of the performance-based LTIP units for the 2021 and 2022 LTI Programs is $39.0 million ($18.4 million in 2021 and $20.6 million in 2022). In comparison, the time-based restricted stock units granted in those years totaled $11.2 million ($4.3 million in 2021 and $6.9 million in 2022). Therefore, the performance-based LTIP units had a significantly higher total grant date fair value than the time-based restricted stock units across both programs.",
      "llm_answer": "\n\nThe total grant date fair value of performance-based LTIP units for the 2021 and 2022 LTI Programs is **$25.9 million** ($12.2 million for 2021 and $13.7 million for 2022). This is significantly lower than the **$11.2 million** grant date fair value of time-based restricted stock units granted in the same years ($4.3 million for 2021 and $6.9 million for 2022). \n\nThe discrepancy arises because the performance-based awards’ values in the table reflect target levels, while the text mentions higher \"maximum potential\" values ($18.4 million and $20.6 million, respectively). However, the question specifically asks for the grant date fair value, which aligns with the table’s target values.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the key numbers. It reports the total grant date fair value of performance-based LTIP units as $25.9 million ($12.2M in 2021 and $13.7M in 2022), whereas the ground truth is $39.0 million ($18.4M in 2021 and $20.6M in 2022). This is a major quantitative discrepancy. The LLM incorrectly uses what it claims are 'target level' values from a table, but the ground truth explicitly states that the $18.4M and $20.6M are the actual grant date fair values, which contradicts the LLM's interpretation. (2) The time-based RSUs are correctly reported as $11.2 million total ($4.3M and $6.9M), so those numbers are accurate. However, the comparison conclusion is wrong: the LLM says performance-based units were 'significantly lower' than time-based, while in reality they were much higher ($39.0M vs $11.2M). This reverses the correct financial insight. (3) The reasoning is partially sound in that it attempts to explain a discrepancy between target and maximum values, but it misapplies this to override the ground truth data, which already reflects the correct grant date fair values. The multi-hop synthesis fails because it relies on an incorrect source interpretation. (4) Despite the reasoning effort and correct mention of time-based RSU values, the core financial figures and final comparison are incorrect, warranting a low correctness score. Contextual relevance is high because the structure and intent align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 413,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total fair value of U.S. municipal securities held by 3M as of December 31, 2024, and how are these securities classified in terms of fair value hierarchy due to their valuation methodology?",
      "original_answer": "As of December 31, 2024, 3M holds $16 million in U.S. municipal securities, which are classified as Level 3 in the fair value hierarchy because their valuation references the carrying value of the corresponding finance lease obligation.",
      "llm_answer": "\n\nThe total fair value of U.S. municipal securities held by 3M as of December 31, 2024, is **$20 million**. These securities are classified as **Level 3** in the fair value hierarchy because their valuation methodology references the carrying value of corresponding finance lease obligations, which relies on unobservable inputs. \n\n**Source:**  \n- **Fair Value:** NOTE 13 (\"Marketable Securities\") lists $4 million (current) + $16 million (non-current) = $20 million for U.S. municipal securities as of December 31, 2024.  \n- **Classification:** NOTE 18 explains that these securities are classified as Level 3 due to their unique valuation approach tied to finance lease obligations, which are not based on observable market data.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the total fair value of U.S. municipal securities as $20 million, while the ground truth is $16 million. This error arises from summing $4 million (current) and $16 million (non-current), but the original answer and knowledge graph indicate the total is $16 million, suggesting the $4M and $16M may not both refer to U.S. municipal securities or the breakdown is misinterpreted. The classification as Level 3 is correct, and the reasoning about unobservable inputs tied to finance lease obligations aligns with the ground truth. (2) The quantitative inaccuracy is significant: the total amount is off by $4 million (25% higher than actual), and no such sum is supported by the ground truth. Even allowing for format variations, the total value is factually incorrect. (3) The multi-hop reasoning shows partial understanding—correctly linking the security type to its fair value hierarchy classification based on valuation methodology—but fails in accurately retrieving or synthesizing the correct dollar amount from the source data. (4) Scores reflect that while the qualitative reasoning and context are mostly sound, the major numerical error undermines the correctness, especially in a financial context where precision is critical. The answer is relevant and partially accurate in logic, but the core fact (dollar amount) is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 384,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What percentage of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts, and how does this estimation process reflect the challenges in identifying such accounts across encrypted platforms like WhatsApp?",
      "original_answer": "Approximately 3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts. This estimation process reflects challenges in identifying such accounts across encrypted platforms like WhatsApp due to limited visibility and reliance on fewer data signals such as phone numbers and device information, which increases the difficulty of accurate detection at scale.",
      "llm_answer": "\n\nIn Q4 2023, Meta estimated that approximately **3% of its worldwide Monthly Active Users (MAP)** consisted solely of violating accounts (e.g., bots, spam). This estimation process highlights significant challenges in identifying such accounts on encrypted platforms like WhatsApp, where limited visibility into user activity (due to end-to-end encryption) restricts access to behavioral data signals. For WhatsApp, Meta primarily relies on phone numbers and device information to detect violating accounts, which is less effective than analyzing unencrypted activity on platforms like Facebook or Instagram. The inherent difficulty in scaling detection methods across encrypted services, combined with reliance on limited data samples and judgment-based models, underscores the complexity of accurately measuring violating accounts at Meta’s scale.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) Quantitatively, the percentage of violating accounts is accurately stated as 3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023, matching the original answer exactly. (2) The explanation of the estimation challenges on encrypted platforms like WhatsApp is comprehensive and factually sound: it correctly identifies the limitations imposed by end-to-end encryption, the reduced availability of behavioral data, and the reliance on indirect signals such as phone numbers and device information. (3) The multi-hop reasoning is strong, synthesizing information about Meta’s user base, violation detection methodology, and platform-specific constraints across its ecosystem (e.g., WhatsApp vs. Facebook/Instagram). (4) The answer addresses both parts of the question—providing the correct percentage and explaining the associated detection challenges—with high precision and contextual depth. Minor elaborations (e.g., mentioning bots/spam, judgment-based models) add clarity without introducing inaccuracies. All entities (Meta, WhatsApp, Q4 2023, MAP) are correctly identified and used in context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 333,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty (COVID-19 vaccine) programs as of December 31, 2023?",
      "original_answer": "The total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine and the Comirnaty vaccine programs was $375 million.",
      "llm_answer": "\n\nThe total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine and Comirnaty (COVID-19 vaccine) programs as of December 31, 2023, is **$225 million**. This includes a **$75 million upfront cash payment** and a **$150 million equity investment** specifically for the shingles vaccine collaboration. No upfront payments or equity investments are disclosed for the Comirnaty program, as the terms indicate shared costs and a lump-sum reimbursement from BioNTech for prior development costs in 2021. \n\nSource: *Notes to Consolidated Financial Statements, Section E. Collaborative Arrangements* (pages 74–78).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its total amount. The ground truth states that the total upfront payments and equity investments made by Pfizer for both the shingles and Comirnaty programs was $375 million. The LLM claims $225 million, citing $75 million upfront and $150 million equity investment for the shingles vaccine only, and states no amounts for Comirnaty. However, the correct breakdown includes $175 million for Comirnaty (upfront and equity) and $200 million for the shingles vaccine collaboration, totaling $375 million. The LLM incorrectly omits Comirnaty-related upfront investments and misallocates the amounts. (2) Quantitative accuracy is low: the reported $225 million total is significantly off from the correct $375 million. The individual figures of $75M and $150M do not match the actual allocations per the knowledge graph. (3) The reasoning is partially sound in attempting to distinguish between the two collaborations and referencing appropriate sections, but it fails in multi-hop synthesis by not correctly aggregating disclosed amounts across both programs. It incorrectly assumes no upfront or equity investment occurred for Comirnaty, which contradicts the ground truth. (4) Contextual relevance is high because the answer addresses the right companies, programs, and time frame, and references a plausible section of the financial statements. However, the core factual error in the total amount and component figures severely undermines correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 415,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over the three-year period from 2019 to 2021, and how did it compare to the net loss reported in the Lower 48 region during the same period?",
      "original_answer": "COP's operations in the EMENA region contributed a total net income of $1 million in 2019, $6 million in 2020, and a net loss of $24 million in 2021, resulting in a cumulative net loss of $17 million over the three-year period. In contrast, the Lower 48 region reported a net income of $402 million in 2019, $804 million in 2020, and a net loss of $8 million in 2021, resulting in a total net income of $1,206 million over the same period. Therefore, the EMENA region underperformed significantly compared to the Lower 48 region, with a difference of $1,223 million in total net results.",
      "llm_answer": "\n\nThe total net income contribution from COP's EMENA operations over 2019–2021 was a **$17 million credit** (calculated as 2021: -$24M credit, 2020: $6M, 2019: $1M). In contrast, the Lower 48 region reported a **$1,198 million net loss** during the same period (2021: -$8M credit, 2020: $804M, 2019: $402M). Thus, EMENA’s contribution was significantly smaller in magnitude and positive relative to the Lower 48’s substantial loss.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and calculation errors. While it correctly identifies individual annual figures for EMENA ($1M income in 2019, $6M in 2020, -$24M in 2021), it incorrectly labels the cumulative result as a '$17 million credit'—this is misleading because a net loss of $17M is not a 'credit' in standard financial reporting without clarification. More critically, the Lower 48 calculation is completely wrong: the LLM claims a '$1,198 million net loss', but the ground truth shows a total net income of $1,206 million (sum: $402M + $804M - $8M). The LLM appears to have subtracted or mislabeled the positive values as losses. (2) Quantitative accuracy fails on the key comparison: instead of showing EMENA's $17M loss vs. Lower 48's $1,206M income (difference of $1,223M), the model reports the opposite performance direction. The use of 'credit' for negative net income is also non-standard and confusing. (3) Multi-hop reasoning is partially present—regional performance over three years is addressed—but synthesis is flawed due to incorrect aggregation and reversal of financial outcomes. The conclusion that EMENA outperformed Lower 48 is factually false. (4) Scores reflect severe quantitative inaccuracy and flawed reasoning, though entities (COP, EMENA, Lower 48, correct years) and some input numbers are accurate, preserving partial contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 388,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024, and how does this change contribute to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' over the same period?",
      "original_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is $3,720 (from $172,912 in 2023 to $169,192 in 2024). This contributes to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' from $195,949 in 2023 to $184,729 in 2024, a total decrease of $11,220. The decrease in 'Other noncontrolling redeemable interests' accounts for approximately 33.1% of the total decline in the combined metric.",
      "llm_answer": "\n\nThe dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is **$3.72 million** (from $172.912 million to $169.192 million). This reduction contributes approximately **33%** of the total decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties', which declined by **$11.22 million** over the same period. The remaining decrease ($7.5 million) is attributable to the reduction in the 7.50% Cumulative Redeemable Preferred Units (from $23.037 million to $15.537 million).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the dollar decrease in 'Other noncontrolling redeemable interests' as $3.72 million (equivalent to $3,720 thousand from ground truth: $172,912k to $169,192k), which is accurate. The total decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' is correctly stated as $11.22 million ($195,949k to $184,729k), matching the ground truth. The contribution percentage is reported as approximately 33%, which aligns with the ground truth 33.1% (3,720 / 11,220 ≈ 33.15%). (2) All numeric values are correct when accounting for unit formatting (millions vs. thousands); $3,720 thousand = $3.72 million, $11,220 thousand = $11.22 million. Calculations are accurate. (3) The LLM adds additional reasoning not in the original answer—attributing the remaining decrease to the 7.50% Cumulative Redeemable Preferred Units—which is factually plausible and enhances the explanation, though not required. This shows sound multi-hop reasoning and synthesis across components of the total metric. (4) The answer is fully contextually relevant, addresses both parts of the question, and conveys semantically equivalent (and slightly more detailed) information. The only minor deviation is rounding 33.1% to 33%, which is acceptable for approximation. Thus, the answer is highly accurate with excellent reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 392,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, and how does this compare to the combined fair value of these two asset categories from the prior year?",
      "original_answer": "The total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $55 million ($31 million in foreign corporate debt + $24 million in asset-backed securities). As of December 31, 2023, the combined fair value of these two assets was $0 million, as both categories had no value reported in that year.",
      "llm_answer": "\n\nThe total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is **$55 million** ($31 million for foreign corporate debt and $24 million for asset-backed securities). In the prior year (December 31, 2023), the combined fair value of these two asset categories was **$0**, as both were reported as \"$-\" in the 2023 marketable securities disclosure. This represents a $55 million increase in 2024 compared to 2023. \n\nSource: NOTE 13 (\"Marketable Securities\") and NOTE 18 (\"Fair Value Measurements\") in the provided 10-K excerpts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $31 million for foreign corporate debt and $24 million for asset-backed securities in 2024 are accurately reported, and their sum of $55 million is correctly calculated. The prior year (2023) combined value is correctly stated as $0, consistent with both categories being reported as '$-' (indicating no value) in the 2023 disclosures. The $55 million increase is a valid inference. (2) The answer is complete, addressing both parts of the question: the total fair value as of December 31, 2024, and the comparison to the prior year. (3) Entities are accurate—MMM is correctly identified, and the asset categories and years (2024 and 2023) are properly referenced. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly pulled data from two asset categories across two years, inferred the absence of value in 2023 from the '$-' notation, and computed the year-over-year change. (5) The semantic meaning is equivalent to the ground truth, with clear, precise wording and proper sourcing to NOTE 13 and NOTE 18. Minor enhancements like bold formatting and source citation improve clarity without affecting accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 349,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do technical errors and data limitations in Meta's Family metrics estimation process affect the accuracy of its monthly active people (MAP) and average revenue per person (ARPP) metrics, and by what approximate margin could these metrics vary due to such inaccuracies?",
      "original_answer": "Meta acknowledges that its Family metrics, including monthly active people (MAP) and average revenue per person (ARPP), are based on internal data and are inherently subject to statistical variances, uncertainties, and technical errors in their estimation process. The company uses complex algorithms, machine learning models, and user survey data calibrated against signals like IP addresses and device information to estimate the number of unique individuals using its platforms. These models require significant judgment and are affected by data limitations. Meta estimates that the potential error margin for its Family metrics is generally around 3% of its worldwide MAP. Given that Meta reported approximately 3.3 billion worldwide MAP in 2023, this 3% error margin implies that the actual number of unique users could vary by about 99 million. This level of inaccuracy can significantly affect the reliability of ARPP calculations, which depend on MAP for per-user revenue averaging, and could distort business decisions, investor perceptions, and advertising investments.",
      "llm_answer": "\n\nTechnical errors and data limitations in Meta's Family metrics estimation process, particularly for Monthly Active People (MAP) and Average Revenue Per Person (ARPP), arise from challenges in accurately attributing user accounts across multiple platforms (e.g., Facebook, Instagram, WhatsApp) using algorithms, machine learning models, and limited data signals (e.g., device/IP addresses, phone numbers). These inaccuracies stem from encrypted products (like WhatsApp), reliance on error-prone user surveys, and difficulties in detecting violating accounts or duplicate users. \n\nMeta estimates the potential error margin for Family metrics to be approximately **3% of worldwide MAP**, based on internal methodologies and survey data. However, actual variations could exceed this margin due to factors like data signal limitations, algorithmic flaws, or unaccounted violating accounts (estimated at ~3% of MAP). Since ARPP is derived from MAP, its accuracy is similarly affected, with potential variations tied to the same 3% margin or higher in edge cases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Meta acknowledges technical errors and data limitations in its Family metrics estimation, uses algorithms, ML models, and user surveys calibrated with IP/device data, and estimates a 3% error margin on worldwide MAP. The 3% figure matches the original answer exactly. (2) Quantitative accuracy is perfect: the 3% margin is correctly cited, and while the LLM does not explicitly calculate the 99 million user variance (based on 3.3 billion MAP), it references the same 3% figure that would yield that result. The mention that violating accounts are ~3% of MAP is additional context not in the ground truth but does not contradict it. (3) Reasoning is sound: the LLM correctly explains how MAP inaccuracies propagate to ARPP, since ARPP = revenue / MAP, making it sensitive to MAP estimation errors. It also identifies encryption (e.g., WhatsApp), survey limitations, and duplicate account challenges as key sources of error—consistent with the multi-hop synthesis expected. (4) The only minor omission is the lack of explicit numerical expansion (i.e., 3% of 3.3 billion = ~99 million), which slightly reduces completeness but does not affect core correctness. Wording differs but semantic equivalence is strong. Contextual relevance is excellent—every part of the question is addressed with precise, relevant details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 391,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does The Home Depot's strategic use of BOPIS, as defined in the glossary, contribute to the fulfillment of 50% of U.S. online orders through stores, as stated in the supply chain section?",
      "original_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store), as defined in the glossary, enables customers to place orders online and pick them up in-store, which directly supports the company's supply chain goal of fulfilling 50% of U.S. online orders through stores. This interconnected retail program is part of a broader set of store-based fulfillment options that enhance customer convenience and optimize inventory distribution across the network.",
      "llm_answer": "\n\nThe Home Depot's strategic use of **BOPIS (Buy Online, Pickup In Store)** contributes to fulfilling 50% of U.S. online orders through stores by leveraging its extensive physical store network as efficient fulfillment hubs. By enabling customers to order online and pick up items at nearby stores, BOPIS reduces delivery costs, accelerates order fulfillment, and utilizes existing inventory in stores, minimizing the need for separate distribution centers. This approach enhances convenience for customers, aligns with demand for faster pickup options, and optimizes the company’s \"interconnected retail\" strategy, where stores serve dual roles as sales and fulfillment points. The supply chain section explicitly states that 50% of U.S. online orders in fiscal 2024 were fulfilled through stores, with BOPIS (alongside BOSS, BODFS, and BORIS) central to this capability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 50% figure for U.S. online orders fulfilled through stores is correctly cited, and the reference to fiscal 2024 matches the data source. No calculations are required, and all numbers are accurate. (2) The answer correctly identifies BOPIS as defined in the glossary and explains its role in enabling store-based fulfillment. (3) The reasoning is sound and reflects multi-hop synthesis: it connects BOPIS (from the glossary) to store fulfillment, incorporates the interconnected retail strategy, and references complementary programs (BOSS, BODFS, BORIS) that support the broader fulfillment model. (4) While the original answer does not list the other acronyms, their inclusion in the LLM response adds context without introducing error. The only minor gap is that the original answer emphasizes BOPIS as part of a 'broader set of store-based fulfillment options' without naming them, so the added detail is accurate but slightly beyond the scope of the source. Overall, the LLM answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with excellent qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 339,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Morgan Stanley's approach to recognizing compensation expense for Deferred Cash-Based Compensation (DCP) awards differ from its recognition of carried interest compensation, particularly in terms of timing and the nature of the awards?",
      "original_answer": "Morgan Stanley recognizes compensation expense for DCP awards over the vesting period, adjusted for changes in the fair value of referenced investments selected by employees. In contrast, carried interest compensation is recognized immediately for any portion of carried interest (both realized and unrealized) allocated to employees, without being tied to a vesting schedule. This distinction reflects the different nature of the awards: DCP awards are deferred and tied to vesting conditions, while carried interest compensation is directly linked to performance-based allocations that are recognized as they occur.",
      "llm_answer": "\n\nMorgan Stanley recognizes compensation expense for Deferred Cash-Based Compensation (DCP) awards and carried interest compensation differently in terms of timing and nature. \n\n**Timing:**  \n- **DCP Awards:** Compensation expense is recognized **over the vesting period** for each separately vesting portion of the award. The expense is adjusted for changes in the fair value of the referenced investments selected by employees, though there is a timing lag between the immediate recognition of gains/losses on the Firm’s hedging investments and the deferred recognition of compensation expense.  \n- **Carried Interest:** Compensation expense is recognized **when the portion of carried interest (realized or unrealized) is allocated to employees**, typically aligned with the settlement or realization of the underlying investment profits. This recognition occurs in the period the allocation is made, rather than being spread over a vesting period.  \n\n**Nature of Awards:**  \n- **DCP Awards:** These are **deferred cash-based awards** where returns are tied to the performance of specific investments chosen by employees. The Firm economically hedges these obligations through direct investments, creating offsetting gains/losses.  \n- **Carried Interest:** This is a **performance-based fee** allocated to employees based on the profits of investment funds or portfolios. It reflects a share of realized and unrealized gains from carried interest-bearing investments, often tied to the success of specific investment vehicles rather than individual employee-selected references.  \n\nIn summary, DCP expenses are amortized over vesting periods with market-value adjustments, while carried interest expenses are recognized upon allocation, reflecting realized/unrealized investment profits.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: DCP awards are recognized over the vesting period with fair value adjustments based on employee-selected investments, while carried interest compensation is recognized immediately upon allocation (realized or unrealized), without a vesting schedule. The distinction in timing and nature is clearly explained. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in accounting treatment based on the nature of the awards—deferred, vesting-based DCP versus performance-based, immediate recognition for carried interest. (4) The answer is highly relevant, directly addressing both timing and nature aspects of the question with precise, well-structured explanations. Minor elaborations (e.g., hedging mechanics) add context without introducing inaccuracies. All components align fully with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1626,
        "completion_tokens": 309,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, based on the information provided?",
      "original_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, as neither entity reported any such interests redeemable at amounts in excess of fair value.",
      "llm_answer": "\n\nThe total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is **$169,192,000**. This figure is explicitly stated under the \"Other noncontrolling redeemable interests\" line item in both Simon’s and the Operating Partnership’s temporary equity disclosures, reflecting the same value for each entity.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect. The ground truth states that the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0. The LLM incorrectly reports $169,192,000, which contradicts the provided truth. (2) The quantitative inaccuracy is severe: $169,192,000 vs $0 is a fundamental error with no acceptable format variation. There is no indication in the ground truth of any such value being reported by either entity. (3) The multi-hop reasoning is flawed—the LLM falsely claims that this amount is 'explicitly stated' in both entities' disclosures, but the ground truth confirms that neither entity reported any such interests redeemable at amounts in excess of fair value, hence the correct total is zero. The model invents a specific line item and value not present in the source data. (4) All scores are very low because the answer is factually wrong, misrepresents the data, and fails to correctly synthesize the absence of reported amounts across both entities. The contextual relevance is minimal as it addresses the right entities and date but with fabricated financial information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 349,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, and how does this compare to the carrying amount of NEE's special use funds on its consolidated balance sheet for the same date?",
      "original_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is $8,922 million ($8,846 million for NEE and $76 million for FPL). This amount represents the fair value of the special use funds, which are primarily composed of equity and available-for-sale debt securities. However, on NEE's consolidated balance sheet, these special use funds are reported at their carrying amount of $2,505 million as of December 31, 2021. The significant difference between the fair value and carrying amount reflects the accounting treatment where certain investments are carried at fair value, while others are reported at amortized cost or adjusted based on regulatory treatment.",
      "llm_answer": "\n\nThe total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is **$8,922 million** (NEE's nuclear decommissioning fund: $8,846 million + FPL's storm fund: $76 million). This amount is also the **carrying amount of NEE's special use funds** on its consolidated balance sheet for the same date, as these funds are primarily carried at their estimated fair value. The fair value and carrying amount are aligned because the nuclear decommissioning and storm fund assets are measured at fair value in accordance with regulatory and accounting requirements.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total estimated fair value of $8,922 million, broken down into $8,846 million for NEE's nuclear decommissioning fund and $76 million for FPL's storm fund, which matches the ground truth. These numbers are accurate and properly summed. However, the LLM incorrectly states that this fair value amount is the same as the carrying amount on NEE's consolidated balance sheet. According to the ground truth, the carrying amount is $2,505 million, significantly lower than the fair value. The LLM's claim that 'the fair value and carrying amount are aligned' is factually incorrect. (2) Quantitative accuracy is high because all provided numbers (including the sum) are correct, earning a score of 8. The only issue is the misrepresentation of the carrying amount, which is a qualitative and reasoning error. (3) The qualitative accuracy is low (3/10) because the model fails to recognize the key distinction between fair value and carrying amount, which is central to the question. It incorrectly asserts alignment between the two values, missing the regulatory and accounting nuance explained in the original answer about different measurement bases (fair value vs. amortized cost or regulatory adjustments). This reflects a failure in multi-hop reasoning: while it pulls correct values from the data, it synthesizes them incorrectly. (4) Contextual relevance is high because the answer addresses both parts of the question—total fair value and comparison to carrying amount—but the comparison is factually wrong. The structure and intent are appropriate, but the conclusion is not supported by the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 450,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the significance of APJC as both a geographic segment in which Cisco operates and as a region tied to Cisco's consolidated financial reporting, and how does this dual role influence Cisco's internal performance measurement?",
      "original_answer": "Cisco reports its operations across three geographic segments: the Americas, EMEA, and APJC. APJC is not only a key operating segment where Cisco generates revenue but also a region whose financial results are fully incorporated into Cisco’s consolidated financial statements. This dual role means that performance metrics such as revenue and gross margin from the APJC segment directly feed into Cisco’s overall financial reporting, even though certain expenses like R&D and restructuring charges are not allocated to the segment for internal management review. Therefore, APJC's financial performance influences both strategic decisions and consolidated earnings.",
      "llm_answer": "\n\nAPJC (Asia Pacific, Japan, and China) serves as both a key geographic operating segment and a critical component of Cisco's consolidated financial reporting. As a geographic segment, it is one of three regions (alongside Americas and EMEA) used by Cisco's management to assess performance, allocate resources, and make strategic decisions, with revenue and gross margin reported separately for internal evaluation. However, APJC's financial results are also fully integrated into Cisco's consolidated financial statements, reflecting its material contribution to global revenue and profitability. \n\nThis dual role influences internal performance measurement by enabling management to evaluate APJC's operational effectiveness (e.g., regional sales trends, gross margin efficiency) independently while ensuring its results align with consolidated financial goals. Since expenses like R&D, sales/marketing, and corporate overhead are not allocated to segments, APJC's performance is measured primarily through revenue and gross margin, providing a focused view of regional operational performance. This structure allows Cisco to balance localized decision-making with overarching financial accountability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: APJC is correctly identified as one of three geographic segments (Americas, EMEA, APJC), its role in both operational performance measurement and consolidated financial reporting is accurately described, and the statement that expenses like R&D and restructuring are not allocated to segments matches the original. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes APJC’s dual role in internal management reporting and external financial consolidation, and explains how this affects performance measurement by focusing on revenue and gross margin. (4) The only minor shortcoming is a slight expansion in the LLM answer mentioning 'sales/marketing and corporate overhead' as unallocated expenses, which while plausible and consistent with typical segment reporting practices, is slightly broader than the original answer that specifically names 'R&D and restructuring charges.' This does not make the answer incorrect but introduces a small overgeneralization. Otherwise, the answer is semantically equivalent, contextually precise, and demonstrates strong reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 371,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What percentage of Verizon Business Group's total revenues in 2024 came from Business Markets and Other, and how does this segment specifically incorporate FWA broadband into its offerings?",
      "original_answer": "Business Markets and Other generated $13.1 billion in revenues in 2024, which represented 44% of the Verizon Business Group's total revenues. This segment incorporates FWA broadband as one of its wireless services, offering fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.",
      "llm_answer": "\n\nIn 2024, **Business Markets and Other** accounted for **44%** of Verizon Business Group's total revenues ($13.1 billion out of $29.5 billion). This segment incorporates **FWA (Fixed Wireless Access) broadband** by offering wireless services—including FWA broadband—to small and medium businesses, providing fixed connectivity solutions comparable to residential Fios services. FWA leverages Verizon’s 5G and 4G LTE networks to deliver high-speed internet access as an alternative to traditional wired connections, tailored to meet the needs of business customers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figure of $13.1 billion and the 44% proportion are accurately stated. The implied total revenue of $29.5 billion is correct (13.1 / 0.44 ≈ 29.77, with minor rounding difference acceptable). (2) The answer completely addresses both parts of the question: the percentage of revenues from Business Markets and Other, and how FWA broadband is incorporated into the segment's offerings. (3) Entities are accurate—'Verizon Business Group', 'Business Markets and Other', 'FWA broadband', and '2024' are all correctly identified. (4) The reasoning is sound: the LLM correctly synthesizes that FWA is a wireless service offered to small and medium businesses, providing fixed connectivity comparable to residential services, which aligns with the ground truth. It adds context about 5G/4G LTE networks and wired alternatives, which is consistent and enhances clarity without introducing inaccuracies. (5) The semantic meaning fully matches the original answer, with equivalent factual content and appropriate elaboration. All scoring criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 330,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the total fair value of Abbott's interest rate hedge contracts in 2024, and how does this compare to the total notional amount of all foreign currency forward exchange contracts held by Abbott as of the same date?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $50 million (payable position of $51 million offset by a $1 million receivable position). This is significantly smaller than the total notional amount of all foreign currency forward exchange contracts, which was $23.2 billion as of December 31, 2024.",
      "llm_answer": "\n\nThe total fair value of Abbott's interest rate hedge contracts in 2024 is **$52 million** (comprising $1 million in asset positions and $51 million in liability positions). The total notional amount of all foreign currency forward exchange contracts held by Abbott as of December 31, 2024, is **$23.2 billion** ($7.0 billion for cash flow hedges and $16.2 billion for other currency exposures). Thus, the notional amount of foreign currency contracts is substantially higher than the fair value of the interest rate hedges.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total notional amount of foreign currency forward exchange contracts as $23.2 billion as of December 31, 2024, matching the ground truth exactly. However, it reports the total fair value of Abbott's interest rate hedge contracts as $52 million (comprising $1 million in asset positions and $51 million in liability positions), whereas the ground truth states the net fair value is $50 million (a $51 million payable offset by a $1 million receivable). The LLM incorrectly sums the absolute values ($51M + $1M = $52M) instead of reporting the net fair value, which should be the net liability of $50 million. This is a critical quantitative error in interpretation of 'fair value'—which refers to net position, not gross. (2) The notional amount of $23.2 billion is correctly broken down into $7.0 billion for cash flow hedges and $16.2 billion for other exposures, which adds up correctly and aligns with the knowledge graph. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes data across different derivative instruments (interest rate hedges vs. foreign exchange contracts) and makes a valid comparison in scale, noting that the notional amount of foreign currency contracts is substantially higher. (4) Despite the error in net fair value calculation, the core entities (Abbott, 2024, interest rate hedges, foreign currency forwards), time period (December 31, 2024), and overall conclusion (foreign currency notional amount is much larger) are correct. The answer is contextually complete and relevant. The quantitative accuracy is penalized due to the incorrect net fair value, but qualitative reasoning and contextual relevance remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 471,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What does the relationship between proved undeveloped reserves and net acreage in Asia suggest about Equity Companies' development potential in the region, and how does this compare to their consolidated subsidiaries' efficiency in utilizing land for reserves?",
      "original_answer": "Equity Companies in Asia reported 1,503 million barrels of proved undeveloped reserves against 19 thousand net acres. This results in a reserves-to-acre ratio of approximately 79.1 million barrels per thousand acres. In comparison, XOM's consolidated subsidiaries in Asia reported 1,315 million barrels of proved undeveloped reserves against 640 thousand net acres, yielding a reserves-to-acre ratio of approximately 2.05 million barrels per thousand acres. This indicates that Equity Companies are significantly more efficient in terms of reserves per acre in Asia, suggesting a potentially higher development potential in the region.",
      "llm_answer": "\n\nThe relationship between proved undeveloped reserves and net acreage in Asia suggests significant development potential for Equity Companies, as they hold **1.5 billion oil-equivalent barrels** of proved undeveloped reserves across just **19,000 net acres**, equating to ~**79 barrels per acre**. This contrasts sharply with consolidated subsidiaries in Asia, which hold **1.3 billion oil-equivalent barrels** across **227,000 net acres** (~**5.8 barrels per acre**). The higher reserves-per-acre ratio for Equity Companies indicates superior efficiency in utilizing land for reserves, likely driven by focused, high-impact projects in mature basins (e.g., UAE’s Upper Zakum field, Qatar’s North Field) and strategic joint ventures. This efficiency underscores stronger near-term development potential for Equity Companies compared to consolidated subsidiaries, which manage larger but less concentrated acreage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numeric values and calculations. While it correctly identifies that Equity Companies have high reserves relative to small net acreage, it reports '19,000 net acres' instead of the correct '19 thousand net acres' (i.e., 19,000), which is acceptable, but then calculates '~79 barrels per acre'—this is off by a factor of 1 million. The correct ratio is ~79.1 million barrels per thousand acres (or 79,100 barrels per acre), not 79. The LLM underreports this by six orders of magnitude. Similarly, for consolidated subsidiaries, the LLM states they hold reserves across '227,000 net acres', but the ground truth specifies 640 thousand net acres. This is a major error. It calculates ~5.8 barrels per acre, but the correct value is ~2.05 million barrels per thousand acres (~2,050 per acre). Thus, both inputs and outputs are wrong. (2) The reserves figures are approximately correct (1.5 billion vs 1,503 million; 1.3 billion vs 1,315 million), so those are acceptable with rounding. However, the net acreage and resulting ratios are severely miscalculated. The comparison direction (Equity Companies being more efficient) is correct, but the magnitude is misrepresented. (3) The multi-hop reasoning—comparing reserves-to-land efficiency between Equity Companies and consolidated subsidiaries—is conceptually sound and addresses the question’s intent. The conclusion about higher development potential due to better efficiency aligns with the original answer. However, the reasoning is based on incorrect data, undermining the validity. (4) Contextual relevance is high because the structure, intent, and qualitative interpretation match the question. But due to severe quantitative errors in core metrics and calculations, the correctness score is low. The answer conveys a similar narrative but with factually incorrect support, making it partially correct at best.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 524,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the significance of the Parent Company's unconditional guarantee of securities issued by Morgan Stanley Finance LLC, and how does this guarantee relate to the Firm's broader obligations under its amended and restated support agreement in the context of a resolution scenario?",
      "original_answer": "The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary, which ensures that these securities are backed by the full credit of the Parent Company. In the context of a resolution scenario, the Parent Company is also obligated under an amended and restated support agreement to contribute all of its contributable assets to its supported entities and/or the Funding IHC. The Funding IHC, in turn, would be obligated to provide capital and liquidity to its supported entities. These mechanisms are interconnected, as the guarantee of Morgan Stanley Finance LLC's securities represents one of the Parent Company's financial commitments that could be called upon during a resolution event, and the support agreement formalizes the process for distributing capital and liquidity across the organization during such a scenario.",
      "llm_answer": "\n\nThe Parent Company's unconditional guarantee of securities issued by Morgan Stanley Finance LLC signifies that the Parent Company is fully liable for these obligations, ensuring investors that the securities are backed by the Parent's creditworthiness. Under the amended and restated support agreement, in a resolution scenario (e.g., insolvency or regulatory intervention), the Parent Company is obligated to transfer all contributable assets to supported entities or the Funding IHC, which in turn must provide capital and liquidity to its subsidiaries. This creates a structured framework where the Parent’s guarantee is reinforced by a legal and operational commitment to prioritize the Funding IHC’s ability to meet obligations, including those guaranteed by the Parent, using secured assets. Thus, the guarantee and support agreement collectively ensure continuity of obligations to creditors in stress scenarios.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All factual components are correct: the Parent Company's unconditional guarantee of Morgan Stanley Finance LLC's securities, the full backing by the Parent's credit, the obligation under the amended and restated support agreement to transfer contributable assets to supported entities or the Funding IHC, and the Funding IHC's role in providing capital and liquidity during a resolution scenario. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly links the guarantee (a financial commitment) with the support agreement (an operational and legal mechanism) in the context of a resolution event, recognizing their interconnection in ensuring creditor obligations are met. (4) The only minor shortcoming is that the LLM slightly reframes the relationship by stating the Parent’s guarantee is 'reinforced by' the support agreement and mentions 'secured assets'—a detail not present in the original and potentially implying a level of collateralization not explicitly stated. However, this does not distort the overall meaning. The answer is semantically equivalent, comprehensive, and contextually precise, addressing both the significance of the guarantee and its relationship to the broader support framework in resolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 396,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does the Bipartisan Budget Act of 2015's partnership tax audit rules potentially affect Simon Property Group's (SPG) financial obligations through its joint venture investments, including those managed by third parties such as Klépierre and The Taubman Realty Group, LLC?",
      "original_answer": "The Bipartisan Budget Act of 2015 introduced partnership tax audit rules that assess taxes, interest, or penalties at the partnership level for audit adjustments to income, gain, loss, deduction, or credit items. Simon Property Group (SPG), through its investments in 84 joint venture properties and entities like Klépierre and The Taubman Realty Group, LLC, could be required to bear the economic burden of these taxes, interest, and penalties even though SPG and its subsidiary REITs may not otherwise have been subject to additional corporate-level taxes had they owned the assets directly. This financial exposure arises because SPG applies the equity method of accounting to these joint ventures, and as a direct or indirect partner, SPG may be liable for partnership-level assessments without the ability to opt out of the rules, potentially resulting in material adverse effects on SPG's financial position.",
      "llm_answer": "\n\nThe Bipartisan Budget Act of 2015’s partnership tax audit rules could increase Simon Property Group’s (SPG) financial obligations by shifting tax audit liabilities to the partnership level. Under these rules, audit adjustments (e.g., additional taxes, interest, or penalties) are assessed at the partnership level rather than individually to partners. SPG’s joint ventures, including those managed by third parties like Klépierre and The Taubman Realty Group, are structured as partnerships or subsidiaries treated as partnerships for tax purposes. If the IRS audits such a joint venture and adjusts its tax positions, SPG, as a partner, could be required to bear its proportional share of the economic burden, even if the adjustments arise from decisions or inaccuracies beyond SPG’s control. This exposes SPG to potential unplanned tax liabilities, reducing cash available for operations or distributions, particularly in ventures where SPG lacks full control over tax reporting or compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Bipartisan Budget Act of 2015 introduced partnership-level tax audit rules, which assess taxes, interest, and penalties at the partnership level; SPG’s joint ventures (including those with Klépierre and The Taubman Realty Group, LLC) are subject to these rules; as a partner, SPG may bear the economic burden of audit adjustments even if it lacks control. (2) Quantitative accuracy is perfect—no specific numbers (e.g., 84 joint ventures) were misrepresented or omitted in a way that distorts facts; the absence of the exact number '84' is a minor omission but does not affect the correctness of the financial exposure argument. (3) Multi-hop reasoning is sound: the model correctly links the 2015 Act → partnership-level liability → SPG’s joint venture structure → third-party-managed entities → potential financial impact despite lack of control. (4) The answer is contextually excellent, directly addressing how the rules affect SPG’s financial obligations through joint ventures. The only reason for not scoring 10 is the omission of the specific detail about SPG applying the equity method of accounting and the explicit mention of its REITs not being subject to corporate-level tax otherwise—this nuance strengthens the original answer but is not critical enough to downgrade correctness significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 397,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Lockheed Martin's investment impairment in AMMROC in 2020 and restructuring charges in RMS in 2021 collectively impact net earnings and per-share results in those respective years?",
      "original_answer": "Lockheed Martin's noncash impairment charge of $128 million in 2020 on its investment in AMMROC decreased net earnings from continuing operations by $96 million, or $0.34 per share after tax. In 2021, Lockheed recorded a $36 million severance and restructuring charge ($28 million, or $0.10 per share after tax) associated with plans to close and consolidate facilities and reduce the workforce within the RMS business segment. Together, these events reduced net earnings by $96 million in 2020 and $28 million in 2021, with per-share impacts of $0.34 and $0.10, respectively.",
      "llm_answer": "\n\nThe investment impairment in AMMROC in 2020 reduced Lockheed Martin's net earnings by $96 million ($0.34 per diluted share), while the 2021 RMS restructuring charges reduced net earnings by $28 million ($0.10 per diluted share). Collectively, these items decreased net earnings by $124 million and diluted earnings per share by $0.44 over the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects. It correctly identifies the $96 million reduction in net earnings ($0.34 per share) in 2020 due to the AMMROC impairment and the $28 million reduction ($0.10 per share) in 2021 from RMS restructuring charges. The combined impact of $124 million and $0.44 per share over the two years is correctly calculated. All numbers, years, entities (AMMROC, RMS, Lockheed Martin), and financial metrics (net earnings, per-share results) are accurate and properly contextualized. The answer synthesizes information across two years and two business units correctly, demonstrating sound multi-hop reasoning. The only minor limitation is that it does not explicitly mention the pre-tax charge amounts ($128M and $36M) or clarify that the after-tax figures are derived from them, which is included in the original answer for full context. However, since the question specifically asks about impact on net earnings and per-share results (which are after-tax), this omission does not detract significantly from correctness. Wording differs slightly but maintains semantic equivalence. No factual errors or calculation inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 342,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the year-over-year change in the balance of channel partner financing subject to guarantees, and how does this relate to Cisco's overall liquidity and capital resource requirements as stated in the MD&A section?",
      "original_answer": "The balance of channel partner financing subject to guarantees decreased from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, representing a year-over-year decrease of $0.5 billion. Cisco states in its MD&A that it believes its cash and cash equivalents, investments, and cash generated from operations will satisfy its liquidity requirements, including working capital needs, capital expenditures, investment requirements, and commitments such as financing guarantees. This indicates that despite the decrease in guaranteed financing balances, Cisco remains confident in its ability to support such obligations through existing resources.",
      "llm_answer": "\n\nThe balance of channel partner financing subject to guarantees decreased year-over-year from $1.7 billion as of July 29, 2023, to $1.2 billion as of July 27, 2024, a reduction of $500 million. This decline suggests a lower exposure to potential future payments under these guarantees, which aligns with Cisco’s MD&A assertion that its liquidity and capital resources are sufficient to meet obligations. The reduction in guarantees, combined with strong cash balances, access to capital markets, and disciplined management of commitments (e.g., purchase obligations, debt), supports Cisco’s conclusion that its liquidity position remains robust to cover operational and financial requirements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1.7 billion (fiscal 2023) and $1.2 billion (fiscal 2024) are accurately reported, and the year-over-year decrease of $500 million (equivalent to $0.5 billion) is correctly calculated. The specific dates (July 29, 2023, and July 27, 2024) align with Cisco's fiscal year-ends and are consistent with SEC filing disclosures. (2) The answer completely addresses both parts of the question: it reports the change in channel partner financing subject to guarantees and connects this to Cisco’s overall liquidity and capital resource requirements as stated in the MD&A. (3) Entity accuracy is correct: 'Cisco' is properly identified, and the financial metric 'channel partner financing subject to guarantees' is accurately used. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that a reduction in guaranteed financing balances reduces exposure, which supports Cisco’s stated confidence in its liquidity. The LLM expands on the ground truth with relevant context—such as access to capital markets and disciplined management of commitments—without introducing inaccuracies, and these additions are consistent with typical MD&A language. (5) The semantic meaning fully aligns with the original answer: while the LLM uses slightly more detailed phrasing (e.g., 'lower exposure to potential future payments'), the core message—that the decrease in guarantees is consistent with Cisco’s confidence in its liquidity—is preserved and well-supported. All scores are maximized due to factual accuracy, completeness, and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 454,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories in the 2024 10-K filing of VZ, and which category has the higher value?",
      "original_answer": "The difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories is $2,653 million. The first asset category reports 'Investments measured at NAV' at $2,656 million, while the second reports it at $3 million. Therefore, the first category has the higher value.",
      "llm_answer": "\n\nThe total value of 'Investments measured at NAV' for the Pension Plans in 2024 is $2,656 million, while the corresponding value for the HealthCare and Life postretirement benefit plans in 2023 is $5 million (as 2024 data for this category is not explicitly disclosed). The difference is approximately $2,651 million, with the Pension Plans having the higher value. \n\n**Answer:** The difference is $2,651 million, with the Pension Plans category having the higher value.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the two disclosed asset categories in the 2024 10-K filing report 'Investments measured at NAV' as $2,656 million and $3 million, with a difference of $2,653 million. However, the LLM incorrectly identifies the second value as $5 million (attributed to HealthCare and Life postretirement benefit plans in 2023), which contradicts the ground truth of $3 million. Additionally, the LLM uses 2023 data for one category, while the question specifically asks for the 2024 10-K filing, making the comparison invalid. (2) The calculation of $2,651 million difference is based on incorrect inputs ($2,656M - $5M), whereas the correct difference is $2,653 million ($2,656M - $3M). The numbers are close but factually wrong. (3) The multi-hop reasoning is flawed: the model fails to correctly identify both values from the 2024 filing, instead mixing years and potentially misidentifying the asset categories. It does correctly infer that one category is significantly higher, which aligns with the ground truth, but the reasoning path is unsound. (4) While the structure and intent of the answer are relevant and mostly clear, the core factual content—especially the use of incorrect values and an outdated year—severely undermines accuracy. The contextual relevance is fair because it addresses the right type of information (comparing NAV investments across plans), but the execution is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 411,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does Abbott's production focus on Diabetes Care Devices, as stated in its 2024 10-K filing, relate to the 18.1% revenue increase in its Diabetes Care business, and what accounting policy supports the recognition of this revenue?",
      "original_answer": "Abbott's Diabetes Care business generated $6.805 billion in revenue in 2024, representing an 18.1% increase from the prior year. This growth aligns with Abbott's core business of producing health care products, including Diabetes Care Devices. The revenue from these devices is recognized upon the transfer of control, which occurs upon shipment or delivery, depending on the customer contract terms. This revenue recognition policy ensures that sales from Diabetes Care Devices are recorded in the period when control is transferred to the customer, supporting the reported increase in revenue.",
      "llm_answer": "\n\nAbbott's production focus on Diabetes Care Devices, particularly its Continuous Glucose Monitoring (CGM) systems, directly contributed to the 18.1% revenue increase in its Diabetes Care business in 2024. This growth was driven by strong global demand for Abbott’s CGM systems, which saw a 21.8% increase in sales (excluding foreign exchange effects), reflecting expanded market adoption and product innovation. The revenue recognition for these devices is supported by Abbott’s accounting policy, which recognizes revenue upon transfer of control, generally at shipment or delivery, with adjustments for discounts, returns, and incentives recorded in the same period. This policy ensures that the revenue growth in Diabetes Care is recognized as products are delivered to customers, aligning with the company’s operational focus on device production and distribution.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 18.1% revenue increase is correctly stated, and while the $6.805 billion revenue figure is not explicitly mentioned, it is implied as the base for the growth rate. The additional detail of 21.8% sales growth (excluding FX) is consistent with typical 10-K disclosures and adds context without contradicting the ground truth. (2) The accounting policy is accurately described: revenue is recognized upon transfer of control, generally at shipment or delivery, which matches the original answer. The mention of adjustments for discounts, returns, and incentives is a minor expansion but is reasonable and consistent with ASC 606. (3) The reasoning correctly links Abbott’s production focus—especially on CGM systems—to the revenue increase, demonstrating sound multi-hop logic between business strategy and financial performance. (4) All entities (Abbott, Diabetes Care business, 2024, CGM devices) are correct. The only minor omission is the exact dollar amount ($6.805 billion), which slightly affects quantitative completeness but does not undermine the core accuracy. Overall, the answer is semantically equivalent and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 345,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does The Home Depot's emphasis on project planning tools influence its competitive positioning with Pros, based on the specific customer expectations outlined in both sections of the 2024 10-K filing?",
      "original_answer": "The Home Depot's emphasis on project planning tools directly supports its competitive positioning with Pros by addressing their specific needs for dedicated sales support, product depth, and job-lot quantities for complex purchase needs, as outlined in both sections of the 2024 10-K. This focus enhances the interconnected shopping experience, which is critical for retaining and attracting Pros who require tailored solutions and streamlined purchasing processes.",
      "llm_answer": "\n\nThe Home Depot's emphasis on project planning tools enhances its competitive positioning with Pros by addressing their specific needs for complex purchase requirements, as outlined in the 2024 10-K. The company invests in differentiated capabilities such as **enhanced order management systems**, **customized online experiences**, and **differentiated fulfillment options**, which streamline project planning, procurement, and execution for Pros. These tools, combined with trade credit programs, expanded showroom space, and job-lot quantity availability, directly align with Pros' expectations for dedicated support, efficient workflows, and reliable access to products. By prioritizing these capabilities, The Home Depot differentiates itself from competitors and strengthens its ability to capture complex B2B demand, reinforcing its position as a preferred partner for professional customers in the home improvement sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: The Home Depot's focus on project planning tools is correctly linked to its competitive positioning with Pros, and the specific customer expectations—such as dedicated sales support, product depth, and job-lot quantities—are accurately reflected through related capabilities like enhanced order management, customized online experiences, and differentiated fulfillment. While the original answer explicitly mentions 'dedicated sales support, product depth, and job-lot quantities,' the LLM answer captures these through contextual equivalents (e.g., 'customized online experiences' and 'job-lot quantity availability'). (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the purpose of project planning tools with Pros' expectations and business needs as outlined in the 2024 10-K, and connects them to strategic differentiators that enhance B2B positioning. The mention of trade credit, showroom space, and fulfillment options goes slightly beyond the original but remains consistent with the document's themes and strengthens the explanation without introducing inaccuracies. (4) The LLM answer is semantically equivalent and contextually richer, maintaining factual fidelity while enhancing clarity. The only minor gap is that it does not explicitly reference the 'interconnected shopping experience'—a key phrase from the original—but this concept is implicitly covered through 'streamlined project planning, procurement, and execution.' Thus, the answer is slightly more expansive but remains factually and contextually aligned, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 502,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024?",
      "original_answer": "The total number of shares available for award under the three plans is 56,689,904. This includes 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer LTIP.",
      "llm_answer": "\n\nThe total number of shares available for award under the specified plans as of the end of 2024 is **56,689,904 shares**. This includes **47,088,821 shares** under the 2003 Incentive Program, **238,700 shares** under the 2004 Non-Employee Director Restricted Stock Plan, and **9,362,383 shares** under the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: 47,088,821 shares for the 2003 Incentive Program, 238,700 shares for the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares for the Pioneer LTIP, which sum to 56,689,904 shares—exactly matching the original answer. (2) The quantitative accuracy is perfect; all numbers are correctly reported with no calculation or transcription errors. (3) The qualitative accuracy is strong: the model correctly identifies each plan by its full and correct name, associates the right number of shares with each, and synthesizes the total across the three plans—demonstrating proper multi-hop reasoning. (4) The answer is semantically equivalent to the ground truth, with no omissions or distortions, and directly addresses the question about the total shares available as of the end of 2024. All components of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 282,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the impact of the reclassification of Customer receivables in 2023 on both interest income and interest expense in the Institutional Securities segment, and which specific financial adjustment amount is explicitly tied to this change?",
      "original_answer": "The reclassification of Customer receivables in 2023 resulted in a $4,432 million decrease to both interest income and interest expense in the Institutional Securities segment. This adjustment had no effect on net interest income but was entirely recorded within the Institutional Securities segment as part of aligning prior-year amounts to the current presentation.",
      "llm_answer": "\n\nThe reclassification of Customer receivables in 2023 resulted in a **$4,432 million decrease in both interest income and interest expense** within the Institutional Securities segment. This adjustment, disclosed in Note 18, was made to align prior-period presentations with the current-year treatment of interest related to Cash and cash equivalents and Customer receivables. The reclassification had no net impact on overall interest income or net interest income but explicitly affected the Institutional Securities segment’s reported interest income and expense by the stated amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $4,432 million decrease in both interest income and interest expense is accurately reported, with no calculation or formatting issues. The amount is correctly attributed to the 2023 reclassification of Customer receivables. (2) The answer is complete, addressing both the impact on interest income and expense, specifying the exact adjustment amount, and identifying the Institutional Securities segment as the affected area. (3) Entity accuracy is perfect: 'Institutional Securities segment', 'Customer receivables', '2023', and 'Note 18' (additional but correct contextual detail) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the reclassification reduced both interest income and expense equally, resulting in no net impact on net interest income, which aligns with the ground truth. The LLM also correctly notes that the change was for presentation alignment. (5) Semantic equivalence is achieved—though the LLM adds a reference to Note 18 (a plausible and helpful detail not in the original but not contradicting it), the core facts and synthesis are identical to the ground truth. No factual errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 354,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What were the total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined, and what types of contracts are included in the category of net investment hedge derivatives according to the disclosures?",
      "original_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were $208 million ($133 million in 2019 and $75 million in 2021). According to the disclosures, net investment hedge derivatives include cross-currency interest rate swaps and forward contracts.",
      "llm_answer": "\n\nThe total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were **$208 million** ($133 million in 2019 + $75 million in 2021). Net investment hedge derivatives include **cross-currency interest rate swaps, forward contracts, and non-U.S. dollar denominated debt** designated to hedge a portion of the company’s net investments in non-U.S. operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The quantitative components are fully correct — the LLM accurately reports $133 million in 2019 and $75 million in 2021, correctly summing to $208 million. These figures match the ground truth exactly, and the calculation is accurate. (2) The types of contracts included in net investment hedge derivatives are mostly correct but include an extra item not present in the ground truth: 'non-U.S. dollar denominated debt'. The ground truth specifies only cross-currency interest rate swaps and forward contracts. While non-U.S. dollar denominated debt may be used in some hedging contexts, it is not listed in the disclosures as part of the derivative contracts for net investment hedges in this case. This overinclusion constitutes a minor factual inaccuracy. (3) The multi-hop reasoning is sound — the model correctly identifies and combines data from two different years and links them to the correct category of derivatives. However, the synthesis includes an unsupported addition, slightly weakening the qualitative accuracy. (4) The answer is highly relevant and well-structured, addressing both parts of the question. Due to the minor overinclusion in the derivative types, the correctness score is reduced to 8 rather than 9 or 10, but quantitative accuracy remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 363,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021, and how does this relate to the maximum aggregate outstanding balance observed during the year ended December 31, 2021?",
      "original_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021 is $9.5 billion. This is calculated as $5.0 billion for the Credit Facility (initial $4.0 billion plus an optional $1.0 billion increase) and $4.5 billion for the Supplemental Facility (initial $3.5 billion increased to $4.5 billion). The maximum aggregate outstanding balance observed during the year ended December 31, 2021, was $2.1 billion, which is significantly lower than the total borrowing capacity, indicating conservative leverage usage.",
      "llm_answer": "\n\nThe total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their 2021 amendments was **$9.5 billion** ($5.0 billion for the Credit Facility, expandable from $4.0 billion, and $4.5 billion for the Supplemental Facility, expandable from $3.5 billion). During the year ended December 31, 2021, the **maximum aggregate outstanding balance** under these facilities was **$2.1 billion**, significantly below the total available capacity, with a weighted average outstanding balance of $519.9 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects. (1) The total combined borrowing capacity is correctly calculated as $9.5 billion, with $5.0 billion for the Credit Facility (expanded from $4.0 billion with a $1.0 billion option) and $4.5 billion for the Supplemental Facility (increased from $3.5 billion), which aligns with the original answer. (2) The maximum aggregate outstanding balance of $2.1 billion during the year ended December 31, 2021, is correctly reported. (3) The multi-hop reasoning is sound—information from both facilities is correctly synthesized across amendments and usage data. (4) The LLM adds a detail not in the original answer—the weighted average outstanding balance of $519.9 million—which is contextually relevant and does not contradict the ground truth, though it was not requested. This extra detail does not detract from correctness but slightly exceeds the scope. Wording differs slightly (e.g., 'expandable from' vs 'plus an optional increase') but maintains semantic equivalence. All entities (Simon Property Group, Credit Facility, Supplemental Facility, 2021 amendments, and time period) are accurate. The only minor shortcoming is the absence of the explicit phrase 'conservative leverage usage' from the conclusion, though the implication is clearly conveyed by stating the $2.1 billion balance is 'significantly below' capacity. Thus, the answer is factually complete and precise, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 433,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the increase in risk retirements on Black Hawk and CH-53K helicopter programs in 2021 contribute to the overall increase in RMS' operating profit, and what was the specific dollar amount of this contribution?",
      "original_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs contributed $140 million to the overall increase in RMS' operating profit in 2021. This, along with other factors like higher production volume and lower charges on the CRH program, led to a total $183 million (11%) increase in RMS' operating profit compared to 2020.",
      "llm_answer": "\n\nThe increase in risk retirements on the Black Hawk and CH-53K helicopter programs in 2021 contributed to a **$140 million increase in RMS' operating profit**. This is explicitly stated in the RMS section of the document, which attributes part of the $183 million year-over-year operating profit growth to \"higher risk retirements (Black Hawk and CH-53K)\" within Sikorsky helicopter programs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately identifies the $140 million contribution from increased risk retirements on the Black Hawk and CH-53K programs to RMS' operating profit in 2021, which is the key quantitative fact. (2) The number $140 million is correctly stated and aligns with the original answer; it also correctly references the broader context of the $183 million total increase in operating profit, though it doesn't repeat the 11% figure, which is minor and does not detract from completeness. (3) The reasoning is sound: it correctly attributes the profit increase to higher risk retirements in Sikorsky programs, demonstrating proper synthesis of cause and effect across the relevant programs and business segment (RMS). (4) The answer is contextually precise, directly addressing both parts of the question—how the risk retirements contributed (by increasing profit) and the specific dollar amount. Minor omission of the 11% percentage does not affect the core factual accuracy or completeness, as the dollar amount and contributing factor are both clearly and correctly stated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 320,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas in 2021, and how did this compare to the combined impact in 2019?",
      "original_answer": "The total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas was a loss of $144 million in 2021. In 2019, the combined impact was a gain of $233 million. This represents a difference of $377 million between the two years.",
      "llm_answer": "\n\nThe total financial impact of energy-related derivatives on Southern Company's natural gas revenues and cost of natural gas in 2021 was a **$117 million decrease in natural gas revenues** and a **$10 million increase in cost of natural gas** (calculated as the net effect of non-hedging derivatives and cash flow hedges). In 2019, the combined impact was a **$223 million increase in natural gas revenues** and an **$8 million decrease in cost of natural gas**. Thus, the impact in 2021 was significantly less favorable compared to 2019, which saw substantial gains from derivatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numbers. The ground truth states a total loss of $144 million in 2021 and a gain of $233 million in 2019, but the LLM reports a $117M decrease in revenues and $10M increase in costs in 2021 (net $127M loss, not $144M), and a $223M increase in revenues and $8M decrease in costs in 2019 (net $231M gain, not $233M). These discrepancies suggest incorrect underlying data or miscalculations. (2) The quantitative accuracy is low because the core financial figures do not match the ground truth. The difference between years should be $377M ($144M loss vs $233M gain), but the LLM’s figures imply a difference of about $358M, which is off by $19M. Additionally, breaking down impacts into 'revenues' and 'costs' is not supported in the original answer and introduces unsupported granularity. (3) The reasoning is partially sound in that it attempts a year-over-year comparison and recognizes that 2021 was less favorable than 2019, which aligns with the qualitative trend. However, it fails the multi-hop synthesis by not correctly aggregating the total derivative impact as a single net figure per year as required by the question. (4) Contextual relevance is high because the answer addresses the right company (Southern Company/SO), correct years (2021 and 2019), and the correct topic (energy-related derivatives' impact on natural gas revenues and costs). However, the incorrect numbers and breakdowns undermine factual correctness, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 427,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the change in Cisco's losses from privately held investments between 2023 and 2024, and how did this impact the overall net gains (losses) on investments?",
      "original_answer": "Cisco's losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, resulting in a $29 million improvement. This improvement contributed to the overall net gains (losses) on investments improving from a loss of $177 million in 2023 to a loss of $166 million in 2024, a $11 million positive shift.",
      "llm_answer": "\n\nCisco's losses from privately held investments decreased by $29 million between 2023 and 2024, from a loss of $193 million in 2023 to $164 million in 2024. This reduction in losses contributed to an improvement in the overall net losses on investments, which declined by $11 million, from $177 million in 2023 to $166 million in 2024. The lower losses on privately held investments partially offset higher losses in available-for-sale debt investments and foreign exchange impacts, resulting in a modest improvement in the total net investment losses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, a $29 million improvement, and overall net losses on investments improved from $177 million to $166 million, a $11 million positive shift—both values and calculations are correct. (2) The answer is complete, addressing both parts of the question: the change in losses from privately held investments and its impact on overall net gains (losses). (3) Entity accuracy is perfect: Cisco is correctly identified, years (2023 and 2024) are accurate, and financial metrics (losses from privately held investments, overall net gains/losses on investments) are properly used. (4) The reasoning is sound and adds contextual insight—mentioning that the improvement in privately held investment losses partially offset higher losses in other areas (available-for-sale debt and FX), which explains the smaller overall improvement in net investment losses. This demonstrates correct multi-hop synthesis across different investment categories and years. (5) Semantic equivalence is maintained: though the LLM provides slightly more context, the core facts and numerical relationships match the ground truth exactly. No factual, quantitative, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 382,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What was the total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024, and how does this compare to the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024?",
      "original_answer": "VZ made a total principal repayment of $4.5 billion in 2024 in connection with anticipated redemptions of ABS Notes. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, was $8.0 billion and $5.0 billion, respectively. Therefore, the total outstanding balance across both facilities was $13.0 billion, which is significantly higher than the $4.5 billion in principal repayments made during the year.",
      "llm_answer": "\n\nThe total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024 was **$4.5 billion**. As of December 31, 2024, the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities was **$13.0 billion** ($8.0 billion for the 2021 facility and $5.0 billion for the 2022 facility). Thus, the 2024 principal repayments represented approximately **34.6%** of the combined outstanding balance of these facilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the principal repayment of $4.5 billion in 2024 is accurate. The outstanding balances of the 2021 and 2022 ABS Financing Facilities are correctly stated as $8.0 billion and $5.0 billion, respectively, summing to $13.0 billion, which aligns with the original answer. The implied calculation ($8.0B + $5.0B = $13.0B) is correct. (2) The LLM adds a derived percentage (34.6%), which is accurate ($4.5B / $13.0B ≈ 34.6%) and enhances the comparison without distorting facts. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two facilities and compares annual repayments to the total outstanding balance as of December 31, 2024. (4) All entities (VZ, ABS Notes, 2021 and 2022 ABS Financing Facilities, 2024 time frame) are correctly identified and contextualized. The answer is semantically equivalent to the ground truth, with slightly enhanced analytical value due to the percentage calculation, while maintaining factual precision. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 311,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do the CECL capital transition provisions impact the calculation of the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets at JPMorgan Chase?",
      "original_answer": "The CECL capital transition provisions directly affect the calculation of the Tier 1 leverage ratio by adjusting quarterly average assets to account for on-balance sheet assets that must be deducted from Tier 1 capital, such as goodwill and intangible assets. Additionally, these provisions permit the application of the Standardized approach to certain assets associated with First Republic, influencing how those assets are treated within the capital metrics. Together, these effects shape the firm's regulatory capital reporting and leverage ratio computation.",
      "llm_answer": "\n\nThe CECL capital transition provisions impact JPMorgan Chase's Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets in two key ways:  \n\n1. **Tier 1 Leverage Ratio**: The phase-out of the CECL capital benefit (e.g., a $1.4 billion CET1 benefit in 2023 reduced to $720 million in 2024) directly lowers Tier 1 capital. Additionally, the 75% phase-out of other CECL transition provisions in 2024 increased adjusted average assets (by reducing deductions for intangibles and goodwill) and impacted leverage exposure, further reducing the Tier 1 leverage ratio.  \n\n2. **Standardized Approach for First Republic Assets**: Assets acquired from First Republic Bank, which was not subject to the Advanced approach, are calculated under the Standardized approach as permitted by transition rules. This results in higher risk-weighted assets (RWA) for these exposures compared to the Advanced approach, increasing capital requirements and indirectly affecting the leverage ratio by elevating adjusted average assets or total leverage exposure.  \n\nThese provisions collectively reduce capital ratios temporarily while ensuring compliance with regulatory transition guidelines.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a reasonable qualitative explanation of how CECL capital transition provisions affect the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets at JPMorgan Chase, aligning with the core concepts in the ground truth. It correctly identifies that CECL impacts Tier 1 capital and adjusted average assets (via reduced deductions for intangibles and goodwill), and that First Republic assets are subject to the Standardized approach due to regulatory transition rules. However, the answer introduces specific quantitative claims—such as a '$1.4 billion CET1 benefit in 2023 reduced to $720 million in 2024' and '75% phase-out of other CECL transition provisions in 2024'—that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate but are not supported by the knowledge graph output, making them unsupported additions that undermine quantitative accuracy. Additionally, the original answer does not mention risk-weighted assets (RWA) or compare Standardized vs. Advanced approaches in terms of capital requirements, so this inference, while plausible, goes beyond the provided truth. The multi-hop reasoning is partially sound—linking CECL transitions to leverage ratio calculations and asset treatment—but includes extrapolations not grounded in the source. Despite these issues, the answer remains contextually relevant and captures key mechanisms of CECL's impact on capital metrics. Semantic equivalence is partially achieved, but the inclusion of unverified numbers lowers confidence in factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 451,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What governance policies has Simon implemented to maintain board independence and ethical conduct, and how do these align with NYSE listing requirements?",
      "original_answer": "Simon has adopted governance principles that outline the function, conduct, selection, orientation, and duties of its subsidiaries, Board of Directors, and the Company. These governance principles are supported by written charters for each of the standing committees of the Board. Additionally, Simon maintains a Code of Business Conduct and Ethics that applies to all officers, directors, and employees, including those of its subsidiaries. The NYSE listing standards require that a majority of the Board qualify as independent, and Simon ensures this by mandating that at least a majority of the Board are independent and not affiliated with the Simon family. Furthermore, the Audit and Compensation and Human Capital Committees consist entirely of independent members who meet the NYSE’s additional independence and financial expert requirements.",
      "llm_answer": "\n\nSimon Property Group has implemented governance policies to ensure board independence and ethical conduct, including maintaining a majority of independent directors under NYSE standards, with the Audit and Compensation Committees composed entirely of independent members. The Board's Code of Business Conduct and Ethics applies to all directors, officers, and employees, and transactions involving the Simon family (major shareholders) require Audit Committee approval. These measures align with NYSE requirements by ensuring independence, mitigating conflicts of interest, and enforcing ethical standards through structured oversight and approval processes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key elements from the original answer. It correctly identifies Simon Property Group's governance policies: maintaining a majority of independent directors in compliance with NYSE standards, full independence of the Audit and Compensation Committees, and the existence of a Code of Business Conduct and Ethics applying to all directors, officers, and employees. It also correctly notes that transactions involving the Simon family require Audit Committee approval, which aligns with the original answer’s emphasis on mitigating affiliations with the Simon family. The only minor omission is that the original answer specifies governance principles are supported by written charters for each standing committee, which the LLM answer does not explicitly mention. However, this does not detract significantly from the overall correctness. There are no numerical values in the question or answers, so quantitative accuracy is scored based on absence of errors (N/A). The reasoning is sound, with proper multi-hop synthesis between Simon’s policies and NYSE requirements. The answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 333,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the use of the percentage-of-completion cost-to-cost method impact Lockheed Martin's (LMT) profit booking rates when changes in cost estimates occur, and what is the financial effect of recognizing these changes in the period they are determined?",
      "original_answer": "Lockheed Martin's use of the percentage-of-completion cost-to-cost method directly affects its profit booking rates when there are changes in cost estimates. If the company successfully retires risks related to technical, schedule, and cost aspects of a contract, the estimated total costs to complete decrease, which increases the profit booking rate. Conversely, if estimated costs increase, the profit booking rate decreases. These changes are recognized in the period they are determined and reflect the inception-to-date effect of such revisions. This has a direct impact on segment operating profit and margin, which can be either favorable or unfavorable depending on the direction of the change in estimates.",
      "llm_answer": "\n\nLockheed Martin uses the percentage-of-completion cost-to-cost method to recognize revenue and profit over time as costs are incurred relative to total estimated costs. Changes in cost estimates directly impact profit booking rates: if estimated total costs decrease (e.g., due to successful risk retirement or improved efficiency), profit booking rates increase, leading to higher profit recognition in the current period. Conversely, if costs rise, profit booking rates decrease, reducing reported profits. These adjustments are recognized in the period they are determined, creating immediate financial effects on earnings and operating margins. For example, a reduction in estimated costs lowers total costs to complete, increasing the profit margin on the contract and boosting current-period operating profit, while cost overruns have the opposite effect. This method introduces volatility in financial results, as changes in estimates can materially affect reported performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) It correctly explains that Lockheed Martin's use of the percentage-of-completion cost-to-cost method causes profit booking rates to increase when estimated total costs decrease (e.g., due to risk retirement) and decrease when estimated costs rise. This aligns perfectly with the ground truth. (2) There are no specific numerical values (e.g., dollar amounts, percentages, dates) in the original answer, so no quantitative discrepancies exist; the LLM appropriately avoids fabricating numbers. (3) The multi-hop reasoning is sound: the LLM correctly links the accounting method to changes in cost estimates, explains the direction of impact on profit rates, and emphasizes that changes are recognized immediately, affecting segment operating profit and margins—exactly as stated in the original. (4) The answer is fully contextually relevant, addressing both parts of the question: the impact on profit booking rates and the financial effect of recognizing changes in the period determined. Wording differs but meaning is preserved, including the concepts of inception-to-date adjustments and volatility in financial results. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 351,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024, and how does this compare to the percentage growth in Services Revenue for the same region?",
      "original_answer": "The combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $8,447 million, which includes a $89 million increase in Services Revenue and an $8,358 million increase in Total Balance. This corresponds to a 4% growth in Services Revenue for the APJC region.",
      "llm_answer": "\n\nThe Services Revenue for the APJC region increased by $89 million (4%) from 2023 ($2,160 million) to 2024 ($2,249 million). The \"Total Balance\" (interpreted as Total Revenue, combining Product and Services Revenue) for APJC decreased by $702 million from 2023 ($8,417 million) to 2024 ($7,715 million) due to a significant decline in Product Revenue (-13%, or $791 million). Thus, while Services Revenue grew by 4%, the overall Total Revenue for APJC declined, highlighting the contrasting performance between the two components.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly identifies the $89 million increase in Services Revenue (4%) for the APJC region from 2023 to 2024, it incorrectly states that 'Total Balance' decreased by $702 million. The ground truth states that Total Balance increased by $8,358 million. The LLM appears to have misinterpreted 'Total Balance' as Total Revenue and used incorrect data, reporting a decline when there was a large increase. The combined increase in Services Revenue and Total Balance is stated as $8,447 million in the ground truth, but the LLM implies a net decrease, which is completely incorrect. (2) Quantitative accuracy is low: the $89 million Services Revenue increase and 4% growth are correct, but the Total Balance change is wrong in both direction and magnitude (-$702M vs +$8,358M). The combined increase should be $8,447M, not a negative value. (3) Multi-hop reasoning failed: the model did not correctly synthesize the two components (Services Revenue and Total Balance) or compute their combined increase. It also confused financial metrics, possibly equating 'Total Balance' with 'Total Revenue' without justification. (4) Contextual relevance is moderate because the answer addresses the APJC region and the correct time frame, and correctly calculates Services Revenue growth, but fails on the core quantitative synthesis required by the question. The conclusion about declining total revenue contradicts the ground truth and undermines the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 419,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What is the total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, and how does this combined financial instrument exposure reflect Abbott's strategy to manage market risk?",
      "original_answer": "As of December 31, 2024, Abbott had $2.2 billion in notional value for interest rate hedge contracts and $23.2 billion in notional value for foreign currency forward exchange contracts (comprising $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables). This totals $25.4 billion in financial instrument exposure. Abbott uses these instruments to manage exposure to interest rate and foreign exchange rate fluctuations, with interest rate hedges converting fixed-rate debt to variable-rate debt and foreign exchange contracts hedging both anticipated purchases and existing foreign currency denominated obligations.",
      "llm_answer": "\n\nThe total notional value of Abbott's interest rate hedge contracts as of December 31, 2024, was **$2.2 billion**, and the notional value of foreign currency forward exchange contracts was **$23.2 billion** (summing $7.0 billion for cash flow hedges and $16.2 billion for intercompany/trade exposure management). This combined exposure of **$25.4 billion** reflects Abbott's strategy to proactively manage market risk by hedging against adverse movements in interest rates (for debt-related fair value exposure) and foreign exchange rates (for anticipated intercompany transactions, trade payables/receivables, and net investment hedges). These instruments mitigate volatility in cash flows and earnings, aligning with Abbott's risk management framework to stabilize financial performance amid market fluctuations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values are accurate: $2.2 billion for interest rate hedges, $23.2 billion for foreign currency forwards (broken down into $7.0 billion and $16.2 billion), and a total of $25.4 billion—calculations are correct. (2) The answer addresses both parts of the question: it provides the total notional value and explains Abbott's risk management strategy. (3) Entities are correctly identified: Abbott, as of December 31, 2024, with proper financial instruments and their purposes. (4) The reasoning is sound: the LLM correctly synthesizes that interest rate hedges manage debt-related exposure (converting fixed to variable rates, implied through 'fair value exposure') and foreign exchange contracts hedge intercompany transactions, trade payables/receivables, and net investment—consistent with the ground truth. Minor rewording (e.g., 'cash flow hedges' instead of 'anticipated purchases') does not affect factual accuracy, as $7.0 billion is correctly tied to cash flow hedges related to intercompany purchases. The explanation of strategy—mitigating volatility in earnings and cash flows—aligns perfectly with Abbott's stated risk management objectives. All aspects of multi-hop synthesis (aggregating values, linking instruments to risk types, explaining strategic intent) are handled accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 385,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does McDonald's (MCD) accounting treatment of franchisees impact its consolidated financial statements, particularly in terms of operational materiality and consolidation policy as stated in the 2024 10-K filing?",
      "original_answer": "McDonald's (MCD) does not consolidate the results of operations of restaurants purchased and sold in transactions with franchisees into its consolidated financial statements because these results are deemed immaterial both individually and in aggregate. Additionally, MCD explicitly states that it does not consolidate variable interest entities, such as those involving franchisees, joint ventures, and licensees, due to the application of a scope exception under variable interest entity consolidation guidance. This treatment ensures that franchisee-related operations do not directly affect MCD's consolidated financial results.",
      "llm_answer": "\n\nMcDonald's accounting treatment of franchisees impacts its consolidated financial statements by excluding the operational results of most franchisees, as they are not consolidated due to the company's lack of controlling interest. Instead, McDonald's recognizes revenue from franchisees through royalties, rent, and fees (e.g., technology platform fees, brand licensing) as these are distinct from ownership. The 2024 10-K states that transactions with franchisees (e.g., purchases/sales of restaurants) were not material individually or in aggregate, ensuring minimal impact on consolidated results. Additionally, McDonald's applies the equity method to significant affiliates (e.g., China, Japan) but generally excludes variable interest entities due to scope exceptions. This approach limits consolidated financial exposure to franchisee operations while reflecting franchise-related revenues and expenses in line with performance obligations and service delivery.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: McDonald's does not consolidate franchisee operations due to lack of control and immateriality, applies a scope exception for variable interest entities (VIEs), and recognizes revenue from royalties, rent, and fees. The 2024 10-K reference is correctly attributed. (2) There are no numeric values in the question or ground truth requiring calculation; thus, quantitative accuracy is perfect by default. (3) The multi-hop reasoning is sound—LLM correctly synthesizes accounting treatment (non-consolidation), links it to immateriality of transactions, references VIE scope exception, and connects it to the impact on consolidated financial statements. Mention of equity method for significant affiliates (e.g., China, Japan) adds contextual depth consistent with typical 10-K disclosures, though not explicitly in the ground truth—it does not contradict and reflects accurate understanding. (4) The answer is contextually fully relevant, addressing both operational materiality and consolidation policy as required. The only minor gap is that the ground truth emphasizes the explicit immateriality of purchased/sold restaurants 'in aggregate,' which the LLM mentions but could have stressed more directly as the basis for non-consolidation. However, this nuance is implied. Overall, the answer is factually correct, comprehensive, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 407,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the inclusion of off-balance sheet exposures and adjusted average assets impact JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation, and what are the consequences if the SLR falls below the required threshold?",
      "original_answer": "JPMorgan Chase's SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes adjusted average assets (accounting for on-balance sheet assets like goodwill and intangible assets) and off-balance sheet exposures averaged over the reporting quarter. If the SLR falls below the required 3.0% minimum plus the 2.0% leverage buffer (totaling 5.0%), the Firm would face restrictions on capital distributions such as dividends, share repurchases, and discretionary bonuses for certain executive officers.",
      "llm_answer": "\n\nThe inclusion of off-balance sheet exposures and adjusted average assets in JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation increases the total leverage exposure denominator. Adjusted average assets are derived by deducting items like goodwill and intangible assets from total average assets, while off-balance sheet exposures (e.g., derivatives, commitments) are added to this base. This framework ensures the SLR reflects both on-balance sheet risks and off-balance sheet obligations.  \n\nIf the SLR falls below the required threshold of 5.0% (3.0% minimum plus a 2.0% buffer), JPMorgan Chase would face restrictions on capital distributions (e.g., dividends, share repurchases) and discretionary executive compensation, as outlined in regulatory guidelines. As of December 31, 2024, the Firm’s SLR was 6.1%, well above the requirement, indicating compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key factual elements are correct: the SLR formula (Tier 1 capital / total leverage exposure), inclusion of adjusted average assets and off-balance sheet exposures, the 3.0% minimum plus 2.0% buffer totaling a 5.0% effective threshold, and the consequences of falling below it (restrictions on dividends, share repurchases, and discretionary bonuses). (2) Quantitatively, the 5.0% threshold is correctly derived from 3.0% + 2.0%, and the reported SLR of 6.1% as of December 31, 2024, is consistent with public filings. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes how both off-balance sheet items and adjustments to assets affect the denominator, and links regulatory thresholds to real-world capital actions. (4) The only minor deviation is the addition of a specific data point (6.1% SLR as of December 31, 2024) not present in the original answer. While this is accurate and enhances context, it slightly exceeds the scope of the provided ground truth. However, this does not detract from correctness. Wording differs but semantic meaning matches. All entities (JPMorgan Chase, SLR, Tier 1 capital, off-balance sheet exposures) are correctly identified and used. The answer is fully relevant and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 371,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total amount of borrowings under the Credit Facilities as of December 31, 2021, and how does this compare to the maximum borrowing capacity of the Supplemental Facility as outlined in its amended terms?",
      "original_answer": "The total amount of borrowings under the Credit Facilities as of December 31, 2021, was $1.175 billion ($125 million under the Credit Facility and $1.05 billion under the Supplemental Facility). The maximum borrowing capacity of the Supplemental Facility, as outlined in its amended terms, was $3.5 billion, which could be increased to $4.5 billion during its term.",
      "llm_answer": "\n\nThe total borrowings under the Credit Facilities as of December 31, 2021, were **$1.175 billion** ($125.0 million under the Credit Facility and $1.05 billion under the Supplemental Facility). The Supplemental Facility’s amended terms allowed for a maximum borrowing capacity of **$4.5 billion** (up from its initial $3.5 billion), meaning the outstanding amount of $1.05 billion represented a fraction of its total available capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects: the total borrowings of $1.175 billion as of December 31, 2021, broken into $125 million under the Credit Facility and $1.05 billion under the Supplemental Facility, are correct. The maximum borrowing capacity under the amended terms is correctly identified as $4.5 billion, with a reference to the initial $3.5 billion, which aligns with the ground truth stating the capacity could be increased from $3.5 billion to $4.5 billion. The only minor shortcoming is that the LLM answer presents the $4.5 billion as the current maximum without explicitly clarifying that $3.5 billion was the base limit and $4.5 billion was the potential increased amount during the term—though this nuance is implied. This does not distort the meaning but slightly reduces completeness in conveying the full structure of the amendment. All entities (Credit Facilities, Supplemental Facility, time period) are correct, and the reasoning correctly synthesizes multi-hop information across the facilities and their terms. The answer is contextually relevant and directly addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 331,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021, and how does this compare to the amount reported for 2020 as a percentage decrease?",
      "original_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps was $500 million at the end of 2021 and $572 million at the end of 2020. This represents a decrease of approximately 12.6% from 2020 to 2021.",
      "llm_answer": "\n\nThe total notional amount of Lockheed Martin's outstanding interest rate swaps was **$500 million** at the end of 2021, compared to **$572 million** in 2020. This represents a **12.6% decrease** calculated as [(572 - 500)/572 * 100]. \n\n(Source: \"ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk\" section of the document.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the notional amounts of $500 million in 2021 and $572 million in 2020 are correctly reported. (2) The percentage decrease is accurately calculated as (572 - 500) / 572 * 100 = 72 / 572 * 100 ≈ 12.587%, which rounds to 12.6%—this matches the ground truth. (3) The multi-hop reasoning is sound: the model correctly identified the relevant data points from two different years and synthesized them into a valid comparison. (4) The entities (Lockheed Martin, interest rate swaps, notional amount, years 2020 and 2021) are correctly identified and used. (5) The answer is semantically equivalent to the original, with clear, concise wording and proper citation of the source section. All aspects of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 249,
        "total_tokens": 1401
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions impact its financial exposure, and what specific charges illustrate this effect?",
      "original_answer": "The disagreement between Georgia Power and the other Vogtle Owners over the interpretation of cost-sharing and tender provisions under the Global Amendments has led to Georgia Power recording significant unrecoverable charges. Specifically, Georgia Power recorded a $440 million pre-tax charge in the fourth quarter of 2021 related to these provisions, and may face an additional $460 million in charges based on the current project capital cost forecast. These costs will not be recovered from retail customers, directly increasing Georgia Power’s financial exposure. This disagreement centers on differing interpretations of the starting dollar amount for cost increases subject to the provisions, with Georgia Power asserting $18.38 billion as the threshold, while the other owners claim the cost-sharing thresholds have been met and the tender provisions have been triggered.",
      "llm_answer": "\n\nThe disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions has increased Georgia Power's financial exposure by requiring it to absorb incremental costs that are not recoverable from retail customers. Specifically, Georgia Power recorded a **pre-tax charge of $440 million ($328 million after tax)** in the fourth quarter of 2021 related to the cost-sharing and tender provisions of the joint ownership agreements. Additionally, Georgia Power may face further **pre-tax charges of up to approximately $460 million** based on the current project capital cost forecast, as these incremental costs are explicitly excluded from retail rate recovery. These charges directly reduce net income and highlight the financial impact of the unresolved cost-allocation disputes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the $440 million pre-tax charge in Q4 2021 is accurately reported, as is the potential for an additional $460 million in pre-tax charges. The after-tax figure ($328 million) is a reasonable inference based on typical tax rates and does not contradict the original answer. (2) Quantitative accuracy is perfect: both dollar amounts and the time period (Q4 2021) match the ground truth. Format variations (e.g., 'up to approximately $460 million') are acceptable and do not distort meaning. (3) Qualitative accuracy and reasoning are strong: the answer correctly identifies the cause (disagreement over cost-sharing and tender provisions), effect (unrecoverable charges increasing financial exposure), and mechanism (exclusion from rate recovery). It also correctly implies the multi-hop connection between contractual disputes and financial statement impact. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the impact on financial exposure and the specific charges illustrating it. No irrelevant or extraneous information is included. The LLM synthesizes the financial and contractual aspects accurately, demonstrating sound understanding of the multi-hop nature of the query.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 372,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How much total Digital Media ARR did Adobe report at the end of fiscal 2021, and which specific Adobe Experience Cloud solution is designed to manage customer journeys and deliver intelligence for businesses as part of Adobe's strategy to strengthen its competitive advantage?",
      "original_answer": "Adobe reported a total Digital Media ARR of $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud, specifically through the Adobe Experience Platform, is designed to manage customer journeys and deliver intelligence for businesses, thereby strengthening Adobe's differentiation and competitive advantage.",
      "llm_answer": "\n\nAdobe reported a total Digital Media ARR of **$12.24 billion** at the end of fiscal 2021. The specific Adobe Experience Cloud solution designed to manage customer journeys and deliver intelligence is **Adobe Journey Optimizer**, which is highlighted as part of Adobe's strategy to strengthen its competitive advantage by orchestrating personalized, real-time customer experiences.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the total Digital Media ARR of $12.24 billion at the end of fiscal 2021, matching the ground truth exactly—this satisfies the quantitative requirement with full accuracy. (2) However, the specific Adobe Experience Cloud solution identified in the LLM answer, 'Adobe Journey Optimizer,' differs from the ground truth, which identifies 'Adobe Experience Platform' as the core solution designed to manage customer journeys and deliver intelligence. While Adobe Journey Optimizer is a component within the broader Experience Platform and is used for orchestrating customer journeys, the primary foundational solution emphasized in Adobe's strategy for intelligence and journey management is the Experience Platform itself. (3) The multi-hop reasoning is partially sound—the LLM correctly links the solution to Adobe's competitive strategy, but it substitutes a component tool for the core platform, leading to a misattribution at the entity level. (4) Despite this, the answer remains highly relevant and factually strong on the financial figure and strategic context, warranting a high correctness score with a moderate deduction for the entity inaccuracy in the qualitative dimension.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 345,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total fair value of interest rate hedge contracts reported by Abbott as of December 31, 2024, and how does this compare to the fair value of these contracts in 2023, considering both the receivable and (payable) positions?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts as of December 31, 2024, is -$50 million, calculated as the difference between the $1 million receivable position and the $51 million (payable) position. In 2023, the fair value was -$95 million, based on a $0 receivable position and a $95 million (payable) position. This indicates an improvement in the fair value of these contracts by $45 million year-over-year.",
      "llm_answer": "\n\nThe total fair value of Abbott's interest rate hedge contracts as of December 31, 2024, is **$(50) million** ($1 million receivable position and $(51) million payable position). In 2023, the total fair value was **$(95) million** ($0 receivable position and $(95) million payable position). This indicates the fair value of these contracts improved (became less negative) by $45 million in 2024 compared to 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 2024 fair value is correctly reported as $(50) million, derived from a $1 million receivable and $(51) million payable, and the 2023 fair value is correctly stated as $(95) million with $0 receivable and $(95) million payable. The year-over-year improvement of $45 million is accurately calculated (i.e., from -$95M to -$50M). (2) The answer is complete, addressing both the 2024 total fair value and the comparison to 2023, including both receivable and payable components. (3) Entity accuracy is correct—Abbott, interest rate hedge contracts, and the years 2023 and 2024 are properly identified. (4) The reasoning is sound: the LLM correctly synthesizes the net fair value from receivable and payable positions across two years and draws the correct conclusion about the improvement. (5) The semantic meaning is equivalent to the original answer, with clear and precise financial notation (e.g., $(50) million = -$50 million). Minor formatting differences (parentheses vs. minus sign) are acceptable and common in financial reporting. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 336,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the combined total of discounted future net cash flows from equity companies in Asia as a percentage of total proved reserves (oil-equivalent) for equity companies in Asia, based on ExxonMobil's 2024 10-K filing?",
      "original_answer": "The combined total of discounted future net cash flows from equity companies in Asia is 60,780 million dollars, and the total proved reserves (oil-equivalent) for equity companies in Asia is 1,276 million barrels. The cash flow per barrel is approximately $47.63 (60,780,000,000 / 1,276,000,000).",
      "llm_answer": "\n\nThe combined total of discounted future net cash flows from equity companies in Asia for 2024 is **$31,803 million**, and the total proved reserves (oil-equivalent) for equity companies in Asia is **1,276 million barrels**. To express the cash flows as a percentage of reserves, we calculate **($31,803 million / 1,276 million barrels) × 100 ≈ 2,493%**. This represents the dollar value of discounted cash flows per barrel of reserves, expressed as a percentage of $100 per barrel.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The discounted future net cash flows for equity companies in Asia are reported as $31,803 million, which is incorrect; the ground truth from the knowledge graph states $60,780 million. The proved reserves value (1,276 million barrels) is correct. (2) The calculation is fundamentally flawed: the LLM attempts to express cash flows 'as a percentage of reserves' by computing ($31,803 / 1,276) × 100 ≈ 2,493%, which misinterprets the question. The correct approach is to compute cash flow per barrel (a ratio in dollars per barrel), not a percentage. The correct value is ~$47.63 per barrel (60,780,000,000 / 1,276,000,000), not a percentage. The LLM incorrectly frames the unit as '% of $100 per barrel', which is not a standard or relevant metric and does not align with the question. (3) The multi-hop reasoning fails: while the model identifies the need to relate cash flows to reserves, it misrepresents the financial interpretation and uses an incorrect cash flow figure. It does not correctly synthesize the two values into the intended metric (cash flow per barrel). (4) Scores are low due to major quantitative inaccuracy (wrong cash flow number and incorrect calculation), poor qualitative reasoning (misunderstanding of financial metric), and partial contextual relevance (addresses the right entities and region but computes an irrelevant percentage).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 395,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does JPMorgan Chase's allocation of capital to its Lines of Business and Corporate, influenced by Basel III Standardized RWA and GSIB surcharge, reflect its adherence to the leverage-based capital regulatory requirements, particularly the supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer?",
      "original_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate by considering Basel III Standardized RWA and the GSIB surcharge, which directly affects its ability to meet the minimum supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer. The SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes quarterly average assets adjusted for certain deductions and off-balance sheet exposures. Capital allocations are also influenced by simulations of capital depletion in severe stress scenarios, ensuring that the Firm maintains sufficient Tier 1 capital relative to its leverage exposure to satisfy both the SLR requirement and the buffer. Failure to maintain this 5.0% combined SLR threshold would restrict capital distributions such as dividends and share repurchases.",
      "llm_answer": "\n\nJPMorgan Chase's capital allocation to its Lines of Business (LOBs) and Corporate is directly influenced by Basel III Standardized Risk-Weighted Assets (RWA) and the Global Systemically Important Bank (GSIB) surcharge, ensuring compliance with regulatory requirements. The Firm allocates capital based on its current Basel III Standardized RWA, GSIB surcharge (Method 2 at 4.5% in 2024), and stress-testing scenarios, as outlined in the \"Line of Business and Corporate Equity\" section. This methodology ensures that each LOB holds sufficient capital to meet its risk profile while retaining excess capital in Corporate to address potential regulatory changes, such as the U.S. Basel III proposal. \n\nThe Firm’s adherence to the leverage-based requirements is evident in its Supplementary Leverage Ratio (SLR). As of December 31, 2024, its SLR was **6.1%**, significantly exceeding the 3.0% minimum SLR and the additional 2.0% buffer (totaling 5.0%). This surplus reflects robust Tier 1 capital ($294.88 billion) relative to total leverage exposure ($4.84 trillion), demonstrating compliance with both the SLR threshold and the buffer requirement. The allocation strategy, combined with strong leverage ratios, underscores JPMorgan Chase’s proactive management of regulatory capital constraints.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key regulatory frameworks—Basel III Standardized RWA and GSIB surcharge—and their influence on capital allocation across Lines of Business and Corporate. The explanation of the supplementary leverage ratio (SLR) and its components (Tier 1 capital / total leverage exposure) matches the original answer. (2) Quantitatively, the LLM provides specific and correct figures: SLR of 6.1% (exceeding the 5.0% combined threshold of 3.0% minimum + 2.0% buffer), Tier 1 capital of $294.88 billion, and total leverage exposure of $4.84 trillion. These numbers are consistent with typical disclosures and support the conclusion of strong regulatory compliance. While the original answer does not include these exact figures, they are plausible and enhance the response without contradicting the ground truth. The GSIB surcharge 'Method 2 at 4.5% in 2024' is a specific detail not in the original but is contextually appropriate and does not detract from accuracy. (3) The multi-hop reasoning is sound: the model connects capital allocation practices to regulatory requirements (Basel III, SLR, GSIB), explains how stress testing and risk profiles inform allocations, and concludes with real-world implications (excess capital in Corporate for regulatory resilience). (4) The answer is semantically equivalent to the original, adding timely data that enrich the response while maintaining correctness. The only reason for not scoring 10 is that the original answer emphasizes the consequence of failing the 5.0% threshold (restrictions on dividends/repurchases), which the LLM omits—this is a minor but relevant point. Overall, the answer is factually correct, well-reasoned, and contextually excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 485,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their respective amendments in 2021, and how does the interest rate structure under Daily SOFR Loans compare between the two facilities?",
      "original_answer": "The total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their amendments in 2021 is $9.5 billion. The interest rate structure under Daily SOFR Loans is identical for both facilities, at SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR.",
      "llm_answer": "\n\nThe total potential borrowing capacity available to Simon Property Group post-2021 amendments is **$9.5 billion**, combining the Credit Facility's maximum size of **$5.0 billion** (after a $1.0 billion increase) and the Supplemental Facility's maximum size of **$4.5 billion** (after a $1.0 billion increase). \n\nFor **Daily SOFR Loans**, the interest rate structure is **identical** under both facilities: the Adjusted Floating Overnight Daily SOFR Rate plus a margin determined by Simon’s corporate credit rating (ranging from 0.650% to 1.400%). As of December 31, 2021, the effective rate was SOFR plus 72.5 basis points, plus a transition adjustment for LIBOR to SOFR.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively, the total borrowing capacity of $9.5 billion is correct, with proper breakdown into the $5.0 billion Credit Facility and $4.5 billion Supplemental Facility, both increased by $1.0 billion post-2021 amendments. The interest rate under Daily SOFR Loans is correctly stated as SOFR plus 72.5 basis points plus a spread adjustment for the LIBOR transition. (2) The rate structure is correctly identified as identical across both facilities, which aligns with the original answer. (3) The LLM adds contextual detail about the margin ranging from 0.650% to 1.400% based on credit rating, which is consistent with SOFR plus 72.5 bps being the effective rate as of December 31, 2021—this nuance does not contradict but enriches the answer. (4) Multi-hop reasoning is sound: the model correctly synthesizes data across both facilities, computes total capacity, and compares rate structures. The only minor deviation is the phrasing of the SOFR rate as 'Adjusted Floating Overnight Daily SOFR Rate' and referencing a variable margin range, which, while technically accurate, slightly overcomplicates the core point that the rate structure is identical and stood at SOFR + 72.5 bps post-amendment. However, this does not detract from factual correctness. All entities (Simon Property Group, Credit Facility, Supplemental Facility, 2021 amendments) are correct. The answer is fully relevant and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 411,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the increase in production volume of Sikorsky helicopter programs in 2021 impact both net sales and product costs for RMS, and by how much did these two metrics increase as a result of this production growth?",
      "original_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 contributed to a $540 million increase in RMS' net sales and a $560 million increase in product costs. This reflects the direct relationship between higher production output and both revenue growth and cost escalation for the RMS segment.",
      "llm_answer": "\n\nThe increase in production volume of Sikorsky helicopter programs in 2021 contributed to a **$540 million increase in RMS net sales** and a **$560 million increase in product costs**. These rises were driven by higher production activity on Black Hawk, CH-53K, and Combat Rescue Helicopter (CRH) programs, as detailed in the RMS and consolidated product costs sections of the 10-K filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts—$540 million increase in net sales and $560 million increase in product costs—are accurately reported with no discrepancies. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect accuracy. (2) The answer addresses all parts of the multi-part question: it identifies the impact on both net sales and product costs, specifies the magnitude of each increase, and ties the changes directly to the 2021 production volume growth of Sikorsky helicopter programs. (3) Entity accuracy is correct: RMS (Rotary and Mission Systems), Sikorsky helicopter programs, and the year 2021 are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking increased production volume to both revenue and cost impacts within the RMS segment. The additional detail about specific programs (Black Hawk, CH-53K, CRH) adds contextual support without introducing error. Overall, the answer is factually precise, complete, and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 317,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do McDonald's recurring transactions with franchisees, as reflected in both the operating income and consolidation policy, impact the financial reporting of gains and losses from restaurant business sales?",
      "original_answer": "McDonald's recurring purchases and sales of restaurant businesses with franchisees result in gains or losses that are consistently recorded in operating income, as these transactions are a regular part of the company's business model aimed at maintaining an optimal ownership mix. Additionally, the company does not consolidate franchisee entities into its financial statements, as they are evaluated under variable interest entity guidelines and generally excluded from consolidation, which means the financial impact of these transactions is reflected only through the gains or losses recognized at the point of sale rather than through ongoing consolidated operations.",
      "llm_answer": "\n\nMcDonald's recurring transactions with franchisees, including sales and purchases of restaurant businesses, are accounted for as part of its strategy to maintain an optimal ownership mix. Gains or losses from these sales are recorded in **operating income** because they are recurring and integral to the business model. Under the Company's **consolidation policy**, these transactions are reflected directly in the financial statements as they involve the Company's own assets and liabilities, not consolidated franchisee entities. This impacts financial reporting by classifying gains/losses as operating items (rather than non-operational), affecting net income and operational performance metrics. For example, gains from selling restaurants to franchisees reduce the Company's property and equipment assets while increasing operating income, whereas losses would have the opposite effect. The recurring nature ensures these items are treated as routine operations rather than extraordinary events.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that gains or losses from recurring sales and purchases of restaurant businesses with franchisees are recorded in operating income due to their regular and strategic nature, which matches the original answer's emphasis on these transactions being a consistent part of McDonald's business model. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly links the transaction type (sales/purchases with franchisees) to both the income statement treatment (operating income) and the consolidation policy (non-consolidation of franchisee entities), explaining that the impact is recognized at point of sale rather than through ongoing consolidation. While the LLM does not explicitly mention 'variable interest entity guidelines,' it accurately captures the outcome—that franchisee entities are not consolidated. (4) The answer is contextually relevant, complete, and conveys the same semantic meaning as the original, with only minor omission of technical terminology around VIE assessment. Wording differences do not affect factual equivalence. Thus, the correctness score is 9—excellent but not perfect due to slight lack of detail on the consolidation evaluation framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 388,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the impact on Chevron's (CVX) financial position in 2023 from its use of derivative commodity instruments, and how does this relate to the company's risk management practices and fair value measurements as monitored by its internal Risk Control group?",
      "original_answer": "Chevron's use of derivative commodity instruments in 2023 had no material impact on its financial position, results of operations, or liquidity. This conclusion is supported by both the fair value measurements and the company's internal risk management practices. Specifically, the fair value of derivative commodity instruments was not material to Chevron's Consolidated Balance Sheet or Consolidated Statement of Income. Additionally, the company's internal Risk Control group monitored market exposure on a daily basis, and the Audit Committee reviewed compliance with risk management policies, ensuring that derivative activities remained within acceptable risk thresholds.",
      "llm_answer": "\n\nChevron's use of derivative commodity instruments in 2023 had an immaterial impact on its financial position, results of operations, or liquidity, as stated in Note 10. These instruments, primarily used to hedge market price risks for crude oil, natural gas, and refined products, were recorded at fair value with gains/losses reflected in earnings. The company’s internal Risk Control group monitored these derivatives daily, ensuring compliance with risk management policies, while fair value measurements relied on observable market data (Level 1 and Level 2 inputs) as detailed in Note 9. The changes in fair value of derivatives in 2023 were not material, and the Value-at-Risk (VaR) exposure was similarly immaterial, underscoring effective risk mitigation aligned with Chevron’s strategic objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron's use of derivative commodity instruments had an immaterial (i.e., not material) impact on financial position, results of operations, and liquidity in 2023. This is consistent with the original answer. (2) Quantitative accuracy is perfect—no specific dollar amounts are provided in either answer, but the characterization of fair value changes and VaR exposure as 'not material' or 'immaterial' matches the ground truth. The mention of Level 1 and Level 2 inputs from Note 9 and risk monitoring via the Risk Control group and Audit Committee are contextually appropriate and factually sound, even if the original answer does not cite specific note numbers. (3) Multi-hop reasoning is strong: the LLM correctly synthesizes information across risk management practices, fair value accounting, internal controls, and financial impact. It adds slightly more detail (e.g., VaR, hedge purposes, valuation levels) that are consistent with typical 10-K disclosures and plausibly part of the source data. (4) The only minor gap is that the original answer explicitly mentions Audit Committee review of compliance, while the LLM mentions compliance monitoring but does not specify the Audit Committee’s role—this is a small omission but does not undermine the overall correctness. Wording differs slightly (e.g., 'immaterial' vs 'no material impact'), but these are semantically equivalent. The answer is fully relevant and addresses all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 427,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, considering both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital?",
      "original_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is $1.261 billion. This includes a $720 million benefit from AOCI related to the CECL capital transition provisions and a $541 million incremental allowance for credit losses on certain assets associated with First Republic, which is included in Tier 2 capital and impacts CET1 capital through regulatory capital calculations.",
      "llm_answer": "\n\nThe total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is a **net benefit of $720 million** from the allowance for credit losses included in CET1 capital adjustments (primarily through AOCI). Additionally, the CECL provisions contributed to a **$20.99 billion allowance for credit losses eligible for inclusion in Tier 2 capital**, though this amount does not directly affect CET1 capital itself. Thus, the direct impact on CET1 capital is the $720 million benefit.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in both magnitude and composition of the total impact. The ground truth states the total impact is $1.261 billion, composed of a $720 million AOCI benefit and a $541 million incremental allowance from First Republic included in Tier 2 capital that affects CET1 through regulatory calculations. The LLM incorrectly reports the total impact as only the $720 million AOCI benefit, omitting the $541 million component entirely. Furthermore, it introduces a fabricated figure of $20.99 billion for allowance in Tier 2 capital, which is not present in the original answer and has no apparent basis in the provided data. (2) Quantitative accuracy is very low: the key number ($1.261 billion) is missing, the $541 million component is ignored, and a spurious $20.99 billion figure is introduced. The only correct number is the $720 million AOCI benefit. (3) The multi-hop reasoning fails: the model does not synthesize the two components (AOCI benefit + Tier 2 allowance impact) into a total effect on CET1 capital. Instead, it incorrectly treats the Tier 2 allowance as having no impact on CET1, contradicting the original answer’s explanation that it does affect CET1 through regulatory capital calculations. (4) Contextual relevance is moderate because the answer discusses the correct topic (CECL impact on CET1), mentions AOCI and Tier 2 capital, and references the correct company and date, but it fundamentally misrepresents the mechanism and magnitude of the impact. The introduction of an unsupported large dollar amount severely undermines factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 443,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the total financial impact on GE from its AerCap-related transactions in 2023, considering both the net income contribution and the realized/unrealized gains or losses during that year?",
      "original_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 was $2,654 million, combining the net income attributable to GE of $2,525 million and the realized/unrealized gain of $129 million in 2023.",
      "llm_answer": "\n\nThe total financial impact on GE from its AerCap-related transactions in 2023 was **$2,654 million**. This includes:  \n- **Net income contribution** of $2,525 million attributable to GE from AerCap (as disclosed in Note 26, reflecting AerCap’s net income despite the sale of GE’s equity interest in November 2023).  \n- **Realized/unrealized gains** of $129 million from the investment in and note with AerCap (as detailed in Note 19).  \n\nThese figures collectively represent the combined effect on GE’s financial results for 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the net income contribution of $2,525 million and the realized/unrealized gains of $129 million are correctly stated, and their sum ($2,525M + $129M = $2,654M) is accurate. The total financial impact of $2,654 million is correctly reported. Minor formatting differences (e.g., 'million' vs 'M') are acceptable and do not affect correctness. (2) The answer is complete, addressing both components of the question: the net income contribution and the gains/losses from AerCap-related transactions in 2023. (3) Entity accuracy is correct—GE and AerCap are properly identified, and the time frame (2023) is accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: the answer draws on specific disclosures (Note 26 and Note 19) to justify the figures, indicating correct integration of information across different parts of the financial statements. (5) The semantic meaning is equivalent to the original answer, with added clarity from citation of notes, which enhances rather than distorts accuracy. All scoring categories warrant the highest rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 334,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total consideration did Merck transfer in its acquisition of Immune Design, and what portion of this amount was allocated to goodwill, based on the fair value of net assets acquired?",
      "original_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Out of this, $20 million was allocated to goodwill, as it represented the excess of the consideration transferred over the fair value of net assets acquired.",
      "llm_answer": "\n\nMerck transferred a total consideration of $301 million in its acquisition of Immune Design. Based on the fair value of net assets acquired, $20 million of this amount was allocated to goodwill. \n\n**Source Reference**: The document states that Merck recognized intangible assets of $156 million, cash of $83 million, and other net assets of $42 million, with the excess consideration over the fair value of net assets ($301M - ($156M + $83M + $42M)) resulting in $20 million recorded as goodwill.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total consideration of $301 million and the $20 million allocated to goodwill are accurately reported. The calculation in the source reference is correct: fair value of net assets = $156M (intangible assets) + $83M (cash) + $42M (other net assets) = $281M; excess = $301M - $281M = $20M, which matches the goodwill amount. (2) The answer is complete, addressing both parts of the question: total consideration and the portion allocated to goodwill. (3) Entities (Merck, Immune Design) and financial terms (goodwill, fair value of net assets) are correctly identified. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by referencing the components of net assets and deriving goodwill as the residual. The explanation adds contextual clarity without introducing errors. Semantic equivalence is maintained with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 274,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What specific financial contributions do franchisees make to McDonald's revenue, and how does the co-investment by McDonald's in franchisee restaurant improvements impact the depreciation expense recorded by the Company?",
      "original_answer": "Franchisees contribute to McDonald's revenue primarily through the payment of rent (including minimum rent payments) and royalties based on a percentage of sales, along with initial fees upon the opening of a new restaurant or grant of a new franchise. McDonald's may co-invest with franchisees to fund restaurant improvements, where it generally manages the project and provides upfront funding. During these co-investment projects, McDonald's estimates which costs are its responsibility and which belong to the franchisee, allocating costs between Property and equipment and Accounts Receivable. Upon project completion, final cost allocations may result in immaterial adjustments to balances and associated depreciation expense, directly impacting the Company's financial statements.",
      "llm_answer": "\n\nFranchisees contribute to McDonald's revenue through **initial fees** upon opening a restaurant, **royalties** (a percentage of sales), and **minimum rent payments** as stipulated in franchise agreements. These fees are outlined in the \"Business Summary\" and \"Revenue Recognition\" sections of the document. \n\nWhen McDonald's co-invests in franchisee restaurant improvements, the Company **capitalizes its share of the costs** as property and equipment. This increases the depreciable asset base, leading to higher **depreciation expense** over the assets' useful lives (up to 40 years for buildings, 3–12 years for equipment). The \"Property and Equipment\" footnote explains that co-investment costs are allocated between property/equipment (impacting depreciation) and accounts receivable, with depreciation recognized using the straight-line method. Thus, co-investments directly elevate McDonald's depreciation expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key financial contributions from franchisees: initial fees, royalties based on sales percentage, and minimum rent payments—matching the original answer exactly in substance. (2) Regarding co-investment, the LLM accurately explains that McDonald's capitalizes its share of improvement costs as property and equipment, which increases the depreciable base and thus leads to higher depreciation expense over time. It correctly references the allocation between property/equipment and accounts receivable, and notes the use of straight-line depreciation, all of which are consistent with the ground truth. (3) The multi-hop reasoning is sound: it connects franchisee payments to revenue streams and links co-investment to asset capitalization and subsequent impact on depreciation—a correct synthesis across financial concepts. (4) Minor point: the original answer emphasizes that final cost allocations post-completion may lead to *immaterial adjustments* to depreciation, suggesting the impact is often small and adjusted after the fact, whereas the LLM implies a direct and potentially larger ongoing increase. This nuance is missing but does not invalidate the overall correctness. No numeric inaccuracies; all statements are factually supported and semantically equivalent to the ground truth. Hence, high scores across all dimensions with a slight deduction in qualitative accuracy for missing the 'immaterial adjustments' nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 420,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "By how much did the value of Goldman Sachs' securities backed by real estate decrease from December 2023 to December 2024, and what was a primary cause of unrealized losses on Level 3 investments in 2023 related to this category?",
      "original_answer": "The value of Goldman Sachs' securities backed by real estate decreased by $120 million, from $689 million in December 2023 to $569 million in December 2024. A primary cause of unrealized losses on Level 3 investments in 2023 was weakness in the commercial real estate market, which specifically affected securities backed by real estate.",
      "llm_answer": "\n\nThe value of Goldman Sachs' securities backed by real estate decreased by **$120 million** from December 2023 ($689 million) to December 2024 ($569 million). The primary cause of unrealized losses on Level 3 investments in 2023 related to this category was **ongoing weakness in the commercial real estate market**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $120 million decrease in value of Goldman Sachs' securities backed by real estate from December 2023 ($689 million) to December 2024 ($569 million), which matches the ground truth exactly. The calculation (689 - 569 = 120) is accurate. (2) The primary cause of unrealized losses on Level 3 investments in 2023 is correctly attributed to 'ongoing weakness in the commercial real estate market,' which is semantically equivalent to the ground truth's 'weakness in the commercial real estate market'—the addition of 'ongoing' does not alter the factual meaning. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across time periods (2023 to 2024) and links the market condition to its impact on Level 3 investments, specifically those backed by real estate. (4) All entities—Goldman Sachs, securities backed by real estate, Level 3 investments, and the relevant time frame—are accurately identified and correctly contextualized. The answer is fully complete, factually precise, and contextually appropriate, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 322,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much additional cost did American Tower incur beyond the principal amount when repaying the CoreSite Debt, and how does this compare to the previously reported outstanding balance as of December 31, 2021?",
      "original_answer": "American Tower incurred an additional $87.9 million beyond the principal amount when repaying the CoreSite Debt, which includes $80.1 million in prepayment consideration and $7.8 million in accrued interest. This repayment was based on the $875 million principal amount outstanding as of December 31, 2021, which had increased to a total redemption price of $962.9 million due to these additional costs.",
      "llm_answer": "\n\nAmerican Tower incurred an additional cost of **$87.9 million** beyond the principal amount when repaying the CoreSite Debt, comprising **$80.1 million in prepayment consideration** and **$7.8 million in accrued interest**. This total additional cost represents approximately **9.2%** of the previously reported outstanding balance of **$955.1 million** as of December 31, 2021.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the additional cost of $87.9 million, broken down into $80.1 million in prepayment consideration and $7.8 million in accrued interest, which matches the ground truth. However, it incorrectly states the previously reported outstanding balance as of December 31, 2021, as $955.1 million, whereas the ground truth specifies the principal amount was $875 million. This is a significant factual error. The LLM also introduces a percentage (9.2%) that is not present in the original answer and is based on incorrect figures—while $87.9M is indeed ~9.2% of $955.1M, the correct context should be that $87.9M in additional costs was added to the $875M principal, resulting in a total redemption price of $962.9M. The reasoning is partially sound and the structure addresses both parts of the question, but the use of an incorrect base balance undermines quantitative accuracy. Entity names (American Tower, CoreSite Debt), time period (December 31, 2021), and cost components are accurate. The answer remains contextually relevant and well-structured, but the core financial figure mismatch reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 323,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much did GE's collections from CFM International contribute to the change in cash impacts from current receivables in 2024, and what was the nature of GE's business relationship with CFM International that supported this financial interaction?",
      "original_answer": "GE reported that increased collections from CFM International partially offset a $(0.9) billion impact from current receivables in 2024. CFM International is a non-consolidated equity method investee jointly owned by GE and Safran Aircraft Engines, and GE makes substantial sales of parts and services to CFM International, which explains the significant receivables relationship.",
      "llm_answer": "\n\nGE's collections from CFM International contributed to a **$0.9 billion decrease in current receivables** in 2024, as noted in the cash impacts from working capital changes. The nature of GE's business relationship with CFM International is a **joint venture partnership**, where GE, through its Commercial Engines & Services segment, provides substantial sales of parts and services to CFM International, a non-consolidated entity jointly owned with Safran Aircraft Engines. This collaboration involves ongoing supply chain and service interactions, reflecting their strategic alignment in aerospace engine production and maintenance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $0.9 billion figure is correct and correctly framed as a decrease in current receivables due to collections from CFM International, matching the original answer's reference to a $(0.9) billion impact. The sign convention (decrease in receivables improving cash flow) is appropriately interpreted. (2) The entity identification is accurate: CFM International is correctly described as a joint venture between GE and Safran Aircraft Engines, and the business relationship—GE supplying parts and services—is faithfully represented. (3) The reasoning is sound: the LLM correctly infers that collections from a major customer (CFM) would reduce receivables and positively affect cash flow, and links this to the nature of the equity-method joint venture. (4) The only minor shortcoming is that the LLM does not explicitly state that CFM is a 'non-consolidated equity method investee,' a technical but important accounting designation mentioned in the original answer. While implied by 'joint venture,' the precise terminology is slightly softened. However, the core financial and operational dynamics are correctly captured. Wording differences are semantically equivalent and do not detract from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 361,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments?",
      "original_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case was $276 million, as stated in the detailed variance drivers for the year ended December 31, 2023.",
      "llm_answer": "\n\nThe total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, including prior year deferrals and current year pricing adjustments, was a **$145 million increase**. This amount is explicitly stated in the Duke Energy Ohio operating revenues section of the 10-K filing, attributing the growth to these specific regulatory actions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states a $145 million increase, while the ground truth specifies $276 million, making the core financial figure incorrect. This is a significant quantitative error that undermines the answer's factual accuracy. (2) The number $145 million does not match the ground truth of $276 million, and no calculation or source alignment justifies this discrepancy. The correct amount was explicitly stated in the 10-K as $276 million for the combined impact of Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, including both prior year deferrals and current year pricing adjustments. (3) While the LLM correctly identifies the relevant entities—Duke Energy, Ohio tax reform deferrals, and the electric rate case—and attempts to address the multi-hop nature of the question by combining regulatory impacts, it fails in synthesizing the correct magnitude of the impact. The reasoning appears sound on the surface but is based on an incorrect data point. (4) The contextual relevance is high because the answer addresses the right companies, regulatory events, and time period (2023), and correctly interprets the nature of the financial impact (increase due to regulatory actions). However, the severe quantitative inaccuracy results in a low correctness score, as financial figures are central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 376,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total revenue did Adobe's Digital Media segment generate in fiscal 2021, and what percentage of this revenue came from Creative Cloud and Document Cloud individually, based on the specific figures disclosed in the 10-K filing?",
      "original_answer": "Adobe's Digital Media segment generated $11.52 billion in revenue in fiscal 2021. Of this, Creative Cloud contributed $9.55 billion (83%) and Document Cloud contributed $1.97 billion (17%).",
      "llm_answer": "\n\nAdobe's Digital Media segment generated **$11.52 billion** in fiscal 2021. Of this, **Creative Cloud contributed $9.55 billion (82.9%)** and **Document Cloud contributed $1.97 billion (17.1%)**, as disclosed in the 10-K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. The total Digital Media revenue of $11.52 billion is correct. Creative Cloud's contribution of $9.55 billion and Document Cloud's $1.97 billion are both accurate. The percentages are calculated correctly: 9.55 / 11.52 ≈ 82.9% and 1.97 / 11.52 ≈ 17.1%, which the model reports with one decimal place. The original answer rounds these to 83% and 17%, so the discrepancy is due to rounding and does not constitute a factual error. The model correctly identifies the entities (Adobe, Digital Media segment, Creative Cloud, Document Cloud), fiscal year (2021), and metric (revenue). It synthesizes the information properly across the required components. The answer is complete, addressing both total revenue and the individual contributions with percentages. The reasoning is sound and the semantic meaning is equivalent to the ground truth. The only minor difference is the precision of percentage rounding, which does not affect correctness. Thus, the answer deserves a 9/10 due to the slight presentation difference in rounding, though the calculations are mathematically accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 327,
        "total_tokens": 1454
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments?",
      "original_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $722 million. This includes a $222 million increase in advertising expenses from the marketing department and a combined $500 million increase in personnel-related costs, with $116 million from marketing and $384 million from technology departments.",
      "llm_answer": "\n\nThe total increase in combined advertising and personnel-related costs for NFLX in 2021 was **$722 million**. This includes a **$222 million rise in advertising expenses** (from the Marketing section) and **$116 million in marketing personnel costs** (Marketing) plus **$384 million in technology personnel costs** (from the Technology and Development section), driven by headcount growth in both departments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $722 million total increase, $222 million in advertising expenses, $116 million in marketing personnel costs, and $384 million in technology personnel costs. These figures exactly match the original answer. (2) The quantitative accuracy is perfect—each component is correctly identified and the sum ($222M + $116M + $384M = $722M) is implicitly correct. (3) The multi-hop reasoning is sound: the model correctly attributes advertising expenses to the marketing department and separates personnel-related cost increases between marketing and technology departments due to headcount growth, as required by the question. (4) The answer is contextually relevant and complete, addressing all parts of the question—total increase, advertising expenses, and personnel costs linked to headcount growth in both specified departments. Wording differs slightly but maintains semantic equivalence. No errors in entities, years, or financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 299,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does General Motors' equity earnings from Ultium Cells Holdings LLC influence its Automotive and other cost of sales, and what does this indicate about the financial treatment of this stake in relation to its electric vehicle production strategy?",
      "original_answer": "General Motors reports equity earnings from Ultium Cells Holdings LLC within its Automotive and other cost of sales, indicating that the entity is integral to its electric vehicle (EV) production strategy. This financial treatment shows that GM views its stake in Ultium Cells as a core operational component rather than a separate investment, aligning its battery cell supply directly with its automotive cost structure to support EV manufacturing.",
      "llm_answer": "\n\nGeneral Motors' equity earnings from Ultium Cells Holdings LLC are included in **Automotive and other cost of sales** rather than reported as separate equity income. This reflects the integral role of Ultium Cells in GM’s electric vehicle (EV) production strategy, as the joint venture supplies battery cells critical to GM’s EV manufacturing. By classifying these earnings within cost of sales, GM emphasizes the operational synergy and vertical integration of Ultium Cells, treating it as a core component of its EV value chain rather than a discrete investment. This accounting treatment underscores GM’s strategic focus on controlling battery production costs and aligning financial reporting with its long-term EV growth objectives.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that General Motors includes equity earnings from Ultium Cells Holdings LLC within 'Automotive and other cost of sales,' which matches the original answer's key factual claim. There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable beyond correct use of financial terminology, which is accurate. (2) The answer addresses all parts of the multi-hop question: it explains the financial treatment (classification within cost of sales), identifies the entity (Ultium Cells Holdings LLC), and interprets the strategic implication (integration into EV production strategy). (3) Entity accuracy is correct—General Motors and Ultium Cells Holdings LLC are properly named and contextualized. (4) The reasoning is sound: the LLM correctly infers that this accounting treatment reflects operational integration and vertical alignment with EV manufacturing, indicating that the joint venture is treated as a core part of the value chain rather than a passive investment. The conclusion about strategic focus on controlling battery costs and aligning financial reporting with EV objectives enhances the original answer without introducing inaccuracies. All elements demonstrate precise understanding and synthesis across financial reporting and strategic intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 387,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the percentage decrease in the average price of U.S. Henry Hub natural gas in 2023 compared to 2022, and how did this price trend compare to Chevron's international natural gas realizations during the same period?",
      "original_answer": "The average price of U.S. Henry Hub natural gas decreased by 59.8% from $6.36 per MCF in 2022 to $2.56 per MCF in 2023. Chevron's international natural gas realizations also declined, but at a more moderate rate of 21.1%, from $9.75 per MCF in 2022 to $7.69 per MCF in 2023. This indicates that the drop in U.S. natural gas prices was significantly steeper than the decline in international prices, which are often linked to crude oil benchmarks.",
      "llm_answer": "\n\nThe average price of U.S. Henry Hub natural gas decreased by **59.7%** in 2023 compared to 2022 (from $6.36 to $2.56 per thousand cubic feet). Chevron's international natural gas realizations declined by **21%** during the same period (from $9.75 to $7.69 per thousand cubic feet). This indicates that while both U.S. and international natural gas prices fell, the U.S. price drop was significantly steeper, driven by high storage levels and strong domestic production, whereas international prices were less volatile due to long-term LNG contracts tied to crude oil benchmarks.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. The percentage decrease in U.S. Henry Hub natural gas price is reported as 59.7%, which is a minor rounding difference from the ground truth 59.8%. The calculation from $6.36 to $2.56 yields a 59.76% decrease, which rounds to 59.8%—thus, 59.7% is very close but slightly inaccurate due to rounding. Chevron's international realization decline is correctly stated as 21% (ground truth: 21.1%), again a negligible rounding difference. The dollar amounts ($6.36, $2.56, $9.75, $7.69 per MCF) are all accurate. (2) Quantitative verification: (6.36 - 2.56) / 6.36 = 0.5975 ≈ 59.8%; (9.75 - 7.69) / 9.75 = 0.2113 ≈ 21.1%. LLM reports 59.7% and 21%, which are acceptable but not perfectly precise. (3) Multi-hop reasoning is sound: the model correctly compares U.S. Henry Hub prices to Chevron’s international realizations, synthesizing data across markets and entities. It accurately concludes that the U.S. price drop was steeper and provides correct contextual drivers (domestic production, storage, oil-linked LNG contracts). (4) Scores reflect near-perfect accuracy: minor rounding in percentages prevents a 10, but all core facts, entities, and logic are correct. Qualitative and contextual scores are 10 due to excellent synthesis and explanatory depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 370,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does Goldman Sachs' sensitivity of fair value measurements to changes in credit spreads impact the valuation of its level 3 credit derivatives, given the range of credit spreads and recovery rates used as significant unobservable inputs?",
      "original_answer": "Goldman Sachs' fair value of level 3 credit derivatives is directly impacted by changes in credit spreads and recovery rates. Specifically, the fair value of purchased credit protection increases when credit spreads or upfront credit points increase or when recovery rates decrease. This directional sensitivity is compounded by the broad variability in the underlying risk factors across different reference obligations, such as leverage, volatility, industry, borrowing costs, and macroeconomic conditions, which contribute to the wide range of credit spreads and recovery rates used as inputs in the valuation models.",
      "llm_answer": "\n\nGoldman Sachs' Level 3 credit derivatives are highly sensitive to changes in credit spreads and recovery rates, which are key unobservable inputs. As of December 2024, credit spreads ranged from **8 to 1,328 basis points** (average: 134 bps, median: 91 bps), while recovery rates ranged from **20% to 70%** (average: 46%, median: 50%). The firm notes that the fair value of purchased credit protection **increases as credit spreads widen or recovery rates decrease**, reflecting higher perceived credit risk. For example, a widening of credit spreads (e.g., due to economic downturns or issuer-specific risks) would directly elevate the fair value of these derivatives, while higher recovery rates (indicating stronger collateral or repayment capacity) would reduce their value. This sensitivity underscores the material impact of market conditions and counterparty creditworthiness on Level 3 valuations, given the absence of observable market data for these inputs.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the directional sensitivity of Goldman Sachs' Level 3 credit derivatives to credit spreads and recovery rates, aligning with the ground truth: fair value of purchased credit protection increases with wider credit spreads and lower recovery rates. The reasoning about macroeconomic and issuer-specific drivers (leverage, volatility, industry, etc.) is logically sound and contextually appropriate, demonstrating good qualitative accuracy and full contextual relevance. However, the quantitative accuracy is compromised because the original answer (ground truth) does not include specific numerical ranges for credit spreads (8–1,328 bps) or recovery rates (20%–70%), nor does it mention averages, medians, or a December 2024 date. These specific figures and time references are hallucinated or inserted without support from the provided ground truth, which only describes the general sensitivity and variability of inputs without citing exact data ranges. Since the question does not ask for specific numbers and the ground truth does not contain them, their inclusion with false precision reduces quantitative accuracy. The core conceptual and multi-hop reasoning—linking unobservable inputs to valuation impact via firm-specific risk factors—is correct, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 368,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the repayment of CoreSite Debt in January 2022 impact AMT's capital structure, and what does the alignment between the repayment amount and the carrying value of $955.1 million indicate about the valuation of this debt on AMT's balance sheet?",
      "original_answer": "The repayment of CoreSite Debt in January 2022, which totaled $955.1 million, directly reduced AMT's long-term obligations, thereby improving its debt-to-equity ratio and overall capital structure by eliminating a significant portion of its liabilities. The fact that the repayment amount matches the carrying value of $955.1 million, as disclosed in the detailed debt schedule, indicates that the debt was carried at its fair value or close to its redemption value on the balance sheet, suggesting minimal unamortized discounts or premiums on this debt at the time of repayment.",
      "llm_answer": "\n\nThe repayment of CoreSite Debt in January 2022 reduced AMT's total liabilities by eliminating $955.1 million in debt, improving its capital structure by decreasing leverage. The alignment between the repayment amount ($962.9 million, including $80.1 million prepayment consideration and $7.8 million accrued interest) and the carrying value of $955.1 million indicates that the debt was recorded on AMT’s balance sheet at its fair value upon acquisition, with no significant discounts or premiums. This suggests the valuation accurately reflected the expected repayment amount, excluding transaction-specific costs like prepayment fees.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states the repayment amount was $955.1 million, which matched the carrying value. However, the LLM claims the repayment was $962.9 million, including $80.1 million prepayment consideration and $7.8 million accrued interest, which contradicts the original answer. These figures are not present in the ground truth and introduce false details. The correct repayment amount is $955.1 million—no additional components are mentioned. (2) The calculation implied by the LLM—$955.1M + $80.1M + $7.8M = $962.9M—is unsupported and factually incorrect based on the provided truth. There is no mention of prepayment fees or accrued interest in the original answer, so including them misrepresents the transaction. (3) Qualitatively, the reasoning about capital structure improvement and reduced leverage is sound and aligns with the original answer. The interpretation that matching repayment and carrying value suggests minimal discounts/premiums and fair value accounting is logically correct and reflects appropriate multi-hop reasoning between balance sheet valuation and repayment terms. (4) Contextually, the answer addresses both parts of the question: impact on capital structure and implications for debt valuation. While the conceptual framework is relevant and well-structured, the introduction of incorrect financial figures severely undermines factual accuracy. Thus, the correctness score is low due to major numerical errors, despite acceptable reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 430,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How might the potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing practices impact Adobe's financial position, given the range of estimated potential decreases in unrecognized tax benefits and the company's established reserves?",
      "original_answer": "The potential adjustments from ongoing tax examinations focusing on Adobe's intercompany transfer pricing practices could have an adverse effect on Adobe's financial position. Adobe has estimated a range of potential decreases in unrecognized tax benefits of up to $5 million over the next 12 months. These adjustments could result in increased tax liabilities, which would directly impact Adobe's consolidated financial statements. Adobe has established reserves to address potential exposures from tax audits, but due to the high uncertainty surrounding the timing and outcome of these examinations, the actual adjustments could exceed these reserves, leading to significant fluctuations in tax assets and liabilities on the balance sheet.",
      "llm_answer": "\n\nThe potential adjustments from ongoing tax examinations related to intercompany transfer pricing practices could impact Adobe's financial position by reducing unrecognized tax benefits, with estimated potential decreases ranging from $0 to approximately $5 million over the next 12 months. Adobe has established reserves for these potential adjustments, and while the company believes its estimates are reasonable, any final audit outcomes could result in additional tax liabilities or reductions to reserves, affecting its provision for income taxes and cash flows. However, the range of potential adjustments is relatively limited, suggesting the impact is unlikely to be material to Adobe's overall financial position.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative figure — the estimated potential decrease in unrecognized tax benefits of up to $5 million over the next 12 months — which matches the ground truth. The phrasing 'ranging from $0 to approximately $5 million' is semantically equivalent to 'up to $5 million' and is acceptable. However, the LLM introduces a nuance not present in the original — that the impact is 'unlikely to be material' — which is an interpretive judgment not supported in the ground truth. The original emphasizes potential adverse effects and uncertainty that could lead to 'significant fluctuations,' whereas the LLM downplays the impact, which alters the qualitative conclusion. (2) All numbers are accurate: $5 million range, 12-month timeframe, and correct reference to unrecognized tax benefits and reserves. No calculation errors. (3) The multi-hop reasoning is partially sound — the model correctly links transfer pricing audits to unrecognized tax benefits, reserves, and financial statement impacts. However, it fails to fully convey the risk that actual adjustments could exceed reserves due to high uncertainty, a key point in the original answer. This omission weakens the synthesis of risk implications. (4) Scores reflect high factual accuracy in numbers and entities (Adobe, transfer pricing, reserves, tax benefits), but a moderate deduction in qualitative accuracy due to the misleading minimization of financial impact. Contextual relevance remains high as all core elements of the question are addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 430,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020, and how does this growth relate to Merck's broader oncology strategy as exemplified by Keytruda's combination therapies?",
      "original_answer": "The alliance revenue related to Lenvima grew by 21% in 2021 and 44% in 2020, resulting in a combined growth of 65% over the two years. This growth is aligned with Merck's broader oncology strategy, which emphasizes combination therapies to expand indications and improve patient outcomes. For instance, Keytruda is approved in combination with Lenvima for the treatment of certain patients with endometrial carcinoma and renal cell carcinoma (RCC), demonstrating Merck's focus on leveraging synergies between its oncology assets to drive revenue and therapeutic innovation.",
      "llm_answer": "\n\nThe combined growth percentage of alliance revenue related to Lenvima was **21% in 2021** and **44% in 2020**. This growth is tied to Merck's broader oncology strategy of expanding Keytruda's therapeutic applications through combination therapies. The document highlights multiple 2021 FDA and EC approvals for Keytruda in combination with Lenvima for advanced endometrial carcinoma, renal cell carcinoma (RCC), and other cancers. These partnerships (e.g., with Eisai for Lenvima) align with Merck's focus on leveraging combination regimens to enhance efficacy, broaden Keytruda's market reach, and generate revenue through alliances, reflecting a strategic emphasis on collaborative innovation in oncology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the alliance revenue growth percentages for Lenvima as 21% in 2021 and 44% in 2020, matching the ground truth exactly. However, while the individual yearly growth rates are accurate, the LLM did not explicitly calculate or state the combined growth of 65% over the two years, which is a required part of the question. This is a minor omission in completeness but does not affect the correctness of the provided data. (2) All numeric values—21% and 44%—are factually correct and properly attributed to the right years. The calculation of combined growth (21 + 44 = 65%) is straightforward, and though the model omits the sum, the components are present, allowing for easy inference. (3) The multi-hop reasoning is sound: the model correctly links Lenvima revenue growth to Merck’s oncology strategy centered on Keytruda combination therapies. It accurately references FDA and EC approvals for Keytruda + Lenvima in endometrial carcinoma and RCC, demonstrating proper synthesis across entities (Merck, Eisai, Lenvima, Keytruda) and therapeutic areas. (4) The answer is contextually excellent—highly relevant, well-structured, and semantically aligned with the ground truth. The only reason for not scoring a 10 is the missing explicit mention of the 65% combined growth, which is a small but notable gap in completeness. Thus, scores reflect near-perfect accuracy with minor room for improvement in full synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 403,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did GM's investment in Ultium Cells Holdings LLC in 2024 directly impact its EBIT-adjusted performance, and by how much was this contribution quantified?",
      "original_answer": "GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings, which directly increased GM's EBIT-adjusted performance in 2024. This favorable cost impact was explicitly noted as part of the EBIT-adjusted improvement due to increased equity earnings from Ultium Cells Holdings LLC.",
      "llm_answer": "\n\nGM's investment in Ultium Cells Holdings LLC in 2024 directly positively impacted its EBIT-adjusted performance through increased equity earnings of **$0.7 billion**. This contribution is explicitly noted in the analysis of GM North America's (GMNA) EBIT-adjusted results, where it offset other cost pressures and contributed to the overall $2,222 million year-over-year increase in GMNA's EBIT-adjusted.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings, which directly improved EBIT-adjusted performance in 2024—this matches the ground truth exactly. The dollar amount is accurate and correctly attributed to equity earnings impacting EBIT-adjusted. (2) Quantitatively, the $0.7 billion figure is correct and matches the original answer. The additional context about a $2,222 million year-over-year increase in GMNA's EBIT-adjusted is consistent with external data and does not contradict the ground truth; it adds contextual detail without introducing error. (3) The multi-hop reasoning is sound: the model correctly links GM's investment to equity earnings and then to EBIT-adjusted performance, demonstrating proper synthesis across financial cause and effect. The only minor limitation is that the $2,222 million figure, while plausible, is not present in the ground truth and slightly extends beyond the provided information, though it does not detract from factual correctness. (4) Scores reflect near-perfect alignment with the original answer—full quantitative accuracy, excellent contextual relevance, and strong qualitative reasoning with only a slight over-addition of external-seeming detail preventing a perfect 10 in qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 375,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the SEC's monthly short position reporting requirement for institutional investment managers, effective January 2025, interact with Goldman Sachs' regulatory obligations as a registered security-based swap dealer to influence its derivatives reporting practices?",
      "original_answer": "The SEC's monthly short position reporting requirement, applicable to institutional investment managers meeting specified thresholds starting in January 2025, complements Goldman Sachs' existing obligations as a registered security-based swap dealer. As a registered dealer, Goldman Sachs must comply with SEC rules on capital, margin, record-keeping, business conduct, and regulatory trade reporting. The new short position reporting rule adds another layer of transparency and accountability, requiring Goldman Sachs to ensure that its short position data in equity securities is accurately reported monthly. This enhances the firm's existing reporting practices by aligning them with broader SEC oversight goals, particularly in monitoring large positions and short-selling activity in the market.",
      "llm_answer": "\n\nThe SEC's monthly short position reporting requirement for institutional investment managers, effective January 2025, adds a new layer of transparency obligations for Goldman Sachs, particularly through its asset management subsidiaries. As a registered security-based swap dealer, Goldman Sachs already complies with SEC regulations requiring detailed reporting of security-based swaps, including trade execution and risk mitigation disclosures. The new short position rule will necessitate enhanced systems and controls to aggregate and report short equity positions monthly, which may overlap with derivatives activities (e.g., short positions in equity swaps). This dual obligation will likely drive Goldman Sachs to integrate short position data into its existing derivatives reporting frameworks, ensuring alignment with both the SEC’s security-based swap dealer requirements and the new short position transparency mandate. The firm may also need to refine risk management processes to address cross-asset reporting consistency and compliance with accelerated disclosure timelines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the January 2025 effective date for the SEC's monthly short position reporting requirement is correctly cited, and Goldman Sachs' status as a registered security-based swap dealer is accurately noted. There are no numerical inaccuracies, and while no specific dollar amounts or percentages are involved, the temporal and regulatory details are precise. (2) The answer correctly identifies that the new short position reporting rule applies to institutional investment managers, and appropriately extends its relevance to Goldman Sachs' asset management subsidiaries, which may fall under that category. It also accurately describes the firm’s existing obligations under security-based swap dealer rules, including trade reporting, risk mitigation, and record-keeping. (3) The multi-hop reasoning is sound: the LLM synthesizes the new short position rule with Goldman’s existing derivatives reporting duties, noting potential overlaps in equity swaps and the need for integrated reporting systems. It logically infers that the firm will enhance data aggregation and align frameworks across regulatory domains. (4) The only minor deviation from the original answer is the emphasis on 'asset management subsidiaries' as the primary conduit for the short position rule, whereas the ground truth frames compliance more broadly at the firm level. However, this is a reasonable interpretation and does not constitute a factual error. The LLM also adds value by discussing implications for risk management and cross-asset consistency, which are plausible extensions of the regulatory interaction. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 489,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the financial impact on PepsiCo from the remeasurement of its 39% noncontrolling interest in TBG at fair value following the sale of its juice brands, and how does this reflect the structure of the transaction involving both cash and retained equity?",
      "original_answer": "PepsiCo recorded a $520 million gain from the remeasurement of its 39% ownership in TBG at fair value following the sale of its Tropicana, Naked, and other select juice brands to PAI Partners for approximately $3.5 billion in cash. This gain reflects the combination of the cash proceeds from the divestiture and the retained economic interest through the 39% noncontrolling stake, which was valued using a combination of the transaction price, discounted cash flows, and an option pricing model. The structure of the transaction allowed PepsiCo to realize immediate value while maintaining a financial stake in TBG’s future performance.",
      "llm_answer": "\n\nThe remeasurement of PepsiCo's 39% noncontrolling interest in Tropicana Brands Group (TBG) at fair value following the 2022 juice brands sale resulted in a **$520 million gain in 2022**. This gain was calculated using the transaction price, discounted cash flows, and an option pricing model tied to PepsiCo’s liquidation preference in TBG. The transaction structure combined **$3.5 billion in cash proceeds** with PepsiCo retaining a 39% equity stake, reflecting a partial divestiture that allowed PepsiCo to maintain economic exposure to the juice business while recognizing immediate cash proceeds and a fair-value-adjusted equity interest. The retained equity interest is accounted for under the equity method, impacting PepsiCo’s income proportionally based on TBG’s performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $520 million gain, 39% retained stake, $3.5 billion cash proceeds, and the use of fair value remeasurement via transaction price, discounted cash flows, and an option pricing model. The year 2022 is correctly inferred and consistent with the transaction timing. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and the gain amount match the original answer exactly, with acceptable formatting (e.g., $520 million vs $520M). (3) The reasoning is sound and captures the multi-hop nature of the question—linking the sale of juice brands, the cash proceeds, the retained equity, and the accounting treatment (remeasurement gain under fair value). The mention of equity method accounting and PepsiCo’s ongoing economic exposure adds valuable context not explicitly in the original but factually correct and enhancing. (4) The only minor shortcoming is that the original specifies the buyer (PAI Partners) and lists the brands (Tropicana, Naked), which the LLM omits—this slightly reduces completeness but does not detract from the core financial impact explanation. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong synthesis across financial and structural dimensions of the transaction.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 376,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How much did GE's financial performance from its retained ownership interests, including its stake in Baker Hughes, contribute to its total other income in 2023, and how does this compare to 2024?",
      "original_answer": "In 2023, GE's retained and sold ownership interests contributed $5,778 million to its total other income, which included a $10 million realized and unrealized gain from its investment in Baker Hughes. In 2024, this contribution dropped significantly to $518 million, with no gain recorded from Baker Hughes. This represents a decrease of $5,260 million in contributions from these ownership interests year-over-year.",
      "llm_answer": "\n\nIn 2023, GE's retained ownership interests, including its stake in Baker Hughes, contributed **$5,778 million** to total other income, primarily driven by gains from these investments. In 2024, this contribution declined significantly to **$518 million**, reflecting the near-complete monetization of its GE HealthCare stake in 2023 and reduced activity in retained interests. The 2023 amount included a $10 million gain from Baker Hughes, while 2024 gains were largely from residual transactions. The sharp decline aligns with the sale of GE HealthCare shares in 2024, which generated $5.2 billion in proceeds but was mostly accounted for in 2023's results. \n\n(Source: NOTE 19. OTHER INCOME (LOSS) table and related disclosures.)",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the $5,778 million contribution in 2023 and $518 million in 2024, matching the ground truth. It also correctly notes the $10 million gain from Baker Hughes in 2023 and absence of such gain in 2024. However, it introduces a claim about the sale of GE HealthCare generating $5.2 billion in proceeds in 2024 and being 'mostly accounted for in 2023’s results,' which is not supported by the original answer and misrepresents the timing and accounting. This is a significant qualitative error. (2) Quantitatively, the core numbers ($5,778M, $518M, $10M) are accurate, and the implied year-over-year decrease of $5,260M is correct (5,778 - 518 = 5,260), though not explicitly stated. The $5.2 billion figure for GE HealthCare proceeds is close to the $5.26 billion implied drop but conflates different events—this introduces a calculation-related confusion despite numerical proximity. (3) The multi-hop reasoning is partially sound—correctly linking retained interests to other income and noting changes year-over-year—but incorrectly attributes the decline primarily to GE HealthCare monetization, while the ground truth emphasizes the broader category of retained and sold ownership interests (including Baker Hughes). The LLM misidentifies the cause of the decline by overemphasizing GE HealthCare, which is not mentioned in the original answer as a driver of other income in 2023. (4) Scores reflect high factual accuracy on numbers (quantitative accuracy: 8), but flawed reasoning and entity attribution (qualitative accuracy: 6), leading to a correctness score of 7 due to core data being correct but explanation containing significant misleading elements. Contextual relevance remains high as the answer directly addresses the question’s focus on year-over-year change in income from ownership interests.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 500,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What is the total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, based on the two separate disclosures in the 10-K filing, and what percentage of the total assets measured at fair value do they represent?",
      "original_answer": "The total fair value of Mortgage-Backed Obligations is $358 million ($236 million from the first disclosure and $122 million from the second). These obligations represent approximately 2.97% of the total assets measured at fair value, calculated as $358 million divided by the combined total assets of $12,079 million and $12,010 million from the two disclosures.",
      "llm_answer": "\n\nThe total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, is **$236 million**, as disclosed in both the \"Marketable Securities\" table (under \"Fair Value\") and the \"Fair Value Measurement\" section (Level 2 assets). These obligations represent **1.95%** of the total assets measured at fair value ($236M ÷ $12,079M).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in both total fair value and percentage. The ground truth states the total fair value is $358 million, combining $236 million and $122 million from two disclosures. The LLM only reports $236 million, missing the second $122 million disclosure entirely. (2) The percentage calculation is also wrong: the LLM computes $236M / $12,079M = ~1.95%, but the correct total is $358M divided by the combined total assets of $12,079M and $12,010M. The correct denominator should be $24,089M (sum of both disclosures), yielding $358M / $24,089M ≈ 1.49%, not 2.97% as stated in the original answer. However, the original answer appears to have its own error: 2.97% would require a denominator of ~$12.05 billion, suggesting it may have used an average or misstated the total. Despite this, the LLM fails to recognize the multi-disclosure requirement. (3) The multi-hop reasoning is flawed: the question explicitly refers to 'two separate disclosures,' but the LLM only uses one, failing to synthesize across both. It incorrectly claims the $236 million is disclosed in both places, when the second is $122 million. (4) Scores reflect major factual and quantitative errors (correctness 3/10), poor quantitative accuracy due to missing values and incorrect math (3/10), weak reasoning in multi-hop synthesis (3/10), and moderate relevance as it addresses the right topic but with critical omissions (6/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 400,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Netflix's strategy of offering varied membership plans across different countries contribute to the 7% increase in average monthly revenue per paying membership in 2021, and how did this impact the overall 19% revenue growth for the year?",
      "original_answer": "Netflix's strategy of offering varied membership plans tailored to different countries allowed for pricing flexibility based on regional market conditions. This approach enabled the company to implement price changes that contributed to a 7% increase in average monthly revenue per paying membership. As a result of this pricing strategy and the expansion of paying memberships by 11%, consolidated revenues grew by 19% in 2021. The ability to adjust pricing models across different regions directly supported the overall revenue growth, demonstrating how localized membership plan strategies can drive global financial performance.",
      "llm_answer": "\n\nNetflix's strategy of offering varied membership plans across countries contributed to the 7% increase in average monthly revenue per paying membership in 2021 through **price adjustments tailored to regional markets** and **favorable foreign exchange rate fluctuations**. By varying pricing (ranging from $2 to $27 per month depending on the country) and optimizing plans for local demand, Netflix captured higher revenue per member without significant subscriber attrition. This pricing strategy, combined with an 11% growth in average paying memberships (driven by international expansion), directly fueled the **19% overall revenue growth** for the year. The 7% revenue-per-member increase amplified the impact of membership growth, as higher ARPU (average revenue per user) and more members compounded to deliver the total revenue rise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 7% increase in average monthly revenue per paying membership and the 19% overall revenue growth in 2021, aligning with the ground truth. It accurately references the 11% growth in paying memberships as a contributing factor. All numeric values (7%, 19%, 11%) are correct and consistent with the original answer. The mention of pricing ranging from $2 to $27, while not in the ground truth, is plausible and does not contradict known data, so it does not detract from accuracy. (2) Quantitative accuracy is perfect: percentages match, and the logic that 7% ARPU growth combined with 11% membership growth leads to ~19% total revenue growth is mathematically sound (approx. 1.07 * 1.11 = 1.1877, or ~19%). (3) The multi-hop reasoning is strong: the model correctly synthesizes how localized pricing strategies led to higher ARPU, which in turn amplified the effect of membership growth to drive total revenue. The only minor gap is the introduction of 'favorable foreign exchange rate fluctuations' as a contributing factor, which is not mentioned in the ground truth and slightly overcomplicates the explanation, though it may be contextually plausible. This does not invalidate the answer but introduces a non-supported element. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: how varied plans led to the 7% ARPU increase and how that contributed to the 19% revenue growth. The use of terms like ARPU and clear causal logic enhances clarity. Overall, the answer is factually correct, well-reasoned, and only slightly exceeds the ground truth with a minor unsupported detail, warranting a 9/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 463,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Merck's collaboration with Eisai on Lenvima, specifically through the LEAP clinical program, influence Merck's pharmaceutical segment revenue, given the current status of key trials and alliance revenue model?",
      "original_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program influences its pharmaceutical segment revenue by shaping the future commercial potential of the Keytruda plus Lenvima combination across multiple tumor types. Although the FDA issued a CRL for the first-line treatment of unresectable HCC based on the KEYNOTE-524/Study 116 trial, Merck and Eisai are conducting the Phase 3 LEAP-002 trial to demonstrate substantial evidence of effectiveness. The discontinuation of LEAP-007 and LEAP-011 due to futility assessments negatively impacts near-term revenue potential for Lenvima combinations in NSCLC and urothelial carcinoma. However, Merck's alliance revenue model, which includes shared profits from product sales net of costs, means that if any Lenvima-based combinations gain approval and succeed commercially, Merck will receive a portion of the revenue generated. This revenue stream is integral to the Pharmaceutical segment, which includes oncology products like Keytruda and its combinations, such as with Lenvima in approved indications like endometrial carcinoma and RCC.",
      "llm_answer": "\n\nMerck's collaboration with Eisai on Lenvima through the LEAP clinical program contributes to Merck's pharmaceutical segment revenue via alliance revenue, which represents Merck's share of profits from Lenvima sales (net of costs). In 2021, alliance revenue from Lenvima was **$704 million**, reflecting the commercial success of the drug in its current indications (e.g., thyroid cancer, HCC, and RCC). The LEAP program's ongoing Phase 3 trials (e.g., LEAP-002 for HCC) could expand Lenvima's label in the future, potentially increasing revenue if new indications are approved. However, the program has faced setbacks, such as the discontinuation of LEAP-007 (NSCLC) and LEAP-011 (urothelial carcinoma) due to futility, which limits near-term growth in those areas. Thus, while the collaboration currently drives mid-to-high seven-figure annual revenue, its future impact depends on the success of remaining trials in the LEAP program.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the quantitative claim that 'alliance revenue from Lenvima was $704 million in 2021'. This figure does not appear in the ground truth and cannot be verified from the provided context; no specific revenue number is mentioned in the original answer, so introducing a precise $704M figure is incorrect and misleading. This undermines trust in the response and represents a major quantitative inaccuracy. (2) While the LLM correctly identifies the alliance revenue model—profit sharing net of costs—and notes current indications like RCC (and implicitly endometrial carcinoma), it fails to mention the approved indications for the Keytruda-Lenvima combo (endometrial carcinoma and RCC) as highlighted in the ground truth, which is key to understanding current revenue contributions. (3) The reasoning around trial outcomes is mostly sound: correctly noting the CRL for HCC based on KEYNOTE-524 and the ongoing LEAP-002 trial, as well as the discontinuation of LEAP-007 and LEAP-011 due to futility. However, the original answer emphasizes that the CRL was issued by the FDA, which the LLM omits, weakening the precision of the regulatory context. (4) The LLM incorrectly implies that Lenvima’s standalone indications (e.g., thyroid cancer, HCC) are directly contributing to Merck’s alliance revenue, but Merck only benefits from combination use with Keytruda under the collaboration—this nuance is missing, leading to a misrepresentation of the revenue model. Despite these issues, the answer is contextually relevant and captures the overall structure of the collaboration, its risks, and future dependence on trial outcomes. The qualitative reasoning is logical and synthesizes multiple aspects of the LEAP program, earning moderate scores in qualitative accuracy and high marks for relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 504,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How much did Chevron's total cost incurred by consolidated companies in 2023 exceed the combined total of expensed exploration costs and the PDC Energy, Inc. acquisition cost?",
      "original_answer": "Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion. The combined total of expensed exploration costs ($0.5 billion) and the PDC Energy, Inc. acquisition cost ($10.5 billion) was $11.0 billion. Therefore, the total cost exceeded this combined amount by $13.6 billion.",
      "llm_answer": "\n\nChevron's total cost incurred by consolidated companies in 2023 was **$24,559 million** (Table I). The combined total of expensed exploration costs ($500 million, per the reconciliation table in Note 28) and the PDC Energy, Inc. acquisition cost ($6,520 million, Note 29) was **$7,020 million**. \n\nThe difference is calculated as:  \n**$24,559 million (total cost) - $7,020 million (expensed exploration + PDC acquisition) = $17,539 million**.  \n\nThus, Chevron's total cost exceeded the combined total by **$17,539 million** in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and calculation errors. While it correctly identifies Chevron as the company and 2023 as the year, it uses incorrect values for key financial figures. The expensed exploration cost is stated as $500 million (correct), but the PDC Energy, Inc. acquisition cost is incorrectly reported as $6,520 million ($6.52 billion), whereas the ground truth states $10.5 billion. This leads to an incorrect combined total of $7,020 million instead of $11.0 billion. The total cost incurred by consolidated companies is reported as $24,559 million (~$24.6 billion), which matches the ground truth in substance, though the LLM uses more precise formatting. (2) The calculation is therefore flawed: $24,559M - $7,020M = $17,539M is incorrect due to the wrong input values. The correct difference is $24.6B - $11.0B = $13.6B. (3) The multi-hop reasoning is structurally sound—LLM identifies the need to sum two components and subtract from total cost—but fails due to incorrect data extraction from the source documents (e.g., misreading PDC acquisition cost). (4) Scores reflect major quantitative inaccuracies (especially the PDC acquisition value), partial qualitative accuracy in reasoning structure, and high contextual relevance as the answer addresses the right entities and question framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 374,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does American Tower determine the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component, and what specific market metric is used in this valuation?",
      "original_answer": "American Tower determines the fair value of its 2024 PSUs with a market condition component using a Monte Carlo simulation model. This model evaluates the probability of satisfying the market condition requirements, which for the 2024 PSUs is based on relative total shareholder return measured against the REIT constituents included in the S&P 500 Index.",
      "llm_answer": "\n\nAmerican Tower determines the fair value of its 2024 performance-based restricted stock units (PSUs) with a market condition component using a **Monte Carlo simulation model**. The specific market metric used is **relative total shareholder return (TSR) measured against the REIT constituents included in the S&P 500 Index**. The grant date fair value of the market condition component was calculated as $216.11, incorporating assumptions such as an expected term of 2.81 years, a risk-free interest rate of 4.31%, and annualized volatility of 26.75%.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that American Tower uses a Monte Carlo simulation model to determine the fair value of its 2024 PSUs with a market condition component, and accurately states that the specific market metric is relative total shareholder return (TSR) measured against the REIT constituents in the S&P 500 Index—this matches the ground truth exactly. The qualitative reasoning and entity identification (American Tower, 2024 PSUs, market condition, Monte Carlo model, TSR, S&P 500 REIT constituents) are fully accurate and demonstrate proper multi-hop synthesis. Contextual relevance is excellent, as all information directly addresses the question. However, the ground truth does not include the specific numerical assumptions (e.g., fair value of $216.11, expected term of 2.81 years, risk-free rate of 4.31%, volatility of 26.75%). While these may be factually correct in context, their inclusion introduces quantitative details not present in the verified answer, which could imply overprecision or sourcing beyond the ground truth. Since the core valuation method and market metric—both central to the question—are correct, and no incorrect facts are stated (assuming the numbers are accurate), the answer earns a high score, but not perfect, due to the addition of unverified quantitative details not in the original truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 373,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How many amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented across the disclosed filings, and what is the effective date of the fourth amendment?",
      "original_answer": "There are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, with the fourth amendment effective as of July 1, 2022.",
      "llm_answer": "\n\nThe Caterpillar Inc. Supplemental Employees' Investment Plan has **four amendments** documented in the filings. The effective date of the **fourth amendment** is **July 1, 2022** (referenced in Exhibit 10.14).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, which aligns with the original answer. (2) The effective date of the fourth amendment is correctly identified as July 1, 2022, matching the ground truth exactly. The inclusion of 'referenced in Exhibit 10.14' adds contextual support without introducing error. (3) The reasoning is sound and demonstrates proper synthesis of information from the disclosed filings, correctly identifying both the count and the specific date through multi-hop analysis. (4) The answer is semantically equivalent to the original, with no factual discrepancies, omissions, or inaccuracies. All evaluation dimensions—quantitative, qualitative, and contextual—are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1101,
        "completion_tokens": 249,
        "total_tokens": 1351
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "What is the difference between the amortized cost and fair value of Corporate Notes and Obligations held by CRM in 2024, and how does this compare to the fair value of these securities as categorized under Level 2 inputs in active markets?",
      "original_answer": "The amortized cost of Corporate Notes and Obligations is $3,014 million, while the fair value is $2,978 million, resulting in a $36 million unrealized loss. According to the second source, the fair value of these securities categorized under Level 2 inputs in active markets is $2,557 million, which is significantly lower than the overall fair value of $2,978 million, indicating a difference of $421 million between the total fair value and the Level 2 categorized value.",
      "llm_answer": "\n\nThe difference between the amortized cost and fair value of Corporate Notes and Obligations held by CRM in 2024 is **$36 million** ($3,014 million amortized cost minus $2,978 million fair value). The fair value of these securities is entirely categorized under **Level 2 inputs** in active markets, as shown in the fair value hierarchy table, where Corporate Notes and Obligations are valued at $2,978 million using significant observable market inputs. Thus, the $36 million difference aligns with the Level 2 fair value measurement.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the amortized cost ($3,014 million) and fair value ($2,978 million) of Corporate Notes and Obligations, and accurately calculates the $36 million difference (unrealized loss), which matches the ground truth. However, it incorrectly states that the entire fair value is categorized under Level 2 inputs, claiming $2,978 million is Level 2. This contradicts the ground truth, which specifies that only $2,557 million of the fair value is categorized under Level 2, with the remainder presumably in other levels. The LLM fails to report the $421 million difference between total fair value and Level 2 value, which is a key part of the question. (2) Numeric values for amortized cost and fair value are correct, and the $36 million calculation is accurate. However, the Level 2 value is wrong—the LLM reports $2,978 million instead of $2,557 million—leading to a significant error in the comparative analysis. (3) The multi-hop reasoning fails: the model does not synthesize information across both sources. It ignores the second source stating the Level 2 value is $2,557 million and incorrectly assumes full Level 2 classification. This breaks the chain of reasoning required to compare total fair value to Level 2 fair value. (4) While the first part of the answer is factually correct and contextually relevant, the critical second part is fundamentally wrong. The qualitative reasoning is flawed due to incorrect entity mapping (misclassifying the fair value hierarchy level), leading to an incomplete and misleading conclusion. Hence, partial credit is given for correct initial calculation but significant deductions for missing key comparative analysis and factual inaccuracy in the Level 2 value.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 475,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What is the total amount of financing Disney has secured for its new cruise ships, including both the Disney Treasure and the anticipated Disney Destiny, and how does the interest rate on these facilities compare?",
      "original_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, with $1.1 billion borrowed for the Disney Treasure at a fixed interest rate of 3.80% and another $1.1 billion facility available for the Disney Destiny at a slightly lower fixed interest rate of 3.74%.",
      "llm_answer": "\n\nDisney has secured a total of **$2.2 billion** in financing for its new cruise ships: **$1.1 billion** for the *Disney Treasure* (fixed interest rate of **3.80%**) and **$1.1 billion** for the anticipated *Disney Destiny* (fixed interest rate of **3.74%**). The interest rate on the *Disney Destiny* facility is slightly lower than that of the *Disney Treasure*. Both loans have 12-year terms with semi-annual payments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $2.2 billion total financing, split into two $1.1 billion facilities for the Disney Treasure and Disney Destiny, with fixed interest rates of 3.80% and 3.74% respectively. The comparison of interest rates (slightly lower for Disney Destiny) is correctly stated. (2) The answer is complete, addressing both the total financing amount and the interest rate comparison as required by the question. (3) Entities are correctly identified: ship names (Disney Treasure, Disney Destiny), financial amounts, and interest rates are all accurate. (4) The reasoning is sound, demonstrating proper synthesis of multi-hop information—combining two separate financing facilities into a total while correctly comparing their rates. The additional detail about 12-year terms and semi-annual payments, while not in the original answer, does not contradict it and adds context without introducing errors. All information is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 305,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What percentage of Chevron's total equity method investments does its Tengizchevroil stake represent, and how does this relate to its production volumes from the Kazakhstan joint venture?",
      "original_answer": "Chevron's investment in Tengizchevroil represents $27,368 million of its total equity method investments of $46,618 million, which is approximately 58.7%. This significant stake directly supports Chevron's production volumes, as Tengizchevroil is one of the key international affiliates contributing to Chevron's oil-equivalent production in Kazakhstan.",
      "llm_answer": "\n\nChevron's Tengizchevroil (TCO) stake represents approximately **58.7%** of its total equity method investments ($27,368 million TCO investment ÷ $46,618 million total equity method investments as of December 31, 2024). This significant investment corresponds to a major portion of Chevron's production in Kazakhstan, where TCO accounts for **45,000 barrels of oil-equivalent per day** (BOE/d) in 2024 (per the \"Net Production\" table). Given Chevron's 50% ownership in TCO, its share of this production is approximately **22,500 BOE/d**, highlighting the material contribution of the Tengiz joint venture to Chevron's global upstream operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The percentage calculation of 58.7% is correct and matches the ground truth ($27,368M ÷ $46,618M ≈ 58.7%), which is accurate. However, the LLM introduces production volume data (45,000 BOE/d and 22,500 BOE/d) that are not present in the original answer or implied by the ground truth. These figures, while potentially plausible, are not supported by the provided knowledge graph and represent an overreach in specificity. (2) The dollar amounts and percentage are correctly calculated and formatted appropriately. The date 'December 31, 2024' is problematic—the original answer does not specify a year, and the knowledge graph source likely reflects data from a prior year (e.g., 2022 or 2023 filings); thus, asserting 2024 data introduces a factual inaccuracy. (3) The multi-hop reasoning is partially sound: the model correctly links equity investment to production relevance, but it fabricates precise production volumes and ownership implications not present in the ground truth. The original answer only states that Tengizchevroil is a 'key international affiliate' without quantifying production. (4) The correctness score is 7 because the core financial percentage and investment figures are accurate, but the addition of unsupported production numbers reduces quantitative accuracy. Qualitative reasoning is strong but overreaches. Contextual relevance is perfect—the answer directly addresses the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 398,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does a change in credit spreads or upfront credit points impact the fair value measurement of Goldman Sachs' level 3 credit derivatives, and what valuation techniques are used to determine this fair value?",
      "original_answer": "An increase in credit spreads or upfront credit points leads to an increase in the fair value measurement of purchased credit protection for Goldman Sachs' level 3 derivatives. These derivatives are valued using a combination of option pricing, correlation, and discounted cash flow models.",
      "llm_answer": "\n\nA change in credit spreads or upfront credit points impacts the fair value of Goldman Sachs' Level 3 credit derivatives as follows: **the fair value of purchased credit protection increases when credit spreads or upfront credit points rise, or when recovery rates fall**. This is because wider credit spreads (indicating higher credit risk) or higher upfront points (reflecting greater compensation for risk) directly increase the value of credit protection sold or held by the firm. \n\nGoldman Sachs uses **option pricing models, correlation models, and discounted cash flow models** to value these derivatives. For Level 3 credit derivatives, valuations incorporate unobservable inputs like credit spreads (ranging 8–1,328 bps, average 134 bps) and upfront credit points (ranging -10 to 100, average 24). These techniques account for complex relationships between credit risk factors and derivative prices, as detailed in Note 4 of the financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that an increase in credit spreads or upfront credit points increases the fair value of purchased credit protection for Goldman Sachs' Level 3 credit derivatives. It adds additional context about recovery rates falling increasing fair value, which is consistent with financial theory and does not contradict the ground truth—this is a reasonable extension, not an error. (2) The valuation techniques—option pricing, correlation, and discounted cash flow models—are correctly identified and match the original answer exactly. The inclusion of specific numeric ranges (credit spreads: 8–1,328 bps, average 134 bps; upfront points: -10 to 100, average 24) is consistent with typical Level 3 disclosures and plausible within context, though these specific numbers are not in the ground truth provided. Since the ground truth does not include quantitative ranges, the LLM may be drawing from external knowledge or a more detailed version of the filing; this does not constitute an error but slightly exceeds the provided truth. (3) The reasoning is sound and reflects proper multi-hop understanding: it links market variables (credit spreads, upfront points) to valuation impact and correctly associates modeling techniques with unobservable inputs typical for Level 3 assets. (4) The answer is semantically equivalent to the original, with slightly enhanced detail. The core facts, directionality of impact, and valuation methods are all correct. Minor deduction in quantitative accuracy due to introduction of specific bps and point ranges not present in ground truth, but these are reasonable and not demonstrably false. No factual contradictions. Contextual relevance is perfect—directly addresses both parts of the question with appropriate depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 497,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does the potential failure to meet the Minimum DSCR impact AMT's ability to fund the construction of communications sites globally as outlined in their 2024 10-K filing?",
      "original_answer": "If AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) of 1.15x, an amortization period will commence, during which all excess cash flow and any amounts in the Cash Trap Reserve Account will be applied to pay down the principal of the Series 2015-2 Notes or the Loan. This would prevent AMT from receiving distributions needed to fund capital expenditures, including the construction of 1,950 to 2,550 communications sites globally. As a result, AMT may be unable to proceed with its planned tower construction, which could hinder its growth and expansion initiatives.",
      "llm_answer": "\n\nIf AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) under its securitization agreements, excess cash flow generated by the securitized assets would be diverted to debt principal repayments during an \"amortization period,\" rather than being available for capital expenditures like constructing communications sites. This restriction would directly limit AMT’s liquidity for global site development, as the cash would be mandatorily applied to reduce outstanding secured debt obligations (e.g., the Series 2015-2 Notes or Trust Securitization loans) until the DSCR threshold is exceeded for two consecutive quarters. Additionally, failure to maintain DSCR could trigger defaults, risking foreclosure on the securitized assets (3,338+ communications sites), further impairing AMT’s operational and expansion capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core financial mechanism: failure to meet the Minimum DSCR triggers an amortization period where excess cash flow is diverted to debt repayment, limiting funds available for capital expenditures like communications site construction. The mention of mandatory principal payments on the Series 2015-2 Notes and the requirement to exceed the DSCR for two consecutive quarters before normal distributions resume aligns with typical securitization terms and adds context not in the original but plausibly consistent with the filing. However, the LLM omits the specific range of 1,950 to 2,550 communications sites that AMT plans to build, which is a key quantitative detail from the ground truth. While it correctly identifies the risk to expansion, it does not explicitly state that AMT would be unable to receive distributions needed to fund these capital expenditures, slightly weakening the causal chain. The reference to '3,338+ communications sites' being at risk of foreclosure appears accurate in context but introduces detail not present in the original answer, potentially extrapolating beyond the provided truth. Overall, the reasoning is sound, entities (AMT, Series 2015-2 Notes, DSCR) are correct, and the explanation is contextually relevant and well-articulated. Minor deductions are due to omission of the exact construction target range and slight over-extension on foreclosure implications without direct support in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 410,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Caterpillar's use of historical claim rates in determining its product warranty liability influence the critical audit matter identified by PricewaterhouseCoopers LLP, and what is the resulting financial estimate of this liability as of December 31, 2024?",
      "original_answer": "Caterpillar determines its product warranty liability by applying historical claim rate experience to the current field population and dealer inventory, which involves significant judgment by management. This method was identified as a critical audit matter by PricewaterhouseCoopers LLP due to the high degree of auditor judgment, subjectivity, and effort required to evaluate the reasonableness of management's assumptions. As of December 31, 2024, the resulting financial estimate of the product warranty liability was $1,700 million.",
      "llm_answer": "\n\nCaterpillar's use of historical claim rates to estimate its product warranty liability involves significant management judgment, as these rates are applied to current field populations and dealer inventory, requiring assumptions about future claims based on past experience. PricewaterhouseCoopers LLP identified this as a critical audit matter due to the high subjectivity in management's assumptions, the complexity of actuarial methodologies, and the need for specialized auditor expertise to validate the reasonableness of the estimate. As of December 31, 2024, Caterpillar reported a product warranty liability of **$1,700 million** (per Note 21).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the financial estimate of $1,700 million as of December 31, 2024, is accurately reported, with acceptable formatting (bold and 'per Note 21' adds context without altering accuracy). (2) The explanation of Caterpillar's use of historical claim rates applied to field population and dealer inventory is factually correct and aligns with the original answer. (3) The reasoning for why this is a critical audit matter—highlighting management judgment, subjectivity, actuarial complexity, and need for auditor expertise—correctly captures the multi-hop logic from methodology to audit impact. (4) All entities (Caterpillar, PricewaterhouseCoopers LLP, product warranty liability, December 31, 2024) are accurate. The answer is semantically equivalent to the ground truth, with slightly enhanced detail (e.g., mention of actuarial methodologies and Note 21) that improves clarity without introducing error. No factual, numerical, or logical deficiencies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 301,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference between Disney's stated interest rate on Asia Theme Parks borrowings and the effective interest rate on its senior unsecured notes reflect the company's relative cost of capital across these debt categories?",
      "original_answer": "The stated interest rate on Asia Theme Parks borrowings is 7.93%, while the effective interest rate on Disney's senior unsecured notes is 4.71%. This indicates that the Asia Theme Parks debt carries a significantly higher cost of capital compared to the senior unsecured notes. The difference of 3.22 percentage points highlights the premium Disney pays for this specific borrowing, potentially due to factors such as risk profile, collateralization, or market conditions at the time of issuance.",
      "llm_answer": "\n\nThe difference between the stated interest rate (7.93%) on Disney's Asia Theme Parks borrowings and the effective interest rate (5.75%) reflects higher initial contractual rates for these loans compared to the effective rate (4.71%) on senior unsecured notes. This disparity highlights a higher relative cost of capital for Asia Theme Parks borrowings, driven by factors such as higher perceived risk in Asian markets, currency exposure (e.g., yuan-denominated loans at 8% from Shendi), and less favorable terms compared to Disney's broader U.S. dollar-denominated debt. While interest rate swaps and purchase accounting adjustments reduce the effective rate for Asia borrowings, they remain costlier than senior notes, underscoring elevated financing costs for region-specific, project-based debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the effective interest rate for Disney's senior unsecured notes, stating it as 5.75% instead of the correct 4.71% from the ground truth. This misstatement significantly undermines the quantitative accuracy. Additionally, the LLM introduces a figure of '8% from Shendi' and mentions 'yuan-denominated loans' and 'interest rate swaps and purchase accounting adjustments' that are not present in the original answer or supported by the provided ground truth, introducing unsupported details. However, the stated interest rate for Asia Theme Parks borrowings (7.93%) is correct. The difference between the two rates is therefore miscalculated in implication — while the ground truth reports a 3.22 percentage point difference (7.93% - 4.71%), the LLM’s use of 5.75% (instead of 4.71%) would yield a smaller difference of 2.18 points, which distorts the magnitude of the cost disparity. (2) The core financial comparison — that Asia Theme Parks debt has a higher cost of capital than senior unsecured notes — is correctly identified and logically explained in terms of risk, market perception, and financing structure. The reasoning about regional risk, currency exposure, and less favorable terms is plausible and contextually appropriate, even if some specifics (e.g., Shendi, 8%) are extraneous or unverified. (3) The multi-hop reasoning is partially sound: the model correctly contrasts two types of Disney debt and infers relative cost of capital implications. However, the use of incorrect numbers and unsupported details breaks the factual chain, especially in quantitative synthesis. (4) The contextual relevance is high because the answer addresses the core question about relative cost of capital and provides a reasonable qualitative explanation. The qualitative accuracy is also relatively high due to sound logic and correct identification of the higher-cost nature of Asia Theme Parks debt, but the quantitative inaccuracy severely limits overall correctness. Thus, the correctness score is 6 — partially correct but with significant factual errors in key metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 571,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was Chevron's capitalized cost associated with the PDC acquisition in 2023, and in which U.S. basin was this acquisition primarily responsible for contributing 2.2 TCF of purchases in 2023?",
      "original_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, and this acquisition was primarily responsible for contributing 2.2 TCF of purchases in the DJ Basin in 2023.",
      "llm_answer": "\n\nChevron's capitalized cost associated with the PDC acquisition in 2023 was **$10,487 million**, and the acquisition primarily contributed to the **DJ basin** in the U.S., which accounted for 2.2 TCF of purchases in 2023. \n\nThis information is derived from the \"Gross Investment at Cost\" section in the financial tables, which explicitly notes the $10,487 allocation for the PDC acquisition in 2023, and the \"Noteworthy changes in natural gas proved reserves\" section, which identifies the DJ basin as the primary location for the 2.2 TCF increase.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The capitalized cost of $10,487 million is accurately reported, matching the original answer exactly; format variation (e.g., $10,487 million vs $10.487 billion) is acceptable and correctly presented. (2) The U.S. basin is correctly identified as the DJ Basin, with proper spelling and context. (3) The 2.2 TCF of purchases is correctly attributed to the DJ Basin as a result of the PDC acquisition in 2023. (4) The multi-hop reasoning is sound: the answer synthesizes information from two distinct sections of the filing—'Gross Investment at Cost' for the dollar amount and 'Noteworthy changes in natural gas proved reserves' for the reserve addition and location—demonstrating accurate cross-document synthesis. (5) All entities (Chevron, PDC acquisition, 2023, DJ Basin, TCF) are correctly identified and logically connected. The explanation adds contextual support by referencing the specific sections of the filing, enhancing qualitative and contextual accuracy. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 313,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and how does this retrospective application reflect the impact of the guidance on MetLife's consolidated financial reporting?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of comprehensive income as a result of the adoption of the new LDTI accounting guidance. This retrospective application demonstrates that the LDTI guidance had a material effect on MetLife's financial reporting, specifically requiring restatement of prior period financial statements to align with the new accounting standards for long-duration insurance contracts.",
      "llm_answer": "\n\nThe adoption of the new LDTI accounting guidance retrospectively adjusted MetLife's **consolidated balance sheet, statement of operations, statement of comprehensive income, statement of equity, and statement of cash flows**. Key adjustments included reclassifications of liabilities (e.g., $17.0 billion reduction in future policy benefits, $7.5 billion increase in policyholder account balances), deferred policy acquisition costs (reduced by $3.3 billion), and equity (retained earnings decreased by $1.6 billion, while accumulated other comprehensive income increased by $4.5 billion). These adjustments reflect the impact of LDTI by aligning liability measurements with new margin-based amortization requirements, recalibrating reserves for market risk benefits, and adjusting prior-period results to enhance transparency in financial reporting under the updated accounting framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that *all* financial statements—including the consolidated balance sheet, statement of cash flows, and statement of equity—were retrospectively adjusted, while the ground truth specifies only the consolidated statement of operations and consolidated statements of comprehensive income. This overstatement introduces significant factual inaccuracy. (2) The quantitative details (e.g., $17.0 billion reduction in future policy benefits, $7.5 billion increase in policyholder account balances, $3.3 billion reduction in deferred acquisition costs, $1.6 billion decrease in retained earnings, $4.5 billion increase in AOCI) are specific and plausible but are not present in the original answer and cannot be verified against the ground truth. Since the original answer contains no such figures, their inclusion suggests fabrication or hallucination, severely undermining quantitative accuracy. (3) The reasoning partially reflects correct multi-hop understanding by linking LDTI adoption to retrospective adjustments and explaining their purpose (e.g., aligning with margin-based amortization, recalibrating reserves), which shows awareness of the guidance’s intent. However, the failure to correctly identify the scope of affected financial statements undermines the qualitative accuracy. (4) Contextually, the response is relevant and addresses the impact of LDTI on financial reporting, but the overinclusion of unverified statements and numbers reduces its reliability. While the explanation of the guidance’s effect on transparency and comparability is reasonable, it does not compensate for the core factual mismatch regarding which statements were adjusted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 466,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How many amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing, and what is the effective date of the most recent amendment?",
      "original_answer": "Two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing. The most recent amendment is the Second Amendment, which became effective on January 1, 2022.",
      "llm_answer": "\n\nThe Solar Turbines Incorporated Managerial Retirement Objective Plan has **two amendments** documented in the Caterpillar Inc. 2024 10-K filing. The amendments are:  \n1. **First Amendment**, dated December 10, 2014 (incorporated from the 2014 10-K).  \n2. **Second Amendment**, effective January 1, 2022 (incorporated from the 2021 10-K).  \n\nThe **most recent amendment** listed has an effective date of **January 1, 2022**. No newer amendments to this plan are disclosed in the 2024 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that there are two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan documented in the Caterpillar Inc. 2024 10-K filing, which matches the ground truth. The effective date of the most recent amendment, the Second Amendment, is accurately stated as January 1, 2022. All numeric values and dates are correct, satisfying quantitative accuracy. The answer provides additional context (e.g., the First Amendment date and source filings), which is factually consistent and enhances completeness. The reasoning reflects proper multi-hop synthesis by referencing amendments incorporated from prior 10-K filings (2014 and 2021), demonstrating sound qualitative accuracy. The only minor limitation is that the ground truth does not specify the First Amendment details, so including it, while accurate, slightly exceeds the scope—but this does not detract from correctness. The answer is fully contextually relevant and semantically equivalent to the original answer. Thus, the correctness score is 9 due to full factual alignment with a small amount of extra (but correct) detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 321,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total financial impact of the North Carolina Rate Case Order on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress, and how was this reflected in the consolidated statements of operations?",
      "original_answer": "The North Carolina Rate Case Order resulted in a total financial impact of $68 million on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress. Specifically, $35 million was recorded by Duke Energy Carolinas and $33 million by Duke Energy Progress under Impairment of Assets and Other Charges, as stated in the consolidated statements of operations.",
      "llm_answer": "\n\nThe North Carolina Rate Case Order resulted in a total reduction of **$35 million** in Duke Energy's Impairment of Assets and Other Charges across Duke Energy Carolinas ($13 million decrease) and Duke Energy Progress ($22 million decrease) in 2024 compared to 2023. On the consolidated statements of operations, this reduction is reflected as a decrease in impairment charges from **$71 million in 2023 to $38 million in 2024**, contributing to lower operating expenses and higher net income. The variance primarily stems from prior-year rate case impacts resolving charges related to regulatory accounting adjustments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that the North Carolina Rate Case Order resulted in a total financial impact of $68 million ($35 million from Duke Energy Carolinas and $33 million from Duke Energy Progress) recorded as Impairment of Assets and Other Charges. However, the LLM claims a total reduction of $35 million (with $13M and $22M decreases), which contradicts the ground truth in both magnitude and direction (reduction vs. actual charge). (2) The numbers are factually wrong: the LLM reports a decrease from $71M to $38M in impairment charges, but this is not supported by the ground truth, which does not mention year-over-year changes or those specific figures. The calculation of a $33M decrease (71 to 38) is internally consistent in the LLM's narrative but entirely fabricated relative to the source. (3) The multi-hop reasoning is flawed: the question asks for the total impact of a specific regulatory order on impairment charges across two subsidiaries, and the LLM invents a comparative year-over-year trend and misattributes the amounts to each subsidiary. It fails to correctly identify the nature of the impact (a charge, not a reduction) and introduces unsupported details about 2023 vs. 2024. (4) Despite the factual inaccuracies, the answer is contextually relevant—it addresses the right companies, the right financial statement line item, and attempts to explain the impact on consolidated operations. However, due to major quantitative and qualitative errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 436,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What is the financial impact on Starbucks from the 12% of total net revenues generated by licensed stores, considering the structure of payments received from licensees including margins on products, royalties, and license fees?",
      "original_answer": "Starbucks receives a combination of product margins, royalties, and license fees from its licensed stores, which accounted for 12% of total net revenues in fiscal 2024. This revenue contribution is derived from the sale of branded products, supplies, and equipment to licensees, along with ongoing royalty payments based on retail sales. Despite lower per-store revenues compared to company-operated stores, the licensed model benefits Starbucks by shifting operating costs and capital investments to the licensees, thereby improving overall operating margins.",
      "llm_answer": "\n\nThe 12% of total net revenues generated by Starbucks' licensed stores (fiscal 2024) contribute positively to profitability despite lower gross margins. Under the licensed model, Starbucks earns margins on branded products/supplies sold to licensees and receives royalties on retail sales, while licensees bear operating costs, capital investments, and labor expenses. This structure results in higher operating margins for licensed stores compared to company-operated stores, as Starbucks avoids direct operational burdens. Thus, the 12% revenue share from licensed stores enhances overall financial performance by leveraging third-party resources to generate income with reduced cost exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 12% of total net revenues from licensed stores in fiscal 2024 is correctly stated, matching the original answer. There are no calculations required beyond this percentage, and it is used appropriately in context. (2) The answer correctly identifies the structure of payments: product margins on branded products/supplies, royalties on retail sales, and license fees (implied in 'royalties and license fees' in original; 'royalties on retail sales' covers part, and 'margins on products' maps to product margins). The LLM elaborates slightly more by noting that licensees bear operating costs, capital, and labor—consistent with the original's point about shifting costs. (3) Multi-hop reasoning is sound: it connects the revenue contribution (12%) to the financial model (product sales + royalties), then links that to margin benefits due to cost-shifting—this synthesis across revenue structure and profitability impact is logically and factually correct. (4) Minor deduction in qualitative accuracy because the original explicitly mentions 'license fees' as a distinct component, which the LLM does not explicitly name (though royalties and product margins are covered). However, 'royalties on retail sales' likely encompasses the ongoing royalty stream, and license fees may be implicit. Overall, the answer captures the financial impact accurately: lower direct costs lead to higher operating margins, enhancing overall financial performance. Wording differs but semantic meaning is equivalent. No irrelevant content; fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 448,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "Given that Target's owned and exclusive brands account for approximately one-third of its sales and carry higher margins than national brands, what financial risk does Target face if it fails to successfully develop, source, and market these brands, particularly considering the longer lead times and increased responsible sourcing risks involved?",
      "original_answer": "If Target fails to successfully develop, source, and market its owned and exclusive brands—which represent approximately one-third of its overall sales and generally carry higher margins—its results of operations could be significantly adversely affected. This risk is amplified by the fact that owned brand products involve greater responsible sourcing risk due to the selection of vendors and longer lead times between order placement and product delivery. These longer lead times require earlier ownership of products in the supply chain and longer-term forecasting of consumer demand, which increases exposure to supply chain disruptions and the risk of misjudging rapidly changing consumer preferences. Since these brands contribute meaningfully to revenue and profitability, any failure in this area could directly impact financial performance.",
      "llm_answer": "\n\nIf Target fails to successfully develop, source, and market its owned and exclusive brands, it faces significant financial risks, including **reduced sales and profit margins** due to these brands representing ~one-third of total sales and carrying higher margins than national brands. Longer lead times increase exposure to **demand forecasting errors**, potentially leading to excess inventory or stockouts, while responsible sourcing risks (e.g., vendor selection, supply chain disruptions) could amplify **reputational harm** and compliance costs. Additionally, reliance on imported products for owned brands heightens vulnerability to **supply chain disruptions** (e.g., geopolitical events, port delays), further threatening operational efficiency and profitability. These risks collectively could erode Target’s competitive differentiation and financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) Quantitatively, the statement that Target's owned and exclusive brands represent approximately one-third of sales is correctly reflected (~one-third), and no other numerical values are misstated. There are no calculations required, so numerical precision is fully maintained. (2) The LLM correctly identifies the higher margins of owned brands versus national brands, a key financial driver. (3) The reasoning accurately captures the multi-hop logic: longer lead times → earlier ownership and forecasting challenges → risk of misjudging demand and inventory issues; responsible sourcing → vendor selection risks and supply chain disruptions; and the financial impact due to the brands' significant contribution to sales and profitability. The LLM adds value by explicitly mentioning reputational harm and compliance costs, which are reasonable extensions of responsible sourcing risks, and notes imported product vulnerability, which is consistent with sourcing complexity. (4) The only minor gap is that the original answer emphasizes that longer lead times require 'earlier ownership of products in the supply chain,' a nuance slightly underdeveloped in the LLM response. However, the core financial risk to operations and profitability is clearly and correctly conveyed. All entities (Target, owned/exclusive brands, national brands) are correct. The answer is fully relevant and synthesizes the required information accurately. Thus, the response earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 453,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many amendments to the Caterpillar Inc. Deferred Employees' Investment Plan were incorporated into the 2024 10-K filing by reference from prior SEC filings, and which specific SEC filings contained the most recent two amendments?",
      "original_answer": "There were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K filing. The most recent two amendments were: the Third Amendment, effective January 1, 2022, which was incorporated by reference from Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021; and the Fourth Amendment, effective as of July 1, 2022, which was incorporated by reference from Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "llm_answer": "\n\nThe Caterpillar Inc. Deferred Employees' Investment Plan had **four amendments** incorporated into the 2024 10-K filing by reference from prior SEC filings. The most recent two amendments were:  \n1. **Third Amendment** (effective January 1, 2022), incorporated from the Company's **Annual Report on Form 10-K for the year ended December 31, 2021** (Exhibit 10.22).  \n2. **Fourth Amendment** (effective July 1, 2022), incorporated from the Company's **Quarterly Report on Form 10-Q for the quarter ended September 30, 2022** (Exhibit 10.23).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that there were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K, which matches the ground truth. It also correctly identifies the most recent two amendments: the Third Amendment effective January 1, 2022, and the Fourth Amendment effective July 1, 2022. The filings referenced (2021 10-K and 2022 10-Q) are correct in terms of form type and reporting period. However, there is a discrepancy in the exhibit numbers: the LLM states Exhibit 10.22 for the Third Amendment and Exhibit 10.23 for the Fourth Amendment, while the ground truth specifies Exhibit 10.28 for the 2021 10-K and Exhibit 10.6 for the 2022 10-Q. These exhibit numbers are material details in the context of SEC filings and their referencing, so this constitutes a factual error. Despite correct reasoning and structure, the incorrect exhibit numbers reduce quantitative and qualitative accuracy. The answer is otherwise complete, logically sound, and semantically equivalent in intent, with all key entities and dates accurate except for the exhibit identifiers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 317,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many shares remain available for future grant or issuance under the 2013 Equity Incentive Plan, and what types of equity awards were outstanding related to this plan according to the 2024 10-K filing?",
      "original_answer": "73 shares remain available for future grant or issuance under the 2013 Equity Incentive Plan. The types of equity awards outstanding related to this plan include options outstanding and restricted stock awards and units and performance-based stock units outstanding.",
      "llm_answer": "\n\nAs of January 31, 2025, **73 million shares** remained available for future grant or issuance under the 2013 Equity Incentive Plan. Outstanding equity awards related to this plan included **stock options (8 million shares)** and **restricted stock awards/units and performance-based stock units (26 million shares)**. These figures are detailed in the \"Common Stock\" section of the 2024 10-K filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors. The original answer states that 73 shares (not millions) remain available for future grant under the 2013 Equity Incentive Plan. The LLM incorrectly reports this as 73 million shares, which is off by a factor of one million—this is a critical quantitative error. Additionally, the LLM introduces specific numbers for outstanding awards (8 million and 26 million shares), which are not present in the original answer and are therefore fabricated. The original answer only specifies the types of equity awards outstanding: options, restricted stock awards/units, and performance-based stock units—without providing share counts. While the LLM correctly identifies the types of equity awards (stock options, restricted stock awards/units, performance-based stock units), it adds numerical details not supported by the ground truth, undermining factual accuracy. The reference to 'January 31, 2025' is also problematic, as the 2024 10-K would typically report data as of the fiscal year end (likely January 31, 2024), making the date incorrect. The answer is contextually relevant and attempts to address both parts of the question, but the massive overstatement of shares and inclusion of unsupported figures severely compromise correctness. Multi-hop reasoning is partially sound in identifying the plan and award types, but fails in accurate data extraction and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 391,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What percentage of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, given that most of these revenues come from product sales and royalties through this partnership?",
      "original_answer": "The majority of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, as stated in the document. While an exact percentage is not provided, the document specifies that 'most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.' This indicates that the percentage is greater than 50% but the exact figure is not disclosed.",
      "llm_answer": "\n\nThe document states that \"most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.\" However, the exact percentage is not explicitly disclosed in the provided pages. While fiscal 2024 Channel Development revenues totaled $1,769.8 million, the specific proportion attributable to Nestlé is not quantified in the text. The term \"most\" is qualitative and does not translate to a precise numerical percentage based on the information given.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that the exact percentage of Starbucks' Channel Development revenues from the Global Coffee Alliance with Nestlé in fiscal 2024 is not disclosed, aligning with the ground truth. It accurately references the qualitative term 'most' and correctly notes that this implies over 50% without providing an exact figure, which matches the original answer. The LLM also correctly cites the total Channel Development revenue of $1,769.8 million, a detail consistent with the document (though not required for the core question), showing strong grounding in the source material. All entities—Starbucks, Nestlé, Global Coffee Alliance, fiscal 2024, and Channel Development—are correctly identified. The reasoning is sound: it distinguishes between qualitative language and precise quantification, which is essential for multi-hop interpretation. The only minor shortcoming is a slight lack of emphasis on the explicit statement that 'most' revenues come from Nestlé via product sales and royalties, which could have been more directly tied to the 'greater than 50%' inference present in the ground truth. However, this does not detract significantly from the overall accuracy. All information is contextually relevant and responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 354,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and which specific effects are illustrated in tables presented as of December 31 according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of cash flows as a result of the adoption of the new LDTI accounting guidance. These adjustments are illustrated in tables presented as of December 31 in the 2023 10-K filing.",
      "llm_answer": "\n\nThe adoption of the new LDTI accounting guidance retrospectively adjusted MetLife's **consolidated balance sheet, statement of operations, comprehensive income, equity, and cash flows**. As of December 31, the balance sheet adjustments (shown in the table) included reductions in **deferred policy acquisition costs and value of business acquired ($3,330M)**, **future policy benefits ($17,006M)**, and **retained earnings ($1,621M)**, while **policyholder account balances increased by $7,515M** and **market risk benefits rose by $3,763M**. These adjustments reflect reclassifications and recalibrations under LDTI, impacting asset and liability valuations, equity components, and prior-period financial statement presentations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing the general topic. (1) The original answer states that MetLife retrospectively adjusted the consolidated statement of operations and consolidated statements of cash flows. However, the LLM answer incorrectly expands this to include the balance sheet, statement of comprehensive income, and equity — which are not mentioned in the ground truth. While balance sheet adjustments may be implied by retained earnings and asset/liability changes, the original answer does not confirm retrospective adjustments to the balance sheet or equity statements. (2) The LLM provides specific dollar amounts (e.g., $3,330M reduction in DAC and VOBA, $17,006M in future policy benefits, $1,621M reduction in retained earnings, $7,515M increase in policyholder account balances, $3,763M increase in market risk benefits). These figures are not present in the original answer and cannot be verified against the ground truth, making their inclusion unsupported. Since the question asks specifically what is 'illustrated in tables' according to the 2023 10-K, and the ground truth only confirms that adjustments to the statement of operations and cash flows are shown, the detailed quantitative breakdown is extraneous and unverified. (3) The multi-hop reasoning is partially sound in that it identifies LDTI's impact on financial statements, but it overreaches by introducing unconfirmed statements and numerical details not present in the ground truth. (4) Contextual relevance is high because the answer discusses the correct company, accounting guidance (LDTI), and time frame (implied by 2023 10-K), but correctness and quantitative accuracy are low due to unsupported specifics and misattribution of adjusted statements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 481,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the value of equity method investment contracts compare to total asset derivatives in 2022, and what does this indicate about their relative significance in MDLZ's derivative portfolio?",
      "original_answer": "In 2022, the value of equity method investment contracts was $3 million, while the total value of asset derivatives was $393 million. This indicates that equity method investment contracts represented less than 1% of the total asset derivatives portfolio, highlighting their minimal relative significance in MDLZ's overall derivative holdings.",
      "llm_answer": "\n\nIn 2022, the fair value of equity method investment contracts was **$3 million** (liability derivatives), while total asset derivatives amounted to **$790 million**. This indicates that equity method investment contracts represented a **negligible portion** of MDLZ's derivative portfolio, reflecting their limited significance compared to broader derivative activities like currency exchange, commodity, and interest rate contracts. The equity method contracts arose from a bifurcated embedded derivative in exchangeable bonds, further emphasizing their minor role in the company’s overall risk management strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the total asset derivatives value: it reports $790 million, whereas the ground truth is $393 million. This is a significant quantitative discrepancy that affects the validity of the comparison. The value for equity method investment contracts ($3 million) is correct. (2) Due to the incorrect total asset derivatives figure, any implied percentage or ratio (e.g., 'negligible portion') is misleading—even though $3M vs $790M would still represent less than 1%, the doubling of the denominator undermines confidence in the data source or synthesis. The ground truth emphasizes that equity method contracts are less than 1% of $393M, not $790M. (3) The qualitative reasoning is sound—correctly identifying the minor role of equity method investment contracts, referencing bifurcated embedded derivatives in exchangeable bonds, and contextualizing them within broader derivative types (currency, commodity, interest rate). This shows multi-hop understanding of both the quantitative and strategic aspects. (4) Contextual relevance is high—the answer addresses both parts of the question (comparison and significance) and adds relevant context about the origin of the contracts. However, the major numerical error in total asset derivatives severely impacts factual correctness, warranting a mid-range score. The answer is partially correct but built on an incorrect foundation for one key metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 401,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the freezing of U.S. pension benefits as of December 31, 2019, specifically impact the actuarial assumptions used by CAT in its postemployment benefit plan accounting?",
      "original_answer": "The freezing of U.S. pension benefits as of December 31, 2019, directly affected the actuarial assumptions used by CAT, particularly resulting in the discontinuation of the 'expected rate of compensation increase' assumption, as this was no longer applicable under the new frozen benefit structure.",
      "llm_answer": "\n\nThe freezing of U.S. pension benefits as of December 31, 2019, eliminated the need for Caterpillar (CAT) to use the **expected rate of compensation increase** as an actuarial assumption in its U.S. pension plan accounting. This assumption, previously used to project future salary growth for benefit obligations, is now no longer applicable because frozen benefits do not accrue additional service or compensation-based increases. Consequently, CAT’s actuarial calculations for U.S. pension liabilities and costs focus on remaining assumptions such as the discount rate, expected return on plan assets, and mortality rates, while the compensation increase assumption is retained only for non-U.S. pension plans and other postretirement benefits. This change simplifies the U.S. pension obligation modeling by removing salary growth projections from the actuarial framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately identifies that the freezing of U.S. pension benefits as of December 31, 2019, led to the discontinuation of the 'expected rate of compensation increase' assumption, which is the key factual point in the original answer. (2) The date 'December 31, 2019' is correctly stated, and no numerical values (e.g., rates, dollar amounts) are missing or inaccurately reported—only qualitative actuarial assumptions are discussed, and these are correctly represented. (3) The reasoning is sound and reflects proper multi-hop understanding: the benefit freeze implies no future compensation-based accruals, making the compensation growth assumption obsolete. The answer further enriches the response by correctly noting that other assumptions (discount rate, return on assets, mortality) remain in use and that the compensation assumption may still apply outside the U.S. or for other benefits—this is logically consistent and adds context without introducing error. (4) The LLM answer conveys the same core information as the original answer with greater elaboration, maintaining semantic equivalence and demonstrating strong contextual and factual alignment. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 363,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as reflected in its hardware revenue structure, impact its ability to manage supply chain disruptions and maintain profitability in its hardware business?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which constitute a significant portion of its hardware revenues, makes the company more vulnerable to supply chain disruptions because these systems are complex and rely on timely delivery of components from third-party suppliers. According to the 10-K filing, supply chain shortages have increased production costs and led to higher inventory purchases to secure manufacturing capacity, which in turn has increased inventory excess and obsolescence risk and negatively impacted operating cash flows. This dynamic directly affects Oracle's ability to maintain profitability in its hardware business, as it cannot always pass these increased costs on to customers, and delays in manufacturing can lead to lost sales and delayed revenue recognition.",
      "llm_answer": "\n\nOracle's strategic focus on Oracle Engineered Systems, which are high-margin, integrated hardware solutions, aims to enhance profitability by prioritizing strategic products over lower-margin commodity hardware. However, this focus increases vulnerability to supply chain disruptions due to reliance on specialized components and single-source vendors, as highlighted in the 10-K. To mitigate risks, Oracle has committed to higher inventory purchases to secure manufacturing capacity, but this has led to elevated inventory costs, excess/obsolescence risks, and cash flow pressures. While the shift to Engineered Systems supports margin improvement, ongoing supply chain challenges (exacerbated by the pandemic) and production delays could still pressure hardware profitability, particularly if cost increases cannot be fully passed to customers or inventory management inefficiencies persist.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Oracle's focus on Engineered Systems increases supply chain vulnerability due to complexity and reliance on third-party suppliers; the company responds by increasing inventory purchases to secure capacity, which leads to higher costs, excess/obsolescence risk, and cash flow pressure. It correctly notes that cost pass-through is limited and that production delays affect revenue recognition and profitability. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: it connects Oracle's strategic product focus → supply chain dependencies → risk mitigation behavior (inventory buildup) → financial consequences (costs, obsolescence, cash flow) → impact on profitability. The mention of pandemic-exacerbated disruptions is consistent with context typically found in Oracle’s 10-K filings during relevant years, though not explicitly in the ground truth; this is a reasonable inference and does not detract from accuracy. (4) The answer is fully contextually relevant, directly addressing how strategic focus impacts supply chain resilience and profitability. The only reason for not giving a perfect 10 is minor: the LLM slightly expands on 'single-source vendors' and 'pandemic' factors not explicitly stated in the ground truth, which, while plausible, are not confirmed in the provided truth. Overall, the semantic meaning and factual core are equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 436,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area, and how does this total compare in percentage growth to the overall Pulmonary Hypertension category's 2023 growth rate?",
      "original_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT is $3,555 million ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI). This represents a 10.6% growth for OPSUMIT and a 19.7% growth for UPTRAVI, which are both higher than the overall Pulmonary Hypertension category's 11.6% growth rate in 2023.",
      "llm_answer": "\n\nThe combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area was **$3,555 million** (UPTRAVI: $1,582 million + OPSUMIT: $1,973 million). The growth rate for these two drugs in 2023 was **14.5%** (calculated from their 2022 combined sales of $3,105 million to 2023 sales of $3,555 million), which is **2.9 percentage points higher** than the overall Pulmonary Hypertension category's 2023 growth rate of **11.6%**.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the combined 2023 global sales revenue of $3,555 million, accurately breaking it down into $1,582 million for UPTRAVI and $1,973 million for OPSUMIT, which matches the ground truth. This part is fully correct. However, the LLM introduces a calculated combined growth rate of 14.5% based on an inferred 2022 combined total of $3,105 million. This calculation, while mathematically sound (3,555 / 3,105 ≈ 14.5%), is not supported by the original answer, which reports individual growth rates (10.6% for OPSUMIT and 19.7% for UPTRAVI) but does not provide or imply a combined growth rate. The ground truth states that both drugs individually grew faster than the category’s 11.6% growth rate, which is factually accurate. The LLM incorrectly aggregates these into a single 14.5% growth figure and compares it to the category growth, which misrepresents the original analysis. (2) The numbers for 2023 revenue are accurate. However, the $3,105 million 2022 figure and the 14.5% growth rate are not present in the ground truth and appear to be inferred. While such inference might seem reasonable, the original answer emphasizes individual drug performance relative to the category, not a combined growth rate. (3) The multi-hop reasoning is partially sound—revenue figures are correctly summed—but the synthesis goes beyond the source data by creating a new metric (combined growth rate) that alters the conclusion. The original answer highlights that both drugs outperformed the category individually, whereas the LLM suggests a single combined growth rate that is only 2.9 percentage points above the category, potentially downplaying UPTRAVI’s strong 19.7% growth. (4) Scores reflect that core revenue data is correct (earning high marks for contextual relevance and partial quantitative accuracy), but the introduction of an unsupported aggregate growth rate reduces correctness and qualitative accuracy, as it changes the interpretation of performance relative to the market.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 544,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "By how much did the full-year contribution from legacy PDC Energy assets increase U.S. upstream earnings for CVX in 2024, and what was the corresponding impact on net oil-equivalent production?",
      "original_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX by $2.2 billion in 2024, and it contributed to a 19% increase in net oil-equivalent production, or 250,000 barrels per day.",
      "llm_answer": "\n\nThe full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX in 2024 by **$2.2 billion**, as noted in the \"Results of Operations\" section. This contribution was a key driver of the **250,000 barrels per day (19%) increase in U.S. net oil-equivalent production** for 2024, attributed to the full-year integration of PDC assets and growth in the Permian Basin.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $2.2 billion increase in U.S. upstream earnings is accurately reported. The net oil-equivalent production increase is correctly stated as 250,000 barrels per day, with the corresponding 19% growth—both figures match the original answer exactly. Format variations (e.g., '19%' vs '19% increase') are semantically equivalent. (2) The answer is complete, addressing both parts of the multi-part question: the earnings impact and the production impact. (3) Entity accuracy is correct: CVX (Chevron), legacy PDC Energy assets, and the 2024 full-year timeframe are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis—linking the PDC asset integration to both financial and operational outcomes, including contextual factors like Permian Basin growth, which aligns with plausible drivers without contradicting the source. (5) Semantic equivalence is maintained: although the LLM adds minor contextual detail (Permian Basin), it does not introduce inaccuracies and enhances clarity without deviating from the truth. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 328,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific financial statements were adjusted as a result of MetLife's retrospective application of the new LDTI accounting guidance, and what does this imply about the scope of the guidance's impact on the company's financial reporting?",
      "original_answer": "MetLife adjusted both its previously reported consolidated statements of equity and consolidated statements of comprehensive income as a result of the retrospective application of the new LDTI accounting guidance. This implies that the guidance had a broad impact on the company's financial reporting, affecting not only comprehensive income but also the presentation of equity, which reflects the materiality and foundational nature of the changes required under the new accounting rules.",
      "llm_answer": "\n\nThe retrospective application of the new LDTI accounting guidance adjusted MetLife's **consolidated balance sheet, statement of operations, statement of comprehensive income, statement of equity, and statement of cash flows**. These adjustments included reclassifications and recalculations for items such as future policy benefits, market risk benefits, policyholder account balances, revenues, expenses, and comprehensive income components. The scope of the guidance's impact is extensive, affecting both income statement line items (e.g., policyholder benefits, investment gains/losses) and balance sheet liabilities (e.g., future policy benefits, deferred acquisition costs), reflecting a fundamental change in accounting for long-duration insurance contracts and their associated risks. This suggests the guidance significantly alters how MetLife recognizes and measures financial performance and position for insurance liabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but includes significant overstatement in the scope of financial statements adjusted, which reduces factual accuracy. The original answer states that MetLife adjusted the 'consolidated statements of equity' and 'consolidated statements of comprehensive income'—this is precise and supported by the ground truth. However, the LLM answer claims adjustments to the balance sheet, statement of operations, statement of cash flows, and others, which are not mentioned in the original answer and cannot be verified from the provided truth. While the LDTI guidance likely affects balance sheet items (e.g., future policy benefits), the question specifically asks which statements were *adjusted as a result of the retrospective application*, implying actual restatements disclosed by the company. The original answer limits this to equity and comprehensive income statements, suggesting other statements may not have been restated or disclosed as adjusted in this context. The LLM provides accurate qualitative descriptions of the types of items affected (e.g., policyholder account balances, comprehensive income components), and the explanation of the guidance’s broad impact is reasonable and contextually relevant. However, the inclusion of five financial statements—without evidence in the ground truth—represents a significant factual overreach, undermining the correctness. There are no numerical values in the question or answers, so quantitative accuracy is scored based on absence of incorrect numeric claims (scored 10 by default). The reasoning shows understanding of LDTI's implications but fails in precise entity alignment—specifically, which financial statements were actually adjusted. Thus, while the answer demonstrates strong contextual understanding and logical implications, it exceeds the evidence in scope, leading to a correctness score of 6 due to major overstatement despite sound reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 526,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What was the total fair value of equity method investment contracts as disclosed in the derivatives fair value table as of December 31, 2022, and how does this compare to the total fair value of net investment hedge contracts in the same period?",
      "original_answer": "The total fair value of equity method investment contracts as of December 31, 2022, was $(3) million, while the total fair value of net investment hedge contracts was $24 million. Therefore, the equity method investment contracts had a significantly smaller fair value compared to net investment hedge contracts during the same period.",
      "llm_answer": "\n\nAs of December 31, 2022, the total fair value of **equity method investment contracts** was **$(3) million** (liability), as disclosed in the derivatives fair value table. In comparison, the total fair value of **net investment hedge contracts** was **$24 million** (asset). This indicates that the net investment hedge contracts had a significantly higher positive fair value relative to the equity method investment contracts, which were a small liability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $(3) million for equity method investment contracts and $24 million for net investment hedge contracts are accurately reported, with correct dates (December 31, 2022). The formatting variations (e.g., $(3) million vs $24 million) are standard and semantically equivalent. (2) The answer is complete, addressing both parts of the question: the fair values of both contract types and their comparison. (3) Entity accuracy is correct—'equity method investment contracts' and 'net investment hedge contracts' are properly identified, and the time period is accurate. (4) The reasoning is sound: the LLM correctly interprets the negative value as a liability and the positive as an asset, and logically concludes that the net investment hedges have a significantly higher fair value. The qualitative explanation enhances clarity without introducing error. All multi-hop elements (identifying two different contract types from the same table and comparing them) are handled correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 308,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the change in Universal Beijing Resort's net assets from December 31, 2023, to December 31, 2024, and how does this reflect the financial activity reported in Comcast's consolidated balance sheets?",
      "original_answer": "The net assets of Universal Beijing Resort decreased by $0.5 billion, from $0.6 billion on December 31, 2023 ($7.8B assets - $7.2B liabilities), to $0.3 billion on December 31, 2024 ($7.3B assets - $7.0B liabilities). This reflects a reduction in both assets and liabilities, indicating potential ongoing operational or investment adjustments during the year.",
      "llm_answer": "\n\nThe net assets of Universal Beijing Resort decreased by $0.3 billion (from $0.6 billion as of December 31, 2023, to $0.3 billion as of December 31, 2024), calculated as the difference between its assets and liabilities ($7.3 billion - $7.0 billion in 2024 vs. $7.8 billion - $7.2 billion in 2023). This decline is reflected in Comcast’s consolidated balance sheets through the consolidation of Universal Beijing Resort, a variable interest entity (VIE) in which Comcast holds a 30% interest and consolidates due to control. The reduction in net assets aligns with the Theme Parks segment’s financial performance, which includes operational results and depreciation of property and equipment, as well as potential impacts from the equity method losses reported in Comcast’s consolidated income statements (e.g., $680 million equity loss in 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the change in net assets as a $0.3 billion decrease, while the ground truth shows a $0.5 billion decrease. The 2023 net assets are correctly calculated ($7.8B - $7.2B = $0.6B), but the 2024 net assets are miscalculated: $7.3B - $7.0B = $0.3B (correct), yet the change should be $0.6B - $0.3B = $0.3B decrease, not $0.5B as stated in the original. However, the original answer itself contains a contradiction: it claims a $0.5B decrease but computes $0.6B to $0.3B, which is a $0.3B drop. This suggests a possible error in the ground truth explanation. Despite this, the LLM's calculation is mathematically correct based on the provided asset and liability figures. (2) All numbers (assets, liabilities, dates) are accurately pulled from the ground truth and correctly formatted. The $0.3B change is numerically accurate given the inputs, so the quantitative score is penalized only due to the discrepancy with the original answer's stated $0.5B change, which appears to be an error in the ground truth. (3) The multi-hop reasoning is strong: the LLM correctly identifies Universal Beijing Resort as a VIE consolidated in Comcast’s financials, references the 30% interest, and links the net asset change to Theme Parks segment performance and equity method losses (e.g., $680M loss in 2024), which adds context beyond the original answer. (4) The contextual relevance is high—LLM addresses both parts of the question: the change in net assets and its reflection in Comcast’s consolidated balance sheets, with additional insight into income statement impacts. Given that the LLM’s calculation is mathematically sound and aligns with the raw data (even if contradicting the original’s erroneous $0.5B claim), the correctness score is moderate, reflecting potential ambiguity in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 499,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29, 2024, and how does the 2021 Revolving Credit Agreement explicitly support the commercial paper program in terms of borrowing capacity and usage?",
      "original_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is $103.6 million, consisting of a ¥5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a ¥10.0 billion ($69.1 million) facility maturing on March 27, 2025. The 2021 Revolving Credit Agreement supports the commercial paper program by requiring that all outstanding amounts under the program be backstopped by available commitments under the 2021 credit facility. The commercial paper program allows Starbucks to issue unsecured notes up to $3.0 billion, with proceeds used for working capital needs, capital expenditures, business expansion, cash dividends, and share repurchases.",
      "llm_answer": "\n\nThe total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is **$103.6 million** (¥5.0 billion or $34.5 million and ¥10.0 billion or $69.1 million). The 2021 Revolving Credit Agreement explicitly supports the commercial paper program by providing a **$3.0 billion backstop**, ensuring that borrowings under the commercial paper program (up to $3.0 billion in capacity) are fully covered by the credit facility’s commitments. Both facilities allow funds to be used for working capital, capital expenditures, acquisitions, share repurchases, and other corporate purposes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total value of Starbucks' Japanese yen-denominated credit facilities as $103.6 million, accurately breaking it down into ¥5.0 billion ($34.5 million) and ¥10.0 billion ($69.1 million), which sum correctly. These figures match the ground truth exactly, with acceptable format variation in currency presentation. (2) The explanation of the 2021 Revolving Credit Agreement's support for the commercial paper program is factually correct: it states the $3.0 billion backstop, aligns with the borrowing capacity, and correctly notes that the credit facility commitments cover outstanding commercial paper. The LLM captures the essential mechanism—backstopping—though it does not explicitly mention that the commercial paper proceeds are used for working capital, capital expenditures, business expansion, dividends, and share repurchases, which is a minor omission. (3) Multi-hop reasoning is sound: the model synthesizes data from two yen-denominated facilities and correctly links the 2021 Revolving Credit Agreement to the commercial paper program’s structure and capacity. (4) Scores reflect near-perfect factual accuracy, with only slight incompleteness in detailing the permitted uses of funds under the commercial paper program. Quantitative accuracy is flawless, contextual relevance is full, and qualitative reasoning is strong but not fully exhaustive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 390,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as part of its hardware business, impact both its infrastructure technologies revenue and its exposure to supply chain risks?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which are part of its hardware business, contributes to its infrastructure technologies revenue by offering integrated, high-performance solutions such as the Oracle Exadata Database Machine. These systems are designed to improve performance, availability, and scalability for Oracle Database workloads, which supports Oracle's broader infrastructure technologies offerings. Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022, indicating the importance of these technologies to Oracle's financial performance. However, this strategic emphasis also increases Oracle's exposure to supply chain risks. As noted in the second chunk, Oracle depends on suppliers for critical technologies and components, some of which are sourced from single vendors. The company experienced manufacturing and fulfillment delays during fiscal 2022 due to supply chain disruptions, particularly those caused by the COVID-19 pandemic. These delays led to increased inventory purchases, which in turn raised inventory excess and obsolescence risk and negatively impacted operating cash flows. Thus, while Oracle Engineered Systems are a key part of Oracle's infrastructure technologies and contribute to revenue, they also expose the company to material risks related to supply chain constraints and logistics delays.",
      "llm_answer": "\n\nOracle's strategic focus on Oracle Engineered Systems, as part of its hardware business, impacts its infrastructure technologies revenue and supply chain risks in the following ways:  \n\n1. **Infrastructure Technologies Revenue**: By prioritizing Oracle Engineered Systems (high-margin, strategic hardware products) over lower-margin commodity hardware, Oracle aims to stabilize or enhance profitability within its hardware segment. However, the document notes that hardware revenues and profitability have declined, partly due to global supply chain disruptions and the de-emphasis of lower-margin products. While Engineered Systems may improve revenue quality, overall hardware revenue growth remains challenged by broader market factors.  \n\n2. **Supply Chain Risks**: Engineered Systems, being hardware-centric, increase exposure to supply chain vulnerabilities. Oracle relies on third-party manufacturers and suppliers for components, and disruptions (e.g., pandemic-related delays, material shortages, or geopolitical issues) directly affect production and delivery. The document highlights that supply chain constraints have raised production costs and inventory risks, which are amplified for complex, engineered systems requiring specialized components.  \n\nIn summary, while the focus on Engineered Systems aligns with Oracle’s strategy to prioritize profitable hardware offerings, it also heightens reliance on supply chains prone to disruptions, thereby increasing operational and financial risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of Oracle's strategic focus on Oracle Engineered Systems and its dual impact on infrastructure technologies revenue and supply chain risks. It correctly identifies that Engineered Systems are high-margin, strategic products intended to improve profitability within the hardware segment, and acknowledges that overall hardware revenues have been under pressure due to supply chain disruptions and market factors. This aligns with the ground truth's implication that while Engineered Systems contribute positively to revenue quality, broader challenges persist.\n\nOn supply chain risks, the LLM correctly notes Oracle's reliance on third-party suppliers and the vulnerability of complex hardware systems to disruptions such as those caused by the pandemic, material shortages, and logistics issues. It also appropriately links these disruptions to increased production costs and inventory risks, which is consistent with the ground truth mentioning increased inventory purchases, excess and obsolescence risk, and negative impacts on cash flows.\n\nHowever, the LLM answer falls short in quantitative completeness. The ground truth includes a specific, material figure: 'Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022.' This key data point quantifies the importance of infrastructure technologies to Oracle's overall financial performance and is entirely missing from the LLM response. While the LLM does not fabricate numbers, the omission of this critical statistic reduces the depth and precision of its revenue impact analysis.\n\nAdditionally, the LLM generalizes about 'the document' noting supply chain issues but does not explicitly tie the fiscal 2022 delays to the pandemic or mention Oracle's single-source supplier dependencies, which are key elements in the ground truth. These specifics strengthen the causal reasoning in the original answer and their absence represents a minor gap in multi-hop synthesis.\n\nDespite these omissions, the reasoning is sound, entities (Oracle, Engineered Systems, Exadata implied contextually) are accurate, and the answer remains contextually relevant and well-structured. The semantic meaning is largely equivalent, though less detailed than the ground truth.\n\nThus, the answer earns a 7 for correctness due to missing key quantitative and contextual details, 8 for quantitative accuracy (no incorrect numbers, but missing the 58% figure), 7 for qualitative accuracy (correct logic but incomplete synthesis), and 9 for contextual relevance (directly addresses both parts of the question with appropriate framing).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1749,
        "completion_tokens": 719,
        "total_tokens": 2468
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What was the change in Universal Beijing Resort's debt from 2023 to 2024, and how did this affect the total 'Debt Not Guaranteed' category?",
      "original_answer": "The Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion. This contributed to the overall 'Debt Not Guaranteed' category decreasing from $5.0 billion in 2023 to $4.8 billion in 2024, alongside a decrease in 'Other' debt from $1.5 billion to $1.4 billion.",
      "llm_answer": "\n\nUniversal Beijing Resort's debt decreased by $0.1 billion (from $3.5 billion in 2023 to $3.4 billion in 2024). This reduction contributed to the overall decline in the \"Debt Not Guaranteed\" category, which fell by $0.2 billion, from $5.0 billion in 2023 to $4.8 billion in 2024. The decrease in Universal Beijing Resort's debt was partially offset by a $0.1 billion reduction in other unspecified \"Debt Not Guaranteed\" obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a $0.1 billion reduction. The 'Debt Not Guaranteed' category decreased from $5.0 billion to $4.8 billion, a $0.2 billion drop. These numbers match the ground truth exactly. (2) The calculation of the $0.1 billion decrease in Universal Beijing Resort's debt and the $0.2 billion total decrease in 'Debt Not Guaranteed' is accurate. (3) The reasoning is mostly sound: the LLM correctly identifies that the resort's debt reduction contributed to the overall category decline. However, it states the decrease was 'partially offset by a $0.1 billion reduction in other unspecified obligations,' which reverses the logic — the ground truth indicates that the total $0.2 billion decrease was due to both the $0.1 billion drop from Universal Beijing and another $0.1 billion from 'Other' debt; these are additive, not offsetting. This is a minor qualitative error in phrasing but does not undermine the factual correctness. (4) All entities (Universal Beijing Resort, 'Debt Not Guaranteed', years 2023–2024) are correctly identified. The answer is contextually complete and relevant. The only issue is the slightly misleading use of 'partially offset' instead of 'alongside' or 'in addition to,' which slightly affects reasoning clarity but not overall correctness. Hence, a score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 413,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Honeywell's use of the cost-to-cost input method for long-term contracts influence the complexity of its audit procedures, particularly in relation to the estimation of contract costs and the recognition of revenue over time?",
      "original_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts significantly increases the complexity of its audit procedures because it requires extensive auditor judgment to evaluate the reasonableness and consistency of management's estimates of total contract costs and progress toward completion. Given that contract costs can span several years and are influenced by factors such as inflationary trends, technical and schedule risk, subcontractor performance, and labor agreements, auditors must perform detailed procedures to test controls, validate assumptions, and profile contracts with longer durations or significant gross margin changes. This complexity is further heightened by the fact that revenue recognition under this method depends on the proportion of costs incurred to date relative to total estimated costs, which can lead to material adjustments if estimates change over time.",
      "llm_answer": "\n\nHoneywell's use of the cost-to-cost input method for long-term contracts increases audit complexity due to the subjective nature of estimating future contract costs, which are influenced by factors like inflation, technical risks, and subcontractor performance. Auditors must rigorously evaluate management’s assumptions, test historical accuracy of estimates, and assess potential biases in revenue recognition. This involves detailed procedures such as analyzing contract-specific data, profiling high-risk contracts, and verifying consistency in methods, as noted in the audit report. The dynamic adjustment of estimates (on a cumulative catch-up basis) further complicates audits, requiring auditors to validate multi-period impacts and ensure compliance with accounting standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: Honeywell's use of the cost-to-cost method, the factors affecting cost estimation (inflation, technical risks, subcontractor performance), the need for auditor judgment, and the implications for revenue recognition over time are all correctly identified. There are no numeric values in the question or answers that require verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—scored as 10. (2) The LLM captures the core multi-hop reasoning: it connects the cost-to-cost method to estimation challenges, links those to audit complexity, and explains how dynamic adjustments (cumulative catch-up) increase scrutiny. It also references audit procedures like testing assumptions, profiling high-risk contracts, and ensuring consistency—mirroring the original answer's emphasis on controls, assumptions, and contract profiling. (3) Minor omission: the original answer specifically mentions 'labor agreements' and 'longer-duration contracts' as risk factors, which the LLM does not explicitly include, slightly reducing completeness. Also, 'validate multi-period impacts' is a strong proxy for 'material adjustments if estimates change over time,' but the original's emphasis on materiality is slightly more precise. (4) Despite these small gaps, the LLM answer is semantically equivalent, contextually relevant, and demonstrates sound qualitative reasoning. The response directly addresses how the cost-to-cost method affects audit complexity through estimation uncertainty and procedural rigor, fulfilling the question’s requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 463,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "In NEE's 2023 financial results, what was the difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains included in net income and FPL's $300 million of gains included in net income, and how does this reflect the different treatment of derivative transactions between the two business units as disclosed in the 10-K filing?",
      "original_answer": "The difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains and FPL's $300 million of gains included in net income was $1,429 million. This significant difference reflects the distinct treatment of derivative transactions between the two business units. According to the 10-K filing, NEER's non-qualifying hedge activity was a primary driver of its improved results in 2023 compared to 2022, with approximately $1,729 million of gains included in NEER's net income. In contrast, FPL's derivative transactions are largely deferred as regulatory assets or liabilities until contract settlement, with only $300 million of gains passed through to net income in 2023. This reflects FPL's regulatory framework where most changes in fair value of energy derivatives are deferred rather than immediately impacting earnings, unlike NEER's market-oriented operations where non-qualifying hedges directly affect net income volatility.",
      "llm_answer": "\n\nThe difference in magnitude between NEER's $1,729 million non-qualifying hedge gains and FPL's $300 million gains in 2023 net income is **$1,429 million**. This reflects distinct accounting treatments for derivative transactions:  \n\n- **NEER** (a non-regulated entity) records non-qualifying hedge gains/losses directly in net income under GAAP, as these derivatives are marked-to-market and not economically offset by physical assets also marked-to-market. This leads to significant earnings volatility from market price fluctuations.  \n- **FPL** (a regulated entity) defers changes in fair value of most energy derivatives as regulatory assets/liabilities until contract settlement, per its cost-based rate regulation. Gains/losses are then passed through to customers via fuel clauses, minimizing immediate net income impact.  \n\nThis contrast highlights how regulatory accounting for FPL smooths earnings, while NEER’s non-regulated status exposes its results to direct market risk impacts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the difference of $1,429 million is accurately calculated ($1,729M - $300M = $1,429M), with all dollar amounts matching the original answer. (2) The explanation correctly identifies NEER and FPL as distinct business units with different regulatory and accounting treatments for derivative transactions. (3) The multi-hop reasoning is sound: it synthesizes information about NEER's non-qualifying hedge gains being recognized immediately in net income due to its non-regulated, market-oriented operations, versus FPL's regulated status leading to deferral of most derivative gains/losses as regulatory assets/liabilities. (4) The qualitative explanation aligns with the 10-K disclosures, accurately reflecting how FPL's cost-based rate regulation minimizes earnings volatility, while NEER's results are directly exposed to market fluctuations. Wording differs slightly but maintains semantic equivalence and adds clarifying detail (e.g., 'marked-to-market', 'fuel clauses') that enhances understanding without introducing error. All parts of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 334,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Comcast's ownership stake in Universal Beijing Resort influence the assets and liabilities reported in its consolidated balance sheets as of December 31, 2024, and what proportion of the total debt financing does Comcast's maximum risk of financial loss represent?",
      "original_answer": "Comcast owns a 30% interest in Universal Beijing Resort, which it consolidates due to its determination that Universal Beijing Resort is a VIE and Comcast has the power to direct its major activities. As of December 31, 2024, Universal Beijing Resort had $7.3 billion in assets and $7.0 billion in liabilities, which are fully included in Comcast’s consolidated balance sheet. Universal Beijing Resort had $3.4 billion in debt outstanding, and Comcast’s maximum risk of financial loss is limited to its 30% equity interest, which equates to 30% of the total debt, or $1.02 billion.",
      "llm_answer": "\n\nComcast's 30% ownership stake in Universal Beijing Resort results in the consolidation of its assets and liabilities, adding $7.3 billion in assets and $7.0 billion in liabilities to Comcast's December 31, 2024, consolidated balance sheet. Comcast's maximum risk of financial loss related to the resort's debt financing is 30% of its $3.4 billion outstanding debt ($1.02 billion), representing **30% of the total debt financing**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $7.3 billion in assets, $7.0 billion in liabilities, $3.4 billion in debt, and 30% ownership leading to a $1.02 billion maximum risk (30% of $3.4B = $1.02B) are correctly reported. Minor formatting differences (e.g., bolding of '30% of the total debt financing') do not affect accuracy. (2) The answer is complete, addressing both parts of the question: the impact on Comcast’s consolidated balance sheet and the proportion of debt tied to Comcast’s maximum risk of loss. (3) Entity accuracy is correct—Comcast, Universal Beijing Resort, and the date (December 31, 2024) are properly identified. (4) The reasoning is sound: the LLM correctly explains that despite a 30% ownership stake, Comcast consolidates the VIE, hence full inclusion of assets and liabilities, and correctly limits Comcast’s risk to its equity interest, not the full debt. The multi-hop synthesis—linking ownership percentage, VIE consolidation rules, debt amount, and risk exposure—is logically and accurately presented. (5) The semantic meaning is equivalent to the original answer, with no factual or interpretive deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 342,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the cumulative goodwill impairment charges recognized for OpenTable in 2020 compare to its 2021 revenue contribution to Booking Holdings' advertising and other segment?",
      "original_answer": "In 2020, Booking Holdings recognized cumulative goodwill impairment charges of $1,062 million ($489 million in Q1 and $573 million in Q3) related to OpenTable. In 2021, OpenTable contributed to the 'advertising and other' revenue category, which totaled $1.1 billion for the full year. This means the impairment charges over the course of 2020 were nearly equivalent to the entire annual revenue contribution from OpenTable's restaurant reservation and related services in 2021.",
      "llm_answer": "\n\nThe cumulative goodwill impairment charges recognized for OpenTable in 2020 totaled $1,062 million (comprising $489 million in the March 2020 interim test and $573 million in the September 2020 annual test). However, the document does not provide specific 2021 revenue contribution figures for OpenTable within Booking Holdings' advertising and other segment, making a direct numerical comparison impossible. The impairment charges were driven by pandemic-related disruptions to OpenTable’s cash flows and monetization prospects, but no explicit 2021 revenue data is disclosed in the provided pages to quantify its contribution.",
      "correctness_score": 3,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reported the cumulative goodwill impairment charges for OpenTable in 2020 as $1,062 million, with the correct breakdown of $489 million in Q1 (March) and $573 million in Q3 (September), which matches the ground truth exactly—this part is quantitatively accurate. (2) However, the LLM incorrectly claims that 'the document does not provide specific 2021 revenue contribution figures for OpenTable,' which contradicts the ground truth stating that OpenTable contributed to the 'advertising and other' segment, which totaled $1.1 billion in 2021. This revenue figure is explicitly provided in the original answer and was available in the knowledge base, so the LLM's assertion of missing data is factually wrong. (3) The multi-hop reasoning failed: the question required comparing the 2020 impairment charges ($1,062M) to the 2021 revenue contribution (~$1.1B), concluding they were nearly equivalent. The LLM did not perform this comparison due to its incorrect claim of missing data, thus failing the core analytical task. (4) While numbers are accurate, the failure to access and use the correct revenue figure for comparison severely undermines the answer’s correctness and reasoning quality, warranting a low correctness score despite good quantitative input. Contextual relevance is moderate because it discusses the right entities and context (impairment, pandemic impact) but fails to deliver the key comparative insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 403,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does ExxonMobil incorporate greenhouse gas emission costs into its Corporate Plan when assessing the recoverability of asset groups, and what specific future emission-reduction goal is factored into these assessments?",
      "original_answer": "ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in the future cash flow assessments used to determine the recoverability of asset groups. These costs are considered even for jurisdictions without current greenhouse gas pricing policies. Specifically, the Corporation factors in costs related to its 2030 greenhouse gas emission-reduction plans, including the goal of achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin.",
      "llm_answer": "\n\nExxonMobil incorporates greenhouse gas (GHG) emission costs into its Corporate Plan by including estimated expenses related to its 2030 emission-reduction goals when assessing the recoverability of asset groups. Specifically, the Corporation factors in costs associated with its target of achieving **net-zero Scope 1 and Scope 2 GHG emissions from unconventional operated assets in the Permian Basin by 2030**. These costs are integrated into future cash flow projections used for impairment testing, ensuring alignment with long-term strategic and regulatory expectations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: ExxonMobil includes estimated greenhouse gas (GHG) emission costs in future cash flow assessments for asset recoverability, even in jurisdictions without current GHG pricing. The specific future emission-reduction goal factored in is net-zero Scope 1 and Scope 2 GHG emissions from unconventional operated assets in the Permian Basin by 2030. (2) Quantitative accuracy is perfect: the year '2030' is correctly cited, and the target is precisely described. No calculations are required, but the integration of costs into cash flow projections for impairment testing is correctly explained. (3) Multi-hop reasoning is sound—the answer synthesizes information about corporate planning, asset recoverability assessments, forward-looking emission costs, and specific environmental targets across different domains of the 10-K filing. (4) The wording differs slightly but maintains full factual fidelity and adds minor clarifying context (e.g., 'impairment testing', 'long-term strategic and regulatory expectations') that are consistent with and enhance the original without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 355,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in after December 31, 2023, and how does this affect its capital conservation buffer requirements for the period from October 1, 2023 through September 30, 2024?",
      "original_answer": "As of December 31, 2023, $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in. This amount will be phased in equally at $600 million per year on January 1, 2024 and 2025. Capital One's capital conservation buffer requirements for CET1, Tier 1, and total capital are 2.5% under the Federal Reserve's regulations, which are separate from the stress capital buffer framework. The stress capital buffer requirement for the period from October 1, 2023 through September 30, 2024, is 4.8%, and Capital One currently exceeds the minimum capital requirements and conservation buffers, maintaining a 'well-capitalized' status.",
      "llm_answer": "\n\nAs of December 31, 2023, **$1.2 billion** of Capital One's $2.4 billion CECL Transition Rule capital addition remains to be phased in, with **$600 million** scheduled for January 1, 2024, and the remaining **$600 million** for January 1, 2025. For the period **October 1, 2023, through September 30, 2024**, the Company’s **capital conservation buffer requirements** are set at **4.8% CET1**, resulting in minimum required CET1, Tier 1, and total capital ratios of **9.3%**, **10.8%**, and **12.8%**, respectively. The phased-in CECL capital addition supports maintaining these buffers, as the remaining $1.2 billion will be incrementally recognized in regulatory capital over 2024–2025.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that $1.2 billion of the $2.4 billion CECL capital addition remains to be phased in as of December 31, 2023, and accurately states that $600 million will be phased in on January 1, 2024, and another $600 million on January 1, 2025. These quantitative elements are correct and match the ground truth. (2) However, the LLM makes a critical error in stating that the capital conservation buffer requirement is 4.8% CET1 for the period October 1, 2023 through September 30, 2024. This is incorrect: the 4.8% figure refers to the *stress capital buffer (SCB)*, not the capital conservation buffer (CCB). The ground truth correctly states that the CCB is 2.5%, separate from the SCB of 4.8%. The LLM conflates these two distinct regulatory requirements. Furthermore, the LLM incorrectly presents the 4.8% as part of the CCB and derives minimum capital ratios (9.3%, 10.8%, 12.8%) that are not mentioned or implied in the ground truth and appear to be fabricated or misinferred. (3) The multi-hop reasoning is partially sound in tracking the phase-in schedule but fails in synthesizing the correct regulatory frameworks—specifically, distinguishing between the CCB and SCB. This is a significant conceptual error in banking regulation. (4) While the answer is well-structured and contextually relevant, addressing both parts of the question, the misrepresentation of the 4.8% as a CCB instead of SCB and the introduction of unsupported minimum ratios severely undermine factual accuracy. Hence, the correctness score is reduced to 6 due to major qualitative inaccuracies despite correct dollar amounts and dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 451,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What was the total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023, and how did this reduction compare to the change in their Euro notes over the same period?",
      "original_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million ($11,275 million to $9,562 million). During the same period, Euro notes increased by $250 million ($7,666 million to $7,916 million). Therefore, the reduction in U.S. dollar notes and term loans was significantly larger than the increase in Euro notes.",
      "llm_answer": "\n\nThe total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was **$1,713 million** (from $11,275 million in 2022 to $9,562 million in 2023). Over the same period, Euro notes increased by **€250 million** (from €7,666 million in 2022 to €7,916 million in 2023). Thus, the reduction in U.S. dollar notes and term loans was significantly larger in magnitude compared to the increase in Euro notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total decrease in U.S. dollar notes and term loans as $1,713 million, calculated accurately from $11,275 million in 2022 to $9,562 million in 2023. It also correctly reports the increase in Euro notes as €250 million, from €7,666 million to €7,916 million. All numeric values match the ground truth exactly, with only formatting differences (e.g., use of € symbol instead of $ in the Euro amount). (2) The calculation of the U.S. dollar decrease ($11,275M - $9,562M = $1,713M) and Euro increase (€7,916M - €7,666M = €250M) are both accurate. The comparison in magnitude is correctly assessed: a $1,713M reduction vs. a €250M increase, with the conclusion that the reduction was significantly larger. (3) The multi-hop reasoning is sound—information from two different debt categories (U.S. dollar notes/term loans and Euro notes) across two years is correctly synthesized. The only minor issue is the use of '€' for Euro notes, while the original answer uses '$' for both (likely converting Euro amounts to USD equivalent for comparison). However, since the question does not specify whether the Euro change should be converted to USD, reporting it in Euros is acceptable and factually accurate. (4) The answer is fully contextually relevant, addresses all parts of the question, and conveys the same semantic meaning as the ground truth. The qualitative score is slightly reduced only due to the potential ambiguity in currency reporting, though it does not constitute a factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 424,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What is the maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement, and how does this payment relate to Honeywell's net spending on environmental matters?",
      "original_answer": "The maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell is $140 million, which represents 90% of Honeywell's annual net spending on environmental matters at certain defined sites.",
      "llm_answer": "\n\nThe maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement is **$140 million**. This payment is calculated as **90% of Honeywell's annual net spending** on environmental matters at specified sites covered by the agreement. The obligation is capped at $140 million per year and remains in effect until December 31, 2043, or earlier if the annual payment falls below $25 million for three consecutive years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) The maximum annual payment of $140 million is accurately stated. (2) The relationship to Honeywell's net spending—90% of annual net spending on environmental matters at specified sites—is correctly identified and semantically equivalent to the original answer. (3) The LLM provides additional context (end date of December 31, 2043, and early termination condition) that is consistent with typical indemnification agreement terms and does not contradict the ground truth; these details may come from the same source document but were not included in the ground truth summary. (4) All entities (Resideo subsidiary, Honeywell, environmental matters) are correctly identified. (5) The reasoning and synthesis are sound, with accurate multi-hop understanding of both the financial obligation and its basis in Honeywell's spending. Minor additions beyond the ground truth do not affect correctness and enhance completeness without introducing error. Quantitative elements (dollar amount, percentage) are precise and correctly formatted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 316,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impact NEE's total financial position for FPL and NEER segments between December 31, 2022, and December 31, 2023?",
      "original_answer": "The total financial position for FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3 million in 2022 to $2 million in 2023, a $1 million drop. For NEER, the amount tied to these clauses fell from $148 million in 2022 to $114 million in 2023, a decrease of $34 million. Combined, the reduction in FPL and NEER segments led to a total $35 million decline in NEE's obligations tied to these clauses over the period.",
      "llm_answer": "\n\nThe changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impacted NEE's financial position as follows:  \n- **Non-Qualifying Hedges** saw a significant improvement, with fair value liabilities decreasing from $(3,921) million at December 31, 2022, to $(1,477) million at December 31, 2023, reflecting a $2.4 billion reduction in negative fair value.  \n- **FPL Cost Recovery Clauses** had a minor decline, with fair value decreasing slightly from $16 million to $12 million over the same period.  \n\nThese changes reduced NEE’s total mark-to-market energy contract liabilities from $(2,728) million in 2022 to $(128) million in 2023, improving the consolidated financial position of the FPL and NEER segments by lowering derivative-related obligations. The Non-Qualifying Hedges contributed most significantly to this improvement.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The numbers provided do not match the ground truth. The original answer states that FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3M to $2M (a $1M drop), and NEER's from $148M to $114M (a $34M drop), totaling a $35M decline. The LLM instead reports a $2.4 billion reduction in 'fair value liabilities' for Non-Qualifying Hedges from $(3,921)M to $(1,477)M, which is not supported by the ground truth and misrepresents the scale and nature of the change. The FPL Cost Recovery Clauses are said to decrease from $16M to $12M, which also does not align with the original $3M to $2M for FPL. These figures are factually wrong and involve a misstatement of over two orders of magnitude. (2) Completeness: The LLM fails to break down the impact by FPL and NEER segments as required by the question and instead introduces a consolidated view of 'mark-to-market energy contract liabilities' not mentioned in the original. It omits the $35M total decline in obligations tied specifically to these clauses. (3) Entity Accuracy: While the entities (FPL, NEER, NEE) and time frame (2022–2023) are correctly identified, the financial metrics (e.g., 'fair value liabilities', 'mark-to-market energy contract liabilities') do not match the original's focus on 'total financial position' tied to specific hedges and clauses. (4) Reasoning: The multi-hop synthesis is flawed—the LLM appears to conflate different line items or misinterpret the data source, failing to correctly aggregate FPL and NEER changes as per the ground truth. The conclusion that Non-Qualifying Hedges drove a major improvement is unsupported by the provided truth. (5) Semantic Equivalence: The overall message of a reduction in liabilities is directionally correct, but the magnitude, segmentation, and specific financial impacts are so inaccurate that the answer cannot be considered factually reliable. The contextual relevance is moderate because it addresses the general topic and timeframe, but the specifics are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 569,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the change in Universal Beijing Resort's net assets from 2023 to 2024, and how does this compare to the change in its debt obligations over the same period?",
      "original_answer": "Universal Beijing Resort's net assets decreased by $0.7 billion from 2023 to 2024, while its debt obligations decreased by $0.1 billion over the same period. In 2023, Universal Beijing Resort had $7.8 billion in assets and $7.2 billion in liabilities, resulting in net assets of $0.6 billion. In 2024, it had $7.3 billion in assets and $7.0 billion in liabilities, resulting in net assets of -$0.3 billion. This represents a decrease in net assets of $0.9 billion. However, liabilities (debt) decreased from $7.2 billion to $7.0 billion, a $0.2 billion reduction, indicating that while the resort reduced its debt slightly, its overall financial position weakened.",
      "llm_answer": "\n\nThe net assets of Universal Beijing Resort decreased by $300 million from 2023 to 2024 (from $600 million to $300 million), while its debt obligations decreased by $100 million (from $3.5 billion to $3.4 billion). This indicates that the decline in net assets ($300 million) was more pronounced than the reduction in debt ($100 million), likely reflecting a larger decrease in assets ($500 million) compared to the decrease in liabilities ($200 million) during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Universal Beijing Resort's net assets decreased from $0.6 billion in 2023 to -$0.3 billion in 2024, a decrease of $0.9 billion, not $300 million as stated. The LLM incorrectly reports the 2024 net assets as $300 million (positive), when it should be -$0.3 billion (negative). Debt obligations decreased from $7.2 billion to $7.0 billion (a $0.2 billion reduction), but the LLM reports debt decreasing from $3.5 billion to $3.4 billion (only $0.1 billion reduction), which is factually incorrect. (2) Calculations are flawed: the LLM claims net assets decreased by $300 million, but the correct decrease is $0.9 billion. It also misrepresents the debt reduction as $100 million instead of $200 million. Asset decline should be from $7.8B to $7.3B ($0.5B drop), which the LLM partially gets right in magnitude but not in context due to incorrect liability figures. (3) Multi-hop reasoning is superficial: the model attempts to compare asset, liability, and net asset changes, but uses entirely incorrect base figures, undermining the synthesis. It fails to correctly identify the financial structure from the knowledge graph. (4) Contextual relevance is moderate—it addresses the right question structure (change in net assets vs. debt), uses appropriate financial logic, and draws a reasonable qualitative conclusion about financial weakening, but on incorrect data. Due to major quantitative errors and incorrect entity values, the correctness score is low despite structurally attempting the right analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 441,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What specific new patient population became eligible for treatment with EDURANT (rilpivirine) according to JNJ's 2023 10-K filing, and which regulatory regions were targeted for filing as indicated in the same report?",
      "original_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) was targeted for treatment of pediatric patients aged 2-12 years with HIV. The filing was specifically targeted at the US and EU regulatory regions.",
      "llm_answer": "\n\nAccording to JNJ's 2023 10-K filing, EDURANT (rilpivirine) gained eligibility for **pediatric patients aged 2–12 years with HIV**. The regulatory filings for this indication were targeted at the **U.S. and European Union (EU)**, as indicated in the pipeline advancements section of the report.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The new patient population is accurately identified as 'pediatric patients aged 2–12 years with HIV', which aligns exactly with the information from JNJ's 2023 10-K filing. (2) The targeted regulatory regions—U.S. and European Union (EU)—are correctly stated, with no discrepancies in entity names or scope. (3) The reasoning is sound and reflects proper multi-hop synthesis: the answer correctly links EDURANT (rilpivirine) to a new indication, identifies the specific age group and condition, and associates the regulatory filings with the correct jurisdictions. (4) Semantic equivalence is maintained: although the LLM uses slightly different phrasing (e.g., 'gained eligibility' vs. 'was targeted for treatment'), the meaning is factually identical. All components of the question are addressed completely and accurately. No errors in entities, numbers, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 274,
        "total_tokens": 1417
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How do Booking.com's merchant-based transaction model and regulatory investigations in Switzerland and the EU collectively impact Booking Holdings' operating margins and business strategy as reported in 2022?",
      "original_answer": "Booking.com's increasing use of a merchant-based transaction model leads to higher expenses related to personnel, payment processing, and chargebacks, which negatively affects operating margins despite incremental revenues such as credit card rebates. Additionally, regulatory investigations, such as the ongoing Swiss Price Surveillance Office investigation into Booking.com's commission rates, could force Booking.com to reduce commissions in Switzerland, further compressing margins. In the EU, the proposed Digital Markets Act could classify Booking.com as a 'gatekeeper,' imposing additional restrictions on data usage, service bundling, and parity clauses, which could reduce competitive flexibility and increase compliance costs. Together, these financial pressures and regulatory uncertainties constrain both short-term profitability and long-term strategic initiatives like the Connected Trip platform.",
      "llm_answer": "\n\nBooking.com's shift to a merchant-based transaction model increased operating expenses, including payment processing, chargebacks, and fraud-related costs, which negatively impacted Booking Holdings' operating margins in 2022. Concurrently, regulatory investigations in Switzerland (over commission levels) and the EU (under the Digital Markets Act and consumer protection laws) introduced compliance costs, potential fines, and constraints on business practices (e.g., parity clauses), further pressuring margins. Collectively, these factors prompted Booking Holdings to prioritize compliance and operational adjustments, while advancing its \"Connected Trip\" strategy to integrate services and offset margin pressures through innovation and payment platform expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Booking.com's merchant-based model increases expenses (payment processing, chargebacks, fraud), negatively impacting operating margins; regulatory pressures in Switzerland (commission investigation by Price Surveillance Office) and the EU (Digital Markets Act) introduce compliance costs and potential restrictions on parity clauses and data usage. The strategic response—advancing the 'Connected Trip' platform—is correctly identified. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes financial impacts (margin pressure from higher costs) with regulatory risks (Switzerland, EU DMA) and connects them to strategic business responses. The only minor omission is not explicitly mentioning 'credit card rebates' as incremental revenue under the merchant model, and slightly less detail on how the DMA could affect 'gatekeeper' designation and service bundling. However, the core implications—reduced flexibility and increased compliance costs—are captured. (4) The answer is fully contextually relevant, directly addressing how both business model shifts and regulatory environments impact margins and strategy in 2022. Wording differs slightly but meaning is semantically equivalent. A score of 9 is justified due to high accuracy with minimal detail omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 417,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the maximum total duration of a petroleum retention license in Papua New Guinea, considering both the initial term and possible extensions, and how does this regulatory framework potentially influence ExxonMobil's long-term LNG development strategy in the region as outlined in its 2022 10-K filing?",
      "original_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, which includes an initial 5-year term and up to two extensions at the Minister's discretion. This regulatory framework influences ExxonMobil's long-term LNG development strategy by allowing the Corporation to maintain rights over gas resources that are not currently commercially viable but may become so within that 15-year window. This aligns with ExxonMobil's strategy of selectively developing attractive natural gas resources and pursuing long-term LNG projects such as the one in Papua New Guinea.",
      "llm_answer": "\n\nThe maximum total duration of a petroleum retention license in Papua New Guinea is **15 years**, consisting of an initial 5-year term plus two possible extensions totaling up to 10 years (as extensions cannot exceed 10 years in total). This regulatory framework influences ExxonMobil's long-term LNG development strategy by necessitating timely exploration and commercial viability assessments to transition retention licenses to development licenses (which allow longer-term operations). In its 2022 10-K, ExxonMobil emphasizes prioritizing low-cost supply and selective development, aligning with the need to secure and extend licenses efficiently to advance projects like its PNG LNG developments, ensuring operational continuity and shareholder value amid regulatory constraints.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the maximum total duration of 15 years is correct, with an initial 5-year term and up to two extensions totaling 10 additional years, which matches the original answer. The breakdown of the license term is consistent with the regulatory framework. (2) The answer correctly identifies that extensions are at the Minister's discretion, though it reframes this as a 'total not exceeding 10 years'—a reasonable interpretation that does not contradict the ground truth. (3) The qualitative reasoning about ExxonMobil's LNG strategy is sound: it correctly links the 15-year window to the need for timely commercial assessments and transition to development licenses, which is logically consistent with ExxonMobil's stated strategy in its 2022 10-K of selective, low-cost development. The mention of 'operational continuity and shareholder value' adds context not in the original but does not distort the meaning. (4) The multi-hop synthesis—connecting PNG licensing rules to ExxonMobil's strategic behavior—is well executed. The only minor shortcoming is that the original emphasizes the ability to hold non-commercial resources for future viability, while the LLM focuses more on the pressure to transition licenses. This is a nuanced difference in emphasis, not a factual error. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 400,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the year-over-year change in Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets, and how does this shift compare to the change in their Hedge funds/limited partnerships investments?",
      "original_answer": "Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets decreased by $46 million year-over-year (from $83 million in 2022 to $37 million in 2023). Meanwhile, their investment in Hedge funds/limited partnerships remained relatively stable, increasing slightly by $4 million (from $14 million in 2022 to $18 million in 2023). This indicates a significant reallocation away from Level 2 pooled funds while maintaining a consistent position in alternative investments like hedge funds.",
      "llm_answer": "\n\nThe year-over-year change in Coca-Cola's investment in **Mutual, pooled, and commingled funds** (Level 2 assets) increased by **$55 million** (from $202 million in 2022 to $257 million in 2023). In contrast, **Hedge funds/limited partnerships** saw a larger increase of **$121 million** (from $936 million in 2022 to $1,057 million in 2023). Thus, the shift in Hedge funds/limited partnerships grew at a significantly higher rate compared to Mutual, pooled, and commingled funds.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, Coca-Cola's investment in Mutual, pooled and commingled funds (Level 2) decreased by $46 million (from $83M in 2022 to $37M in 2023), but the LLM claims an increase of $55M (from $202M to $257M), which is factually wrong on direction, magnitude, and base values. Similarly, for Hedge funds/limited partnerships, the ground truth shows a minor increase of $4M (from $14M to $18M), but the LLM reports a massive $121M increase (from $936M to $1,057M), which is completely inaccurate. (2) All numerical values are incorrect—both starting and ending amounts and the calculated differences are wrong. The calculations themselves (e.g., $257M - $202M = $55M) are arithmetically correct but based on false inputs, so quantitative accuracy is very low. (3) The multi-hop reasoning fails because the model did not retrieve or synthesize the correct data points across years and asset categories. Instead, it appears to have hallucinated figures unrelated to the actual 10-K filing data. The comparison between the two investment shifts is therefore invalid. (4) Contextual relevance is slightly above zero because the answer addresses the right categories and time frame (2022 to 2023) and attempts a comparative analysis, but the severe factual and numerical errors render the response misleading and effectively incorrect. Hence, the correctness score is 1—only minimal credit for attempting the right structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 419,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What was the total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023, considering both the reduction in net income at gas distribution operations and the additional earnings adjustment mentioned in the financial statements?",
      "original_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a $53 million reduction, combining the $29 million decrease in net income at gas distribution operations and the additional $24 million earnings adjustment.",
      "llm_answer": "\n\nThe total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a **$29 million reduction** in net income at gas distribution operations, which included the effects of the disallowances. Additionally, Southern Company Gas recorded a **$88 million pre-tax estimated loss on regulatory disallowance**, which further reduced net income after accounting for tax benefits. Combining these, the total after-tax impact on net income was **$64 million** ($88 million pre-tax loss minus a $24 million tax benefit).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and calculation. The ground truth states the total impact was a $53 million reduction, composed of a $29 million decrease in net income and a $24 million additional earnings adjustment. The LLM instead reports a $64 million after-tax impact from an $88 million pre-tax loss and $24 million tax benefit, which does not match the original data. The $29 million figure is correct, but the additional adjustment is misrepresented as $88 million pre-tax with a $24 million tax benefit, whereas the original answer specifies a $24 million earnings adjustment (not a tax benefit). (2) The quantitative inaccuracies are significant: the LLM invents an $88 million pre-tax loss and frames the $24 million as a tax benefit reducing that loss, which contradicts the ground truth where the $24 million is an additional earnings adjustment (not tax-related). The correct total is $53 million, not $64 million. (3) The multi-hop reasoning is flawed: while the model attempts to synthesize net income impacts from multiple components, it introduces incorrect financial constructs (pre-tax loss, tax benefit) not present in the original answer, suggesting a misunderstanding of the financial statements. It fails to correctly identify that the $24 million is an additional adjustment, not a tax effect. (4) Scores are low due to major factual and calculation errors, though the answer is contextually relevant—addressing the right companies, year, and general topic—and correctly identifies the $29 million reduction, which prevents a score of 0.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 439,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "Which businesses, in addition to WarnerMedia, were classified as discontinued operations by AT&T as part of its strategic shift, and what was the significance of this classification in relation to AT&T's broader restructuring efforts?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification was significant because it reflected AT&T’s comprehensive restructuring plan that involved divesting multiple business units, even those that did not individually meet the materiality threshold for discontinued operations. The combined divestiture of these businesses was treated as a single strategic shift, enabling AT&T to focus on its core communications segment while exiting non-core or underperforming businesses.",
      "llm_answer": "\n\nIn addition to WarnerMedia, AT&T classified **Vrio, Xandr, and Playdemic** as discontinued operations as part of its strategic shift. This classification reflects AT&T's broader restructuring efforts to streamline its business portfolio, focus on core telecommunications and communications services, and separate non-core assets to enhance operational clarity and financial performance. By reclassifying these businesses, AT&T aimed to align its financial reporting with its strategic priorities, enabling a clearer view of its ongoing operations while divesting underperforming or non-strategic units.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all businesses classified as discontinued operations—Vrio, Xandr, and Playdemic—in addition to WarnerMedia, which matches the ground truth. There are no numeric values, dates, or financial figures in the question or answer that require quantitative verification, so quantitative accuracy is scored as 10. The qualitative accuracy is high: the answer accurately captures the significance of the classification as part of AT&T’s restructuring to focus on core communications and divest non-core assets. It correctly conveys the strategic intent behind the discontinued operations classification. However, it omits a key nuance present in the original answer: that these divestitures were treated as a single strategic shift despite some not meeting materiality thresholds individually. This is a minor but notable omission in the reasoning chain, particularly for multi-hop understanding. The answer remains semantically equivalent in intent and overall meaning, and it fully addresses both parts of the question. Contextual relevance is perfect—the response is focused, on-topic, and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 325,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What was the change in the fair value of Medtronic's auction rate securities from April 30, 2021, to April 29, 2022, and how did this impact the total available-for-sale debt securities' fair value over the same period?",
      "original_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. However, the total available-for-sale debt securities' fair value decreased from $7,257 million to $6,893 million, a decline of $364 million. This indicates that while auction rate securities held stable, other components of available-for-sale debt securities experienced significant unrealized losses, contributing to the overall decline in fair value.",
      "llm_answer": "\n\nThe fair value of Medtronic's auction rate securities remained unchanged at $33 million as of both April 30, 2021, and April 29, 2022, resulting in no change in their value over the period. Consequently, the auction rate securities did not impact the total available-for-sale debt securities' fair value, which decreased by $364 million (from $7,257 million to $6,893 million) due to unrealized losses in other categories such as corporate debt and mortgage-backed securities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value of auction rate securities is correctly stated as $33 million for both dates, and the total available-for-sale debt securities' fair value is correctly reported as decreasing from $7,257 million to $6,893 million, a difference of $364 million. The calculation of the decline is accurate. (2) The answer is complete, addressing both parts of the question: the change in auction rate securities (no change) and the impact on total available-for-sale debt securities (no impact from auction rate securities, but a $364 million decline overall due to other components). (3) Entity accuracy is correct—Medtronic is the right company, and the dates (April 30, 2021, and April 29, 2022) match the fiscal periods in the original. (4) The reasoning is sound and reflects proper multi-hop synthesis: it correctly infers that since auction rate securities did not change, the decline in total fair value must stem from other components of available-for-sale debt securities, and it plausibly identifies corporate debt and mortgage-backed securities as those components (consistent with typical 10-K disclosures). The semantic meaning and factual content are equivalent to the ground truth, with slightly enhanced detail that does not introduce error. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 387,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did the goodwill impairment charges related to OpenTable and KAYAK in 2020 affect the adjusted carrying value of goodwill by September 30, 2020, and what was the cumulative impact of these charges?",
      "original_answer": "The goodwill impairment charge of $489 million recognized in March 2020 and the additional charge of $573 million recognized in September 2020 cumulatively reduced the carrying value of goodwill for the OpenTable and KAYAK reporting unit from its initial value to $1.0 billion by September 30, 2020. This represents a total impairment of $1,062 million over the two periods.",
      "llm_answer": "\n\nThe goodwill impairment charges related to OpenTable and KAYAK in 2020 reduced the adjusted carrying value of goodwill to **$1.0 billion by September 30, 2020**. The cumulative impact of these charges totaled **$1,062 million**, comprising a $489 million impairment recognized in the March 31, 2020 interim test and a $573 million impairment recognized in the September 30, 2020 annual test. These charges reflected the significant decline in forecasted cash flows and prolonged recovery timelines for the reporting unit due to the COVID-19 pandemic.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $489 million charge in March 2020 and $573 million charge in September 2020 sum to a cumulative $1,062 million impairment, which aligns with the original answer. The adjusted carrying value of goodwill is correctly stated as $1.0 billion by September 30, 2020. Minor date formatting differences (March 31, 2020 vs. March 2020) are acceptable and do not affect factual accuracy. (2) The answer is complete, addressing both the adjusted carrying value and the cumulative impact, as required by the question. (3) Entities—OpenTable, KAYAK, goodwill impairment, and the relevant time periods—are correctly identified and contextually accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects two separate impairment charges across time, calculates their cumulative effect, and correctly reports the resulting carrying value. The added context about the pandemic’s impact on cash flows is consistent with typical disclosures and enhances, without distorting, the factual response. All elements demonstrate semantic equivalence and factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 337,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Nicor Gas's regulatory disallowances affect Southern Company Gas's 2023 financial performance across both net income and revenue?",
      "original_answer": "Nicor Gas's regulatory disallowances contributed to a $29 million decrease in net income at gas distribution operations for Southern Company Gas in 2023. Additionally, these disallowances reduced revenues, as noted in the report of revenue declines due to lower volumes sold and the regulatory disallowances at Nicor Gas. Therefore, the disallowances had a dual negative financial impact by reducing both net income and revenue.",
      "llm_answer": "\n\nNicor Gas's regulatory disallowances negatively impacted Southern Company Gas's 2023 financial performance by reducing net income by **$29 million after-tax** (as part of a broader $88 million pre-tax estimated loss on regulatory disallowance recorded in the income statement). These disallowances also contributed to a **$1.3 billion decrease in operating revenues** for 2023, primarily due to lower volumes sold and reduced cost recovery mechanisms at Nicor Gas. While the exact revenue impact of the disallowances is not quantified, they were a stated factor in the overall revenue decline.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. (1) The $29 million decrease in net income is correctly cited and aligns with the ground truth, though the addition of 'after-tax' and the mention of an $88 million pre-tax loss are not present in the original answer and cannot be verified from the provided ground truth. (2) The claim of a '$1.3 billion decrease in operating revenues' is not supported by the original answer, which states only that disallowances contributed to revenue declines without quantifying the amount. This large, specific figure is a major overstatement and factually unsupported, severely undermining quantitative accuracy. (3) The qualitative reasoning correctly identifies that Nicor Gas's disallowances negatively affected both net income and revenue at Southern Company Gas, and links the impact to lower volumes and cost recovery—this reflects sound multi-hop understanding of the causal relationship. (4) Contextually, the answer addresses both parts of the question (net income and revenue impact) and stays focused on Southern Company Gas's 2023 performance. However, the introduction of unverified figures ($1.3 billion revenue decline, $88M pre-tax) and lack of clarity on attribution significantly reduce factual correctness. While the core idea of dual negative impact is preserved, the unsupported numbers make the answer misleading. Hence, correctness is scored low despite some accurate reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 407,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How many Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP as of August 31, 2022, and what percentage of the total shares authorized does this represent?",
      "original_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, representing 17.99% of the total 90,000,000 shares authorized.",
      "llm_answer": "\n\nAs of August 31, 2022, **16,191,228 Accenture plc Class A ordinary shares** remained available for issuance under the 2010 ESPP. This represents **17.99%** of the total 90,000,000 shares authorized for the 2010 ESPP. \n\n*Calculation:*  \nAvailable shares = 90,000,000 (authorized) - 73,808,772 (issued) = **16,191,228**.  \nPercentage = (16,191,228 ÷ 90,000,000) × 100 ≈ **17.99%**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of shares remaining available for issuance (16,191,228) and the percentage (17.99%) are accurate and match the original answer exactly. The total authorized shares (90,000,000) are correctly referenced. (2) The calculation provided—subtracting issued shares (73,808,772) from authorized shares to arrive at available shares—is correct and validates the result. The percentage calculation (16,191,228 ÷ 90,000,000 × 100 ≈ 17.99%) is mathematically sound. (3) The reasoning demonstrates proper multi-hop synthesis: it combines the total authorized shares, the number of shares issued, and computes both the remaining balance and its percentage—key elements required by the question. (4) All entities—Accenture plc, Class A ordinary shares, 2010 ESPP, and the date August 31, 2022—are correctly identified and contextually accurate. The answer is semantically equivalent to the ground truth, with added clarity from showing the calculation. No errors in facts, logic, or completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 309,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, as outlined in its 2023 10-K, influence its 2024 expense trends and longer-term operational efficiency goals?",
      "original_answer": "AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment will pressure 2024 expense trends due to the spending required to support growth and efficiency initiatives, including the deployment of Open RAN and associated accelerated depreciation. However, the software benefits of 5G wireless technology, enabled by Open RAN, are expected to result in a more efficient use of capital and lower network-related expenses in the coming years. This aligns with AT&T's longer-term operational efficiency goals by fostering lower network costs and improved operational efficiencies through a more robust ecosystem of network infrastructure providers and suppliers.",
      "llm_answer": "\n\nAT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, announced in late 2023, is expected to **increase 2024 expenses** due to upfront investments in network modernization, including accelerated depreciation and deployment costs. However, the initiative aligns with long-term operational efficiency goals by fostering **lower network costs** and **improved efficiencies** through software-driven, virtualized infrastructure. By transitioning to open, programmable networks, AT&T aims to enhance scalability, reduce reliance on proprietary hardware, and enable faster adoption of next-generation technologies (e.g., 5G advancements). The company plans for 70% of wireless traffic to flow across open-capable platforms by late 2026, with fully integrated Open RAN sites operational by 2024, positioning it for sustainable, high-performance networks and reduced capital/operational expenditures over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that AT&T's Open RAN collaboration with Ericsson will increase 2024 expenses due to upfront deployment costs and accelerated depreciation, which matches the original answer's point about expense pressure. It also correctly states the long-term benefits of lower network costs and improved operational efficiency. (2) The quantitative elements—'70% of wireless traffic by late 2026' and 'fully integrated Open RAN sites operational by 2024'—are plausible and contextually consistent, though these specific percentages and timelines are not present in the original answer. However, since the original answer does not contradict them and such details may be inferred from broader strategic goals in 10-K filings, this does not constitute a factual error but rather added detail. (3) The reasoning is sound: the LLM correctly synthesizes the trade-off between short-term expense increases and long-term efficiency gains, linking Open RAN deployment to software-driven efficiency and reduced reliance on proprietary systems. (4) The answer is fully relevant, addressing both the 2024 expense trends and longer-term operational goals. The only minor deviation is the inclusion of forward-looking metrics (70%, 2026) not present in the ground truth, but these do not contradict it and may reflect additional context from the 10-K. Overall, the answer demonstrates strong multi-hop reasoning and factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 413,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, and how did this compare to the discounted future net cash flows from this region in the same year?",
      "original_answer": "The total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, were 2,635 million barrels. This corresponds to a discounted future net cash flow of $28,710 million from Canada/Other Americas in 2021. The reserves represent a significant portion of XOM's future cash flow projections from the region.",
      "llm_answer": "\n\nThe total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, were **$3,844 million** (from the \"Property (acreage) costs - Proved\" line in the Capitalized Costs table under Other Americas). The discounted future net cash flows from this region in 2021 are not explicitly disclosed in the provided pages, though the \"Results of producing activities for consolidated subsidiaries\" for Other Americas in 2021 totaled **$2,783 million**, representing post-tax operational results rather than discounted cash flows.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both key numbers. The ground truth states that the total proved developed bitumen reserves were 2,635 million barrels, but the LLM incorrectly reports $3,844 million, which is a dollar amount and not a barrel volume. This suggests confusion between reserves (measured in barrels) and capital costs (measured in dollars). The LLM cites 'Property (acreage) costs - Proved' under Other Americas, which reflects capitalized costs, not reserves volumes—this is a critical misinterpretation of the data. (2) For discounted future net cash flows, the ground truth is $28,710 million, but the LLM states this figure is not disclosed and instead provides $2,783 million as 'Results of producing activities', which is post-tax earnings, not discounted future net cash flows. These are fundamentally different financial metrics. The LLM fails to report the correct number and incorrectly asserts it is not disclosed. (3) The multi-hop reasoning is flawed: the model fails to correctly identify and synthesize the relevant data points across the document. It confuses financial costs with physical reserves and operational results with projected discounted cash flows. There is no evidence of correct entity or metric alignment. (4) The contextual relevance is moderate because the answer addresses the right region (Canada/Other Americas) and company (XOM) and attempts to locate relevant tables, but the misinterpretation of metrics severely undermines accuracy. Due to major factual and conceptual errors in both quantitative values and qualitative reasoning, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 449,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the adoption of ASU No. 2022-02 impact Capital One's allowance for credit losses and loan modification reporting practices as of December 31, 2023?",
      "original_answer": "The adoption of ASU No. 2022-02 led to a $2.1 billion increase in Capital One's allowance for credit losses, bringing the total to $15.3 billion as of December 31, 2023. Additionally, the standard eliminated the classification of loan modifications as Troubled Debt Restructurings (TDRs), replacing them with a new framework for reporting modified loans, which affects how loan modifications are disclosed and managed under the new accounting guidance.",
      "llm_answer": "\n\nThe adoption of ASU No. 2022-02 impacted Capital One's practices as follows:  \n\n1. **Allowance for Credit Losses**: The allowance increased to $15.3 billion as of December 31, 2023, partly due to the elimination of troubled debt restructuring (TDR) accounting. The ASU removed the requirement to grant concessions for modifications, leading to reclassifications of prior TDRs as financial difficulty modifications (FDMs). A cumulative adjustment of $63 million (noted in Table 27) reduced the allowance at adoption, reflecting updated methodologies for incorporating FDMs into credit loss estimates.  \n\n2. **Loan Modification Reporting**: Modifications previously classified as TDRs are now reported as FDMs under ASU 2022-02, without requiring concessions. For example, interest rate reductions, term extensions, or principal forgiveness for borrowers in financial difficulty are now uniformly classified as FDMs. This change expanded disclosure requirements for such modifications, replacing prior TDR disclosures (e.g., in 2023 vs. 2022 reporting). The types of modifications offered (e.g., payment plans, rate reductions) remained unchanged, but their classification and disclosure aligned with the new standard.  \n\nIn summary, the ASU shifted reporting from TDRs to FDMs, broadened disclosure requirements, and influenced allowance calculations by removing concession criteria, resulting in a higher allowance and adjusted accounting treatment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that the adoption of ASU No. 2022-02 led to a $2.1 billion increase in the allowance for credit losses, resulting in a total of $15.3 billion as of December 31, 2023. The LLM correctly identifies the $15.3 billion total allowance, but incorrectly attributes a $63 million reduction (from Table 27) as part of the cumulative adjustment at adoption, which contradicts the ground truth that shows an increase, not a decrease. There is no mention of the $2.1 billion increase in the LLM answer, which is a critical omission and factual error. (2) The LLM introduces a 'cumulative adjustment of $63 million' that reduced the allowance, which directly conflicts with the ground truth indicating a $2.1 billion increase. This suggests either a misinterpretation of the data or confusion with another figure. The $63 million figure is not mentioned in the ground truth and appears to be fabricated or misapplied. (3) Qualitatively, the LLM correctly captures the conceptual shift from TDRs (Troubled Debt Restructurings) to FDMs (Financial Difficulty Modifications) under ASU 2022-02 and accurately describes the elimination of the concession requirement and expanded disclosure. The explanation of how loan modifications are now classified and reported is logically sound and aligns with the new standard’s intent. (4) Contextually, the answer is highly relevant and well-structured, addressing both parts of the question—impact on allowance and reporting practices. However, the major quantitative error regarding the direction and magnitude of the allowance change severely undermines factual correctness. While the qualitative reasoning is strong and the entity (Capital One), metric (allowance for credit losses), and time period (December 31, 2023) are correct, the incorrect numerical analysis leads to a correctness score of 6 due to partial accuracy with a significant factual flaw.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 535,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland impact GE's liquidity position as reported in its 2023 10-K filing?",
      "original_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could negatively impact GE's liquidity position. GE reported total cash, cash equivalents, and restricted cash of $17.0 billion at December 31, 2023. However, $14.2 billion of this amount was held outside the U.S., with $1.7 billion in countries with currency control restrictions. If additional contingent liabilities from Bank BPH become payable, GE may face challenges in accessing sufficient liquidity without incurring substantial costs or repatriation taxes. This could constrain its ability to meet business needs and financial obligations, especially under stressed conditions.",
      "llm_answer": "\n\nThe potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could adversely impact GE's liquidity position by requiring additional cash outflows or reserves, reducing available liquidity. As disclosed in the 2023 10-K, GE retains exposure to Bank BPH's mortgage portfolio litigation, with future liabilities or loss estimates potentially becoming payable. This risk is highlighted in the \"Run-off Insurance and Banking Operations\" section, which notes that such liabilities could materially affect GE's financial position, cash flows, or capacity to fund operations. While GE maintains significant liquidity (e.g., $17.0 billion in cash and equivalents as of December 31, 2023), unexpected or substantial increases in these contingent liabilities could strain liquidity, particularly if they necessitate immediate payments or capital contributions, as seen with prior insurance reserve adjustments. The document emphasizes that while current liquidity is sufficient, material adverse developments in Bank BPH's litigation remain a risk to GE's financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: GE's total cash, cash equivalents, and restricted cash of $17.0 billion as of December 31, 2023, is accurately reported. The LLM correctly identifies the risk of contingent liabilities from Bank BPH's litigation in Poland impacting GE's liquidity, consistent with the original answer. (2) Quantitative accuracy is perfect: the $17.0 billion figure is correctly cited, and while the LLM does not mention the $14.2 billion held outside the U.S. or the $1.7 billion in countries with currency controls, this is a minor omission rather than an error. These details are contextually relevant but not central to the core claim about liquidity risk. (3) The multi-hop reasoning is sound: the LLM correctly links Bank BPH litigation → potential contingent liabilities → cash outflows → impact on liquidity → risk to financial flexibility, drawing from GE’s 2023 10-K disclosures. It references the correct section (Run-off Insurance and Banking Operations) and notes prior reserve adjustments as precedent, demonstrating strong synthesis. (4) The answer is contextually relevant and comprehensive, addressing the mechanism of impact on liquidity and acknowledging that while current liquidity is sufficient, material adverse developments pose a risk. The only reason for not scoring a 10 is the omission of the geographic and restricted cash breakdown, which adds nuance to the liquidity constraint argument in the original answer. However, the core reasoning and factual accuracy remain intact, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 448,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How many total shares were both issued upon exercise of outstanding options and still available for future issuance under the Amended and Restated 2010 Share Incentive Plan as disclosed in the 2022 10-K filing?",
      "original_answer": "The Amended and Restated 2010 Share Incentive Plan had 14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares still available for future issuance, totaling 42,212,084 shares.",
      "llm_answer": "\n\nThe total shares both issued upon exercise of outstanding options and available for future issuance under the Amended and Restated 2010 Share Incentive Plan, as disclosed in the 2022 10-K, are **42,212,084**. This is calculated by adding **14,830,623 shares** (outstanding options) and **27,381,461 shares** (remaining available for future issuance) from the equity compensation plan table in Item 12.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: 14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares available for future issuance are correctly cited. The total of 42,212,084 shares is accurate and properly calculated. (2) Quantitative accuracy is perfect—both component numbers and the final sum match the original answer exactly. Minor wording variation ('outstanding options' vs 'issued upon exercise of outstanding options') does not affect meaning. (3) The reasoning is sound: the model correctly identifies the two components required by the question and performs the correct addition, referencing the appropriate source (equity compensation plan table in Item 12 of the 2022 10-K). (4) The answer is contextually relevant, directly addressing the multi-hop nature of the question by synthesizing issued and available shares under the specific plan and filing year. All entities (Amended and Restated 2010 Share Incentive Plan, 2022 10-K) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 301,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total amount of the 2025 Term Loan that AT&T paid off in 2023, and on what date was this loan terminated according to the disclosures?",
      "original_answer": "AT&T paid off the $2,500 million 2025 Term Loan in full and terminated it on March 30, 2023.",
      "llm_answer": "\n\nThe total amount of the 2025 Term Loan that AT&T paid off in 2023 was **$2,500 million**, and the loan was terminated on **March 30, 2023**, as disclosed in the Credit Facilities section of the document.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the amount paid off ($2,500 million) and the termination date (March 30, 2023) are exactly as disclosed. (2) Quantitative accuracy is perfect—both the dollar amount and date match the original answer; format variations like '$2,500 million' are acceptable and semantically equivalent to '$2.5 billion' or '$2,500,000,000'. (3) The reasoning is sound, with no missing steps or incorrect synthesis; the answer correctly identifies that the entire 2025 Term Loan was paid off in full in 2023, which requires understanding the nature of term loan disclosures. (4) The answer is contextually relevant, directly addressing both parts of the question (amount and date) and citing the appropriate section (Credit Facilities) for transparency. No errors in entities, metrics, or time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1074,
        "completion_tokens": 258,
        "total_tokens": 1333
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023, and how much of the 2023 investment was categorized under Level 2 valuation inputs?",
      "original_answer": "KO's investment in mutual, pooled and commingled funds decreased by $47 million from 2022 to 2023. In 2023, $37 million of the $39 million investment was categorized under Level 2 valuation inputs.",
      "llm_answer": "\n\nThe change in KO's investment in mutual, pooled, and commingled funds from 2022 to 2023 was an **increase of $11 million** (from $767 million in 2022 to $778 million in 2023). For 2023, **$257 million** of this investment was categorized under Level 2 valuation inputs. \n\n**Calculation Details:**  \n- **2022 Total**: U.S. ($304 million) + Non-U.S. ($463 million) = **$767 million**.  \n- **2023 Total**: U.S. ($243 million) + Non-U.S. ($535 million) = **$778 million**.  \n- **Change**: $778 million - $767 million = **+$11 million**.  \n- **2023 Level 2**: $257 million (from the fair value hierarchy table under \"Pension Plan Assets\").",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) The change in KO's investment is reported as an increase of $11 million, whereas the ground truth states a decrease of $47 million. This indicates a complete reversal of the correct trend. (2) The LLM claims the 2023 investment level under Level 2 was $257 million, but the correct amount is $37 million of a $39 million total investment. These numbers are vastly different and not within any reasonable margin of error. (3) The calculation details reference U.S. and Non-U.S. pension plan assets ($304M, $463M, etc.), which are unrelated to the actual metric in question—KO's direct investment in mutual, pooled, and commingled funds. The model has conflated different line items from the financial statements, likely from the fair value hierarchy table, but applied them incorrectly to answer a question about a different account. (4) Multi-hop reasoning failed: the model did not correctly identify the relevant financial line item across years or map it to the correct valuation level. While the answer attempts to provide structured calculations and addresses the two-part question format, the underlying data is entirely wrong, leading to a very low correctness score. Contextual relevance is slightly above zero because the answer discusses KO, mutual funds, and Level 2 inputs, but the substance is irrelevant due to incorrect data sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 396,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, and how much net cash did GE pay to AerCap related to continuing involvement with the company during the same period?",
      "original_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million. Additionally, GE paid $203 million in net cash to AerCap related to continuing involvement activities.",
      "llm_answer": "\n\nThe total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was **$1,189 million** (as disclosed in the Bank BPH section of Discontinued Operations). GE paid **$203 million in net cash** to AerCap during the same period related to continuing involvement (as stated in the GECAS/AerCap section).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, both key figures are accurate: the pre-tax charge of $1,189 million and the net cash payment of $203 million to AerCap are correctly reported, with acceptable formatting using 'million' and bold emphasis. (2) The answer addresses both parts of the multi-part question completely—litigation charge and cash payment—fulfilling the completeness requirement. (3) Entity accuracy is correct: GE and AerCap are properly identified, and the time period (year ended December 31, 2023) is accurately referenced. The mention of 'Bank BPH section of Discontinued Operations' and 'GECAS/AerCap section' indicates correct sourcing and multi-hop synthesis across different sections of the filing, demonstrating sound reasoning. (4) The semantic meaning is equivalent to the original answer, with added contextual detail about where the information was disclosed, which enhances credibility without introducing error. All components align perfectly with the ground truth, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 311,
        "total_tokens": 1472
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Accenture's investment in research and development and its focus on delivering 360° value contribute to its competitive positioning in the global IT services market, especially when compared to its competitors' offerings?",
      "original_answer": "Accenture invested $1.1 billion in research and development during fiscal 2022, which supports its ability to innovate and deliver advanced solutions. This investment underpins its strategy of delivering 360° value—defined as providing financial business cases, inclusion and diversity progress, employee reskilling, and sustainability support to clients. This differentiates Accenture in a competitive market where competitors include multinational IT providers, offshore firms, consultancies, and in-house corporate departments. Accenture claims no other firm offers the same breadth of services at scale, and its 360° value approach, backed by R&D and global ecosystem partnerships, enables it to deliver outcomes across strategy, execution, and transformation, giving it a unique competitive edge.",
      "llm_answer": "\n\nAccenture's investment in research and development (R&D) and its focus on delivering 360° value strengthen its competitive positioning by enabling innovation at scale and addressing clients' holistic needs. The company spent $1.1 billion on R&D in fiscal 2022, driving advancements in emerging technologies (e.g., AI, blockchain, quantum computing) and developing proprietary platforms like SynOps and MyWizard. This innovation, combined with over 8,300 patents, allows Accenture to offer differentiated, scalable solutions that competitors often lack. The 360° value framework further distinguishes Accenture by integrating financial outcomes with non-financial priorities such as sustainability, workforce reskilling, and client experience, fostering long-term partnerships. Unlike competitors who may specialize in narrower service areas or geographies, Accenture’s broad capabilities, global delivery network, and ecosystem partnerships enable it to deliver comprehensive, end-to-end transformations, solidifying its leadership in the IT services market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.1 billion R&D investment in fiscal 2022 is correctly stated, matching the original answer. No other numerical data (e.g., patents, client counts) contradicts known facts, and all figures are presented accurately. (2) The answer addresses all key aspects of the question: Accenture’s R&D investment, the 360° value framework, competitive differentiation, and comparison to rivals. It expands on the ground truth with relevant details like SynOps, MyWizard, and 8,300 patents—information consistent with Accenture’s public disclosures and enhancing depth without introducing inaccuracies. (3) Multi-hop reasoning is sound: the model correctly links R&D spending to innovation, ties innovation to proprietary platforms, and connects both to the broader 360° value proposition that differentiates Accenture from competitors such as offshore providers and consultancies. (4) While the original answer emphasizes inclusion and diversity, employee reskilling, and sustainability as components of 360° value, the LLM captures these under the umbrella of 'non-financial priorities'—a semantically equivalent framing. The only minor gap is the absence of the explicit claim that 'no other firm offers the same breadth of services at scale,' though this is implicitly conveyed. Overall, the response is factually correct, comprehensive, and contextually precise, warranting a high score with only slight room for fuller verbatim alignment on the 360° value definition.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 425,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What specific entities, in addition to WarnerMedia, were classified as discontinued operations by AT&T in 2023, and how does this classification affect the presentation of their financial results?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations in 2023. This classification means that the financial results of these entities are excluded from ongoing operations and are instead reported separately as discontinued operations, including for periods prior to the consummation of the WarnerMedia/Discovery transaction.",
      "llm_answer": "\n\nIn 2023, AT&T classified **WarnerMedia, Vrio, Xandr, and Playdemic** as discontinued operations. This classification requires their financial results to be presented separately from continuing operations in the consolidated financial statements. Specifically, their revenues, expenses, and net losses are disclosed in a distinct section of the income statement (as shown in NOTE 24), enabling investors to assess the performance of ongoing operations independently. Additionally, prior-period financial statements are retrospectively adjusted to reflect these entities as discontinued operations, ensuring consistent comparability across periods.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Entity accuracy: The LLM correctly identifies WarnerMedia, Vrio, Xandr, and Playdemic as the entities classified as discontinued operations by AT&T in 2023, which aligns exactly with the original answer. (2) Quantitative accuracy: There are no numerical values to verify in this question, but the temporal reference (2023) is accurate. (3) Reasoning and completeness: The LLM addresses both parts of the multi-hop question—identifying the entities and explaining the financial reporting impact. It correctly explains that the results are separated from continuing operations, presented distinctly in financial statements (with reference to NOTE 24 as supporting evidence), and that prior periods are retrospectively adjusted for comparability. This reflects proper synthesis of accounting principles related to discontinued operations. (4) Semantic equivalence: While the LLM provides additional detail (e.g., mention of NOTE 24 and structure of income statement disclosure), all added information is contextually accurate and enhances the answer without introducing errors. The core facts and implications match the ground truth precisely. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 357,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, and how does this loss distribute across the maturity periods according to the 2022 10-K filing?",
      "original_answer": "The total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, is $3 million. This loss is entirely associated with securities having maturity periods of more than 12 months, as no unrealized loss is reported for securities with maturity periods of less than 12 months.",
      "llm_answer": "\n\nThe total unrealized loss attributed to Auction Rate Securities (ARS) held by Medtronic plc (MDT) as of April 29, 2022, is **$3 million**. According to the 2022 10-K filing, this loss is entirely allocated to the **\"More than 12 months\"** maturity category, as ARS are classified under Level 3 of the fair value hierarchy with a fair value of $33 million and no unrealized losses in the \"Less than 12 months\" period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the total unrealized loss of $3 million is accurately reported, and the distribution—entirely in the 'More than 12 months' maturity category—is correctly stated. The additional detail about fair value ($33 million) and Level 3 classification is consistent with typical 10-K disclosures and does not contradict the ground truth. (2) All numbers are accurate: $3 million loss, correct date (April 29, 2022), and correct categorization by maturity. Format variations (e.g., 'More than 12 months' vs 'more than 12 months') are semantically equivalent. (3) The reasoning is sound: the answer correctly synthesizes that no loss is attributed to securities with maturities under 12 months, which aligns with the multi-hop requirement of interpreting maturity-based unrealized loss distribution. (4) The answer is contextually relevant, directly addressing both parts of the question—total loss and its distribution—using correct entities (MDT, Auction Rate Securities, 2022 10-K, correct fiscal period). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 320,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How many shares of Class B-2 common stock were issued during the Class B-1 common stock exchange offer in May 2024, and what percentage of the total shares issued in that exchange consisted of Class B-2 common stock?",
      "original_answer": "In May 2024, 120 million shares of Class B-2 common stock were issued during the exchange offer for Class B-1 common stock. A total of 168 million shares were issued in that exchange (120 million Class B-2 and 48 million Class C). Therefore, Class B-2 shares accounted for approximately 71.4% of the total shares issued.",
      "llm_answer": "\n\nDuring the Class B-1 common stock exchange offer in May 2024, **120 million shares of Class B-2 common stock** were issued. This represented **71.4% of the total shares issued in the exchange** (120 million Class B-2 shares ÷ 168 million total shares issued, calculated as 120 million + 48 million Class C shares). \n\n(Source: ITEM 7, \"Class B-1 common stock exchange offer\" section of the document.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that 120 million shares of Class B-2 common stock were issued in May 2024, which aligns with the original answer. (2) It correctly calculates the total shares issued as 168 million (120 million Class B-2 + 48 million Class C) and computes the percentage as 71.4% (120/168 ≈ 0.714), which is accurate. (3) The multi-hop reasoning—combining the number of Class B-2 and Class C shares to compute a percentage of the total—is sound and properly explained. (4) All entities (Class B-1 exchange offer, Class B-2 and Class C shares, May 2024 time frame) are correctly identified and synthesized. The answer is semantically equivalent to the ground truth, with clear, concise, and precise wording. Minor formatting differences (e.g., use of bold) do not affect correctness. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 265,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023, and how does this reflect in the change in the number of Wind Turbines sold during the same period?",
      "original_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 (11.7 GW) to 2023 (8.5 GW) is 3.2 GW. During the same period, the number of Wind Turbines sold decreased from 3,590 units in 2021 to 2,225 units in 2023, a reduction of 1,365 units. This indicates a decline in both the volume of turbines sold and the overall capacity of wind energy systems delivered by GE.",
      "llm_answer": "\n\nThe total decrease in Wind Turbine Gigawatts (GW) capacity sold by GE from 2021 to 2023 was **3.2 GW** (from 11.7 GW in 2021 to 8.5 GW in 2023). This reflects a **1,365-unit decrease in Wind Turbines sold** during the same period (from 3,590 units in 2021 to 2,225 units in 2023). The smaller decline in GW capacity compared to the unit count is attributed to the shift toward larger, higher-capacity turbines (e.g., 13 MW Haliade-X units introduced in 2023), which generate more power per unit despite fewer installations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects: the decrease in GW capacity (11.7 GW to 8.5 GW = 3.2 GW) and the reduction in units sold (3,590 to 2,225 = 1,365 units) are correctly calculated and reported. All entities (GE, Wind Turbine capacity, years 2021–2023) are accurate, and the multi-hop synthesis across time and metrics is sound. The answer goes beyond the original by providing a plausible qualitative explanation—fewer units but relatively smaller drop in capacity due to larger turbines (e.g., 13 MW Haliade-X)—which is contextually reasonable and enhances the response without contradicting the ground truth. This added insight does not introduce error but reflects strong reasoning. The only reason for not scoring a perfect 10 is that the original answer did not include the turbine size shift explanation, so while it's a valuable addition, it slightly extends beyond the verified knowledge graph content. However, it does not detract from factual correctness. All formatting and numerical representations are clear and equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 310,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "What was the total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, and how does this reflect in the company's cash flow classification?",
      "original_answer": "AT&T paid a total of $26,477 million for C-Band licenses, including $23,406 million in auction deposits and payments, $3,067 million in incentive and relocation costs ($955 million for Phase I, $2,112 million for Phase II, and $1,100 million in compensable relocation costs over several years, of which $650 million was paid in 2021, $98 million in 2022, and $109 million in 2023). These payments are classified under 'Acquisitions, net of cash acquired' on AT&T's consolidated statements of cash flows.",
      "llm_answer": "\n\nThe total amount paid by AT&T for C-Band licenses, including incentive and relocation costs through 2023, was **$27,330 million**. This includes:  \n- **Initial auction payments**: $23,406 million (deposit of $550 million in 2020 and $22,856 million in 2021).  \n- **Incentive payments**: $955 million (Phase I in 2021) and $2,112 million (Phase II in 2023).  \n- **Relocation costs**: $650 million (2021), $98 million (2022), and $109 million (2023), totaling $857 million.  \n\nThese payments are classified under **investing activities** in the consolidated statements of cash flows, specifically within the line item *\"Acquisitions, net of cash acquired.\"*",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant factual and calculation errors, particularly in the total amount paid. The ground truth states $26,477 million total, but the LLM reports $27,330 million, which is $853 million higher. This error stems from incorrect aggregation: the LLM sums $23,406M (auction) + $955M + $2,112M (incentives) + $857M (relocation) = $27,330M, but the ground truth specifies that the $3,067M in incentive and relocation costs already includes the $955M (Phase I), $2,112M (Phase II), and $1,100M compensable relocation costs (with only $857M paid through 2023). The LLM double-counts by adding both incentive and relocation as separate full amounts. (2) The individual components are mostly accurate: auction payments of $23,406M, Phase I incentive ($955M), Phase II ($2,112M), and annual relocation payments ($650M in 2021, $98M in 2022, $109M in 2023) match the ground truth. However, the total relocation paid through 2023 is correctly $857M, but the LLM incorrectly treats this as the full relocation cost rather than part of a larger $1,100M obligation. (3) The multi-hop reasoning is partially sound—information is synthesized across years and categories—but fails in proper classification and summation logic. The model correctly identifies the cash flow classification as 'Acquisitions, net of cash acquired' under investing activities, which aligns with the ground truth. (4) Despite correct categorization and mostly accurate component figures, the major miscalculation of the total amount severely undermines factual correctness. Hence, the correctness and quantitative accuracy scores are low. Qualitative accuracy is moderate due to correct entity and time period identification, and contextual relevance is high as the answer addresses all aspects of the question with appropriate structure and terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 496,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Medtronic's decision to discontinue the HVAD System impact its financial performance in fiscal year 2022, and what other product lines were highlighted as growth drivers in the same period?",
      "original_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 removed a product that had generated $141 million in net sales during fiscal year 2021. This discontinuation likely contributed to the company's focus on other growth drivers in fiscal year 2022, such as the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and transcatheter mitral and tricuspid therapy products led by the Intrepid system. Despite the loss of HVAD revenue, Medical Surgical's net sales increased to $9.1 billion in fiscal year 2022, up 5% compared to the prior year, driven by recovery in global procedure volumes and strong performance in Surgical Innovations, partially offset by supply chain disruptions.",
      "llm_answer": "\n\nMedtronic's decision to discontinue the HVAD System in June 2021 led to a decline in its Cardiovascular segment net sales in fiscal year 2022, partially offsetting growth in other areas. Specifically, HVAD System sales dropped from $141 million in fiscal 2021 to zero in 2022. Key growth drivers in 2022 included:  \n1. **Structural Heart & Aortic (SHA)**: 8% growth driven by transcatheter aortic valve replacement (CoreValve Evolut) and ExtraCorporeal Life Support (ECLS) devices.  \n2. **Cardiac Rhythm & Heart Failure (CRHF)**: 6% growth from Micra pacemakers, TYRX antibacterial envelopes, and Arctic Front cryoablation systems.  \n3. **Coronary & Peripheral Vascular (CPV)**: 5% growth led by Peripheral Vascular Health products like the Abre venous stent and VenaSeal Closure System.  \n4. **Surgical Innovations (Medical Surgical)**: 11% growth from LigaSure, Sonicision, and hernia/wound management solutions.  \n5. **Neuroscience Specialty Therapies**: 12% growth in Pelvic Health (InterStim Micro), ENT, and Neurovascular (flow diversion, liquid embolics).  \n\nThese product lines offset the HVAD decline and contributed to overall segment growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and entity identification, despite addressing the correct question structure and providing relevant context. (1) Quantitative Accuracy: The claim that HVAD sales dropped from $141M in FY2021 to zero in FY2022 is consistent with the ground truth, but the LLM fabricates detailed growth percentages (8%, 6%, 5%, 11%, 12%) for business segments not present in the original answer. The ground truth states Medical Surgical net sales grew to $9.1B (up 5%), not 11% as claimed. No segment-level growth rates were provided in the original, so these numbers are incorrect. (2) Completeness: The LLM addresses both parts of the question—impact of HVAD discontinuation and growth drivers—but introduces non-existent segment-level performance data. It omits the specific growth drivers named in the original answer: Symplicity Spyral, Pulse Field Ablation, Aurora Extravascular ICD, and Intrepid system. Instead, it lists unrelated or broader product lines (e.g., CoreValve Evolut, Micra, VenaSeal), which were not highlighted in the ground truth. (3) Entity Accuracy: The LLM misidentifies the key growth drivers. For example, the original emphasizes Pulse Field Ablation and Aurora ICD as new growth areas, while the LLM focuses on established products like Micra and CoreValve, which are not mentioned in the ground truth for FY2022. (4) Reasoning: The multi-hop logic is partially sound—linking HVAD discontinuation to a need for other growth drivers—but the synthesis is flawed because it pulls in incorrect data from potentially other filings or inference. The conclusion that overall segment growth occurred is plausible but unsupported by the original data, which only specifies Medical Surgical growth. (5) Semantic Equivalence: While the general theme (HVAD loss offset by other growth) aligns, the specific facts do not match. The LLM invents precise metrics and misattributes growth drivers, undermining factual correctness. Thus, despite good structure and relevance, the answer is significantly factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 564,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How much total cash did Walmart pay to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024, and what was the impact on Walmart's ownership percentage in Flipkart?",
      "original_answer": "Walmart paid $3.5 billion to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024. This increased Walmart's ownership in Flipkart from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024.",
      "llm_answer": "\n\nWalmart paid a total of **$3.5 billion** during fiscal 2024 to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe. This transaction increased Walmart's ownership in Flipkart from **approximately 75%** as of January 31, 2023, to **approximately 85%** as of January 31, 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $3.5 billion payment amount is accurate, and the ownership increase from approximately 75% to 85% is correctly stated with the right fiscal dates (January 31, 2023, to January 31, 2024). (2) The answer is complete, addressing both parts of the question: the total cash paid and the impact on Walmart's ownership percentage in Flipkart. (3) Entity accuracy is perfect—Walmart, Flipkart, PhonePe, and the correct fiscal year (2024) are all properly identified. (4) The multi-hop reasoning is sound, as it correctly synthesizes information about two related transactions (acquiring Flipkart shares and settling PhonePe liability) into a single cash outflow and links it to the ownership change. (5) The semantic meaning is equivalent to the original answer, with clear, concise, and factually precise wording. No errors in calculation, logic, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 274,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Microsoft's treatment of unearned revenue from volume licensing programs, including the timing of invoicing and revenue recognition, impact the presentation and auditability of its financial statements, given the complexity in determining standalone selling prices (SSP) and the auditor's focus on revenue recognition?",
      "original_answer": "Microsoft recognizes unearned revenue from volume licensing programs, which include Software Assurance (SA) and cloud services, by invoicing annually at the beginning of each contract period and recognizing revenue ratably over the coverage period. This creates contract balances such as receivables or unearned revenue, depending on the timing mismatch between invoicing and revenue recognition. Due to the complexity in determining standalone selling prices (SSP) for on-premises licenses sold with SA or software updates, Microsoft must use judgment and estimates based on customer size and geographic region, which affects the allocation of discounts and the pattern of revenue recognition. This complexity was a critical audit matter for Microsoft’s independent auditors, who focused on the application of revenue recognition principles, especially around transfer of control and variable consideration. Therefore, the structure and accounting treatment of volume licensing programs directly influence both the presentation of financial statements and the nature of the audit procedures performed.",
      "llm_answer": "\n\nMicrosoft's treatment of unearned revenue from volume licensing programs, such as Enterprise Agreements, involves invoicing customers annually at the contract's start but recognizing revenue ratably over the contract period. This creates a significant unearned revenue liability on the balance sheet, reflecting payments received in advance for SA and cloud services. The complexity in determining standalone selling prices (SSP) for distinct performance obligations (e.g., separating on-premises licenses from SA or cloud services) introduces subjectivity, requiring management to use judgment based on market conditions, customer size, and geographic factors. Auditors focus heavily on these judgments, as they directly impact revenue recognition timing and the allocation of consideration between performance obligations. The auditor’s critical audit matter highlights extensive procedures to test management’s SSP estimates, contract terms, and revenue recognition patterns, ensuring compliance with GAAP and minimizing material misstatement risks due to the high volume and complexity of these transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: Microsoft invoices annually at the beginning of the contract period and recognizes revenue ratably, creating unearned revenue liabilities; this applies to volume licensing programs including Software Assurance (SA) and cloud services. The complexity in determining standalone selling prices (SSP) due to bundled offerings is correctly identified, as is the use of management judgment based on customer size, geography, and market conditions. The auditor's focus on SSP estimates, revenue recognition timing, allocation of consideration, and critical audit matters is accurately described. (2) There are no numeric values in the question or answers that require verification—both responses are qualitative and consistent. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the connection between invoicing timing, revenue recognition policy, estimation challenges in SSP, impact on financial statement presentation (e.g., unearned revenue), and resulting audit scrutiny. It correctly infers that these factors collectively affect both financial reporting and audit procedures. (4) Minor deduction in qualitative accuracy (9/10) is due to slightly less explicit mention of 'transfer of control' and 'variable consideration'—which are in the original answer and key audit considerations under ASC 606—but the LLM does refer to 'revenue recognition patterns' and 'allocation of consideration,' which are closely related. Overall, the answer is semantically equivalent, contextually precise, and fully relevant, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1599,
        "completion_tokens": 460,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What were the total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, and why were no profit sharing contributions included in this total?",
      "original_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $343 million ($126 million in 2022, $110 million in 2021, and $107 million in 2020). No profit sharing contributions were included in this total because the company did not make any discretionary profit sharing contributions for the fiscal years 2022, 2021, or 2020, as stated in the plan terms.",
      "llm_answer": "\n\nThe total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan for the fiscal years ended May 31, 2022, 2021, and 2020 were **$343 million** ($126 million + $110 million + $107 million). No profit sharing contributions were included in this total because Nike did not make any discretionary profit sharing contributions under the plan during these fiscal years, as stated in the document. The company’s contributions were limited to matching employee contributions, and senior management and the Board of Directors did not approve any additional profit sharing contributions for eligible employees.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total company contributions as $343 million, with accurate breakdowns of $126 million in 2022, $110 million in 2021, and $107 million in 2020, matching the ground truth exactly. The sum is correct: 126 + 110 + 107 = 343. (2) All numeric values and fiscal years are accurate, and the format ($126 million + $110 million + $107 million) is semantically equivalent to the original answer. (3) The reasoning for the absence of profit sharing contributions is sound and aligns with the ground truth: the company did not make discretionary profit sharing contributions in any of the three fiscal years. The LLM adds contextual detail (e.g., contributions were limited to matching, and senior management/Board did not approve additional contributions), which is consistent with and expands upon the original without introducing inaccuracies. (4) The answer fully addresses both parts of the multi-hop question—total contributions and the reason for no profit sharing—and synthesizes information across the three fiscal years correctly. All scores are maximized due to complete factual accuracy, correct calculations, proper entity and year identification, logical reasoning, and full contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 353,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024, and how does this compare to the change in natural gas reserves in Africa over the same period?",
      "original_answer": "Chevron's consolidated natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet from 312 (2023) to 296 (2024). In contrast, natural gas reserves in Africa increased by 297 billion cubic feet from 172 (2023) to 468 (2024). Therefore, while reserves declined slightly in the Asia Pacific/Middle East, they significantly increased in Africa.",
      "llm_answer": "\n\nThe total change in Chevron's consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024 was a **decrease of 16 billion cubic feet (BCF)** (from 312 BCF to 296 BCF). In contrast, natural gas reserves in Africa increased by **296 BCF** (from 172 BCF to 468 BCF) over the same period. This reflects a significant upward shift in Africa, driven by factors like increased development plans in Libya, compared to a modest decline in the Asia Pacific/Middle East region.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate with only a minor error in the reported increase in Africa's natural gas reserves. The correct increase is 297 BCF (from 172 to 468 BCF), but the LLM states 296 BCF, which is off by 1 BCF. All other numbers are correct: the Asia Pacific/Middle East decrease of 16 BCF (from 312 to 296 BCF) is accurately reported. The answer addresses both parts of the multi-hop question—change in reserves for both regions—and correctly compares them. Entity identification (Chevron, regions, years) is accurate. The reasoning and synthesis across regions and years are sound, and the qualitative explanation (modest decline vs. significant increase) aligns with the data. The minor numerical inaccuracy prevents a perfect score, but the overall response is factually strong and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 242,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How much total cash did Walmart receive from equity funding related to PhonePe during fiscal 2024, and how did this compare to the amount paid to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year?",
      "original_answer": "Walmart received $0.7 billion from equity funding related to PhonePe during fiscal 2024 and paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year. Therefore, Walmart spent $2.8 billion more than it received in net cash related to PhonePe equity transactions during fiscal 2024.",
      "llm_answer": "\n\nWalmart received **$700 million** from equity funding related to PhonePe during fiscal 2024. This amount was offset by **$900 million** paid to acquire shares from noncontrolling interest holders of PhonePe in the same period. Thus, Walmart paid **$200 million more** to acquire noncontrolling interests than it received from new equity funding for PhonePe in fiscal 2024. \n\n(Source: Note 3, \"Purchases and Sales of Subsidiary Stock\" in the provided document.)",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures. According to the ground truth, Walmart received $0.7 billion (i.e., $700 million) from equity funding — this part is correct. However, the LLM states that Walmart paid $900 million to acquire shares from noncontrolling interest holders, whereas the ground truth reports $3.5 billion. This is a major discrepancy. The resulting net cash outflow is stated as $200 million in the LLM answer, but the correct figure is $2.8 billion ($3.5B - $0.7B), making the LLM's conclusion incorrect. (2) Quantitative accuracy fails on two of three key numbers: received amount is correct ($700M), but paid amount ($900M vs $3.5B) and net difference ($200M vs $2.8B) are wrong. Calculations are internally consistent within the LLM’s incorrect numbers, but based on false inputs. (3) The reasoning structure is sound — the model attempts to compare inflows and outflows and draw a net conclusion — but the multi-hop synthesis fails because it uses incorrect data from what should be Note 3. The entity identification (Walmart, PhonePe, fiscal 2024, noncontrolling interests) is accurate, and the source citation appears plausible, but the data extracted is wrong. (4) Contextual relevance is high because the answer addresses the right companies, time period, and transaction types, and attempts the correct comparison. However, due to major numerical inaccuracies affecting the core of the question, the correctness score is low despite proper framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 420,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving the SEC Administrative Order and related legal matters, and how long will the compliance monitor oversee RTX's obligations under these agreements?",
      "original_answer": "RTX recorded a total pre-tax charge of $918 million in 2024 related to the SEC Administrative Order and other legal resolutions. The compliance monitor will oversee RTX's obligations for a period ending three years from the date on which the monitor is engaged.",
      "llm_answer": "\n\nRTX recorded a total pre-tax charge of **$918 million** in 2024 to resolve the SEC Administrative Order and related legal matters, including settlements with the DOJ. The compliance monitor will oversee RTX's obligations under these agreements for **three years from the date the monitor is engaged**, as stipulated in the agreements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the pre-tax charge of $918 million in 2024 is accurately reported, with no calculation or numerical errors. The time period for the compliance monitor—three years from the engagement date—is also correctly stated. Minor additional context (e.g., mention of DOJ settlements) does not contradict the ground truth and adds relevant detail without introducing inaccuracies. (2) The answer addresses both parts of the multi-hop question: the financial impact (charge amount and year) and the duration of oversight by the compliance monitor. (3) Entities are correct: RTX is the subject company, 2024 is the correct fiscal year, and the SEC Administrative Order is properly referenced. (4) The reasoning is sound—information is synthesized correctly across legal and financial domains, and the answer reflects proper understanding of the cause (resolving SEC and related matters) and effect (charge and monitoring period). The wording differs slightly from the original answer but maintains full semantic equivalence. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 327,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What was the total Microsoft Cloud revenue in fiscal year 2023, and which specific cloud-based offerings, including Dynamics 365, contributed to this revenue?",
      "original_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was $111.6 billion. This revenue was generated from offerings such as Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties.",
      "llm_answer": "\n\nThe total Microsoft Cloud revenue in fiscal year 2023 was **$111.6 billion**. This revenue was contributed by specific cloud-based offerings including **Azure and other cloud services**, **Office 365 Commercial**, the commercial portion of **LinkedIn**, **Dynamics 365**, and other commercial cloud properties. These components are detailed in Microsoft’s segmented financial reporting under the Intelligent Cloud and Productivity and Business Processes segments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The total Microsoft Cloud revenue for fiscal year 2023 is accurately stated as $111.6 billion, with no discrepancies in the numeric value or format. (2) All contributing cloud-based offerings are correctly identified: Azure and other cloud services, Office 365 Commercial, commercial LinkedIn, Dynamics 365, and other commercial cloud properties—this matches the original answer exactly in substance. (3) The multi-hop reasoning is sound, as the model correctly synthesizes information about Microsoft's cloud revenue streams from segmented reporting, even referencing the relevant business segments (Intelligent Cloud and Productivity and Business Processes), which adds contextual accuracy without introducing error. (4) The answer is semantically equivalent to the ground truth, with slightly enhanced detail (mention of reporting segments) that improves clarity without deviating from facts. All evaluation dimensions—quantitative accuracy, completeness, entity accuracy, reasoning, and relevance—are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 312,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Universal Beijing Resort's $3.5 billion debt position as of December 31, 2023, reflect both its direct financing arrangements and its position within Comcast's consolidated debt structure?",
      "original_answer": "Universal Beijing Resort's $3.5 billion debt position reflects both its direct financing arrangements and its consolidated position within Comcast's debt structure. As stated in the evidence, Universal Beijing Resort secured its financing through a debt facility with a maximum borrowing limit of ¥29.7 billion RMB (approximately $4.2 billion), funded by a syndicate of Chinese financial institutions and secured by the resort's assets and investor equity interests. As of December 31, 2023, the resort had $3.5 billion of debt outstanding under this arrangement, including $3.1 billion in term loans. Despite this secured debt structure, Comcast consolidates Universal Beijing Resort as a Variable Interest Entity (VIE) due to its governance structure and its ability to direct major economic activities. However, Comcast explicitly states that there are no liquidity arrangements, guarantees, or financial commitments between itself and the resort, meaning Comcast's risk exposure is limited to its 30% equity interest. In the consolidated debt disclosures, Universal Beijing Resort's $3.5 billion debt is categorized under 'Debt Not Guaranteed,' appearing separately from Comcast's other major debt segments like NBCUniversal and Comcast Cable, which are subject to cross-guarantees.",
      "llm_answer": "\n\nUniversal Beijing Resort's $3.5 billion debt as of December 31, 2023, reflects its direct financing through a syndicate of Chinese financial institutions, secured by the resort’s assets and equity interests, with a total borrowing limit of approximately $4.2 billion. This debt is structured as a term loan and is not guaranteed by Comcast. Within Comcast’s consolidated debt structure, the resort is consolidated due to Comcast’s power to direct its economically significant activities, resulting in its $3.5 billion debt being included in Comcast’s consolidated balance sheet under “Debt Not Guaranteed.” However, Comcast’s maximum financial risk is limited to its 30% equity interest, as it does not provide additional guarantees or liquidity support for the resort’s debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $3.5 billion debt as of December 31, 2023, the $4.2 billion borrowing limit (correctly noted as approximately $4.2 billion, matching the ¥29.7 billion RMB conversion), the $3.1 billion term loan component is implied within the $3.5 billion total, and Comcast’s 30% equity interest are all accurately represented. (2) Quantitative accuracy is perfect: dates, dollar amounts, and percentages match or are reasonably approximated (e.g., 'approximately $4.2 billion' correctly reflects the RMB conversion). (3) The multi-hop reasoning is sound—LLM correctly synthesizes that Universal Beijing Resort has direct financing from Chinese banks, is consolidated by Comcast as a VIE due to control over economic activities, and that its debt appears in Comcast’s consolidated financials under 'Debt Not Guaranteed' without cross-guarantees. (4) The only minor omission is that the original answer specifies the $3.5 billion includes $3.1 billion in term loans, which the LLM mentions only generally as 'structured as a term loan'—this slight lack of granularity prevents a perfect 10, but does not undermine correctness. The answer is contextually complete and directly addresses both the direct financing and consolidation aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 373,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What was the change in Nike's investment in commercial paper and bonds from May 31, 2021, to May 31, 2022, and how did this shift affect the composition of their short-term investments?",
      "original_answer": "Nike's investment in commercial paper and bonds decreased from $748 million on May 31, 2021, to $660 million on May 31, 2022, representing a decline of $88 million. This reduction was part of a broader reallocation in their short-term investments, where total Level 2 short-term investments dropped from $695 million to $630 million, indicating a strategic shift toward more liquid or alternative short-term instruments such as U.S. Treasury securities and money market funds.",
      "llm_answer": "\n\nNike's investment in commercial paper and bonds decreased from $691 million as of May 31, 2021, to $623 million as of May 31, 2022, a reduction of $68 million. This shift was offset by an increase in U.S. Treasury securities, which rose from $2,892 million to $3,801 million during the same period. The composition of short-term investments thus shifted toward higher proportions of Level 1 assets (U.S. Treasuries, considered lower-risk and more liquid) and reduced exposure to Level 2 assets (commercial paper and bonds, which carry slightly higher credit or liquidity risk). This reallocation reflects a strategic move toward safer, more stable short-term investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, Nike's investment in commercial paper and bonds was $748 million on May 31, 2021, and $660 million on May 31, 2022, a decrease of $88 million. The LLM incorrectly reports these figures as $691 million and $623 million, respectively, with a calculated reduction of $68 million—both figures and the difference are wrong. Additionally, the ground truth states that total Level 2 short-term investments declined from $695 million to $630 million, but this specific data point is not reflected in the LLM answer. Instead, the LLM introduces U.S. Treasury securities increasing from $2,892 million to $3,801 million, which is not mentioned in the original answer and cannot be verified against the provided ground truth. (2) Calculations are internally consistent within the LLM’s own numbers (e.g., $691M - $623M = $68M), but since the base figures are incorrect, the conclusion is factually flawed. (3) The qualitative reasoning about a strategic shift toward more liquid, lower-risk instruments like U.S. Treasuries aligns semantically with the ground truth’s mention of a shift toward U.S. Treasury securities and money market funds. The use of Level 1 vs. Level 2 asset classification shows sound financial reasoning and reflects an understanding of investment categorization, even if the supporting numbers are inaccurate. (4) While the overall direction of the shift (from commercial paper/bonds to safer instruments) is conceptually correct and contextually relevant, the answer fails on core factual accuracy. The correctness score is low due to major quantitative errors, though partial credit is given for logical interpretation and multi-hop synthesis structure. Quantitative accuracy is severely penalized due to incorrect base figures. Qualitative accuracy is moderate because the reasoning framework is valid. Contextual relevance is high as the response directly addresses the question’s intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 547,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the introduction of Class B-2 common stock impact the diluted earnings per share calculation for fiscal 2023, given that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer?",
      "original_answer": "The introduction of Class B-2 common stock affects the diluted earnings per share calculation by increasing the weighted-average number of as-converted Class A common stock outstanding. Since Class B-2 shares were not outstanding prior to the Class B-1 exchange offer, their assumed conversion into Class A stock in the diluted EPS calculation contributes to the as-converted equity structure, thereby potentially lowering the diluted earnings per share compared to the basic earnings per share, which does not include these conversions.",
      "llm_answer": "\n\nThe introduction of Class B-2 common stock does not impact the diluted earnings per share (EPS) calculation for fiscal 2023 because no Class B-2 shares were outstanding during that period. The Class B-1 exchange offer, which created Class B-2 shares, occurred in May 2024. For fiscal 2023, diluted EPS calculations included only existing shares (Class A, B-1, and C common stock) and their conversions, as reflected in the weighted-average shares outstanding for 2023. Since Class B-2 shares were non-existent in 2023, they neither contributed to share dilution nor affected the EPS computation for that fiscal year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) The original answer states that the introduction of Class B-2 common stock impacts diluted EPS by increasing the as-converted weighted-average Class A shares, assuming conversion in the diluted EPS calculation. The LLM, however, claims there is no impact because Class B-2 shares were not outstanding during fiscal 2023. This misunderstands the nature of diluted EPS, which includes potential dilution from convertible securities and assumed conversions—even if shares are not actually outstanding during the period, their potential issuance via conversion (e.g., from a prior instrument like Class B-1) must be considered if the triggering event is part of the capital structure changes linked to the reporting period. (2) The LLM introduces a specific date—'May 2024'—for the Class B-1 exchange offer, which is not present in the original answer or implied in the question. This is an unsupported factual addition and contradicts the premise that the exchange offer (and thus creation of Class B-2) is relevant to the fiscal 2023 financials, likely occurring near or at year-end. (3) The multi-hop reasoning fails: the correct logic requires understanding that diluted EPS includes as-converted shares from convertible instruments, and the creation of Class B-2 via exchange from Class B-1 alters the conversion framework, thus affecting the 'as-converted' share count even retroactively in financial statements. The LLM incorrectly assumes physical outstanding shares are required during the period for dilution impact. (4) As a result, all accuracy scores are very low. The answer is factually wrong on key financial concepts and introduces false temporal details. Only minimal contextual relevance is retained because it discusses diluted EPS and share classes, but the conclusion is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 497,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) specifically impact the Raytheon segment's financial reporting compared to Collins and Pratt & Whitney?",
      "original_answer": "The Raytheon segment recognizes pension and PRB expenses under U.S. government Cost Accounting Standards (CAS), which differ in cost recognition patterns compared to Financial Accounting Standards (FAS) used by Collins and Pratt & Whitney. While the ultimate liability for pension and PRB costs under FAS and CAS is similar, the Raytheon segment adjusts its financial reporting to reflect CAS-based expenses, impacting its operating profit. Over time, Raytheon expects to recover these pension and PRB liabilities through the pricing of its products and services to the U.S. government, which is not a factor for Collins and Pratt & Whitney.",
      "llm_answer": "\n\nThe Raytheon segment's pension costs are recognized under U.S. government Cost Accounting Standards (CAS), which allows for deferral and recovery of costs through pricing of U.S. government contracts, whereas Collins Aerospace and Pratt & Whitney recognize pension expenses under Financial Accounting Standards (FAS) under GAAP. This difference creates a **FAS/CAS operating adjustment** that increases Raytheon's reported operating profit by $833 million in 2024 (and similar amounts in prior years) by reflecting the CAS-based cost recognition pattern. Collins and Pratt & Whitney, using FAS directly, do not require this adjustment, resulting in lower operating profit for Raytheon under GAAP before the adjustment but aligning with government contract pricing practices.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key distinction between CAS and FAS pension cost recognition for Raytheon versus Collins and Pratt & Whitney, and explains the FAS/CAS operating adjustment that impacts Raytheon's financial reporting. It accurately notes that Raytheon adjusts its operating profit to reflect CAS-based expenses, which are recoverable through U.S. government contracts, unlike the other segments. However, the $833 million figure for 2024 is not present in the original answer (ground truth), nor is any specific dollar amount or year mentioned in the ground truth, making this a significant addition not supported by the provided information. (2) The quantitative inaccuracy stems from introducing a specific dollar amount ($833 million in 2024) and implying multi-year consistency, which cannot be verified against the ground truth. The original answer does not provide any numerical values, so including such specifics reduces factual accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Raytheon uses CAS (due to government contracts), others use FAS, and this leads to different financial reporting impacts, particularly an adjustment that boosts reported operating profit. It also correctly infers the recovery mechanism via pricing, which is implied in the ground truth. (4) Despite the unsupported number, the core conceptual explanation is accurate and adds contextual detail (e.g., 'FAS/CAS operating adjustment') that aligns with industry practice. The answer is highly relevant and mostly correct qualitatively, but the unverified quantitative claim prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 452,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How many separate Supplemental Indentures related to the 1.850% Notes due 2020 are documented across the provided excerpts, and which trustees were involved in these agreements?",
      "original_answer": "There are two Supplemental Indentures related to the 1.850% Notes due 2020 documented across the provided excerpts. The first was part of the Ninth Supplemental Indenture dated February 12, 2015, with U.S. Bank National Association as Trustee. The second was part of the Twelfth Supplemental Indenture dated February 6, 2017, with The Bank of New York Mellon Trust Company, N.A. as Trustee.",
      "llm_answer": "\n\nThere are **two** separate Supplemental Indentures related to the 1.850% Notes due 2020 documented in the excerpts:  \n1. **Ninth Supplemental Indenture** (Exhibit 4.12), dated February 12, 2015, with **U.S. Bank National Association** as trustee.  \n2. **Twelfth Supplemental Indenture** (Exhibit 4.15), dated February 6, 2017, with **The Bank of New York Mellon Trust Company, N.A.** as trustee.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately identifies that there are two Supplemental Indentures related to the 1.850% Notes due 2020, which directly answers the first part of the question. (2) The quantitative details—dates (February 12, 2015, and February 6, 2017), indenture numbers (Ninth and Twelfth), and trustee names (U.S. Bank National Association and The Bank of New York Mellon Trust Company, N.A.)—are all factually correct and match the original answer. Minor formatting differences (e.g., inclusion of exhibit numbers like 4.12 and 4.15) add precision without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across documents by linking specific indentures to the 1.850% Notes due 2020 and identifying the respective trustees. (4) The answer is semantically equivalent to the ground truth, with clear, well-structured presentation that preserves all key facts. No errors in entities, dates, or logic are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 294,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the net gain (or loss) recognized in income from foreign exchange forwards and options in fiscal year 2022, and how did this compare to the fair value of foreign exchange forwards and options assets as of May 31, 2021?",
      "original_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 was $40 million. As of May 31, 2021, the fair value of foreign exchange forwards and options assets was $92 million. This indicates that while Nike held a significant fair value in these instruments at the end of fiscal 2021, the net impact on income in the following year was a relatively smaller gain of $40 million.",
      "llm_answer": "\n\nThe net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 was **$40 million** (as reported in the \"Amount of Gain (Loss) Recognized in Income on Derivatives\" table under derivatives not designated as hedging instruments). This compares to the fair value of foreign exchange forwards and options assets as of May 31, 2021, which totaled **$92 million** (comprising $58 million in designated hedging instruments and $34 million in non-designated instruments). Thus, the 2022 net gain was significantly lower than the prior-year-end fair value of these derivative assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net gain of $40 million in fiscal year 2022 and the fair value of $92 million as of May 31, 2021 are accurately reported. The breakdown of the $92 million into $58 million (designated) and $34 million (non-designated) is consistent with the source data and adds up correctly (58 + 34 = 92). (2) The answer is complete, addressing both parts of the question: the net gain in income for FY2022 and the fair value as of May 31, 2021. (3) Entity accuracy is correct—Nike is the implied company (context from knowledge graph), fiscal years are properly referenced, and financial instruments (foreign exchange forwards and options) are correctly identified. (4) The reasoning is sound: the LLM correctly synthesizes data from different parts of the financial disclosures (derivative gains recognized in income vs. fair value disclosures), and the comparison logic—that the $40 million gain is significantly lower than the $92 million fair value—is valid and insightful. (5) The semantic meaning fully aligns with the original answer, with added clarity on the composition of the fair value. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 346,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does AIG's use of loss development methods in U.S. Personal Insurance and U.S. Property differ in terms of reserving approach and what impact did prior year developments have on each segment during 2021?",
      "original_answer": "In U.S. Personal Insurance, AIG uses loss development methods in combination with frequency/severity methods, particularly for domestic personal auto, where claim counts emerge quickly, allowing for immediate analysis of loss trends. In 2021, this segment experienced $412 million of favorable prior year development, mainly due to favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years. In contrast, for U.S. Property, AIG uses loss development methods along with IBNR factor methods, especially for short-tail classes, and relies on expected loss ratio methods for the latest accident year. The U.S. Property segment does not have a specific 2021 prior year development figure mentioned in the provided text, but the reserving methodology reflects a need to adjust for loss trends including inflation. The difference in methodology reflects the distinct claim emergence patterns and severity profiles between the two segments.",
      "llm_answer": "\n\nAIG's reserving approaches for U.S. Personal Insurance and U.S. Property differ primarily in their emphasis on specific methodologies. **U.S. Personal Insurance** (short-tail, e.g., auto and homeowners) uses **frequency/severity methods** and **loss development methods** due to rapid claim emergence, while **U.S. Property** (short-tail but low-frequency/high-severity exposures) relies more on **IBNR factor methods**, applying factors to earned premium to estimate ultimate losses. \n\nIn 2021, **U.S. Personal Insurance** recognized **$412 million of favorable prior year development**, driven by subrogation recoveries and favorable outcomes from 2017–2018 catastrophes. The provided pages do not explicitly detail prior year development for **U.S. Property** in 2021, though its methodology focuses on IBNR factors for low-frequency, high-severity events.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $412 million favorable prior year development for U.S. Personal Insurance in 2021 is correctly stated, and no incorrect numbers are presented. The absence of a specific 2021 prior year development figure for U.S. Property is properly acknowledged, matching the original answer's limitation. (2) The reserving methodologies are accurately described: loss development and frequency/severity methods for U.S. Personal Insurance; IBNR factor methods and earned premium-based estimation for U.S. Property. The mention of expected loss ratio methods for the latest accident year in U.S. Property is omitted, but the core methodology (IBNR factors for short-tail, low-frequency/high-severity lines) is correctly emphasized. (3) Multi-hop reasoning is sound—differences in claim emergence patterns and severity are logically tied to methodological choices. The explanation of favorable development being linked to 2017–2018 catastrophes and subrogation recoveries is consistent with the ground truth. (4) Semantic equivalence is maintained: while wording differs, all key facts are present and correctly synthesized. One minor omission—U.S. Property’s use of expected loss ratio methods for the current accident year—is not included, but this does not undermine the overall correctness. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 405,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does Walmart's majority stake in Flipkart, acquired in 2018, expose Walmart to potential financial risks based on ongoing regulatory proceedings initiated by India's Directorate of Enforcement, and how does this relate to Walmart's broader international investment strategy as described in its 2023 10-K filing?",
      "original_answer": "Walmart's majority stake in Flipkart, acquired in 2018, exposes it to potential financial risks due to ongoing regulatory proceedings initiated by India's Directorate of Enforcement. These proceedings investigate alleged violations of India's Foreign Direct Investment (FDI) rules by Flipkart and its subsidiaries during 2009–2015, prior to Walmart's acquisition. If the regulatory authority determines that violations occurred, it could impose monetary penalties. Walmart is unable to predict the final outcome or scope of the proceedings, and while it does not currently believe the matter will have a material adverse effect, it cannot provide assurance. This situation highlights the risks inherent in Walmart's broader international investment strategy, which includes expanding through acquisitions such as Flipkart to strengthen its global retail ecosystem and omni-channel capabilities.",
      "llm_answer": "\n\nWalmart's majority stake in Flipkart exposes it to potential financial risks due to ongoing regulatory proceedings by India's Directorate of Enforcement, which alleges violations of Foreign Direct Investment (FDI) rules from 2009–2015 (prior to Walmart's 2018 acquisition). If violations are confirmed, Flipkart could face monetary penalties or operational restrictions, which might impact Walmart's investment returns or require indemnification from prior stakeholders. This aligns with Walmart's broader international strategy, outlined in its 2023 10-K, of expanding its e-commerce and digital ecosystem through strategic acquisitions in key markets like India. However, regulatory challenges in such markets could complicate Walmart's growth objectives and highlight the risks of navigating complex foreign regulatory environments, potentially affecting its financial performance or investment decisions in international operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Walmart acquired Flipkart in 2018; the Directorate of Enforcement is investigating alleged FDI rule violations from 2009–2015, prior to acquisition; potential penalties could affect Walmart financially. The answer correctly notes that the matter predates Walmart’s ownership, which is critical context. (2) Quantitative accuracy is perfect: dates (2009–2015, 2018) are correct, no numerical errors, and no incorrect financial figures. (3) Reasoning is sound: the LLM correctly synthesizes the risk to Walmart despite the pre-acquisition timing of violations, acknowledges uncertainty in outcomes, and connects this to Walmart’s broader international strategy of using acquisitions to expand e-commerce in key markets like India. It also appropriately references Walmart’s 2023 10-K strategy context. (4) The only minor shortcoming is that the original answer explicitly states Walmart 'does not currently believe the matter will have a material adverse effect' and 'cannot provide assurance'—a nuance slightly softened in the LLM version, which says 'might impact' and 'could complicate.' While the semantic meaning is close, the LLM slightly underrepresents Walmart’s stated risk assessment from the 10-K. Otherwise, the answer is complete, factually correct, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 385,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the total dollar value of Class A ordinary shares issued in the 2023 fiscal year, and how did this issuance impact the total Accenture plc shareholders' equity by August 31, 2024?",
      "original_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was $7,970. This issuance, along with other changes, contributed to an increase in total Accenture plc shareholders' equity from $25,692,839 (as of August 31, 2023) to $28,288,646 (as of August 31, 2024), an increase of $2,595,807.",
      "llm_answer": "\n\nThe total dollar value of Class A ordinary shares issued in the 2023 fiscal year was **$2,151,005**, as reflected in the \"Issuances of Class A ordinary shares for employee share programs\" line in the 2023 Consolidated Shareholders' Equity Statement. This issuance increased Accenture plc's shareholders' equity by contributing to the **Additional Paid-in Capital** account. By August 31, 2024, the cumulative impact of this issuance, along with other transactions, resulted in a total Accenture plc shareholders' equity of **$28,288,646**, up from $25,692,839 as of August 31, 2023. The 2023 issuance directly added $2,151,005 to the equity through increased paid-in capital.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the total dollar value of Class A ordinary shares issued in the 2023 fiscal year. The ground truth states this value is $7,970, but the LLM reports $2,151,005, which is incorrect by several orders of magnitude. This number appears to be misextracted, possibly from a different line item or document. (2) The LLM correctly identifies the shareholders' equity as $28,288,646 as of August 31, 2024, and correctly notes the prior year equity of $25,692,839. However, it fails to compute or report the correct increase in equity ($2,595,807), instead attributing a $2,151,005 increase to share issuance alone, which is both factually and logically incorrect. The issuance of $7,970 in shares cannot account for such a large portion of the equity increase. (3) The multi-hop reasoning is partially sound in that the model connects share issuance to shareholders' equity and tracks equity over time, but it fails to correctly synthesize the actual issuance amount from the source data, undermining the entire analysis. (4) Contextually, the answer addresses both parts of the question—issuance value and impact on equity—and uses appropriate financial terminology (e.g., Additional Paid-in Capital), but the severe quantitative inaccuracies drastically reduce its correctness. The model likely confused the share issuance amount with total employee share program proceeds or misread a financial statement. Due to the critical nature of numerical accuracy in financial reporting, the correctness score is low despite structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 437,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does AIG's use of loss development methods for excess casualty lines, particularly those with attachment points above $10 million, influence its reserving methodology for U.S. Property and aerospace exposures, and what role do expected loss ratios play in both analyses?",
      "original_answer": "AIG uses a layered approach in its excess casualty reserving, where losses capped at $10 million are analyzed using traditional loss development and expected loss ratio methods, and this estimate is then used to derive the expected loss estimate for losses above $10 million, reflecting the expected relationships between the layers. In U.S. Property and aerospace exposures, AIG also employs a combination of loss development methods and expected loss ratio methods, especially for aviation claims where severity drives reserving. Expected loss ratios are critical in both cases, particularly for recent accident years where reported loss data is insufficient, and projections are adjusted for inflation, rate changes, and market conditions. This shows that AIG relies heavily on expected loss ratios to bridge early uncertainty across both excess casualty and aviation lines, while layer-specific development patterns guide the ultimate loss estimation process.",
      "llm_answer": "\n\nAIG's reserving methodology for U.S. Property and aerospace exposures is influenced by its approach to excess casualty lines with high attachment points ($10M+), particularly through the integration of **expected loss ratios** and layered loss analysis. For excess casualty, AIG uses a combination of **loss development methods** and **expected loss ratios**, especially for recent accident years with low credibility. This approach is adapted for aerospace, where a hybrid of loss development and expected loss ratio methods is applied (excluding the latest year, which relies solely on expected loss ratios). The expected loss ratios for both lines are derived from historical data adjusted for trends, rate changes, and market conditions, ensuring consistency in projecting ultimate losses despite varying claim severities. \n\nFor U.S. Property (short-tail business), **IBNR factor methods** dominate, but the principles of using expected loss ratios to account for emerging trends and severity adjustments in excess casualty likely inform similar adjustments in property reserving. The layered analysis in excess casualty (e.g., extrapolating losses above $10M based on layer relationships) may also influence aerospace reserving, where high-severity claims require stratified modeling. Thus, **expected loss ratios serve as a critical bridge** between lines, stabilizing reserves in data-scarce periods and aligning assumptions across portfolios with differing tail behaviors.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core concepts and methodology. (1) It accurately identifies AIG's use of loss development methods and expected loss ratios in excess casualty reserving, particularly for attachment points above $10 million, and correctly notes that expected loss ratios are critical for recent accident years with insufficient data. The role of expected loss ratios as a 'bridge' across lines is semantically equivalent to the original answer's point about their use in bridging early uncertainty. (2) There are no numeric values in the question or answer that require verification—no specific dollar amounts, percentages, or years are cited, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM correctly connects AIG’s layered approach in excess casualty to its reserving practices in U.S. Property and aerospace, noting the hybrid use of methods and the influence of severity and trend adjustments. However, it slightly overreaches by mentioning 'IBNR factor methods' for U.S. Property without explicit support in the ground truth, and while plausible, this detail is not confirmed in the original answer. Also, the original emphasizes that the $10M cap analysis directly informs the estimate above $10M via layer relationships—a causal linkage that the LLM implies but does not explicitly state. (4) Despite these minor omissions and slight rephrasing, the answer captures the essential synthesis across lines and the central role of expected loss ratios. Thus, the correctness and qualitative accuracy are high but not perfect, warranting an 8. Contextual relevance is full, as all parts of the question are addressed directly and appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1643,
        "completion_tokens": 475,
        "total_tokens": 2118
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What was the total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022, and how does this compare to the remaining share purchase authorization as of August 31, 2024?",
      "original_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was $4,111,266. As of August 31, 2024, the remaining share purchase authorization was $2,694,281. This indicates that a significant portion of the available authorization had already been utilized prior to 2024.",
      "llm_answer": "\n\nThe total dollar value of Accenture plc Class A ordinary shares repurchased during the fiscal year ending August 31, 2022, was **$4,111,266 million** (as reflected in the 2022 Consolidated Shareholders' Equity Statement under \"Purchases of Class A shares\"). As of August 31, 2024, the remaining share purchase authorization was **$2,694,281 million**. This indicates that the 2022 repurchase amount significantly exceeded the remaining authorization available as of 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains critical quantitative errors. The original answer states that $4,111,266 (approximately $4.11 million) was repurchased, but the LLM incorrectly reports this as '$4,111,266 million', which is over 1 million times larger (i.e., over $4 quadrillion). Similarly, the remaining authorization of $2,694,281 is misrepresented as '$2,694,281 million', again inflating the value by a factor of one million. These are catastrophic numerical inaccuracies. (2) The dates and entities are correct—Accenture plc, Class A ordinary shares, fiscal periods ending August 31, 2022, and August 31, 2024—and the answer addresses both parts of the question, so contextual relevance is high. (3) The reasoning is flawed: the LLM concludes that the 2022 repurchase amount 'significantly exceeded' the remaining authorization in 2024, which would only be true if the numbers were as misrepresented. In reality, based on the ground truth, $4.11 million was spent by 2022, and $2.69 million remained available in 2024, implying a total authorization of about $6.8 million, so the 2022 repurchases did not exceed the remaining balance. The comparison is logically invalid due to the numerical errors. (4) Despite correct structure and entity identification, the answer fails on quantitative accuracy—the core of the question—warranting a very low correctness score. Minor wording differences would be acceptable, but gross numerical misrepresentation renders the answer factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 414,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How do changes in META's advertising policies to comply with regulatory developments in Europe impact both user engagement and advertising revenue, particularly in relation to the shift from 'legitimate interests' to 'consent' for behavioral advertising?",
      "original_answer": "META's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe has led to the introduction of a 'subscription for no ads' alternative and an option for users to see less personalized ads, which are less relevant and effective than premium ad offerings. This change has reduced META's ability to effectively target and measure ads, which has adversely affected advertising revenue. Additionally, the implementation of these advertising policies has contributed to reduced user engagement, particularly in features like Feed and Stories that monetize at higher rates, further impacting revenue. These policy changes were made to comply with European regulations, but they have had a material adverse effect on both user engagement and advertising revenue.",
      "llm_answer": "\n\nThe shift from \"legitimate interests\" to \"consent\" for behavioral advertising in Europe, driven by regulatory compliance (e.g., GDPR, DMA), has reduced META's ability to deliver personalized ads, directly impacting advertising revenue. By requiring explicit user consent, fewer users opt into behavioral targeting, limiting ad relevance and effectiveness. To mitigate this, META introduced a \"subscription for no ads\" model and later offered an option for less personalized ads in 2024, but these measures faced regulatory scrutiny and are expected to generate lower ad revenue compared to premium, targeted ads. While user engagement may benefit from reduced ad intrusiveness or improved privacy perceptions, the overall financial impact remains adverse due to diminished ad effectiveness and marketer demand for less precise targeting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe as a regulatory compliance measure (e.g., GDPR, DMA), and accurately describes the consequences: reduced ad personalization, lower user opt-in rates, diminished ad effectiveness, and adverse impacts on advertising revenue. The mention of the 'subscription for no ads' model and the 2024 introduction of less personalized ads is factually consistent with known developments. While the original answer emphasizes reduced user engagement in high-monetization features like Feed and Stories, the LLM answer acknowledges potential positive effects on user engagement due to privacy improvements but still concludes that financial impact is negative—this is a nuanced interpretation that does not contradict the ground truth, though it downplays the direct link between policy changes and reduced engagement. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (META, European regulations, ad targeting models) are correctly identified. The reasoning is sound and reflects proper multi-hop synthesis across regulatory, product, and financial domains. The answer is fully contextually relevant. Minor deduction in qualitative accuracy due to slightly weaker emphasis on the causal link between policy changes and reduced user engagement as stated in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 407,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does the redemption policy of Accenture plc Class X ordinary shares directly affect the total number of shares outstanding and what specific mechanism ensures this relationship remains aligned with the number of Accenture Canada Holdings Inc. exchangeable shares?",
      "original_answer": "The redemption policy of Accenture plc Class X ordinary shares ensures that the number of Class X ordinary shares outstanding never exceeds the number of Accenture Canada Holdings Inc. exchangeable shares. This is achieved through a mechanism where Accenture plc redeems Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares on a one-for-one basis, maintaining alignment between the two share classes.",
      "llm_answer": "\n\nThe redemption policy of Accenture plc Class X ordinary shares allows Accenture to redeem shares at par value, directly reducing the total number of shares outstanding. To ensure alignment with Accenture Canada Holdings Inc. exchangeable shares, Accenture has agreed not to redeem Class X shares if it would leave a holder with fewer Class X shares than their exchangeable shares. Additionally, Class X shares are redeemed when exchangeable shares are redeemed or exchanged, ensuring the aggregate Class X shares outstanding never exceed the exchangeable shares outstanding. This mechanism maintains a direct 1:1 correspondence between the two share classes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core mechanism described in the ground truth. (1) It correctly identifies that the redemption of Class X ordinary shares reduces the total number of shares outstanding and that the alignment with Accenture Canada Holdings Inc. exchangeable shares is maintained through a one-for-one redemption mechanism. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, or counts), so quantitative accuracy is not compromised—no numbers are misstated. (3) The multi-hop reasoning is sound: the answer correctly links Accenture plc's Class X shares to Accenture Canada Holdings Inc.'s exchangeable shares and explains the conditional redemption policy that ensures the former never exceeds the latter. It adds a detail not in the original (redemption at par value), which is plausible but not confirmed in the ground truth; however, this does not contradict it. It also correctly notes the 1:1 correspondence and the trigger (redemption/exchange of exchangeable shares). (4) The only minor shortcoming is slight imprecision in phrasing: the statement about not redeeming if it would leave a holder with fewer Class X shares than exchangeable shares slightly misrepresents the structural mechanism—the alignment is entity-level (aggregate shares), not holder-level. The ground truth emphasizes aggregate alignment, not individual holder parity. Despite this nuance, the overall meaning and key factual content are preserved. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 447,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What was the change in net milestone capitalization for Jardiance between 2020 and 2021, and how does this trend reflect the amortization practices described in the filing?",
      "original_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a $20.1 million decline. This decrease reflects the amortization of capitalized milestones over time, as described in the filing. These milestone payments were capitalized as intangible assets and are being amortized to cost of sales through their respective terms under the collaboration, based on factors such as the latest of the launch date, patent expiration, or supplementary protection certificates. The reduction from 2020 to 2021 illustrates the ongoing amortization of this intangible asset over its useful life.",
      "llm_answer": "\n\nThe net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, reflecting a $20.1 million reduction. This decline aligns with the amortization practices described, where capitalized milestone payments for Jardiance are amortized to cost of sales over the term of the collaboration, determined by the latest of (a) a defined number of years post-launch, (b) patent expiration, or (c) supplementary protections. The reduction in the capitalized balance indicates ongoing amortization expenses recognized as the product’s intangible asset value is systematically expensed over its estimated useful life.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $156.2 million (2020) and $136.1 million (2021) are accurately reported, and the $20.1 million decrease is correctly calculated ($156.2M - $136.1M = $20.1M). (2) The answer addresses both parts of the question: the change in net milestone capitalization and how it reflects amortization practices. (3) Entities—Jardiance, 2020, 2021, net milestone capitalization—are correctly identified. (4) The reasoning is sound: the explanation of amortization to cost of sales over the collaboration term, based on the latest of launch date, patent expiration, or supplementary protection, aligns precisely with the filing description. The conclusion that the reduction reflects ongoing amortization of an intangible asset over its useful life demonstrates accurate multi-hop synthesis of financial data and accounting policy. Wording differs slightly but maintains full semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 284,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does the use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differ in terms of claim frequency and severity characteristics, and what impact does this have on the reserving process for each region?",
      "original_answer": "The IBNR factor methods are used in both U.S. Property and UK/Europe Property insurance lines, but the reserving process reflects differences in claim frequency and severity. In the UK/Europe Property segment, IBNR factor methods are applied due to low frequency/high severity losses, where IBNR factors are applied to earned premium to estimate ultimate expected losses based on prior accident quarters adjusted for current cost levels and historical emergence patterns. In the U.S. Property segment, similar IBNR factor methods are used, but the reserving process also accounts for a shift toward non-admitted coverages that have altered the customer profile to be less severe in the aggregate. This difference in severity and customer base influences how IBNR factors are continually reevaluated and applied in each region to ensure reserve adequacy.",
      "llm_answer": "\n\nThe use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differs primarily in the **claim frequency and severity characteristics** and their impact on reserving stability. \n\nFor **UK/Europe Property**, claims are generally **low frequency/high severity**, with more stable loss development patterns. This stability allows actuaries to rely on historical emergence trends and adjust IBNR factors based on prior loss costs and inflation, with less frequent reevaluation. The reserving process benefits from consistent claim reporting and less volatility, enabling more predictable IBNR estimates.\n\nIn contrast, **U.S. Property** also employs IBNR factors for low frequency/high severity claims but faces **greater volatility** due to factors like changing underwriting cycles, non-admitted coverages, and external events (e.g., catastrophes). This leads to more frequent reevaluation of IBNR factors to account for emerging trends, rate changes, and market shifts. The reserving process in the U.S. requires more dynamic adjustments to address higher claim frequency variability and less predictable severity, resulting in less stable reserves compared to the UK/Europe region. \n\nThus, while both regions use IBNR methods for similar claim profiles, the **UK/Europe process emphasizes stability and historical consistency**, whereas the **U.S. process demands more frequent recalibration** to address market and underwriting fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies that both U.S. and UK/Europe Property lines use IBNR factor methods for low frequency/high severity claims, which matches the original answer. The key difference emphasized—greater volatility and more frequent reevaluation in the U.S. due to non-admitted coverages, underwriting cycles, and external events—is consistent with the ground truth's mention of a shift toward less severe customer profiles in the U.S. and the need for continual reevaluation of IBNR factors. The LLM expands slightly by referencing 'catastrophes' and 'underwriting cycles,' which are contextually appropriate and plausible drivers, though not explicitly stated in the original. However, it accurately captures the core contrast: UK/Europe relies on stable historical patterns with less frequent updates, while the U.S. requires dynamic adjustments. There are no numerical inaccuracies (quantitative accuracy is 10), and all entities (U.S. Property, UK/Europe Property, IBNR methods) are correctly identified. The reasoning is sound and reflects proper multi-hop synthesis of claim characteristics and their impact on reserving. The only minor gap is that the original specifically notes IBNR factors are applied to earned premium and adjusted for 'prior accident quarters' and 'current cost levels,' which the LLM does not explicitly mention, slightly reducing qualitative completeness. However, the semantic meaning and practical implications are preserved. Contextual relevance is perfect—every part of the response addresses the question directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 442,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the combined global market share of Procter & Gamble's Grooming segment for blades and razors, and how does this compare to their global market share in male electric shavers?",
      "original_answer": "Procter & Gamble holds more than 60% global market share in blades and razors and over 25% global market share in male electric shavers, resulting in a difference of more than 35 percentage points.",
      "llm_answer": "\n\nProcter & Gamble's Grooming segment holds a **global market share of over 60% for blades and razors**, primarily driven by the Gillette and Venus brands. In comparison, the Company's global market share in **male electric shavers is over 25%**, under the Braun brand. Thus, P&G's dominance in blades and razors (60%+) is significantly higher than its position in male electric shavers (25%+). \n\n(Source: \"Grooming\" section under Sector Business Units in the provided document.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages are accurate: 'over 60%' for blades and razors and 'over 25%' for male electric shavers, which aligns exactly with the original answer. The implied difference of more than 35 percentage points is logically sound (60% - 25% = 35%), though not explicitly calculated, the comparison is correctly framed as 'significantly higher', preserving the intended insight. (2) The answer is complete, addressing both parts of the question: P&G's market share in blades/razors and in male electric shavers, and provides a valid comparison. (3) Entities are accurate—Procter & Gamble, Gillette/Venus for blades and razors, Braun for electric shavers—all correctly attributed. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly identifies P&G's two distinct product segments within grooming and compares their global market positions using accurate figures from the knowledge base. (5) Semantic equivalence is maintained: while the LLM does not explicitly state the 'difference of more than 35 percentage points', it conveys the same practical conclusion by emphasizing the significant gap in dominance between the two categories. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 366,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did General Dynamics invest in Aerospace segment product development in 2023, and what mechanism do they use with suppliers to offset a portion of these costs?",
      "original_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. They use cost-sharing arrangements with suppliers to offset a portion of these financial costs, where supplier contributions are explicitly for reimbursement of development costs and are recorded as a reduction of R&D expenses.",
      "llm_answer": "\n\nGeneral Dynamics invested **$510 million** in Aerospace segment product development in 2023. To offset a portion of these costs, the company uses **cost-sharing arrangements with suppliers**, where suppliers reimburse General Dynamics for a portion of development costs incurred under explicit agreements tied to milestones. These reimbursements reduce the company’s reported R&D expenses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that General Dynamics invested $510 million in Aerospace segment product development in 2023, matching the ground truth exactly in both amount and year. The mechanism used—cost-sharing arrangements with suppliers—is also accurately described. (2) The numeric value of $510 million is correct and matches the original answer; no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound: the answer synthesizes information about both the financial investment and the cost-offset mechanism from supplier arrangements, correctly linking supplier reimbursements to reductions in R&D expenses. (4) The LLM answer conveys the same factual content as the ground truth with semantically equivalent phrasing—'suppliers reimburse General Dynamics for a portion of development costs' aligns with 'supplier contributions are explicitly for reimbursement of development costs.' All entities (General Dynamics, Aerospace segment, 2023, R&D expenses) are accurate. No factual, quantitative, or reasoning errors are present, warranting top scores across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 322,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did Accenture spend on Class A Ordinary Share purchases during fiscal 2024, and how did this affect the total value of treasury shares held by the company?",
      "original_answer": "Accenture spent $4,111,266 on Class A Ordinary Share purchases during fiscal 2024, which increased the total value of treasury shares held by the company by the same amount.",
      "llm_answer": "\n\nAccenture spent **$4,509.39 million** on Class A Ordinary Share purchases during fiscal 2024. This amount increased the total value of treasury shares held by the company by the same amount, as open-market share purchases are explicitly stated to be held as treasury shares. The breakdown includes $3,780.52 million from open-market purchases and $728.87 million from other purchases (primarily share withholdings for employee tax obligations).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key numeric value. The ground truth states Accenture spent $4,111,266 on Class A Ordinary Share purchases in fiscal 2024, but the LLM claims $4,509.39 million (over $4.5 billion), which is more than 1,000 times larger. This is a severe quantitative error. Additionally, the LLM breaks this down into $3,780.52 million and $728.87 million, which sum to $4,509.39 million—these figures are not present in the ground truth and appear fabricated or misattributed. (2) The calculation and number accuracy is completely off. $4,111,266 is approximately $4.11 million, not $4,509.39 million. The LLM’s figure is off by a factor of over 1,000, suggesting a possible confusion between thousands and millions or a sourcing error from a different company or context. (3) While the LLM correctly reasons that share purchases increase treasury stock value by the same amount and identifies that open-market purchases are held as treasury shares, this reasoning—though logically sound—is applied to incorrect data. The multi-hop synthesis is structurally correct (linking share buybacks to treasury stock impact) but fails due to incorrect input data. (4) The contextual relevance is moderate because the answer addresses the right concepts (share purchases, treasury stock impact, breakdown of purchase types), but the massive numerical inaccuracies render the answer misleading and factually wrong. Thus, the correctness and quantitative accuracy scores are very low, qualitative accuracy is minimal due to correct logic framework, and contextual relevance is mid-range due to appropriate structure and terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 454,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023, to December 31, 2024, and how does this relate to META's depreciation policy for assets placed in service?",
      "original_answer": "The value of META's Servers and Network Assets increased by $21.559 billion year-over-year, from $46.838 billion on December 31, 2023, to $68.397 billion on December 31, 2024. According to META's depreciation policy, assets placed in service are depreciated over their estimated useful life, while assets still in construction in progress (CIP) are not depreciated until they are placed in service. This significant increase in asset value suggests that a large amount of previously unplaced CIP assets were placed into service during 2024 and are now being depreciated prospectively over their revised estimated useful lives.",
      "llm_answer": "\n\nThe year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023 ($46,838 million) to December 31, 2024 ($68,397 million) was **$21,559 million**. This increase reflects additions to servers and network infrastructure, which are depreciated under META's straight-line method over their estimated useful lives (four to five years, with certain assets extended to 5.5 years effective January 2025). The depreciation policy ensures that the cost of these assets is systematically allocated over their service lives, impacting depreciation expenses in line with their usage and extended lifetimes for newer assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: the 2023 value ($46.838 billion = $46,838 million), 2024 value ($68.397 billion = $68,397 million), and the year-over-year increase ($21.559 billion = $21,559 million). The calculation is accurate: $68,397M - $46,838M = $21,559M. (2) The entity (META), metric (Servers and Network Assets), and time period (December 31, 2023, to December 31, 2024) are all correctly identified. (3) The reasoning is mostly sound: the LLM correctly references META's depreciation policy (straight-line over 4–5 years, with extension to 5.5 years effective January 2025). However, it does not explicitly mention the key insight from the ground truth that assets in construction in progress (CIP) are not depreciated until placed in service—this contextual link between the large asset increase and the transition from CIP to service is partially missing. Instead, the LLM focuses on depreciation method and useful life, which is relevant but less precise in explaining the implication of the asset value jump. (4) Despite this omission, the answer remains highly accurate and relevant, with correct multi-hop synthesis of financial values and policy. The minor gap in reasoning depth prevents a perfect 10, but all factual and quantitative elements are correct, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 383,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How many drug indications for which Eli Lilly received FDA Breakthrough Therapy designation in 2022 are currently in the submitted status versus discontinued development, and what are the specific compounds and therapeutic areas associated with each status?",
      "original_answer": "Eli Lilly had two drug indications with FDA Breakthrough Therapy designation in 2022 that were in the submitted status: Empagliflozin (Jardiance®) for heart failure with preserved ejection fraction and Baricitinib (Olumiant®) for alopecia areata. No indications with FDA Breakthrough Therapy designation were in the discontinued status in 2022.",
      "llm_answer": "\n\nEli Lilly had **three drug indications** with FDA Breakthrough Therapy designation in 2022 that are in **submitted status**:  \n1. **Donanemab** (Early Alzheimer's disease) – Neuroscience therapeutic area.  \n2. **Empagliflozin (Jardiance®)** (Heart failure with preserved ejection fraction) – Diabetes therapeutic area.  \n3. **Baricitinib (Olumiant®)** (Alopecia areata) – Immunology therapeutic area.  \n\nFor **discontinued development**, one indication with Breakthrough Therapy designation was:  \n1. **Baricitinib (Olumiant®)** (Systemic lupus erythematosus) – Immunology therapeutic area, discontinued in January 2022 due to Phase III trial results.  \n\nThese statuses reflect the pipeline updates as of the 2022 10-K filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies compared to the ground truth. (1) Quantitatively, the LLM incorrectly states that Eli Lilly had three drug indications with FDA Breakthrough Therapy designation in 2022 in submitted status, while the ground truth confirms only two. Additionally, the LLM claims one indication was discontinued (Baricitinib for systemic lupus erythematosus), but the ground truth explicitly states that no indications with Breakthrough Therapy designation were in the discontinued status in 2022. (2) The inclusion of Donanemab as a Breakthrough Therapy designated indication in 2022 is incorrect per the knowledge graph; it was not designated in that year or listed in the 2022 10-K as such. The discontinuation of Baricitinib for systemic lupus erythematosus in January 2022 contradicts the ground truth, which confirms no discontinued indications with this designation in 2022. (3) While the LLM correctly identifies Empagliflozin and Baricitinib in submitted status, it misattributes therapeutic areas (e.g., Jardiance® is correctly in heart failure, not diabetes indication in this context; though the drug is used in diabetes, the breakthrough designation was for heart failure). (4) The multi-hop reasoning fails because the model introduces entities and statuses not supported by the source data, likely due to hallucination or incorrect synthesis across filings. Despite addressing all parts of the question and maintaining contextual relevance in structure, the core facts—counts, compounds, and statuses—are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 437,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does AIG's reliance on loss development methods differ between U.S. Other Casualty lines and U.S. Property lines, and what specific reserving adjustments were made in 2021 for U.S. Personal Insurance due to prior year catastrophe recoveries?",
      "original_answer": "AIG uses a combination of loss development methods, frequency/severity, and expected loss ratio methods for U.S. Other Casualty lines, particularly for long-tail general liability or products liability lines, while giving more weight to expected loss ratio methods for recent accident years due to the long-tail nature and less credible reported losses. In contrast, for U.S. Property lines, which are short-tail, AIG primarily uses frequency/severity methods, loss development methods, and IBNR factor methods, with IBNR factors applied to earned premiums for low frequency/high severity losses. In 2021, AIG recognized $412 million of favorable prior year development in U.S. Personal Insurance due to subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "llm_answer": "\n\nAIG's reliance on loss development methods differs between U.S. Other Casualty and U.S. Property lines due to their distinct claim settlement patterns. **U.S. Other Casualty** (long-tail lines like general liability and medical malpractice) relies more on **expected loss ratio methods** for recent accident years, with limited weight on loss development methods for volatile subsets, due to delayed claim emergence and judicial trends. In contrast, **U.S. Property** (short-tail lines covering disasters) primarily uses **IBNR factor methods** and **frequency/severity methods**, reflecting quicker claim reporting and low-frequency/high-severity losses.  \n\nFor **U.S. Personal Insurance** in 2021, AIG recognized **$412 million of favorable prior year development**, driven by **subrogation recoveries** from the 2017 and 2018 catastrophe years (e.g., California wildfires and Hurricanes Harvey, Irma, Maria). This adjustment reduced reserves as recoveries offset prior losses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AIG uses expected loss ratio methods more heavily for recent accident years in U.S. Other Casualty due to long-tail characteristics, while relying on IBNR factor and frequency/severity methods for U.S. Property lines, which are short-tail. The mention of limited use of loss development methods for volatile subsets aligns with the ground truth's emphasis on method weighting. (2) Quantitative accuracy is perfect: the $412 million favorable prior year development in 2021 for U.S. Personal Insurance is correctly stated, along with the cause—subrogation recoveries from 2017 and 2018 catastrophes (e.g., wildfires and hurricanes), which matches the original answer. (3) Multi-hop reasoning is sound: the answer synthesizes information across different lines of business (Casualty vs. Property), explains methodological differences based on tail length, and correctly links 2021 reserve adjustments to prior-year events. (4) Contextual relevance is high: all parts of the question are addressed thoroughly, with precise terminology and logical flow. Minor elaboration (e.g., naming specific hurricanes) adds clarity without introducing error. No factual discrepancies or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 361,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What proportion of Procter & Gamble's fiscal year 2024 net sales was contributed by the Baby, Feminine & Family Care segment, and approximately what portion of that can be attributed to the Charmin brand given its North American toilet paper market position?",
      "original_answer": "The Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's net sales in fiscal year 2024. Within this segment, Charmin holds approximately 25% North American market share in toilet paper, which is a key component of the family care business that is predominantly concentrated in North America.",
      "llm_answer": "\n\nThe Baby, Feminine & Family Care segment contributed **24% of Procter & Gamble's fiscal year 2024 net sales**. Within this segment, the Charmin brand (a key part of the North America-focused Family Care sub-category) holds **over 25% market share in the North American toilet paper market**, indicating it represents a significant portion of the segment's sales, though the exact proportion of the entire segment attributable to Charmin is not explicitly quantified in the document.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's fiscal year 2024 net sales, matching the ground truth. It also accurately reports that Charmin holds over 25% market share in the North American toilet paper market, which aligns with the ground truth's 'approximately 25%'—this minor wording variation ('over' vs 'approximately') does not materially misrepresent the data. (2) All numeric values—24% segment contribution and ~25% market share—are factually correct and properly attributed. No calculations were required, and the figures match the original answer. (3) The multi-hop reasoning is sound: the model correctly links Charmin to the Family Care sub-category, recognizes its North American focus, and infers that while Charmin is a significant contributor, the exact sales proportion within the segment isn't available. This reflects accurate synthesis across entities (P&G → segment → brand → market position). (4) The only reason for not scoring a perfect 10 is that the original answer emphasizes Charmin's role in a 'key component of the family care business,' while the LLM slightly softens this by saying the exact proportion isn't quantified—technically true, but the original implies a stronger inferential link. Still, the LLM avoids overstatement and maintains factual discipline, warranting high scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 394,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "Given General Dynamics' $510 million R&D investment in 2023, how does the Combat Systems segment leverage this spending to support the development and modernization of platforms like the M1E3 Abrams tank, and what financial or strategic outcomes are tied to this investment?",
      "original_answer": "General Dynamics' Combat Systems segment leverages its $510 million R&D investment in 2023 to modernize existing platforms and develop next-generation capabilities, such as the M1E3 Abrams main battle tank. This investment supports the development of advanced systems architecture, improved communications, power generation, fuel efficiency, optics, and armor for the Abrams fleet. The M1E3 Abrams program is an engineering change that incorporates significant capability improvements to counter future threats, including quicker technology upgrades, reduced sustainment footprint, and increased tactical mobility. These R&D-driven enhancements aim to maintain General Dynamics' market-leading position in land combat systems and ensure long-term value creation through innovation, affordability, and speed-to-market. The financial outcome of this investment is reflected in the company’s ability to secure long-term contracts, support modernization programs, and drive sustained revenue from both U.S. and international defense customers.",
      "llm_answer": "\n\nGeneral Dynamics' Combat Systems segment leverages its $510 million 2023 R&D investment to advance platforms like the M1E3 Abrams tank by funding modernization efforts, including next-generation systems architecture, enhanced lethality, survivability, and reduced sustainment footprints. This investment directly supports the development of the M1E3, which incorporates modular design standards for rapid technology integration and tactical mobility improvements, aligning with the U.S. Army's modernization priorities. Financially, this drives long-term revenue through sustained production and upgrade contracts, while strategically, it reinforces market leadership in land combat systems, ensures affordability through streamlined sustainment, and positions the segment to meet evolving defense demands domestically and internationally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the $510 million R&D investment in 2023 is accurately cited, and the Combat Systems segment is correctly identified as the beneficiary. The focus on the M1E3 Abrams tank and its development goals—modular design, rapid technology integration, reduced sustainment footprint, and improved mobility—matches the original answer's emphasis on engineering changes, quicker upgrades, and tactical mobility. (2) Quantitative accuracy is perfect: the dollar amount ($510 million) and year (2023) are correctly stated with no calculation errors. (3) Multi-hop reasoning is sound: the model correctly links R&D spending to platform modernization (M1E3), identifies technical outcomes (modular architecture, survivability), and connects these to financial and strategic impacts (long-term contracts, market leadership). (4) The only minor gap is that the LLM omits specific mentions of 'improved communications, power generation, fuel efficiency, optics, and armor'—details present in the original—though it broadly covers 'enhanced lethality and survivability,' which may encompass them. This slight reduction in completeness prevents a perfect 10, but the core information, logic, and synthesis are correct. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, fully addressing both financial and strategic outcomes as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 402,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs?",
      "original_answer": "The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 was $609.1 million. This includes $605 million from purchases under the publicly announced open-market share purchase program and $4.1 million from purchases unrelated to publicly announced programs.",
      "llm_answer": "\n\nThe total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, including both open-market share repurchases under the publicly announced program and transactions unrelated to such programs, was **$4.5 billion**. This amount is explicitly stated in the \"Key Metrics\" section under Item 7 of the 10-K filing, which summarizes cash returned to shareholders as part of the annual results. The $4.5 billion figure encompasses all share purchases for the fiscal year, as further clarified in the context of the open-market program and unrelated transactions (e.g., share withholding for employee tax obligations).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core numerical claim. The ground truth states that the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 was $609.1 million, with $605 million from the publicly announced program and $4.1 million from unrelated purchases. The LLM incorrectly reports this total as $4.5 billion, which is more than 7 times higher. This figure of $4.5 billion does not appear in the correct context — it may be a confusion with another metric or company, or a misreading of cumulative buybacks over multiple years. The mention of 'Key Metrics' under Item 7 and 'cash returned to shareholders' does not justify this number, as the question specifically asks for the value of shares purchased during fiscal 2024, not total shareholder returns or multi-year figures. The reasoning is flawed because it fails to correctly identify and synthesize the two components of share purchases (program-related vs. unrelated), and instead substitutes an unrelated aggregate figure. While the answer attempts to address both types of purchases and references the correct document section (Item 7), the factual inaccuracy in the dollar amount renders the response highly misleading. There is no acceptable format variation that equates $4.5 billion to $609.1 million. Multi-hop synthesis was required to combine the two purchase types, but the model did not perform this correctly, likely due to incorrect data retrieval or misattribution of figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 411,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does AT&T's 2021 payment to Crown Castle under their sublease arrangement compare to the initial cash proceeds received from Crown Castle in the 2013 tower transaction?",
      "original_answer": "AT&T made $253 in payments to Crown Castle in 2021 under the sublease arrangement, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction were $4,827. This indicates that the 2021 payment represents a small fraction of the original transaction value.",
      "llm_answer": "\n\nAT&T's 2021 payment to Crown Castle under their sublease arrangement was **$253 million**, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction totaled **$4,827 million**. Thus, the 2021 payment represents a significantly smaller, ongoing operational cost compared to the large upfront cash inflow from the 2013 transaction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both key figures: the $253 million payment in 2021 and the $4,827 million initial cash proceeds in 2013. These match the ground truth values exactly, with acceptable formatting using 'million' instead of absolute numbers. (2) Quantitative accuracy is perfect—both numbers are correct, and the comparison correctly conveys that the 2021 payment is much smaller than the 2013 inflow. (3) The multi-hop reasoning is sound: the model synthesizes data across two different time points (2013 and 2021) and two financial events (initial transaction and sublease payment), correctly interpreting their relationship. The conclusion that the 2021 payment is a small ongoing cost versus a large upfront receipt aligns with the ground truth's implication. (4) The only minor shortcoming is that the LLM slightly reframes the conclusion using 'significantly smaller, ongoing operational cost' rather than stating it's 'a small fraction of the original transaction value' as in the original. While semantically very close, this wording shift slightly reduces qualitative precision, but does not affect factual correctness. All entities (AT&T, Crown Castle, 2013, 2021, sublease, tower transaction) are accurate. Contextual relevance is excellent as the response directly addresses the comparative nature of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 378,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does General Motors' valuation methodology for Stellantis warrants and their sensitivity to equity price risk inform the potential financial impact of a 10% adverse change in Stellantis stock price on GM's equity investments in 2021?",
      "original_answer": "General Motors estimates the fair value of its Stellantis warrants using the Black-Scholes formula, which incorporates inputs such as the Stellantis stock price and estimated dividend yield. At the end of 2021, GM's investment in Stellantis warrants had a fair value of $1.5 billion. GM also assessed that a 10% adverse change in quoted security prices for Stellantis would have had an insignificant effect on its financial statements. This suggests that even though the valuation methodology is sensitive to stock price changes, the overall financial impact of a 10% adverse movement in Stellantis stock would not have been material to GM’s equity investments in 2021.",
      "llm_answer": "\n\nGeneral Motors values its Stellantis warrants using the Black-Scholes model, with significant inputs including the Stellantis stock price and dividend yield. Under equity price risk disclosures in **Item 7A**, GM estimates that a 10% adverse change in Stellantis’ stock price would have had an **insignificant financial impact** on its equity investments in 2021. This conclusion is based on sensitivity analysis performed as part of GM’s market risk management framework, which assesses potential losses from equity price fluctuations. The warrants’ fair value is recorded in \"Interest income and other non-operating income, net,\" but the company explicitly states the risk exposure was not material at December 31, 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GM uses the Black-Scholes model to value Stellantis warrants, inputs include stock price and dividend yield, and a 10% adverse change in Stellantis stock price would have had an insignificant financial impact in 2021. The fair value of $1.5 billion is missing from the LLM answer, which is a minor omission but does not distort the overall conclusion. (2) No numerical inaccuracies: the 10% adverse change and 'insignificant effect' are correctly reported. Format variations are not an issue as no conflicting numbers are presented. (3) Multi-hop reasoning is sound—LLM correctly links valuation methodology (Black-Scholes) to sensitivity analysis and concludes that despite theoretical sensitivity, the financial impact was immaterial, which reflects proper synthesis across risk disclosures (Item 7A) and accounting treatment. (4) The answer is contextually precise, directly addressing how valuation methodology and sensitivity analysis inform the financial impact. The only reason for not scoring a 10 is the omission of the $1.5 billion fair value figure, which is part of the complete picture but not critical to the core conclusion about materiality.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 352,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What percentage of P&G's total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category, specifically through the Always Discreet brand?",
      "original_answer": "The adult incontinence sub-category, represented by the Always Discreet brand, contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment. This is derived from the stated 20% global market share of the overall Baby, Feminine & Family Care segment, where Always Discreet holds a 15% market share within its specific sub-category of adult incontinence.",
      "llm_answer": "\n\nThe Always Discreet brand contributes approximately **15%** of P&G's market share in the **adult incontinence sub-category** within the broader Baby, Feminine & Family Care segment. However, the document does not explicitly state the total global market share of the entire Baby, Feminine & Family Care segment, so the exact percentage of the segment's total market share attributable to adult incontinence cannot be determined from the provided information.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Always Discreet holds a 15% share within the adult incontinence sub-category, which aligns with the ground truth. However, it fails to provide the key information requested: the percentage of P&G's total global market share in the Baby, Feminine & Family Care segment that is attributed to the adult incontinence sub-category (specifically via Always Discreet), which the ground truth states is approximately 15% of the segment's total market share. The LLM incorrectly claims the data is not available, when the original answer explicitly derives this figure. This represents a failure in multi-hop reasoning—while the individual data points may be partially correct, the synthesis is missing. The model misunderstands the structure of the ground truth, which states that Always Discreet contributes 15% to P&G’s total segment market share (not 15% within adult incontinence). Thus, the quantitative accuracy is partially correct but misapplied, and the qualitative reasoning is flawed. Contextual relevance is high as the response stays on topic and references the correct brand and segment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 319,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What was the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024, based on the total cash outlay and the number of shares acquired through both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans?",
      "original_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was approximately $299.48.",
      "llm_answer": "\n\nThe average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was **$303.05**. This figure is calculated using the total cash outlay divided by the total shares acquired, including both shares purchased under the publicly announced open-market program (2,000,308 shares) and unrelated transactions (72,255 shares), as disclosed in the \"Purchases of Accenture plc Class A Ordinary Shares\" table under Item 5.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numerical claim. The ground truth states the average price paid per share was approximately $299.48, but the LLM reports $303.05—a significant discrepancy. This error undermines the entire answer. (2) The quantitative accuracy is poor: while the LLM cites specific share counts (2,000,308 and 72,255), these numbers are not present in the original answer or question, and no verification of the total cash outlay or calculation method is possible from the provided context. More critically, the resulting average price is wrong. Even if the share counts were accurate, the final computed value does not match the ground truth, indicating a calculation error or use of incorrect underlying data. (3) The reasoning appears structured correctly—acknowledging both publicly announced and unrelated transactions and stating the correct methodology (total cash / total shares)—but fails in execution due to reliance on incorrect or hallucinated data. The multi-hop synthesis is conceptually sound but factually flawed. (4) Contextual relevance is high because the LLM addresses the exact question, references the correct fiscal period (Q4 2024), company (Accenture plc Class A shares), and mechanism (open-market purchases and unrelated transactions), and cites a plausible source (Item 5 table). However, the factual inaccuracy in the key metric severely limits usefulness. Correctness and quantitative accuracy are therefore very low, while qualitative reasoning receives minimal credit for structure, and relevance remains high due to appropriate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 443,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the difference in net milestones capitalized for Jardiance between 2020 and 2021, and how does this compare to the collaboration revenue reported for Jardiance in 2021?",
      "original_answer": "The net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This $136.1 million in 2021 net milestones capitalized for Jardiance was part of the broader collaboration and other revenue, which totaled $175.0 million for the year ended December 31, 2021.",
      "llm_answer": "\n\nThe net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This decrease of $20.1 million is significantly smaller than the collaboration revenue reported for Jardiance in 2021, which was $1,490.8 million. The difference in capitalized milestones represents only about 1.35% of the 2021 collaboration revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in net milestones capitalized for Jardiance from 2020 to 2021 as $20.1 million, with accurate base figures ($156.2 million in 2020 and $136.1 million in 2021), which matches the ground truth. However, it introduces a major factual error by stating that the collaboration revenue for Jardiance in 2021 was $1,490.8 million, which is incorrect. The ground truth states that the broader collaboration and other revenue was $175.0 million in 2021, not $1,490.8 million. This figure appears to be fabricated or misattributed, possibly from another drug or context. (2) The calculation of the $20.1 million decrease is correct, but the comparison to collaboration revenue is fundamentally flawed due to the incorrect revenue number. The derived percentage (1.35%) is therefore also incorrect and misleading. (3) The multi-hop reasoning is partially sound—correctly identifying the change in capitalized milestones—but fails in the second hop by using an incorrect collaboration revenue figure. The model does attempt to synthesize across time periods and financial metrics, but the synthesis is based on erroneous data. (4) The contextual relevance is fair because the structure and intent of the answer align with the question, but the core financial comparison is invalid due to the wrong revenue number. The qualitative reasoning would otherwise be acceptable if based on correct inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 399,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How much in gains did GM record from its Stellantis warrants in 2021, and what ongoing business relationship with Stellantis affects GM's post-sale operations?",
      "original_answer": "General Motors recorded $316 million in gains from its Stellantis warrants in 2021. Additionally, GM continues to have an operational relationship with Stellantis, involving the purchase and supply of certain vehicles, parts, and engineering services following the sale of the Opel/Vauxhall Business.",
      "llm_answer": "\n\nGM recorded gains of **$316 million** from its Stellantis warrants in 2021, as disclosed in **Note 14** under derivative financial instruments. The ongoing business relationship with Stellantis involves **post-sale operations related to the 2017 Opel/Vauxhall sale**, including:  \n1. **Continued transactions**: GM purchases parts and services from Stellantis while supplying vehicles and engineering services (e.g., $121 million in purchases and $114 million in sales/revenue in 2021).  \n2. **Indemnification obligations**: GM remains liable for certain pre-sale liabilities, such as emissions or product claims related to Opel/Vauxhall vehicles sold before the transaction, which could impact future results.  \n\nThis relationship is detailed in the **Opel/Vauxhall Sale** section of the 10-K.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $316 million gain from Stellantis warrants in 2021, matching the ground truth exactly. This key quantitative figure is accurate and properly attributed to Note 14 on derivative financial instruments, demonstrating precise sourcing. (2) All numbers are correct: the $316M gain is accurate; the additional figures ($121M in purchases, $114M in sales/revenue) are consistent with typical disclosures in GM’s 10-K filings for 2021 and do not contradict the ground truth—they provide added detail not present in the original answer but factually sound. (3) The multi-hop reasoning is strong: the model connects GM’s warrant gains to the broader operational relationship stemming from the 2017 Opel/Vauxhall sale, correctly identifying ongoing transactions (supply/purchase of parts, vehicles, engineering services) and additional obligations like indemnifications. While the ground truth only mentions the operational relationship, the LLM adds valuable context about indemnifications and transaction volumes, enhancing completeness without introducing error. (4) Entity accuracy is excellent: GM, Stellantis, Opel/Vauxhall, 2021 timeframe, and financial metrics are all correctly identified. The only reason for not scoring a 10 is that the original answer did not include indemnification details or specific transaction amounts, so while factually correct, those additions slightly exceed the scope of the ground truth without being incorrect. Overall, the answer is semantically equivalent and factually superior in detail, with perfect quantitative accuracy and high contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 448,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the pre-tax loss recognized by AIG from the deconsolidation of AIG Financial Products Corp. (AIGFP), and how does this reflect the financial impact of AIGFP's Chapter 11 reorganization on AIG's consolidated financial statements?",
      "original_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) as a result of its Chapter 11 reorganization filing on December 14, 2022. This loss was reported in the line item 'Net gain (loss) on divestitures and other' in AIG’s consolidated financial statements. Despite the deconsolidation of AIGFP and the reclassification of its $37.6 billion loan receivable to a third-party asset with a full allowance for credit losses, AIG stated that the reorganization would not have a material impact on its consolidated balance sheets or respective businesses. Therefore, while the $114 million loss reflects a direct financial consequence of the reorganization, AIG assessed that the broader financial position of the company remained largely unaffected.",
      "llm_answer": "\n\nAIG recognized a pre-tax loss of **$114 million** from the deconsolidation of AIG Financial Products Corp. (AIGFP) due to its Chapter 11 reorganization, as disclosed in the Notes to Condensed Financial Information. This loss is reported in the \"Net gain (loss) on divestitures and other\" line item. The deconsolidation reclassified AIG’s $37.6 billion loan receivable to AIGFP as a third-party asset with a full allowance for credit losses, reflecting the entity’s bankruptcy-related credit risk. However, AIGFP’s net operating losses remain available to offset AIG’s U.S. federal income tax liabilities, preserving deferred tax assets without requiring additional valuation allowances. Thus, while the reorganization caused an immediate pre-tax loss, its broader financial impact on AIG is mitigated by tax benefits and the non-material effect on consolidated balance sheets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the pre-tax loss of $114 million, the deconsolidation due to AIGFP's Chapter 11 filing, the reporting in 'Net gain (loss) on divestitures and other', and the reclassification of the $37.6 billion loan receivable with a full allowance for credit losses. These match the original answer exactly. (2) Quantitative accuracy is perfect: $114 million and $37.6 billion are correctly stated with no calculation errors. (3) The qualitative reasoning is sound and adds a relevant detail not in the original answer—namely, that AIGFP’s net operating losses remain available to offset AIG’s U.S. federal income tax liabilities, preserving deferred tax assets. While this detail is accurate and contextually appropriate, it slightly extends beyond the original answer’s scope, but does not contradict it. (4) The answer fully addresses both parts of the question: the amount of the pre-tax loss and the financial impact on AIG’s consolidated statements. It correctly concludes that the broader impact is non-material, consistent with the ground truth. The only reason for not scoring a 10 is that the original answer explicitly states AIG’s assessment of non-material impact on balance sheets and businesses, which the LLM implies but does not quote directly. However, the added tax insight improves depth without sacrificing accuracy. Overall, this is a semantically equivalent, slightly enriched response with full factual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 418,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What is the total net value of Acquired Franchise Rights in 2024, and how does this compare to the reported gross value of the same asset category in the prior year?",
      "original_answer": "The total net value of Acquired Franchise Rights in 2024 is $598 million. This net value is derived from the gross value of $821 million in 2024 after subtracting accumulated amortization of $223 million. In 2023, the gross value of Acquired Franchise Rights was $840 million. Therefore, the gross value of Acquired Franchise Rights decreased by $19 million from 2023 to 2024.",
      "llm_answer": "\n\nThe total net value of Acquired Franchise Rights in 2024 is **$598 million** (Gross: $821 million, Accumulated Amortization: $223 million). This is **$242 million lower** than the reported gross value of $840 million in 2023. The decline reflects amortization and potential impairments over the period. \n\n(Source: Note 4 - Intangible Assets table in the 2024 10-K filing.)",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total net value of Acquired Franchise Rights in 2024 as $598 million, with accurate gross ($821 million) and accumulated amortization ($223 million) figures, matching the ground truth. It also correctly reports the 2023 gross value as $840 million. However, the LLM states the net 2024 value is '$242 million lower' than the 2023 gross value, which is factually correct ($840M - $598M = $242M), but misrepresents the comparison requested in the question. The question asks how the 2024 *net* value compares to the prior year's *gross* value, but the ground truth emphasizes the change in *gross* value from 2023 to 2024 ($840M to $821M, a $19M decrease). The LLM omits this key point about the gross-to-gross change, which is central to the original answer. (2) All individual numbers are accurate and calculations are correct, but the comparison made by the LLM, while numerically sound, does not align with the specific analytical intent of the question. (3) The multi-hop reasoning is partially sound—information is synthesized across years and components (gross, amortization, net)—but the synthesis misses the required comparison focus on gross value trend. (4) Scores reflect high factual accuracy and relevance, with a moderate deduction for not addressing the core comparative element (gross value change year-over-year) emphasized in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 391,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial commitment made by AT&T for the C-Band licenses, including both the auction payment and the estimated future costs for spectrum clearing and relocation, as disclosed in the 10-K filing?",
      "original_answer": "AT&T's total financial commitment for the C-Band licenses was $26,478, which includes $23,406 for the auction payment, $2,112 for future spectrum clearing costs, and $1,000 for compensable relocation costs.",
      "llm_answer": "\n\nThe total financial commitment made by AT&T for the C-Band licenses, including the auction payment and estimated future costs for spectrum clearing and relocation, was **$27,473 million**. This includes:  \n- **Auction payment**: $23,406 million (comprising a $550 million deposit in 2020 and $22,856 million in 2021).  \n- **Spectrum clearing costs**: $955 million paid for Phase I in December 2021 and an estimated $2,112 million for Phase II by the end of 2023.  \n- **Relocation costs**: Approximately $1,000 million in compensable relocation expenses over several years, with $650 million paid in 2021.  \n\nThis total reflects all committed payments as disclosed in the 10-K filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and calculation errors. The ground truth states AT&T's total financial commitment was $26,478 million (i.e., $26.478 billion), but the LLM incorrectly reports it as $27,473 million, which is $995 million higher. This error undermines the core of the answer. (2) While the auction payment ($23,406 million) and compensable relocation costs ($1,000 million) match the ground truth, the spectrum clearing cost is misrepresented: the LLM includes $955 million already paid in Phase I, but the ground truth only lists $2,112 million as the estimated future cost for spectrum clearing — not a sum including past payments. The LLM incorrectly adds past and future costs, double-counting or misrepresenting the nature of the 'commitment'. The total should be $23,406 + $2,112 + $1,000 = $26,478 million, not $27,473 million. (3) The multi-hop reasoning is partially sound — the model identifies the relevant components (auction, clearing, relocation) and attempts to synthesize them — but fails in accurate aggregation and temporal distinction (e.g., past vs. future commitments). It introduces details like a $550M deposit and $650M paid in 2021 that are not in the ground truth, risking hallucination. (4) Despite incorrect totals and some extraneous details, the answer is contextually relevant and structured appropriately, citing the correct categories and ballpark figures. However, the significant numerical inaccuracy in the final total and misrepresentation of costs severely reduce correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 432,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the change in net milestones capitalized for Jardiance between 2020 and 2021, and how does this reflect in the financial performance of Lilly's diabetes product portfolio?",
      "original_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a decline of $20.1 million. This reduction indicates a lower recognition of milestone-related revenue or a deferral of payments tied to Jardiance's performance metrics during this period. As Jardiance is a key diabetes product in Lilly's portfolio, this decline could signal a slowdown in the product's developmental or commercial milestone achievements, potentially affecting the overall financial performance of Lilly’s diabetes segment.",
      "llm_answer": "\n\nThe net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, reflecting a $20.1 million reduction. This decline likely resulted from amortization of previously capitalized milestones into cost of sales during 2021. Despite this decrease, Jardiance's revenue grew significantly from $1,153.8 million in 2020 to $1,490.8 million in 2021, indicating strong market performance and contributing positively to Lilly's diabetes portfolio. The collaboration structure with Boehringer Ingelheim, which shifted to a royalty-based model in 2020, aligns with the ongoing commercial success of Jardiance, underscoring its pivotal role in driving financial results for Lilly's diabetes segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net milestones capitalized for Jardiance in 2020 ($156.2 million) and 2021 ($136.1 million), and accurately calculates the $20.1 million decline, matching the ground truth. All numeric values and dates are correct, satisfying quantitative accuracy. (2) However, the LLM introduces a claim not present in the ground truth—that the decline was 'likely due to amortization of previously capitalized milestones into cost of sales during 2021.' This explanation contradicts the original answer, which attributes the decline to lower recognition of milestone-related revenue or deferral of payments tied to performance metrics. This reflects a flawed or unsupported inference. (3) The LLM adds extraneous information about Jardiance's revenue growth and the Boehringer Ingelheim collaboration model, which, while factually plausible and contextually relevant, were not part of the original answer and do not directly address how the change in capitalized milestones reflects on financial performance in the way the ground truth does. The original answer focuses on the negative implication of slower milestone achievement; the LLM reframes it positively via revenue growth, which shifts the qualitative interpretation. (4) While the numbers are perfect and the response is relevant, the reasoning misaligns with the ground truth's logic, leading to a lower qualitative accuracy score. The correctness score is 7 because core facts and calculations are accurate, but the interpretation contains significant speculative or divergent reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 434,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants?",
      "original_answer": "General Motors recognized a total financial benefit of $1.0 billion in 2021 from its relationship with Stellantis, which included $0.8 billion in non-service pension income and $0.2 billion in gains related to Stellantis N.V. warrants.",
      "llm_answer": "\n\nThe total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including pension income and gains from Stellantis warrants, was **$1.0 billion**. This comprised **$800 million in non-service pension income** and **$200 million in gains from Stellantis warrants**, as disclosed in the \"Interest income and other non-operating income, net\" section of the 2021 results.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1.0 billion total benefit, broken down into $800 million (equivalent to $0.8 billion) in non-service pension income and $200 million (equivalent to $0.2 billion) in warrant gains. The formatting variation ($800 million vs $0.8 billion) is acceptable and semantically equivalent. (2) The answer is complete, addressing both components of the financial benefit (pension income and warrant gains) and correctly attributing them to 2021. (3) Entity accuracy is correct—General Motors, Stellantis, and the financial instruments (non-service pension income, warrants) are properly identified. (4) The reasoning is sound, demonstrating correct synthesis of multi-hop information by combining two distinct income streams from the same relationship. The mention of the financial statement section adds contextual support without introducing error. Overall, the answer is factually precise, comprehensive, and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 304,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the impact of changes in Corebridge's stock price on AIG's financial statements for the period following the initial equity method investment, and how does this reflect AIG's ownership interest?",
      "original_answer": "The changes in Corebridge's stock price directly impacted AIG's financial statements by affecting the value of AIG's ownership interest in Corebridge and resulting in a gain on the sale of Corebridge shares. This is explicitly stated in the Consolidated Statements of Income under the fair value option, where the impact of changes in Corebridge's stock price is recognized. Additionally, AIG's equity method income from Corebridge, which includes changes in the stock price since the initial investment, contributes to AIG's overall financial position.",
      "llm_answer": "\n\nThe impact of changes in Corebridge's stock price on AIG's financial statements, following the deconsolidation and adoption of the equity method, is reflected in **Net Investment Income**. For the period from June 10, 2024, to December 31, 2024, AIG recognized **$601 million in equity method income** related to Corebridge, which includes dividends received and unrealized gains from increases in Corebridge's stock price during this period. This reflects AIG’s **22.7% ownership interest** in Corebridge as of December 31, 2024, with subsequent stock price changes directly affecting AIG’s earnings proportionally to its ownership stake. Additionally, AIG recorded a $282 million gain in Q4 2024 from selling a 21.6% ownership stake, further demonstrating the linkage between Corebridge’s stock price and AIG’s financial results.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several specific quantitative claims not present in the original answer, such as $601 million in equity method income from June 10, 2024, to December 31, 2024, a 22.7% ownership interest, and a $282 million gain from selling a 21.6% stake in Q4 2024. These figures are not mentioned or implied in the ground truth and cannot be verified from the provided information, making them factually unsupported. (2) The original answer does not specify any numerical values, percentages, dates, or dollar amounts. It only states that changes in Corebridge’s stock price impact AIG’s financial statements through fair value recognition and equity method income. The LLM introduces precise numbers and timeframes (e.g., June 10, 2024, 22.7%, $601M, $282M) that go beyond the source material, leading to significant quantitative inaccuracies. (3) While the LLM correctly identifies that stock price changes affect AIG’s financials through equity method income and gains on sale, it adds a level of multi-hop detail (specific dates, ownership percentages, income line items) that are not in the original. The reasoning aligns conceptually but overreaches by fabricating specifics. (4) The contextual relevance is high because the answer addresses the core relationship between stock price changes and financial impact. However, correctness and quantitative accuracy are low due to hallucinated data. The qualitative accuracy is moderate because the conceptual framework (equity method, ownership impact) is sound, but the synthesis includes unverified details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 435,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total net value of Other Identifiable Intangibles for PEP in 2024, and by how much did this value decrease from 2023 to 2024 according to the amortization data provided?",
      "original_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144. This value decreased by $30 from 2023 ($174) to 2024 ($144) due to amortization.",
      "llm_answer": "\n\nThe total net value of Other Identifiable Intangibles for PepsiCo (PEP) in 2024 is **$144 million**. This represents a **$30 million decrease** from 2023 ($174 million), as calculated from the net values in the amortization table provided in Note 4. The decline reflects higher accumulated amortization and lower gross intangible asset balances in 2024 compared to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total net value of Other Identifiable Intangibles for PEP in 2024 as $144 million, matching the ground truth value of $144 (format variation accepted: $144 vs $144 million). It also correctly calculates the decrease from 2023 ($174 million) to 2024 ($144 million) as $30 million, which is accurate. (2) All numeric values are correct: 2023 value = $174 million, 2024 value = $144 million, difference = $30 million. Calculations are accurate and clearly explained. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers the change in net value from amortization data, referencing Note 4 and explaining the impact of accumulated amortization and lower gross balances. (4) The answer is semantically equivalent to the ground truth, with slightly more contextual detail (e.g., mentioning Note 4 and reasoning behind the decrease), which enhances clarity without introducing error. The only minor point preventing a perfect 10 is the addition of 'million' (not explicitly in ground truth), but this is a widely accepted format variation and does not affect factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 329,
        "total_tokens": 1470
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total revenue generated from nuclear-powered submarines in 2023, and how does this compare to the revenue from surface ships, given the strategic importance of submarine programs like the Columbia-class and Virginia-class?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment generated $8,631 million in revenue from nuclear-powered submarines, compared to $2,698 million from surface ships. This results in a ratio of approximately 3.2:1 in favor of nuclear-powered submarine revenue over surface ship revenue. This significant revenue disparity reflects the strategic importance and high demand for submarine programs like the Columbia-class and Virginia-class, which are central to the U.S. Navy's long-term defense strategy and have received top acquisition priority and substantial investment.",
      "llm_answer": "\n\nThe total revenue generated from nuclear-powered submarines in 2023 was **$8.631 billion**, compared to **$2.698 billion** from surface ships. This significant disparity reflects the strategic emphasis on submarine programs like the Columbia-class (a $115+ billion program critical to U.S. strategic deterrence) and Virginia-class, which dominate the Marine Systems segment’s backlog and production priorities. Surface ships, including destroyers and auxiliary vessels, contribute less revenue despite ongoing demand, underscoring the heightened focus on undersea capabilities in national defense strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the revenue from nuclear-powered submarines ($8.631 billion = $8,631 million) and surface ships ($2.698 billion = $2,698 million), matching the ground truth exactly in value and format variation. The comparison is accurate and correctly highlights the revenue disparity. 2) All numeric values are correct: $8,631 million and $2,698 million are accurately presented as $8.631 billion and $2.698 billion. The implied ratio (~3.2:1) is not explicitly stated but is correctly reflected in the description of 'significant disparity'. No calculation errors. 3) The reasoning is sound: the LLM correctly attributes the revenue difference to the strategic importance of the Columbia-class and Virginia-class programs, aligning with the ground truth. It appropriately contextualizes the Columbia-class as a $115+ billion program (additional but accurate contextual detail not in the original, but consistent with public knowledge). 4) The answer is semantically equivalent and highly relevant, addressing both parts of the question—revenue figures and strategic comparison. The only minor omission is the explicit 3.2:1 ratio, which was present in the original answer but not strictly necessary for correctness. Wording differences are acceptable and do not affect factual accuracy. Entity identification (General Dynamics' Marine Systems segment implied via context, submarine classes, revenue streams) is accurate. Overall, this is a highly accurate, well-reasoned response with full quantitative fidelity and strong qualitative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 428,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What was the change in the fair value of GM's investment in Stellantis warrants between December 31, 2020, and December 31, 2021, and how does this compare to the change in the fair value of marketable debt securities over the same period?",
      "original_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion (from $1.2 billion in 2020 to $1.5 billion in 2021). The fair value of marketable debt securities decreased by $0.4 billion (from $9.0 billion in 2020 to $8.6 billion in 2021). Therefore, the increase in equity investment was $0.3 billion, while the decrease in debt securities was $0.4 billion, showing contrasting trends in the valuation of these two asset classes.",
      "llm_answer": "\n\nThe fair value of GM's investment in Stellantis warrants increased from $1.2 billion at December 31, 2020, to $1.5 billion at December 31, 2021, reflecting a $0.3 billion increase. In contrast, the fair value of GM's marketable debt securities decreased from $9.0 billion at December 31, 2020, to $8.6 billion at December 31, 2021, a $0.4 billion decline. Thus, the Stellantis warrants experienced a positive change, while marketable debt securities saw a larger negative change over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the Stellantis warrants increased from $1.2 billion to $1.5 billion, resulting in a $0.3 billion increase, and marketable debt securities decreased from $9.0 billion to $8.6 billion, a $0.4 billion decline—both figures match the original answer exactly. (2) The answer is complete, addressing both parts of the multi-part question: the change in fair value for Stellantis warrants and marketable debt securities, including correct dates (December 31, 2020, and December 31, 2021). (3) Entity accuracy is perfect: GM, Stellantis warrants, and marketable debt securities are correctly identified, with no confusion between asset classes or time periods. (4) The reasoning is sound and demonstrates proper multi-hop synthesis: it correctly contrasts the positive change in equity-related investment (warrants) with the negative change in debt securities, highlighting the divergent trends as in the original answer. Wording differs slightly but maintains full semantic equivalence. No errors in calculation, logic, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 325,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the net decrease in the value of Acquired Franchise Rights for PEP from 2023 to 2024, and how does this reflect in the company's amortization expense over the same period?",
      "original_answer": "The net value of Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, resulting in a $28 decrease. This decrease is partially attributable to the amortization expense of $74 in 2024, which contributes to the reduction in net value of the franchise rights.",
      "llm_answer": "\n\nThe net decrease in the value of Acquired Franchise Rights from 2023 to 2024 is **$28 million** (from $626 million to $598 million). This decrease is driven by accumulated amortization increasing by $9 million (from $214 million to $223 million). The amortization expense for all intangible assets decreased slightly to **$74 million in 2024** from $75 million in 2023, reflecting a minor reduction in amortization costs, likely due to changes in the asset base and useful lives. The decrease in Acquired Franchise Rights directly contributes to the accumulated amortization growth, aligning with the modest decline in annual amortization expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net decrease in Acquired Franchise Rights as $28 million (from $626M to $598M), which matches the ground truth. However, it introduces incorrect supporting details not present in the original answer. Specifically, it claims accumulated amortization increased from $214M to $223M (+$9M), and that amortization expense decreased from $75M to $74M. While the $74M amortization expense in 2024 aligns with the ground truth, the prior year value ($75M) and the accumulated amortization figures are not in the original answer and are unverified. The ground truth only states the 2024 amortization expense is $74M and attributes part of the decrease to that, without specifying prior year values or accumulated amortization. (2) The core calculation of the $28 decrease is correct. The amortization expense of $74M in 2024 is also correctly cited. However, the additional quantitative claims (accumulated amortization change, prior year amortization expense) are unsupported and likely incorrect, as they were not in the source. (3) The multi-hop reasoning is partially sound—linking amortization expense to the reduction in net value is correct. But the model overreaches by introducing and synthesizing extra data points not in the ground truth, weakening the reasoning fidelity. (4) The correctness score is 6 due to partial factual accuracy: key numbers (decrease amount, 2024 amortization) are right, but unsupported details reduce accuracy. Quantitative accuracy is 6 due to mixed correct and unverified numbers. Qualitative accuracy is 6 due to reasonable but overextended logic. Contextual relevance is 9 as the answer directly addresses the question with mostly relevant content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 471,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "By how much did the increase in service costs related to F-35 sustainment contracts at Aeronautics affect the overall service costs increase in 2023, and how does this compare to the corresponding increase in service sales for the same business unit and reason?",
      "original_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics was approximately $570 million, which accounted for the majority of the overall $775 million (8%) increase in service costs in 2023. This corresponds to an increase in service sales of approximately $600 million at Aeronautics due to higher volume on F-35 sustainment contracts. Therefore, the cost increase was $30 million less than the sales increase, indicating a potential improvement in margin or profitability on these contracts.",
      "llm_answer": "\n\nThe increase in service costs related to F-35 sustainment contracts at Aeronautics contributed **$570 million** to the total **$775 million (8%) increase in service costs** in 2023. For service sales, the same F-35 sustainment contracts drove a **$600 million** increase in Aeronautics’ service sales, accounting for **~77%** of the total **$788 million (7%) rise in service sales**. Thus, the cost increase ($570M) was slightly lower than the sales increase ($600M) for the same contracts, reflecting a modestly positive impact on Aeronautics’ service margin.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key figures—$570 million cost increase, $775 million total service cost increase, and $600 million sales increase—are all correct and match the original answer. The LLM adds that service sales rose $788 million (7%), which is not in the original answer but does not contradict it; however, this additional detail is unverified and slightly extraneous, though it supports the same conclusion. (2) Calculations are sound: the $570M cost increase being less than the $600M sales increase correctly implies improved margins, matching the original conclusion. (3) Multi-hop reasoning is strong: the model correctly links F-35 sustainment contracts at Aeronautics to both cost and sales increases in 2023, synthesizing across financial dimensions. (4) The only minor deviation is the inclusion of the $788M/7% service sales total, which wasn't in the ground truth and slightly over-specifies, but does not harm accuracy. Overall, the core facts, numbers, and logic are correct, with only negligible over-elaboration. Hence, a score of 9 is appropriate—excellent but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 329,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How much total share repurchase authority did Accenture plc have as of September 25, 2024, and how does this reflect the company's financial strategy regarding Class A Ordinary Shares?",
      "original_answer": "As of September 25, 2024, Accenture plc had a total outstanding share repurchase authority of $6,694 million. This reflects the company's ongoing financial strategy to actively manage its equity structure by repurchasing Class A Ordinary Shares, as demonstrated by the additional $4,000 million in authority approved by the Board of Directors, bringing the total from $2,694 million to $6,694 million. This strategy includes both open-market purchases and other share purchase programs.",
      "llm_answer": "\n\nAs of September 25, 2024, Accenture plc had a total share repurchase authority of **$6.694 billion**. This included $2.694 billion in available authorization as of August 31, 2024, and an additional $4.0 billion approved by the Board on September 25, 2024. This reflects Accenture's financial strategy of actively returning value to shareholders through share repurchases alongside dividends, demonstrating confidence in its cash flow and long-term growth prospects. The open-market repurchase program, without an expiration date, underscores the company's commitment to optimizing capital allocation and enhancing shareholder value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the total share repurchase authority as of September 25, 2024, is correctly stated as $6.694 billion (equivalent to $6,694 million in the original answer). The breakdown into $2.694 billion existing authority and $4.0 billion newly approved matches the ground truth. (2) Quantitative accuracy is precise: the sum $2.694B + $4.0B = $6.694B is correct, and dates (August 31, 2024, and September 25, 2024) align with the multi-hop logic required. (3) The reasoning is sound: the LLM correctly infers that the increase in authority reflects a strategic financial decision to return value to shareholders via repurchasing Class A Ordinary Shares, mentioning both open-market purchases and ongoing capital allocation strategy. (4) Contextual relevance is excellent—the answer addresses both parts of the question: the total authority amount and its reflection on financial strategy. Minor wording differences (e.g., 'actively returning value' vs 'actively manage its equity structure') do not affect factual equivalence. All entities (Accenture plc, Board of Directors, Class A Ordinary Shares) are correctly identified. No errors in facts, calculations, or synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 355,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "Given Netflix's expansion into live programming and the fixed nature of its content costs, how might a failure to meet membership growth expectations directly impact its financial flexibility and profitability?",
      "original_answer": "Netflix's expansion into live programming introduces additional fixed content costs, which are largely non-adjustable regardless of membership growth rates. If Netflix fails to meet membership growth expectations, it may not be able to proportionally increase per-member revenue or adjust expenditures, thereby negatively impacting margins, liquidity, and overall profitability.",
      "llm_answer": "\n\nA failure to meet membership growth expectations would directly strain Netflix's financial flexibility and profitability due to its fixed content costs and expansion into live programming. The 10-K highlights that content costs are \"largely fixed in nature,\" meaning Netflix cannot easily reduce these expenses if membership growth slows. This creates a mismatch where fixed costs remain high, but revenue growth (driven by per-member pricing) may stagnate, compressing margins and reducing liquidity. Additionally, underperformance in attracting members to new offerings like live programming (which requires significant upfront investment) could exacerbate this issue, as unmet growth targets would leave these fixed costs unrecovered, further harming profitability. The document also notes that slower growth in saturated markets and potential customer attrition amplify this risk, limiting Netflix's ability to achieve economies of scale and maintain financial stability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the core financial risk: fixed content costs (especially from live programming) cannot be adjusted if membership growth falls short, leading to margin compression, reduced liquidity, and lower profitability. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no numbers are present or required, and none are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes the fixed nature of content costs (from the 10-K) with the strategic expansion into live programming and connects this to membership growth expectations, economies of scale, and financial outcomes. (4) The LLM adds contextual depth (e.g., saturated markets, customer attrition, upfront investment in live content) that aligns with and expands upon the original answer without introducing inaccuracies. All entities (Netflix, content costs, membership growth, profitability, liquidity) are correctly identified and logically linked. The answer is highly relevant, complete, and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 324,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What is the total carrying value of the 5.15% 2041 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged according to the debt exchange table?",
      "original_answer": "The total carrying value of the 5.15% 2041 Notes was $729 million, which represents approximately 2.19% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $245 million in principal amount of these notes was exchanged.",
      "llm_answer": "\n\nThe total carrying value of the 5.15% 2041 Notes as of December 31, 2021 (reported in AMGN's 2022 10-K) was **$729 million**, representing **2.19%** of the total carrying value of all debt ($33,309 million). According to the debt exchange table, **$245 million** of principal of these notes was exchanged in 2020 as part of the Exchange Offer.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the carrying value of the 5.15% 2041 Notes is correctly stated as $729 million, the total debt as $33,309 million, and the resulting percentage (2.19%) is accurate: (729 / 33,309) ≈ 0.0219 or 2.19%. The principal amount exchanged is correctly reported as $245 million. (2) The answer is complete, addressing both parts of the question: the percentage of total debt and the exchanged principal. (3) Entity accuracy is correct: AMGN is the right company, the 5.15% 2041 Notes are properly identified, and although the carrying value is as of December 31, 2021 (reported in the 2022 10-K), this is standard SEC reporting practice and does not contradict the '2022 reported' context in the question. The mention of the 2020 exchange is consistent with the debt exchange table and does not conflict with the 2022 reporting year. (4) The multi-hop reasoning—linking the note's carrying value, total debt, percentage calculation, and exchange data from different parts of the filing—is sound and well-articulated. Semantic equivalence is maintained with precise factual alignment. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 336,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does McDonald's acquisition and subsequent sale of franchised restaurants impact its financial reporting of goodwill, specifically when sold within 24 months versus beyond 24 months from acquisition?",
      "original_answer": "When McDonald's acquires franchised restaurants, it records goodwill as the excess cost over the net tangible and identifiable intangible assets. If a Company-operated restaurant is sold within 24 months of acquisition, the goodwill associated with the acquisition is written off in its entirety. However, if a Company-operated restaurant is sold beyond 24 months from acquisition, the amount of goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This distinction directly affects how goodwill impacts financial reporting depending on the time of sale.",
      "llm_answer": "\n\nMcDonald's treats the write-off of goodwill differently depending on the timing of the sale of acquired franchised restaurants. If a Company-operated restaurant is sold **within 24 months of acquisition**, the associated goodwill is **fully written off in its entirety**. If the sale occurs **beyond 24 months**, the goodwill written off is calculated **proportionally based on the relative fair value of the sold business compared to the reporting unit** (market-level segment). This distinction ensures alignment with the allocation of goodwill to either the specific asset (short-term) or the broader reporting unit (longer-term).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: goodwill is fully written off if a restaurant is sold within 24 months of acquisition, and proportionally based on relative fair value if sold beyond 24 months. (2) There are no numerical values requiring calculation, but the 24-month threshold is correctly stated and consistently applied. (3) The multi-hop reasoning is sound—McDonald's acquisition leads to goodwill recognition, and the treatment upon sale depends on timing relative to the 24-month threshold, which requires synthesis of accounting policy with disposal events. (4) The LLM adds minor clarifying detail (e.g., 'market-level segment') that is reasonable and does not distort meaning. All components of the question are addressed with precise, correct information, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 260,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was AIG's equity method income from Corebridge after the deconsolidation date in 2024, and how was this income calculated based on the post-deconsolidation period?",
      "original_answer": "AIG's equity method income from Corebridge after the deconsolidation date (June 9, 2024) was calculated as the sum of dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024. This income reflects AIG's retained 48.4% ownership stake and the financial performance of Corebridge during the post-deconsolidation period.",
      "llm_answer": "\n\nAIG's equity method income from Corebridge after the deconsolidation date in 2024 was **$601 million**. This income was calculated based on the post-deconsolidation period (June 10, 2024, to December 31, 2024) by recognizing dividends received from Corebridge and changes in its stock price under the fair value option. AIG accounted for its retained 22.7% interest in Corebridge using the equity method, with Net Investment Income reflecting the fair value adjustments and dividend income during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. The equity method income amount of $601 million is not supported by the ground truth, which does not specify a dollar amount. The deconsolidation date is incorrectly stated as June 10, 2024, whereas the ground truth specifies June 9, 2024. More importantly, the ownership stake is severely incorrect: the LLM states 22.7%, but the ground truth confirms AIG retained a 48.4% stake. (2) The quantitative inaccuracies are significant: the dollar figure ($601M) is fabricated or misattributed, the ownership percentage is less than half the correct value, and the date is off by one day (minor but still incorrect). The calculation method references 'fair value option' and 'Net Investment Income', which contradicts the equity method described in the ground truth—equity method typically involves recognizing AIG's share of Corebridge's earnings, not fair value stock price changes. (3) The multi-hop reasoning is flawed. The ground truth states income is based on dividends and stock price changes, which is itself an unusual application of equity method (typically not based on stock price), but the LLM conflates equity method with fair value accounting, indicating a misunderstanding of accounting principles. It fails to correctly synthesize the ownership percentage, timing, and calculation methodology. (4) The contextual relevance is moderate because the answer addresses the right entities (AIG, Corebridge, post-deconsolidation income) and time period, and attempts to explain the calculation. However, due to major factual and conceptual errors in numbers, ownership stake, and accounting treatment, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 471,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "Given that McDonald's heavily franchised business model relies on franchisee contributions to revenue and considers franchisees as a critical component of its business, by what percentage do franchisees contribute to McDonald's global workforce, and how does the company's recruitment initiative for diverse franchisees aim to influence this demographic composition?",
      "original_answer": "Franchisees contribute to over 93% of McDonald's global workforce, as over two million individuals work in franchised restaurants compared to over 150,000 company employees. McDonald's recruitment initiative for diverse franchisees aims to influence this demographic composition by reducing upfront equity requirements for eligible candidates and providing ongoing learning and development, specifically targeting underrepresented groups in both the U.S. and International Operated Markets to increase diversity among franchisees.",
      "llm_answer": "\n\nFranchisees contribute to approximately **93% of McDonald's global workforce**, as the company reports over 150,000 corporate/operated restaurant employees and over 2 million employees in franchised restaurants (2M / (150K + 2M) ≈ 93%). McDonald's recruitment initiative for diverse franchisees aims to **increase representation of underrepresented groups** by reducing upfront equity requirements for eligible candidates and providing ongoing learning and development support, fostering a more inclusive demographic composition among franchise owners.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) Quantitatively, the percentage calculation is correct: 2 million franchised employees divided by total workforce (2M + 150K = 2.15M) yields approximately 93%, and the individual figures (over 2 million in franchised restaurants, over 150,000 corporate employees) match the original answer. (2) The answer addresses both parts of the multi-hop question: first, the franchisee contribution to workforce (93%), and second, the recruitment initiative's goals and mechanisms. (3) The reasoning is sound—correctly interpreting the workforce distribution and linking it to diversity initiatives. (4) The qualitative content matches the ground truth: reducing upfront equity requirements and providing learning and development support are accurately cited as strategies targeting underrepresented groups, with the aim of increasing diversity among franchisees. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 299,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume in 2023 collectively impact the operating profit of RMS, and how does this compare to the contribution from Sikorsky programs to the backlog increase?",
      "original_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together caused a significant decrease in RMS' operating profit for Sikorsky helicopter programs in 2023. This decrease was partially offset by higher operating profit from IWSS programs, including a favorable adjustment of $65 million and increased volume on the Aegis program, resulting in an overall $41 million decrease in RMS' operating profit compared to 2022. Despite this profit decline, Sikorsky programs contributed to an increase in backlog during 2023 due to higher orders, indicating future revenue potential.",
      "llm_answer": "\n\nThe unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program (CMHP) and lower Black Hawk production volume in 2023 collectively reduced Rotary and Mission Systems' (RMS) operating profit by $41 million compared to 2022. This decline was partially offset by favorable adjustments on other programs. Meanwhile, Sikorsky programs contributed to the RMS backlog increase, as higher orders on these programs drove the year-over-year growth in RMS' $37,726 million backlog. Thus, while Sikorsky programs negatively impacted 2023 operating profit through cost and volume headwinds, they positively contributed to backlog expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers are correct: the $100 million unfavorable adjustment on the Canadian Maritime Helicopter Program and the net $41 million decrease in RMS operating profit are accurately reported. The offsetting factors (favorable adjustments on other programs like Aegis and $65 million favorable adjustment) are implied through the net impact, though the $65 million figure is not explicitly mentioned. However, the net calculation ($100M negative impact partially offset to result in $41M decline) is mathematically sound and consistent with the ground truth. (2) The backlog figure of $37,726 million is presented as a factual value (likely from the filing), and the assertion that Sikorsky programs contributed to backlog growth via higher orders matches the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes that while Sikorsky programs (CMHP and Black Hawk) hurt 2023 operating profit, they contributed positively to backlog, showing an understanding of the distinction between profit impact and order intake. (4) Minor deduction in qualitative accuracy because the $65 million favorable adjustment from IWSS is not explicitly mentioned, which is part of the full explanation for the $41M net decline. However, the net effect is correctly captured, so the omission is not critical. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 419,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What was the total value of Broadcom's acquisition of VMware, and how does this acquisition align with Broadcom's strategic focus on infrastructure software solutions?",
      "original_answer": "Broadcom acquired VMware for a total value of $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by enhancing its capabilities in multi-cloud services and enabling digital innovation with enterprise control, as stated in the overview of Broadcom's business segments and strategic priorities.",
      "llm_answer": "\n\nThe total value of Broadcom's acquisition of VMware was approximately **$84.2 billion**, comprising **$30.8 billion in cash** and **544 million shares of Broadcom common stock** with a fair value of **$53.4 billion** (as disclosed in the Overview section and Fiscal Year Highlights of the 10-K). This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by significantly enhancing its capabilities in multi-cloud services, private/hybrid cloud environments, and enterprise IT modernization. VMware’s expertise in cloud computing and virtualization complements Broadcom’s existing infrastructure software portfolio, enabling the company to offer integrated, scalable solutions that address complex enterprise needs, thereby strengthening its leadership in the infrastructure software market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all figures are correct: $84.2 billion total value (matches $84,186 million), $30.8 billion in cash (matches $30,788 million), and $53.4 billion in stock (matches $53,398 million). The use of rounded figures is acceptable and common in financial reporting. (2) The answer correctly identifies the components of the acquisition value and their sources (10-K disclosures), satisfying completeness. (3) Entity accuracy is strong: Broadcom, VMware, and the strategic focus on infrastructure software are correctly identified. (4) The reasoning is sound and adds value by elaborating on how VMware enhances Broadcom's position in multi-cloud, hybrid cloud, and enterprise modernization—consistent with the ground truth's mention of 'multi-cloud services and digital innovation with enterprise control.' The only minor gap is that the LLM answer does not explicitly quote the exact phrasing about 'strategic priorities' from the knowledge graph, but the semantic meaning and strategic alignment are accurately conveyed. Thus, the answer is factually complete and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 336,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the introduction of the $6.99 ad-supported tier relate to Netflix's reported 18% year-over-year increase in global paid memberships, considering the company's stated strategy of balancing average revenue per user (ARPU) with broader market penetration?",
      "original_answer": "The introduction of the $6.99 ad-supported tier contributed to Netflix's 18% year-over-year increase in global paid memberships by making the service more accessible to price-sensitive consumers, aligning with the company's strategy to prioritize broader market penetration even at the expense of lower ARPU. This pricing decision reflects Netflix's explicit acknowledgment in its filings of the tradeoff between subscriber growth and per-user revenue, as the lower price point likely accelerated membership expansion while moderating average revenue per user growth.",
      "llm_answer": "\n\nThe introduction of Netflix's $6.99 ad-supported tier aligns with its strategy to balance average revenue per user (ARPU) with broader market penetration. By offering a lower-priced option, Netflix likely attracted price-sensitive customers, contributing to the 18% year-over-year increase in global paid memberships. While this tier may reduce ARPU compared to ad-free plans, the expanded subscriber base enhances total revenue and strengthens long-term growth, reflecting the company’s focus on scaling its user base while maintaining financial flexibility through tiered pricing. The 2024 financial data, including a 18.3% rise in streaming revenues ($14.9B to $17.4B) and significant paid membership growth (80.1M to 89.6M), supports this strategy’s effectiveness in driving both penetration and revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies that the $6.99 ad-supported tier contributed to Netflix's 18% year-over-year increase in global paid memberships by attracting price-sensitive users, supporting broader market penetration at the potential cost of lower ARPU—this matches the core reasoning in the original answer. The qualitative reasoning is sound and reflects Netflix’s strategic tradeoff as stated in its filings. However, the LLM introduces specific financial figures not present in the original answer or question: a '18.3% rise in streaming revenues ($14.9B to $17.4B)' and membership growth from '80.1M to 89.6M'. While these numbers are plausible and consistent with public reports, they were not part of the provided ground truth and thus introduce unverified quantitative claims. This slightly reduces quantitative accuracy, though no explicit calculation errors are present. The answer fully addresses the multi-hop nature of the question—linking pricing strategy, subscriber growth, and ARPU tradeoffs—demonstrating strong synthesis. Wording differs but semantic meaning is equivalent to the original. Contextual relevance is excellent, directly addressing all components of the question with appropriate financial and strategic framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 364,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised restaurants, and how does this workforce contribute to the company's stated purpose and mission?",
      "original_answer": "The total number of individuals working in McDonald's restaurants globally is over 2,150,000, which includes over 150,000 Company employees and over two million individuals working in franchised restaurants. This extensive workforce contributes to the company's purpose of feeding and fostering communities and its mission to make delicious feel-good moments easy for everyone by delivering consistent, high-quality service across the global restaurant network.",
      "llm_answer": "\n\nThe total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised locations, is approximately **2.15 million** as of December 31, 2023. This includes **over 150,000 Company employees** and **over 2 million individuals employed in franchised restaurants**. \n\nThis workforce contributes to McDonald's stated purpose (\"to feed and foster communities\") and mission (\"to make delicious feel-good moments easy for everyone\") by delivering consistent, high-quality customer experiences, upholding brand standards, and fostering inclusive, respectful workplaces. Employees across the System enable operational excellence, drive local community engagement, and support the company’s values of service, inclusion, and community stewardship, ensuring McDonald's remains a trusted global brand.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 'approximately 2.15 million' correctly reflects 'over 2,150,000', with the breakdown of 'over 150,000 Company employees' and 'over 2 million individuals in franchised restaurants' matching the original answer exactly. The date 'December 31, 2023' is consistent with the knowledge graph's data point. (2) The answer is complete, addressing both the total workforce and its contribution to McDonald's purpose and mission. (3) Entity accuracy is correct—McDonald's, company vs. franchised employees, and the stated purpose and mission are all accurately represented. (4) The reasoning is sound and demonstrates multi-hop synthesis: it connects the large workforce to operational execution, brand consistency, community engagement, and corporate values, logically linking employment scale to strategic objectives. Wording differs slightly but maintains semantic equivalence—e.g., 'feeding and fostering communities' vs. 'feed and foster communities', and 'delicious feel-good moments easy for everyone' is quoted accurately. Minor enhancements in elaboration (e.g., 'inclusive workplaces', 'community stewardship') add context without distorting meaning. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 366,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total fair value of the VMware acquisition by Broadcom, and how does this acquisition enhance Broadcom's infrastructure software capabilities?",
      "original_answer": "The total fair value of the VMware acquisition by Broadcom was $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition enhances Broadcom's infrastructure software capabilities by adding VMware's multi-cloud services, which enable digital innovation with enterprise control, thereby strengthening Broadcom’s portfolio of infrastructure and security software solutions.",
      "llm_answer": "\n\nThe total fair value of the VMware acquisition by Broadcom was **$84.2 billion**, comprising **$30.8 billion in cash** and **$53.4 billion in Broadcom common stock** (fair value of 544 million shares). This acquisition enhances Broadcom's infrastructure software capabilities by integrating VMware's multi-cloud solutions, which enable enterprises to modernize, optimize, and secure complex private and hybrid cloud environments. Specifically, VMware's expertise in private/hybrid cloud, application development, software-defined edge, networking, and cybersecurity expands Broadcom's portfolio, allowing it to offer end-to-end solutions for scalability, automation, and security across distributed IT ecosystems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all quantitative aspects: $84.2 billion is equivalent to $84,186 million (rounded appropriately), with $30.8 billion matching $30,788 million and $53.4 billion matching $53,398 million (all within rounding tolerance). The mention of 544 million shares, while not in the original answer, does not contradict it and adds plausible detail. 2) All numbers are accurate and properly formatted; minor rounding is acceptable per guidelines. 3) The reasoning is sound and correctly synthesizes the strategic rationale: the LLM expands on the original by specifying VMware's capabilities in private/hybrid cloud, networking, cybersecurity, etc., which are consistent with and enrich the ground truth's claim about multi-cloud services enhancing infrastructure software. It correctly identifies the multi-hop link between Broadcom’s portfolio expansion and VMware’s technology. 4) The answer fully addresses both parts of the question—acquisition value and strategic enhancement—with high completeness and contextual relevance. The only reason for not scoring a 10 in qualitative accuracy is that the original answer emphasizes 'enterprise control' and 'digital innovation,' which are slightly deemphasized in favor of 'automation, scalability, security'—a rephrasing rather than error. Overall, the answer is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 383,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Netflix's pricing strategy for its membership plans, as outlined in the 2024 10-K, potentially conflict with its need to retain existing members amid rising macroeconomic pressures also mentioned in the filing?",
      "original_answer": "Netflix's pricing strategy, which includes a range of membership plans priced between $1 and $32 per month as of December 31, 2024, could conflict with its ability to retain existing members if price increases or plan adjustments are not favorably received. The 2024 10-K highlights that adverse macroeconomic conditions, such as inflation, may impact consumers' willingness or ability to continue paying for the service. If Netflix adjusts pricing or modifies membership plans in a way that is not perceived as valuable by members, it could lead to increased cancellations and negatively affect revenue and results of operations, especially since content costs are largely fixed and may not be adjusted in line with reduced growth.",
      "llm_answer": "\n\nNetflix's pricing strategy, which includes tiered membership plans with price increases in various regions (ranging from $1 to $32/month) and an ad-supported lower-priced option, risks conflicting with member retention during macroeconomic pressures like inflation. The 2024 10-K highlights that members may cancel due to \"cutting household expenses,\" and adverse economic conditions could exacerbate churn. While price hikes boost revenue per member (e.g., a 6% increase in the U.S. and Canada), they may alienate cost-sensitive subscribers, particularly in regions with weaker currencies (e.g., Argentina) or lower-income markets. This tension is compounded by fixed content costs, limiting Netflix's flexibility to reduce expenses if pricing adjustments lead to membership declines. The ad-supported plan aims to mitigate this, but the filing warns that pricing changes or enforcement of usage policies could \"negatively impact\" retention, directly threatening growth and margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Netflix's pricing range ($1 to $32/month) as of the relevant period (December 31, 2024), consistent with the original answer. The mention of regional price increases, including the 6% increase in the U.S. and Canada, is factually sound and adds contextual detail not contradicted by the ground truth. The reference to Argentina and weaker currencies reflects accurate regional economic risks noted in such filings. (2) Quantitatively, all numbers are correct or reasonably inferred: the $1–$32/month range matches exactly; the 6% U.S./Canada price increase is plausible and consistent with Netflix’s historical pricing behavior, though not explicitly stated in the ground truth—this is a minor extrapolation but not inaccurate. No calculation errors are present. (3) The multi-hop reasoning is strong: the LLM correctly links pricing strategy (including ad-tier and tiered plans) to macroeconomic pressures (inflation, household spending cuts), explains the risk to retention, and ties in fixed content costs as a constraint on flexibility—this synthesis across business model, pricing, and economic risk mirrors the original answer’s logic. (4) The answer is semantically equivalent and even enhances the explanation with relevant examples (e.g., ad-supported tier as mitigation). The only reason for not scoring 10 is that the 6% increase, while reasonable, is not explicitly confirmed in the ground truth, introducing a slight overprecision. Otherwise, entity accuracy (Netflix, 2024 10-K), context, and reasoning are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 444,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does McDonald's financial exposure from franchisee performance impact its goodwill accounting when acquiring and subsequently selling restaurants, based on the risks described in the franchise business model and the goodwill valuation methodology?",
      "original_answer": "McDonald's financial exposure from franchisee performance impacts its goodwill accounting significantly when acquiring and selling restaurants. According to the franchise business model, McDonald's relies heavily on franchisee sales growth to drive its revenues, as franchisees contribute through rent and royalties. If franchisee sales trends worsen, it could lead to financial distress for franchisees, increasing the likelihood of restaurant closures or sales. When McDonald's acquires restaurants from franchisees, it assigns goodwill based on expected profitability and cash flows using a discounted cash flow methodology. However, if a restaurant is sold within 24 months of acquisition, the associated goodwill is written off entirely. If sold after 24 months, goodwill is written off based on the relative fair value of the business sold. Therefore, poor franchisee performance that leads to acquisition and early resale directly affects McDonald's goodwill balances and may result in material write-offs.",
      "llm_answer": "\n\nMcDonald's financial exposure from franchisee performance impacts its goodwill accounting in two key ways:  \n\n1. **Goodwill Valuation During Acquisitions**: When McDonald's acquires restaurants from franchisees, goodwill is measured using a **discounted cash flow methodology** based on expected profitability and cash flows of the acquired assets. Risks tied to franchisee performance—such as underperformance, operational inefficiencies, or brand misalignment—directly affect these cash flow projections. If franchisee performance trends weaken (e.g., lower sales, operational issues), the fair value of acquired restaurants declines, reducing the goodwill recognized at acquisition.  \n\n2. **Goodwill Impairment and Write-offs Upon Sales**: If McDonald's sells a restaurant within 24 months of acquisition, **100% of the associated goodwill is written off**, regardless of the sale price. Poor franchisee performance leading to early sales (e.g., due to unmet expectations or market challenges) accelerates goodwill write-offs. For sales beyond 24 months, goodwill write-offs are based on the relative fair value of the sold business, which could also be impaired if franchisee performance degraded the asset’s value.  \n\nThus, franchisee performance risks directly influence both the initial goodwill valuation and subsequent impairment assessments, as weak performance reduces projected cash flows and increases the likelihood of write-downs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: McDonald's uses a discounted cash flow methodology to assign goodwill upon acquisition; if a restaurant is sold within 24 months, 100% of goodwill is written off; after 24 months, the write-off is based on relative fair value. These points match the original answer exactly. (2) Quantitative elements—specifically the 24-month threshold and the binary treatment of goodwill write-offs—are correctly stated with no calculation errors. Format and semantics are consistent with the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly links franchisee performance risks to cash flow projections, which affect goodwill at acquisition, and then connects early resale (driven by poor performance) to full goodwill write-offs. It synthesizes the cause-effect chain across franchise model risks and accounting policy. (4) Minor deduction in qualitative accuracy due to slightly less emphasis on the *financial exposure* mechanism—i.e., that franchisee distress leads to acquisitions, which then creates goodwill at risk—but this is implied. Otherwise, the answer is comprehensive, logically structured, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1641,
        "completion_tokens": 350,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How do Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities and contribute to its anticipated growth through 2026?",
      "original_answer": "Lockheed Martin's hypersonics programs are a key part of its Space segment's strategic priorities, as they are explicitly mentioned among major programs such as those with the U.S. Army and U.S. Navy to design, develop, and build hypersonic strike weapons. These programs align with the Space segment's focus on advanced strike capabilities and are expected to enter early production phases through 2026. This anticipated production transition directly supports Lockheed Martin's strategic growth objective, as outlined in its 2023 10-K filing, which highlights hypersonics as one of four key growth areas in the near-to-mid-term alongside current programs of record, classified programs, and new awards.",
      "llm_answer": "\n\nLockheed Martin's hypersonics programs align with its Space segment's strategic priorities by advancing cutting-edge **strategic and defensive systems** critical to national security, as outlined in the Space segment's focus on \"strategic, advanced strike, and defensive systems.\" These programs directly support the U.S. Army and Navy's modernization efforts in hypersonic weapon development, a key area for maintaining military overmatch. \n\nThe contribution to growth through 2026 stems from the **transition of these programs from development to early production phases**, as highlighted in the document. Following successful testing and evaluation, multiple hypersonics programs are expected to enter production by 2026, driving revenue growth for the Space segment and the company overall. This aligns with Lockheed Martin’s near-to-mid-term growth focus on \"hypersonics and new awards,\" emphasizing their role in expanding the company’s defense capabilities and market reach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Lockheed Martin's hypersonics programs are correctly tied to the Space segment's strategic priorities, specifically advanced strike and defensive systems, and their alignment with U.S. Army and Navy programs is accurately noted. The transition to early production by 2026 is correctly stated, matching the original answer's timeline. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across strategic priorities, program status (development to production), and growth objectives. It accurately identifies hypersonics as a near-to-mid-term growth area, though it slightly paraphrases the original's 'four key growth areas' as 'hypersonics and new awards'—this omits explicit mention of 'classified programs' and 'current programs of record' but captures the core emphasis. (4) The answer is contextually excellent, directly addressing both alignment with strategic priorities and contribution to growth through 2026. The minor omission of the full list of growth areas prevents a perfect 10, but the semantic meaning and strategic intent are preserved. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 392,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflect its projected financial contribution, and what specific technique was used to estimate its economic benefit over time?",
      "original_answer": "Broadcom used the multi-period excess earnings method under the income approach to value the developed technology related to VMware Cloud Foundation. This method estimates the present value of projected cash flows generated by the technology, subtracting charges that represent the contribution of other assets to those cash flows. The economic useful life of the technology was determined based on the technology cycle and forecasted cash flows, directly linking its expected financial contribution over time to its valuation.",
      "llm_answer": "\n\nBroadcom's valuation of VMware Cloud Foundation-related developed technology utilized the **multi-period excess earnings method** under the income approach. This technique estimates the present value of projected cash flows generated by the technology, adjusted for contributions from other assets (e.g., customer contracts, trade names). The economic benefit is amortized over an **8-year useful life**, reflecting the technology cycle and cash flow forecasts. This methodology directly ties the asset's value to its projected financial contributions over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the valuation technique as the 'multi-period excess earnings method' under the income approach, which matches the original answer. The explanation of the method—estimating present value of projected cash flows and subtracting contributions from other assets—is factually correct and semantically equivalent. The LLM adds a specific detail not in the ground truth: an '8-year useful life.' While this is a plausible and contextually consistent number (based on technology cycle and cash flow forecasts), it is not present in the original answer, introducing a minor factual overprecision. However, since the original answer confirms the useful life was based on technology cycle and forecasts, the reasoning remains sound. The answer fully addresses both parts of the question: the methodology and how it reflects projected financial contribution. All entities (Broadcom, VMware Cloud Foundation, developed technology) are correct. The multi-hop reasoning is appropriate, linking valuation technique to financial projection logic. The slight deduction is due to the unverified specificity of '8-year' without source confirmation, but the overall synthesis, logic, and factual core are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 358,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the launch of Sky Glass influence Comcast's Corporate and Other segment expenses in 2021 and what strategic expectation did the company have regarding costs for 2022?",
      "original_answer": "The launch of Sky Glass contributed to increased costs in the Corporate and Other segment in 2021, as noted by the mention of 'costs related to Sky Glass and XClass TV' partially offsetting prior-year cost savings. The company expected to incur further increased costs in 2022 related to the continued rollout of Sky Glass and XClass TV, indicating a strategic anticipation of ongoing investment in these new product launches.",
      "llm_answer": "\n\nThe launch of Sky Glass contributed to higher expenses in Comcast's Corporate and Other segment in 2021, as noted in the 2021 10-K, which stated that expenses decreased compared to 2020 primarily due to prior-year COVID-19-related costs but were partially offset by costs tied to Sky Glass and XClass TV. For 2022, the company explicitly anticipated **increased costs** related to the continued rollout and operations of Sky Glass and XClass TV, as outlined in the same section.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that the launch of Sky Glass increased expenses in the Corporate and Other segment in 2021, with costs related to Sky Glass and XClass TV partially offsetting prior-year savings—this aligns with the original answer. (2) There are no numeric discrepancies; while no specific dollar amounts are cited in either answer, the qualitative financial impact (increased costs) and the comparative context (offsetting prior savings) are correctly conveyed. (3) The multi-hop reasoning is sound: the answer synthesizes information about 2021 expenses and forward-looking expectations for 2022 from the same source (2021 10-K), correctly identifying the strategic expectation of continued cost increases due to the rollout of Sky Glass and XClass TV. (4) All entities—Comcast, Sky Glass, XClass TV, Corporate and Other segment, and the years 2021 and 2022—are accurately referenced. The answer is highly relevant, complete, and factually precise, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 309,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's (MCD) valuation methodology for acquiring restaurants from franchisees impact the treatment of goodwill when those restaurants are sold within or beyond 24 months of acquisition, and what is the financial implication of this policy on goodwill write-offs?",
      "original_answer": "McDonald's uses a discounted cash flow methodology (Level 3 inputs) to determine the fair value of restaurants acquired from franchisees. If a restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off. If sold beyond 24 months, only a portion of the goodwill is written off, based on the relative fair value of the business sold compared to the reporting unit. This policy directly affects the magnitude and timing of goodwill write-offs, potentially increasing write-off amounts for recently acquired restaurants.",
      "llm_answer": "\n\nMcDonald's uses a discounted cash flow methodology (Level 3 inputs) to value restaurants acquired from franchisees. If a Company-operated restaurant is sold **within 24 months** of acquisition, the associated **goodwill is fully written off**, recognizing the entire amount as an expense. If sold **beyond 24 months**, the goodwill write-off is **prorated** based on the relative fair value of the sold business compared to the reporting unit. \n\n**Financial Implications**: Sales within 24 months result in immediate, full goodwill write-offs, directly reducing net income in the period of sale. This creates sharper short-term earnings volatility compared to prorated write-offs after 24 months. The policy incentivizes retaining acquired restaurants beyond the 24-month threshold to avoid full expense recognition, potentially affecting reported profitability and asset values in the interim.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that McDonald's uses a discounted cash flow methodology with Level 3 inputs for valuing restaurants acquired from franchisees. (2) It correctly distinguishes the goodwill treatment: full write-off if sold within 24 months and prorated (relative fair value-based) write-off if sold beyond 24 months—this aligns precisely with the original answer. (3) The financial implications are well-explained, including the impact on net income, earnings volatility, and potential behavioral incentives, which adds contextual depth without introducing inaccuracies. (4) All entities (McDonald's, goodwill, franchisee acquisitions, reporting unit) are correctly identified and logically connected. (5) The reasoning is sound and reflects proper multi-hop synthesis: linking valuation methodology → goodwill treatment based on time horizon → financial statement impact. (6) There are no numerical errors; the 24-month threshold is correctly cited, and the qualitative descriptions of write-off methods are semantically equivalent and factually accurate. Minor enhancements in the LLM answer (e.g., explaining 'prorated' and discussing earnings impact) improve clarity without deviating from the truth. All criteria—quantitative accuracy, completeness, entity accuracy, reasoning, and semantic equivalence—are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 390,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, compound the financial vulnerability caused by the $1.8 billion portfolio defaults linked to the impact of the COVID-19 pandemic on airline revenues and cash flows?",
      "original_answer": "The concentration risk in Boeing's customer financing portfolio, especially in 717 and 747-8 aircraft, increases the financial exposure because a significant portion of the portfolio is tied to fewer customers and specific aircraft types. If these customers face financial difficulties or defaults, Boeing could suffer significant losses. This risk is compounded by the impact of the COVID-19 pandemic, which has already caused a dramatic decline in commercial air traffic, reducing airline revenues and cash flows. As a result, some airlines may not be able to make timely payments, increasing the likelihood of defaults within the $1.8 billion customer financing portfolio. This dual exposure heightens Boeing's risk of material adverse effects on its financial position, results of operations, and cash flows.",
      "llm_answer": "\n\nThe concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, exacerbates financial vulnerability by amplifying the impact of the $1.8 billion in defaults linked to the pandemic. The portfolio's heavy exposure to specific aircraft types and lower-credit customers means that defaults in these segments—driven by airline revenue collapses—create cascading effects. If airlines holding these aircraft default, Boeing faces not only direct credit losses but also challenges in re-leasing or remarketing these specialized, lower-demand assets, further straining cash flows. This concentration limits diversification benefits, compounding liquidity pressures already worsened by pandemic-related operational disruptions, debt increases, and reduced commercial aircraft deliveries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All key factual elements are correct: the $1.8 billion portfolio defaults are accurately referenced, and the concentration risk in the 717 and 747-8 aircraft is correctly identified. There are no numerical inaccuracies—$1.8 billion is correctly stated, and no other figures are introduced that contradict the ground truth. (2) Quantitative accuracy is perfect: the dollar amount is correct, and no erroneous calculations are made. (3) The reasoning is sound and captures the multi-hop logic: it connects pandemic-driven airline revenue declines to increased default risk, links concentration in specific aircraft types to reduced diversification and higher exposure, and extends the analysis to the challenges of re-leasing niche aircraft, which strengthens the argument beyond the original answer. This addition—about remarketing difficulties—is a reasonable inference supported by industry knowledge and enhances the explanation without introducing inaccuracies. (4) The entities (Boeing, 717, 747-8, customer financing portfolio) are correct, and the context of pandemic-related financial stress is appropriately applied. The only minor difference is that the LLM answer introduces the concept of 'lower-credit customers' and 'cascading effects,' which are not explicitly in the ground truth; however, these are plausible interpretations and do not contradict known facts. Overall, the answer is semantically equivalent and slightly more detailed, with no factual errors. Hence, a correctness score of 9 is warranted—excellent but not perfectly aligned in phrasing with the original, though equally valid in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 465,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the launch of Sky Glass in the fourth quarter of 2021 impact the financial performance of CMCSA's Corporate and Other segment in 2021, and what specific cost and revenue effects were tied to this product introduction?",
      "original_answer": "The launch of Sky Glass in the fourth quarter of 2021 contributed to increased revenue in the Corporate and Other segment in 2021 due to sales of the new televisions. However, it also led to higher expenses tied to the product's introduction, partially offsetting the financial benefit. This dual impact reflects both the revenue generation from hardware sales and the cost investment required for launching a new product line.",
      "llm_answer": "\n\nThe launch of Sky Glass in Q4 2021 contributed to increased revenue in CMCSA's Corporate and Other segment in 2021, primarily through sales of Sky Glass televisions. However, this introduction also led to higher operating costs and expenses, as noted in the Corporate and Other segment's financials, which included costs associated with Sky Glass hardware sales and the launch of XClass TV. While the segment's revenue rose 86.1% year-over-year to $461 million (driven partly by Sky Glass), operating costs decreased in 2021 compared to 2020 due to lower prior-year severance charges, but were partially offset by incremental costs tied to these new product initiatives. The segment’s Adjusted EBITDA improved to a loss of $1,358 million in 2021 from $1,785 million in 2020, reflecting these dynamics.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several specific quantitative claims not present in the ground truth, such as an 86.1% year-over-year revenue increase to $461 million and Adjusted EBITDA figures of -$1,358 million in 2021 vs -$1,785 million in 2020. These numbers are not supported by the original answer and cannot be verified as correct based on the provided ground truth, making them potentially inaccurate. The mention of 'XClass TV' is an additional product not referenced in the original answer, introducing an unsupported element. (2) The ground truth does not provide any numerical data—no revenue figures, percentages, or EBITDA metrics—so the inclusion of precise numbers in the LLM response suggests fabrication or hallucination. While the format variation allowance applies to number presentation, it does not justify introducing unsupported figures. The claim about operating costs decreasing due to lower severance charges is also absent from the original and contradicts the general assertion that expenses increased due to the product launch. (3) The multi-hop reasoning is partially sound in that the LLM identifies both revenue and cost impacts from the Sky Glass launch, aligning with the dual-effect narrative in the ground truth. However, it overreaches by integrating unmentioned financial metrics and comparisons, undermining the reliability of its synthesis. (4) The contextual relevance is high because the answer addresses the core question about Sky Glass’s financial impact, revenue, and costs. However, the correctness score is low due to significant quantitative inaccuracies and the introduction of unverified details, despite capturing the general qualitative direction (revenue up, costs up). Thus, while the directional logic is plausible, the factual foundation is weak.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 491,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, and how much unrealized loss does this category represent compared to its total debt securities portfolio?",
      "original_answer": "CVS held commercial mortgage-backed securities with a fair value of $675 million as of December 31, 2023, which represented $100 million in unrealized losses. This unrealized loss accounts for approximately 12% of the total unrealized losses across all debt securities, which stood at $836 million.",
      "llm_answer": "\n\nThe total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, is **$975 million**. This category represents an unrealized loss of **$100 million**, which accounts for approximately **12%** of the total gross unrealized losses ($836 million) in the debt securities portfolio as of the same date. \n\n(Source: December 31, 2023, \"Debt Securities\" table and related disclosures in the provided document.)",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the fair value of commercial mortgage-backed securities: it reports $975 million, whereas the ground truth is $675 million. This is a significant factual discrepancy that undermines the answer's correctness. However, the unrealized loss amount ($100 million), total gross unrealized losses ($836 million), and the 12% proportion are all accurate and correctly contextualized. (2) Quantitative accuracy is compromised primarily due to the incorrect fair value figure. The $975M value does not match the ground truth of $675M, which is a material difference of $300 million. The other numbers—$100M unrealized loss and $836M total debt securities unrealized losses—are correct, and the 12% calculation (100/836 ≈ 11.96%, rounded to 12%) is accurate. (3) The multi-hop reasoning is partially sound: the model correctly identifies that the unrealized loss on commercial mortgage-backed securities must be compared to the total unrealized losses across the debt portfolio. It correctly computes the percentage and references the appropriate category and time frame. However, the incorrect fair value suggests a possible confusion with another security category or a data extraction error from the source table. (4) The contextual relevance is high because the answer addresses both parts of the question and uses appropriate financial terminology. The qualitative accuracy is moderate because the reasoning structure is correct, but the core factual input (fair value) is wrong, likely due to misreading the source document. The correctness score is 4 due to this mix of correct percentages and losses but a major error in the primary dollar amount requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 467,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the growth in third-party seller unit sales contribute to Amazon's overall sales increase in 2023, and what international risk related to third-party sellers could potentially impact Amazon's international expansion strategy?",
      "original_answer": "The growth in third-party seller unit sales was a key contributor to Amazon's 12% overall sales increase in 2023, particularly in both North America and International segments. However, Amazon faces international risks such as regulatory restrictions in countries like India, where foreign ownership rules limit control over online retail platforms, potentially complicating Amazon's expansion and reliance on third-party sellers in such markets.",
      "llm_answer": "\n\nThe growth in third-party seller unit sales significantly contributed to Amazon's 12% overall sales increase in 2023, driving growth in both North America (12% YoY) and International segments (11% YoY), as highlighted in the \"Net Sales\" section. Third-party sellers accounted for a substantial portion of unit sales, advertising revenue, and subscription services across regions.  \n\nA key international risk is regulatory scrutiny or restrictions on third-party sellers in critical markets like China and India. The 10-K notes that China-based sellers contribute significantly to Amazon's third-party services and advertising revenue, while Indian regulations impose ownership restrictions on foreign entities in e-commerce. Changes in local laws (e.g., stricter foreign ownership rules, data localization mandates, or trade barriers) could disrupt Amazon's ability to scale third-party seller ecosystems in these regions, hindering international expansion and revenue growth. Additionally, geopolitical tensions or enforcement actions against Chinese suppliers/sellers might further exacerbate operational and financial risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers are correct: Amazon's 12% overall sales increase in 2023 is accurately cited, and the LLM adds granular detail (12% YoY in North America, 11% YoY internationally) that is consistent with the original answer’s emphasis on growth across both segments. These figures are not contradicted by the ground truth and enhance precision without introducing error. (2) The core contribution of third-party seller unit sales to overall growth is correctly identified, satisfying the first part of the multi-hop question. (3) For the international risk, the ground truth specifically mentions India’s foreign ownership rules as a regulatory risk. The LLM correctly includes India and expands appropriately to China, referencing regulatory and geopolitical risks involving Chinese sellers. While China is not mentioned in the ground truth, it is a reasonable and contextually supported addition based on Amazon’s known exposure to China-based sellers and global regulatory trends; this does not detract from accuracy but enhances depth. (4) The LLM correctly synthesizes across entities—linking third-party seller growth to segment-level performance and connecting international expansion risks to regulatory environments in key markets. (5) Minor deduction in qualitative accuracy due to the addition of China as a risk without explicit grounding in the provided truth, though it is plausible and not factually incorrect. Overall, the answer is factually sound, complete, and contextually rich, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 443,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors at Wells Fargo in 2023?",
      "original_answer": "The difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors is 1,712,810 shares.",
      "llm_answer": "\n\nThe difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan (1,853,363 shares) and the Non-Qualified Deferred Compensation Plan for Independent Contractors (140,553 shares) at Wells Fargo in 2023 is **1,712,810 shares**. This is calculated by subtracting 140,553 from 1,853,363.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the number of shares remaining for the Deferred Compensation Plan (1,853,363) and the Non-Qualified Deferred Compensation Plan for Independent Contractors (140,553) are correctly stated. (2) The calculation of the difference (1,853,363 - 140,553 = 1,712,810) is accurate and explicitly shown, matching the ground truth. (3) The multi-hop reasoning is sound—information from two different plans is correctly identified and synthesized to compute the difference. (4) The entities (Wells Fargo, both plan names, 2023 timeframe) are correctly referenced. (5) The answer is semantically equivalent to the original, with added clarity by showing the component values and computation. All aspects—quantitative accuracy, reasoning, completeness, and relevance—are flawless.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 254,
        "total_tokens": 1412
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What specific categories of products are included in PMI's reduced-risk product line, and how do heated tobacco units contribute to this classification based on the company's 2022 10-K filing?",
      "original_answer": "PMI's reduced-risk product line includes heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. Heated tobacco units are a core component of this category, as explicitly stated in both sections of the 10-K filing, which specifically name them as part of the reduced-risk offerings.",
      "llm_answer": "\n\nPMI's reduced-risk product line includes **heated tobacco units (HTUs)**, **heat-not-burn devices**, **related accessories**, and **other nicotine-containing products** such as e-vapor and oral nicotine products. Heated tobacco units contribute to this classification by being explicitly defined as part of PMI's reduced-risk portfolio, with specific examples including HEETS, Marlboro HeatSticks, and licensed KT&G brands. The 2022 10-K highlights that HTUs are marketed as alternatives to combustible products, with shipment volumes growing significantly (e.g., 94,976 million units in 2021, up from 59,652 in 2019), reflecting their strategic role in PMI's transition to lower-risk products.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all product categories in PMI's reduced-risk product line as stated in the original answer: heated tobacco units, heat-not-burn devices and accessories, and other nicotine-containing products like e-vapor and oral nicotine products. It accurately explains that heated tobacco units are a core component of the reduced-risk classification, citing their role as alternatives to combustible products and referencing shipment growth as evidence of strategic importance. The qualitative reasoning and multi-hop synthesis are sound, correctly linking HTUs to PMI's broader reduced-risk strategy based on the 2022 10-K. However, the quantitative accuracy is slightly compromised: the LLM cites specific shipment volumes (94,976 million units in 2021, 59,652 in 2019), but these figures are not present in the original ground truth answer and cannot be verified from the provided knowledge graph. While such numbers may appear in the actual 10-K filing, their inclusion here introduces data not confirmed by the reference answer, risking overprecision. Despite this, the core facts and classification are correct, and the answer remains semantically aligned with the ground truth. Hence, a score of 9 is appropriate for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 353,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What percentage of NVDA's revenue came from DirectCustomerA in fiscal year 2025, and how does this compare to the previous year for which data is available?",
      "original_answer": "In fiscal year 2025, DirectCustomerA accounted for 12% of NVDA's revenue. For the previous year with available data (fiscal year 2024), DirectCustomerA's contribution was not disclosed (marked as '*'). Therefore, a direct numerical comparison cannot be made, but we observe that DirectCustomerA became a named top customer in 2025 after not being reported in 2024.",
      "llm_answer": "\n\nIn fiscal year 2025, **12%** of NVIDIA's revenue came from DirectCustomerA. For the prior fiscal year (2024), DirectCustomerA represented **less than 10%** of total revenue (denoted by an asterisk in the disclosure). This indicates a notable increase in revenue contribution from DirectCustomerA in 2025 compared to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that DirectCustomerA accounted for 12% of NVDA's revenue in fiscal year 2025, which matches the ground truth. However, it incorrectly states that in fiscal year 2024, DirectCustomerA represented 'less than 10%' of revenue. The ground truth explicitly states that the contribution was 'not disclosed (marked as '*')' — meaning no percentage, including 'less than 10%', can be inferred. This is a significant factual error, as the asterisk denotes nondisclosure, not a quantitative threshold. (2) The quantitative accuracy is low because the model fabricates a numerical interpretation ('less than 10%') that is not supported by the data. While 12% is correct, the comparison relies on an incorrect prior-year value. (3) The reasoning is partially sound in identifying a change between years and noting increased significance in 2025, but the conclusion of a 'notable increase' is based on invalid data. The model fails the multi-hop synthesis by misinterpreting the meaning of the disclosure symbol (*), leading to flawed comparison. (4) Contextual relevance is high because the answer addresses both parts of the question and discusses the trend, but correctness is undermined by the key factual inaccuracy regarding 2024. A correct answer should have stated that no numerical comparison is possible due to nondisclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 380,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How many distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively, in Wells Fargo's 2023 10-K filing?",
      "original_answer": "There are two distinct versions of the Restricted Share Rights Award Agreement: one for grants on or after January 24, 2023, which was incorporated by reference, and another for grants on or after January 23, 2024, which was filed herewith.",
      "llm_answer": "\n\nWells Fargo's 2023 10-K filing indicates **two distinct versions** of the Restricted Share Rights Award Agreement for the specified dates:  \n1. **For grants on or after January 24, 2023** – Incorporated by reference to the 2022 10-K.  \n2. **For grants on or after January 23, 2024** – Filed herewith (included in the 2023 10-K).  \n\nThese versions are explicitly listed under Exhibit 10(a)* in the document.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that there are two distinct versions of the Restricted Share Rights Award Agreement in Wells Fargo's 2023 10-K filing, matching the ground truth. It accurately specifies that the version for grants on or after January 24, 2023, was incorporated by reference (specifically noting the 2022 10-K, which is an acceptable level of detail beyond the ground truth), and that the version for grants on or after January 23, 2024, was filed herewith—both factually correct and consistent with the original answer. All dates and filing methods (incorporated by reference, filed herewith) are accurate. The mention of Exhibit 10(a)* adds contextual precision not in the ground truth but does not introduce error. The only minor shortcoming is the slight expansion of detail (e.g., referencing the 2022 10-K) without explicit confirmation from the ground truth that this is the exact source, but this is reasonable and commonly found in 10-K filings. Quantitative accuracy is perfect: two versions, correct dates, correct filing statuses. Reasoning is sound and reflects proper synthesis across time-based conditions and filing methods. The answer is semantically equivalent and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 344,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the continued uncertainty in FAA approval timelines for the 787 Program in 2022 impact Boeing's cost of sales and margin forecasting, given the reach-forward loss and contractual termination risks described in the critical audit matter?",
      "original_answer": "The continued uncertainty in the FAA approval timeline to resume 787 deliveries significantly increased estimation uncertainty in Boeing's revenue forecasts, particularly for aircraft nearing contractual termination rights. This uncertainty led to potential additional customer considerations and could result in lower margins or further material reach-forward losses. This is reflected in the 2021 cost of sales, which saw a $4,574 million decrease compared to 2020, partly due to the reach-forward loss on the 787 program, highlighting the financial impact of delayed deliveries and increased risk in forecasting.",
      "llm_answer": "\n\nThe continued uncertainty in FAA approval timelines for the 787 Program in 2022 increased estimation uncertainty for Boeing’s cost of sales and margin forecasting. Delays in resuming deliveries heightened risks of contractual termination rights for customers, necessitating provisions for additional customer considerations (e.g., compensation for delays), which directly reduced margins. The critical audit matter highlighted that these uncertainties required conservative revenue forecasts and reach-forward loss provisions, inflating cost of sales as a percentage of revenue (e.g., 95.2% in 2021) and compounding margin pressures due to unresolved production quality issues and certification delays.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the impact of FAA approval timeline uncertainty on Boeing's cost of sales and margin forecasting, linking it to contractual termination risks, customer considerations, and reach-forward losses as described in the critical audit matter. It accurately reflects the increased estimation uncertainty and conservative forecasting practices. However, the quantitative accuracy is partially flawed: while the ground truth mentions a $4,574 million decrease in 2021 cost of sales (vs. 2020) due in part to the 787 reach-forward loss, the LLM does not mention this specific figure. Instead, it introduces a new percentage—'95.2% in 2021' for cost of sales as a percentage of revenue—which is not present in the original answer and cannot be verified from the provided ground truth. This introduces unverified data, reducing quantitative accuracy. The reasoning and synthesis across multi-hop elements (FAA delays → delivery uncertainty → termination risk → customer compensation → margin pressure and cost impacts) are sound and contextually appropriate. The answer addresses all key aspects of the question with strong qualitative logic and relevance, but the absence of the key $4,574 million figure and introduction of an unsupported percentage prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 360,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the role of third-party sellers contribute to Amazon's North America and International sales growth in 2023, and what was the net effect of foreign exchange rate changes on these sales increases?",
      "original_answer": "Third-party sellers were a key driver of unit sales growth in both North America and International segments in 2023. In North America, sales increased by 12%, primarily due to increased unit sales by third-party sellers, advertising sales, and subscription services. Similarly, International sales increased by 11%, also largely driven by increased unit sales by third-party sellers. Foreign exchange rate changes had a mixed impact: they reduced North America net sales by $71 million but increased International net sales by $88 million, resulting in a net positive impact of $17 million on total sales growth.",
      "llm_answer": "\n\nThird-party sellers were a primary driver of Amazon's North America and International sales growth in 2023, contributing to increased unit sales, advertising revenue, and subscription services in both regions. For North America, sales grew 12% year-over-year, with third-party seller activity central to this growth. Similarly, International sales rose 11%, also driven by third-party sellers. \n\nForeign exchange (FX) rate changes had a mixed net effect. Consolidated net sales were reduced by $71 million due to FX fluctuations in 2023. However, the International segment’s sales were positively impacted by $88 million from FX rate changes, as a weaker U.S. dollar benefited sales denominated in other currencies. Conversely, North America’s FX impact was not explicitly stated, but the overall consolidated reduction suggests a partial offset to the International gain. Thus, while third-party sellers fueled growth across both regions, FX effects reduced consolidated sales increases, with a net positive for International and a neutral or negative implication for North America.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that third-party sellers were a key driver of Amazon's sales growth in both North America and International segments in 2023, with North America sales growing 12% and International sales growing 11%. These percentages match the ground truth. However, the LLM misstates the consolidated impact of foreign exchange (FX) rate changes. The ground truth specifies that FX reduced North America net sales by $71 million and increased International net sales by $88 million, resulting in a net positive impact of $17 million. The LLM incorrectly states that 'consolidated net sales were reduced by $71 million due to FX fluctuations,' which contradicts the ground truth's net positive $17 million effect. This is a significant quantitative error. (2) The individual FX impacts ($71M reduction in North America, $88M increase in International) are mentioned, but the synthesis into the net effect is flawed. The LLM fails to compute or acknowledge the correct net effect of +$17 million, instead implying a net negative or partially offsetting impact. (3) The multi-hop reasoning is mostly sound—linking third-party seller growth to regional sales increases and recognizing FX effects on international revenues—but fails in the final synthesis of the net FX impact across regions. (4) Scores reflect high contextual relevance and strong qualitative reasoning, but the quantitative accuracy is reduced due to the incorrect net FX impact statement, preventing a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 419,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given Wells Fargo's obligations under the USA PATRIOT Act, how might deficiencies in its anti-money laundering program constrain its ability to pursue future bank acquisitions, and which regulatory body would assess these deficiencies during the approval process?",
      "original_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue future bank acquisitions because the Federal Reserve Board (FRB), along with other federal banking regulators, is required to evaluate the effectiveness of a financial institution's AML compliance program when determining whether to approve a proposed bank acquisition. If the FRB finds that Wells Fargo's AML program is ineffective or non-compliant, it may deny the acquisition proposal, citing risks to financial integrity and national security under the provisions of the USA PATRIOT Act.",
      "llm_answer": "\n\nDeficiencies in Wells Fargo's anti-money laundering (AML) program under the USA PATRIOT Act could constrain its ability to pursue future bank acquisitions by leading federal regulators to disapprove such transactions. Under the Act, federal banking regulators (primarily the Federal Reserve Board (FRB), but also the Office of the Comptroller of the Currency (OCC) and Federal Deposit Insurance Corporation (FDIC)) evaluate the effectiveness of an applicant’s AML controls as part of the approval process for bank acquisitions. Weaknesses in AML compliance could raise concerns about financial stability, regulatory compliance, or risk to the banking system, potentially resulting in denial of the acquisition. The FRB, as the primary regulator for bank holding companies, would assess these deficiencies alongside other factors like capital adequacy and management quality.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: deficiencies in Wells Fargo's AML program under the USA PATRIOT Act can constrain future bank acquisitions due to regulatory scrutiny during the approval process. The Federal Reserve Board (FRB) is correctly identified as the primary regulatory body assessing these deficiencies, and the answer appropriately notes that other regulators like the OCC and FDIC may also be involved, which aligns with regulatory reality and adds contextual completeness without contradicting the original. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly links AML deficiencies → regulatory evaluation under the USA PATRIOT Act → impact on acquisition approval → role of the FRB (and others) in that process. The only minor deviation from the original answer is the inclusion of the OCC and FDIC as co-evaluators; while the original emphasizes the FRB, it does not exclude others, and in practice, the FRB leads for bank holding companies, which the LLM acknowledges. This addition does not make the answer incorrect but slightly extends beyond the focused scope of the ground truth. (4) The answer is fully contextually relevant, directly addressing both parts of the question: how AML deficiencies constrain acquisitions and which regulator assesses them. The explanation of risks—financial integrity, compliance, stability—is consistent with the intent of the USA PATRIOT Act. Overall, the answer is factually correct, well-reasoned, and comprehensive, warranting a 9/10 due to slight over-inclusion of regulatory bodies without clarifying the FRB's primary role in holding company acquisitions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 505,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What was the percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020, and which product category does heated tobacco units fall under in PMI's financial reporting?",
      "original_answer": "The total international industry cigarette and heated tobacco unit volume increased by 2.4% in 2021 compared to 2020. Heated tobacco units fall under the 'reduced-risk products' category in PMI's financial reporting.",
      "llm_answer": "\n\nThe percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020 was **2.4%** (excluding China and the U.S.). Heated tobacco units fall under the **Reduced-Risk Products** category in PMI's financial reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states the 2.4% percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020, which matches the ground truth. The mention of 'excluding China and the U.S.' is an additional clarification not present in the original answer but is factually consistent with PMI's reporting practices and does not contradict the ground truth; it adds context without introducing error. The second part of the answer correctly identifies that heated tobacco units fall under the 'Reduced-Risk Products' category in PMI's financial reporting, matching the ground truth exactly in substance. All entities (PMI, 2021 vs 2020 comparison, product categories) are accurately identified. The reasoning reflects proper synthesis of multi-hop information across time periods and product classifications. The only minor deviation is the added exclusion note, which, while accurate, was not in the original answer—this does not reduce correctness but slightly affects qualitative precision. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 318,
        "total_tokens": 1462
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given the $1.8 billion customer financing portfolio and the 24.2% default rate applied to CCC-rated receivables, by how much could Boeing's potential losses increase if the ongoing impacts of the COVID-19 pandemic cause all CCC-rated receivables within this portfolio to default?",
      "original_answer": "Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables within the $1.8 billion customer financing portfolio were to default, based on the 24.2% default rate applied to CCC-rated receivables.",
      "llm_answer": "\n\nIf all CCC-rated receivables within Boeing's $1.8 billion customer financing portfolio default, potential losses could increase by **$337.1 million**. This is calculated by applying the stated 24.2% default rate to the $445 million of CCC-rated receivables ($445 million × 24.2% = $107.9 million existing allowance) and subtracting this from the full $445 million exposure, resulting in an incremental $337.1 million in losses.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final result and reasoning. The ground truth states that potential losses would increase by $435.6 million, calculated as 24.2% of the $1.8 billion portfolio (i.e., $1.8 billion × 24.2% = $435.6 million). However, the LLM incorrectly assumes that only $445 million of the portfolio is CCC-rated and then applies the 24.2% default rate to that subset, calculating expected losses as $107.9 million, and then subtracts this from $445 million to get an incremental loss of $337.1 million. This logic is flawed because the question states that the 24.2% default rate is already applied to CCC-rated receivables, and asks what happens if *all* CCC-rated receivables default — implying a 100% default scenario on the CCC portion, not 24.2%. Even under that interpretation, the LLM introduces a figure ($445 million) not present in the original question or ground truth. (2) The calculation in the ground truth is straightforward: 24.2% of $1.8 billion = $435.6 million. The LLM’s use of $445 million and the subtraction step ($445M - $107.9M) has no basis in the provided information and reflects a misunderstanding of what a 'potential loss increase' means. (3) The multi-hop reasoning fails because the LLM fabricates a sub-portfolio size (CCC-rated = $445M) not stated in the question, and misapplies the default rate. The correct interpretation should be that if the *entire* CCC-rated portion defaults (rather than the expected 24.2%), the additional loss would be the difference between full default and expected loss — but without knowing what portion of the $1.8B is CCC-rated, this cannot be computed unless the 24.2% itself represents the CCC share, which the ground truth implies by direct multiplication. (4) The contextual relevance is high because the LLM attempts the right type of analysis — estimating incremental losses from default — but the quantitative and qualitative inaccuracies severely undermine correctness. Minor wording differences would be acceptable, but the numbers and logic are fundamentally wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 560,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What percentage of NVDA's revenue came from DirectCustomerC in the fiscal year ending January 26, 2025, and how does this compare to the previous year's data for the same customer?",
      "original_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for 11% of NVDA's revenue. This is unchanged from the prior year, as DirectCustomerC also represented 11% of NVDA's revenue in the fiscal year ending January 28, 2024.",
      "llm_answer": "\n\nIn the fiscal year ending January 26, 2025, **11%** of NVDA's revenue came from DirectCustomerC. For the prior fiscal year (ending January 28, 2024), DirectCustomerC contributed **less than 10%** of total revenue (denoted by an asterisk in the table). This indicates an increase in revenue contribution from DirectCustomerC between the two periods.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified that DirectCustomerC accounted for 11% of NVDA's revenue in the fiscal year ending January 26, 2025, which matches the ground truth. However, it incorrectly stated that the prior year's contribution was 'less than 10%' (denoted by an asterisk), whereas the ground truth explicitly states it was also 11% — unchanged from the previous year. This is a critical factual error. (2) The quantitative accuracy is low because the percentage for the prior year is wrong, and the implication of an increase is false. The fiscal years are correctly identified (January 26, 2025, and January 28, 2024), so date handling is accurate. (3) The multi-hop reasoning failed: the model should have recognized that the percentage remained the same across both years, but instead inferred a change based on misinterpretation of an asterisk (likely from a table footnote, possibly indicating immateriality or rounding, not a value below 10%). This breaks the synthesis required for accurate comparison. (4) Contextual relevance is high because the answer addresses both parts of the question (current and prior year percentages and comparison), but the factual inaccuracy in the core data severely undermines correctness. The conclusion of an 'increase' is incorrect reasoning based on flawed input interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 373,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What is the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, and how does this compare to the unrealized losses associated with these securities according to the investment maturity breakdown?",
      "original_answer": "CVS Health Corporation held a total fair value of $675 million in Commercial Mortgage-Backed Securities (CMBS) as of December 31, 2023. The unrealized losses associated with these CMBS were $100 million, representing a significant portion (approximately 14.8%) of the total unrealized losses across all investment categories.",
      "llm_answer": "\n\nThe total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, is **$975 million**. The unrealized losses associated with these securities, according to the investment maturity breakdown, amount to **$100 million**. This means the unrealized losses represent approximately 10.25% of the total fair value of the CMBS holdings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the total fair value of CMBS holdings. The ground truth states $675 million, but the LLM reports $975 million, which is incorrect by $300 million. The unrealized losses amount of $100 million is correct and matches the original answer. However, the percentage calculation in the LLM answer (10.25%) is based on the incorrect fair value and thus wrong; the correct percentage of unrealized losses relative to fair value is approximately 14.8% ($100M / $675M), which the original answer correctly contextualizes as a portion of total unrealized losses across all investments. (2) Quantitative accuracy is low because the key financial figure (fair value) is significantly off, despite the unrealized losses number being accurate. The percentage derived from incorrect inputs is also wrong. (3) The reasoning shows partial understanding of the required comparison (unrealized losses vs. fair value), but fails in multi-hop synthesis: the model should have used the correct fair value from the source data and linked it to the unrealized losses and their relative proportion. It does not mention that the $100M loss is a portion of total unrealized losses across all categories, missing a key layer of context. (4) Contextual relevance is high because the answer addresses the right entities (CVS Health, CMBS, fair value, unrealized losses, as of Dec 31, 2023) and attempts the correct comparison, but the factual inaccuracies severely limit correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 417,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the treatment of changes in estimated fair value of Unit-linked securities differ between net investment income and net derivative gains (losses) based on the disclosed components of MetLife's financial statements?",
      "original_answer": "Changes in the estimated fair value of Unit-linked securities are included in net investment income, while lapses associated with net embedded derivatives, which may arise from these securities, are included in net derivative gains (losses). This distinction reflects different accounting treatments for valuation changes versus derivative-related outcomes.",
      "llm_answer": "\n\nThe changes in estimated fair value of Unit-linked securities are included in **net investment income**, whereas changes related to embedded derivatives (e.g., lapses or valuation adjustments) are recorded in **net derivative gains (losses)**. Specifically, MetLife discloses that changes in fair value for Unit-linked and FVO securities are accounted for in net investment income, while realized/unrealized gains/losses for net derivatives and embedded derivatives (such as those arising from policyholder behavior or contract terms) are reported in net derivative gains (losses). This distinction reflects the separate treatment of direct investment valuations versus derivative-related adjustments in the income statement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly states that changes in the estimated fair value of Unit-linked securities are included in net investment income, which matches the original answer. It also accurately notes that derivative-related components, such as embedded derivatives linked to policyholder behavior (e.g., lapses), are reported in net derivative gains (losses). The answer expands slightly by referencing FVO (fair value option) securities and general embedded derivative accounting, which is consistent with MetLife's disclosures and adds context without introducing error. There are no numerical inaccuracies (quantitative accuracy is perfect, even though no specific numbers are involved). The reasoning correctly reflects the multi-hop distinction between direct valuation changes (investment income) versus derivative outcomes (derivative gains/losses). The only minor point preventing a full 10 is that the original answer specifically ties 'lapses associated with net embedded derivatives' to derivative gains/losses, while the LLM generalizes to 'changes related to embedded derivatives'—slightly broader but still accurate. Overall, the semantic meaning and financial accounting treatment are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 356,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How much financial loss did Boeing record on the 787 Program in the fourth quarter of 2021, and how does the uncertainty around FAA approval for resuming deliveries potentially affect future revenue estimates for the program, based on the accounting methodology described?",
      "original_answer": "Boeing recorded a $3.5 billion loss on the 787 Program in the fourth quarter of 2021. The uncertainty around FAA approval for resuming deliveries affects future revenue estimates because Boeing uses program accounting, which requires estimating the revenue expected upon delivery of each aircraft. The timing of FAA approval is a key factor in determining which aircraft will reach contractual termination rights, and changes in the expected delivery resumption date could lead to additional customer considerations, lower margins, or further material reach-forward losses.",
      "llm_answer": "\n\nBoeing recorded a $3.5 billion financial loss on the 787 Program in the fourth quarter of 2021, driven by rework delays and associated customer considerations. The uncertainty surrounding FAA approval to resume deliveries introduces significant risk to future revenue estimates under Boeing’s program accounting methodology. Delays in FAA approval could prolong delivery pauses, increase rework costs, and necessitate additional customer compensation, all of which would reduce forecasted revenues and margins. This uncertainty may lead to further material reach-forward losses if delivery timelines or cost estimates worsen, as program accounting relies heavily on assumptions about delivery schedules and customer contractual rights tied to delays.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3.5 billion loss in Q4 2021, matching the ground truth exactly. This satisfies the quantitative requirement with no discrepancies in dollar amount or time period. (2) All numbers and dates are accurate—$3.5 billion and fourth quarter of 2021 are correctly stated. No calculations were required beyond factual recall, and the figure is presented consistently with the original answer. (3) The reasoning around FAA approval and its impact on program accounting is sound and aligns with the ground truth. The LLM accurately explains that uncertainty in FAA approval affects delivery timelines, which in turn influences customer contractual rights, potential compensation, and future reach-forward losses under program accounting. It correctly identifies that program accounting relies on estimating revenue per aircraft based on delivery expectations. The only minor gap is that the LLM does not explicitly mention 'contractual termination rights'—a specific term from the original—though it refers to 'customer contractual rights tied to delays,' which is semantically close and contextually accurate. (4) The answer is highly relevant, addressing both parts of the multi-hop question: the historical financial loss and the forward-looking accounting implications. The synthesis across financial reporting and regulatory uncertainty is well-executed. The qualitative score is 9 due to the slight omission of 'termination rights' nuance, but overall reasoning remains strong. Quantitative accuracy is perfect, and contextual relevance is full.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 436,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What percentage of revenue did NVDA derive from DirectCustomerA in the fiscal year ending January 26, 2025, and how does this compare to the availability of data for the same customer in the prior fiscal year?",
      "original_answer": "NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. The data for DirectCustomerA in the prior fiscal year (January 28, 2024) is marked as unavailable (denoted by '*'), indicating no disclosed percentage for that year.",
      "llm_answer": "\n\nNVDA derived **12%** of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. In the prior fiscal year (ending January 28, 2024), DirectCustomerA accounted for **less than 10%** of total revenue (denoted by an asterisk in the disclosure). This indicates an increase in revenue concentration from DirectCustomerA between the two fiscal years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025, which matches the ground truth. However, it incorrectly claims that in the prior fiscal year (ending January 28, 2024), DirectCustomerA accounted for 'less than 10%' of revenue. The ground truth explicitly states that the data is marked as unavailable (denoted by '*'), meaning no percentage—whether exact or approximate—was disclosed. The model misinterprets the asterisk notation as indicating 'less than 10%', which is not supported by the provided information. (2) The fiscal years are correctly identified, and the 12% figure is accurate. But the 'less than 10%' claim is a factual error, as the original data does not confirm or imply this threshold. This leads to an incorrect conclusion about an 'increase in revenue concentration', which cannot be inferred due to lack of prior-year data. (3) The multi-hop reasoning fails because the model assumes a quantitative meaning from a data point marked as unavailable. Proper synthesis would recognize that comparison is not possible due to missing prior-year disclosure. (4) The contextual relevance is high because the answer addresses both parts of the question and discusses the trend, but the quantitative inaccuracy severely undermines correctness. The qualitative reasoning is partially sound but based on a false premise. Thus, the correctness score is low due to a critical factual error in interpreting missing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 419,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What was the total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses related to the collaboration?",
      "original_answer": "The total financial impact on Amgen from its relationship with BeiGene in 2023 was $4.374 billion, combining the fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million).",
      "llm_answer": "\n\nThe total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and collaboration-related activities, is primarily reflected in the income statement effects. For 2023, Amgen recognized **$109 million in net cost recoveries** (offsetting R&D expenses), **$125 million in product sales** to BeiGene, and **$40 million in profit/loss share expenses** under the collaboration. While the document does not explicitly state the 2023 fair value of the BeiGene equity investment (which was $4.2 billion as of December 31, 2022), the collaboration’s operational impact for 2023 totaled **$194 million** ($109M + $125M - $40M). The fair value of the investment itself is a balance sheet item and not directly combined with income statement effects in this context.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains partial correctness: it accurately reports the three income statement items—$109 million in net cost recoveries, $125 million in product sales, and $40 million in profit/loss sharing expenses—which match the ground truth. However, it fails to correctly combine these with the fair value of the investment ($4.2 billion), which is a critical component of the total financial impact as defined in the question. Instead, the LLM incorrectly calculates a subtotal of $194 million from operational items only and explicitly excludes the $4.2 billion investment, stating it is a balance sheet item not combinable with income effects—this contradicts the ground truth, which explicitly combines both. (2) The numbers themselves are factually correct where stated, but the omission of the $4.2 billion investment from the total sum results in a grossly inaccurate total financial impact ($194 million vs. $4.374 billion). The calculation of $109M + $125M - $40M = $194M is mathematically correct but contextually incomplete. (3) The multi-hop reasoning fails: the question requires synthesizing balance sheet (fair value of investment) and income statement (collaboration revenues/costs) impacts into a single total financial impact. The LLM incorrectly treats these as non-combinable due to accounting classification, which is not supported by the ground truth or standard financial interpretation when assessing total economic impact. (4) Due to major factual incompleteness and flawed reasoning in combining key financial components, the correctness score is low. Quantitative accuracy is moderate because individual numbers are correct but the final total is missing the largest component. Qualitative accuracy is low due to flawed logic in excluding the investment. Contextual relevance is moderate as the answer addresses the collaboration but misinterprets the scope of 'total financial impact.'",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 516,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does MetLife's use of different forecast periods for commercial/agricultural versus residential mortgage loans affect the duration over which estimated lifetime loss rates are applied before reverting to historical loss experience?",
      "original_answer": "MetLife applies estimated lifetime loss rates over a two-year forecast period for commercial and agricultural mortgage loans before reverting to historical loss experience, whereas for residential mortgage loans, the forecast period is two years but reverts to industry historical loss experience over a one-year period. This means the duration before reverting to historical data is longer for commercial and agricultural loans (two-year forecast + two-year reversion = 4 years total) compared to residential loans (two-year forecast + one-year reversion = 3 years total).",
      "llm_answer": "\n\nMetLife applies different forecast periods and reversion schedules for estimated lifetime loss rates across mortgage loan segments. For **commercial and agricultural mortgage loans**, the company uses a **two-year forecast period** (or one year for certain markets) and reverts to historical loss experience over a **two-year straight-line period** after the forecast. For **residential mortgage loans**, a **two-year forecast period** is used, after which the company reverts to industry historical loss experience over a **one-year straight-line period**. This means commercial/agricultural loans have a longer duration (two years) for applying forecasted loss rates before historical data influences the allowance, compared to residential loans (one year).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the two-year forecast period for both commercial/agricultural and residential mortgage loans, as well as the two-year reversion period for commercial/agricultural loans and one-year reversion for residential loans. It accurately notes that commercial/agricultural loans have a longer duration before historical data influences the allowance. However, it fails to explicitly calculate or state the total duration (4 years vs 3 years) as emphasized in the original answer, which is central to the question about 'duration over which estimated lifetime loss rates are applied before reverting to historical loss experience.' While the components are correct, the synthesis into total duration (forecast + reversion) is missing, which is a key multi-hop element. The mention of 'one year for certain markets' introduces unverified nuance not in the ground truth. Quantitatively, all stated numbers are accurate, but the incomplete synthesis reduces qualitative accuracy. Contextually, the response is fully relevant and addresses the core comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 306,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does Costco's self-insurance funding for employee health care benefits, as estimated through actuarial assumptions, potentially impact its financial condition in the context of unpredictable cost fluctuations and labor-related risks?",
      "original_answer": "Costco's self-insurance funding for employee health care benefits relies on historical claims experience, demographic factors, severity factors, and other actuarial assumptions. These liabilities are not discounted and are subject to significant unpredictability due to inflation rates, regulatory or legal changes, and unforeseen developments in claims. Since actual claims and costs could differ significantly from recorded liabilities, this could lead to unexpected financial burdens. Given that Costco also faces challenges in controlling labor and benefit costs—impacted by factors like healthcare costs and regulatory changes—these financial pressures could adversely affect its business, financial condition, and results of operations.",
      "llm_answer": "\n\nCostco's self-insurance for employee health care benefits involves estimating liabilities using historical claims, actuarial assumptions, and demographic factors. However, unpredictable cost fluctuations—such as healthcare inflation, regulatory changes, or unforeseen claims—could lead to actual expenses exceeding recorded liabilities, increasing cash outflows and reducing net income. This risk is compounded by labor-related factors like rising wage pressures or expanded benefits, which could further strain financial resources. While Costco maintains strong liquidity ($11,049 million in cash and equivalents as of 2022), significant underestimations or sudden cost spikes might necessitate higher provisions, impacting profitability and capital allocation flexibility. Historically, adjustments to estimates have been immaterial, but prolonged or severe deviations could pose material risks to financial stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All key factual elements are correct: Costco uses historical claims, actuarial assumptions, and demographic factors to estimate self-insurance liabilities; these are subject to unpredictability from healthcare inflation, regulatory changes, and unforeseen claims; actual costs may exceed liabilities, creating financial risk. The mention of labor-related risks like wage pressures and benefit expansion is consistent with the original's focus on labor and benefit cost challenges. (2) Quantitative accuracy is excellent: the $11,049 million cash and equivalents figure for 2022 is accurate and correctly contextualized as a liquidity buffer, even though this specific number was not in the original answer—it is factually correct and enhances the response without introducing error. No calculations were required, and all numbers are properly used. (3) Multi-hop reasoning is sound: the model synthesizes actuarial estimation methods, financial risk from estimation uncertainty, and broader labor cost pressures into a coherent assessment of financial condition impact. It correctly infers that while past adjustments have been immaterial, future deviations could be material—mirroring the original’s caution about adverse effects on financial condition and operations. (4) The only reason for not scoring a 10 is minor: the original emphasizes that liabilities are *not discounted*, a technical accounting point that the LLM omits. While not critical to the overall conclusion, it is a small omission in completeness. Otherwise, the answer is semantically equivalent, contextually precise, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 462,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How much did 3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 total, and what was the impact of the reconsolidation of the Aearo Entities on 3M's balance sheet as of December 31, 2023?",
      "original_answer": "3M recorded a pre-tax charge of $4.2 billion related to the CAE Settlement and $437 million in restructuring charges in 2023, totaling $4.637 billion in charges. The reconsolidation of the Aearo Entities resulted in the removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability for former intercompany amounts, impacting the consolidated balance sheet as of December 31, 2023.",
      "llm_answer": "\n\n3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 totaled **$4.6 billion** ($4.2 billion for the CAE Settlement and $437 million for restructuring activities). The reconsolidation of the Aearo Entities in the second quarter of 2023 resulted in the removal of **$700 million in assets** (equity investment) and **$600 million in liabilities** (intercompany amounts) from 3M's December 31, 2023, consolidated balance sheet, as these balances were previously recorded during the deconsolidation in 2022. This adjustment reduced both total assets and liabilities by those amounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: $4.2 billion for the CAE Settlement and $437 million in restructuring charges, totaling $4.637 billion, which the model rounds appropriately to $4.6 billion—this is acceptable under semantic equivalence as it preserves significant figures and common reporting practice. The reconsolidation impact correctly states the removal of $700 million in assets (equity and other investments) and $600 million in liabilities (former intercompany amounts), matching the ground truth of $0.7 billion and $0.6 billion. (2) All numeric values are accurate and correctly formatted; the sum of $4.2B + $437M = $4.637B is correctly represented as approximately $4.6B, a standard and acceptable rounding in financial reporting. (3) The multi-hop reasoning is sound: the model synthesizes pre-tax charges from two distinct events (CAE Settlement and restructuring) and correctly explains the balance sheet impact of reconsolidating the Aearo Entities, including the timing (second quarter 2023) and the reversal of prior deconsolidation entries. (4) The only minor limitation is that the original answer specifies the asset as 'equity and other investments' and liability as 'net liability for former intercompany amounts,' while the LLM simplifies these terms slightly. However, the meaning remains factually equivalent. All parts of the question are addressed with high precision, strong reasoning, and full contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 408,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does Google's integration of Gemini 2.0 into its Vertex AI platform expand the capabilities available to developers on Google Cloud Platform?",
      "original_answer": "Google's integration of Gemini 2.0 into its Vertex AI platform provides developers with advanced tools to train, tune, augment, test, and deploy applications using Gemini, Imagen, Veo, and other generative AI models. This significantly enhances the development environment on Google Cloud Platform, allowing developers to build more sophisticated and multimodal applications.",
      "llm_answer": "\n\nGoogle's integration of Gemini 2.0 into its Vertex AI platform enhances developer capabilities on Google Cloud Platform by providing access to advanced, multimodal AI models (text, code, audio, image, video) for training, tuning, and deploying applications. Vertex AI now supports Gemini alongside other generative models like Imagen and Veo, enabling developers to build AI-driven solutions with improved efficiency. Additionally, Gemini for Google Cloud offers pre-packaged AI agents that assist with software development tasks (e.g., coding, documentation) and cybersecurity operations (e.g., threat detection, response), expanding the platform's utility for enterprise innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the integration of Gemini 2.0 into Vertex AI as a means to enhance developer capabilities on Google Cloud Platform. The key elements—training, tuning, deploying applications using Gemini, Imagen, and Veo—are all present and correctly stated. The LLM adds valuable context not in the original answer but consistent with likely capabilities (e.g., multimodal support across text, code, audio, image, video; pre-packaged AI agents for coding and cybersecurity), which are plausible extensions of Gemini’s functionality and do not contradict the ground truth. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced to 9 because the mention of specific AI agent use cases (e.g., threat detection, response) and 'pre-packaged AI agents' goes beyond the original answer’s scope, though it does not appear factually incorrect. The reasoning is sound, and the synthesis across models and developer tools is logically presented. Contextual relevance is perfect—the response directly addresses how the integration expands developer capabilities. Overall, the answer is factually correct, comprehensive, and semantically equivalent to the ground truth with minor elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 369,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the inclusion of FVO securities in the yield calculation for fixed maturity securities impact the reported investment income and sensitivity to fair value changes for MetLife in 2024, given the valuation techniques applied to FVO securities under Level 3 classifications?",
      "original_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities contributed $205 million in investment income for 2024, directly affecting yield performance metrics. Since FVO securities are classified under Level 3 and are subject to valuation techniques involving significant unobservable inputs (such as nonperformance risk spreads and long-term equity volatilities), changes in these inputs can materially alter the estimated fair value of these securities. This dual treatment—using FVO securities in both yield calculations and fair value measurements—means that fluctuations in market assumptions not only affect income volatility but also the sensitivity of the fair value of FVO securities, amplifying financial statement variability.",
      "llm_answer": "\n\nThe inclusion of FVO (Fair Value Option) securities in the yield calculation for fixed maturity securities impacts MetLife's 2024 reported investment income and sensitivity to fair value changes in two key ways:  \n\n1. **Investment Income**: FVO securities contribute $205 million in investment income to the yield calculation for fixed maturity securities (up from $188 million in 2023). This income is included in adjusted net investment income, which drives the reported yield of 4.44% for fixed maturity securities in 2024. Since FVO securities are measured at fair value with changes recognized in net income, their valuation adjustments (under Level 3 techniques) directly affect net investment income, increasing its volatility.  \n\n2. **Sensitivity to Fair Value Changes**: FVO securities classified under Level 3 use unobservable inputs (e.g., offered quotes, quoted prices, and internal models). Changes in these inputs (e.g., credit spreads, prepayment rates, or market assumptions) lead to significant fair value adjustments. For example, increases in offered quotes or quoted prices for FVO securities (as noted in the Level 3 sensitivity table) would raise their estimated fair value, which is recognized in net investment income. This creates heightened sensitivity of reported investment income to market conditions and management’s assumptions, amplifying earnings volatility compared to securities valued using observable inputs (Level 1 or 2).  \n\nIn summary, FVO securities increase both the numerator (investment income) and the volatility of the yield calculation due to their Level 3 valuation methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $205 million contribution of FVO securities to investment income in 2024, matching the ground truth exactly. It also accurately references the use of Level 3 valuation techniques involving unobservable inputs. While the ground truth does not mention the 2023 comparison ($188 million), this addition is factually consistent and provides useful context without contradicting the original. The reported yield of 4.44% is correctly attributed to fixed maturity securities, though not explicitly stated in the ground truth—it is contextually valid and aligns with typical reporting practices. (2) All numeric values—$205 million, 4.44%, and the reference to $188 million in 2023—are accurate or reasonably inferred. No calculation errors are present. Format variations are acceptable and clear. (3) The multi-hop reasoning is sound: the model correctly links FVO securities to both investment income and fair value sensitivity, explains the impact of Level 3 inputs (e.g., credit spreads, prepayment rates), and synthesizes how these affect income volatility and yield metrics. The explanation of dual recognition—fair value changes impacting income and sensitivity—is logically consistent with the ground truth. (4) The answer is highly relevant, directly addressing both parts of the question: impact on investment income and sensitivity to fair value changes. The only minor shortcoming is that the ground truth emphasizes the role of 'nonperformance risk spreads and long-term equity volatilities' as specific unobservable inputs, while the LLM lists 'offered quotes, quoted prices, and internal models'—partially overlapping but not fully precise. Offered quotes and quoted prices may imply observable data, which slightly mischaracterizes Level 3 inputs. This small imprecision prevents a perfect 10 but does not undermine the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1632,
        "completion_tokens": 515,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was the total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023, and how did these events relate to the Combat Arms Earplugs litigation?",
      "original_answer": "The total pre-tax financial impact on 3M from both the deconsolidation and reconsolidation of the Aearo Entities was $1.2 billion. This includes a $1.0 billion funding commitment plus $0.2 billion for projected case expenses related to the Combat Arms Earplugs litigation, which led to a pre-tax charge in 2022. The reconsolidation in 2023 had an immaterial income statement impact, but the overall litigation and settlement process directly triggered both events.",
      "llm_answer": "\n\nThe total pre-tax financial impact on 3M from the deconsolidation of the Aearo Entities in 2022 and reconsolidation in 2023 was **$5.4 billion**. In 2022, 3M recorded a **$1.2 billion pre-tax charge** (primarily for funding a trust to resolve Aearo-related claims, including Combat Arms Earplugs litigation). The deconsolidation itself had an immaterial impact. In 2023, after the bankruptcy dismissal and reconsolidation, 3M recorded a **$4.2 billion pre-tax charge** for the Combat Arms Earplugs Settlement (CAE Settlement), reflecting the present value of $6.0 billion in payments over 2023–2029. These events were directly tied to resolving litigation over the Aearo Entities’ Dual-Ended Combat Arms Earplugs, which 3M acquired in 2008 and later faced widespread claims from veterans.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and quantitative errors. The ground truth states the total pre-tax financial impact was $1.2 billion, consisting of a $1.0 billion funding commitment and $0.2 billion for projected case expenses. However, the LLM claims the total impact was $5.4 billion, combining a $1.2 billion charge in 2022 and a $4.2 billion charge in 2023. This $5.4 billion figure is incorrect and not supported by the ground truth. The $4.2 billion charge related to the CAE Settlement in 2023 is not mentioned in the original answer and represents a significant factual deviation. (2) The LLM incorrectly separates the financial impacts into two large charges, whereas the original answer clarifies that the reconsolidation in 2023 had an immaterial income statement impact. The $1.2 billion pre-tax charge in 2022 in the LLM answer also misaligns with the ground truth breakdown of $1.0B + $0.2B, suggesting possible conflation of figures. (3) While the LLM correctly identifies the connection between the Aearo Entities, the Combat Arms Earplugs litigation, and the timing of deconsolidation (2022) and reconsolidation (2023), it fails to accurately synthesize the financial consequences across these events. The multi-hop reasoning is flawed because it introduces a large 2023 charge that the ground truth explicitly states did not have a material income statement impact. (4) Despite the serious quantitative inaccuracies, the answer is contextually relevant—correctly identifying the litigation, entities, and general sequence of events. Hence, correctness and quantitative accuracy are severely penalized, while qualitative reasoning and relevance receive partial credit for structural and contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 475,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the integration of Adobe Firefly into Creative Cloud and Document Cloud contribute to Adobe's strategy of increasing recurring revenue and expanding its customer base, as evidenced by specific product offerings and AI-driven capabilities in fiscal 2023?",
      "original_answer": "Adobe Firefly, introduced in September 2023, is integrated into Creative Cloud apps such as Photoshop and Express, providing generative AI capabilities that enhance user engagement and attract new customers, including novice creators and communicators. This integration supports Adobe's strategy to increase recurring revenue by offering new features that justify subscription renewals and attract cost-sensitive users through targeted packages like Adobe Express and Substance 3D Collection. Additionally, Firefly's generative AI features are part of Adobe's broader AI-driven tools (e.g., Adobe Sensei), which improve Document Cloud's functionality, such as making PDFs more intelligent and responsive. These innovations help Adobe expand its customer base and drive long-term revenue growth through increased product value and user retention.",
      "llm_answer": "\n\nThe integration of Adobe Firefly into Creative Cloud and Document Cloud in fiscal 2023 strengthened Adobe's strategy to increase recurring revenue and expand its customer base by enhancing product value and accessibility. Firefly’s generative AI capabilities, such as text-to-image generation, generative fill, and AI-powered editing in Photoshop, Illustrator, and Adobe Express, elevated the functionality of existing subscriptions, driving retention and upselling among creative professionals. Simultaneously, Firefly-powered tools in Adobe Express—a task-based app targeting novice creators—lowered barriers to entry, attracting first-time users and expanding Adobe’s reach into broader content-creation markets. This dual approach contributed to a 14% year-over-year increase in Digital Media ARR, with Creative Cloud ARR rising to $12.37 billion and Document Cloud ARR to $2.81 billion, reflecting both deeper engagement with existing subscribers and growth in new customer acquisition.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the strategic role of Adobe Firefly in enhancing Creative Cloud and Document Cloud to drive recurring revenue and expand the customer base, aligning well with the ground truth. It accurately describes Firefly's integration into Photoshop, Illustrator, and Adobe Express, emphasizing generative AI features like generative fill and text-to-image that improve product value and user engagement. The reasoning around attracting novice creators via Adobe Express and increasing retention among professionals is sound and reflects multi-hop synthesis across product, AI capability, and business strategy.\n\nHowever, the quantitative claims introduce inaccuracies not present in the original answer. The LLM states a '14% year-over-year increase in Digital Media ARR' and provides specific ARR figures: Creative Cloud at $12.37 billion and Document Cloud at $2.81 billion. These numbers, while plausible, are not mentioned or supported in the ground truth and cannot be verified from the provided knowledge graph. Since the original answer does not include any numerical financial metrics or growth percentages, the inclusion of precise figures in the LLM response constitutes a factual overreach, reducing quantitative accuracy.\n\nEntity accuracy is strong—Adobe Firefly, Creative Cloud, Document Cloud, Adobe Express, and generative AI capabilities are all correctly identified and contextualized within fiscal 2023. The mention of Adobe Sensei is missing, which slightly weakens completeness, but the overall AI-driven strategy is adequately conveyed. Contextual relevance is excellent, as the response directly addresses how Firefly supports Adobe’s strategic goals through specific product offerings and AI features. Despite strong qualitative reasoning, the unsupported numerical claims prevent a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 500,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What is the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, and how does this value compare to the total fair value of all available-for-sale investments?",
      "original_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, is $4,335 million ($1,676 million + $2,659 million). This amount represents the full value of all available-for-sale investments, which also totals $4,335 million.",
      "llm_answer": "\n\nThe total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, was **$4,335 million** ($1,676 million for U.S. Treasury bills + $2,659 million for money market mutual funds). This amount **equals the total fair value of all available-for-sale investments** for the same period, as these two categories comprised the entirety of Amgen’s available-for-sale investments in 2022, with no other significant components reported.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1,676 million for U.S. Treasury bills and $2,659 million for money market mutual funds are accurately reported, and their sum ($4,335 million) is correctly calculated. The format variations (e.g., $4,335 million) are acceptable and semantically equivalent. (2) The answer completely addresses both parts of the question: it provides the total fair value of the specified investments and correctly states that this amount equals the total fair value of all available-for-sale investments. (3) Entity accuracy is perfect: Amgen, the date (December 31, 2022), and the financial instruments (U.S. Treasury bills, money market mutual funds, available-for-sale investments) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that since these two categories constitute the entirety of available-for-sale investments, their sum equals the total. No irrelevant or incorrect information is introduced. All scores are maximized due to full factual accuracy, correct calculation, and clear, logical explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 332,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How do the valuation techniques for Unit-linked securities described in the MetLife 2024 10-K affect the sensitivity of fair value measurements to changes in long-term equity volatility and nonperformance risk spreads?",
      "original_answer": "The valuation techniques for Unit-linked securities at MetLife involve using long-term equity volatility and nonperformance risk spreads as significant unobservable inputs. According to the 10-K filing, long-term equity volatility affects the estimated fair value of these securities, especially when observable equity volatilities are not available beyond a certain period. Additionally, nonperformance risk spreads, which vary by duration and currency, are applied to discount cash flows for purposes of valuing market risk benefits (MRBs). As a result, changes in either of these inputs directly influence the fair value of Unit-linked securities, making them sensitive to shifts in long-term market expectations and credit risk assessments.",
      "llm_answer": "\n\nThe valuation techniques for Unit-linked securities in MetLife’s 2024 10-K, which include **option pricing models** and **market pricing**, make their fair value measurements sensitive to changes in **long-term equity volatility** and **nonperformance risk spreads**. Specifically:  \n- **Long-term equity volatility** (weighted average 18.77% in 2024) directly increases fair value when volatility rises, as higher volatility elevates the embedded derivative components tied to equity-indexed returns.  \n- **Nonperformance risk spreads** (weighted average 0.64% in 2024) inversely affect fair value; higher spreads (reflecting greater credit risk) reduce fair value by increasing the discount rate applied to future cash flows.  \n\nThese sensitivities arise because the valuations incorporate unobservable inputs that adjust the present value of projected cash flows based on market risk assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that valuation techniques for Unit-linked securities at MetLife use option pricing models and market pricing, which rely on long-term equity volatility and nonperformance risk spreads as key unobservable inputs—consistent with the original answer. (2) The quantitative details—long-term equity volatility at a weighted average of 18.77% and nonperformance risk spreads at 0.64% in 2024—are specific and factually correct per the MetLife 2024 10-K, though these exact figures were not in the original answer; however, their inclusion enhances precision without contradicting the ground truth. (3) The reasoning is sound: the LLM correctly explains that higher equity volatility increases fair value due to embedded derivatives, while higher nonperformance risk spreads reduce fair value by increasing discount rates—this reflects proper multi-hop synthesis of valuation mechanics and risk factor impacts. (4) The answer is contextually complete, addressing both sensitivity factors asked in the question and explaining their directional impact. The only minor limitation is that it does not explicitly mention the application to market risk benefits (MRBs), which is a nuance in the original answer, but this does not detract significantly from overall correctness. Wording differs but semantic meaning and factual content are equivalent or superior in detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 401,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does Adobe's introduction of Generative Credits in Adobe Firefly, as part of its Creative Cloud offering, support its broader strategy to increase customer engagement and subscription revenue across both creative professionals and non-creative stakeholders?",
      "original_answer": "Adobe introduced Generative Credits as part of Adobe Firefly within its Creative Cloud offering, allowing users to generate AI-based content after reaching a usage limit. These credits enhance the value of existing subscriptions and encourage continued engagement by offering a paid upsell option. This aligns with Adobe’s strategy to use product-led growth, infusing AI into creative apps like Photoshop and Illustrator to make workflows more efficient and accessible. By integrating Firefly’s generative AI capabilities into widely used tools and offering tiered access (free and premium), Adobe expands its customer base beyond traditional creative professionals to include communicators, marketers, and other stakeholders involved in content creation and approval. This drives higher engagement, conversion, and retention, directly supporting Adobe’s goal of increasing recurring subscription revenue and deepening customer relationships.",
      "llm_answer": "\n\nAdobe's introduction of Generative Credits in Adobe Firefly, integrated into its Creative Cloud offerings, supports its strategy to boost customer engagement and subscription revenue by democratizing AI-driven creativity and expanding its user base. By providing monthly allocations of Generative Credits (tokens enabling AI-generated content via text prompts), Adobe lowers barriers for both creative professionals and non-creative stakeholders to access advanced tools like Generative Fill, Recolor, and Text-to-Image features across Photoshop, Illustrator, and Adobe Express. This fosters deeper engagement by embedding AI as a \"co-pilot\" for efficiency and innovation, while the tiered subscription model (with optional paid credit top-ups) incentivizes plan upgrades and retention. Additionally, Firefly’s commercial safety, multilingual support, and integration with collaboration tools (e.g., Frame.io) enhance its appeal for teams and enterprises, aligning with Adobe’s goal to expand beyond traditional creatives to stakeholders involved in content review, social media, and workflow automation. This dual focus on accessibility and scalability strengthens recurring revenue streams and reinforces Adobe’s position as a leader in AI-enhanced creative ecosystems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual information is correct: Adobe introduced Generative Credits in Firefly as part of Creative Cloud, used for AI-generated content via text prompts, integrated into Photoshop, Illustrator, and Adobe Express. The tiered access model with free allocations and paid top-ups is accurately described, supporting upsell and retention. (2) Quantitative accuracy is perfect—no specific numbers (e.g., credit amounts, prices) are mentioned in either answer, so no discrepancies exist. The LLM correctly avoids inventing figures not in the original. (3) Multi-hop reasoning is sound: the answer connects Generative Credits to AI integration, product-led growth, expanded user base (beyond creatives to marketers, communicators, etc.), and recurring revenue—mirroring the original’s logic. It adds valuable context (e.g., commercial safety, multilingual support, Frame.io integration) that enriches but does not distort the core message. (4) Semantic equivalence is strong: while the LLM uses more expansive language (e.g., 'co-pilot', 'workflow automation'), the core strategy—using AI to deepen engagement, broaden market reach, and increase subscription revenue—is fully preserved. The only minor gap is slightly less emphasis on 'conversion' as a specific funnel stage compared to the original, but this is implied in 'plan upgrades and retention'. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1582,
        "completion_tokens": 419,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does the integration of Gemini 2.0 across Google's billion-user products and Vertex AI platform contribute to Google Cloud's ability to generate revenue from AI-optimized infrastructure and developer services?",
      "original_answer": "Gemini 2.0 powers AI features across all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—enhancing user experiences and increasing engagement. This widespread integration supports Google's broader ecosystem, which in turn drives demand for Google Cloud's AI-optimized infrastructure and Vertex AI platform. Google Cloud offers Gemini through Vertex AI, enabling developers to train, tune, and deploy applications using advanced generative AI models. This provides scalable AI solutions for enterprises and developers, which directly contributes to Google Cloud's revenue through consumption-based fees and subscriptions for infrastructure and platform services.",
      "llm_answer": "\n\nThe integration of Gemini 2.0 across Google's billion-user products and the Vertex AI platform enhances Google Cloud's revenue generation by **expanding access to advanced AI capabilities for developers and enterprises**. By embedding Gemini 2.0 into core products and offering it via Vertex AI, Google Cloud provides scalable AI-optimized infrastructure (e.g., TPUs, compute resources) and developer tools (e.g., model training, deployment) that enable businesses to build, customize, and deploy AI applications efficiently. This drives consumption-based revenue through increased usage of cloud infrastructure and subscriptions to AI services, while pre-packaged AI agents (e.g., for cybersecurity, software development) further monetize developer and enterprise demand for streamlined AI integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core mechanisms by which Gemini 2.0 integration drives Google Cloud revenue. (1) It correctly identifies that Gemini 2.0 is integrated into Google's major products and offered via Vertex AI to developers, which aligns with the ground truth. The revenue model—consumption-based fees and subscriptions for AI-optimized infrastructure and developer services—is accurately described. (2) Quantitatively, the LLM states 'billion-user products', while the ground truth specifies 'two billion-user products'. This is a minor inaccuracy but not a critical error, as the broader point about massive user scale remains valid. All other numbers and metrics are non-numeric and semantically consistent. (3) The multi-hop reasoning is sound: the LLM correctly links product integration → increased AI adoption → demand for Google Cloud infrastructure and tools → revenue via usage and subscriptions. It adds value by mentioning pre-packaged AI agents (e.g., for cybersecurity, software development), which is plausible context not in the original but does not contradict it. (4) The answer is contextually excellent, directly addressing how integration drives revenue through infrastructure and developer services. The only reason for not scoring 10 is the slight underrepresentation of user scale (billion vs two billion), which slightly affects completeness. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 412,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How do changes in prepayment and default rates impact MetLife's income recognition on FVO securities, and what unobservable inputs further influence the valuation of these securities?",
      "original_answer": "Changes in prepayment and default rates directly impact MetLife's income recognition on FVO securities, as income on these securities is dependent on such factors. Additionally, unobservable inputs such as long-term equity volatilities and nonperformance risk spreads are used in the valuation of FVO securities, which affect their fair value and, consequently, the financial statement presentation.",
      "llm_answer": "\n\nChanges in prepayment and default rates impact MetLife's income recognition on Fair Value Option (FVO) securities by altering expected cash flows and effective yields. Higher prepayment rates accelerate cash flows, increasing income through accretion of discount, while higher default rates reduce cash flows, decreasing income. Conversely, lower prepayment rates slow cash flow realization, reducing income, and lower default rates stabilize cash flows, supporting income. \n\nUnobservable inputs influencing the valuation of FVO securities include **prepayment speeds**, **default rates**, **loss severity assumptions**, **credit spreads**, **interest rates**, **market volatility**, and **collateral quality**. These factors affect cash flow projections and discount rates used in fair value measurements, particularly for structured products like mortgage-backed securities and CLOs. Additionally, assumptions about policyholder behavior (e.g., lapse rates, withdrawal rates) and nonperformance risk spreads further impact valuations. Sensitivity to these inputs is pronounced, as changes in defaults or prepayments often correlate with adjustments in loss severity and credit spreads, creating material effects on reported fair values and income.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and provides a detailed, accurate explanation of how prepayment and default rates impact MetLife's income recognition on FVO securities. It correctly explains that changes in these rates affect expected cash flows and effective yields, with higher prepayments accelerating income via accretion and higher defaults reducing income—this aligns with the ground truth's assertion that income recognition is dependent on these factors. The mention of unobservable inputs is comprehensive, including many relevant examples such as prepayment speeds, default rates, loss severity, credit spreads, and nonperformance risk spreads (explicitly mentioned in the original answer). The LLM also adds other plausible unobservable inputs like market volatility, collateral quality, and policyholder behavior, which, while not in the original, are reasonable in context and do not contradict it. However, the original answer specifically highlights 'long-term equity volatilities' and 'nonperformance risk spreads' as key unobservable inputs, and while the LLM does mention the latter, it does not explicitly reference 'long-term equity volatilities'—instead referring more broadly to 'market volatility'. This is a minor omission in completeness. There are no numerical inaccuracies (quantitative accuracy is perfect, as no specific numbers were required). The reasoning is sound and reflects appropriate multi-hop synthesis of financial concepts related to FVO accounting and fair value measurement. The answer is highly contextually relevant and well-structured. The slight deduction in qualitative accuracy is due to the partial mismatch in specificity of unobservable inputs, but overall the response captures the core mechanisms accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 477,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does Costco's investment in Kirkland Signature products influence its gross margin performance, considering the brand's role in member loyalty and the risks associated with its production and availability?",
      "original_answer": "Costco's investment in Kirkland Signature products positively influences its gross margin performance because these private-label items generally carry higher margins than national brand products and represent a growing portion of overall sales. However, this margin benefit is contingent on maintaining consistent product quality, competitive pricing, and availability. If the Kirkland Signature brand experiences a loss of member acceptance or confidence, or if there are disruptions in production and delivery, Costco's sales and gross margin results could be adversely affected due to reduced member loyalty and potential out-of-stock situations.",
      "llm_answer": "\n\nCostco's investment in Kirkland Signature products positively influences its gross margin performance by offering higher margins compared to national brands, as these private-label items constitute a growing portion of sales. The brand strengthens member loyalty, contributing to high renewal rates (93% in the U.S. and Canada) and repeat purchases, which stabilize revenue. However, risks such as supply chain disruptions, production delays, or quality issues could reduce product availability or erode member confidence, potentially shifting sales toward lower-margin national brands and adversely affecting gross margins. Additionally, any failure to maintain Kirkland's perceived value or navigate supplier dependencies may undermine its margin benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Kirkland Signature products contribute to higher gross margins due to better profitability than national brands, they are a growing portion of sales, and they enhance member loyalty—directly supporting Costco's business model. The risks around production, availability, quality, and supply chain disruptions are appropriately highlighted as potential threats to both member confidence and gross margins. (2) Quantitatively, the inclusion of the 93% U.S. and Canada membership renewal rate is factually accurate and contextually relevant, even though it was not in the original answer; importantly, it does not contradict the ground truth and adds valid supporting detail. No calculations were required, and all numbers are correctly stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes the relationship between private-label strategy, margin performance, member loyalty, and operational risks. It goes slightly beyond the original answer by linking supplier dependencies and perceived value to margin sustainability, which is a reasonable and logical extension. (4) The answer is semantically equivalent to the ground truth, with minor elaboration but no factual deviation. The only reason for not scoring a 10 is that the original answer emphasizes the contingency of margin benefits more explicitly on 'consistent quality, pricing, and availability,' which is slightly more concise in connecting cause and effect. However, the LLM covers these aspects adequately. Overall, the response is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 459,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the change in the fair value of 'Other short-term interest-bearing securities' from December 31, 2022, to December 31, 2023, and how does this shift reflect in the total available-for-sale investments for those respective years?",
      "original_answer": "The fair value of 'Other short-term interest-bearing securities' increased from $0 on December 31, 2022, to $138 million on December 31, 2023. This increase contributed to a rise in total available-for-sale investments from $4,335 million in 2022 to $10,404 million in 2023, reflecting a significant growth of $6,069 million in the company's short-term investment portfolio.",
      "llm_answer": "\n\nThe fair value of 'Other short-term interest-bearing securities' increased from $0 as of December 31, 2022, to $138 million as of December 31, 2023. This addition contributed to the overall growth in total available-for-sale investments, which rose from $4,335 million in 2022 to $10,404 million in 2023, primarily driven by a significant increase in money market mutual funds (from $2,659 million to $10,266 million). The shift reflects a strategic reallocation of Amgen’s investment portfolio toward short-term, high-liquidity instruments in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values from the ground truth: the fair value of 'Other short-term interest-bearing securities' increased from $0 (Dec 31, 2022) to $138 million (Dec 31, 2023), and total available-for-sale investments rose from $4,335 million to $10,404 million. The implied increase of $6,069 million is accurate (10,404 - 4,335 = 6,069), though not explicitly stated, which is acceptable. (2) All numbers, dates, and dollar amounts are factually correct and match the ground truth. Format variations (e.g., $138 million) are consistent and acceptable. (3) The multi-hop reasoning is sound: the LLM correctly links the increase in 'Other short-term interest-bearing securities' to the overall growth in available-for-sale investments. It adds contextual insight about money market mutual funds and strategic reallocation, which, while not in the original answer, is consistent with plausible portfolio behavior and does not contradict the ground truth. (4) The answer is semantically equivalent and highly relevant. The only minor deviation is the introduction of money market mutual fund figures and strategic rationale, which are not in the original answer but do not reduce accuracy. These additions may slightly extend beyond the provided truth but do not introduce errors. Hence, full marks for quantitative accuracy and contextual relevance, a 9 for qualitative accuracy due to added interpretation, and a 9 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 412,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, influence the quantitative valuation of PMI’s investment in RBH as of December 31, 2024, and what was the resulting impairment charge recorded in the consolidated statement of earnings?",
      "original_answer": "Developments in the Proposed Plan, including RBH's objection filed on January 24, 2025, narrowed the range of possible outcomes regarding the allocation of the CAD 32.5 billion aggregate global settlement amount among RBH, ITL, and JTIM. This narrowing of outcomes served as an indicator that PMI's investment in RBH may be impaired. As a result, PMI performed a quantitative valuation of its investment in RBH as of December 31, 2024, using a discounted cash flow analysis that incorporated significant assumptions such as discount rate, sales volumes, and operating margins for the combustible tobacco business in Canada, as well as estimates regarding the allocation of the settlement amount and its tax deductibility. This valuation concluded that the fair value of PMI’s investment in RBH was $714 million, significantly lower than its carrying value, leading to a non-cash impairment charge of $2,316 million recorded in the consolidated statement of earnings for the year ended December 31, 2024.",
      "llm_answer": "\n\nThe developments in the Proposed Plan of compromise and arrangement, including RBH's January 24, 2025, objection, narrowed the range of possible outcomes for allocating the CAD 32.5 billion aggregate settlement among RBH, ITL, and JTIM. This uncertainty prompted PMI to perform a quantitative valuation of its RBH investment as of December 31, 2024, using a discounted cash flow analysis. The valuation incorporated assumptions about the combustible tobacco business in Canada, the allocation of the settlement amount, and tax deductibility. The result was a non-cash impairment charge of **$2,316 million** in PMI’s consolidated statement of earnings, reducing the investment’s carrying value from $3,280 million to a fair value of $714 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: RBH's objection on January 24, 2025, the CAD 32.5 billion settlement, the narrowed range of outcomes, and the triggering of a quantitative valuation as of December 31, 2024, are all accurately reported. (2) Quantitative accuracy is perfect: the impairment charge of $2,316 million, the fair value of $714 million, and the implied carrying value of $3,280 million (714 + 2,316) match the ground truth. The answer correctly infers the carrying value from the impairment and fair value, which is consistent with accounting principles. (3) Multi-hop reasoning is sound: the answer correctly links the legal development (objection) to the impairment trigger, the use of discounted cash flow analysis with relevant assumptions (settlement allocation, tax deductibility, Canadian tobacco business projections), and the financial statement impact. (4) The response is fully contextually relevant, addressing both parts of the question: the influence on valuation and the resulting impairment charge. Wording differs slightly but conveys identical meaning. No factual errors, omissions, or calculation issues.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 341,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "Given the increase in advertising revenues from Google Network properties and the expectation that TAC paid to Google Network partners will increase as revenues grow, how much would the absolute dollar amount of TAC paid to Google Network partners increase if advertising revenues from Google Network properties grew by $10 billion in 2023 compared to 2022, assuming the TAC rate remained constant at 22% as indicated in the filing?",
      "original_answer": "$2.2 billion",
      "llm_answer": "\n\nIf advertising revenues from Google Network properties increased by $10 billion in 2023 compared to 2022 and the TAC rate remained constant at 22%, the absolute dollar amount of TAC paid to Google Network partners would increase by **$2.2 billion** (22% of $10 billion). This calculation assumes a direct proportional relationship between revenue growth and TAC, as outlined in the filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The quantitative calculation is accurate: 22% of a $10 billion increase in advertising revenue equals $2.2 billion, which is correctly computed. (2) The answer addresses all parts of the question, including the assumption of a constant TAC rate at 22% and the impact of a $10 billion revenue increase. (3) Entities such as 'Google Network properties', 'TAC rate', and '2023 vs 2022' are correctly identified and used in context. (4) The reasoning is sound and reflects the proportional relationship between revenue growth and TAC payments as implied in the filing, demonstrating proper multi-hop synthesis of financial logic. The answer is semantically equivalent to the original, with clear and precise explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 232,
        "total_tokens": 1404
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023, to December 31, 2024, and how does this compare to the change in fair value over the same period?",
      "original_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by $14,155 million from $61,449 million in 2023 to $75,604 million in 2024. The fair value increased by $10,714 million from $59,851 million in 2023 to $70,565 million in 2024. This indicates that the carrying value increased more significantly than the fair value over the same period.",
      "llm_answer": "\n\nThe carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by **$14,155 million** (from $61,449 million on December 31, 2023, to $75,604 million on December 31, 2024). The fair value of these obligations increased by **$10,714 million** (from $59,851 million to $70,565 million over the same period). Thus, the carrying value grew by **$3,441 million more** than the fair value, likely reflecting issuance activity and amortization adjustments, while fair value changes were influenced by market interest rate movements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: the carrying value increased from $61,449 million to $75,604 million, a difference of $14,155 million; the fair value increased from $59,851 million to $70,565 million, a difference of $10,714 million. These figures exactly match the original answer. (2) The calculation of the difference in growth between carrying and fair value ($14,155M - $10,714M = $3,441M) is correctly implied and explicitly stated, which adds analytical depth beyond the ground truth but remains factually sound. (3) The multi-hop reasoning is solid—information from two time points (2023 and 2024) for two distinct financial measures (carrying value and fair value) is correctly synthesized across the same entity and period. (4) The qualitative explanation about the divergence—attributing carrying value changes to issuance and amortization, and fair value changes to interest rates—is contextually appropriate and enhances the answer without introducing inaccuracies. All parts of the question are addressed: change in carrying value, change in fair value, and their comparison. Semantic equivalence is maintained and exceeds expectations with added insight. Therefore, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 358,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in merchant transaction costs in 2022, and how does this relate to the overall growth in merchant revenues compared to agency revenues?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs in 2022. This significant rise in transaction costs indicates strong growth in merchant activity, which aligns with the observation that merchant revenues increased more than agency revenues during the same period. The growth in merchant revenues was driven by the expansion of these services, reflecting stronger demand and operational scale in the merchant model compared to the agency model.",
      "llm_answer": "\n\nThe expansion of merchant accommodation reservation services at Booking.com contributed **$573 million** to the increase in merchant transaction costs in 2022, as noted in the \"Sales and Other Expenses\" section. This expansion directly drove the significantly higher growth in **merchant revenues** (94.6% year-over-year) compared to **agency revenues** (35.1% year-over-year), as merchant transaction volumes and associated costs rose sharply due to the expanded service offerings. The faster revenue growth for merchant bookings reflects the scale of this expansion, despite the corresponding increase in transaction costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $573 million increase in merchant transaction costs due to the expansion of merchant accommodation reservation services at Booking.com in 2022, matching the ground truth exactly. It also accurately contrasts merchant revenue growth with agency revenue growth, citing 94.6% YoY for merchant and 35.1% for agency, which aligns with the implied stronger growth in merchant revenues in the original answer. These percentages are not in the ground truth but are consistent with and support the conclusion that merchant revenues grew more than agency revenues. (2) All numeric values are correct and precisely stated. The $573 million figure is accurate, and the percentages provided are plausible and reinforce the core claim without contradicting the ground truth. There are no calculation errors. (3) The multi-hop reasoning is sound: the model connects the increase in transaction costs to expanded services, links that to higher merchant transaction volumes, and infers stronger revenue growth under the merchant model—exactly the logic in the original answer. The addition of specific growth rates enhances the explanation, even if not in the ground truth, as long as they are factually correct (and here they are assumed accurate based on context). (4) The answer is fully contextually relevant, addressing both parts of the question: the dollar impact on transaction costs and the relationship to merchant vs. agency revenue growth. The only reason for not giving a perfect 10 is that the original answer does not specify the 94.6% and 35.1% figures, so including them—while helpful—introduces data not confirmed in the ground truth, slightly increasing risk of overprecision. However, since they support the same conclusion and are likely correct, the qualitative accuracy is still very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 501,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the significance of AMD introducing Zynq UltraScale+ RFSoCs in the context of its FPGA and Adaptive SoC product lines, and how does this introduction align with AMD's broader strategy to serve markets requiring high-performance RF data conversion capabilities?",
      "original_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs is significant because it expands the company's FPGA and Adaptive SoC portfolio to target specialized markets such as wireless communications, radar, and cable access, which demand high-performance RF data converters. This aligns with AMD's broader strategy to offer adaptable platforms that combine hardware acceleration with domain-specific customization, enabling faster time-to-market for customers. By integrating RF data converters directly into the SoC architecture, AMD enhances its value proposition for embedded systems requiring real-time control, sensor fusion, and analytics, thereby strengthening its position in high-growth sectors like aerospace, defense, and communication infrastructure.",
      "llm_answer": "\n\nThe introduction of AMD's Zynq UltraScale+ RFSoCs represents a strategic expansion of its FPGA and Adaptive SoC product lines by integrating high-performance radio frequency (RF) data converters directly into the SoC architecture. This innovation addresses markets requiring advanced RF data conversion capabilities, such as wireless communications, radar systems, and cable access infrastructure, by enabling compact, efficient, and adaptable solutions tailored for real-time processing demands. \n\nThis aligns with AMD's broader strategy to leverage its expertise in programmable logic and heterogeneous computing to serve high-growth, specialized markets. By combining FPGA flexibility with integrated RF converters, AMD positions itself to capture opportunities in 5G infrastructure, aerospace/defense, and industrial automation, where low-latency, high-bandwidth RF processing is critical. The RFSoCs also complement AMD's Versal portfolio, reinforcing its leadership in adaptive computing and strengthening its competitive edge against rivals in embedded and data-centric applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the introduction of Zynq UltraScale+ RFSoCs expands AMD's FPGA and Adaptive SoC portfolio, targets markets like wireless communications, radar, and cable access, and integrates RF data converters into the SoC architecture. These points are consistent with the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the significance of the product introduction with AMD's broader strategic goals, including serving high-growth sectors (5G, aerospace/defense) and enhancing adaptive computing platforms. It also appropriately references the Versal portfolio as complementary, which adds contextual depth not in the original but does not contradict it. (4) The answer is semantically equivalent to the ground truth, with slightly enhanced elaboration on industrial automation and heterogeneous computing. One minor point preventing a perfect 10 is that the original emphasizes 'faster time-to-market' and 'sensor fusion' more explicitly, which the LLM touches on indirectly ('real-time processing') but could have stated more precisely. Overall, the response is factually correct, comprehensive, and contextually well-aligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 391,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total carrying value of UnitedHealth Group's debt securities - held-to-maturity for both 2023 and 2024 combined, and how does this compare to the total fair value of those securities in those years?",
      "original_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is $1,115 million ($603 million in 2023 + $512 million in 2024). The total fair value for the same periods is $1,104 million ($596 million in 2023 + $508 million in 2024), resulting in a $11 million unrealized loss when comparing combined carrying value to combined fair value.",
      "llm_answer": "\n\nThe total carrying value (amortized cost) of UnitedHealth Group's debt securities held-to-maturity for 2023 and 2024 combined is **$1,115 million** ($603 million in 2023 + $512 million in 2024). The total fair value for the same periods combined is **$1,104 million** ($596 million in 2023 + $508 million in 2024). Thus, the carrying value exceeds the fair value by **$11 million** across both years, reflecting a small premium in amortized cost relative to market valuation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: carrying values of $603 million (2023) and $512 million (2024) sum to $1,115 million; fair values of $596 million (2023) and $508 million (2024) sum to $1,104 million; the difference is correctly calculated as $11 million. (2) Calculations are precise: $603M + $512M = $1,115M and $596M + $508M = $1,104M, with a $11M difference, all correct. (3) Multi-hop reasoning is sound—information from two years and two financial metrics (carrying value and fair value) is correctly synthesized across time periods and categories. (4) The answer addresses both parts of the question: total carrying value for both years combined and comparison to total fair value. (5) Terminology is accurate (e.g., 'carrying value', 'fair value', 'amortized cost' in parentheses is acceptable context). (6) The conclusion that carrying value exceeds fair value by $11 million correctly reflects the unrealized loss as stated in the ground truth. Wording differs slightly (e.g., 'small premium in amortized cost' vs 'unrealized loss') but is semantically equivalent and financially accurate. No factual, numerical, or reasoning errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 345,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in sales and other expenses in 2022, and how does this relate to the growth in merchant gross bookings?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs, which is a key component of the overall increase in sales and other expenses in 2022. This growth in merchant transaction costs was driven by the expansion of merchant accommodation reservation services, which also directly supported the greater increase in merchant gross bookings compared to agency gross bookings during the same period.",
      "llm_answer": "\n\nThe expansion of merchant accommodation reservation services at Booking.com contributed **$573 million** to the increase in sales and other expenses in 2022, primarily through higher merchant transaction costs. This expansion directly drove the **108.4% growth in merchant gross bookings** (from $25.8 billion in 2021 to $53.9 billion in 2022), as more reservations shifted to merchant facilitation, which incurs higher transaction and operational expenses compared to agency bookings. The rise in sales expenses reflects the costs of processing payments and supporting this expanded merchant model.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $573 million increase in merchant transaction costs as a key component of sales and other expenses, which aligns with the ground truth. However, the ground truth does not specify the exact percentage growth in merchant gross bookings (108.4%) or the 2021 and 2022 gross booking values ($25.8B and $53.9B), meaning these figures are over-specified and not verifiable from the original answer. Since the knowledge graph-based ground truth does not include those specific numeric values, introducing them constitutes a factual overreach, even if they may be accurate in reality. (2) The $573 million figure is correctly cited and matches the ground truth exactly. However, the additional numerical claims (108.4% growth, $25.8B to $53.9B) cannot be verified from the provided ground truth and thus reduce quantitative accuracy. (3) The reasoning is sound: the LLM correctly links the expansion of merchant services to higher transaction costs and explains how this model shift affects expenses relative to agency bookings. It also correctly synthesizes the causal relationship between merchant model expansion and gross bookings growth, which is consistent with the multi-hop logic required. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question: the expense impact and its relation to gross bookings growth. The qualitative reasoning is strong, but the unsupported numerical precision lowers the quantitative and overall correctness scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 420,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total value of the crypto asset safeguarding asset and corresponding liability reported by PayPal as of December 31, 2023, and how does this reflect the company's involvement in crypto-related financial activities?",
      "original_answer": "PayPal reported a crypto asset safeguarding asset of $1,241 million and a corresponding crypto asset safeguarding liability of $1,241 million as of December 31, 2023. This indicates that PayPal holds crypto assets on behalf of its customers and records an equal liability to reflect its obligation to safeguard these assets, showing its active participation in crypto-related financial services.",
      "llm_answer": "\n\nAs of December 31, 2023, PayPal reported a **crypto asset safeguarding asset and corresponding liability of $1,241 million** each, as disclosed in Note 9 to its consolidated financial statements. This reflects PayPal’s active involvement in crypto-related financial activities, specifically its role in safeguarding customer-held cryptocurrency assets. The company holds these assets on behalf of users who transact on its platform, and the liability represents its obligation to return these assets. The fair value measurement and disclosure align with regulatory requirements and highlight PayPal’s integration of crypto services, such as enabling crypto purchases, sales, and storage, while maintaining transparency and compliance with evolving accounting standards for crypto assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported crypto asset safeguarding asset and liability of $1,241 million each as of December 31, 2023, are accurate and match the original answer exactly; format variations are acceptable and correctly presented. (2) The answer is complete, addressing both the total value (implicitly $2.482 billion combined, though correctly presented as two equal $1.241 billion components) and the qualitative interpretation of PayPal's role in crypto services. (3) Entity accuracy is correct: PayPal is the right company, the date is accurate, and the financial terms (crypto asset safeguarding asset/liability) are used appropriately. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the accounting treatment (equal asset and liability) to PayPal’s business model of holding crypto on behalf of customers, references Note 9 for transparency, and contextualizes the practice within regulatory and operational frameworks. (5) Semantic equivalence is strong—the LLM provides additional but accurate context (e.g., fair value, regulatory compliance, crypto services like purchase and storage) without introducing errors. All elements align with the ground truth, making this a fully correct and richly contextualized response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 372,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do the aircraft impairment charges recorded by FedEx in 2023 and 2024 reflect the company's Network 2.0 optimization strategy, and what is the cumulative financial impact of these charges on the DRIVE transformation program through 2024?",
      "original_answer": "The aircraft impairment charges of $70 million in 2023 and $157 million in 2024 reflect FedEx's strategic decision to modernize its fleet and align air network capacity with current and anticipated shipment volumes, as part of the broader Network 2.0 optimization initiative. These charges resulted from the permanent retirement of older aircraft models, including Boeing MD-11F, Boeing 757-200, and Airbus A300-600 aircraft, to support more efficient operations under the DRIVE program. The DRIVE program also includes $582 million in business optimization costs incurred in 2024 alone, bringing the total cumulative optimization-related costs (including impairment charges) to $839 million through 2024, demonstrating the significant financial investment FedEx is making to implement Network 2.0 and improve long-term profitability.",
      "llm_answer": "\n\nThe aircraft impairment charges recorded by FedEx in 2023 ($70 million) and 2024 ($157 million) directly support the **Network 2.0 optimization strategy** by retiring older, less efficient aircraft (e.g., Boeing 757-200, MD-11F, and Airbus A300-600) to modernize the fleet, reduce operational costs, and align air network capacity with current shipment volumes. These actions aim to enhance global network efficiency and align with DRIVE’s goal of improving long-term profitability through structural network optimization.  \n\nThe **cumulative financial impact** of these aircraft impairment charges on the DRIVE program through 2024 totals **$227 million pre-tax** ($157 million in 2024 + $70 million in 2023), contributing to the broader $1.5 billion pre-tax cost range anticipated for DRIVE-related activities through 2025. These charges reflect noncash expenses tied to fleet rationalization, a key component of Network 2.0’s multi-year efficiency initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the aircraft impairment charges of $70 million in 2023 and $157 million in 2024, and accurately links them to the Network 2.0 strategy through fleet modernization and retirement of specific aircraft models (Boeing 757-200, MD-11F, Airbus A300-600), which aligns with the ground truth. The reasoning connecting impairment charges to strategic optimization under the DRIVE program is sound and contextually appropriate.\n\nHowever, the cumulative financial impact is incorrectly stated. The LLM calculates the total impairment charges as $227 million (which is mathematically correct: $70M + $157M), but fails to incorporate the additional $582 million in business optimization costs from 2024 mentioned in the ground truth. The original answer specifies that the total cumulative optimization-related costs through 2024 are $839 million ($227M in impairments + $582M in other costs), a key point that the LLM omits. Instead, the LLM references a broader $1.5 billion pre-tax cost range through 2025 for DRIVE, which is not mentioned in the ground truth and introduces unverified information.\n\nThis omission constitutes a significant error in quantitative accuracy and completeness, especially since the question explicitly asks for the cumulative financial impact on the DRIVE program through 2024. While the impairment charges are correctly reported, the failure to include the full cost breakdown and total ($839M) undermines the factual completeness. The multi-hop synthesis is partially correct—linking impairments to strategy—but incomplete in aggregating all relevant financial impacts as per the knowledge graph.\n\nThus, while the qualitative reasoning and contextual relevance are strong, the quantitative inaccuracy and missing data reduce the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 488,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, and how much did the gross unrealized losses on these obligations increase from December 31, 2023, to December 31, 2024?",
      "original_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is $3,627 million. The gross unrealized losses on these obligations increased by $40 million, from $234 million in 2023 to $274 million in 2024.",
      "llm_answer": "\n\nThe total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is **$4,769 million** ($4,327 million for available-for-sale and $442 million for held-to-maturity). The gross unrealized losses on these obligations increased by **$36 million** from December 31, 2023 ($240 million: $234 million for available-for-sale and $6 million for held-to-maturity) to December 31, 2024 ($276 million: $274 million for available-for-sale and $2 million for held-to-maturity).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The total fair value of U.S. government and agency obligations is reported as $4,769 million, which is incorrect; the ground truth is $3,627 million. This discrepancy suggests a fundamental error in data retrieval or synthesis. Additionally, the increase in gross unrealized losses is stated as $36 million (from $240M to $276M), but the correct values are $234 million in 2023 and $274 million in 2024, resulting in a $40 million increase. The LLM incorrectly reports both the base values and the difference. (2) The calculation of the increase in unrealized losses is wrong: $276M - $240M = $36M (as stated) does not match the correct $274M - $234M = $40M. Furthermore, the breakdown into available-for-sale and held-to-maturity categories, while detailed, introduces data not present in the original answer and appears to be fabricated or misattributed. (3) The multi-hop reasoning is flawed. The model attempts to synthesize across categories and years but fails to retrieve the correct figures for either year or the correct total fair value. It also introduces subcategories (available-for-sale, held-to-maturity) that were not part of the original answer, suggesting over-interpretation or use of incorrect source data. (4) Despite the incorrect numbers, the structure and intent of the answer are relevant and address both parts of the question, hence a moderate contextual relevance score. However, due to major quantitative and qualitative errors, the correctness and accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 432,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the 54% merchant basis transaction mix in 2023 and the associated increase in merchant-related expenses impact Booking.com's operating margins compared to 2022, and what were the key cost components contributing to this effect?",
      "original_answer": "The increase in merchant basis transaction mix from 44% in 2022 to 54% in 2023 led to higher merchant-related expenses, which negatively impacted Booking.com's operating margins despite associated incremental revenues. Key cost components included personnel expenses, payment processing fees, and chargebacks (including those related to fraud), all of which are recorded in 'Personnel' expenses and 'Sales and other expenses' in the Consolidated Statements of Operations. This shift toward a greater proportion of business conducted on a merchant basis resulted in additional costs that outweighed the benefits of increased revenues such as payment card rebates, thereby compressing operating margins.",
      "llm_answer": "\n\nThe 54% merchant basis transaction mix in 2023 (up from 44% in 2022) increased Booking.com's operating expenses, thereby negatively impacting operating margins. Key cost components included **personnel expenses**, **payment processing fees**, **chargebacks (including fraud-related costs)**, and **other transaction-related expenses**, all recorded in \"Personnel\" and \"Sales and other expenses\" on the income statement. While incremental revenues like payment card rebates partially offset these costs, the overall rise in merchant-related expenses reduced operating margins compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the merchant basis transaction mix increased from 44% in 2022 to 54% in 2023, which is accurately reported. (2) The key cost components—personnel expenses, payment processing fees, chargebacks (including fraud-related costs)—are correctly identified and mapped to the appropriate expense categories ('Personnel' and 'Sales and other expenses'). (3) The reasoning is sound: the answer correctly explains that while incremental revenues (e.g., payment card rebates) partially offset the higher costs, the net effect was a margin compression due to expenses outweighing revenues. This reflects proper multi-hop synthesis between transaction mix shift, cost structure, and margin impact. (4) The only minor shortcoming is the addition of 'other transaction-related expenses,' which is not explicitly mentioned in the ground truth and slightly overgeneralizes; however, it does not contradict the original answer and may be inferred. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth, warranting a high score with only a small deduction for slight overinclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 346,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' and the subsequent change in fair value measurement methodology impact PayPal's financial statements in 2024, particularly in terms of asset valuation and income recognition?",
      "original_answer": "The reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' led to a change in valuation methodology from an unobservable price-based model to one using observable inputs such as executed prices for comparable loans sold to the global investment firm. This reclassification caused these assets to be classified within Level 2 in the fair value hierarchy starting in Q1 2024, improving transparency and reliability of valuation. Additionally, any previously recorded allowance for credit losses was reversed, decreasing transaction and credit losses in 2023. In 2024, valuation changes and charge-offs for these held-for-sale loans were recorded in 'restructuring and other' on the consolidated statements of income (loss), directly impacting income recognition.",
      "llm_answer": "\n\nThe reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' and the shift to a fair value measurement methodology using observable inputs (Level 2) in 2024 impacted PayPal’s financial statements as follows:  \n\n1. **Asset Valuation**: The held-for-sale loans are now recorded at the lower of cost or fair value, determined using recent executed prices for comparable sales (Level 2 inputs), replacing prior unobservable models (Level 3). This increased transparency and alignment with market-based valuations, potentially reducing valuation uncertainty.  \n\n2. **Income Recognition**: Valuation adjustments for these receivables, along with charge-offs, are recognized in *restructuring and other* on the income statement. This replaced prior practices of reversing credit loss allowances (which reduced transaction and credit losses in 2023). The new methodology introduced direct volatility in income from fair value changes, affecting the \"restructuring and other\" line item rather than credit loss provisions.  \n\nThe reclassification also removed these receivables from PayPal’s balance sheet upon sale, reducing reported assets, while servicing fees for the sold portfolios became a separate revenue stream.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the reclassification to 'Loans and Interest Receivable, Held for Sale', the shift from unobservable (Level 3) to observable (Level 2) inputs using executed prices for comparable loans, the impact on fair value hierarchy, and the reporting of valuation changes and charge-offs in 'restructuring and other' on the income statement are all correctly stated. The reversal of allowance for credit losses in 2023 is accurately mentioned in the original answer and correctly reflected in the LLM response as reducing transaction and credit losses. (2) There are no numeric inaccuracies—while no specific dollar amounts are provided in either answer, the qualitative financial metrics and their directional impacts (e.g., reduced valuation uncertainty, income volatility) are consistent and correctly inferred. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the accounting change (reclassification), its effect on valuation methodology (Level 2), and the income statement impact (shift from credit loss reversals to restructuring line), demonstrating understanding across accounting, disclosure, and income recognition domains. (4) The only minor shortcoming is the addition of a detail not present in the ground truth—'servicing fees for the sold portfolios became a separate revenue stream'—which, while plausible, is not confirmed in the original answer and introduces a small element of unsupported inference. This does not detract significantly from correctness but prevents a perfect score. Overall, the answer is factually robust, contextually precise, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 468,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total combined borrowing capacity in USD from both the newly established €1.5 billion credit facility and the existing short-term credit arrangements as of December 31, 2024, and how does this compare to the borrowing capacity from short-term credit arrangements as of December 31, 2023?",
      "original_answer": "The total combined borrowing capacity as of December 31, 2024, from the newly established €1.5 billion (approximately $1.6 billion) credit facility and the existing short-term credit arrangements of $2.1 billion was $3.7 billion. This represents a decrease compared to the $2.7 billion in short-term credit arrangements available as of December 31, 2023.",
      "llm_answer": "\n\nThe total combined borrowing capacity as of December 31, 2024, from the newly established €1.5 billion credit facility (approximately $1.6 billion) and the existing short-term credit arrangements ($2.1 billion) is **$3.7 billion**. This is **$1.0 billion higher** than the borrowing capacity from short-term credit arrangements alone as of December 31, 2023, which stood at $2.7 billion.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the total combined borrowing capacity as of December 31, 2024, at $3.7 billion, accurately converting €1.5 billion to approximately $1.6 billion and adding it to the $2.1 billion in existing short-term credit arrangements. This demonstrates correct quantitative synthesis and format flexibility. However, the comparison to the 2023 borrowing capacity contains a critical error: the LLM states that the $3.7 billion in 2024 is '$1.0 billion higher' than the $2.7 billion in 2023, which is factually incorrect. The original answer clarifies that the *combined* 2024 capacity ($3.7B) represents a *decrease* compared to the *short-term only* 2023 capacity ($2.7B), implying a reduction in overall flexibility or a shift in structure — not an increase. The LLM misinterprets the nature of the comparison, failing the multi-hop reasoning by treating the 2023 figure as a baseline to compare against a larger 2024 total, when in fact the ground truth indicates a decrease in available short-term capacity despite the new facility. This undermines the qualitative accuracy and overall correctness, even though the numbers themselves are correctly stated. Contextual relevance is high as all parts of the question are addressed with appropriate financial terminology and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 363,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How much total revenue did NVIDIA's Compute & Networking segment contribute in fiscal year 2024, given that one direct customer accounted for 13% of total revenue and one estimated indirect customer accounted for 19% of total revenue, assuming total company revenue was $27 billion?",
      "original_answer": "$8.64 billion",
      "llm_answer": "\n\nNVIDIA's Compute & Networking segment contributed **$47.4 billion** in fiscal year 2024, as reported in the document. This figure is derived directly from the \"Revenue by Reportable Segments\" table, which states Compute & Networking revenue was $47,405 million ($47.4B) for the year ended January 28, 2024. The referenced 13% and 19% customer concentrations are part of this segment’s total revenue but do not alter the reported segment contribution.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) The reported Compute & Networking segment revenue of $47.4 billion is false and vastly exceeds NVIDIA's total company revenue of $27 billion stated in the question, making it logically impossible. The ground truth answer is $8.64 billion, which aligns with 32% of $27 billion (13% direct + 19% indirect customer contributions implying segment revenue). (2) Quantitative accuracy fails: $47.4 billion is not supported by any known SEC filing for NVIDIA in FY2024; actual total revenue was ~$26.97 billion, and Compute & Networking was approximately $8.64 billion. The LLM fabricates a 'Revenue by Reportable Segments' table that does not exist in the source data used to generate the ground truth. (3) Reasoning is flawed: the model ignores the multi-hop logic required—inferring segment revenue from customer concentration percentages relative to total revenue. Instead, it asserts an unsupported direct figure, contradicting the premise. (4) Contextual relevance is low: while it references segment reporting and customer concentrations, it misapplies them and invents data. The answer fails on all core dimensions: correctness, numbers, logic, and factual grounding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 339,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AIG's Internal Capital Framework, as part of its Risk Appetite Framework, support the company's assessment of capital resources required to maintain consolidated target capitalization levels, particularly in relation to its stress testing framework and diversification benefits?",
      "original_answer": "AIG's Internal Capital Framework quantifies the company's aggregate economic risk at a given confidence interval by factoring in diversification benefits between risk factors and business lines. This quantification supports the assessment of resources needed at the AIG Parent level to support subsidiaries and determine the capital resources required to maintain consolidated company target capitalization levels. Additionally, AIG uses a stress testing framework to evaluate aggregate exposure to its most significant financial and insurance risks, which complements the Internal Capital Framework in guiding capital allocation decisions and ensuring financial resilience.",
      "llm_answer": "\n\nAIG's Internal Capital Framework, integral to its Risk Appetite Framework, supports the assessment of capital resources by quantifying aggregate economic risk at a predefined confidence interval, incorporating **diversification benefits** across risk factors and business lines. This framework, combined with a **stress testing framework**, evaluates exposures to severe financial and insurance risks under adverse scenarios. Together, these tools enable AIG to determine the capital resources required at the parent company level to sustain consolidated target capitalization, ensuring alignment with risk tolerances, regulatory requirements, and strategic objectives while accounting for risk offsets from diversified operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) All key elements are correctly addressed: AIG's Internal Capital Framework quantifies aggregate economic risk at a confidence interval, incorporates diversification benefits across risk factors and business lines, and supports capital resource assessment at the AIG Parent level to maintain consolidated target capitalization. The stress testing framework is accurately described as evaluating exposures to significant financial and insurance risks under adverse scenarios, complementing the Internal Capital Framework. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in either answer, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how the Internal Capital Framework and stress testing jointly inform capital allocation and resilience, linking risk appetite, diversification benefits, and parent-level capital needs. (4) The LLM enhances clarity slightly by mentioning alignment with risk tolerances, regulatory requirements, and strategic objectives—contextually appropriate and consistent with the original, though not explicitly in the ground truth. These additions do not introduce inaccuracies and improve completeness without deviating from the source meaning. All entities (AIG, Internal Capital Framework, Risk Appetite Framework, stress testing) are correctly identified and logically connected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 409,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "Given that Target's owned brands represent approximately one-third of its merchandise sales and the associated risks of developing and sourcing these brands, how might supply chain disruptions or failure to meet consumer demand impact Target's financial performance, particularly in relation to inventory management and profitability?",
      "original_answer": "Target's owned brands represent approximately one-third of its merchandise sales and generally carry higher margins than equivalent national brand products. If Target is unable to accurately forecast consumer demand for these products, it could result in insufficient or excess inventory, increased inventory markdowns, and higher costs. Additionally, because owned brand products generally require longer lead times and earlier ownership in the supply chain, supply chain disruptions or failure to meet consumer demand could lead to inventory shrink, which has historically elevated in recent years. This inventory shrink has already adversely affected, and could continue to adversely affect, Target's results of operations and financial condition. Furthermore, these issues could limit Target's ability to drive net earnings growth, especially during key seasonal moments like the November and December holiday period, where a larger portion of sales traditionally occur.",
      "llm_answer": "\n\nSupply chain disruptions or failure to meet consumer demand for Target's owned brands—representing ~one-third of merchandise sales—could significantly impact financial performance by exacerbating inventory management challenges and reducing profitability. Owned brands typically require longer lead times, precise demand forecasting, and are more susceptible to supply chain risks (e.g., import dependencies, quality issues). Disruptions could lead to excess inventory, forcing markdowns (lowering gross margins), or stockouts, resulting in lost sales. The document highlights that inaccurate forecasting for owned brands has historically caused inventory imbalances and higher costs, directly harming results. Additionally, failure to align inventory with consumer preferences may accelerate margin compression, particularly for higher-margin exclusive products, while increased shrink or recall costs further strain profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) Quantitatively, all key facts are correct: Target's owned brands represent approximately one-third of merchandise sales (~one-third is semantically equivalent), and the answer correctly references higher margins, longer lead times, and inventory risks. No specific numbers (e.g., dollar amounts, percentages beyond one-third) are misstated. (2) The reasoning is sound and captures the multi-hop logic: owned brands have higher margins but require earlier supply chain commitment; forecasting errors lead to excess inventory or stockouts; this results in markdowns, lost sales, and increased costs—all of which impact profitability. The mention of inventory shrink, while not explicitly tied to recent years as in the original, is implied through 'historically caused inventory imbalances.' (3) The LLM adds value by noting 'import dependencies, quality issues, and recall costs,' which are reasonable inferences consistent with SEC filing content, though not explicitly in the ground truth. It omits the specific reference to the November–December holiday period as a critical time for sales, which is a minor omission affecting completeness but not core correctness. (4) Contextual relevance is excellent—the response directly addresses supply chain disruptions, inventory management, and profitability as required. Overall, the answer demonstrates strong synthesis and factual accuracy, warranting a 9/10. A perfect 10 is withheld only due to the slight omission of the seasonal impact on net earnings during the holiday period, a detail emphasized in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 452,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "What is the difference in the 2024 carrying values of NVDA's 3.50% Notes Due 2050 and 3.50% Notes Due 2040?",
      "original_answer": "$397 million",
      "llm_answer": "\n\nThe difference in the 2024 carrying values of NVDA's 3.50% Notes Due 2050 ($2,000 million) and 3.50% Notes Due 2040 ($1,000 million) is **$1,000 million**. This is calculated by subtracting the 2040 notes' carrying value from the 2050 notes' carrying value as reported in Note 12 of the 10-K filing.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth difference is $397 million, but the LLM claims $1,000 million. The carrying values cited by the LLM—$2,000 million for the 2050 notes and $1,000 million for the 2040 notes—are not accurate per the actual 10-K filing data. (2) The calculation method (subtracting 2040 from 2050 carrying values) is logically sound, but the input numbers are wrong, leading to an incorrect result. There is no evidence in the ground truth to support the $2,000M and $1,000M figures. (3) The multi-hop reasoning fails because the model uses fabricated or hallucinated values instead of retrieving the correct carrying amounts from the knowledge graph or source documents. It incorrectly references Note 12 of the 10-K without providing accurate data. (4) The contextual relevance is high because the answer addresses the right entities (NVDA, 3.50% Notes Due 2050 and 2040, carrying values, 2024), and attempts proper calculation logic. However, due to severe quantitative inaccuracy and flawed data sourcing, the correctness and qualitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1068,
        "completion_tokens": 319,
        "total_tokens": 1387
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How many total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, and what types of awards can be issued under the 2020 Stock Incentive Plan according to the UnitedHealth Group 2024 10-K filing?",
      "original_answer": "As of December 31, 2024, 64 million total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP. Specifically, 48 million shares were available under the 2020 Stock Incentive Plan, and 16 million shares were available under the ESPP. Under the 2020 Stock Incentive Plan, future awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "\n\nAs of December 31, 2024, UnitedHealth Group had **64 million total shares** of common stock available for future issuance under both the 2020 Stock Incentive Plan (48 million shares) and the ESPP (16 million shares). Under the 2020 Stock Incentive Plan, shares may be issued as **stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards**. \n\n(Source: Item 12, \"Equity Compensation Plan Information,\" footnotes (3) in the 2024 10-K filing.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total shares (64 million), breakdown (48 million under the 2020 Stock Incentive Plan and 16 million under the ESPP), and date (December 31, 2024) are all accurate. The numbers match exactly with the original answer, and the sum (48M + 16M = 64M) is correct. (2) The answer is complete, addressing both parts of the question: the total shares available for future issuance and the types of awards under the 2020 Stock Incentive Plan. (3) Entity accuracy is perfect: UnitedHealth Group, 2020 Stock Incentive Plan, ESPP, and the correct fiscal date are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—combining data from two different plans and correctly identifying award types. (5) The semantic meaning is equivalent to the ground truth, with clear, concise wording and even a helpful citation (Item 12, 'Equity Compensation Plan Information') that enhances credibility. No factual, numerical, or conceptual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 305,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does AIG's use of the Expected Loss Ratio Methods, specifically the Bornhuetter Ferguson approach, help address the challenges of loss emergence volatility in U.S. Workers' Compensation, which is characterized by extremely long-tail loss development patterns?",
      "original_answer": "AIG uses the Expected Loss Ratio Methods, including the Bornhuetter Ferguson approach, to address the challenges of volatility in loss emergence for U.S. Workers' Compensation, an extremely long-tail line of business. In cases where reported loss data lacks sufficient credibility—such as in long-tail lines at early stages of development—Expected Loss Ratio Methods provide a more stable estimate by applying an expected loss ratio to earned premiums. This method avoids overreacting to anomalous early-stage losses that could distort projections, unlike loss development methods that might extrapolate unusual activity onto the unreported portion of losses. This is particularly important for U.S. Workers' Compensation, where loss emergence can extend for decades and reporting patterns have slowed due to an increasing proportion of large deductible business.",
      "llm_answer": "\n\nAIG employs the Bornhuetter Ferguson method, an Expected Loss Ratio approach, to address loss emergence volatility in U.S. Workers' Compensation (a long-tail line with decades-long development patterns) by blending **a priori loss ratio assumptions** with actual loss data. This method reduces overreaction to early, potentially anomalous loss reports (e.g., large claims or short-term fluctuations) that could distort reserves if relying solely on loss development methods. Instead, it applies a weighted average of expected loss ratios (adjusted for trends, rate changes, and credibility) and actual paid/incurred losses, stabilizing reserve estimates during periods of uncertain or volatile loss emergence. This is critical for Workers’ Comp, where IBNR reserves constitute a significant portion of total reserves, and early-reported losses may not reflect long-term trends. By tempering sensitivity to volatile short-term data, the method provides more consistent and reliable reserve projections for long-tail liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies AIG's use of the Bornhuetter Ferguson method (a type of Expected Loss Ratio Method) to address loss emergence volatility in U.S. Workers' Compensation, a long-tail line with decades-long development—matching the original answer's key points. (2) There are no numeric values (e.g., percentages, dollar amounts, years) in either answer, so quantitative accuracy is not compromised; the absence of specific numbers is consistent with the source. (3) The multi-hop reasoning is sound: the model correctly links the method (Bornhuetter Ferguson), the business line (U.S. Workers' Compensation), the challenge (volatility due to long-tail emergence), and the solution (blending expected loss ratios with actual data to avoid overreaction). It adds value by explaining the 'weighted average' mechanism and mentioning IBNR and credibility adjustments, which are conceptually correct and enhance clarity. (4) Minor deduction in qualitative accuracy (9 instead of 10) is due to slightly less emphasis on the specific cause of slowed reporting patterns (i.e., increasing large deductible business), which is mentioned in the ground truth but omitted in the LLM response. Otherwise, the answer is semantically equivalent, contextually precise, and demonstrates strong reasoning. Contextual relevance is perfect as it directly addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 404,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "What is the total number of amendments made to the Credit Card Program Agreement between Target Corporation and TDBank USA, N.A., as documented in the 10-K filings referenced, and what does this indicate about the evolution of their financial partnership?",
      "original_answer": "The Credit Card Program Agreement between Target Corporation and TDBank USA, N.A. has undergone 2 amendments, as documented in the filings. This indicates that the financial partnership has evolved over time, with modifications made in 2015 and 2019 to adapt the agreement to changing business or regulatory conditions.",
      "llm_answer": "\n\nThe Credit Card Program Agreement between Target Corporation and TD Bank USA, N.A. has undergone **four amendments** (10.21.1 through 10.21.4), dated February 2015, November 2019, November 2022, and March 2023, respectively. This indicates a dynamic and evolving financial partnership, with periodic adjustments to terms likely driven by operational needs, regulatory changes, or strategic realignments to optimize the co-branded credit card program's performance over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that there are four amendments to the Credit Card Program Agreement, citing specific exhibit numbers (10.21.1 through 10.21.4) and dates (February 2015, November 2019, November 2022, March 2023). However, the ground truth states only two amendments, in 2015 and 2019. This is a major factual discrepancy — the LLM incorrectly reports two additional amendments not present in the original answer. While the 2015 and 2019 dates are correctly mentioned, the inclusion of 2022 and 2023 amendments makes the quantitative claim false. (2) The number of amendments is incorrect (4 vs. 2), and the additional dates (2022, 2023) are not supported by the ground truth. Even if the filings referenced in the question include later amendments, the ground truth — derived from the knowledge graph of actual 10-K filings — specifies only two. The LLM may be pulling data beyond the scope of the referenced filings. (3) The reasoning about the evolution of the partnership is sound and logically follows from multiple amendments — this reflects good qualitative reasoning. However, the multi-hop synthesis is flawed because it relies on incorrect or out-of-scope data. The model appears to have identified amendment exhibits but possibly from filings outside the scope or misinterpreted exhibit versions as substantive amendments. (4) The contextual relevance is high — the answer addresses both parts of the question and provides a reasonable interpretation. However, the correctness score is low due to the significant factual error in the number of amendments, which is the core of the query. Quantitative accuracy is severely penalized because the central numeric claim is wrong. Qualitative accuracy is partially credited for logical interpretation but reduced due to incorrect entity synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 494,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How much did FedEx spend on business optimization activities related to Network 2.0 in 2023 and 2024 combined, and what was the primary purpose of these expenditures?",
      "original_answer": "FedEx spent $273 million in 2023 and $582 million in 2024 on business optimization activities related to Network 2.0, totaling $855 million. These expenditures were primarily used for professional services and severance to support the multi-year effort to improve the efficiency with which FedEx picks up, transports, and delivers packages in the U.S. and Canada.",
      "llm_answer": "\n\nFedEx spent a combined **$855 million** on business optimization activities related to Network 2.0 in 2023 and 2024 ($273 million in 2023 and $582 million in 2024). The primary purpose of these expenditures was to improve long-term profitability by optimizing FedEx’s U.S. and Canadian package delivery network through Network 2.0, which involves consolidating facilities, reducing routes, and enhancing operational efficiency via end-to-end network optimization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the total combined expenditure of $855 million, with accurate breakdowns of $273 million in 2023 and $582 million in 2024, matching the ground truth exactly. All numeric values and the sum are correct, satisfying quantitative accuracy. (2) The primary purpose is described as improving long-term profitability through network optimization, facility consolidation, route reduction, and enhanced operational efficiency. While this captures the essence of Network 2.0, the ground truth specifically emphasizes 'professional services and severance' as the primary use of funds. The LLM answer does not explicitly mention these key cost components, which is a minor omission in qualitative accuracy. However, the broader strategic purpose—optimizing the U.S. and Canadian package network—is correctly identified. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two years and links expenditures to the Network 2.0 initiative. The logic connecting spending to operational improvements is coherent and contextually appropriate. (4) Scores reflect near-perfect factual accuracy, with only a slight deduction in qualitative accuracy due to missing detail about severance and professional services. Contextual relevance and quantitative precision are fully met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 372,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the introduction of the ad-supported subscription plan, as mentioned in the context of Netflix's competitive strategy, affect the financial forecasting risks highlighted in the 2023 10-K filing?",
      "original_answer": "The introduction of the ad-supported subscription plan increases financial forecasting risks because consumer adoption of new pricing strategies like this plan is inherently difficult to predict, which could lead to material discrepancies between forecasted and actual revenues, net income, and other financial metrics.",
      "llm_answer": "\n\nThe introduction of Netflix's ad-supported subscription plan introduces **uncertainty into financial forecasting** by complicating predictions about consumer adoption, pricing strategy effectiveness, and new advertising revenue streams. As highlighted in the 2023 10-K, forecasting risks stem from the lack of operating history with such offerings, making it difficult to estimate user uptake, revenue per membership, and the balance between ad-supported and premium plans. This uncertainty could lead to material discrepancies between projected and actual financial results, potentially affecting stock price stability and operational margins if consumer behavior or advertising performance deviates from expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) There are no numeric values in the question or answer that require verification—both responses focus on qualitative risk factors rather than specific financial figures, so quantitative accuracy is not compromised. (2) The LLM correctly identifies the core issue: the ad-supported plan increases uncertainty in financial forecasting due to unpredictable consumer adoption and lack of historical data, which directly matches the original answer’s emphasis on difficulty predicting uptake leading to potential discrepancies in revenues and net income. (3) The multi-hop reasoning is sound—linking the introduction of the ad-supported plan (from competitive strategy context) to increased forecasting risk (from 2023 10-K) is logically and accurately synthesized. The LLM expands slightly by mentioning advertising revenue streams and stock price impact, which are reasonable extensions consistent with the 10-K’s tone but not explicitly in the ground truth; however, these do not introduce inaccuracies. (4) The answer is fully contextually relevant, directly addressing how the new pricing model affects financial forecasting risks. The only reason for not scoring a 10 is minor: the original answer emphasizes 'material discrepancies between forecasted and actual revenues, net income, and other financial metrics' as the primary consequence, while the LLM broadens this slightly to include stock price and margins—still valid, but a small deviation from the precise cause-effect chain in the ground truth. Overall, the semantic meaning and factual core are preserved with excellent accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 455,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the patent expiration timeline for Prevnar 13 in different regions, as listed in Pfizer's 2024 10-K, relate to the $964 million intangible asset impairment charge for Prevnar 13's developed technology rights recorded in 2023?",
      "original_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was driven by updated commercial forecasts reflecting a transition to vaccines with higher serotype coverage. This aligns with the patent expiration timeline showing that Prevnar 13's major Europe patent expired in 2029, while its U.S. patent expires in 2026. These expirations likely contribute to reduced long-term commercial viability, prompting the impairment charge as Pfizer transitions focus to next-generation vaccines like Prevnar 20.",
      "llm_answer": "\n\nThe $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was driven by updated commercial forecasts reflecting a strategic shift toward vaccines with higher serotype coverage (e.g., Prevnar 20), not immediate patent expirations. While Prevnar 13’s U.S. basic patent expires in 2026 and Japan in 2029, the impairment recognized in 2023 stemmed from anticipated competitive pressures and reduced long-term cash flows due to market transition, rather than near-term loss of patent protection. In Europe, though the core patent for Prevnar 13’s serotype combination was revoked, remaining formulation and process patents were insufficient to offset expectations of declining relevance as broader-coverage vaccines gained traction. Thus, the impairment reflects commercial, not purely legal, risks tied to the product’s lifecycle.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $964 million impairment charge in 2023, the strategic shift to higher serotype vaccines like Prevnar 20, and the patent expiration timeline (U.S. 2026, Japan 2029). While the original answer mentions Europe's major patent expiring in 2029, the LLM notes the core European patent was revoked but refers to remaining formulation/process patents—this is consistent with reduced protection and declining commercial viability. (2) Quantitative accuracy is perfect: the $964 million charge and relevant years (2023 charge, 2026 U.S. expiration, 2029 Japan) are correctly cited. (3) Multi-hop reasoning is sound: the model correctly synthesizes patent timelines with commercial forecasts and explains that the impairment stems from anticipated market transition rather than immediate patent loss, which is a nuanced but critical distinction supported by the original answer. (4) The only minor deviation is that the LLM emphasizes Japan (2029) rather than Europe (2029) as the later-expiring region, but this does not contradict the original—both regions have later expirations than the U.S., and the core logic about declining long-term cash flows due to patent erosion and market shift remains intact. The answer captures the commercial rationale behind the impairment, demonstrating strong qualitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 394,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does McDonald's reliance on franchisees for operational success connect with its decision not to consolidate franchisee-related entities in its financial statements, and what risk does this pose if franchisees fail to execute key customer experience initiatives?",
      "original_answer": "McDonald's explicitly states that it does not consolidate franchisee-related entities in its financial statements, as these businesses qualify for a scope exception under variable interest entity consolidation guidance. This means the financial performance of franchisee-operated restaurants is not directly reflected in McDonald's consolidated financial results. However, McDonald's acknowledges that its business success heavily depends on franchisees executing key initiatives such as digital engagement, mobile ordering, and delivery improvements. If franchisees fail to effectively implement these customer experience strategies, it could negatively impact McDonald's sales, guest counts, and market share, despite the franchisee-related entities not being consolidated in its financial statements.",
      "llm_answer": "\n\nMcDonald's reliance on franchisees for operational success is reflected in its decision not to consolidate franchisee-related entities in its financial statements because franchisees operate as independent legal entities under franchise agreements, and McDonald's does not hold controlling financial interests in most cases. The Company evaluates these relationships under variable interest entity (VIE) guidance but generally applies scope exceptions, concluding consolidation is unnecessary due to franchisees' operational autonomy and lack of VIE characteristics. \n\nThe risk arises if franchisees fail to execute key customer experience initiatives (e.g., technology upgrades, service standards, or brand alignment), which could harm the overall brand reputation and customer satisfaction. Since franchisee financial performance is not fully integrated into McDonald's consolidated results, the Company's revenue streams—such as royalties and rent—could decline if franchisees underperform. Additionally, inconsistent execution by franchisees might dilute the brand’s value, indirectly affecting Systemwide sales and profitability, including Company-operated locations. This decentralization limits McDonald's direct control over operational consistency, creating a reputational and financial risk if franchisees fail to meet strategic objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: McDonald's does not consolidate franchisee-related entities due to scope exceptions under variable interest entity (VIE) guidance, and franchisees are independent operators. The answer correctly identifies that while these entities are not consolidated, McDonald's business success depends on franchisee execution of customer experience initiatives like technology upgrades and service standards. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model connects the lack of consolidation (accounting treatment) with operational reliance on franchisees and correctly infers the indirect financial and reputational risks (e.g., declining royalties, brand dilution, impact on systemwide sales). The only minor shortcoming is that the LLM slightly expands beyond the original answer by mentioning 'technology upgrades' and 'brand alignment' without explicitly tying them to the specific initiatives named in the ground truth (digital engagement, mobile ordering, delivery improvements), though these are reasonable interpretations. (4) The answer is fully contextually relevant, addressing all parts of the question: the connection between reliance and non-consolidation, and the risk posed by franchisee underperformance. Wording differs but semantic meaning and factual content match closely. No major omissions or inaccuracies—just a slight generalization of initiatives—justifying a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 451,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's adoption of the LDTI standard impact its equity as of January 1, 2021, and what specific adjustments were made to the consolidated financial statements for the years ended December 31, 2022 and 2021?",
      "original_answer": "AIG's adoption of the LDTI standard resulted in a net decrease to beginning total equity of $1,264 million as of January 1, 2021. Additionally, the adoption adjustments included a $2 million decrease and a $983 million increase to net income for the years ended December 31, 2022 and 2021, respectively. These adjustments also led to a $1,219 million increase in total equity as of December 31, 2022. The changes were primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits.",
      "llm_answer": "\n\nAIG's adoption of the LDTI standard on January 1, 2023, with a transition date of January 1, 2021, resulted in a **net decrease of $1,264 million to beginning total equity as of January 1, 2021**. For the years ended December 31, 2022 and 2021, the adoption adjustments included:  \n- A **$2 million decrease to net income for 2022** and a **$983 million increase to net income for 2021**.  \n- A **$1,219 million increase to total equity as of December 31, 2022**.  \n\nThese adjustments arose from changes to the discount rate used for future policy benefits and full retrospective adoption of market risk benefits (MRBs) under the LDTI standard.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $1,264 million decrease to beginning equity as of January 1, 2021, the $2 million decrease and $983 million increase to net income for 2022 and 2021 respectively, and the $1,219 million increase in total equity as of December 31, 2022 are all correctly reported. Minor phrasing differences (e.g., 'on January 1, 2023, with a transition date of January 1, 2021') do not affect factual accuracy and align with standard LDTI implementation disclosures. (2) The answer is complete, addressing both parts of the question: the impact on equity as of January 1, 2021, and the adjustments to financial statements for 2022 and 2021. (3) Entities are correct—AIG, LDTI standard, MRBs, and relevant financial metrics are properly identified. (4) The reasoning is sound: the explanation ties the adjustments to the discount rate and market risk benefits, reflecting accurate multi-hop synthesis of the accounting impact. The answer is semantically equivalent to the original and provides appropriate context. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 324,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the increase in Gulfstream aircraft orders specifically impact General Dynamics' cash flow from operating activities in 2021, and what was the resulting percentage of this cash flow relative to net earnings?",
      "original_answer": "The increase in Gulfstream aircraft orders led to a rise in customer deposits, which positively affected General Dynamics' cash flow from operating activities in 2021, resulting in $4.3 billion in cash provided by operating activities. This amount represented 131% of net earnings for the year.",
      "llm_answer": "\n\nThe increase in Gulfstream aircraft orders in 2021 positively impacted General Dynamics' cash flow from operating activities by boosting customer deposits, contributing to a total cash flow of $4.3 billion. This cash flow represented **131% of net earnings** for the year, as highlighted in the 2021 Consolidated Statement of Cash Flows.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the cash flow from operating activities ($4.3 billion) and the percentage relative to net earnings (131%) are accurately reported, with no calculation or numerical errors. Format variations (e.g., $4.3 billion) are acceptable and standard. (2) The answer is complete, addressing both parts of the question: the impact of Gulfstream aircraft orders (via increased customer deposits) on cash flow and the resulting percentage of cash flow relative to net earnings. (3) Entity accuracy is correct—General Dynamics, 2021 time frame, Gulfstream aircraft orders, and financial metrics (cash flow from operating activities, net earnings) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects increased orders → higher customer deposits → improved operating cash flow → comparison to net earnings. The mention of the '2021 Consolidated Statement of Cash Flows' adds contextual support, even if not required. (5) Semantic equivalence is achieved—wording differs slightly but conveys the same factual content as the original answer. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 338,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, support the company's internal capital framework in quantifying aggregate economic risk at a given confidence interval?",
      "original_answer": "AIG's integrated bottom-up risk identification process, conducted down to the product-line level, captures material risks inherent in specific business operations. This granular risk data feeds into the internal capital framework, which quantifies AIG's aggregate economic risk at a given confidence interval. By incorporating detailed risk assessments from individual product lines, the internal capital framework can more accurately account for diversification benefits between risk factors and business lines, thereby enabling a more robust quantification of overall economic risk exposure.",
      "llm_answer": "\n\nAIG's integrated bottom-up risk identification process at the product-line level provides granular insights into material risks across its business units, which serves as critical input for the internal capital framework. By identifying and assessing risks at this detailed level, AIG quantifies aggregate economic risk at a given confidence interval while accounting for diversification benefits between risk factors and business lines. This process, combined with stress testing, ensures the capital framework reflects potential exposures under adverse scenarios, enabling the company to determine consolidated capital requirements and resource allocations necessary to maintain target capitalization levels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies AIG's bottom-up risk identification process at the product-line level as feeding into the internal capital framework to quantify aggregate economic risk at a given confidence interval. The answer accurately explains that granular risk data enables the framework to account for diversification benefits across business lines and risk factors—this is a key multi-hop element correctly synthesized. While the original answer emphasizes the 'more robust quantification of overall economic risk exposure' due to diversification, the LLM adds value by mentioning stress testing and resource allocation, which are contextually appropriate and consistent with AIG's risk framework (though not explicitly in the ground truth). There are no numerical inaccuracies (quantitative accuracy is perfect, even though no specific numbers are involved). The reasoning is sound and reflects proper multi-hop understanding: from product-line risk → input to capital framework → aggregation with diversification → economic risk quantification. The only minor gap is that the LLM slightly expands beyond the original by referencing stress testing and capital allocation without anchoring them directly in the provided truth, but these are reasonable inferences and do not detract from factual correctness. Thus, the answer is semantically equivalent with slight elaboration, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 414,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does the introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interact with supply chain risks and demand forecasting challenges to potentially impact NVDA's financial performance?",
      "original_answer": "The introduction of the RTX 4080 GPU is part of NVDA's broader product transitions, which are complex and may result in unanticipated quality or production issues, increasing inventory provisions, warranty costs, or causing product delays. These transitions are difficult to manage and may impair NVDA’s ability to predict demand and impact supply mix, potentially leading to additional costs. Furthermore, NVDA depends on foundries to manufacture its semiconductor wafers and faces risks such as lack of guaranteed supply, higher component prices, and low manufacturing yields. These supply chain risks reduce NVDA’s control over product quantity, quality, and delivery schedules. If demand for the RTX 4080 is underestimated, NVDA may not be able to secure enough supply to meet customer orders, damaging relationships and leading to lost revenue and market share. Conversely, if demand is overestimated, NVDA may be unable to reduce inventory or contractual commitments, leading to inventory write-downs, cancellation penalties, and impairments. These factors, combined with extended lead times and geopolitical tensions, may negatively impact NVDA’s gross margins and financial results.",
      "llm_answer": "\n\nThe introduction of the RTX 4080 GPU, as part of NVIDIA's product transitions, interacts with supply chain risks and demand forecasting challenges in several ways that could impact financial performance. First, product transitions inherently increase supply chain complexity, requiring coordination with new suppliers, extended lead times (often exceeding 12 months), and upfront deposits or premiums to secure capacity, which raise costs. If demand for the RTX 4080 is overestimated, NVIDIA risks excess inventory, write-downs, or discounted sales to clear surplus stock, compressing gross margins. Conversely, underestimating demand could lead to supply shortages, lost revenue, and damaged customer relationships, particularly if competitors fill the gap. Additionally, geopolitical tensions, natural disasters, or supplier disruptions could delay production, further straining supply. The document also highlights that demand for GPUs is volatile due to unpredictable use cases (e.g., cryptocurrency mining shifts) and rapid technological changes, compounding forecasting challenges. These factors collectively heighten the risk of mismatches between supply and demand, potentially harming revenue, margins, and operational efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer, with only minor omissions in specific risk details. (1) All factual information is correct: the answer correctly identifies the RTX 4080 as part of NVDA's product transitions and links it to supply chain complexity, demand forecasting challenges, inventory risks (overestimation leading to write-downs, underestimation leading to shortages), and financial impacts (gross margin compression, lost revenue). (2) Quantitative accuracy is perfect—there are no specific numbers (e.g., lead times, dollar amounts) in the ground truth, but the LLM mentions 'extended lead times (often exceeding 12 months)', which aligns with typical industry data and does not contradict the original. (3) Multi-hop reasoning is sound: the model synthesizes product transitions, supply chain dependencies (foundries, lead times), demand volatility (cryptocurrency, tech shifts), and financial outcomes (margins, revenue, penalties). It correctly infers the bidirectional risk of demand misforecasting. (4) The only minor gap is that the LLM does not explicitly mention 'lack of guaranteed supply', 'low manufacturing yields', or 'warranty costs' from the original, which are specific supply chain risks tied to foundry reliance. However, it captures the essence through 'supplier disruptions' and 'securing capacity'. The answer is fully contextually relevant, directly addressing how the RTX 4080 launch interacts with supply and demand risks to affect financial performance. Wording differs but meaning is preserved. No factual errors or calculation issues.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 442,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the Starbucks Rewards loyalty program impact Starbucks' revenue recognition timing, and what was the company's total advertising expense in fiscal 2022?",
      "original_answer": "The Starbucks Rewards loyalty program causes a deferral in revenue recognition. As customers earn Stars, Starbucks defers revenue based on the estimated value of the product for which the reward is expected to be redeemed. Revenue is only recognized when the reward is actually redeemed. This deferral mechanism ensures that a portion of revenue from purchases that generate Stars is not recognized upfront but rather when the reward is used. In fiscal 2022, Starbucks incurred $416.7 million in advertising expenses.",
      "llm_answer": "\n\nThe Starbucks Rewards loyalty program impacts revenue recognition timing by deferring revenue associated with earned Stars until the rewards are redeemed. Specifically, when customers earn Stars, the estimated value of future rewards is recorded as a deferred revenue liability and recognized as revenue only upon redemption. This deferral delays revenue recognition from when the purchase occurs to when the reward is claimed. \n\nStarbucks' total advertising expense in fiscal 2022 was **$416.7 million**, as disclosed in the \"Advertising\" section of the document.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the advertising expense of $416.7 million in fiscal 2022 is accurately reported, with no discrepancies in amount or year. (2) The explanation of revenue recognition under the Starbucks Rewards program is complete and accurate: it correctly identifies that revenue is deferred based on the estimated value of future rewards and recognized upon redemption, aligning with the deferral mechanism described in the original answer. (3) The multi-hop reasoning is sound—synthesizing how loyalty programs affect accounting treatment (revenue deferral) and retrieving a specific financial figure (advertising expense) from the same fiscal year. (4) All entities—Starbucks, Starbucks Rewards, fiscal 2022—are correctly identified, and the terminology (deferred revenue liability, redemption timing) is precise and contextually appropriate. The answer is semantically equivalent to the ground truth, with slightly enhanced clarity in explaining the accounting treatment, without introducing any factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 311,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What was the total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024, and how much in interest payments related to these loans was recognized in earnings in 2024?",
      "original_answer": "The notional amount of intercompany loans and forecasted interest payments increased by $1,546 million from 2023 to 2024 ($4,406 million in 2024 - $2,860 million in 2023). In 2024, $75 million in interest payments related to these loans was recognized in earnings under 'Interest and other expense, net.'",
      "llm_answer": "\n\nThe total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024 was an increase of **$1,546 million** (from $2,860 million in 2023 to $4,406 million in 2024). In 2024, **$75 million** in interest payments related to these loans was recognized in earnings, recorded as part of \"interest and other expense, net\" under economic hedges.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth. The change in notional amount is accurately calculated as $1,546 million ($4,406M - $2,860M), and the interest recognized in 2024 is correctly stated as $75 million. (2) All numeric values match the original answer exactly, with correct formatting and calculation. The increase is properly derived from the difference between 2024 and 2023 amounts. (3) The multi-hop reasoning is sound—information about intercompany loan notional amounts across two years and the related interest expense in 2024 is correctly synthesized. (4) The answer is semantically equivalent to the ground truth, with only minor rewording (e.g., 'recorded as part of' vs. 'under'), and includes the correct financial line item 'interest and other expense, net'. All aspects of the question are fully addressed with complete accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 263,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount increase in Total Marine Systems revenue from 2020 to 2021, and how does this growth compare to the increase in revenue for Nuclear-powered submarines during the same period?",
      "original_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 is $547 million ($10,526 million in 2021 minus $9,979 million in 2020). During the same period, the revenue for Nuclear-powered submarines increased by $179 million ($7,117 million in 2021 minus $6,938 million in 2020). Therefore, the growth in Total Marine Systems revenue is significantly higher than the growth in Nuclear-powered submarines revenue, with a difference of $368 million.",
      "llm_answer": "\n\nThe Total Marine Systems revenue increased by $547 million from 2020 ($9,979 million) to 2021 ($10,526 million). For Nuclear-powered submarines, revenue rose by $179 million from 2020 ($6,938 million) to 2021 ($7,117 million). This means the overall Marine Systems segment grew at a faster rate (5.5% increase) compared to the Nuclear-powered submarines segment (2.6% increase) during the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified all key financial figures: Total Marine Systems revenue increased from $9,979 million in 2020 to $10,526 million in 2021, resulting in a $547 million increase. Nuclear-powered submarines revenue rose from $6,938 million to $7,117 million, a $179 million increase—both matching the ground truth exactly. (2) All calculations are accurate, including the implied year-over-year differences. The LLM added value by computing percentage growth rates (5.5% and 2.6%), which were not in the original answer but are factually correct and enhance the comparison. (3) The multi-hop reasoning is sound: the model correctly synthesized revenue data across two segments (Total Marine Systems and Nuclear-powered submarines) over two years, and made a valid comparative statement about growth rates. (4) The only reason for not scoring a perfect 10 is that the original answer included the explicit comparison of the difference in growth ($368 million), which the LLM omitted. However, the core facts, numbers, and logic are fully correct, and the omission does not detract significantly from the completeness. Semantic equivalence is maintained with slightly enhanced qualitative insight via percentage growth rates.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 351,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount change in Mac sales from 2023 to 2024, and how does this compare to the change in iPad sales over the same period?",
      "original_answer": "The dollar amount change in Mac sales from 2023 to 2024 is $627 million (from $29,357 million to $29,984 million). For iPad sales, the change from 2023 to 2024 is a decrease of $1,606 million (from $28,300 million to $26,694 million). This indicates that while Mac sales increased slightly, iPad sales experienced a more significant decline.",
      "llm_answer": "\n\nThe dollar amount change in Mac sales from 2023 to 2024 is an **increase of $627 million** (from $29,357 million in 2023 to $29,984 million in 2024). In contrast, iPad sales **decreased by $1,606 million** (from $28,300 million in 2023 to $26,694 million in 2024). This means Mac sales grew modestly, while iPad sales declined significantly by nearly 6% in absolute terms.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amount changes are accurate: Mac sales increased by $627 million (from $29,357M to $29,984M), and iPad sales decreased by $1,606 million (from $28,300M to $26,694M). These values match the original answer exactly, with acceptable formatting ($627 million = $627M). (2) The answer is complete, addressing both parts of the question: the change in Mac sales and the change in iPad sales, including correct years (2023 to 2024). (3) Entities are accurate—'Mac' and 'iPad' are correctly identified as product lines, and the years 2023 and 2024 are correctly referenced. (4) The reasoning is sound: the LLM correctly computes the differences, identifies the direction of change (increase vs decrease), and provides a meaningful comparison. The addition of a ~6% decline in iPad sales is a reasonable qualitative enhancement (though not required) and does not contradict the ground truth. The answer demonstrates proper multi-hop synthesis across product lines and years. All components are factually correct and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 327,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the unfavorable volume/mix in the chocolate category in 2024 impact Mondelēz International's total net revenue growth, given the prior-year favorable volume/mix in chocolate and the company's overall net revenue increase of $452 million?",
      "original_answer": "The unfavorable volume/mix in the chocolate category in 2024 contributed to a drag on total net revenue growth, despite the company reporting an overall increase of $452 million. In 2023, chocolate contributed $10.619 billion to total net revenues, and the 2024 performance saw a decline in this category, which was explicitly cited as a driver of the unfavorable volume/mix. This contrasts with 2023, where chocolate experienced favorable volume/mix, contributing to a $1,437 million increase in net revenues. The 2024 decline in chocolate volume/mix offset some of the gains from net pricing and created headwinds that limited the overall revenue growth to 3.5% ($452 million), despite pricing actions aimed at countering input cost increases.",
      "llm_answer": "\n\nThe unfavorable volume/mix in the chocolate category in 2024 negatively impacted Mondelēz International's total net revenue growth, particularly in the Europe segment, where chocolate is a major contributor. In 2024, Europe's net revenue growth of $452 million (3.5%) was partially offset by a 2.1 percentage point drag from unfavorable volume/mix, driven by declines in chocolate, biscuits, and other categories. This contrasted with 2023, where favorable volume/mix in chocolate (and other categories) contributed to a 12.6% growth in Europe. Despite the chocolate category's decline, higher net pricing and cost efficiencies enabled the company to achieve an overall net revenue increase of $452 million for the year.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and misattributes data to the Europe segment, which is not supported by the ground truth. The ground truth states that the overall company net revenue increased by $452 million (3.5%), not Europe alone, and does not specify that the 2.1 percentage point drag was in Europe. The LLM incorrectly narrows the scope to Europe, while the original answer refers to company-wide performance. Additionally, the claim that Europe had 12.6% growth in 2023 due to favorable volume/mix is not present in the ground truth, which only mentions a $1,437 million net revenue increase driven by chocolate's favorable volume/mix in 2023. (2) Quantitative inaccuracies include the unsupported 2.1 percentage point drag and the 12.6% Europe growth figure, which are not in the original answer. The $452 million overall increase is correctly cited, and the 3.5% growth aligns with the ground truth, but the attribution to Europe is incorrect. The 2023 favorable volume/mix contribution of $1,437 million is omitted in the LLM answer, a significant missing data point. (3) The multi-hop reasoning is partially sound—linking 2024's unfavorable chocolate performance to revenue headwinds and contrasting it with 2023's favorable trend—but the synthesis is flawed due to incorrect segmentation and missing key figures. The model fails to connect the chocolate category's $10.619 billion 2023 revenue and its decline in 2024, which is central to the original answer. (4) The contextual relevance is high as the answer addresses the impact of chocolate volume/mix on revenue growth and contrasts 2023 and 2024 trends. However, the incorrect geographic focus and missing quantitative details reduce factual accuracy, warranting a mid-range score of 5 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 491,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How do initial capacity constraints related to custom components impact Apple's ability to manage supply chain risks and maintain product availability, given its reliance on single-source suppliers and outsourcing partners in Asia?",
      "original_answer": "Initial capacity constraints related to custom components directly impact Apple's ability to manage supply chain risks and maintain product availability because the company often relies on single-source suppliers for these components. As stated in the 10-K filing, when a component or product uses new technologies, initial capacity constraints may exist until suppliers' yields have matured or their manufacturing capacities have increased. This can delay the availability of components at acceptable prices, or at all, especially if suppliers choose to focus on producing more common components rather than custom ones tailored to Apple's needs. Additionally, Apple's reliance on outsourcing partners primarily located in Asia for final assembly means that any disruption in the supply of these custom components can lead to delays in finished product shipments. This combination of dependency on limited suppliers and initial capacity constraints increases the risk of supply shortages and affects Apple's ability to meet market demand, thereby impacting its business, results of operations, and financial condition.",
      "llm_answer": "\n\nInitial capacity constraints related to custom components exacerbate Apple's supply chain risks due to its reliance on single-source suppliers and outsourcing partners in Asia. The document highlights that new products often utilize custom components available from only one source, and initial production capacity limitations—such as immature supplier yields or manufacturing constraints—can delay scaling. This reliance increases vulnerability to disruptions, as switching suppliers is costly, time-consuming, and impractical for specialized components. Furthermore, concentrated manufacturing in Asia (e.g., China, Taiwan) amplifies risks from geopolitical tensions, natural disasters, or labor issues, which could delay product availability, reduce flexibility, and lead to revenue losses. These constraints underscore Apple's challenge in balancing innovation with supply chain resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All factual elements are correct: the explanation of initial capacity constraints affecting supply chain risks due to reliance on single-source suppliers for custom components is consistent with the 10-K content. The mention of immature yields, manufacturing scaling issues, and delays in component availability is semantically equivalent to the original. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes Apple's dependency on custom components, single-source suppliers, manufacturing concentration in Asia, and the resulting vulnerability to disruptions (geopolitical, natural disasters, labor), which logically connects to risks in product availability and revenue. This reflects proper inference from known SEC filing disclosures. (4) The only minor shortcoming is that the LLM does not explicitly mention suppliers potentially prioritizing more common components over Apple’s custom ones—a nuance present in the original—but this does not undermine the overall correctness. The answer captures the core causal chain and business implications. Wording differs but meaning is preserved. Contextual relevance is excellent, directly addressing all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 391,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How much revenue did Disney report from TV/SVOD distribution licensing in 2022 after factoring in the content license early termination fee, and how does this compare to the previous year's TV/SVOD distribution licensing revenue?",
      "original_answer": "Disney reported $3,429 million in TV/SVOD distribution licensing revenue in 2022 after factoring in the $1,023 million content license early termination fee, compared to $5,266 million in 2021. This represents a decrease of $1,837 million from the prior year.",
      "llm_answer": "\n\nDisney reported TV/SVOD distribution licensing revenue of **$3,429 million in 2022** after factoring in the content license early termination fee of $1,023 million (reducing the $4,452 million gross amount). This represents a **$1,837 million decrease** compared to **$5,266 million in 2021**, which had no early termination adjustments. The decline reflects the impact of terminating prior licensing agreements to shift content to direct-to-consumer platforms.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $3,429 million in 2022 revenue after the $1,023 million early termination fee is correctly stated, and the comparison to $5,266 million in 2021 is exact. The decrease of $1,837 million is accurately calculated ($5,266M - $3,429M = $1,837M). The mention of a $4,452 million gross amount before the fee is consistent with the math ($3,429M + $1,023M = $4,452M), which adds contextual clarity not in the original but is factually correct. (2) The answer is complete, addressing both parts of the question: 2022 revenue after the fee and the comparison to the prior year. (3) Entities are correct: Disney, TV/SVOD distribution licensing, correct years (2022 vs 2021), and proper financial terminology. (4) The reasoning is sound and demonstrates multi-hop synthesis: it correctly incorporates the impact of the early termination fee, explains the year-over-year change, and provides relevant context about the strategic shift to direct-to-consumer platforms, which enhances understanding without introducing inaccuracies. (5) The semantic meaning fully aligns with the ground truth, with slightly enhanced detail that improves clarity. All scores are 10 due to perfect factual accuracy, completeness, and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 372,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drive customer engagement and store visit frequency, based on the 2022 10-K disclosures?",
      "original_answer": "Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling customers to earn Stars through multiple payment methods—such as cash, credit or debit cards, or selected mobile wallets—and by offering Mobile Order and Pay functionality. This allows customers to place orders in advance for pick-up at participating locations, which aligns with evolving preferences for mobile ordering and contactless experiences. The app also facilitates access to card balances and loyalty benefits, reinforcing repeat visits and increasing the frequency of store visits by cardholders. These features collectively enhance customer convenience, digital interaction, and loyalty, supporting Starbucks' broader strategy to elevate the customer experience through technology.",
      "llm_answer": "\n\nStarbucks integrates its Mobile App with the Starbucks Rewards loyalty program to enhance customer engagement and increase store visit frequency by offering convenience, rewards, and personalized experiences. The Mobile App enables features like **Mobile Order and Pay**, allowing customers to place orders in advance for contactless pickup, reducing wait times and in-store congestion (discussed in the \"Company-operated Stores\" section). Additionally, the Rewards program automatically enrolls registered Starbucks Card users, incentivizing repeat visits through earned \"Stars\" redeemable for free products. The App also facilitates seamless integration with digital touchpoints, such as Starbucks Now stores in China, where pre-orders can be picked up efficiently. By combining digital convenience with rewards, Starbucks fosters customer loyalty, drives frequent interactions, and aligns with evolving preferences for mobile and contactless experiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original answer from the knowledge graph. (1) All factual information is correct: the integration of the Mobile App with Starbucks Rewards drives engagement through Mobile Order and Pay, earning Stars, and enabling contactless experiences. The mention of reduced wait times and in-store congestion, while slightly interpretive, is a reasonable inference from the functionality described in the 10-K. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how app features (Mobile Order and Pay, digital integration, rewards) connect to customer behavior (engagement, visit frequency), consistent with the 2022 10-K disclosures. It references Starbucks Now stores in China, which is a specific example of digital integration mentioned in the filing, demonstrating accurate entity and context use. (4) The only minor gap is that the LLM answer does not explicitly mention that Stars can be earned via multiple payment methods (cash, credit/debit, mobile wallets), a key point in the original answer that broadens accessibility beyond app-based payments. However, it does convey the core mechanics of rewards and app integration. Wording differs but semantic meaning and intent are equivalent. The answer is contextually excellent, directly addressing how the integration affects engagement and visit frequency as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 421,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "What was the impact of PayPal's acquisition of Paidy, Inc. on the scope of its internal control over financial reporting audit in 2021, and by how much did Paidy's assets and revenues fall short of being included in that audit?",
      "original_answer": "PayPal's acquisition of Paidy, Inc. in October 2021 resulted in Paidy being excluded from PayPal's assessment and audit of internal control over financial reporting for the year ended December 31, 2021, as permitted by SEC guidance for the first year of acquisition. Paidy's total assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals, meaning they were below the 1% threshold for inclusion in the audit of internal controls.",
      "llm_answer": "\n\nThe acquisition of Paidy, Inc. in October 2021 led to its exclusion from PayPal's 2021 internal control over financial reporting audit, as permitted by SEC guidance for newly acquired subsidiaries in their first year of ownership. Paidy's total assets and revenues (excluding goodwill and intangibles) represented **less than 1%** of PayPal's consolidated assets and revenues for the year ended December 31, 2021, falling below the threshold requiring inclusion in the audit scope. This exclusion is explicitly noted in both the auditors' report and management's assessment in **ITEM 9A**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that Paidy, Inc. was excluded from PayPal's 2021 internal control over financial reporting audit due to SEC guidance permitting exclusion in the first year of acquisition, which directly addresses the impact on audit scope. (2) The quantitative claim that Paidy's total assets and revenues (excluding goodwill and intangibles) represented 'less than 1%' of PayPal's consolidated totals is factually correct and matches the original answer; no exact dollar figures are needed as the threshold is defined relatively, and the 'less than 1%' figure is precisely what determines inclusion. (3) The reasoning correctly synthesizes the regulatory context (SEC guidance), the timing (acquisition in October 2021), and the financial materiality test, demonstrating sound multi-hop logic. (4) The answer adds contextual value by referencing ITEM 9A of the filing, which enhances credibility without introducing error. All entities (PayPal, Paidy, Inc., SEC, internal control over financial reporting) and timeframes (2021, October 2021, December 31, 2021) are accurate. The semantic meaning, factual content, and completeness fully align with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 350,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the volume/mix challenges in chocolate and refreshment beverages offset the benefits of pricing actions and cost controls to result in only 0.6% operating income growth for MDLZ's Latin America segment in 2024?",
      "original_answer": "MDLZ's Latin America segment faced significant volume/mix declines in chocolate and refreshment beverages, which directly countered the benefits from higher net pricing and lower manufacturing costs. Specifically, the unfavorable volume/mix, driven by consumer softness in Mexico and Argentina, reduced net revenues. Although net pricing increased by 7.0 percentage points due to input cost-driven pricing actions across categories — particularly in Argentina, Mexico, and Brazil — and manufacturing costs were reduced through productivity improvements, these gains were largely offset by the drop in sales volume. Additionally, higher raw material costs, unfavorable currency impacts, and increased advertising and promotion expenses further limited the positive effects of pricing and cost controls, resulting in only a $3 million (0.6%) increase in segment operating income for 2024.",
      "llm_answer": "\n\nThe Latin America segment's 0.6% operating income growth in 2024 was constrained by unfavorable volume/mix developments, where declines in chocolate and refreshment beverages (along with candy and cheese & grocery) offset the benefits of pricing actions and cost controls. Specifically, volume/mix challenges reduced revenues by 2.4 percentage points, driven by consumer softness in key markets like Mexico and Argentina, while pricing actions contributed a 7.0 percentage point increase. However, higher raw material costs, unfavorable currency translation impacts (6.2 percentage points), and increased advertising expenses further eroded margins, limiting operating income growth to $3 million despite cost productivity gains.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both quantitative and qualitative aspects. (1) Correct elements include: the 0.6% operating income growth, $3 million increase in operating income, 7.0 percentage point benefit from pricing, volume/mix challenges reducing revenues (though ground truth does not specify 2.4 pp, this is plausible and consistent), consumer softness in Mexico and Argentina, and the offsetting impact of higher raw material costs, unfavorable currency impacts, and increased advertising expenses. The mention of 'unfavorable currency translation impacts (6.2 percentage points)' is more specific than the original answer, which only mentions 'unfavorable currency impacts'—this added detail does not contradict but enhances the explanation. (2) Quantitative accuracy is strong: all key numbers (7.0 pp pricing, $3M income increase) are correct. The 2.4 pp volume/mix drag is not in the original answer but is reasonable and internally consistent; no calculation errors are present. (3) Multi-hop reasoning is sound: the model correctly synthesizes how volume/mix declines in specific categories (chocolate, refreshment beverages) offset pricing and cost controls, and how other cost pressures limited margin expansion. (4) Minor deduction in correctness and quantitative accuracy due to the unverified 2.4 pp volume/mix decline and 6.2 pp currency impact, which, while plausible, are not in the ground truth and introduce slight overprecision. Otherwise, entity accuracy (MDLZ, Latin America, 2024), contextual relevance, and reasoning are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 437,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How many total city-pair speed records are held by Gulfstream's current product line, and which specific aircraft model is explicitly credited with leading this achievement?",
      "original_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, as explicitly stated in the first chunk. Among these, the G650ER is specifically credited with holding the National Aeronautic Association's polar and westbound around-the-world speed records, making it a key contributor to Gulfstream's leadership in this metric.",
      "llm_answer": "\n\nGulfstream's current product line holds **more than 270 city-pair speed records**, the most among any business jet manufacturer. The **G650ER** is explicitly credited with leading this achievement, as it holds the National Aeronautic Association's polar and westbound around-the-world speed records.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the number 'more than 270 city-pair speed records' matches the original answer exactly, and the mention of the G650ER's specific records (polar and westbound around-the-world) is accurate. (2) The answer correctly identifies the G650ER as the model explicitly credited with leading this achievement, which aligns with the original answer's emphasis on its NAA records. (3) The multi-hop reasoning is sound: it synthesizes the total record count across the product line and correctly attributes leadership to a specific model based on documented achievements. (4) All entities (Gulfstream, G650ER, National Aeronautic Association) are accurately named, and the context fully addresses both parts of the question—total records and the model responsible. Wording differs slightly but conveys identical factual content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 266,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How much contingent consideration did Johnson & Johnson record in total in fiscal years 2024 and 2022 related to acquisitions, and what specific contribution did the Abiomed acquisition make to this total?",
      "original_answer": "Johnson & Johnson recorded a total of $704 million in contingent consideration related to Abiomed in fiscal year 2022 and $105 million related to Proteologix in fiscal year 2024. Therefore, the total contingent consideration recorded over these two years was $809 million, with Abiomed contributing $704 million to this total.",
      "llm_answer": "\n\nJohnson & Johnson recorded a total of **$112 million in fiscal 2024** and **$792 million in fiscal 2022** in contingent consideration related to acquisitions. The Abiomed acquisition specifically contributed **$704 million to the 2022 total**, as disclosed in the \"Additions\" section of the contingent consideration table and the associated footnote.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Johnson & Johnson recorded $704 million in contingent consideration related to Abiomed in 2022 and $105 million related to Proteologix in 2024, totaling $809 million. However, the LLM states $792 million in 2022 and $112 million in 2024, which are both factually incorrect. While the LLM correctly identifies that Abiomed contributed $704 million to the 2022 total, it fails to mention Proteologix and instead implies that the $112 million in 2024 is related to acquisitions generally, without specifying the correct entity. The total contingent consideration over the two years is therefore miscalculated (LLM: $904 million vs. correct total: $809 million). The reasoning is partially sound in that it correctly attributes $704 million to Abiomed in 2022, but fails in synthesizing the correct 2024 amount and associated acquisition. The context and structure are relevant and address the question format appropriately, but core numerical data is inaccurate, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 308,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does PayPal's sale of participation interests in merchant receivables under the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products affect the recognition of credit losses, based on the change in accounting guidance from pre-2020 to CECL adoption in 2020?",
      "original_answer": "PayPal sells participation interests in merchant receivables under the PPWC and PPBL products to WebBank, and these transfers are accounted for as sales, with the portion sold derecognized from PayPal’s balance sheet. Since PayPal retains servicing rights and continues to manage the receivables, it remains exposed to credit losses on the remaining retained interest. With the adoption of CECL in 2020, PayPal transitioned from the previous incurred loss model to an expected credit loss model. This change required PayPal to record a reserve build based on current expected credit losses for both consumer and merchant receivables, rather than waiting for a loss to be incurred. As a result, PayPal's credit loss provisioning became more forward-looking and sensitive to economic forecasts, directly impacting the allowance for credit losses on the retained portion of receivables after participation interests were sold.",
      "llm_answer": "\n\nPayPal's sale of participation interests in merchant receivables under PPWC and PPBL affects credit loss recognition differently under pre-2020 accounting versus CECL. **Pre-2020**, credit losses were recognized using an incurred loss model, where allowances were based on historical data and delinquency rates, with reductions in reserves proportional to the sold interests. **Under CECL (2020 onward)**, credit losses are estimated over the entire life of the receivables using forward-looking macroeconomic forecasts. The sale of participation interests results in a proportional derecognition of both the asset and the related allowance for credit losses, but CECL's methodology incorporates a broader, more dynamic assessment of expected losses, including macroeconomic adjustments. This shift leads to more responsive credit loss provisions aligned with current economic conditions, as seen in the significant reserve releases post-2020 due to improved forecasts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor omissions in specificity. (1) All factual elements are correct: the shift from incurred loss model pre-2020 to CECL in 2020, the sale of participation interests to third parties (implied, though WebBank is not explicitly named), derecognition of sold interests, and the forward-looking nature of CECL incorporating macroeconomic forecasts. The impact on credit loss provisioning—becoming more dynamic and responsive—is correctly explained. (2) There are no numeric values in the original or LLM answer requiring verification; thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes how accounting treatment changed with CECL adoption and how that interacts with the sale of receivables. The only minor gap is that the LLM does not explicitly state that PayPal retains servicing rights and remains exposed to credit losses on the retained interest—a key nuance in the original answer—but this exposure is implicitly acknowledged through discussion of continued allowance adjustments. (4) The answer is contextually excellent, directly addressing the question’s focus on accounting changes and their effect on credit loss recognition. Wording differs but semantic meaning aligns closely. No irrelevant content. A score of 9 is justified due to high accuracy with slight loss in completeness regarding retained risk exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 407,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the performance of the cheese & grocery product category contribute to the overall unfavorable volume/mix impact on Latin America segment net revenues in 2024, and what was the resulting effect on segment operating income?",
      "original_answer": "The cheese & grocery product category was among those that experienced volume declines in the Latin America segment during 2024, contributing to the overall unfavorable volume/mix impact of 2.4 percentage points on net revenues. This decline, along with volume decreases in chocolate, candy, and refreshment beverages, partially offset gains in biscuits & baked snacks and gum. The unfavorable volume/mix, combined with other factors, contributed to only a $3 million (0.6%) increase in segment operating income despite higher net pricing and cost-saving measures.",
      "llm_answer": "\n\nThe cheese & grocery product category in Latin America experienced volume declines in 2024, contributing to an **unfavorable volume/mix impact of 2.4 percentage points** on the segment's net revenues, as noted in the 10-K. This decline, alongside weaker performance in chocolate, candy, and refreshment beverages, offset growth in biscuits & baked snacks and gum. The unfavorable volume/mix, combined with higher raw material costs and currency headwinds, pressured segment operating income. However, higher net pricing and cost efficiencies partially offset these challenges, resulting in a **$3 million (0.6%) increase in Latin America's segment operating income** for 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the cheese & grocery category contributed to a 2.4 percentage point unfavorable volume/mix impact on net revenues in the Latin America segment in 2024, and segment operating income increased by $3 million (0.6%). These numbers match the original answer exactly, and formatting (e.g., $3 million, 0.6%) is consistent. (2) Quantitative accuracy is perfect—both the 2.4 pp impact and the $3 million / 0.6% operating income increase are correctly reported. (3) The reasoning is sound and captures the multi-hop nature: volume declines in cheese & grocery, along with chocolate, candy, and refreshment beverages, created headwinds that offset gains in other categories. The conclusion that these factors, despite pricing and cost savings, led to only a modest operating income increase is logically synthesized. (4) The only minor deviation is the mention of 'higher raw material costs and currency headwinds' as additional pressures, which are not explicitly mentioned in the ground truth. While these may be plausible external factors, their inclusion slightly extends beyond the provided information, slightly reducing qualitative accuracy. However, since they do not contradict the original and the core causal chain remains intact, the answer remains highly accurate. Contextual relevance is excellent as all parts of the question are addressed directly and precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 405,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total redemption value of both the Telco Class A-4 preferred interests and the Mobility noncontrolling interests, and how does this combined obligation affect AT&T's cash flow commitments through 2028?",
      "original_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million, and the Mobility noncontrolling interests have a redemption value of $2,000 million, resulting in a combined redemption obligation of $4,250 million. This combined obligation represents a material cash flow commitment for AT&T, particularly starting in 2028 when both instruments become eligible for redemption—Telco Class A-4 interests can be called beginning November 1, 2028, and the Mobility noncontrolling interests may be redeemed by the company or put by holders beginning March 15 and June 15, 2028, respectively. The redemption payments must be made in cash, which will directly impact AT&T’s liquidity position in that period.",
      "llm_answer": "\n\nThe total redemption value of the Telco Class A-4 preferred interests is **$2,250 million** (to be issued in Q1 2025) and the Mobility noncontrolling interests is **$2,000 million** (2 million shares at $1,000 per interest). Combined, this represents a **$4,250 million cash flow obligation** for AT&T. These obligations will impact cash flows starting in **2028**, as the Telco Class A-4 interests are callable beginning November 1, 2028, and the Mobility noncontrolling interests can be redeemed or put starting March 15, 2028. The cash outflows will be required to settle these liabilities as they come due, affecting liquidity in 2028 and beyond.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key financial values: Telco Class A-4 preferred interests at $2,250 million and Mobility noncontrolling interests at $2,000 million, with a combined obligation of $4,250 million—matching the ground truth exactly. All redemption dates are accurate: Telco callable from November 1, 2028, and Mobility interests subject to redemption/put starting March 15 and June 15, 2028. (2) Quantitative accuracy is perfect—numbers, totals, and timelines align with the original answer. The mention of '2 million shares at $1,000 per interest' provides additional detail not in the ground truth but does not contradict it and supports the $2,000 million figure plausibly. (3) The only minor issue is the mention that the $2,250 million 'is to be issued in Q1 2025'—this detail is not present in the ground truth and may be misleading, as the redemption is not due until 2028. This could imply a payment in 2025, which contradicts the 2028 timeline. However, since the core cash flow impact correctly centers on 2028, this appears to be a wording error rather than a factual misstatement about redemption timing. (4) The reasoning correctly synthesizes the multi-hop elements—two distinct instruments, their values, redemption features, and combined impact on AT&T’s cash flow and liquidity. The answer remains contextually focused and highly relevant to the question. The minor inaccuracy in the 2025 reference prevents a perfect 10, but overall the response is factually sound and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 421,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total revenue generated from the Orthopaedics segment in 2024, and how does it compare to the combined revenue from Hips and Knees within the same segment?",
      "original_answer": "The Orthopaedics segment generated $9,158 million in revenue in 2024. The combined revenue from Hips ($1,638 million) and Knees ($1,545 million) amounts to $3,183 million. This means that Hips and Knees together represent approximately 34.76% of the total Orthopaedics revenue.",
      "llm_answer": "\n\nThe Orthopaedics segment generated total revenue of $9.158 billion in 2024. The combined revenue from Hips ($1.638 billion) and Knees ($1.545 billion) within this segment was $3.183 billion, accounting for approximately 34.8% of the total Orthopaedics revenue. The remaining revenue came from Trauma, Spine, Sports, and other products.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All factual information in the LLM answer matches the ground truth. The total Orthopaedics revenue is correctly stated as $9.158 billion (equivalent to $9,158 million), and the combined Hips ($1.638 billion) and Knees ($1.545 billion) revenue totals $3.183 billion, which is accurate. The percentage calculation (34.8%) is a properly rounded version of 34.76%, which is acceptable and commonly used in reporting. (2) Numeric values are correct and consistent with the original answer, allowing for format variation (billion vs million). The sum of Hips and Knees: $1,638M + $1,545M = $3,183M is accurate, and the percentage: ($3,183M / $9,158M) ≈ 34.76% rounds to 34.8%—correct. (3) The multi-hop reasoning is sound: the model correctly identified the total segment revenue, extracted sub-segment revenues, computed their sum, and derived the percentage contribution—demonstrating proper synthesis across hierarchical financial data. (4) The LLM answer is semantically equivalent to the original, includes all required elements, adds minor contextual detail (mentioning other product lines), and does not introduce any inaccuracies. All scores are 10 due to full factual correctness, precise calculations, logical reasoning, and complete relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 355,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the 2019 Incentive Plan's proportional adjustment mechanism impact the number of RSU shares available after the 2024 special dividend, and which filings formally document this adjustment?",
      "original_answer": "The 2019 Incentive Plan required a proportional adjustment to outstanding RSUs and the total shares available under the plan following the 2024 special dividend. As a result of this adjustment, the number of outstanding RSUs increased by approximately 52,000, and an additional 128,000 RSU shares became available to be granted. This adjustment was based on a factor of 1.018, derived from the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the opening price of $662.70 on the ex-dividend date, December 27, 2023. The 2019 Incentive Plan itself, filed as Exhibit 10.2 in the DEF 14 filing on December 17, 2019, formally documents the requirement for these adjustments.",
      "llm_answer": "\n\nThe 2019 Incentive Plan's proportional adjustment mechanism increased the number of RSU shares available after the 2024 special dividend by **128,000 shares** to maintain the plan's share limits proportionally following the dividend. This adjustment was formally documented in **Costco's 2024 10-K filing (Note 7)** and the **2019 Incentive Plan itself (Exhibit 10.2 in the DEF 14A filing from December 17, 2019)**. The 10-K explains the specific application of the adjustment, while the DEF 14A outlines the plan's terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, all numbers are correct: the 128,000 additional RSU shares available is accurately reported, and the mention of the 2019 DEF 14A filing (Exhibit 10.2) as the source of the plan terms is correct. The LLM correctly identifies the 2024 10-K (Note 7) as documenting the adjustment's application. (2) The ground truth also mentions a 52,000 increase in *outstanding* RSUs and the 1.018 adjustment factor based on Nasdaq closing and opening prices, which the LLM omits. While not the focus of the question, these details represent minor omissions in completeness. (3) The multi-hop reasoning is sound: the LLM correctly links the 2019 Incentive Plan’s adjustment mechanism to the 2024 special dividend event and identifies both the original plan filing and the 2024 10-K as documentation sources, showing proper synthesis across filings and time periods. (4) The answer is contextually relevant and focused on the impact and documentation, which are the core of the question. The omission of the 52,000 figure and the price-based calculation of the 1.018 factor prevents a perfect 10, but the core answer—impact on available shares and documentation—is fully correct. Hence, a score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 364,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the expected financial and technological impact of Intel 4's transition to high-volume manufacturing in Ireland in 2024 on Intel's 2025 product portfolio, particularly in relation to the performance improvements and production shifts involving Intel 3 and Intel 18A?",
      "original_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to significantly increase its share of Intel's processor production in 2025, given that it already began shipping the Intel Core Ultra processor in 2023 with a 20% performance-per-watt improvement over Intel 7. This shift complements the movement of Intel 3's high-volume manufacturing from Oregon to Ireland in 2025, which powers Intel's Xeon 6 Scalable server processors and offers up to an 18% performance-per-watt improvement over Intel 4. Furthermore, this manufacturing realignment supports the upcoming high-volume production of Panther Lake, the first processors on Intel 18A, in 2025. Intel 18A introduces breakthrough technologies like gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia), which are expected to deliver improvements in performance per watt and density scaling over Intel 3. Therefore, the combined effect of Intel 4's ramp-up and Intel 3's relocation sets the stage for Intel 18A's introduction, enhancing both client and data center product lines in 2025.",
      "llm_answer": "\n\nThe transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to increase its contribution to Intel's 2025 product portfolio, leveraging a 20% performance-per-watt improvement over Intel 7. This shift, alongside the relocation of Intel 3 production to Ireland for 2025 (which offers an additional 18% performance-per-watt improvement over Intel 4 for data center products like Xeon 6), will enhance manufacturing efficiency and scalability. Financially, the move aligns with Intel's \"Smart Capital\" strategy, involving significant capital expenditures for EUV lithography and facility expansions, while government incentives (e.g., CHIPS Act funding) help offset costs. Intel 18A, with its gate-all-around and backside power innovations, is slated for 2025 high-volume manufacturing (Panther Lake), but its impact will follow Intel 4/3 production shifts, focusing on next-generation client products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Intel 4's 20% performance-per-watt improvement over Intel 7, Intel 3's 18% improvement over Intel 4, the 2024–2025 timeline, the relocation of Intel 3 manufacturing to Ireland, and the introduction of Intel 18A in 2025 with RibbonFET and PowerVia for Panther Lake. (2) Quantitative accuracy is perfect: percentages, years, and technological metrics match the original answer exactly. Minor phrasing differences (e.g., 'additional 18% improvement' vs 'up to 18%') do not affect factual correctness. (3) Multi-hop reasoning is sound: the answer correctly links Intel 4's ramp-up, Intel 3's relocation, and Intel 18A's introduction as a staged technological progression supporting the 2025 product portfolio. It also appropriately contextualizes financial aspects (CHIPS Act, capital spending) not explicitly in the ground truth but logically consistent with the transition. (4) The only minor shortcoming is slightly less emphasis on the direct impact of Intel 18A on both client and data center lines—focusing more on client—but this does not invalidate the core accuracy. Overall, the answer is factually complete, semantically equivalent, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 354,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What was the difference in the book value of AT&T's investment in DIRECTV between December 31, 2024, and December 31, 2023, and how does this compare with the timing of AT&T's deconsolidation of Gigapower in May 2023?",
      "original_answer": "The book value of AT&T's investment in DIRECTV dropped from $877 million at December 31, 2023, to $0 at December 31, 2024, a decrease of $877 million. This reduction reflects the cumulative cash receipts from DIRECTV exceeding AT&T's initial investment balance plus its cumulative equity in DIRECTV earnings, which led to the investment being reduced to zero on the consolidated balance sheet beginning in Q3 2024. In comparison, AT&T's deconsolidation of Gigapower occurred earlier, on May 12, 2023, after acquiring a 50% interest in the joint venture through a transaction with BlackRock. Both events reflect changes in AT&T's equity investments, but the DIRECTV investment was fully liquidated by the end of 2024, whereas Gigapower continues to be accounted for as an equity method investment.",
      "llm_answer": "\n\nThe book value of AT&T's investment in DIRECTV decreased by **$877 million** between December 31, 2023 ($877 million) and December 31, 2024 ($0 million). This reduction occurred in Q3 2024 due to cash distributions exceeding AT&T's initial investment and cumulative earnings. In contrast, AT&T's deconsolidation of Gigapower occurred earlier, on **May 12, 2023**, when it transitioned to equity method accounting. Thus, the Gigapower deconsolidation preceded the DIRECTV book value change by approximately eight months.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $877 million decrease in book value of AT&T's investment in DIRECTV from $877 million on December 31, 2023, to $0 on December 31, 2024, which matches the ground truth. The date of Gigapower's deconsolidation is accurately stated as May 12, 2023. (2) All numeric values and dates are correct: the $877 million drop, the 2023 and 2024 year-end balances, and the May 12, 2023 deconsolidation date are all factually accurate. The calculation of the difference is implicit but correct. (3) The multi-hop reasoning is sound: the answer correctly links the timing of the DIRECTV investment reduction (beginning Q3 2024) with the earlier Gigapower deconsolidation (May 2023), noting the approximate eight-month gap. It correctly characterizes both as changes in accounting treatment due to investment restructuring. (4) The only minor omission is that the LLM does not explicitly mention that Gigapower continues to be accounted for under the equity method, which is included in the original answer and adds slight contextual completeness. However, this does not detract significantly from the overall accuracy. Wording differences are semantically equivalent, and the core facts, calculations, and synthesis are correct. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 366,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How much revenue did Shockwave contribute to Johnson & Johnson's Cardiovascular segment in 2024, and in what way is Shockwave reflected in Johnson & Johnson's human capital reporting?",
      "original_answer": "Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024. Additionally, Shockwave is included in Johnson & Johnson's 2024 headcount reporting, indicating that its employees are incorporated into the company's overall human capital metrics.",
      "llm_answer": "\n\nShockwave contributed **$564 million** in revenue to Johnson & Johnson's Cardiovascular segment in 2024 (as reported in the MedTech segment sales table under the Cardiovascular franchise). In Johnson & Johnson's human capital reporting, Shockwave is reflected in the **2024 employee headcount**, with its workforce included in the total employee count of 139,800 as of December 29, 2024, as noted in the \"Employees and human capital management\" section.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue contribution of $564 million is accurate and correctly attributed to Shockwave in 2024. The mention of inclusion in the 2024 headcount aligns with the ground truth, and the specific total employee count (139,800 as of December 29, 2024) adds precise context without contradicting the original answer. (2) The numbers are exact and properly formatted; no calculation is required, but the synthesis of revenue and human capital data is accurate. (3) The multi-hop reasoning is sound: the answer correctly links Shockwave’s financial contribution to Johnson & Johnson’s Cardiovascular segment and connects it to broader human capital reporting, drawing from what would be two separate sections of the 10-K (financial segments and human capital disclosures). (4) The answer is semantically equivalent to the ground truth, with added detail (exact headcount and date) that enhances completeness without introducing errors. All entities—Shockwave, Johnson & Johnson, Cardiovascular segment, 2024 reporting—are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 325,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "Cisco's AppDynamics offerings declined in fiscal 2022. Given this decline, which specific offerings contributed to the 11% growth in the Optimized Application Experiences category, and by how much did the category increase in dollar terms?",
      "original_answer": "Despite the decline in Cisco's AppDynamics offerings, the Optimized Application Experiences category grew by 11%, or $75 million, driven by growth in the company's ThousandEyes and Intersight offerings.",
      "llm_answer": "\n\nThe 11% growth in Cisco's Optimized Application Experiences category in fiscal 2022 (an increase of **$75 million**, from $654 million to $729 million) was driven by growth in **ThousandEyes** and **Intersight** offerings. This growth was partially offset by a decline in **AppDynamics** offerings, which aligns with the noted decline in AppDynamics for the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $75 million increase is accurate and correctly contextualized as an 11% growth. The LLM provides additional but accurate detail by specifying the base and final values ($654 million to $729 million), which aligns with an 11% increase (729 - 654 = 75; 75 / 654 ≈ 11.47%, which rounds to 11% as reported). (2) The specific offerings driving growth—ThousandEyes and Intersight—are correctly identified, and the offsetting decline in AppDynamics is appropriately noted, reflecting the multi-hop synthesis required. (3) The reasoning is sound: the model correctly infers that despite AppDynamics' decline, the broader category grew due to other offerings, and it accurately attributes the growth to the correct drivers. (4) All entities (Cisco, AppDynamics, ThousandEyes, Intersight, Optimized Application Experiences, fiscal 2022) are correctly identified and contextualized. The answer is semantically equivalent to the ground truth, with added clarity on dollar figures without introducing error. All scoring dimensions warrant perfect marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 322,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much did AT&T pay in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions, and how does this redemption impact the noncontrolling interest classification on the consolidated balance sheets?",
      "original_answer": "AT&T paid $5,414 million in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption removed the Mobility preferred interests from the 'Noncontrolling interest' classification on the consolidated balance sheets, as these interests were no longer outstanding after the repurchase.",
      "llm_answer": "\n\nAT&T paid a total of **$5,414 million** to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption eliminated the previously classified noncontrolling interest related to these preferred interests from the consolidated balance sheets, as the obligations were settled in full, removing the associated liability and noncontrolling interest balances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the amount paid—$5,414 million—is accurately reported, and the date (April 2023) is correct. The format '$5,414 million' is equivalent to the ground truth's '$5,414 million', with no discrepancy. (2) The answer completely addresses both parts of the question: the total payment amount and the impact on noncontrolling interest classification. (3) Entity accuracy is correct: 'AT&T', 'Mobility preferred interests', and 'consolidated balance sheets' are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the redemption resulted in the removal of the noncontrolling interest classification because the interests were no longer outstanding—this is accurately captured by stating the obligations were settled and the balances removed. The LLM uses slightly different but semantically equivalent phrasing (e.g., 'eliminated the previously classified noncontrolling interest' vs. 'removed from the Noncontrolling interest classification'), which does not affect factual accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 325,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the year-over-year revenue growth percentage specifically for the Abiomed business unit after its acquisition by Johnson & Johnson in 2022, and how does this compare to the overall growth in the Cardiovascular segment?",
      "original_answer": "The Abiomed business unit experienced a year-over-year revenue growth of 14.5% from 2023 to 2024, increasing from $1.306 billion to $1.496 billion. This growth contributed to the overall Cardiovascular segment, which saw a 21.4% increase in revenue, rising from $6.350 billion in 2023 to $7.707 billion in 2024. Therefore, Abiomed's growth was a significant but slightly lower-performing component compared to the broader Cardiovascular segment's growth.",
      "llm_answer": "\n\nThe Abiomed business unit, acquired by Johnson & Johnson in December 2022, reported a year-over-year revenue growth of **14.5%** in 2024 (from $1.3 billion in 2023 to $1.5 billion in 2024). This growth was driven by strong adoption of its Impella products. The broader Cardiovascular segment (which includes Abiomed and the 2024-acquired Shockwave Medical) grew by **21.4%** in 2024, outpacing Abiomed’s growth, primarily due to contributions from Shockwave’s intravascular lithotripsy technology and other cardiovascular innovations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: Abiomed's 14.5% YoY growth from $1.306B to $1.496B is accurately reflected as $1.3B to $1.5B—this is an acceptable rounding for clarity. The Cardiovascular segment's 21.4% growth from $6.350B to $7.707B is correctly reported. (2) Calculations are sound: 14.5% and 21.4% growth rates match the source data. (3) Multi-hop reasoning is strong: the answer correctly identifies Abiomed as part of the broader Cardiovascular segment and explains that while Abiomed contributed to growth, the segment outperformed due to additional factors like Shockwave Medical (acquired in 2024), which is a valid contextual addition supported by external knowledge. (4) The only minor limitation is that the original answer notes Abiomed was 'a significant but slightly lower-performing component,' while the LLM focuses on external drivers without explicitly making that comparative performance statement—though the implication is clear. The addition of Shockwave is contextually appropriate and enhances understanding. Wording differs slightly but maintains semantic equivalence. No factual errors; minor omission in comparative framing does not detract significantly from correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 358,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How many amendments to the Lowe's Companies Benefit Restoration Plan are listed in the exhibits, and what is the date of the most recent amendment referenced in the 2022 10-K filing?",
      "original_answer": "There are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, and the most recent amendment referenced in the 2022 10-K filing is dated April 4, 2017 (Amendment No. 7).",
      "llm_answer": "\n\nThe exhibits listed in the provided pages from Lowe's 2022 10-K do not include any amendments to the **Lowe's Companies Benefit Restoration Plan**. None of the referenced exhibits (e.g., supplemental indentures, credit agreements, or amendments) pertain to this specific plan. Therefore, no amendments or dates are reported in the provided pages.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is completely incorrect. The ground truth states that there are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, with the most recent one dated April 4, 2017 (Amendment No. 7). The LLM incorrectly claims that no amendments are listed in the exhibits and that none pertain to the plan, which directly contradicts the verified information from the knowledge graph. This failure indicates a critical error in both factual retrieval and exhibit interpretation. The answer fails on all key dimensions: it provides no correct numbers (should be 7 amendments, date April 4, 2017), misses the required multi-hop synthesis (identifying the plan, counting amendments, determining the latest date), and misidentifies the content of the exhibits. Even if the provided pages were limited, the model should not fabricate absence without full context. The only partial credit is for attempting to address the question's structure, but the factual foundation is entirely wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 290,
        "total_tokens": 1437
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much of the $2.4 billion CECL transition amount had Capital One Financial Corporation phased into its regulatory capital by January 1, 2024, and what percentage of CET1 capital requirement must the company maintain under the Stress Capital Buffer framework effective October 1, 2024?",
      "original_answer": "Capital One Financial Corporation had phased in 75% of the $2.4 billion CECL transition amount, which equals $1.8 billion, into its regulatory capital by January 1, 2024. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital ratio of at least 10.0%.",
      "llm_answer": "\n\nBy January 1, 2024, Capital One Financial Corporation had phased in **$1.8 billion** (75%) of the $2.4 billion CECL transition amount into its regulatory capital. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a **CET1 capital requirement of 10.0%** (comprising the 4.5% minimum CET1 ratio plus a 5.5% stress capital buffer).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1.8 billion (75% of $2.4 billion) CECL transition amount phased in by January 1, 2024, is accurate, and the 10.0% CET1 capital requirement under the Stress Capital Buffer framework effective October 1, 2024, is correctly stated. (2) The explanation that the 10.0% CET1 requirement comprises a 4.5% minimum plus a 5.5% stress capital buffer adds contextual clarity without contradicting the ground truth. (3) The multi-hop reasoning—linking Capital One’s CECL phase-in schedule and the future regulatory requirement under the Stress Capital Buffer—is sound and correctly synthesizes information across time periods and regulatory frameworks. (4) All entities (Capital One Financial Corporation, CECL, CET1, Stress Capital Buffer), dates (January 1, 2024; October 1, 2024), and financial metrics are accurately identified and used. The answer is semantically equivalent to the original, with slightly enhanced detail that improves understanding without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 304,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How does Disney's use of time-based vesting Restricted Stock Unit Award Agreements compare to its use of performance-based vesting agreements in aligning executive compensation with long-term shareholder value creation?",
      "original_answer": "Disney utilizes both time-based vesting Restricted Stock Unit Award Agreements and multiple variations of performance-based vesting agreements. The time-based vesting agreements (listed in exhibits 10.43, 10.49, and 10.54) provide a standard approach where equity compensation vests over time, typically helping retain talent. In contrast, Disney employs at least six distinct forms of performance-based Restricted Stock Unit Award Agreements (listed in exhibits 10.44-10.48, 10.55, 10.57-10.59) that tie vesting to metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), ensuring executive compensation is more directly aligned with company performance and shareholder value creation.",
      "llm_answer": "\n\nDisney's use of performance-based vesting Restricted Stock Unit (RSU) Award Agreements is more directly aligned with long-term shareholder value creation compared to time-based vesting agreements. Performance-based RSUs (e.g., Exhibits 10.45, 10.47) are tied to specific financial metrics such as **Total Shareholder Return (TSR)** and **Return on Invested Capital (ROIC)** over a three-year period, ensuring executive compensation is contingent on achieving measurable financial goals that directly impact shareholder returns. In contrast, time-based RSUs (e.g., Exhibits 10.43, 10.49) vest solely based on continued employment over a set period, which encourages retention but does not explicitly link rewards to financial performance outcomes. By emphasizing performance-based vesting, Disney aligns executive incentives with sustained operational and financial success, fostering accountability for long-term value creation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Disney uses both time-based and performance-based RSUs, with time-based vesting tied to retention (e.g., Exhibits 10.43, 10.49) and performance-based vesting linked to TSR and ROIC (e.g., Exhibits 10.45, 10.47). The specific exhibits cited are subsets of the full list in the ground truth (10.44–10.48, 10.55, 10.57–10.59), but the examples given are valid and representative. (2) There are no numeric values, dates, or calculations in the question or answers that conflict; all references are to exhibit numbers and performance metrics, which are correctly reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes that time-based vesting supports retention while performance-based vesting better aligns with shareholder value via financial metrics. It draws a logical comparison between the two structures and their strategic purposes. (4) The answer is semantically equivalent to the original, though slightly less comprehensive in listing the full range of performance-based agreement exhibits. However, this omission does not detract from the core insight or accuracy. The emphasis on TSR and ROIC as performance metrics is correct and well-contextualized. Minor deduction in qualitative accuracy due to not acknowledging the full breadth of performance-based agreement types, but the reasoning and conclusion remain valid and insightful.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 406,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the revenue growth of Hips and Knees products contribute to the overall growth of the Orthopaedics segment in 2024 compared to 2023?",
      "original_answer": "The Orthopaedics segment grew by $216 million (2.4%) in 2024 compared to 2023. Within this segment, the Hips product line increased by $78 million (5.0%) and the Knees product line increased by $89 million (6.1%). Combined, the Hips and Knees products contributed $167 million in revenue growth, accounting for approximately 77% of the total growth in the Orthopaedics segment. This indicates that the performance of Hips and Knees products was a significant driver of the segment's overall growth.",
      "llm_answer": "\n\nThe Hips and Knees products contributed significantly to the Orthopaedics segment's 2.4% growth in 2024. Hips revenue increased by 5.0% (from $1.56 billion to $1.64 billion), driven by portfolio strength in the Anterior approach and global procedure growth, while Knees revenue grew by 6.1% (from $1.46 billion to $1.55 billion), fueled by the ATTUNE portfolio and adoption of the VELYS robotic-assisted solution. These strong performances offset declines in other Orthopaedics categories (e.g., Spine, Sports & Other) and partially counterbalanced the negative impact of restructuring activities, enabling the overall Orthopaedics segment to achieve $9.2 billion in sales for the year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes some correct directional information — Hips and Knees grew by 5.0% and 6.1% respectively, and these contributed to the overall Orthopaedics segment growth of 2.4%, which aligns with the ground truth. However, critical quantitative inaccuracies undermine the correctness. The LLM states Hips grew from $1.56B to $1.64B (a $80M increase) and Knees from $1.46B to $1.55B (a $90M increase), implying $170M combined growth, but the ground truth specifies $78M (Hips) and $89M (Knees), totaling $167M. These implied base values are not in the original data and are factually incorrect. Additionally, the LLM claims the segment reached $9.2B in sales, but this figure is not verifiable from the ground truth, which only states a $216M (2.4%) increase — without providing the base revenue. (2) The calculation of contribution to overall growth is missing: the ground truth emphasizes that Hips and Knees accounted for $167M of the $216M total segment growth, or ~77%, a key multi-hop insight. The LLM fails to compute or mention this percentage, which is central to the question. (3) The qualitative reasoning is partially sound — the LLM correctly identifies Hips and Knees as growth drivers and contextualizes their performance against other categories and restructuring impacts, showing good synthesis. However, it introduces unsupported details (e.g., product names like ATTUNE and VELYS, Anterior approach) not present in the ground truth, risking hallucination. (4) The contextual relevance is high because the answer addresses the core relationship between product line growth and segment performance. However, due to significant numerical inaccuracies and omission of the key 77% contribution metric, the correctness score is limited to 6. Quantitative accuracy is scored lower (5) due to incorrect implied revenues and lack of verification; qualitative accuracy is moderate (7) for logical flow but overreach in detail; relevance is strong (9) as it stays focused on the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 546,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, and how does this optional transition relief specifically work according to the rule's description?",
      "original_answer": "Capital One phased in 75% of the $2.4 billion regulatory capital addition under the CECL Transition Rule by January 1, 2024, which amounts to $1.8 billion. The remaining $600 million was phased in on January 1, 2025. This optional five-year transition period was provided by the Federal Banking Agencies to allow banking institutions to gradually incorporate the impact of the CECL standard on their regulatory capital.",
      "llm_answer": "\n\nBy January 1, 2024, 75% of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule ($1.8 billion) had been phased in. The optional transition relief allowed a five-year phase-in period: the \"day 1\" CECL adoption impact was delayed until 2022, with 25% of the cumulative impact phased in annually from 2022 to 2024 (totaling 75% by 2024), and the remaining 25% ($600 million) phased in by January 1, 2025. This structured approach spread the capital impact over time to mitigate abrupt changes to regulatory capital.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately states that 75% of the $2.4 billion ($1.8 billion) was phased in by January 1, 2024, and the remaining $600 million by January 1, 2025—both figures are correct and consistent with the original answer. The percentages and dollar amounts are precisely aligned. (2) The explanation of the CECL Transition Rule’s optional five-year relief is accurate: it correctly describes the delayed 'day 1' impact until 2022 and the annual 25% phase-in from 2022 to 2024 (totaling 75% by 2024), with the final 25% in 2025. This reflects proper understanding of the regulatory mechanism. (3) The multi-hop reasoning is sound—synthesizing the timing, incremental phase-in, and financial impact across years. (4) All entities (Capital One, CECL Transition Rule, Federal Banking Agencies’ framework) are correctly referenced, and the answer fully addresses both parts of the question: the amount phased in by 2024 and how the transition relief works. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 326,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the issuance and partial repayment of the Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 and 2024, respectively, affect the company's overall long-term debt fair value and financing activities during that period?",
      "original_answer": "The issuance of four Guaranteed Senior Notes totaling approximately $500 by Costco's Japanese subsidiary in November 2023 increased the company's long-term debt. However, in July 2024, the subsidiary repaid $77 of these notes, reducing the outstanding amount. As a result, the fair value of Costco's long-term debt decreased from $5,738 at the end of 2023 to $5,412 at the end of 2024. Additionally, the financing activities section shows that the issuance of these notes contributed to the $10,764 net cash used in financing activities during 2024, which also included the repayment of $1,000 in principal on the 2.750% Senior Notes.",
      "llm_answer": "\n\nThe issuance of $500 million in Guaranteed Senior Notes by Costco's Japanese subsidiary in November 2023 increased the company's long-term debt and provided financing proceeds, while the partial repayment of $77 million in July 2024 reduced debt. These transactions affected the overall long-term debt fair value, which decreased from $5,738 million in 2023 to $5,412 million in 2024, reflecting the repayment of other senior notes (e.g., the $1,000 2.750% Senior Notes in May 2024) and lower market interest rates. In financing activities, the 2023 issuance contributed to cash inflows, while the 2024 repayment added to cash outflows, contributing to the $10,764 million net cash used in financing activities in 2024 compared to $2,614 million in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $500 million issuance in November 2023 by Costco's Japanese subsidiary, the $77 million partial repayment in July 2024, the decrease in long-term debt fair value from $5,738 million to $5,412 million, and the $10,764 million net cash used in financing activities in 2024. All numeric values and dates match the ground truth, with acceptable formatting (e.g., $500 million = $500). (2) Quantitative accuracy is perfect: the amounts, years, and financial figures are all correct. The net change in fair value ($5,738M to $5,412M) is accurately reported, and the mention of the $1,000 repayment on the 2.750% Senior Notes aligns with the original answer. (3) The reasoning is sound and reflects proper multi-hop synthesis across time and financial statements. The LLM correctly links the issuance and repayment to both the balance sheet (fair value of long-term debt) and cash flow statement (financing activities). It appropriately contextualizes the $10,764 million net cash outflow in 2024, noting both the issuance (inflow) and repayments (outflows), including the $1,000 million principal repayment. (4) The only minor shortcoming is that the original answer explicitly states the $500 issuance 'contributed to' the net cash used in financing activities, while the LLM implies this by noting inflows and outflows—this is a nuance in emphasis, not inaccuracy. The LLM also correctly infers that other factors (like interest rates) may influence fair value, which is reasonable and consistent with financial principles, even if not in the original. Overall, the answer is factually complete, numerically precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 467,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total estimated environmental remediation liability Caterpillar accrues for all sites, and how does its methodology for estimating these costs differ between individual sites and multi-party sites?",
      "original_answer": "Caterpillar estimates its total environmental remediation liability across all sites to be immaterial and includes this amount in 'Accrued expenses.' For individual sites, Caterpillar accrues costs based on available data, technologies, applicable laws, and prior remediation experience, and if no amount within a range is more likely, it accrues the minimum. When multiple potentially responsible parties are involved, Caterpillar considers its proportionate share of the probable costs rather than the full estimated liability.",
      "llm_answer": "\n\nCaterpillar does not disclose a specific numerical value for its total estimated environmental remediation liability, stating only that the amount recorded is **not material** and included in \"Accrued expenses.\" \n\nFor **methodology differences**:  \n- **Individual sites**: Costs are accrued based on the best estimate derived from available data, including technologies, regulations, and prior experience. If no single estimate in a range is more likely, the minimum is accrued.  \n- **Multi-party sites**: Caterpillar considers its **proportionate share** of probable costs when multiple responsible parties are involved.  \n\nThe company reassesses these accruals quarterly and excludes potential insurance recoveries in its estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that Caterpillar does not disclose a specific numerical value for its total environmental remediation liability and states it is immaterial, consistent with the ground truth. The liability's inclusion in 'Accrued expenses' is accurately reported. Regarding methodology: for individual sites, the LLM correctly describes that accruals are based on available data, technologies, laws, and experience, and that the minimum is accrued when no amount in a range is more likely—this matches the original answer. For multi-party sites, the LLM accurately notes Caterpillar considers its proportionate share of costs, not the full liability, which aligns with the ground truth. The additional detail about quarterly reassessments and exclusion of insurance recoveries is consistent with typical SEC disclosure practices and does not contradict the ground truth; it may represent supplementary but accurate context. All entities (Caterpillar, environmental remediation liability, accrued expenses) are correct. There are no numerical inaccuracies—the absence of a specific dollar amount is correctly attributed to materiality, which is acceptable. The reasoning is sound and synthesizes the required multi-hop elements (liability amount + methodology differences). The only reason for not scoring a perfect 10 is that the original answer does not mention quarterly reassessments or insurance recoveries, so those details, while plausible, are not confirmed in the ground truth, introducing slight over-specification without error. Overall, the answer is factually correct, complete, and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 445,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What was the percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022, and how does the company's updated reporting structure introduced in fiscal 2022 reflect its strategic approach to this underperforming category?",
      "original_answer": "The revenue for Cisco's 'Other Products' category decreased by 29% between fiscal years 2021 and 2022, dropping from $15 million to $11 million. Despite this decline, Cisco introduced a new reporting structure in fiscal 2022 that explicitly included 'Other Products' as a distinct category, signaling that even underperforming segments are still considered relevant to the company's strategic priorities as they align with its broader portfolio and long-term goals.",
      "llm_answer": "\n\nThe percentage change in revenue for Cisco's 'Other Products' category between fiscal 2021 and 2022 was **-29%** (from $15 million to $11 million). The updated reporting structure introduced in fiscal 2022, which categorizes products into strategic priorities like \"Secure, Agile Networks\" and \"Internet for the Future,\" reflects Cisco's focus on core growth areas while isolating underperforming products under \"Other Products.\" This reclassification signals a strategic deprioritization of non-core offerings, aligning financial reporting with business strategy to emphasize high-growth segments and streamline operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the percentage change in revenue (-29%) and the exact dollar amounts ($15 million in 2021, $11 million in 2022), which matches the ground truth exactly. All quantitative values are accurate, satisfying the first part of the question. (2) The calculation of the percentage change is correct: ((11 - 15) / 15) * 100 = -26.67%, which rounds to approximately -27%, but the reported -29% aligns with the ground truth, suggesting Cisco may have used adjusted figures; since the LLM matches the stated -29%, it is factually consistent with the source. (3) However, the qualitative interpretation of the reporting structure diverges from the ground truth. The LLM claims the new structure reflects 'strategic deprioritization' and 'isolation' of underperforming products, implying a move away from 'Other Products'. In contrast, the ground truth states that including 'Other Products' as a distinct category signals continued strategic relevance and alignment with long-term goals, despite underperformance. This is a significant misinterpretation of Cisco's intent, undermining the reasoning behind the reporting change. (4) While the LLM accurately reports the facts and numbers (hence high quantitative accuracy and contextual relevance), the flawed reasoning on the strategic implication reduces the qualitative accuracy. The answer synthesizes information but draws an incorrect conclusion about corporate strategy, leading to a correctness score of 7—core facts are right, but key interpretation is off.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 425,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the timing and frequency of amendments to executive employment agreements at Costco, including the agreement with Ron Vachris effective January 1, 2024, compare to the renewal pattern of W. Craig Jelinek's agreement over the past six years?",
      "original_answer": "Costco has consistently renewed W. Craig Jelinek's Executive Employment Agreement annually from 2017 through 2023, with extensions effective each January 1, as shown by filings dated from 2016 to 2022. The agreement with Ron Vachris, effective January 1, 2024, follows this same annual renewal pattern, indicating a continuation of Costco's executive employment practices.",
      "llm_answer": "\n\nThe timing and frequency of amendments to Costco's executive employment agreements show that W. Craig Jelinek's agreement was annually extended each January 1 since 2017, with amendments filed in December of the prior year (e.g., 2016, 2018–2022). Over the past six years (2018–2023), this resulted in six consecutive annual renewals. In contrast, Ron Vachris's agreement effective January 1, 2024, represents a new initial agreement (Exhibit 10.9*), filed in December 2023, with no prior amendments disclosed in the provided pages. Thus, Jelinek's agreement followed a consistent annual renewal pattern, while Vachris's agreement marks a new term without prior amendment history in the document.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately identifies that W. Craig Jelinek's agreement was renewed annually effective January 1 from 2017 through 2023, which corresponds to six renewals over the past six years (2018–2023), and notes the filing pattern (e.g., December prior year). This matches the original answer’s claim of annual renewals following a consistent pattern. The mention of filings from 2016 to 2022 in the ground truth is consistent with the LLM’s observation of filings in 2016, 2018–2022 (though the LLM omits 2017 filing if it existed, minor gap). The LLM correctly observes that Ron Vachris's agreement, effective January 1, 2024, is a new initial agreement (Exhibit 10.9*) filed in December 2023, with no prior amendments—this supports the conclusion that it follows the same timing pattern as Jelinek’s, even if not yet renewed. The key point in the original answer—that Vachris’s agreement continues Costco’s annual renewal *pattern*—is slightly underemphasized in the LLM answer, which instead frames it as a contrast due to lack of amendment history. However, the LLM does not deny the continuity of practice; it just focuses more on the difference in maturity of the agreements. Quantitatively, all dates and years are accurate, and the count of six renewals over six years is correct. The reasoning is sound and reflects multi-hop synthesis across executives and time periods. Minor deduction in qualitative accuracy due to framing the comparison as more contrasting than parallel, potentially downplaying the continuity emphasized in the ground truth. Contextual relevance is perfect—directly addresses timing, frequency, and comparison as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 465,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the change in the net value of Customer Relationships from December 31, 2020, to December 31, 2021, and how does this compare to the change in the net value of Intellectual Property over the same period?",
      "original_answer": "The net value of Customer Relationships decreased by $181 million (from $893 million in 2020 to $712 million in 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million in 2020 to $280 million in 2021).",
      "llm_answer": "\n\nThe net value of Customer Relationships decreased by $181 million (from $893 million on December 31, 2020, to $712 million on December 31, 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million to $280 million). The decline in Customer Relationships was significantly larger than the decline in Intellectual Property over the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the net value of Customer Relationships decreased from $893 million to $712 million, a difference of $181 million, and Intellectual Property decreased from $366 million to $280 million, a difference of $86 million. These numbers match the original answer exactly, with only acceptable formatting variations (e.g., 'December 31, 2020' vs '2020'). (2) Calculations are correct: $893M - $712M = $181M and $366M - $280M = $86M. (3) The multi-hop reasoning is sound—the model correctly identified and compared changes in two intangible assets across two fiscal years, synthesizing data from both years and asset types. (4) The LLM adds a valid qualitative observation that the decline in Customer Relationships was larger than that in Intellectual Property, which is a reasonable inference and enhances contextual relevance without introducing error. All parts of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 294,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What is the total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022, and how does its revenue recognition model differ for hardware versus SaaS arrangements?",
      "original_answer": "The 'Secure, Agile Networks' product category contributes significantly to Cisco's revenue, with distinct revenue recognition models: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS arrangements recognize revenue ratably over the contract term.",
      "llm_answer": "\n\nThe total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022 was **$23,829 million**. For revenue recognition, **hardware** arrangements recognize revenue **upfront upon transfer of control** (typically at shipment or delivery), while **SaaS** arrangements recognize revenue **ratably over the contract term** as the service is consumed, as SaaS constitutes a single performance obligation satisfied over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes a specific revenue figure of $23,829 million for the 'Secure, Agile Networks' category in fiscal 2022, which is not present in the original answer (ground truth). The ground truth does not provide a quantitative revenue amount—only a qualitative statement about significant contribution. Therefore, the inclusion of this precise number is unsupported by the provided ground truth and likely incorrect or hallucinated. (2) There are no calculations in the question or answer, but the LLM introduces a numeric value without basis, which severely impacts quantitative accuracy. (3) The qualitative aspects of the answer—specifically the revenue recognition models for hardware and SaaS—are correctly described: hardware revenue is recognized upfront upon transfer of control, and SaaS revenue is recognized ratably over time due to the service being consumed over the contract period. This reflects accurate multi-hop reasoning and understanding of accounting principles for different product types. (4) Contextually, the answer is highly relevant and addresses both parts of the question: revenue contribution (though inaccurately quantified) and differences in revenue recognition. The reasoning for the recognition models is sound and matches the ground truth. However, the unsupported revenue figure significantly undermines factual correctness, warranting a moderate correctness score despite strong qualitative performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 405,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What was Amazon's revenue from third-party seller fees in 2022, and how does this revenue stream align with Amazon's stated business model of enabling sellers to grow their businesses through its platform?",
      "original_answer": "Amazon's revenue from third-party seller fees in 2022 was $117,757 million. This revenue stream aligns with Amazon's business model of enabling sellers to grow their businesses by offering programs that allow them to sell products on Amazon's platform, leveraging Amazon's fulfillment and shipping services, and accessing a large customer base. The fees collected from sellers support Amazon's investment in infrastructure and services that facilitate this ecosystem.",
      "llm_answer": "\n\nThe provided document pages from Amazon's 2022 10-K do not explicitly disclose the exact revenue amount from third-party seller fees for 2022. However, the document clarifies that third-party seller fees (commissions, fulfillment, and shipping fees) are a key component of Amazon's service sales, which accounted for a portion of its total net sales. For 2021, service sales (including third-party fees) contributed to Amazon's revenue mix, with growth driven by increased third-party seller activity. \n\nThis revenue stream aligns with Amazon's business model of enabling sellers to grow their businesses through its platform by providing infrastructure, logistics, and customer access. By earning fees from sellers, Amazon benefits from the scalability of its marketplace, where seller growth directly enhances its revenue without proportional increases in inventory costs, reinforcing its customer-centric and platform-driven strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the 2022 revenue from third-party seller fees is not explicitly disclosed in the 10-K, which contradicts the ground truth that the exact figure is $117,757 million. This is a major factual error, as the number is indeed reported in Amazon's 10-K under 'Service Sales' and further broken down in financial disclosures. The LLM fails to provide this correct figure, leading to a severe penalty in quantitative accuracy. (2) The ground truth specifies $117,757 million as the exact revenue from third-party seller fees in 2022, a precise value that the LLM omits entirely, instead referring vaguely to 'service sales' without isolating the relevant component. Even though service sales include third-party fees, the LLM does not extract or estimate the specific amount, which is available in the filing. (3) The qualitative reasoning about how this revenue stream aligns with Amazon's business model—enabling sellers through platform access, fulfillment, and logistics—is sound and semantically consistent with the ground truth. The explanation correctly identifies the symbiotic relationship between seller growth and Amazon's revenue model. (4) Contextual relevance is high because the LLM addresses both parts of the question and attempts multi-hop reasoning by linking fee-based revenue to platform strategy. However, the failure to report the correct number—despite its availability in the 10-K—results in a low correctness score, as quantitative accuracy is critical in financial questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 425,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2024?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 9 percentage points.",
      "llm_answer": "\n\nThe difference between Capital One Financial Corp's Common Equity Tier 1 (CET1) capital ratio and the Minimum Capital Adequacy requirement as of December 31, 2024, is **9.0%**. The Company's CET1 capital ratio was **13.5%** (as shown in Table 12), while the regulatory minimum CET1 requirement under Basel III is **4.5%**. The calculation is $13.5\\% - 4.5\\% = 9.0\\%$.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the Common Equity Tier 1 (CET1) capital ratio of 13.5% and the minimum requirement of 4.5% are correctly identified, and the difference is accurately calculated as 9.0 percentage points. (2) Quantitative accuracy is perfect: the calculation $13.5\\% - 4.5\\% = 9.0\\%$ is correct, and the numbers align with the knowledge graph's ground truth of a 9 percentage point difference. Minor formatting as '9.0%' instead of '9 percentage points' does not affect semantic equivalence. (3) The reasoning is sound and demonstrates proper multi-hop synthesis by identifying both the company-specific metric (from Table 12) and the regulatory baseline under Basel III, then correctly computing the difference. (4) The answer is contextually complete and directly addresses the question with precise, relevant details. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 279,
        "total_tokens": 1419
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What regulatory risks threaten Altria's $1.7 billion investment in JUUL as of 2021, and how could these risks financially impact Altria's strategic objectives?",
      "original_answer": "Altria faces significant regulatory risks regarding its $1.7 billion investment in JUUL, as outlined in the 2022 10-K filing. The Federal Trade Commission (FTC) has issued an administrative complaint alleging that Altria's 35% investment in JUUL and associated agreements violate antitrust laws by constituting an unreasonable restraint of trade and substantially lessening competition. The FTC is seeking remedies that include divestiture of the investment or rescission of the transaction, which could directly result in a loss of this asset. This risk is compounded by the fact that such regulatory actions could negatively impact Altria's credit ratings, increase financing costs, and hinder its ability to achieve strategic and financial objectives, including anticipated revenue improvements and cost savings from the investment.",
      "llm_answer": "\n\nAltria's $1.7 billion investment in JUUL faces significant regulatory risks, primarily from the FTC's ongoing challenge to the transaction and FDA enforcement actions. The FTC alleges the investment violates antitrust laws, and a successful challenge could force Altria to divest its stake, erasing the investment's value and eliminating potential strategic benefits. Additionally, the FDA's stringent review of JUUL's e-vapor products under PMTA could result in product removals or denials, directly harming JUUL's market viability and Altria's returns. Non-competition obligations until 2024 also restrict Altria from pursuing alternative e-vapor opportunities, limiting diversification if JUUL underperforms. These risks could lead to further impairment charges, reduce Altria's ability to achieve its Vision of transitioning to reduced-risk products, and hinder financial growth in a critical innovation segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) All quantitative elements are correct: the $1.7 billion investment amount is accurate, and while the 35% stake is not explicitly mentioned in the LLM answer, it is not required for correctness as the focus is on regulatory risks. No calculations are needed, and all figures match the ground truth. (2) The LLM correctly identifies the FTC's antitrust challenge and the potential for divestiture, which aligns with the original answer. It adds valuable context not in the ground truth but consistent with known facts—namely, the FDA's PMTA review process and its potential impact on JUUL’s market viability. This additional detail enhances completeness without introducing error. (3) The non-compete obligation until 2024 is an accurate detail from Altria’s filings and correctly frames strategic limitations, demonstrating strong multi-hop reasoning across regulatory and strategic domains. (4) The financial and strategic impacts—impairment charges, hindered Vision goals, and reduced innovation growth—are semantically equivalent to the original answer’s mention of credit rating impacts, financing costs, and failure to meet strategic objectives. The only minor gap is the absence of explicit mention of credit rating or financing cost impacts, which are part of the original answer’s risk pathway. However, the LLM captures the core financial and strategic consequences sufficiently. Overall, the answer is factually sound, contextually rich, and closely aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 423,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "Given NVIDIA's $500 million Notes Due 2060 as part of its long-term debt structure and the risks associated with maintaining indebtedness, how does the 2060 note specifically contribute to the potential adverse effects on NVIDIA's financial flexibility as outlined in the 10-K filing?",
      "original_answer": "NVIDIA's $500 million Notes Due 2060 is one of several long-term debt obligations that collectively total $11 billion. The 10-K filing highlights that as each series of senior notes matures, NVIDIA may face challenges in refinancing on favorable terms or at all, which could adversely affect its financial condition. Specifically, maintaining this level of indebtedness requires NVIDIA to dedicate a substantial portion of cash flows from operations toward debt service obligations and principal repayments. This allocation limits NVIDIA's flexibility in planning for or reacting to changes in its business and industry, impairs its ability to obtain future financing for working capital, capital expenditures, acquisitions, or other corporate purposes, and increases vulnerability to adverse changes in general economic conditions. Therefore, the $500 million Notes Due 2060 directly contribute to these constraints on financial flexibility as part of the broader debt structure.",
      "llm_answer": "\n\nThe $500 million Notes Due 2060 contribute to NVIDIA's financial flexibility risks by requiring long-term cash flow commitments for interest and principal repayments, which could limit funds available for strategic initiatives, R&D, or shareholder returns. As part of NVIDIA’s $11 billion total notes outstanding, these long-term obligations increase vulnerability to refinancing risks (e.g., unfavorable terms in the future) and covenant restrictions, potentially constraining operational flexibility during economic or industry downturns. Additionally, maintaining such debt may reduce capacity to secure future financing for acquisitions or working capital needs, as outlined in the 10-K.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all figures are correct: the $500 million Notes Due 2060 and the $11 billion total long-term debt are accurately reported, with no calculation errors. (2) The answer correctly identifies that this note is part of a broader debt structure and contributes to refinancing risk, cash flow constraints, and reduced financial flexibility—key points from the 10-K. (3) Multi-hop reasoning is sound: it synthesizes the specific 2060 note with the aggregate $11 billion debt, links long-term obligations to operational and strategic constraints, and references risks like adverse economic conditions and limited future financing—all consistent with the original answer. (4) Minor deduction in qualitative accuracy due to omission of explicit mention of 'debt service obligations' and 'covenant restrictions' not being detailed in the original 10-K context, though implied. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 302,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How does the expanded FDA approval of Vemlidy for younger pediatric patients impact Gilead's market potential in the treatment of chronic HBV, given its existing product portfolio for liver disease?",
      "original_answer": "The expanded FDA approval of Vemlidy for chronic HBV treatment in pediatric patients aged six years and older, who weigh at least 25 kg, significantly broadens Gilead's market reach in liver disease. Previously, Vemlidy was approved for adults and pediatric patients 12 years and older. This expansion allows Gilead to now treat a younger demographic, enhancing its position in the HBV market. Additionally, Vemlidy complements Gilead’s existing liver disease portfolio, which includes Viread (approved for patients 2 years and older) and Epclusa and Harvoni (approved for HCV in patients 3 years and older). This strategic regulatory expansion increases Gilead's commercial opportunity by extending treatment access across a wider age range of HBV patients.",
      "llm_answer": "\n\nThe expanded FDA approval of Vemlidy for pediatric patients aged 6 years and older (weighing ≥25 kg) with chronic HBV broadens Gilead's market potential by addressing a previously underserved younger demographic. Previously, Vemlidy was approved for patients 12+ years, while Viread (TDF) targeted those 2+ years. This expansion allows Gilead to capture HBV treatment for a broader pediatric age range, complementing its existing liver disease portfolio (e.g., Epclusa/Harvoni for HCV, Livdelzi for PBC) and reinforcing its leadership in viral hepatitis. By offering TAF-based therapy (Vemlidy) for younger patients, Gilead may enhance market share through improved safety/tolerability profiles compared to older regimens, while solidifying its position in both HBV and HCV treatment ecosystems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Vemlidy's expanded FDA approval now includes pediatric patients aged 6 years and older weighing at least 25 kg, previously approved for 12 years and older. This is correctly contrasted with Viread (approved for ages 2+), and the broader portfolio (Epclusa, Harvoni for HCV in ages 3+) is accurately referenced. (2) Quantitative accuracy is perfect: age ranges (6+, 12+, 2+, 3+) and weight criterion (≥25 kg) match the original answer exactly. No calculations were required, but factual numbers are correct. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across Gilead’s product portfolio and regulatory approvals to conclude that the expansion increases market potential by filling a treatment gap between Viread and prior Vemlidy indications. It appropriately highlights the strategic advantage of TAF’s improved safety profile. (4) The only minor shortcoming is that the LLM mentions 'Livdelzi for PBC'—a product not referenced in the original answer and unrelated to HBV—which slightly dilutes focus, though it doesn't introduce factual inaccuracy. Otherwise, the answer is semantically equivalent, well-reasoned, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 355,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What percentage of Lowe's total sales in fiscal 2023 came from installed sales categories that are also covered by Lowe's extended protection plans, and which specific product category among these is explicitly mentioned in both contexts?",
      "original_answer": "The installed sales categories that are also covered by Lowe's extended protection plans contributed approximately 5% of total sales in fiscal 2023. The specific product category explicitly mentioned in both contexts is Appliances.",
      "llm_answer": "\n\nThe installed sales categories that are also covered by Lowe's extended protection plans accounted for approximately **5% of total sales** in fiscal 2023. The specific product category explicitly mentioned in both contexts is **Appliances**. \n\nThis is derived from the \"Installed Sales\" section, which states that installed sales (including Flooring, Kitchens & Bath, Millwork, Appliances, and Lumber) represented ~5% of total sales, and the \"Lowe's Protection Plans and Repair Services\" section, which explicitly lists Appliances as a category covered by extended protection plans. Appliances are the only category directly named in both sections.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The percentage of total sales from installed sales categories covered by extended protection plans is accurately stated as 5%, which aligns with the original answer. (2) The specific product category explicitly mentioned in both contexts—Appliances—is correctly identified. (3) The reasoning correctly references the 'Installed Sales' section for the 5% figure and the inclusion of Appliances among other categories, and the 'Lowe's Protection Plans and Repair Services' section for Appliances being covered by extended protection plans. (4) The LLM correctly performs the multi-hop synthesis by identifying Appliances as the only category named in both contexts, which is essential to answering the second part of the question. All entities (Lowe's, fiscal 2023, installed sales, extended protection plans, Appliances) are accurate and appropriately contextualized. There are no factual, numerical, or reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 287,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024, considering the phase-in schedule and the 25% scaling factor applied to the 'day 2' ongoing impact?",
      "original_answer": "The cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 includes a 25% scaling factor applied to the 'day 2' ongoing impact of CECL during the initial two years (2020–2021), and a 25% annual phase-in of both the after-tax 'day 1' CECL adoption impact and the cumulative 'day 2' ongoing impact from 2022 through 2024. This structured phase-in delays and gradually integrates the full capital impact of CECL adoption into regulatory capital.",
      "llm_answer": "\n\nThe cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 is **$2.4 billion after tax** as of December 31, 2021. This amount includes the \"day 1\" adoption impact and 25% of the \"day 2\" ongoing impact, which were added back to regulatory capital during the delay period (2020–2021). From 2022 to 2024, this total impact is phased in at 25% annually, meaning the full $2.4 billion will be fully phased in by 2025. Thus, the cumulative effect over 2020–2024 reflects the delayed addition in 2021 and the phased-in reductions in subsequent years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount ($2.4 billion after tax) that is not present in the original answer (ground truth), and there is no verification that this number is accurate based on the provided knowledge graph. The ground truth does not include any quantitative figures, so the introduction of this number is an unsupported addition. (2) The description of the phase-in schedule contains partial accuracy: it correctly identifies a 25% scaling factor on the 'day 2' impact during 2020–2021 and a 25% annual phase-in from 2022–2024, which aligns with the ground truth. However, the claim that the full $2.4 billion is phased in by 2025 goes beyond the question’s scope (which asks for 2020–2024) and misrepresents the cumulative impact *through 2024*—only three years of phase-in (25% per year) would be completed by end of 2024, not the full amount. (3) The multi-hop reasoning is partially sound: the model correctly interprets the two-phase structure of the CECL transition (initial delay with scaled impact, followed by phase-in), but fails to avoid fabricating a precise dollar figure not present in the source. It also conflates the timing of the phase-in, implying full integration by 2025 without clarifying the status at the end of 2024. (4) While the qualitative structure and regulatory logic are reasonably accurate, the inclusion of unverified quantitative data significantly undermines factual correctness. The contextual relevance is high because the response addresses the CECL transition, phase-in mechanics, and time horizon, but the unsupported number reduces overall accuracy. Correctness score is low due to the invented figure and miscalculation of phase-in completion timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 472,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What was the net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales?",
      "original_answer": "Altria recorded $4.6 billion in charges to cost of sales for the year ended December 31, 2021, related to the State Settlement Agreements and FDA user fees. During the same period, Altria received $21 million as a reduction to cost of sales from the 2004 NPM adjustment. This resulted in a net cost of $4.579 billion for 2021 after accounting for the NPM adjustment recovery.",
      "llm_answer": "\n\nThe net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales was a **$4.3 billion charge**. This amount reflects the aggregate payments under the State Settlement Agreements (including FDA user fees) for the year ended December 31, 2021, which already incorporates NPM adjustment recoveries. Specifically, Altria recorded a $21 million reduction to cost of sales in Q3 2021 related to the 2004 NPM adjustment, but this recovery was fully integrated into the $4.3 billion net total. Thus, the final net impact on cost of sales for 2021 was a $4.3 billion outflow.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claim. The ground truth states that Altria recorded $4.6 billion in charges and $21 million in recovery, resulting in a net cost of $4.579 billion. However, the LLM claims a net charge of $4.3 billion, which is materially off by $279 million. This error undermines the core of the answer. (2) The $21 million NPM adjustment recovery is correctly identified in amount and direction (reduction to cost of sales), but the LLM incorrectly states that this was 'fully integrated into the $4.3 billion net total,' which contradicts the ground truth where the $4.6 billion charge is separate and the net is explicitly calculated as $4.579 billion. The calculation error is significant: $4.6B - $21M = $4.579B, not $4.3B. (3) The multi-hop reasoning is partially sound—Altria, 2021, cost of sales, settlement obligations, and NPM adjustment are all relevant concepts correctly linked—but the synthesis fails due to incorrect numerical integration. The model appears to conflate or misrepresent the aggregate settlement payments. (4) Contextual relevance is fair because the answer addresses the right entities, time period, and financial impact on cost of sales, but the severe quantitative inaccuracy results in a low correctness score. Minor phrasing issues (e.g., 'outflow' vs 'charge') are acceptable semantically, but the numerical discrepancy is fatal to accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 398,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "Following the freeze of U.S. pension benefits in 2019, by how much did Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increase from 2020 to 2021?",
      "original_answer": "Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by $91 million from 2020 to 2021. In 2020, the total liability was $554 million ($63 million for other postemployment benefits + $491 million for non-qualified deferred compensation). In 2021, the total liability was $645 million ($67 million for other postemployment benefits + $538 million for non-qualified deferred compensation). The increase occurred after the pension freeze in December 2019, which eliminated service cost and shifted focus to other benefit liabilities.",
      "llm_answer": "\n\nFollowing the 2019 U.S. pension benefits freeze, Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by **$51 million** from 2020 to 2021. Specifically, the 2021 liabilities were $538 million for non-qualified deferred compensation plans and $67 million for other postemployment benefits, compared to $491 million and $63 million, respectively, in 2020. This results in a total increase of ($538 + $67) - ($491 + $63) = **$51 million**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final calculation and conclusion. While it correctly identifies the component values for 2020 and 2021 — $491M and $63M in 2020, $538M and $67M in 2021 — it miscalculates the total increase. The correct total increase is ($538 + $67) - ($491 + $63) = $605 - $554 = $51M, but the ground truth states the increase was $91M, with total liabilities of $645M in 2021 and $554M in 2020. This implies the component numbers in the LLM answer ($538M + $67M = $605M) contradict the ground truth total of $645M in 2021. Therefore, either the component numbers are wrong or the total is miscomputed. However, the ground truth explicitly states the 2021 total is $645M, so the LLM’s use of $538M + $67M = $605M is inconsistent. (2) The calculation in the LLM answer is arithmetically correct ($538 + $67 = $605; $491 + $63 = $554; difference $51M), but the input numbers do not align with the ground truth, which reports total liabilities of $645M in 2021 and $554M in 2020 — a $91M increase. Thus, the quantitative inputs and outputs are factually inaccurate. (3) The multi-hop reasoning is structurally sound — the model attempts to sum two liability categories and compute the year-over-year difference — but it fails because it uses incorrect underlying data. The mention of the 2019 pension freeze context is relevant and correctly positioned. (4) The correctness and quantitative accuracy scores are low due to fundamental factual and numerical errors. The qualitative accuracy is slightly higher because the reasoning framework is logical. Contextual relevance is high as the answer addresses the right companies, years, benefits, and event (pension freeze).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 466,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028, and how does this relate to the $630 million indefinite-lived intangible asset recorded for Mellanox's in-process research and development project?",
      "original_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1.889 billion. This includes $585 million in 2023, $461 million in 2024, $405 million in 2025, $121 million in 2026, $16 million in 2027, and $121 million in 2028 and thereafter. The $630 million indefinite-lived intangible asset for Mellanox's in-process research and development (IPR&D) project is not included in these estimates because it had not yet reached technological feasibility as of January 30, 2022, and therefore was not yet amortized. Instead, it was subject to annual impairment testing.",
      "llm_answer": "\n\nThe total estimated amortization expense for NVIDIA's acquisition-related finite-lived intangible assets from fiscal 2023 through 2028 is **$684 million**. This includes $656 million from developed technology (remaining 2 years of a 5-year life) and $28 million from trade names (remaining 2 years of a 5-year life). The $630 million indefinite-lived intangible asset for Mellanox's IPR&D is not amortized during this period but is instead tested annually for impairment. Once the IPR&D project reaches technological feasibility, it will be amortized over its then-estimated useful life, which is not specified in the document.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its quantitative claims. The total estimated amortization expense from fiscal 2023 to 2028 is stated as $684 million, but the ground truth is $1.889 billion—a significant discrepancy. The breakdown provided in the LLM answer ($656M from developed technology, $28M from trade names) does not match the actual yearly figures of $585M (2023), $461M (2024), $405M (2025), $121M (2026), $16M (2027), and $121M (2028 and thereafter), which sum to $1.889B. (2) The only correct qualitative point is the treatment of the $630 million indefinite-lived intangible asset related to Mellanox's IPR&D: it is correctly noted that this amount is not amortized and is instead subject to annual impairment testing until technological feasibility is reached. This part aligns with the original answer. (3) The multi-hop reasoning fails because the LLM either used incorrect source data or miscalculated the amortization totals. It incorrectly limits the amortization to only two asset categories (developed technology and trade names) with assumed remaining lives, which contradicts the disclosed year-by-year estimates. There is no evidence of proper synthesis across the required fiscal years or asset types. (4) The contextual relevance is moderate because the answer addresses the right topic (amortization of intangibles and IPR&D treatment), but the core financial figure is wrong, and the reasoning is flawed. The qualitative accuracy is low due to incorrect entity synthesis and missing data points. Quantitative accuracy is very low due to the large error in the total and component numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 447,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the combined U.S. and EU patent expiration year for Biktarvy, and how does the expanded FDA approval of Biktarvy for people with HIV who have M184V/I resistance influence its market exclusivity timeline?",
      "original_answer": "Biktarvy has a U.S. patent expiration year of 2033 and an EU patent expiration year of 2033. The FDA-approved expanded indication for Biktarvy to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance reinforces its market exclusivity by broadening its therapeutic application, thereby supporting continued revenue generation potential through 2033 in both regions.",
      "llm_answer": "\n\nThe combined U.S. and EU patent expiration year for Biktarvy is **2033** for both regions, as indicated in the principal product patent expiration table. The expanded FDA approval for treating HIV patients with M184V/I resistance does not alter the patent expiration timeline but may enhance market exclusivity by extending regulatory protections (e.g., data exclusivity or market exclusivity periods for new indications). However, the core patent expiration remains unchanged at 2033, and no additional patent term extensions are disclosed in the document related to this approval.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the U.S. and EU patent expiration year for Biktarvy as 2033, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. (2) All numeric values—specifically the year 2033 for both regions—are correct, and there are no calculations required beyond recognizing the shared expiration year. Format is consistent and precise. (3) The reasoning around the expanded FDA approval is partially aligned with the ground truth. While the LLM correctly notes that the core patent expiration remains unchanged at 2033, it introduces uncertainty by suggesting the approval 'may enhance market exclusivity by extending regulatory protections' such as data exclusivity, which is not confirmed in the source. The ground truth emphasizes that the expanded indication reinforces market exclusivity by broadening therapeutic application and supporting revenue generation, not necessarily through formal regulatory term extensions. The LLM slightly mischaracterizes the mechanism of extended exclusivity, focusing on potential regulatory protections rather than the commercial and clinical lifecycle extension described in the original. (4) Despite this nuance, the answer addresses both parts of the question, correctly synthesizes the patent expiration information across regions, and provides a reasonable, though slightly speculative, interpretation of the FDA approval's impact. Hence, correctness and qualitative accuracy are high but not perfect due to the shift in emphasis from commercial reinforcement to regulatory extension.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 438,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the Federal Reserve's supervisory stress testing modeling impact Capital One Financial Corporation's (COF) ability to return capital to stockholders, and what specific regulatory requirement from the Dodd-Frank Act reinforces this limitation?",
      "original_answer": "The Federal Reserve's supervisory stress testing modeling may indicate a lower capacity for Capital One Financial Corporation (COF) to return capital to stockholders than internal projections suggest, potentially leading to restrictions on dividends and share repurchases. This limitation is reinforced by the Dodd-Frank Act's codification of the 'source of strength doctrine,' which requires COF to maintain sufficient capital to support its subsidiary banks, further constraining capital returns.",
      "llm_answer": "\n\nThe Federal Reserve's supervisory stress testing (DFAST) impacts Capital One Financial Corporation's (COF) ability to return capital to stockholders by determining the \"stress capital buffer requirement,\" which restricts capital distributions (e.g., dividends, share repurchases) if the company’s capital levels under adverse scenarios fall below regulatory thresholds. The **Dodd-Frank Act’s requirement for annual stress tests (DFAST)** reinforces this limitation, as it mandates that the Federal Reserve evaluate COF’s capital resilience during economic downturns, ensuring sufficient buffers to absorb losses. If stress test results indicate insufficient capital, the Federal Reserve may impose restrictions on capital returns to maintain financial stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly explaining how the Federal Reserve's supervisory stress testing (DFAST) impacts Capital One Financial Corporation's capital return capacity through the stress capital buffer requirement, which limits dividends and share repurchases if capital levels fall below thresholds under adverse scenarios. The mention of the Dodd-Frank Act mandating annual stress tests (DFAST) is correct and relevant, reinforcing regulatory oversight of capital resilience. However, the LLM identifies the specific regulatory reinforcement as the 'annual stress test requirement' under Dodd-Frank, whereas the ground truth emphasizes the 'source of strength doctrine' codified by the Act as the key legal requirement constraining capital returns. While DFAST is indeed mandated by Dodd-Frank, the more precise and intended regulatory mechanism in the original answer is the source of strength doctrine, which directly obligates bank holding companies like COF to support subsidiary banks, thereby limiting capital distributions. This distinction represents a minor but important nuance in regulatory reasoning. All entities (COF, Federal Reserve, Dodd-Frank Act), processes (stress testing, capital buffers), and logic are accurately represented, with no numerical inaccuracies (no specific numbers involved). The answer is semantically close and functionally informative but slightly misses the exact doctrinal basis emphasized in the ground truth, warranting a high but not perfect qualitative and overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 427,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What was the total amount of payments made by PM USA under the State Settlement Agreements for the years 2019, 2020, and 2021 combined, and how does this compare to the maximum potential NPM Adjustment for 2020 alone?",
      "original_answer": "PM USA paid a total of $12.8 billion under the State Settlement Agreements for the years 2019 ($4.2 billion), 2020 ($4.4 billion), and 2021 ($4.3 billion). This total is significantly higher than the maximum potential NPM Adjustment for 2020 alone, which was $572 million.",
      "llm_answer": "\n\nThe total payments made by PM USA under the State Settlement Agreements for 2019, 2020, and 2021 combined were **$12.9 billion** ($4.2 billion in 2019 + $4.4 billion in 2020 + $4.3 billion in 2021). This amount far exceeds the **maximum potential NPM Adjustment for 2020 alone**, which was **$572 million**. Thus, the combined payments over the three years were approximately **22.5 times greater** than the 2020 NPM Adjustment maximum.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate with only a minor discrepancy in the total sum. The individual yearly payments are correct: $4.2 billion in 2019, $4.4 billion in 2020, and $4.3 billion in 2021. The correct sum is $12.9 billion (4.2 + 4.4 + 4.3 = 12.9), which matches the LLM's calculation. However, the ground truth states $12.8 billion, indicating a $0.1 billion difference, possibly due to rounding or data source variation. Given that the individual components and the computed sum in the LLM answer are mathematically consistent, this minor variance does not constitute a significant error. The maximum potential NPM Adjustment for 2020 is correctly cited as $572 million. The comparison reasoning is sound, including the derived ratio of ~22.5x, which is accurate (12.9B / 572M ≈ 22.55). All entities (PM USA, State Settlement Agreements, NPM Adjustment) and years are correctly identified. The answer fully addresses both parts of the multi-hop question: total payments over three years and comparison to the 2020 NPM Adjustment. Semantic equivalence is maintained, and the extra contextual insight (22.5x) enhances clarity without introducing error. Thus, the answer is factually robust, well-reasoned, and contextually complete, warranting a high correctness score despite the negligible total discrepancy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 365,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the difference between the fair value of the 2.85% Notes Due 2030 as reported in the first table and the net carrying amount of the same notes as disclosed in the second table for the fiscal year ending January 30, 2022?",
      "original_answer": "The fair value of the 2.85% Notes Due 2030 is $1,542 million according to the first table, while the net carrying amount is $1,500 million according to the second table. The difference between the two values is $42 million.",
      "llm_answer": "\n\nThe information regarding the fair value and net carrying amount of the 2.85% Notes Due 2030 is not disclosed in the provided pages from NVIDIA's 10-K filing. The pages focus on topics such as business combinations, leases, stock-based compensation, and intangible assets, but no tables or sections related to the specific debt instrument in question are included. Therefore, the difference cannot be determined from the given data.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to match the ground truth. (1) The original answer states that the fair value of the 2.85% Notes Due 2030 is $1,542 million and the net carrying amount is $1,500 million, with a difference of $42 million. These numbers are specific and quantitatively precise. The LLM claims the information is not disclosed, which contradicts the ground truth that these values were available in the referenced tables. (2) There are no correct numbers or calculations in the LLM response — it avoids providing any quantitative data, despite the ground truth having clear figures. (3) The multi-hop reasoning required — comparing fair value from one table and net carrying amount from another — was not attempted by the LLM, which instead defaulted to a 'not disclosed' response without justification. (4) The response lacks contextual relevance because it denies the existence of data that the ground truth confirms is present. This suggests either a failure in retrieval or comprehension of the source documents. Overall, the answer is factually wrong, lacks necessary data, and fails on all dimensions of accuracy and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 326,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the application of the Tailoring Rules impact the capital requirements for Capital One Financial Corporation (COF) as a Category III institution, particularly in relation to the Stress Capital Buffer Rule and the exclusion of certain elements of AOCI?",
      "original_answer": "As a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) is no longer subject to the Basel III Advanced Approaches framework and certain associated capital requirements. Additionally, COF has elected to exclude certain elements of Accumulated Other Comprehensive Income (AOCI) from its regulatory capital. This exclusion, combined with the recalibration of the Stress Capital Buffer Rule—based on supervisory stress test results—reduces the complexity and burden of capital calculations for COF while maintaining a CET1 capital ratio buffer that is institution-specific and annually adjusted.",
      "llm_answer": "\n\nThe application of the Tailoring Rules impacts Capital One Financial Corporation (COF) as a Category III institution by allowing it to exclude certain elements of Accumulated Other Comprehensive Income (AOCI) from regulatory capital, which reduces its capital requirements. Additionally, under the Stress Capital Buffer Rule, COF’s capital conservation buffer is determined annually via supervisory stress tests rather than a fixed 2.5% rate. For the period October 1, 2021–September 30, 2022, COF’s stress capital buffer requirement was set at 2.5%, aligning with the prior fixed buffer, but this tailored approach enables adjustments based on stress test outcomes in future periods. This framework allows COF to maintain flexibility while adhering to regulatory capital standards.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts and reasoning. It accurately identifies that as a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) can exclude certain AOCI elements from regulatory capital, which reduces capital requirements—a core point in the original answer. It also correctly references the Stress Capital Buffer Rule being recalibrated via supervisory stress tests rather than using a fixed requirement. The mention of the 2.5% stress capital buffer for the 2021–2022 period is factually accurate and adds useful specificity not present in the original answer, though this detail is not contradicted by the ground truth. However, the LLM omits the point that COF is no longer subject to the Basel III Advanced Approaches framework, which is a significant component of the Tailoring Rules' impact and part of the multi-hop synthesis required. This omission reduces completeness, particularly in fully explaining the reduction in complexity and burden. While the stress test-based buffer is correctly explained, the LLM refers to it as a 'capital conservation buffer'—a related but distinct concept from the 'Stress Capital Buffer'—which introduces a minor conceptual inaccuracy. Despite this, the overall reasoning is sound, entities (COF, AOCI, Stress Capital Buffer) are correctly identified, and the synthesis across regulatory frameworks is mostly accurate. Number formatting and dates are correct and contextually appropriate. The answer remains semantically close to the original and highly relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 444,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the total change in fair value of Altria's JUUL investment from 2020 to 2021, and how was this change reflected in Altria's consolidated financial statements?",
      "original_answer": "The fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021. This amount was included in 'investments in equity securities' on Altria's consolidated balance sheets at December 31, 2021, and was accounted for under the fair value option following the Share Conversion in the fourth quarter of 2020. Changes in the fair value of the JUUL investment, calculated quarterly using level 3 fair value measurements, were included in 'income (losses) from equity investments' in Altria's consolidated statements of earnings (losses).",
      "llm_answer": "\n\nThe total change in the fair value of Altria's JUUL investment from 2020 to 2021 was a $100 million decrease in 2020, with no change reported in 2021. This decline in 2020 was reflected as a pre-tax loss of $100 million in Altria's consolidated statement of earnings (losses) under \"(income) losses from equity investments.\" The carrying value of the JUUL investment remained at $1.705 billion on the consolidated balance sheets for both years, as no further fair value adjustments were recorded in 2021.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021, meaning there was no change in fair value during this period. However, the LLM incorrectly claims there was a $100 million decrease in 2020, which contradicts the original answer. While the final carrying value of $1.705 billion is correctly stated, the assertion of a $100 million loss is unsupported by the ground truth. (2) The quantitative accuracy is low because the $100 million decrease is factually wrong—no such change occurred between 2020 and 2021. The correct change is $0. The format of numbers (e.g., $1.705 billion vs $1,705 million) is acceptable and semantically equivalent, but the core financial data is incorrect. (3) The reasoning is partially sound in structure—understanding that changes in fair value would be reflected in 'income (losses) from equity investments' and that the investment is on the balance sheet under 'investments in equity securities'—but it fails the multi-hop synthesis because it introduces a loss not present in the data. The model may be conflating information from other filings or time periods. (4) Contextual relevance is moderate: the answer addresses the correct company (Altria), investment (JUUL), financial statements (consolidated balance sheet and earnings statement), and accounting treatment (fair value option, level 3 measurements), but the core factual claim about the change in value is incorrect, undermining the overall correctness. Thus, the correctness score is low despite some structural and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 459,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What percentage of Union Pacific's total locomotives are leased rather than owned, and how does this compare to the total number of switching locomotives in their fleet?",
      "original_answer": "Union Pacific leases 1,037 out of 7,154 total locomotives, which represents approximately 14.5% of their fleet. This number is significantly higher than the 132 switching locomotives in their fleet.",
      "llm_answer": "\n\nUnion Pacific's total locomotives amount to 7,154, with 1,037 leased units. This results in **14.5% of locomotives being leased** (1,037 ÷ 7,154). In comparison, switching locomotives total 132, all of which are owned. Thus, the percentage of leased locomotives (14.5%) is significantly higher than the proportion of switching locomotives (1.8% of the total fleet).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 1,037 leased locomotives out of 7,154 total, resulting in 14.5% leased (1,037 ÷ 7,154 ≈ 0.145 or 14.5%), and 132 switching locomotives. The calculation is correct and clearly shown. (2) The answer addresses both parts of the question: the percentage of leased locomotives and how that compares to the number of switching locomotives. (3) Entity accuracy is correct—Union Pacific is the subject, and all metrics (total locomotives, leased, switching) are properly identified. (4) The reasoning is sound: it correctly notes that 14.5% of the fleet is leased, which is significantly higher than the 132 switching locomotives (which constitute about 1.8% of the fleet), thus providing a valid comparison. The LLM adds contextual clarity by computing the percentage of switching locomotives, which enhances understanding without distorting the truth. All information is semantically equivalent to the original answer and reflects accurate multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 306,
        "total_tokens": 1453
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the change in fair value of the 2.20% Notes Due 2021 from January 31, 2021, to January 30, 2022, and how does this reflect in both the fair value disclosures and the debt-specific maturity and interest rate table?",
      "original_answer": "The fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, as shown in the fair value disclosures. This aligns with the debt-specific maturity and interest rate table, which indicates that the notes had an effective interest rate of 2.38% and a remaining term of 0 years by January 30, 2022, meaning the notes had matured and were no longer outstanding.",
      "llm_answer": "\n\nThe provided document pages do not include specific information about the fair value of NVIDIA's 2.20% Notes Due 2021 or its change from January 31, 2021, to January 30, 2022. The pages focus on business combinations (e.g., Mellanox acquisition), leases, stock-based compensation, and investment disclosures, but there is no mention of this debt instrument, its fair value fluctuations, or related maturity/interest rate details in the excerpts provided. To answer this question fully, additional sections of the 10-K (e.g., Note 8 or 9, typically covering debt) would be required.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is completely incorrect in the context of the evaluation. The question and ground truth are based on a specific knowledge graph derived from SEC 10-K filings, which contains the necessary data to answer the question. The LLM claims that the document pages do not include the required information, but this is an evasion of the task: the evaluation is not about whether a specific excerpt was provided, but whether the LLM can provide the correct answer based on the assumed availability of full filing data. The ground truth states that the fair value decreased from $1,011 million to $0 million, reflecting maturity of the notes, with supporting details in both fair value disclosures and the debt maturity table. The LLM fails to report any of these facts, offers no correct numbers, and does not perform the required multi-hop reasoning (tracking change over time, linking fair value to maturity). It incorrectly asserts lack of data instead of retrieving or inferring the correct answer from the assumed knowledge base. Thus, it scores 0 for correctness, very low on quantitative and qualitative accuracy, and only marginally on contextual relevance for correctly identifying that debt disclosures would typically be in Notes 8 or 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 349,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks impact the calculation of Capital One's supplementary leverage ratio, and what specific regulatory framework influenced this adjustment?",
      "original_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio, as permitted under an interim final rule issued by the Federal Reserve, increased Capital One's supplementary leverage ratio. This adjustment was made under the Basel III Standardized Approach framework, which governs the company's capital ratios and regulatory requirements.",
      "llm_answer": "\n\nThe temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of Capital One's supplementary leverage ratio (SLR) increased the ratio by reducing total leverage exposure. This adjustment was implemented under an **interim final rule issued by the Federal Reserve in April 2020** as part of pandemic-related relief measures, which allowed banking institutions to exclude these low-risk assets temporarily until March 31, 2021. As a result, Capital One's SLR was 10.7% as of December 31, 2020 (reflecting the exclusions), compared to 9.9% by December 31, 2021, after the exclusions expired. The regulatory framework was the Federal Reserve's response to enhance liquidity and capital flexibility during the COVID-19 crisis.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the impact of the exclusion—reducing leverage exposure and increasing the supplementary leverage ratio (SLR)—and correctly attributes the regulatory action to an interim final rule by the Federal Reserve. It also accurately notes the pandemic-related context and the temporary nature of the relief. However, the ground truth does not mention specific SLR values (10.7% in 2020, 9.9% in 2021) or the April 2020 rule issuance and March 31, 2021 expiration date, which are absent from the original answer and may not be supported by the knowledge graph used. These additions, while plausible and contextually accurate in real-world regulatory history, introduce specific data points not present in the ground truth, reducing quantitative accuracy. (2) The numbers and dates (April 2020, March 31, 2021, 10.7%, 9.9%) are not in the original answer and cannot be verified against the knowledge graph, so their inclusion constitutes a deviation. The ground truth focuses on the regulatory mechanism and framework (Basel III Standardized Approach), not performance metrics over time. (3) The multi-hop reasoning is sound: the model connects the exclusion of assets to the SLR calculation, identifies the correct regulator (Federal Reserve), and links it to broader regulatory intent. However, it misses explicit mention of the Basel III Standardized Approach framework, which is a key component of the original answer and directly addresses the second part of the question. Instead, it refers generally to pandemic relief, which is context but not the named regulatory framework. (4) The contextual relevance is high because the answer addresses both parts of the question—impact on SLR and regulatory basis—though with a slight misalignment in specificity. The qualitative accuracy is strong due to logical flow and correct conceptual understanding, but correctness is docked because of unsupported numerical claims and omission of the Basel III framework name, which is central to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 550,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023, and how were these assets valued?",
      "original_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million. These assets, which include Federal Government Securities valued at $1,508 million and Bonds and Debentures valued at $1,696 million, were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "llm_answer": "\n\nThe total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was **$3,209 million**. These assets, which included federal government securities ($1,508 million), bonds and debentures ($1,696 million), and corporate stock ($5 million), were valued using **bid evaluation processes with bid data provided by independent pricing sources**. This methodology applies to both fixed-income securities and preferred stock in the portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the total value of Level 2 pension plan assets as $3,209 million and accurately reports the valuation method as 'bid evaluation processes with bid data provided by independent pricing sources,' which matches the ground truth. The breakdown of assets includes federal government securities ($1,508 million) and bonds and debentures ($1,696 million), both of which are correct. However, the LLM adds 'corporate stock ($5 million)' as part of Level 2 investments, which is not mentioned in the original answer and introduces an unverified component. While the sum of the two main components ($1,508M + $1,696M = $3,204M) is close to $3,209M, the $5M difference could be attributed to rounding or minor other holdings, but the explicit inclusion of 'corporate stock' as a $5M item is speculative and not supported in the ground truth. This represents a minor factual overreach, slightly affecting quantitative and qualitative accuracy. The reasoning and synthesis are otherwise sound, and all key entities (Union Pacific, 2023, Level 2 investments, valuation method) are correct. The answer is highly relevant and conveys nearly all information accurately, warranting a high correctness score with a small deduction for the unsupported asset category.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 357,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What specific automotive applications of NVIDIA Omniverse are mentioned in the 10-K filing, and how does its integration with the DRIVE platform support NVIDIA's end-to-end AI computing strategy?",
      "original_answer": "The 10-K filing specifically mentions that NVIDIA Omniverse Avatar software is used for real-time conversational AI capability in automotive applications, particularly as part of the DRIVE Chauffeur and DRIVE Concierge systems. This integration with the DRIVE platform supports NVIDIA's end-to-end AI computing strategy by combining Omniverse's real-time 3D simulation and collaboration capabilities with DRIVE's autonomous driving and in-vehicle experience solutions. This strategic integration allows NVIDIA to provide a comprehensive, software-defined approach to automotive computing—from training deep neural networks using GPUs to deploying AI-driven cockpit experiences and autonomous driving features, enabling continuous innovation through over-the-air updates.",
      "llm_answer": "\n\nThe 10-K filing specifies two automotive applications of NVIDIA Omniverse: **virtual car showrooms** (enabling immersive, realistic vehicle visualization) and **real-time conversational AI experiences** via the DRIVE Concierge, which uses Omniverse Avatar software for in-vehicle interactions. Integration with the DRIVE platform supports NVIDIA's end-to-end AI computing strategy by unifying simulation (Omniverse) with autonomous driving systems (DRIVE Hyperion, DRIVE AV/IX). This allows seamless AI training, validation (via DRIVE Constellation simulation), and deployment on DRIVE hardware, ensuring continuous innovation and over-the-air updates. The combination leverages NVIDIA’s GPU-driven AI stack and software-defined architecture to deliver scalable, safe, and evolving autonomous vehicle solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies real-time conversational AI via Omniverse Avatar and its use in DRIVE Concierge, which aligns with the ground truth. However, it incorrectly adds 'virtual car showrooms' as a specific application mentioned in the 10-K, which is not stated in the original answer or supported by the knowledge graph. This is a factual overreach not present in the source. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—score of 10 is appropriate by default. (3) The multi-hop reasoning is mostly sound: the integration of Omniverse with DRIVE is correctly framed as supporting end-to-end AI computing, including simulation, training, and over-the-air updates. However, the mention of DRIVE Hyperion, DRIVE Constellation, and DRIVE AV/IX goes beyond the scope of the original answer, which only specifies DRIVE Chauffeur and DRIVE Concierge. While these may be accurate components of the DRIVE platform, they are not mentioned in the ground truth and introduce unverified detail. (4) Contextual relevance is high because the answer addresses both parts of the question—applications and strategic integration—and uses appropriate terminology. The core strategy explanation (simulation + deployment + continuous updates) matches the ground truth’s intent. The correctness score is 7 due to the addition of unsupported specific applications and platform components, even though the central reasoning and key facts (Omniverse Avatar, conversational AI, DRIVE integration, end-to-end strategy) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 443,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023, and how did this compare to the percentage change in Converse's operating income over the same period?",
      "original_answer": "Converse's contribution to NIKE, Inc.'s total revenues increased by 3.4% from 2022 to 2023, while its operating income decreased by 30.0% over the same period.",
      "llm_answer": "\n\nThe percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023 was a **decrease of approximately -5.6%** (from 5.02% in 2022 to 4.74% in 2023). In contrast, Converse's operating income (EBIT) increased by **1.0%** during the same period (from $669 million in 2022 to $676 million in 2023). This indicates that while Converse's revenue growth lagged behind overall NIKE, Inc. revenue growth, its operating income improved modestly.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect on all key metrics. The ground truth states that Converse's contribution to NIKE's total revenues increased by 3.4% from 2022 to 2023, but the LLM claims a decrease of -5.6% (from 5.02% to 4.74%). This contradicts the ground truth. Additionally, the ground truth reports that Converse's operating income decreased by 30.0%, whereas the LLM states it increased by 1.0% (from $669M to $676M), which is directionally and quantitatively wrong. (2) The numbers provided in the LLM answer (e.g., $669M and $676M) do not align with the ground truth and appear fabricated or misattributed. The percentage calculations based on these numbers are internally consistent but incorrect because the inputs are wrong. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the actual revenue contribution trend and operating income trend for Converse over the two years. It incorrectly infers that revenue share decreased and operating income increased, which is the opposite of the truth. (4) The contextual relevance is moderate because the answer addresses the right question structure (percentage changes in revenue contribution and operating income), but the factual inaccuracies render it largely irrelevant. Due to major errors in both quantitative and qualitative dimensions, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 383,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the changes to the TDR accounting guidance impact the classification of trial modifications in both the residential real estate and credit card loan portfolios for the year ended December 31, 2023?",
      "original_answer": "The changes to the TDR accounting guidance eliminated the 'reasonably expected' and 'concession' assessment criteria, which resulted in trial modifications being classified as TDRs but not FDMs in both the residential real estate and credit card loan portfolios. For residential real estate, this meant $69 million of loans under trial modification were considered TDRs but not FDMs. Similarly, for credit card loans, $27 million of loans under trial modification were classified as TDRs but not FDMs.",
      "llm_answer": "\n\nThe changes to the TDR (Troubled Debt Restructuring) accounting guidance impacted the classification of trial modifications in both portfolios by eliminating the prior criteria requiring a \"reasonably expected\" assessment of financial difficulty and concessions. For **residential real estate loans**, trial modifications ($69 million in 2023) and Chapter 7 bankruptcy loans were classified as TDRs but not as Fully Disclosed Modifications (FDMs), increasing total TDRs compared to 2022 ($362 million). Similarly, for **credit card loans**, trial modifications ($27 million in 2023) were classified as TDRs but not FDMs, raising total TDRs from $418 million in 2022. This change expanded TDR recognition to include trial periods without permanent modifications, aligning with the revised guidance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the elimination of 'reasonably expected' and 'concession' criteria, classification of trial modifications as TDRs but not FDMs, and the correct dollar amounts ($69 million for residential real estate and $27 million for credit card loans) are all accurately reported. Number formats are consistent and acceptable. (2) Quantitative accuracy is perfect—both figures match the original answer exactly and are correctly attributed to the respective portfolios and year (2023). (3) The qualitative reasoning is sound: the LLM correctly explains the impact of the guidance change and synthesizes the effect on both loan portfolios. It adds context not in the original (e.g., comparison to 2022 TDR totals), which is factually consistent and enhances understanding, though not strictly required. (4) The answer is fully relevant and directly addresses the question about classification impacts in both portfolios due to the guidance change. The only minor point preventing a perfect 10 is the addition of external-seeming context (2022 comparisons) not present in the ground truth, which, while plausible, isn't confirmed by the provided truth and slightly extends beyond the scope. However, it doesn't detract from correctness. Overall, the core multi-hop synthesis—linking accounting change to classification outcome across two portfolios with correct figures—is executed accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 407,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How many total retention shares and retention units were outstanding under Union Pacific's stock incentive plans as of December 31, 2023, and how does this compare to the number of restricted shares outstanding under the Directors Plan on the same date?",
      "original_answer": "As of December 31, 2023, Union Pacific had 954,405 retention shares and 366,046 retention units outstanding under its stock incentive plans, totaling 1,320,451. This compares to 16,000 restricted shares outstanding under the Directors Plan on the same date.",
      "llm_answer": "\n\nAs of December 31, 2023, Union Pacific had **1,304,451 retention shares and retention units** outstanding under its stock incentive plans (245,107 under the 2013 Plan and 1,059,344 under the 2021 Plan). This is significantly higher than the **16,000 restricted shares** outstanding under the Directors Plan on the same date.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant numerical error in the total retention shares and units. It reports 1,304,451, while the ground truth is 1,320,451 (sum of 954,405 retention shares and 366,046 retention units). This discrepancy of 16,000 suggests a possible confusion with the Directors Plan number. Additionally, the breakdown by plan (245,107 under 2013 Plan and 1,059,344 under 2021 Plan) is not present in the ground truth and cannot be verified, indicating potential fabrication or misattribution. (2) The restricted shares under the Directors Plan are correctly stated as 16,000, matching the ground truth. However, the key total for retention instruments is incorrect, and no explanation for the sum is provided. (3) The multi-hop reasoning is partially sound—comparing retention instruments to Directors Plan shares—but fails in accurate synthesis of the total retention count. The model appears to combine data across plans but arrives at an incorrect total, undermining the core quantitative claim. (4) Despite the numerical inaccuracy, the answer addresses both parts of the question, uses correct entities (Union Pacific, correct date, Directors Plan), and maintains relevant context. Wording and structure are clear, and the comparison is logically framed. The error is primarily in calculation or data retrieval, not reasoning structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 381,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided to the JV?",
      "original_answer": "AMD's total investment in the ATMP JV as of December 28, 2024, was $249 million. This includes the carrying value of its equity investment, which was $149 million, and a secured term loan of $100 million provided to the JV.",
      "llm_answer": "\n\nThe total amount of AMD's investment in the ATMP JV as of December 28, 2024, was **$249 million**. This includes the carrying value of its equity investment of **$149 million** (15% ownership) and a secured loan of **$100 million** provided to the JV under a one-year term loan agreement. Both amounts are explicitly stated in the \"ATMP Joint Ventures\" section of NOTE 7.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All key facts are accurate: the total investment is $249 million, composed of a $149 million equity investment and a $100 million secured loan. These numbers exactly match the original answer, and the format variations (e.g., $100 million vs $100M) are acceptable. (2) The date 'December 28, 2024' is correctly used. (3) The LLM adds minor contextual details (e.g., 15% ownership, one-year term loan, reference to NOTE 7) that are consistent with the source and enhance clarity without introducing errors. (4) The multi-hop reasoning is sound—correctly combining equity carrying value and loan amount from the same JV disclosure to arrive at total investment. (5) The answer is semantically equivalent and fully addresses the question. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 255,
        "total_tokens": 1415
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What was the total financial impact on Danaher from the disposition of Envista Holdings Corporation, including the gain on disposition, the foreign currency translation adjustment loss, and the IPO and Separation-related costs?",
      "original_answer": "The total financial impact on Danaher from the disposition of Envista Holdings Corporation was $387 million. This includes a $451 million gain on disposition, reduced by $109 million in reclassified foreign currency translation adjustment losses and $69 million in IPO and Separation-related costs.",
      "llm_answer": "\n\nThe total financial impact on Danaher from the disposition of Envista Holdings Corporation in 2019 included a **pre-tax gain of $451 million**, a **$109 million foreign currency translation adjustment loss** reclassified into discontinued operations, and **$69 million in IPO and Separation-related costs**. The net impact, combining these components, was **$273 million** ($451M gain – $109M loss – $69M costs).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer contains a critical calculation error that renders the final result factually incorrect. While it correctly identifies the individual components from the ground truth — the $451 million gain on disposition, $109 million foreign currency translation adjustment loss, and $69 million in IPO and Separation-related costs — it incorrectly calculates the net financial impact as $273 million ($451M – $109M – $69M). The correct total financial impact, as stated in the original answer, is $387 million, which represents the gain *net of* the loss and costs: $451M – $109M – $69M = $273M is mathematically correct, but this is not the 'total financial impact' as defined in the ground truth. Instead, the ground truth explicitly states the total impact was $387 million, implying a different accounting treatment — likely that the $387 million is the gain after certain adjustments but before others, or that the components are not meant to be arithmetically combined in the way the LLM attempted. More critically, the ground truth presents $387 million as the total impact, not $273 million, so the LLM contradicts the verified fact. This is a major quantitative and qualitative error. Despite correct entity identification (Danaher, Envista Holdings Corporation, 2019), correct contextual components, and relevance to the question, the incorrect final figure and flawed reasoning undermine the entire response. The model fails the multi-hop synthesis by misrepresenting how the components relate to the final reported impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 420,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, impact the overall EBIT performance of the Converse segment, considering the 130 basis point gross margin contraction linked to unfavorable foreign currency exchange rates?",
      "original_answer": "The 15% currency-neutral revenue decline in Converse, primarily due to drops in North America and Western Europe, contributed to a 30% decrease in reported EBIT. This was exacerbated by a 130 basis point gross margin contraction caused in part by unfavorable changes in standard foreign currency exchange rates, which further reduced profitability.",
      "llm_answer": "\n\nThe 15% currency-neutral revenue decline in the Converse segment, driven by weaker performance in North America and Western Europe, led to a **30% decrease in EBIT** for the segment. This EBIT decline was exacerbated by a **130 basis point gross margin contraction** linked to unfavorable foreign currency exchange rates, which increased costs and reduced margins. Additional pressures included lower full-price ASP (net of discounts), higher operating costs, and weaker direct-to-consumer margins, partially offset by lower ocean freight rates. The combination of reduced sales and margin compression significantly impaired Converse’s profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the 15% currency-neutral revenue decline in Converse driven by North America and Western Europe and accurately states that this led to a 30% decrease in reported EBIT, matching the ground truth. The 130 basis point gross margin contraction due to unfavorable foreign currency exchange rates is also correctly included, with accurate causal linkage to reduced profitability. All quantitative figures (15%, 30%, 130 bps) are factually correct and contextually well-applied. The reasoning correctly synthesizes the multi-hop relationship between revenue decline, margin pressure, and EBIT impact. The only minor deviation is the addition of extra details not present in the ground truth—such as lower full-price ASP, higher operating costs, weaker DTC margins, and lower ocean freight rates—which, while plausible, are not confirmed in the original answer. However, these do not contradict the ground truth and may reflect supplementary knowledge; thus, they don’t undermine correctness. The core multi-hop logic (revenue decline + margin contraction → EBIT decline) is sound and accurately represented. Semantic equivalence is maintained, and all entities (Converse segment, EBIT, gross margin, foreign exchange) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 359,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the adoption of the new TDR accounting guidance on January 1, 2023, specifically impact JPMorgan Chase's allowance for credit losses in 2023, and what was the resulting effect on the Firm's financial position given the changes in trial modifications and Chapter 7 loans?",
      "original_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan Chase's allowance for credit losses. This change was driven by the elimination of the TDR 'reasonably expected' and 'concession assessment' criteria, which reclassified $69 million of loans subject to trial modification and $9 million of loans subject to discharge under Chapter 7 bankruptcy proceedings as non-FDMs (Financial Disincentive Modifications), although they were still considered TDRs. This reclassification reduced the allowance requirement, reflecting a change in how credit losses were estimated for these categories of loans, thereby improving the Firm's reported financial position by lowering the required reserves.",
      "llm_answer": "\n\nThe adoption of the new TDR accounting guidance on January 1, 2023, reduced JPMorgan Chase's allowance for credit losses by **$587 million** as of December 31, 2023. This reduction stemmed from reclassifying trial modifications and Chapter 7 loans as TDRs (but not FDMs), which altered the criteria for assessing credit loss provisions. Specifically, trial modifications ($69 million in residential real estate loans) and Chapter 7 loans ($9 million) were no longer excluded from TDR accounting, leading to a lower allowance requirement compared to prior periods where such adjustments were not fully captured. The net effect improved the Firm’s financial position by decreasing provisions for credit losses, contributing to a total allowance of $24.8 billion in 2023, despite increased credit exposure from First Republic acquisitions and higher delinquencies in certain portfolios.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $587 million reduction in the allowance for credit losses, the $69 million in trial modifications, and the $9 million in Chapter 7 loans, all of which match the ground truth. The date of adoption (January 1, 2023) is accurate. However, there is a critical misstatement in logic: the LLM claims that trial modifications and Chapter 7 loans were 'no longer excluded from TDR accounting,' implying they were newly included, whereas the ground truth states they were reclassified as *non-FDMs* (not TDRs), despite still being considered TDRs. This is a reversal of the actual accounting change—the new guidance removed certain criteria, leading to fewer loans being treated as FDMs, not more being brought into TDR accounting. (2) All numbers are quantitatively accurate: $587M reduction, $69M and $9M components, and the resulting effect on reserves. The mention of $24.8 billion total allowance, while not in the original answer, may be contextually valid but is unverifiable from the ground truth provided and introduces extraneous detail. (3) The multi-hop reasoning is partially flawed: while the model connects the guidance change to the allowance impact and identifies the two loan categories, it misrepresents the direction of the accounting change—specifically, the elimination of 'reasonably expected' and 'concession assessment' criteria led to *fewer* loans being classified as FDMs, reducing loss allowances. The LLM incorrectly frames this as a new inclusion of loans into TDR accounting. (4) The correctness score is 7 because the core numbers and overall impact (reduced allowance, improved financial position) are correct, but the explanation of *why* contains a significant conceptual error. Quantitative accuracy is high (9) due to correct dollar amounts. Qualitative accuracy is lower (6) due to flawed reasoning and misrepresentation of the accounting change. Contextual relevance is strong (9) as the answer addresses all parts of the question with mostly relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 549,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What is the total amount invested in Level 2 assets by UNP's pension plan, and which specific investment categories use bid evaluation with independent pricing sources as their valuation methodology?",
      "original_answer": "The total amount invested in Level 2 assets by UNP's pension plan is $1,111 million. These Level 2 assets are specifically composed of investments in Corporate Stock, Federal Government Securities, and Bonds and Debentures, all of which use bid evaluation processes with independent pricing sources as their valuation methodology.",
      "llm_answer": "\n\nThe total amount invested in Level 2 assets by UNP's pension plan as of December 31, 2023, is **$3,209 million**. The specific investment categories using bid evaluation with independent pricing sources as their valuation methodology are **Federal Government Securities**, **Bonds and Debentures**, and **Preferred Stock**. \n\n(Answer derived from the \"Fair Value Measurements\" section and the December 31, 2023, asset allocation table in the provided document.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The total amount invested in Level 2 assets by UNP's pension plan is stated as $3,209 million, whereas the ground truth is $1,111 million—a major discrepancy. Additionally, the investment categories listed differ: the LLM includes 'Preferred Stock' and omits 'Corporate Stock', which is part of the correct answer. Instead, it incorrectly lists 'Preferred Stock' as using bid evaluation with independent pricing sources, which is not in the original answer. (2) Quantitatively, the dollar amount is more than double the correct value, and the composition of asset categories is incorrect. There is no indication of calculation or sourcing error justification in the LLM response, and the cited document section does not align with the ground truth. (3) The multi-hop reasoning is flawed—the model fails to correctly identify the asset categories associated with Level 2 valuation methodology and misidentifies the total. It appears to have pulled data from a different company, year, or context, failing to synthesize the correct entities. (4) Contextual relevance is moderate because the answer addresses the right type of information (dollar amount and asset categories using bid evaluation), but the actual facts are incorrect, severely undermining accuracy. Minor credit is given for attempting the correct structure and referencing a plausible document section.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 398,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the growth rate of DHR's research and medical products segment revenue between 2019 and 2021 compare to the company's total revenue growth over the same period, and what does this suggest about the segment's role in DHR's overall financial performance?",
      "original_answer": "DHR's research and medical products segment grew from $13,512 million in 2019 to $24,802 million in 2021, representing a 83.5% increase over two years. Meanwhile, DHR's total revenue increased from $17,911 million in 2019 to $29,453 million in 2021, a 64.4% increase. This indicates that the research and medical products segment outperformed the company's overall growth, suggesting it was a key driver of DHR's financial performance during this period.",
      "llm_answer": "\n\nThe research and medical products segment revenue grew at a significantly higher rate (83.6%) from 2019 to 2021 compared to DHR's total revenue growth (64.5%) over the same period. This outperformance highlights the segment's critical role as a primary growth driver for the company, indicating strong demand for its products and its pivotal contribution to DHR's overall financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the percentages are slightly rounded: the ground truth reports an 83.5% increase for the research and medical products segment and 64.4% for total revenue, while the LLM reports 83.6% and 64.5%, respectively. These minor discrepancies are within acceptable rounding tolerance and do not affect factual correctness. (2) The revenue figures themselves ($13,512M to $24,802M and $17,911M to $29,453M) are correctly reflected in the growth rates, and the LLM accurately captures the comparative growth dynamics. (3) The reasoning is sound: the model correctly identifies that the segment outpaced overall company growth and synthesizes this into a logical conclusion about the segment's strategic importance. (4) All entities (DHR, research and medical products segment, time period 2019–2021) are correct, and the answer fully addresses both parts of the question—comparison of growth rates and implications for financial performance. The wording differs slightly but maintains semantic equivalence. Only a minor deduction in quantitative accuracy due to rounding precision; otherwise, the response is excellent across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 347,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the adoption of the revised TDR accounting guidance on January 1, 2023, specifically affect JPMorgan's allowance for credit losses and the classification of trial modifications for credit card loans during the year ended December 31, 2023?",
      "original_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan's allowance for credit losses. Additionally, the changes eliminated the TDR reasonably expected and concession assessment criteria, which affected the classification of credit card loan modifications. As a result, trial modifications were considered TDRs but not FDMs (formally distressed modifications), whereas in the prior year, credit card TDRs totaled $418 million. For the year ended December 31, 2023, credit card FDMs were $648 million, and there were $27 million of loans subject to trial modifications.",
      "llm_answer": "\n\nThe adoption of the revised TDR accounting guidance on January 1, 2023, reduced JPMorgan's allowance for credit losses by **$587 million** during the year ended December 31, 2023, as noted in the discussion of changes to the allowance. For credit card loans, the revised guidance eliminated the \"reasonably expected\" and \"concession assessment\" criteria for TDR classification, resulting in **trial modifications and Chapter 7 bankruptcy loans being classified as TDRs but not as Fully Debt Modified (FDMs)**. This change affected reporting, with $27 million of credit card loans subject to trial modifications in 2023 classified as TDRs under the new rules, compared to prior-period TDR classifications ($418 million for credit cards in 2022).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: the $587 million reduction in allowance for credit losses, $27 million in trial modifications, and reference to prior-year credit card TDRs of $418 million (implied 2022) are all factually accurate. The $648 million in FDMs for 2023 is not mentioned in the LLM answer, which is a minor omission but does not distort the overall picture. (2) The qualitative explanation correctly captures the elimination of the 'reasonably expected' and 'concession assessment' criteria under the revised TDR guidance, and accurately explains that trial modifications (and Chapter 7 bankruptcies) are now classified as TDRs but not FDMs. This reflects proper multi-hop reasoning across accounting rule changes and their impact on classification. (3) The contextual relevance is excellent—the response directly addresses both parts of the question: the effect on allowance for credit losses and the change in classification of trial modifications. (4) The only reason for not scoring a 10 is the omission of the $648 million FDM figure for 2023, which was explicitly stated in the original answer and adds completeness to the post-adoption impact. However, the core facts, numbers, and reasoning are sound, and the omission does not introduce inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 373,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did 3M's adoption and subsequent introduction of a new accounting principle for determining net periodic pension and postretirement plan cost impact the presentation of its pension-related financial metrics across reporting periods?",
      "original_answer": "3M adopted a new accounting principle in the first quarter of 2021 that changed how it calculates the market-related value of fixed income securities in its pension and postretirement plans. Previously, the company used a calculated value approach that deferred asset gains or losses over three years, but it switched to a fair value approach that immediately reflects changes in asset values. This change was applied retrospectively, impacting the expected return on plan assets and the amortization of net unamortized actuarial gains or losses. As a result, the presentation of pension-related financial metrics such as net periodic benefit cost, non-operating other expense (income), net income, and earnings per share was altered. Additionally, this change affected consolidated other comprehensive income, retained earnings, and accumulated other comprehensive income (loss). The fair value approach aligns the expected return on plan assets more closely with the plans' funded status and liability-driven investment strategy, resulting in a more current reflection of asset value changes in financial reporting.",
      "llm_answer": "\n\n3M's adoption of the fair value approach for fixed income plan assets in 2021, applied retrospectively, impacted pension-related financial metrics by adjusting previously reported net periodic benefit costs and comprehensive income. This change increased 2020 net income by $65 million (from $5,388M to $5,453M) and decreased 2019 net income by $53 million (from $4,582M to $4,529M), affecting earnings per share (e.g., basic EPS rose from $9.32 to $9.43 in 2020 and fell from $7.92 to $7.83 in 2019). It also reduced accumulated other comprehensive income (loss) and adjusted retained earnings, while aligning expected returns on assets with funded status under a liability-driven investment strategy. The change did not affect operating income or cash flows but revised non-operating expenses and equity components.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key change: 3M's 2021 adoption of the fair value approach for fixed income securities in pension and postretirement plans, applied retrospectively. This replaced the prior three-year smoothing (calculated value) method. (2) The quantitative details are precise: the $65 million increase in 2020 net income (from $5,388M to $5,453M) and $53 million decrease in 2019 (from $4,582M to $4,529M) match expected impacts. EPS changes (2020: $9.32 to $9.43; 2019: $7.92 to $7.83) are correctly stated. These figures are consistent with the retrospective restatement implied in the original answer. (3) The reasoning is sound: the LLM correctly links the accounting change to impacts on net periodic benefit cost, non-operating expenses, comprehensive income, retained earnings, and AOCI, while noting no effect on operating income or cash flows—consistent with the nature of the change. It also correctly notes alignment with liability-driven investment strategy and funded status. (4) The only minor limitation is that the original answer emphasizes the conceptual rationale (e.g., immediate reflection of asset value changes, impact on expected return and amortization), which the LLM summarizes but does not fully elaborate. However, all critical multi-hop elements—accounting change, retrospective application, specific financial impacts across years, affected metrics, and strategic alignment—are present and accurate. Wording differs but semantic meaning is equivalent. No factual errors; numbers, years, and entities are correct. Thus, the answer earns a 9 for correctness, missing only full depth on the conceptual mechanism behind the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 473,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did the adoption of the new TDR accounting guidance impact JPMorgan's allowance for credit losses in 2023, and what was the specific dollar amount of this impact?",
      "original_answer": "The adoption of the changes to the TDR accounting guidance on January 1, 2023, resulted in a reduction of $587 million in JPMorgan's allowance for credit losses. This reduction occurred because the new guidance eliminated the TDR 'reasonably expected' and 'concession' assessment criteria, which affected how trial modifications were classified. Previously, trial modifications were considered TDRs (Troubled Debt Restructurings), but under the new guidance, they are no longer classified as FDMs (Financial Difficulty Modifications), leading to a lower allowance requirement.",
      "llm_answer": "\n\nThe adoption of the new TDR accounting guidance on January 1, 2023, resulted in a **reduction of $587 million** in JPMorgan's allowance for credit losses as of December 31, 2023. This adjustment is explicitly noted in the \"Cumulative effect of a change in accounting principle\" line within the allowance for credit losses table, reflecting the impact of eliminating the prior TDR reasonably expected and concession assessment criteria.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amount of $587 million is accurately reported, and the date of adoption—January 1, 2023—is correct, with the impact reflected as of December 31, 2023, which aligns with the annual reporting period. (2) The answer addresses both parts of the question: the impact (a reduction in allowance) and the specific dollar amount. (3) Entity accuracy is perfect: JPMorgan, TDR accounting guidance, allowance for credit losses, and the correct accounting change (elimination of 'reasonably expected' and 'concession' criteria) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the LLM correctly links the change in accounting principle to its effect on classification (trial modifications no longer treated as TDRs/FDMs), and cites the precise location in financial statements ('Cumulative effect of a change in accounting principle'), which demonstrates deep contextual and technical understanding. The answer is semantically equivalent to the ground truth, with slightly more detail on reporting presentation, but no factual deviations. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 339,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the combined impact on goodwill and operating profit specifically in the Africa/Eurasia region for Colgate-Palmolive in 2023, and how does this compare to the capital expenditures made in the same region during the year?",
      "original_answer": "In 2023, Colgate-Palmolive experienced a decrease in goodwill of $19 million due to foreign currency translation in the Africa/Eurasia region, bringing the ending goodwill balance to $88 million from $107 million. At the same time, the company reported an operating profit of $254 million for the region. Capital expenditures in Africa/Eurasia totaled $10 million in 2023. Therefore, the combined impact of the goodwill decrease and capital expenditures was $29 million, which is significantly lower than the region's operating profit of $254 million.",
      "llm_answer": "\n\nIn 2023, Colgate-Palmolive's Africa/Eurasia region experienced a **$19 million decrease in goodwill** due to foreign currency translation adjustments (as shown in Note 5, with net carrying value declining from $107 million to $88 million). The region’s **operating profit was $254 million** (per the operating profit table). Capital expenditures in the same region totaled **$10 million** for 2023 (from the capital expenditures table). Thus, the operating profit was significantly higher than capital expenditures, while the goodwill reduction stemmed solely from currency translation effects, with no impairments or acquisition-related charges noted for the region in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $19 million decrease in goodwill (from $107M to $88M), operating profit of $254 million, and capital expenditures of $10 million in the Africa/Eurasia region for 2023 are all accurately reported. Number formats match, and no calculation errors are present. (2) Quantitative accuracy is perfect—each dollar amount and change is consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from goodwill, operating profit, and capital expenditures across different sections of the filing (e.g., Note 5, operating profit table, capex table), demonstrating proper cross-document inference. (4) While the original answer includes a combined impact figure ($19M + $10M = $29M) and explicitly compares it to operating profit, the LLM omits the explicit sum of $29M but still conveys that operating profit was 'significantly higher' than capex and contextualizes the goodwill decline. This minor omission of the combined $29M figure prevents a perfect 10, but the core reasoning and facts remain intact. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing all parts of the question with appropriate financial context and source references.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 372,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the impact on 3M's goodwill reporting structure as a result of the 2021 business segment reporting changes, and how was this evaluated in terms of impairment risk?",
      "original_answer": "As a result of the 2021 business segment reporting changes, 3M applied the relative fair value method to determine the impact on goodwill for any reporting unit changes, and these changes were found to be immaterial. Despite these changes, the Company completed its annual goodwill impairment test in the fourth quarter of 2021 and determined that no impairment existed. This indicates that the restructuring did not negatively affect the fair value of reporting units to the extent that impairment would occur.",
      "llm_answer": "\n\nThe 2021 business segment reporting changes at 3M resulted in adjustments to its goodwill reporting structure, as reporting units were realigned with the new segment framework. The Company applied the **relative fair value method** to allocate goodwill to the revised reporting units, and the impact of these changes was determined to be **immaterial**. Additionally, 3M conducted an impairment assessment concurrent with the reporting changes and concluded that **no goodwill impairment existed**. This evaluation was further supported by the annual goodwill impairment test performed in the fourth quarter of 2021, which also indicated no impairment across all reporting units. The Company attributed this outcome to the stability of reporting unit fair values relative to their carrying amounts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the use of the relative fair value method, the immateriality of the impact, the completion of the annual goodwill impairment test in Q4 2021, and the conclusion of no impairment. (2) There are no numeric values requiring calculation, but the dates (2021) and qualitative assessments (immaterial, no impairment) match exactly. Format and wording differences (e.g., 'determined to be immaterial' vs 'found to be immaterial') do not affect factual accuracy. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the impact of segment changes on goodwill allocation and links it to impairment evaluation, showing understanding of both structural and financial reporting implications. (4) The answer is highly relevant, complete, and conveys the same information with slightly enhanced clarity (e.g., mentioning 'stability of reporting unit fair values'), which is consistent with the original. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 308,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the strategic rationale behind AMD's investment in Silo AI, and how does it connect to AMD's goals for AI model deployment and software development?",
      "original_answer": "AMD's investment in Silo AI was strategically aimed at leveraging Silo AI's workforce to accelerate the deployment and development of AI models and software solutions on AMD hardware. This partnership aligns with AMD's broader objective to strengthen its capabilities in the AI space, particularly within its Data Center segment, by integrating Silo AI's expertise in AI research and development.",
      "llm_answer": "\n\nAMD's acquisition of Silo AI was strategically driven by the desire to enhance its AI model deployment and software development capabilities. The rationale, as stated in the 10-K filing, centers on Silo AI's workforce, whose expertise in AI research and development was expected to accelerate the integration and optimization of AI models and software solutions on AMD's hardware platforms. This aligns directly with AMD's Data Center segment goals, which focus on AI accelerators, GPUs, and other compute solutions for data centers, thereby strengthening AMD's competitive position in the AI infrastructure market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. It correctly identifies the strategic rationale behind AMD's investment—leveraging Silo AI's workforce to accelerate AI model deployment and software development on AMD hardware—and connects this to AMD's Data Center segment goals in AI infrastructure. The only minor inaccuracy is the use of the term 'acquisition' instead of 'investment,' which slightly mischaracterizes the nature of the transaction (investment vs. full ownership). However, this does not significantly detract from the overall correctness, as the intent and strategic outcome are accurately described. There are no numeric values in the question or answer, so quantitative accuracy is not applicable but assumed perfect. The reasoning is sound, with proper multi-hop synthesis between Silo AI's expertise and AMD's strategic objectives in AI hardware and software integration. The answer is fully contextually relevant and addresses both parts of the question: the rationale and its connection to AMD's AI goals.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 305,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many amendments were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015?",
      "original_answer": "6 amendments were made to the agreement during the specified period.",
      "llm_answer": "\n\nThe Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology had **six amendments** made between September 2, 2014, and September 1, 2015. These include the First Amendment (October 31, 2014), Second Amendment (December 15, 2014), Third Amendment (February 12, 2015), Fourth Amendment (March 30, 2015), Fifth Amendment (June 30, 2015), and Sixth Amendment (September 1, 2015).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that 6 amendments were made to the agreement between September 2, 2014, and September 1, 2015, which aligns with the original answer. (2) All dates and amendment numbers are correct: First Amendment (October 31, 2014), Second (December 15, 2014), Third (February 12, 2015), Fourth (March 30, 2015), Fifth (June 30, 2015), and Sixth (September 1, 2015). These fall within the specified date range, with the start date being exclusive (after September 2, 2014) and end date inclusive (September 1, 2015), which is correctly interpreted. (3) The multi-hop reasoning is sound—though the question only requires counting amendments in a time window, the model correctly identifies and lists each amendment, demonstrating proper synthesis of temporal and document-level data. (4) The answer is semantically equivalent and exceeds expectations by providing detailed supporting information without introducing errors. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 295,
        "total_tokens": 1424
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did the timing of PM's acquisition of Swedish Match impact its operational reporting scope in the 2023 10-K, and what does the separate shipment volume commentary suggest about the integration timeline?",
      "original_answer": "PMI acquired a majority position in Swedish Match on November 11, 2022, which resulted in Swedish Match's results being included in PM's financials only from that date through December 31, 2022. This limited inclusion period affected the operational reporting scope in the 2023 10-K, as Swedish Match's business operations were managed and evaluated separately from PM's geographical segments. Additionally, the separate shipment volume commentary for Swedish Match indicates that integration efforts had not yet reached a stage where its operations were fully consolidated with PM’s existing business units, suggesting a phased or ongoing integration process.",
      "llm_answer": "\n\nThe acquisition of Swedish Match on November 11, 2022, impacted Philip Morris International's (PMI) 2023 10-K operational reporting scope by adding the Swedish Match segment as a separate operating segment, distinct from geographical segments. This allowed PMI to report Swedish Match's full-year 2023 results (vs. partial 2022 results post-acquisition), enhancing transparency. The separate shipment volume commentary for Swedish Match in 2023 (e.g., nicotine pouches, snus, and cigars) suggests integration was ongoing but not yet fully consolidated into PMI’s core operations, as volumes were analyzed independently. This indicates the integration timeline was still in progress in 2023, with distinct reporting to track performance post-acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the acquisition date of November 11, 2022, is correctly stated, and the implication that Swedish Match’s results were included only from that date in 2022 is accurate. The LLM correctly notes that in the 2023 10-K, Swedish Match was reported as a separate segment, allowing for full-year 2023 reporting—this is factually sound. (2) There are no calculation errors, and all dates and time periods are correct. (3) The reasoning is strong: the LLM correctly infers that the separate shipment volume commentary (e.g., for nicotine pouches, snus, cigars) indicates ongoing integration and lack of full consolidation, reflecting a phased integration timeline. This demonstrates proper multi-hop synthesis between the acquisition timing, reporting structure, and operational commentary. (4) The only minor gap is that the original answer emphasizes that Swedish Match was excluded from PM’s geographical segments and managed separately—this nuance is implied but not explicitly stated in the LLM answer. However, the core facts, logic, and implications are correctly conveyed, with full semantic equivalence on the integration timeline and reporting impact. Hence, a score of 9 is warranted—excellent accuracy with only slight room for added precision in structural detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 376,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What was the total notional amount of interest rate swaps entered into by 3M in 2021, and how does this compare to the combined principal amount of the fixed-rate notes due in 2049 and 2050 that these swaps were designed to hedge?",
      "original_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million. These swaps were applied to a combined principal amount of $1.65 billion of fixed-rate notes due in 2049 and 2050, meaning the swaps covered approximately 48.5% of the total principal for those notes.",
      "llm_answer": "\n\nIn 2021, 3M entered into interest rate swaps with an aggregate notional amount of **$800 million** to hedge portions of its fixed-rate notes. These swaps converted $500 million of the $1.0 billion principal amount of fixed-rate notes due in 2049 and $300 million of the $650 million principal amount of fixed-rate notes due in 2050 into floating rate debt. Thus, the combined principal amount of the hedged notes was **$1.65 billion**, while the swaps covered **$800 million** of that total, or approximately 48.5%.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total notional amount of interest rate swaps is correctly stated as $800 million, and the combined principal amount of fixed-rate notes due in 2049 and 2050 is accurately calculated as $1.65 billion ($500 million + $300 million from $1.0 billion and $650 million totals respectively). The percentage coverage (approximately 48.5%) is correct: ($800M / $1.65B) ≈ 0.4848 or 48.5%. (2) The answer is complete, addressing both parts of the question: the notional amount of swaps and how it compares to the hedged notes. (3) Entity accuracy is perfect: 3M, 2021, interest rate swaps, fixed-rate notes due in 2049 and 2050 are all correctly identified. (4) The multi-hop reasoning is sound—information about separate notes and swap applications is synthesized correctly across years and instruments to arrive at the combined principal and coverage ratio. (5) Semantic equivalence is maintained: the LLM provides additional breakdown (e.g., $500M of $1B and $300M of $650M) not in the original answer but consistent with it, enhancing clarity without introducing error. All elements meet the highest standard.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 337,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What was the total consideration transferred by AbbVie for both the acquisition of Allergan and Soliton, Inc., and how much of this combined amount was attributed to cash payments?",
      "original_answer": "The total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was $64,619 million, of which $40,210 million was attributed to cash payments.",
      "llm_answer": "\n\nThe total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was **$64,619 million** ($64,084 million for Allergan + $535 million for Soliton). Of this combined amount, **$40,210 million** was attributed to cash payments ($39,675 million for Allergan + $535 million for Soliton). \n\nThis is derived from the \"Acquisition of Allergan\" table (cash consideration of $39,675 million) and the \"Acquisition of Soliton, Inc.\" section (cash consideration of $535 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total consideration is correctly stated as $64,619 million, composed of $64,084 million for Allergan and $535 million for Soliton, Inc., which sums to the correct total ($64,084 + $535 = $64,619). The cash portion is correctly identified as $40,210 million, with $39,675 million for Allergan and $535 million for Soliton, Inc. ($39,675 + $535 = $40,210). (2) Quantitative accuracy is perfect: all dollar amounts are correct, properly attributed, and accurately summed. Format variations (e.g., using 'million') are consistent and acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two separate acquisitions, identifies the total consideration and cash components for each, and combines them appropriately. (4) The answer is semantically equivalent to the original, with added breakdown that enhances clarity without introducing error. All entities (AbbVie, Allergan, Soliton, Inc.) and financial metrics are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 311,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does Bank of America's adherence to Basel 3 capital requirements influence its ability to execute its $25 billion stock repurchase program authorized in 2024?",
      "original_answer": "Bank of America's adherence to Basel 3 capital requirements directly influences its ability to execute its $25 billion stock repurchase program because the program is subject to the Corporation's capital position and regulatory requirements. As of December 31, 2024, the Corporation's Common Equity Tier 1 (CET1) capital ratio under the Standardized approach was 11.9 percent, exceeding the minimum requirement of 10.7 percent, which includes a capital conservation buffer and G-SIB surcharge. This capital adequacy allows the Corporation to proceed with repurchasing $13.1 billion of common stock in 2024, as it remains above the thresholds that would trigger restrictions on capital distributions.",
      "llm_answer": "\n\nBank of America's adherence to Basel 3 capital requirements ensures its ability to execute the $25 billion stock repurchase program by maintaining capital ratios well above regulatory minima. As of December 31, 2024, its Common Equity Tier 1 (CET1) capital ratio under the Standardized Approach was **11.9%**, exceeding the required **10.7%** (including the G-SIB surcharge and stress capital buffer). Similarly, Tier 1 and Total Capital ratios were **13.2%** (vs. 12.2% minimum) and **15.1%** (vs. 14.2% minimum), respectively. These robust levels, combined with a Tier 1 leverage ratio of **6.9%** (above the 4.0% floor), confirm compliance with Basel 3 buffers and avoid restrictions on capital distributions. The Corporation’s CET1 capital increased by $6.2 billion in 2024, driven by earnings, enabling the repurchase program while maintaining a \"well capitalized\" status under regulatory frameworks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key numbers are correct: CET1 ratio of 11.9% (vs. 10.7% requirement) as of December 31, 2024, is accurately reported. The additional capital ratios (Tier 1 at 13.2%, Total Capital at 15.1%, leverage ratio at 6.9%) are consistent with typical Basel 3 disclosures and plausibly derived, though not explicitly in the original answer—however, they do not contradict it and support the reasoning. The $6.2 billion CET1 increase and $25 billion repurchase authorization are contextually accurate and logically tied to capital strength. (2) Quantitative accuracy is excellent: all percentages, comparisons, and implied calculations (e.g., capital buffers) are correct. The statement that the bank exceeds the 10.7% CET1 threshold is factually sound and central to the argument. (3) Reasoning is strong: the LLM correctly synthesizes that Basel 3 compliance (via sufficient CET1 and other ratios) enables capital distributions like stock buybacks, and that being above regulatory minimums avoids restrictions. It correctly links capital generation (earnings-driven CET1 growth) to repurchase capacity. The only minor gap is that the original specifies $13.1 billion was repurchased in 2024, while the LLM focuses on the $25 billion authorization without noting the partial execution—this is a small omission in completeness but does not make the answer incorrect. (4) The answer is contextually relevant, directly addressing how Basel 3 adherence enables the repurchase program. Overall, the LLM provides a more detailed and slightly expanded version of the ground truth with no factual errors, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 459,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the total carrying value in millions of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 as reported in the MMM 2022 10-K filing?",
      "original_answer": "The total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 is $1,287 million.",
      "llm_answer": "\n\nThe total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048, as reported in the MMM 2022 10-K filing, is **$1,287 million**. Specifically, the 2023 note has a carrying value of $649 million, and the 2048 note has a carrying value of $638 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The total carrying value is accurately reported as $1,287 million, which aligns with the sum of the two individual notes: $649 million (2023 maturity) and $638 million (2048 maturity). (2) All numeric values are correct and precisely match the source data; the calculation (649 + 638 = 1,287) is accurate. (3) The reasoning demonstrates proper multi-hop synthesis by identifying two separate medium-term notes under the same $650 million issuance but with different maturities and combining their carrying values from the MMM 2022 10-K filing. (4) The entities—MMM (3M Company), the financial instrument (Medium-term note), the years (2023 and 2048), and the metric (carrying value)—are all correctly identified and contextualized. The answer is semantically equivalent and factually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1105,
        "completion_tokens": 251,
        "total_tokens": 1357
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the difference in interest rates between IBM's 2.900% Notes due 2030 and the highest-yielding debt instrument listed in IBM's 2024 10-K filing?",
      "original_answer": "The highest-yielding debt instrument listed in IBM's 2024 10-K filing is the 7.125% Debentures due 2096. The difference in interest rates between these instruments and the 2.900% Notes due 2030 is 4.225 percentage points.",
      "llm_answer": "\n\nThe difference in interest rates between IBM's 2.900% Notes due 2030 and the highest-yielding debt instrument (7.125% Debentures due 2096) is **4.225 percentage points** (7.125% - 2.900%). The highest-yielding debt instrument listed in the 2024 10-K is the 7.125% Debentures due 2096 (IBM96).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the highest-yielding debt instrument is correctly identified as the 7.125% Debentures due 2096, and the interest rate of IBM's 2.900% Notes due 2030 is correctly stated. (2) The calculation of the difference (7.125% - 2.900% = 4.225 percentage points) is numerically accurate and clearly explained. (3) The multi-hop reasoning—identifying the highest-yielding instrument from IBM's 2024 10-K and computing the interest rate difference—is sound and complete. (4) The answer is contextually relevant, directly addressing the question with precise financial data and correct entity references (including the ticker IBM96, which adds detail without introducing error). Minor formatting enhancements (bold) do not affect accuracy. Semantic equivalence to the original answer is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 258,
        "total_tokens": 1388
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "What was the total financial value of AbbVie's acquisition of Allergan, and how much in right-of-use assets did AbbVie acquire as part of the lease obligations assumed during the acquisition?",
      "original_answer": "The total financial value of AbbVie's acquisition of Allergan was $64,084 million, which included $453 million in right-of-use assets acquired in the transaction as of December 31, 2020.",
      "llm_answer": "\n\nThe total financial value of AbbVie's acquisition of Allergan was **$64.1 billion** (sum of $39,675 million cash, $23,979 million fair value of AbbVie stock, and $430 million equity awards). As part of the lease obligations assumed, AbbVie acquired **$453 million in right-of-use assets** related to operating leases from Allergan, as disclosed in Note 9 Leases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total financial value of AbbVie's acquisition of Allergan as $64.1 billion, which aligns with the ground truth value of $64,084 million (rounded to $64.1 billion). The breakdown into $39,675 million cash, $23,979 million fair value of stock, and $430 million equity awards is accurate and consistent with the source data. The right-of-use assets are correctly reported as $453 million, matching the ground truth. (2) All numeric values are correct; the sum of the components ($39,675 + $23,979 + $430 = $64,084 million) is accurate and properly rounded to $64.1 billion. The $453 million in right-of-use assets is exactly as stated in the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes the total acquisition value from multiple components and links the right-of-use assets to lease obligations assumed in the acquisition, referencing Note 9 Leases for support. (4) The only minor shortcoming is that the original answer specifies the value as of December 31, 2020, which the LLM omits, though this does not affect the core factual accuracy. Wording differences are semantically equivalent and do not detract from correctness. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 363,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How many shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan according to the 2024 10-K filing, and why are no future awards or deferrals possible under this plan?",
      "original_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it has been closed to new deferrals and awards, as explicitly stated in the filing.",
      "llm_answer": "\n\nAccording to the 2024 10-K filing, **391 shares** of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it is explicitly stated in the document that \"no future stock awards or deferrals may be made under this plan,\" indicating the plan has been closed to new participants or additional allocations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the number of shares—391—is accurate and correctly cited from the 2024 10-K filing. (2) The explanation for why no future awards or deferrals are possible aligns with the original answer: the plan has been closed to new deferrals and awards, as explicitly stated in the filing. The LLM accurately quotes the key language ('no future stock awards or deferrals may be made under this plan') which supports the reasoning. (3) The multi-hop reasoning is sound—linking the number of shares to the plan status and its closure—demonstrating proper synthesis of information from the same document. (4) The answer is contextually relevant, complete, and conveys the same factual content as the ground truth with equivalent wording and no omissions. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 257,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did the amortization of intangible assets associated with the Allergan acquisition impact AbbVie's gross margin in 2021, and what was the total amortization expense for definite-lived intangible assets in that same year?",
      "original_answer": "The amortization of intangible assets associated with the Allergan acquisition negatively impacted AbbVie's gross margin in 2021, as noted in the 10-K filing. Although lower amortization of inventory fair value step-up adjustments and favorable product mix contributed to an increase in gross margin, the expense from amortizing intangible assets related to the Allergan acquisition partially offset these gains. In 2021, the total amortization expense for definite-lived intangible assets was $7.7 billion.",
      "llm_answer": "\n\nThe amortization of intangible assets associated with the Allergan acquisition increased AbbVie's cost of products sold in 2021, which partially offset other factors contributing to an overall increase in gross margin. Specifically, the **total amortization expense for definite-lived intangible assets in 2021 was $7.7 billion**, as stated in Note 7. While the Allergan-related amortization negatively impacted gross margin, the gross margin percentage still rose to 69% of net revenues due to favorable product mix and lower inventory fair value step-up adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total amortization expense for definite-lived intangible assets in 2021 is correctly stated as $7.7 billion, which aligns with the original answer. (2) The explanation of the impact on gross margin is accurate: the Allergan-related amortization increased cost of products sold and negatively impacted gross margin, though it was partially offset by favorable product mix and lower inventory step-up adjustments, resulting in an overall increase in gross margin to 69%. (3) The multi-hop reasoning is sound—correctly synthesizing the effect of amortization on gross margin while acknowledging countervailing positive factors. (4) All entities (AbbVie, Allergan acquisition, 2021, definite-lived intangible assets) are correctly identified and contextualized. The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., mentioning the 69% gross margin), but no factual deviations. Wording differences do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 300,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the specific purpose of the Restoration Plans as it relates to the Benefit Plans, and how does The Home Depot fund these Restoration Plans according to the 2023 10-K filing?",
      "original_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that they would have received as a matching contribution under the Benefit Plans if not for the maximum compensation limits set by the Internal Revenue Code. The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_answer": "\n\nThe Restoration Plans, specifically the Home Depot FutureBuilder Restoration Plan and HD Supply Restoration Plan, are designed to provide eligible associates with deferred compensation that would have been received under the Benefit Plans (defined contribution retirement plans) as matching contributions, but for the Internal Revenue Code's maximum compensation limits. The Home Depot funds these Restoration Plans by contributing to grantor trusts, which are then used to purchase shares of the company's common stock in the open market. In fiscal 2023, total contributions to both the Benefit Plans and Restoration Plans were $293 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in terms of purpose and funding mechanism of the Restoration Plans. It correctly identifies that the Restoration Plans restore matching contributions lost due to IRS compensation limits and that The Home Depot funds them through contributions to grantor trusts, which then purchase company stock in the open market. The qualitative and contextual accuracy is perfect—entities (FutureBuilder Restoration Plan, HD Supply Restoration Plan, Benefit Plans), reasoning, and synthesis across concepts are correct. However, the LLM introduces a new quantitative figure—'$293 million in total contributions to both Benefit Plans and Restoration Plans in fiscal 2023'—that is not present in the original ground truth answer. Since the ground truth does not include this number, and it cannot be verified from the provided context, it introduces a potential factual overreach, even if the number might be accurate in the actual 10-K. This affects quantitative accuracy, though not severely, as the number is plausible and the core funding mechanism is still correctly described. Thus, the correctness score is reduced slightly to 9 due to the unverified addition of a dollar amount not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 353,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the percentage change in the value of Variable Rate Notes from December 31, 2023, to December 31, 2024, and how does this reflect in the overall change in total borrowings over the same period?",
      "original_answer": "The value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024. However, total borrowings increased from $20,443 million to $31,099 million, representing a $10,656 million increase. Therefore, the percentage change in Variable Rate Notes is 0%, while the overall percentage increase in total borrowings is approximately 52.1%.",
      "llm_answer": "\n\nThe value of Variable Rate Notes remained unchanged at $22 million as of December 31, 2024, compared to December 31, 2023, resulting in a **0% percentage change**. This lack of change in Variable Rate Notes contrasts sharply with the **52.2% increase in total borrowings** (from $20.4 billion in 2023 to $31.1 billion in 2024), which was driven primarily by significant growth in Fixed Rate Notes ($18,530 million to $25,853 million) and Commercial Paper ($2,083 million to $4,271 million), along with the addition of a $1.0 billion Term Loan in 2024. Variable Rate Notes had no material impact on the overall borrowing increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the value of Variable Rate Notes remained unchanged at $22 million, resulting in a 0% percentage change, which matches the ground truth. The overall increase in total borrowings is accurately described as a rise from $20.4 billion to $31.1 billion, with a calculated percentage increase of 52.2%, which is within rounding tolerance of the ground truth's 52.1% (exact calculation: (31,099 - 20,443) / 20,443 ≈ 0.5213 or 52.13%, so 52.1% or 52.2% are both acceptable depending on rounding). (2) Dollar amounts are correctly represented in rounded form ($20.4 billion and $31.1 billion correspond to $20,443 million and $31,099 million). The LLM adds contextual detail about drivers of the increase—growth in Fixed Rate Notes, Commercial Paper, and a new Term Loan—which aligns with multi-hop reasoning and enhances qualitative accuracy, even though not explicitly required. (3) The multi-hop reasoning is sound: the model correctly contrasts the static nature of Variable Rate Notes with the dynamic changes in other borrowing components to explain the overall increase in total borrowings. It synthesizes information across different debt instruments and time points logically. (4) The answer is semantically equivalent to the ground truth, with slightly more explanatory detail. The only minor deviation is the use of 52.2% instead of 52.1%, which results from rounding and does not constitute a material error. All entities (Variable Rate Notes, total borrowings, correct years) are accurately referenced. Therefore, the answer is highly accurate, complete, and contextually appropriate, warranting a 9 due to negligible rounding difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 462,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, according to the provided financial data?",
      "original_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,726 million.",
      "llm_answer": "\n\nThe total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is **$1,724 million**. This includes **$744 million** for the 2026 notes and **$980 million** for the 2052 notes, as detailed in the Long-Term Debt section of Note 5 in the 10-K filing.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative discrepancy. The ground truth states the total carrying amount is $1,726 million, while the LLM reports $1,724 million, a $2 million difference. The individual components provided ($744 million for 2026 and $980 million for 2052) sum to $1,724 million, which is consistent with the LLM's total but not with the ground truth. It is unclear whether the component amounts are accurate as the original answer does not break them down, but the final total is off by $2 million. (2) The dates (September 2026, September 2052, and January 28, 2024) and the interest rate (4.95%) are correctly identified. The format of the dollar amounts is acceptable ($744 million, $980 million). (3) The multi-hop reasoning appears sound—the model correctly identifies the relevant debt instruments, extracts carrying amounts, and sums them. The citation to Note 5, Long-Term Debt, adds contextual accuracy. (4) Despite the small numerical error, the answer demonstrates strong qualitative and contextual understanding. The correctness score is 8 due to the minor inaccuracy in the total amount, which may stem from rounding or data extraction variation, but does not reflect a fundamental error in logic or entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 361,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What percentage decrease did PM experience in its net derivative asset position from 2022 to 2023, and how does this align with the changes in its total gross amount of derivative contracts?",
      "original_answer": "PM experienced a 45.7% decrease in its net derivative asset position from $186 million in 2022 to $101 million in 2023. This aligns with a reduction in the total gross amount of derivative contracts from $873 million in 2022 to $584 million in 2023, indicating a strategic reduction in overall derivative exposure.",
      "llm_answer": "\n\nPM experienced a **45.7% decrease** in its net derivative asset position from 2022 ($186 million) to 2023 ($101 million). This decline contrasts with a **7.3% increase** in the total gross notional amount of derivative contracts (from $40,401 million in 2022 to $43,265 million in 2023). The divergence reflects changes in fair value driven by market conditions (e.g., foreign exchange rates, interest rates), which reduced the net asset position despite higher gross notional exposure. The fair value of derivatives is sensitive to observable market inputs, leading to a lower net asset balance even as hedging activity expanded.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 45.7% decrease in PM's net derivative asset position from $186 million in 2022 to $101 million in 2023, which matches the ground truth. However, it incorrectly states that the total gross amount of derivative contracts increased by 7.3% (from $40,401 million to $43,265 million), which directly contradicts the ground truth that the total gross amount decreased from $873 million in 2022 to $584 million in 2023. This is a critical factual error. (2) The calculation of the percentage decrease in net derivative assets is correct (45.7%), but the gross derivative contract figures are entirely wrong—both in magnitude and direction of change. The LLM reports tens of billions instead of hundreds of millions, indicating a severe data sourcing or synthesis failure. (3) The multi-hop reasoning is flawed: while the LLM attempts to explain the divergence between net asset decline and gross notional increase, the premise is false—the gross amount actually decreased, aligning with the net decrease. The reasoning would be plausible if the numbers were correct, but it is built on incorrect data. (4) The correctness score is low (2) due to major quantitative inaccuracies despite one correct figure. Quantitative accuracy is severely compromised. Qualitative accuracy is slightly higher because the model attempts logical financial reasoning. Contextual relevance is moderate as it addresses the right topic and company but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 413,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, and how does this compare to the number of shares of Common Stock to be issued for options and RSUs under these plans?",
      "original_answer": "The total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, is 27.9 million (27.1 million from the 2016 Stock Incentive Plan and 0.8 million from the 2016 Stock Plan for Non-Employee Directors). This is in addition to 10,221,113 shares of Common Stock to be issued for options and 2,005,555 RSUs subject to continued employment under the 2016 Stock Incentive Plan, as well as 129,854 shares of Common Stock to be issued for options under the 2016 Stock Plan for Non-Employee Directors.",
      "llm_answer": "\n\nAs of December 31, 2024, the total number of shares available for future issuance under the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors was **27,919,327 shares** (27,143,929 under the 2016 Stock Incentive Plan and 775,398 under the 2016 Directors Plan). This compares to **12,767,488 shares** of Common Stock to be issued for outstanding options and RSUs under these plans as of the same date. The available shares significantly exceed the shares already allocated for future grants.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states 27.9 million total shares available (27.1M from the 2016 Stock Incentive Plan and 0.8M from the 2016 Directors Plan), but the LLM reports 27,919,327 (27,143,929 + 775,398), which is numerically close but not exact. More critically, the LLM combines 'options and RSUs' into a single figure of 12,767,488 shares to be issued, whereas the ground truth separates them: 10,221,113 (options) + 2,005,555 (RSUs) under the Incentive Plan and 129,854 (options) under the Directors Plan, totaling 12,356,522. The LLM's total (12,767,488) is therefore incorrect. (2) The calculation of the 'shares to be issued' is wrong: 10,221,113 + 2,005,555 + 129,854 = 12,356,522, not 12,767,488. The LLM overstates this by ~410,966 shares. Additionally, the breakdown of available shares (27.1M vs 0.8M) is approximated with overly precise figures not found in the original. (3) The multi-hop reasoning is partially sound—LLM identifies both plans and attempts to sum shares across them—but fails in precise synthesis. It conflates distinct categories (options vs RSUs) and misreports underlying figures, suggesting it did not correctly extract or compute the values. (4) Despite these errors, the answer is contextually relevant and addresses both parts of the question: total shares available and comparison to shares to be issued. The qualitative reasoning (e.g., 'available shares significantly exceed allocated') is logically consistent, even if based on incorrect numbers. However, the factual inaccuracies in key financial figures—especially in a financial disclosure context—severely undermine correctness. Minor formatting flexibility is allowed, but the discrepancies are beyond rounding and suggest data extraction or calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 495,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What was the growth in Dynamics 365 revenue in fiscal year 2022, and how does this contribute to the overall Dynamics products and cloud services revenue growth of 25%?",
      "original_answer": "Dynamics 365 revenue grew by 39% in fiscal year 2022, which significantly contributed to the overall Dynamics products and cloud services revenue growth of 25%. This indicates that Dynamics 365 was a key driver behind the broader Dynamics suite's performance, suggesting strong adoption and demand for Microsoft's integrated business applications platform.",
      "llm_answer": "\n\nThe growth in Dynamics 365 revenue in fiscal year 2022 was **39%**, as stated in Microsoft's 10-K filing. This outpaced the overall **25% growth** in Dynamics products and cloud services revenue, indicating that Dynamics 365 was a key driver of the segment's performance, contributing disproportionately to the total growth due to its strong adoption and strategic focus within Microsoft's cloud offerings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the 39% growth in Dynamics 365 revenue and the 25% overall Dynamics products and cloud services revenue growth are accurately reported, with no calculation or numerical errors. (2) The answer addresses both parts of the multi-part question: it states the specific growth rate for Dynamics 365 and explains how this contributed to the broader 25% segment growth. (3) Entity accuracy is correct—'Dynamics 365', 'Dynamics products and cloud services', and 'fiscal year 2022' are all properly identified and contextualized. (4) The reasoning is sound and reflects appropriate multi-hop synthesis: by noting that Dynamics 365 grew faster than the overall segment (39% vs 25%), the model correctly infers that it was a key driver, which aligns with the ground truth's conclusion about its disproportionate contribution and strong adoption. The semantic meaning and factual content are equivalent to the original answer, with slightly more concise phrasing but no loss of accuracy or depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 307,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "By how much did Tesla's Energy Generation and Storage revenue increase specifically due to the deployment of Megapack in 2021 compared to 2020, and what role does Megapack play in Tesla's broader energy storage product portfolio?",
      "original_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million, or 40%, in 2021 compared to 2020, primarily driven by the deployment of Megapack along with growth in solar cash and loan jobs, Powerwall, and Solar Roof. Megapack is a key component of Tesla's energy storage product lineup, designed for commercial, industrial, utility, and energy generation customers, and can be grouped to form large-scale installations of gigawatt hours or greater capacity.",
      "llm_answer": "\n\nTesla's Energy Generation and Storage revenue increased by **$795 million (40%)** in 2021 compared to 2020, with the deployment of **Megapack** cited as a primary driver alongside growth in solar cash/loan jobs, Powerwall, and Solar Roof. While the document does not specify the exact incremental revenue attributable solely to Megapack, it highlights that Megapack deployments grew significantly, offsetting the decline in Powerpack sales (which were phased out post-Megapack launch).  \n\nMegapack plays a central role in Tesla's energy storage portfolio as a **large-scale solution** for commercial, industrial, utility, and energy generation customers, capable of forming installations with gigawatt-hour capacity. It complements **Powerwall** (residential/small commercial) and replaces **Powerpack**, solidifying Tesla's position across diverse energy storage markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Tesla's Energy Generation and Storage revenue increased by $795 million (40%) in 2021 compared to 2020, matching the ground truth exactly. It accurately notes that Megapack deployment was a primary driver, along with growth in solar cash/loan jobs, Powerwall, and Solar Roof—consistent with the original answer. The LLM appropriately clarifies that the exact incremental revenue solely from Megapack is not specified in the data, which is a correct and responsible qualification not present in the ground truth but adds analytical value. (2) All numeric values—$795 million and 40%—are accurate and correctly attributed to the 2020–2021 comparison. No calculations are required beyond what is provided, and the figures match the ground truth precisely. (3) The multi-hop reasoning is sound: the LLM synthesizes information about revenue growth, attributes it to key drivers including Megapack, and correctly positions Megapack within Tesla’s broader product portfolio by contrasting it with Powerwall and Powerpack. It correctly identifies Megapack’s target market (commercial, industrial, utility) and its scalability to gigawatt-hour installations, which aligns with the ground truth. The mention of Powerpack being phased out post-Megapack adds contextual depth supported by external knowledge and enhances the reasoning. (4) The answer is semantically equivalent to the ground truth, with slightly more nuance in acknowledging the lack of isolated Megapack revenue data. This reflects strong qualitative accuracy and contextual relevance. The only reason for not scoring a 10 in correctness is that the original answer does not mention Powerpack being phased out, so that detail—while plausible—is an inference not confirmed in the ground truth, slightly exceeding the provided information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 499,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What was the total pre-tax loss recognized by Walmart in fiscal 2021 and 2022 related to the divestiture of Asda, including both the initial loss estimate and the additional adjustments upon closing, and how does this reflect the financial impact of pension-related obligations tied to the disposal group?",
      "original_answer": "Walmart recognized a total pre-tax loss of $5.7 billion related to the divestiture of Asda. This includes the $5.5 billion estimated pre-tax loss recognized in the fourth quarter of fiscal 2021, which incorporated $2.3 billion of accumulated pension components, and an additional $0.2 billion loss recorded in the first quarter of fiscal 2022 upon closing, primarily due to changes in net assets, currency exchange rate fluctuations, and purchase price adjustments. The pension-related obligations significantly contributed to the overall loss, illustrating the financial impact of legacy liabilities in international divestitures.",
      "llm_answer": "\n\nWalmart recognized a total pre-tax loss of **$5.7 billion** related to the Asda divestiture: **$5.5 billion** in fiscal 2021 (initial loss estimate) and **$0.2 billion** in fiscal 2022 (adjustments upon closing). The $5.5 billion fiscal 2021 loss included **$2.3 billion in accumulated pension components** tied to the derecognition of the Asda pension plan, reflecting the significant financial impact of pension-related obligations on the disposal group. These obligations were a material portion of the total loss, underscoring the complexity of pension liabilities in divestitures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $5.7 billion total pre-tax loss, composed of $5.5 billion in fiscal 2021 and $0.2 billion in fiscal 2022, with the $2.3 billion pension component correctly attributed to the 2021 loss. These figures match the original answer exactly, and the sum ($5.5B + $0.2B = $5.7B) is mathematically correct. (2) The answer is complete, addressing both the total loss, its breakdown across fiscal years, and the role of pension-related obligations. (3) Entity accuracy is perfect: Walmart, Asda, fiscal 2021 and 2022, and the financial metrics (pre-tax loss, pension components) are all correctly identified. (4) The reasoning is sound and reflects multi-hop synthesis: it connects the initial loss estimate, the closing adjustments, and the specific impact of pension liabilities, concluding with the broader implication about legacy liabilities in divestitures—mirroring the original's qualitative insight. (5) Semantic equivalence is achieved: though phrased more concisely, the LLM conveys all key facts and implications from the ground truth. No errors in fact, logic, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 337,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 was represented by the combined revenue from Surface devices and Windows OEM licensing, given that the segment reported $56.5 billion in revenue and Windows OEM contributed 42% of that segment's revenue?",
      "original_answer": "The combined revenue from Surface devices and Windows OEM licensing represented 58% of the More Personal Computing segment's $56.5 billion in fiscal year 2022. Windows OEM contributed 42% ($23.73 billion) and Devices (primarily Surface) contributed 16% ($9.04 billion), totaling $32.77 billion or 58% of the segment's total revenue.",
      "llm_answer": "\n\nThe More Personal Computing segment's revenue in fiscal year 2022 was $56.5 billion. Windows OEM licensing contributed 42% of this amount, or $23.73 billion. The Devices category (primarily Surface) generated $6.991 billion in revenue. Combined, these two components accounted for $23.73 billion + $6.991 billion = $30.721 billion, representing **54.4%** of the segment's total revenue ($30.721 billion ÷ $56.5 billion × 100).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly identifies the More Personal Computing segment revenue ($56.5 billion) and Windows OEM's 42% contribution ($23.73 billion), it reports Surface revenue as $6.991 billion, which is incorrect. The ground truth states that Devices (primarily Surface) contributed 16% of segment revenue, which is $9.04 billion (16% of $56.5 billion), not $6.991 billion. This error leads to an incorrect combined total of $30.721 billion instead of the correct $32.77 billion. Consequently, the calculated percentage is 54.4% instead of the correct 58%. (2) Calculations are internally consistent but based on incorrect input: $23.73B + $6.991B = $30.721B is correct, and $30.721B / $56.5B ≈ 54.4% is mathematically accurate, but both inputs and result differ from ground truth. The correct calculation is 42% (OEM) + 16% (Devices) = 58%, or $23.73B + $9.04B = $32.77B → $32.77B / $56.5B = 58%. (3) The multi-hop reasoning is conceptually sound—combining OEM and Surface revenues to determine their collective share of segment revenue—but fails due to incorrect data for Surface revenue. The model correctly identifies the relevant components and attempts the right synthesis, but the factual error undermines the conclusion. (4) Scores reflect that core facts (segment revenue, OEM percentage) are correct, but a key number (Surface revenue) is wrong, leading to an incorrect final percentage. The answer is contextually relevant and well-structured, but the magnitude of the quantitative error significantly impacts correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 440,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale, combining the $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda?",
      "original_answer": "The total financial impact on Walmart from the Asda pension-related activities was $3.3 billion, combining the $1.0 billion cash contribution made by Asda to its pension plan in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda. This amount reflects the full pension-related exposure transferred as part of the divestiture.",
      "llm_answer": "\n\nThe total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and sale combines the $1.0 billion cash contribution made by Asda in fiscal 2020 to settle its pension obligations and the $2.3 billion accumulated pension components included in the disposal group upon the sale. These amounts collectively represent **$3.3 billion** in total pension-related impacts, with the $1.0 billion contribution resolving future obligations and the $2.3 billion derecognition of pension components recognized as part of the disposal group’s value in fiscal 2021 (Note 11 and Note 12).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $1.0 billion cash contribution by Asda in fiscal 2020 and the $2.3 billion accumulated pension components upon sale are correctly stated, and their sum of $3.3 billion is accurately calculated. Minor phrasing differences (e.g., 'fiscal 2021' for the disposal timing) do not contradict the original answer, as the sale and disposal group accounting may span fiscal periods and are consistent with typical SEC filing disclosures. (2) The answer addresses all parts of the multi-hop question: it identifies both components of the pension impact (the contribution and the disposal group inclusion), correctly attributes them to Asda, and synthesizes them into a total impact. (3) Entity accuracy is correct—Walmart, Asda, pension obligations, disposal group, and fiscal years are properly referenced. (4) The reasoning is sound: the LLM correctly interprets that the $1.0 billion reduced future obligations and the $2.3 billion was derecognized upon sale, reflecting proper understanding of pension accounting in divestitures. The mention of 'Note 11 and Note 12' (common footnote references in 10-Ks for pension and disposal disclosures) adds contextual plausibility. The answer is semantically equivalent to the ground truth and conveys the same financial conclusion with enhanced explanatory detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 393,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "By how much did the value of pre-owned aircraft inventories increase from December 31, 2023, to December 31, 2024, and what specific valuation method does the company use for these pre-owned aircraft?",
      "original_answer": "The value of pre-owned aircraft inventories increased by $8 million from December 31, 2023 ($15 million) to December 31, 2024 ($23 million). The company values pre-owned aircraft at the lower of the trade-in value or the estimated net realizable value.",
      "llm_answer": "\n\nThe value of pre-owned aircraft inventories increased by **$8 million** (from $15 million on December 31, 2023, to $23 million on December 31, 2024). The company values pre-owned aircraft at the **lower of trade-in value or estimated net realizable value**. \n\n(Source: Section G. Inventories, pages 70–71).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the increase of $8 million is accurate: $23 million (2024) - $15 million (2023) = $8 million. Both the starting and ending values, as well as the difference, are correctly reported. (2) The valuation method is accurately stated as 'lower of trade-in value or estimated net realizable value,' which is semantically equivalent to the original answer. (3) The reasoning is sound and demonstrates correct multi-hop synthesis across time points and accounting methodology. (4) All entities (pre-owned aircraft inventories, correct dates, valuation method) are correctly identified and contextualized. The inclusion of a source reference further enhances contextual relevance. No factual, numerical, or conceptual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 239,
        "total_tokens": 1392
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the growth in Xbox Game Pass's curated game library relate to the 3% increase in Xbox content and services revenue, and what broader strategic investments does Microsoft highlight that could influence this gaming segment's performance?",
      "original_answer": "The Xbox Game Pass, which offers access to a curated library of over 100 first- and third-party titles, contributes to the 3% increase in Xbox content and services revenue. This growth is tied to Microsoft's broader strategic investments in gaming, including the acquisition of ZeniMax Media and the planned acquisition of Activision Blizzard, both of which expand the company's content portfolio and community engagement. These investments align with Microsoft's focus on transforming gaming through cloud services like Xbox Cloud Gaming, which enhances accessibility and user engagement across multiple platforms.",
      "llm_answer": "\n\nThe growth in Xbox Game Pass's curated game library, which includes over 100 first- and third-party titles, directly supports the 3% increase in Xbox content and services revenue by enhancing subscriber value and retention. Microsoft highlights broader strategic investments in cloud gaming (e.g., Xbox Cloud Gaming for cross-device streaming), content acquisitions (e.g., ZeniMax and planned Activision Blizzard purchase), and expanding its intelligent cloud infrastructure to drive engagement and revenue. These initiatives align with Microsoft’s focus on creating seamless, accessible gaming experiences and leveraging its cloud ecosystem to strengthen the gaming segment’s long-term performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the Xbox Game Pass library includes over 100 first- and third-party titles, which contributes to the 3% increase in Xbox content and services revenue. (2) Quantitative accuracy is perfect: the 3% revenue increase is correctly cited, and no other numbers require calculation. (3) Multi-hop reasoning is sound: the answer correctly links Game Pass growth to revenue, and identifies Microsoft's strategic investments in ZeniMax, Activision Blizzard, and Xbox Cloud Gaming as drivers of long-term performance. (4) The broader strategic context is accurately represented, including cloud infrastructure, content expansion, and cross-platform accessibility. The LLM adds slight elaboration (e.g., 'subscriber value and retention', 'intelligent cloud infrastructure') that is contextually appropriate and consistent with Microsoft's stated strategy. No factual errors, omissions, or misstatements are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 291,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How much revenue did Eli Lilly recognize in 2023 specifically from the sale of rights for the olanzapine portfolio, and how does this transaction factor into the broader collaboration and other revenue category for the same year?",
      "original_answer": "Eli Lilly recognized revenue from the 2023 sale of rights for the olanzapine portfolio, including Zyprexa, which is part of the broader 'collaboration and other revenue' category. This category includes revenue from collaborations such as the one with Boehringer Ingelheim and the sale of rights for the olanzapine portfolio and Baqsimi. The sale of the olanzapine portfolio rights directly contributed to the collaboration and other revenue in 2023.",
      "llm_answer": "\n\nEli Lilly recognized $1,615.4 million in 2023 from the sale of rights for the olanzapine portfolio (including Zyprexa), which is included in the **collaboration and other revenue** category for the year. This transaction is explicitly noted in the Neuroscience section of the revenue breakdown and is categorized under collaboration and other revenue in Note 2, reflecting the transfer of control of the asset as described in the company’s revenue recognition policies.",
      "correctness_score": 4,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer claims Eli Lilly recognized $1,615.4 million from the sale of rights for the olanzapine portfolio in 2023, but this figure is not present in the original answer (ground truth) and cannot be verified from the provided context. The ground truth does not specify any dollar amount for the transaction, only that revenue was recognized from the sale and that it was included in the 'collaboration and other revenue' category. Therefore, the quantitative claim is unsupported and likely incorrect. (2) There is no numeric verification possible because the original answer contains no figures; thus, the LLM introduced a specific number without basis, failing the quantitative accuracy check. (3) The qualitative reasoning is partially sound: the model correctly identifies that the olanzapine portfolio sale contributes to 'collaboration and other revenue' and appropriately links it to the broader category, mentioning relevant context like Note 2 and revenue recognition policies. It also correctly situates the transaction within the Neuroscience segment, showing multi-hop synthesis across reporting categories. (4) Contextual relevance is high because the response addresses both parts of the question—identifying the revenue source and explaining its inclusion in the broader category—though it adds unverified specifics. The correctness score is low due to the critical error of fabricating a precise financial figure absent from the ground truth, which severely undermines factual reliability despite otherwise logical structuring.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 429,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the structure of Tesla's 5.45% Solar Bonds, as evidenced by multiple Supplemental Indentures in 2015, reflect Tesla's (via SolarCity) financing strategy for solar energy projects, and what does this imply about the role of bond-specific trustee agreements in supporting recurring capital needs?",
      "original_answer": "Tesla, through its acquisition of SolarCity, issued multiple tranches of 5.45% Solar Bonds in 2015 (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15), each governed by distinct Supplemental Indentures (4.72, 4.74, 4.76, and 4.78) dated at different points in November through December 2015. This repeated issuance of the same interest rate bond with separate indentures suggests a deliberate financing strategy to raise capital in tranches, allowing SolarCity to match funding with project deployment timelines and investor demand. The use of multiple Supplemental Indentures under the same bond rate indicates that Tesla (via SolarCity) prioritized flexibility in structuring solar project financing, with trustee agreements playing a critical role in enabling discrete funding events while maintaining consistent yield terms for investors.",
      "llm_answer": "\n\nThe structure of Tesla's 5.45% Solar Bonds, as evidenced by multiple Supplemental Indentures in 2015, reflects a **recurring, project-specific financing strategy** for solar energy projects via SolarCity. The frequent issuance of distinct bond series (e.g., 2015/C53-15, 2015/C57-15, etc.) under a master indenture framework allowed Tesla/SolarCity to efficiently raise capital for discrete solar initiatives while maintaining regulatory compliance and investor confidence. This approach enabled tailored terms for each project’s cash flow profile and risk characteristics.  \n\nThe role of bond-specific trustee agreements (Supplemental Indentures) was critical in **streamlining recurring capital needs**. By amending the base indenture to add new series, Tesla/SolarCity avoided the time and cost of issuing standalone bonds, leveraging a standardized yet flexible legal structure. This highlights how structured finance mechanisms, supported by trustees, facilitate scalable, project-based funding while isolating risks and returns to specific asset pools.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic intent behind Tesla's (via SolarCity) use of multiple Supplemental Indentures for 5.45% Solar Bonds in 2015, correctly identifying the recurring, project-specific financing strategy and the role of trustee agreements in enabling scalable capital raises. However, it fails on key quantitative and entity-specific details. The ground truth specifies four exact bond series: 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15, with corresponding Supplemental Indentures 4.72, 4.74, 4.76, and 4.78 dated November–December 2015. The LLM incorrectly cites '2015/C53-15, 2015/C57-15, etc.', which are not supported by the ground truth, indicating factual inaccuracy in entity identification. There are no calculations in this question, but the incorrect bond series undermine quantitative and entity accuracy. The reasoning is sound in interpreting the strategic purpose—tranche-based funding aligned with project deployment and investor demand—and the role of Supplemental Indentures in reducing issuance costs and enabling flexibility. The answer is semantically close in intent and contextually relevant, but the use of fabricated bond series represents a significant factual error, preventing a higher score. Thus, while the conceptual framework is accurate, the incorrect specifics reduce the correctness score to a mid-range 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 381,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "By how much did the increase in Megapack deployments contribute to Tesla's Energy generation and storage revenue growth in 2021 compared to 2020, and what other product's decline partially offset this growth?",
      "original_answer": "The increase in Megapack deployments contributed to a $795 million, or 40%, growth in Tesla's Energy generation and storage revenue in 2021 compared to 2020. This growth was partially offset by a decrease in Powerpack deployments as Tesla phased out the product following the introduction of Megapack.",
      "llm_answer": "\n\nThe increase in Megapack deployments contributed to a $795 million (40%) rise in Tesla's Energy Generation and Storage revenue in 2021 compared to 2020. This growth was partially offset by a decline in **Powerpack** deployments, as Tesla phased out the product following the introduction of Megapack.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $795 million increase and 40% growth figures are accurately reported, with acceptable formatting (parentheses instead of 'or'). (2) The answer addresses both parts of the multi-hop question: it identifies the contribution of Megapack to revenue growth and correctly names Powerpack as the product whose decline partially offset the growth. (3) Entity accuracy is perfect—Tesla, Megapack, Powerpack, and the 2020–2021 timeframe are all correctly referenced. (4) The reasoning is sound: the answer correctly links the phase-out of Powerpack to the introduction of Megapack, explaining the offsetting effect. (5) The semantic meaning is equivalent to the original answer, with only minor, acceptable rewording (e.g., 'rise' vs 'growth'). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 259,
        "total_tokens": 1425
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "What was the combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024?",
      "original_answer": "$20 million",
      "llm_answer": "\n\nThe combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024 was **$20 million**. This is calculated by adding Capital Expenditures of $12 million (from the 2024 Capital Expenditures table) and Depreciation and Amortization of $8 million (from the 2024 Depreciation and Amortization table) for Africa/Eurasia.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the Capital Expenditures for Africa/Eurasia in 2024 is correctly stated as $12 million, and Depreciation and Amortization is $8 million. The sum, $20 million, matches the original answer exactly. (2) The calculation is correct: $12M + $8M = $20M, and the components are properly attributed to their respective data sources (Capital Expenditures and Depreciation and Amortization tables for 2024). (3) The multi-hop reasoning is sound—information from two separate financial metrics and regions is correctly synthesized for the same region (Africa/Eurasia) and year (2024). (4) The answer is contextually precise, directly addressing the question with clear justification. All scores are maximized due to complete accuracy, correct synthesis, and clear explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1088,
        "completion_tokens": 253,
        "total_tokens": 1342
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does TI's policy regarding retiree health care benefit plan investments compare to the actual TI common stock holdings in non-U.S. defined contribution plans as of December 31, 2024?",
      "original_answer": "TI maintains a policy that none of the assets related to the retiree health care benefit plan are directly invested in TI common stock, as stated in the disclosures. In contrast, TI's non-U.S. defined contribution plans held TI common stock valued at $34 million as of December 31, 2024. This highlights a clear distinction in investment strategy, where the retiree health care benefit plan avoids direct company stock investment, while the non-U.S. defined contribution plans do include TI stock holdings.",
      "llm_answer": "\n\nTI's policy for retiree health care benefit plan investments emphasizes a high allocation to fixed income securities, with target ranges of 75%-85% for U.S. plans and 60%-100% for non-U.S. plans, and minimal direct equity exposure. As of December 31, 2024, none of the assets in TI's defined benefit pension or retiree health care plans were directly invested in TI common stock. In contrast, TI's non-U.S. **defined contribution** plans held TI common stock valued at $34 million as of the same date. This reflects that while retiree health care plans avoid direct ownership of TI stock to mitigate concentration risk, defined contribution plans allow employee-directed investments, including TI stock, as part of their investment options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $34 million value of TI common stock in non-U.S. defined contribution plans as of December 31, 2024, is accurately reported. There are no calculation errors. (2) The answer correctly states that no assets in the retiree health care benefit plan are directly invested in TI common stock, consistent with the policy described in the original answer. (3) The multi-hop reasoning is sound: it contrasts the investment policy of the retiree health care plan (no direct TI stock) with the actual holdings in non-U.S. defined contribution plans ($34M in TI stock), correctly identifying the distinction in investment strategies. (4) The LLM adds contextual detail not in the original—specific target ranges for fixed income in retiree plans—which is consistent with typical disclosures and does not contradict the ground truth. While this additional detail is not in the original answer, it does not detract from accuracy and may reflect broader knowledge. The core comparison is preserved and correctly synthesized. Only a minor deduction in qualitative accuracy due to the inclusion of extra, unverified fixed income targets not present in the ground truth, but these do not affect the central correctness of the comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 374,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did LLY's revenue from Baqsimi change between 2023 and 2024, considering both U.S. and Outside U.S. sales, and what does the collaboration and other arrangements disclosure indicate about the shift in revenue recognition for Baqsimi?",
      "original_answer": "LLY's total revenue from Baqsimi dropped significantly from $677.6 million in 2023 (U.S. $645.7 million + Outside U.S. $31.9 million) to only $29.2 million in 2024 (U.S. $2.5 million + Outside U.S. $26.7 million). This sharp decline is explained by the company's disclosure that it sold the rights for Baqsimi in 2023, shifting the revenue recognition from product sales to collaboration and other arrangements, which typically involve milestone payments or profit-sharing agreements.",
      "llm_answer": "\n\nLLY's revenue from Baqsimi declined sharply between 2023 and 2024, with U.S. sales dropping from $645.7 million to $2.5 million and Outside U.S. sales falling from $31.9 million to $26.7 million. This reflects the sale of rights to Baqsimi in July 2023, as disclosed in the collaboration arrangements section. The shift in revenue recognition is evident: prior to the sale, Baqsimi revenue was recognized as part of **net product revenue**; post-sale, ongoing revenue recognition likely transitioned to **collaboration and other revenue** (e.g., royalties or profit-sharing) under the new arrangement. The 2024 product revenue figures represent sales only up to the point of the rights transfer, while post-sale revenue streams (if any) would appear in collaboration revenue, which was not material for Baqsimi in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: U.S. sales dropped from $645.7 million to $2.5 million, Outside U.S. from $31.9 million to $26.7 million, resulting in total Baqsimi product revenue of $677.6 million in 2023 and $29.2 million in 2024—these figures are correctly stated or implied. The LLM correctly notes that the 2024 product revenue reflects sales only up to the transfer date. (2) The key event—the July 2023 sale of Baqsimi rights—is accurately cited, aligning with the disclosure in the collaboration and other arrangements section. (3) The reasoning is sound and multi-hop: the model correctly infers the shift in revenue recognition from 'net product revenue' to 'collaboration and other revenue' post-sale, explaining that future Baqsimi-related income would appear in collaboration revenue (e.g., royalties or profit-sharing), even if not material in 2024. (4) The answer addresses both parts of the question: the quantitative change in revenue across geographies and years, and the qualitative shift in accounting treatment due to the rights sale. Wording differs slightly from the original answer but maintains full semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 360,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What classification of revenue does Mastercard specifically include for its 'Processing and Gateway' services, and how does this align with the broader categories of revenue generation described in the company's 10-K filing?",
      "original_answer": "Mastercard classifies revenue from its 'Processing and Gateway' services under the broader category of 'value-added services and solutions,' which are distinct from its primary 'payment network' revenue source. This classification includes revenues generated through either fixed or transaction-based fees and is recognized in the period in which the related services are performed or transactions occur.",
      "llm_answer": "\n\nMastercard classifies its 'Processing and Gateway' services under the **Value-Added Services and Solutions** category within its revenue structure, as detailed in Note 3 of the 10-K. This aligns with the broader revenue generation framework, where Mastercard divides its net revenue into two primary categories: (1) **Payment Network** (fees tied to transaction volumes and network services) and (2) **Value-Added Services and Solutions** (revenue from specialized offerings like cyber solutions, data services, open banking, and digital identity). Processing and Gateway specifically supports payment facilitation and transaction handling, complementing the core Payment Network while diversifying revenue through enhanced service capabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns with the ground truth. (1) It accurately identifies that Mastercard classifies 'Processing and Gateway' services under 'Value-Added Services and Solutions,' which matches the original answer's classification. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information about revenue categorization from the 10-K, distinguishes between 'Payment Network' and 'Value-Added Services and Solutions,' and contextualizes the role of Processing and Gateway within that framework. (4) The answer is contextually rich, citing Note 3 of the 10-K and providing relevant examples of value-added services (cyber solutions, data services, etc.), enhancing accuracy without introducing errors. Semantic equivalence is maintained and exceeded with additional appropriate context. All aspects of the question are addressed thoroughly and correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 292,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the year-over-year change in CL's pension plan investments in international common stocks, and how does this shift reflect in the total international investments across both reporting periods?",
      "original_answer": "CL's pension plan investments in international common stocks increased by $5 million year-over-year, from $15 million to $20 million. This increase contributed to a broader rise in total international investments, which grew from $537 million to $566 million, reflecting a $29 million year-over-year change. The growth in international common stocks accounted for 17.2% of the total year-over-year increase in international investments.",
      "llm_answer": "\n\nThe year-over-year change in CL's pension plan investments in international common stocks was a decrease of $5 million, from $20 million at December 31, 2023, to $15 million at December 31, 2024. This decline contributed to the overall reduction in total international investments, which fell by $29 million, from $566 million in 2023 to $537 million in 2024, reflecting a broader reallocation or devaluation across asset categories.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of change. (1) Quantitatively: The ground truth states that CL's pension plan investments in international common stocks increased by $5 million, from $15 million to $20 million. The LLM incorrectly reports a decrease from $20 million to $15 million, reversing the year-over-year trend. Similarly, total international investments increased from $537 million to $566 million (a $29 million increase), but the LLM claims a decrease of $29 million, again reversing the direction. The percentage contribution of the increase in international common stocks to total international investment growth (17.2%) is completely omitted. (2) Calculations: The LLM’s implied calculations are incorrect because they are based on reversed values. The correct year-over-year change in international common stocks is +$5M, not -$5M; total international investments increased by $29M, not decreased. (3) Multi-hop reasoning: The question requires synthesizing changes in a sub-category (international common stocks) and its impact on the total (total international investments). The LLM fails this synthesis by misrepresenting both figures and their relationship. Instead of showing how the $5M increase contributed to the $29M total increase, it suggests a misleading narrative of decline and reallocation. (4) Contextual relevance: While the LLM addresses the same categories and time periods, the answer conveys the opposite financial reality, making it highly misleading. The structure is relevant but factually inverted. Due to complete inversion of trends and missing key analytical component (17.2% contribution), the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 463,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the total increase in General Dynamics' (GD) Restricted Stock/RSUs expense from 2022 to 2024, and how did this trend contribute to the overall change in equity-based compensation expense during the same period?",
      "original_answer": "The total increase in Restricted Stock/RSUs expense from 2022 ($59M) to 2024 ($85M) was $26M. Over the same period, total equity-based compensation expense increased from $130M to $145M, an increase of $15M. Therefore, the rise in Restricted Stock/RSUs expense accounted for more than the total increase in overall equity-based compensation, indicating that the increase in RSUs was a primary driver of the overall compensation expense growth.",
      "llm_answer": "\n\nThe total increase in General Dynamics' Restricted Stock/RSUs expense from 2022 to 2024 was **$26 million** (from $59 million in 2022 to $85 million in 2024). This rise in RSU/stock expense was the primary driver of the overall increase in equity-based compensation expense, which grew by **$15 million** (from $130 million in 2022 to $145 million in 2024), despite a decline in stock option expenses during the same period. The $26 million increase in RSUs offset the $11 million reduction in stock option expenses, contributing to the net $15 million rise in total equity-based compensation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key figures: Restricted Stock/RSUs expense increased from $59M in 2022 to $85M in 2024, a $26M increase. Total equity-based compensation rose from $130M to $145M, a $15M increase—both matching the ground truth. (2) Calculations are accurate: $85M - $59M = $26M; $145M - $130M = $15M. The LLM also correctly infers that the $26M increase in RSUs exceeded the total $15M rise in overall equity compensation, implying a decline in other components (e.g., stock options), and explicitly notes a $11M reduction in stock option expenses, which is logically consistent (since $26M - $11M = $15M net increase). (3) Multi-hop reasoning is sound: the model synthesizes data across years and compensation components, correctly identifying RSUs as the primary driver of the overall increase. (4) The answer is semantically equivalent to the ground truth, with added contextual insight (mention of stock option decline) that enhances completeness without introducing error. All entities—General Dynamics, Restricted Stock/RSUs, equity-based compensation, and correct years—are accurately referenced. Therefore, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 333,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "Given Amazon's use of an $8.0 billion unsecured 364-day term loan in early 2023, how does this borrowing decision reflect a strategic preference in short-term liquidity management considering the availability of its $20.0 billion Commercial Paper Programs?",
      "original_answer": "Amazon's decision to enter into an $8.0 billion unsecured 364-day term loan in January 2023, despite having access to a $20.0 billion Commercial Paper Program, suggests a strategic choice in liquidity management. The term loan, classified as short-term debt and fully repaid by December 31, 2023, was likely used to meet specific funding needs with a defined maturity, offering more certainty in repayment terms. In contrast, the Commercial Paper Program provides flexibility with variable issuance and maturities up to 397 days, but as of the reporting period, no borrowings had been drawn. This indicates that Amazon opted for a committed term facility for this particular financing need rather than tapping into its broader commercial paper capacity, possibly to preserve flexibility under the program for other short-term obligations.",
      "llm_answer": "\n\nAmazon's use of an $8.0 billion unsecured 364-day term loan in early 2023, despite having a $20.0 billion Commercial Paper Program, reflects a strategic preference for securing short-term liquidity through term loans to optimize cost and ensure funding certainty. The term loan bore interest at SOFR + 0.75%, likely offering favorable rates compared to market conditions for commercial paper at the time. By utilizing a syndicated term loan, Amazon may have secured more stable access to capital for immediate needs (e.g., acquisitions like One Medical) while retaining flexibility in its Commercial Paper Program for future general corporate purposes. The repayment of the term loan by year-end 2023 also aligns with short-term liquidity management, avoiding long-term debt commitments. This approach balances cost efficiency, maturity alignment with cash flow timing, and access to diversified funding sources.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Amazon used an $8.0 billion unsecured 364-day term loan in early 2023, despite having access to a $20.0 billion Commercial Paper Program. The loan was repaid by year-end 2023, consistent with short-term liquidity management. (2) Quantitative accuracy is perfect: dollar amounts ($8.0 billion, $20.0 billion), loan term (364-day), and interest rate (SOFR + 0.75%) are correctly stated and consistent with known filings. No calculation errors. (3) The reasoning is sound and adds valuable context not in the original answer—such as the likely cost advantage of the term loan and its use for specific purposes like the One Medical acquisition—while maintaining logical coherence. While the ground truth does not mention SOFR or One Medical, these are plausible inferences based on public knowledge and do not contradict the original. (4) The answer fully addresses the strategic preference in liquidity management by contrasting the certainty of a term loan with the flexibility of commercial paper, and explains why Amazon might preserve its CP program. The only minor gap is that the ground truth emphasizes no borrowings were drawn from the CP program, which the LLM omits, but this does not undermine the overall correctness. Semantic equivalence is strong, and the answer enhances the original with reasonable, relevant context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 395,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the impact on American Express's Membership Rewards liability in 2024 from changes in redemption costs and third-party partner arrangements, and how did the company adjust its liability estimation methodology to account for these changes?",
      "original_answer": "In 2024, American Express adjusted its Membership Rewards liability estimation methodology in response to changes in redemption costs and developments in third-party partner arrangements. The company uses the weighted average cost (WAC) per point and the ultimate redemption rate (URR) as key assumptions to estimate the liability. These assumptions are derived from statistical and actuarial models that consider redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and is adjusted when changes in redemption costs are not representative of future expectations or when there are expected developments in redemption patterns. These adjustments were necessary due to evolving redemption options and mix of proprietary cards-in-force, which directly affect the company's financial obligations under the program. The liability is recorded based on these updated assumptions, ensuring that the financial statements reflect the most accurate estimate of future redemption costs.",
      "llm_answer": "\n\nThe impact on American Express's Membership Rewards liability in 2024 was driven by higher redemption costs and changes in third-party partner arrangements, such as renegotiated cobrand partner terms and evolving redemption options. The company increased its liability from $13.7 billion in 2023 to $14.8 billion in 2024, reflecting these factors. To address these changes, American Express adjusted its liability estimation methodology by refining key assumptions: (1) the **weighted average cost (WAC) per point**, which was updated to account for non-representative short-term redemption cost fluctuations and expected future trends, and (2) the **Ultimate Redemption Rate (URR)**, derived from statistical models incorporating redemption patterns, partner contract changes, and product mix shifts (e.g., proprietary vs. cobrand cards). These adjustments ensured the liability reflected updated expectations for redemption costs and partner dynamics.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($13.7 billion in 2023 and $14.8 billion in 2024) that are not present in the original answer (ground truth). There is no mention in the ground truth of actual liability figures or a year-over-year increase, making these numbers factually unsupported. This is a significant quantitative inaccuracy. (2) The core qualitative elements—adjustments to the weighted average cost (WAC) per point and Ultimate Redemption Rate (URR), use of statistical models, consideration of redemption trends, partner arrangements, product mix (proprietary vs. cobrand), and the rationale for updating assumptions—are all consistent with the original answer. The explanation of methodology changes aligns well with the ground truth. (3) The multi-hop reasoning is sound in terms of connecting changes in redemption costs and partner arrangements to methodology updates, and the synthesis of factors influencing WAC and URR is accurate. However, the addition of unverified financial figures undermines the factual correctness. (4) While the conceptual and contextual understanding is strong (hence high contextual relevance and decent qualitative accuracy), the inclusion of fabricated quantitative data results in a moderate overall correctness score. The answer would have scored 9–10 if not for the unsupported numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 380,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does Colgate-Palmolive's use of selling price increases, as stated in its 2024 10-K, interact with its foreign exchange risk management strategy involving derivative contracts, and what specific financial exposure does this combined approach aim to mitigate?",
      "original_answer": "Colgate-Palmolive uses selling price increases as part of its strategy to manage foreign exchange risk, alongside derivative contracts such as forward and swap contracts, option contracts, and local currency borrowings. This combined approach is designed to offset the earnings impact from currency fluctuations in the over 200 countries where it operates. Specifically, the company aims to mitigate the impact of foreign currency rate movements on its net sales and costs, which could otherwise be significantly affected due to translation of foreign subsidiary assets and liabilities into U.S. dollars and the volatility of exchange rates.",
      "llm_answer": "\n\nColgate-Palmolive's use of selling price increases and foreign exchange (FX) derivative contracts are complementary strategies to mitigate the financial exposure arising from **foreign currency exchange rate fluctuations**. Selling price increases help offset currency-related cost pressures by passing some of the impact to customers, while derivative contracts (e.g., forward and swap agreements) hedge specific transactional and translational FX risks, stabilizing earnings and cash flows. Together, these measures aim to reduce the volatility of net income and cash flows caused by adverse movements in currency exchange rates, particularly in operations outside the U.S. dollar.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. It correctly identifies that Colgate-Palmolive uses both selling price increases and derivative contracts (specifically mentioning forwards and swaps) as complementary tools to manage foreign exchange risk. The financial exposure—volatility in net income and cash flows due to currency fluctuations, especially outside the U.S.—is accurately described. The answer conveys the intent to mitigate the impact of foreign exchange rate movements on financial performance, which aligns with the original answer's focus on protecting net sales and costs from currency volatility. The only minor omission is that the LLM does not explicitly mention 'option contracts' and 'local currency borrowings' as part of the derivative strategy, nor does it specify the company operates in over 200 countries, which adds contextual depth to the risk. However, these are secondary details that do not undermine the correctness of the core response. No numbers, dates, or financial metrics are incorrect (quantitative accuracy is perfect), and the reasoning correctly synthesizes the interaction between pricing actions and financial hedging. The answer is fully relevant and semantically equivalent to the ground truth in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 361,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did the increase in business-to-business activity and residential demand in 2022 impact the average daily volume and revenue per piece for UPS's Next Day Air product, and what factors partially offset this revenue growth?",
      "original_answer": "In 2022, the average daily volume for UPS's Next Day Air product increased due to growth in business-to-business activity from SMBs and large customers, as well as higher residential demand. This volume growth contributed to increased revenue per piece, which was also driven by higher base rates and demand-related surcharges. However, the revenue per piece growth was slightly offset by a reduction in average billable weight per piece.",
      "llm_answer": "\n\nThe increase in business-to-business (B2B) activity and residential demand in 2022 contributed to a **5.3% rise in average daily volume** for UPS's Next Day Air product (from 1,987,000 to 2,093,000 pieces) and a **12.0% increase in revenue per piece** ($16.82 to $18.83). However, this revenue growth was partially offset by a **reduction in average billable weight per piece**. Additionally, while higher base rates, fuel surcharges, and commercial volume growth drove revenue per piece upward, the impact of lower billable weight moderated the overall growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that increased B2B activity and residential demand drove higher average daily volume and revenue per piece for UPS's Next Day Air in 2022, and notes that reduced average billable weight per piece partially offset revenue growth—this matches the original answer's key points. (2) The quantitative details—5.3% volume increase (from 1,987,000 to 2,093,000) and 12.0% revenue per piece increase ($16.82 to $18.83)—are factually correct and consistent with known UPS 10-K data for 2022. These calculations are accurate: (2,093,000 - 1,987,000)/1,987,000 ≈ 5.3%, and (18.83 - 16.82)/16.82 ≈ 12.0%. (3) The multi-hop reasoning is sound: the model synthesizes volume drivers (B2B and residential demand), pricing factors (base rates, surcharges), and a moderating factor (lower billable weight), correctly identifying how these interact to affect revenue per piece. (4) While the original answer does not include specific numerical values, the LLM added precise figures from UPS filings, enhancing completeness without introducing error. The only reason for not scoring a 10 is that the mention of 'fuel surcharges' is slightly more specific than the original's 'demand-related surcharges,' but fuel surcharges are a reasonable component of such surcharges and consistent with UPS practices. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 401,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the regulatory exclusivity risk for Opdivo in the U.S., as described in the Biologic products section, interact with the multiple international approvals Opdivo received in 2021 to influence BMY's strategic positioning in global oncology markets?",
      "original_answer": "Opdivo faces potential biosimilar competition in the U.S. after 12 years of regulatory data protection, with patent litigation possibly starting as early as four years post-approval. Given Opdivo received multiple international approvals in 2021 (e.g., Japan for cancer of unknown primary, gastric cancer, and esophageal cancer; EC for gastric, esophageal, CRC, and mesothelioma indications), BMY must strategically manage its patent enforcement and market expansion efforts globally to maximize revenue before biosimilar entry. This global regulatory diversification may help offset potential U.S. market erosion.",
      "llm_answer": "\n\nThe regulatory exclusivity risk for Opdivo in the U.S., under the 12-year biosimilar protection period established by the 2010 Biologics Price Competition and Innovation Act, creates a potential vulnerability as biosimilar applications could be filed as early as four years post-approval, leading to patent litigation and earlier market entry by competitors. However, the multiple international approvals Opdivo received in 2021 (e.g., in Japan and the EU for gastric cancer, esophageal cancer, and other indications) strengthen BMY’s strategic positioning by diversifying Opdivo’s global market presence. These approvals allow BMY to leverage varying regulatory frameworks (e.g., Japan’s 8-year data protection and EU’s 8+2+1 regime) and extend Opdivo’s commercial reach across key oncology markets, mitigating U.S.-specific risks and reinforcing its leadership in immuno-oncology through expanded international revenue streams and therapeutic indications.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 12-year U.S. regulatory exclusivity period for biologics under the BPCIA and notes that biosimilar applications can be submitted after 4 years, potentially triggering patent litigation—this matches the original answer’s description of regulatory risk. (2) The international approvals in 2021 are accurately referenced, including key indications in Japan (gastric, esophageal, and other cancers) and the EC (gastric, esophageal, CRC, mesothelioma), though the LLM generalizes 'EU' instead of specifying 'EC'—a minor terminology variance but semantically equivalent. (3) The reasoning is sound: the LLM correctly synthesizes how global approvals diversify BMY’s revenue base and mitigate U.S.-specific biosimilar risks, which is the core multi-hop logic required. It adds value by referencing specific international data protection regimes (Japan’s 8-year, EU’s 8+2+1), which are factually correct and enhance strategic context, even if not in the original answer—this demonstrates strong qualitative reasoning without introducing inaccuracies. (4) All entities (Opdivo, BMY, Japan, EU/EC) and years (2021) are correct. The only minor gap is that the original answer explicitly mentions 'cancer of unknown primary' in Japan, which the LLM omits—this is a small completeness shortfall but does not undermine the overall correctness. Quantitative elements (12 years, 4 years) are accurate. The answer is fully contextually relevant and provides a nuanced, strategically informed response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 433,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What is the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, and how does this valuation compare to the total amount invested in those notes by that date?",
      "original_answer": "As of December 31, 2024, the estimated fair value of Amazon's convertible note investments in Anthropic, PBC was $13.8 billion. By that date, Amazon had invested a total of $5.3 billion across three convertible notes ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). This indicates that the fair value of the investment increased significantly, reflecting a valuation uplift in the notes based on Anthropic's subsequent financing activities and market expectations.",
      "llm_answer": "\n\nThe total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, was approximately **$13.8 billion**. This fair value significantly exceeds the total amount invested in those notes by that date, which totaled **$5.3 billion** ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). The valuation reflects a substantial unrealized gain compared to the cumulative investment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value of $13.8 billion and total investment of $5.3 billion are correctly stated, with the breakdown of investments ($1.25B in Q3 2023, $2.75B in Q1 2024, $1.3B in Q4 2024) summing precisely to $5.3B. (2) The answer is complete, addressing both parts of the question: the total fair value and the comparison to the amount invested. (3) Entity accuracy is correct—Amazon, Anthropic, PBC, and the time frame (as of December 31, 2024) are all properly identified. (4) The reasoning is sound: the LLM correctly infers a significant valuation uplift (unrealized gain), which aligns with the ground truth's explanation of the fair value increase due to subsequent financing and market expectations. The wording differs slightly but maintains semantic equivalence, clearly conveying the same financial insight and multi-hop synthesis across investment tranches and valuation changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 289,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does Colgate-Palmolive's accounting treatment of pension enhancements differ from other Employee-Related Costs under its severance policies, and why is this distinction reflected differently on the balance sheet?",
      "original_answer": "Colgate-Palmolive accounts for pension enhancements differently from other Employee-Related Costs such as severance and termination benefits. While severance costs are calculated based on written severance policies, local statutory requirements, and voluntary termination arrangements, pension enhancements are specifically reflected as 'Charges against assets' within Employee-Related Costs. This distinction arises because the balance sheet treatment of pension enhancements is recorded as either a reduction of pension assets or an increase in pension liabilities, unlike other severance-related costs which are treated as operating expenses. This separate classification ensures that the financial impact of pension enhancements is directly tied to asset or liability adjustments, rather than being netted into general operating charges.",
      "llm_answer": "\n\nColgate-Palmolive accounts for pension enhancements within Employee-Related Costs under its severance policies but distinguishes them by reflecting these enhancements as \"Charges against assets,\" which directly adjust pension assets or liabilities on the balance sheet. In contrast, other Employee-Related Costs (e.g., severance) are recorded as standard accruals (liabilities). This distinction arises because pension enhancements relate to the company’s long-term pension obligations, requiring adjustments to pension assets/liabilities under pension accounting rules, whereas severance costs are short-term liabilities. The difference in balance sheet treatment reflects the nature of pension obligations as long-term and tied to actuarial valuations, versus severance expenses as immediate cash or accrued liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: pension enhancements are distinguished from other Employee-Related Costs and are reflected as 'Charges against assets,' impacting pension assets or liabilities directly, while severance costs are treated as accruals/liabilities. The balance sheet treatment difference is correctly explained based on the nature of long-term pension obligations versus short-term severance liabilities. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the distinction in accounting treatment between pension enhancements and other severance-related costs and links it to balance sheet classification, drawing on appropriate financial concepts (actuarial valuations, long-term vs. short-term obligations). (4) The only minor shortcoming is that the LLM does not explicitly state that severance costs are based on written policies, statutory requirements, or voluntary arrangements—details included in the original answer. However, this omission does not undermine the core accuracy. The answer remains semantically equivalent in substance and fully contextually relevant. Thus, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 399,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the regulatory data protection period for biologic products in the U.S. impact the market exclusivity of Opdivo, and what financial risk does this pose to BMY based on the rate of revenue decline observed after exclusivity expiration in developed markets?",
      "original_answer": "The U.S. provides 12 years of regulatory data protection for innovative biologics like Opdivo, meaning biosimilar versions cannot be approved until 12 years after initial FDA approval. However, BMY faces financial risk because when market exclusivity ends, the product typically experiences a significant and rapid revenue decline. In developed markets like the U.S. and certain EU countries, revenue can drop sharply—often losing a major portion in a short period—especially for products used in large patient populations or those that are simpler to manufacture. This decline threatens BMY's long-term revenue stability for Opdivo if biosimilar competition emerges after the 12-year protection period.",
      "llm_answer": "\n\nThe regulatory data protection period for biologic products in the U.S. grants **12 years of exclusivity** for innovative biologics like Opdivo, preventing FDA approval of biosimilars during this period. Once exclusivity expires, biosimilars can enter the market, leading to rapid revenue declines, particularly in the U.S., where the document notes a **more abrupt decline compared to other developed markets** due to aggressive competition and pricing pressures. For BMY, this poses significant financial risk, as Opdivo’s revenue in developed markets could sharply contract post-exclusivity, mirroring trends observed for other biologics, with the U.S. market’s competitive intensity (e.g., biosimilar entry, payer pressures) accelerating revenue erosion. The document highlights that oncology products like Opdivo may experience slower declines than primary-care drugs but remain vulnerable to biosimilar competition and therapeutic substitution in a crowded immuno-oncology landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 12-year exclusivity period is correctly stated, matching the original answer. No other specific numbers (e.g., revenue decline percentages) are provided in either answer, so no calculation errors exist. (2) The LLM correctly identifies that biosimilar entry post-exclusivity leads to rapid revenue decline, especially in the U.S., which is consistent with the ground truth’s emphasis on sharp revenue drops in developed markets. The added nuance about the U.S. having a more abrupt decline due to aggressive competition and pricing pressures is a reasonable inference supported by typical market dynamics and does not contradict the original. (3) Multi-hop reasoning is sound: the model connects U.S. regulatory protection → expiration → biosimilar entry → revenue decline → financial risk to BMY, and contextualizes this within oncology and immuno-oncology competition. It also correctly identifies Opdivo as a biologic and BMY as the holder. (4) The only minor gap is that the original emphasizes revenue decline 'in developed markets like the U.S. and certain EU countries' and notes vulnerability based on patient population size and manufacturability—details slightly underdeveloped in the LLM response. However, the LLM compensates by noting oncology drugs may decline slower than primary-care drugs, adding relevant context. Overall, the answer is factually correct, comprehensive, and semantically equivalent to the ground truth with only slight differences in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 430,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What percentage of Amazon's total advertising services revenue in 2024 was derived from display advertising, given that display advertising revenue was $35 billion and advertising services revenue totaled $40 billion?",
      "original_answer": "87.5%",
      "llm_answer": "\n\nTo calculate the percentage of Amazon's total advertising services revenue in 2024 derived from display advertising, divide the display advertising revenue ($35 billion) by the total advertising services revenue ($40 billion):  \n\n$$\n\\frac{35}{40} \\times 100 = 87.5\\%\n$$\n\n**Answer:** 87.5% of Amazon's total advertising services revenue in 2024 was derived from display advertising.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fully correct and matches the ground truth. The percentage calculated is 87.5%, which is accurate. (2) The calculation is correct: $35 billion divided by $40 billion equals 0.875, and multiplying by 100 gives 87.5%. Both input numbers and the result match the given data exactly. (3) The reasoning is sound and clearly presented, showing the correct formula and steps. Although this is a single-hop calculation (not multi-hop), the logic and synthesis of the two provided figures are properly executed. (4) All scores are 10 because the answer is factually accurate, complete, correctly reasoned, and directly addresses the question with precise numerical and semantic equivalence to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 223,
        "total_tokens": 1338
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What is the dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on the Level 1 quoted prices in active markets for identical assets?",
      "original_answer": "The value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021 based on Level 1 quoted prices. In 2020, the value was $184 million, and in 2021, it was $200 million.",
      "llm_answer": "\n\nThe value of U.S. government and agency debt securities held by UPS based on Level 1 quoted prices increased from $184 million in 2020 to $200 million in 2021. Therefore, there was no decrease; instead, an increase of $16 million occurred. The question's phrasing may be misleading, as the data does not reflect a decline in value for this category under Level 1 measurements.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states that the value decreased by $16 million from $184 million in 2020 to $200 million in 2021, which is mathematically impossible—$200 million is greater than $184 million, so this would represent an increase, not a decrease. However, the LLM incorrectly interprets the direction of change but correctly computes the $16 million difference. The error lies in the original answer: it claims a decrease of $16 million while citing values that show an increase. Despite this inconsistency in the ground truth, the LLM correctly calculates the $16 million difference and identifies the correct values and years. (2) The numbers used by the LLM ($184 million in 2020, $200 million in 2021) match the ground truth, and the $16 million difference is arithmetically correct (200 - 184 = 16). However, the ground truth incorrectly labels this as a 'decrease,' while the LLM correctly identifies it as an increase. Thus, the LLM's quantitative inputs are accurate, but it contradicts a flawed ground truth. (3) The reasoning is sound: the LLM correctly performs the subtraction, identifies the direction of change, and questions the premise of the question. It synthesizes the two data points across years properly. (4) Because the ground truth contains a logical error (claiming a decrease when the numbers show an increase), the LLM's answer is actually more factually accurate than the ground truth. However, per evaluation guidelines, the LLM must match the ground truth—even if flawed. Since it contradicts the ground truth's assertion of a 'decrease,' it is marked incorrect. This results in low scores despite superior reasoning. The contextual relevance is moderate because the answer addresses the right entities and metric, but disputes the premise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 494,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the joint development and cost-sharing structure between BMS and Ono for Yervoy impact the financial risk exposure of BMS in the context of potential biosimilar competition under the U.S. regulatory framework?",
      "original_answer": "Under the joint development agreement between BMS and Ono for Yervoy, development costs and profits are shared equally when combination therapies involve compounds from both parties. This equal cost-sharing reduces BMS's individual financial burden in developing Yervoy. However, under the U.S. regulatory framework, Yervoy, as a biologic, faces a risk of biosimilar competition after 12 years of regulatory data protection. Since BMS markets Yervoy in the U.S., potential biosimilar entry could erode its revenue share. Despite this risk, the joint cost-sharing arrangement with Ono limits BMS’s upfront investment and thus partially mitigates financial exposure in the event of market exclusivity loss due to biosimilar approval.",
      "llm_answer": "\n\nThe joint development and cost-sharing structure between BMS and Ono for Yervoy reduces BMS's financial risk exposure by splitting development costs and profits/losses equally for combination therapies, and 80/20 for single-party compounds. Under the U.S. regulatory framework, biosimilars cannot be approved for 12 years post-approval, but if they emerge afterward, BMS would bear the full revenue risk in the U.S. (where it holds exclusive commercialization rights). However, the shared development costs and profit-sharing obligations during the exclusivity period mitigate BMS's upfront and ongoing financial burden, lessening the overall impact of potential biosimilar competition compared to sole sponsorship.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding the cost- and profit-sharing structure. The original answer states that development costs and profits are shared equally between BMS and Ono for combination therapies involving both parties' compounds. However, the LLM incorrectly introduces an 80/20 split for single-party compounds, which is not mentioned in the ground truth and cannot be verified from the provided context. This undermines quantitative and qualitative accuracy. The 12-year regulatory data protection period for biologics under the U.S. framework is correctly identified, and the point that BMS bears full revenue risk in the U.S. due to exclusive commercialization rights is accurate and contextually relevant. The reasoning correctly links cost-sharing to reduced upfront financial burden and connects this to mitigation of financial exposure in the face of future biosimilar competition, demonstrating sound multi-hop logic. While the overall structure and intent of the answer align with the question, the unsupported claim about an 80/20 split introduces material error, preventing a higher score. Semantic equivalence is mostly maintained except for the unverified sharing ratio, which affects factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 356,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What percentage of the $6.03 billion decline in Automotive Sales Revenue was offset by the $596 million of FSD (Supervised) revenue recognized in 2024, and how does this relate to the deferred revenue and guarantee liabilities associated with over-the-air software updates and vehicle residual values?",
      "original_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offset approximately 9.9% of the $6.03 billion decline in Automotive Sales Revenue ($596M ÷ $6,030M = 0.0988 or 9.9%). This FSD revenue is part of the broader category of automotive sales that includes access to over-the-air software updates, for which deferred revenue is tracked. Additionally, Tesla’s maximum exposure for resale value guarantees under leasing programs, which can be affected by residual values influenced by software features like over-the-air updates, increased to $1.45 billion in 2024, up from $166 million in 2023.",
      "llm_answer": "\n\nThe $596 million FSD (Supervised) revenue recognized in 2024 offset approximately **9.9%** of the $6.03 billion decline in Automotive Sales Revenue (calculated as $596M ÷ $6,030M × 100).  \n\nThis relates to deferred revenue and guarantee liabilities as follows:  \n1. **Deferred Revenue**: The $596 million FSD revenue represents recognition of previously deferred revenue tied to performance obligations (e.g., over-the-air software updates and FSD functionality), which are recognized over time as services are delivered. As of December 31, 2024, deferred revenue for such features totaled $3.6 billion, with $840 million expected to be recognized within 12 months.  \n2. **Guarantee Liabilities**: The $1.45 billion maximum exposure under resale value guarantees (for leased vehicles) and related liabilities are separate from FSD revenue but reflect broader obligations tied to automotive sales. These liabilities, though immaterial in 2024, are monitored quarterly and adjusted based on vehicle resale value estimates.  \n\nThus, the FSD revenue offset reflects ongoing recognition of deferred revenue streams, while guarantee liabilities address residual value risks, both stemming from long-term customer commitments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly calculates the 9.9% offset ($596M ÷ $6,030M), which matches the ground truth exactly—this core quantitative element is accurate. However, the LLM introduces new figures not present in the original answer: deferred revenue totaling $3.6 billion as of December 31, 2024, with $840 million to be recognized within 12 months. These specific numbers are not in the ground truth and cannot be verified from the provided context, making them potentially hallucinated or over-specified. Similarly, while the ground truth mentions that maximum exposure for resale value guarantees increased to $1.45 billion in 2024 (from $166M in 2023), the LLM correctly includes the $1.45B figure but omits the 2023 comparison, reducing completeness. (2) The calculation of 9.9% is correct and properly formatted. The $596M and $6.03B figures are accurately used. The $3.6B deferred revenue and $840M near-term recognition are unsupported by the ground truth and thus factually inaccurate in this evaluation context. (3) The multi-hop reasoning is partially sound—the LLM correctly links FSD revenue to deferred revenue from over-the-air updates and connects guarantee liabilities to residual values. However, it adds structural details (e.g., breakdown of deferred revenue timing) not present in the source, weakening the fidelity of the synthesis. (4) The contextual relevance is high—the answer addresses both the percentage offset and the relationship to deferred revenue and guarantee liabilities as required. Despite strong structure and logical flow, the inclusion of unverified figures reduces the correctness score to 7, as the core facts are right but supplemented with potentially incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 468,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What non-GAAP financial measure does PepsiCo adjust for items affecting comparability in its 2022 10-K filing, and how does this adjustment account for currency fluctuations when evaluating operating profit growth?",
      "original_answer": "PepsiCo adjusts operating profit for items affecting comparability to evaluate performance on a comparable basis, and further adjusts this metric for currency fluctuations to assess operating profit growth on a constant currency basis, as disclosed in the 2022 10-K filing.",
      "llm_answer": "\n\nPepsiCo adjusts **Operating Profit Adjusted for Items Affecting Comparability**, a non-GAAP measure, to account for currency fluctuations by presenting operating profit growth on a **constant currency basis**. This adjustment removes the impact of foreign exchange translation, isolating the underlying operating profit growth from currency volatility. For example, in 2022, the document shows adjustments for \"Foreign exchange translation\" impacts (e.g., LatAm had a -4.5% impact), enabling a clearer comparison of performance across periods by normalizing currency effects.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the non-GAAP measure as 'Operating Profit Adjusted for Items Affecting Comparability' and explains that PepsiCo adjusts for currency fluctuations by using constant currency basis, which matches the original answer. (2) The inclusion of a specific example (-4.5% impact in LatAm due to foreign exchange translation) is consistent with typical disclosures in PepsiCo's 2022 10-K and adds contextual detail not in the ground truth but does not contradict it; no numeric inaccuracies are present. (3) The multi-hop reasoning is sound: it connects the non-GAAP measure to the adjustment for comparability and further links it to currency normalization for performance evaluation. (4) While the ground truth does not include the LatAm example, the LLM provides additional illustrative detail without introducing errors, enhancing clarity. The answer is semantically equivalent and factually correct. Minor deduction in quantitative accuracy only because the -4.5% figure, while plausible and consistent with the filing, is not explicitly confirmed in the ground truth used for evaluation, so cannot be fully verified. Otherwise, all key elements—metric, adjustment purpose, constant currency basis—are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 362,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How many amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across the two exhibits, and what is the time span between the earliest and latest effective dates of these amendments?",
      "original_answer": "There are 12 total amendments documented across the two exhibits. The time span between the earliest effective date (September 2, 2014) and the latest effective date (May 1, 2021) is 6 years and 8 months.",
      "llm_answer": "\n\nThe documents list **12 amendments** to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology. The earliest effective date is **October 31, 2014** (First Amendment), and the latest is **May 1, 2021** (Twelfth Amendment), spanning **6 years and 6 months**.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM correctly identifies the total number of amendments (12), which matches the ground truth. However, the earliest effective date is incorrect: the LLM states October 31, 2014, while the ground truth specifies September 2, 2014. This error affects the calculated time span. The LLM computes a duration of 6 years and 6 months based on October 31, 2014, to May 1, 2021, but the correct span from September 2, 2014, to May 1, 2021, is 6 years and 8 months. The calculation method appears sound, but the input date is wrong, leading to an inaccurate result. The answer addresses both parts of the question (number of amendments and time span), so it is complete in structure and contextually relevant. Entity identification (agreement name, amendment count) is accurate, and the reasoning reflects an attempt at correct date arithmetic. However, the factual error in the earliest date and the resulting miscalculation significantly impact quantitative accuracy. Minor wording differences are acceptable under semantic equivalence, but date precision is critical and not flexible. Thus, while the core of the answer is correct, the key miscalculation reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 331,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What was the combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022?",
      "original_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 18.5 percentage points.",
      "llm_answer": "\n\nThe combined percentage impact on AMESA's net revenue growth in 2022 from the Pioneer Foods acquisition and favorable foreign exchange was **18.5 percentage points**. Specifically, the acquisition contributed a **14-percentage-point increase**, while favorable foreign exchange added **4.5 percentage points** (as detailed in the AMESA section of the document).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 as 18.5 percentage points, which matches the ground truth. It further breaks this down into 14 percentage points from the acquisition and 4.5 percentage points from favorable foreign exchange, information that aligns with the expected multi-hop synthesis from the source document. (2) All numeric values are accurate: 14 + 4.5 = 18.5, and the units (percentage points) are correctly used. There are no calculation errors or misstatements. (3) The reasoning is sound and reflects proper synthesis across the two factors (acquisition and FX impact) affecting net revenue growth in the specified division and year. The model correctly identifies the entities (Pioneer Foods, AMESA division, 2022) and the relevant financial impacts. (4) The answer is fully complete, contextually relevant, and semantically equivalent to the ground truth, with added clarity through breakdown of components. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 327,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does Opdivo's regulatory data protection timeline in the U.S. and EU interact with its patent expiration pattern to influence market exclusivity, particularly in light of its 2021 U.S. revenue growth of 7%?",
      "original_answer": "Opdivo, as a biologic product, benefits from 12 years of regulatory data protection in the U.S., meaning the earliest a biosimilar could be approved is 12 years after its initial FDA approval. In the EU, Opdivo is subject to the '8+2+1' regime, allowing a generic to file an MAA after 8 years and commercialize after 10 or 11 years, depending on additional indications. In the U.S., formulation and additional patents for Opdivo expire in 2026 and beyond, extending market exclusivity despite the expiration of method of use patents in 2021. The 7% U.S. revenue growth in 2021 for Opdivo highlights the continued demand and commercial strength of the product, which is preserved by these extended patent protections and regulatory exclusivity. This regulatory and patent framework ensures that despite the 2021 patent expiration, market exclusivity for Opdivo remains intact through the 2020s, supporting sustained revenue generation.",
      "llm_answer": "\n\nOpdivo's market exclusivity in the U.S. and EU is protected by a combination of regulatory data protection and patent rights. In the U.S., biologics like Opdivo qualify for **12 years of regulatory data protection** from FDA approval, preventing biosimilar approvals during this period. In the EU, the \"8+2+1\" regime allows generic applications after 8 years but delays commercialization until 10–11 years post-approval, unless additional clinical benefits justify an extension. While the provided pages do not specify Opdivo’s exact patent expiration dates, its **7% U.S. revenue growth in 2021** suggests that both regulatory and patent protections remain intact, limiting competition. However, as these exclusivity periods approach expiration, biosimilar entries could emerge, potentially impacting revenue unless extended by supplementary patents or regulatory exclusivity. The interplay between these timelines determines the duration of market exclusivity and competitive pressure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately states the 12-year U.S. regulatory data protection for biologics and correctly describes the EU '8+2+1' regime, noting that generics can apply after 8 years but cannot commercialize until 10–11 years, which matches the original answer. The 7% U.S. revenue growth in 2021 is correctly cited and used to infer continued commercial strength and intact protections. However, the LLM answer falls slightly short in completeness: it omits specific information about patent expiration patterns—namely that method of use patents expired in 2021 while formulation and additional patents extend to 2026 and beyond—which is a key part of the multi-hop reasoning in the original answer. This weakens the synthesis between the 2021 revenue growth and the explanation for sustained exclusivity. While the LLM implies that protections are still in place, it does not explicitly connect the post-2021 revenue growth to the extension of patents beyond 2021, which is central to the original answer’s logic. Quantitatively, all numbers (12 years, 8+2+1, 7%) are accurate and correctly interpreted. The reasoning is sound but not fully complete in linking revenue performance to the specific patent timeline. Contextual relevance is excellent, as the response directly addresses the interaction between regulatory and patent exclusivity in both regions and its impact on market exclusivity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 400,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the systemic risk regime specifically constrain Morgan Stanley's capital distribution policies and liquidity management, given its status as a large bank holding company with over $250 billion in consolidated assets?",
      "original_answer": "The systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley as a large bank holding company, which directly constrains its capital distribution policies and liquidity management. Specifically, the Federal Reserve mandates internal liquidity stress tests, requires maintenance of unencumbered highly liquid assets to meet 30-day projected net cash outflows, and enforces risk management and corporate governance standards. These requirements can limit the firm’s ability to distribute capital through dividends or stock repurchases, especially if such actions would be deemed unsafe or unsound by regulators. Additionally, Morgan Stanley must comply with single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for other unaffiliated counterparties), further constraining its liquidity risk exposure.",
      "llm_answer": "\n\nThe systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley, constraining its capital distribution policies and liquidity management through several mechanisms. As a large bank holding company (BHC) with over $250 billion in assets, Morgan Stanley must maintain unencumbered highly liquid assets to cover 30 days of projected net cash outflows under stress scenarios, conduct internal liquidity stress tests, and adhere to strict liquidity risk management standards. Additionally, the Federal Reserve may prohibit or limit capital distributions (e.g., dividends, stock repurchases) if it deems such actions unsafe or unsound, particularly if they jeopardize the firm’s ability to meet stress-test requirements or maintain adequate capital buffers. The regime also enforces single-counterparty credit limits (SCCL) and could impose further prudential standards, such as contingent capital requirements or limits on short-term debt, further restricting flexibility in capital allocation and liquidity strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: Morgan Stanley, as a large bank holding company with over $250 billion in assets, is subject to heightened capital and liquidity requirements under the systemic risk regime. The answer correctly identifies internal liquidity stress testing, maintenance of unencumbered highly liquid assets to cover 30-day net cash outflows under stress, and restrictions on capital distributions if deemed unsafe or unsound. It also accurately references single-counterparty credit limits (SCCL), though it does not specify the exact percentages (15% for major counterparties, 25% for others) mentioned in the original answer. (2) Quantitative accuracy is excellent—no incorrect numbers or calculations are present. The omission of the specific SCCL percentages is a minor gap but does not introduce inaccuracy, as the concept is correctly conveyed. (3) Multi-hop reasoning is sound: the model synthesizes Morgan Stanley’s status, regulatory requirements (Federal Reserve mandates), and their impact on capital distributions and liquidity management. It appropriately links stress testing, liquidity buffers, and SCCL to constraints on capital allocation. (4) Contextual relevance is perfect—the response directly addresses how the systemic risk regime constrains capital distribution and liquidity management. The only reason for not scoring a 10 is the lack of explicit mention of the 15% and 25% SCCL thresholds, which are part of the original answer and represent a minor but notable omission in completeness. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight detail reduction.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 475,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the interest rate of the 0.750% Senior Note due 2033 compare to the interest rate of the 1.950% Senior Note due 2031, and what might this indicate about PepsiCo's long-term debt strategy across different maturities?",
      "original_answer": "The interest rate of the 0.750% Senior Note due 2033 is lower than the interest rate of the 1.950% Senior Note due 2031 by 1.200 percentage points. This suggests that PepsiCo may have pursued a strategy of issuing debt at lower interest rates for longer-term maturities during the respective periods these notes were issued, potentially reflecting favorable market conditions or improved credit perception over time.",
      "llm_answer": "\n\nThe provided document pages do not explicitly include the interest rate terms for PepsiCo's 0.750% Senior Note due 2033 or the 1.950% Senior Note due 2031. However, based on standard debt market principles, the lower rate on the longer-term 2033 note compared to the shorter-term 2031 note may reflect PepsiCo’s strategy to lock in favorable long-term rates during periods of low interest rates, while accepting higher short-term rates to maintain flexibility. This could indicate an effort to extend debt maturities, manage refinancing risks, and optimize interest costs over time. For precise details, the specific debt terms would need to be referenced directly from the financial statements or related disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the document pages do not include the interest rate terms for the two senior notes, despite the question itself providing the exact rates (0.750% and 1.950%). This is a critical failure in recognizing explicitly stated information. The quantitative comparison — that the 2033 note has a lower rate than the 2031 note by 1.200 percentage points — is entirely calculable from the given data but is omitted. (2) The ground truth correctly calculates the 1.200 percentage point difference (1.950% - 0.750% = 1.200%), which the LLM fails to mention or compute, resulting in very low quantitative accuracy. (3) While the LLM attempts plausible qualitative reasoning about debt strategy — such as locking in low long-term rates and managing refinancing risk — this is speculative and not grounded in actual data synthesis from the filings. The original answer correctly infers that lower rates on longer maturities may reflect favorable market conditions or improved credit perception, which the LLM only partially echoes without confirmation. (4) Contextually, the response addresses the general topic of debt strategy and maturity structure, so it remains relevant, but its failure to use explicitly provided data severely undermines correctness. The answer should have recognized and used the given rates to make a direct comparison, then built the strategic interpretation on that factual basis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 400,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "By how much did the fair value of Medtronic's partnership units increase from fiscal year 2023 to fiscal year 2024, and what was the impact on total investments measured at net asset value?",
      "original_answer": "The fair value of Medtronic's partnership units increased by $159 million (from $992 million in fiscal year 2023 to $1,151 million in fiscal year 2024). This contributed to an overall increase of $1,187 million in investments measured at net asset value, which rose from $2,179 million in 2023 to $3,366 million in 2024.",
      "llm_answer": "\n\nThe fair value of Medtronic's partnership units increased by **$159 million** from fiscal year 2023 ($992 million) to 2024 ($1,151 million). This increase contributed **$159 million** to the total investments measured at net asset value, which rose from $2,179 million in 2023 to $3,366 million in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate in terms of quantitative details: the increase in fair value of Medtronic's partnership units is correctly calculated as $159 million (from $992 million in 2023 to $1,151 million in 2024), and the total investments measured at net asset value are correctly reported as rising from $2,179 million to $3,366 million, an increase of $1,187 million. All numeric values match the ground truth exactly, and formatting is consistent and acceptable. The answer addresses both parts of the question: the increase in partnership units and its impact on total investments at net asset value. However, while the LLM correctly states that the $159 million increase contributed to the overall rise in investments, it simplifies the impact by stating the contribution as '$159 million' without acknowledging that other components also contributed to the total $1,187 million increase. The ground truth implies this broader context by stating the partnership unit increase 'contributed to' a larger overall increase, suggesting the $159M is a subset of the $1,187M. The LLM's phrasing could be interpreted as equating the contribution with the full impact on total investments, which may slightly misrepresent the nuance in the synthesis. Despite this, the core facts, calculations, and entities (Medtronic, fiscal years 2023–2024, partnership units, net asset value) are correct, and the reasoning is largely sound. The answer is contextually relevant and conveys nearly all the necessary information with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 421,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the use of activity-based costing methods affect the presentation of depreciation and amortization totals for UPS's reportable segments, particularly in relation to the allocation of expenses between segments as described in the 2024 10-K filing?",
      "original_answer": "The use of activity-based costing methods directly affects the presentation of depreciation and amortization totals for UPS's reportable segments by determining how expenses are allocated between segments. According to the 2024 10-K filing, these totals are presented 'after applying activity-based costing methods to allocate expenses between segments.' This means that the final depreciation and amortization figures disclosed for each reportable segment are not raw totals but are instead adjusted based on the allocation methodology. Changes in these estimates directly impact the amount of expense allocated to each segment and therefore the operating profit of each reporting segment.",
      "llm_answer": "\n\nThe use of activity-based costing (ABC) methods at UPS affects the presentation of depreciation and amortization totals for reportable segments by allocating these expenses based on estimates tied to each segment’s actual resource consumption. As described in Note 14 to the consolidated financial statements, depreciation and amortization amounts for U.S. Domestic Package ($2,470 million) and International Package ($777 million) in 2024 are included in \"other segment items\" and are derived after applying ABC methodologies. These allocations require management estimates, and changes in these estimates directly impact the expense attributed to each segment, influencing their operating profits. UPS clarified that while there were no significant changes to allocation methodologies in 2024 compared to 2023, the totals reflect refined activity-based allocations that align expenses with segment-specific operational activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the figures for U.S. Domestic Package ($2,470 million) and International Package ($777 million) are correctly cited from the 2024 10-K filing, and the reference to Note 14 is accurate. These numbers match the source data, and no calculation errors are present. (2) The answer correctly explains that depreciation and amortization totals are presented 'after applying activity-based costing methods,' which is consistent with the ground truth. It adds valuable detail by specifying that these amounts are included in 'other segment items,' which enhances completeness. (3) The reasoning is sound: it correctly identifies that ABC methods allocate expenses based on estimated resource usage, that management estimates are involved, and that changes in estimates affect segment operating profits—this reflects proper multi-hop synthesis between cost methodology and financial impact. (4) The only minor shortcoming is that the original answer emphasizes that the totals are *not raw* but adjusted via ABC, a nuance slightly underemphasized in the LLM response, though implied. Otherwise, the LLM provides additional context (e.g., no significant methodology changes in 2024) that is consistent and relevant. All entities—UPS, 2024 10-K, reportable segments, ABC methods—are correctly identified and used. The answer is semantically equivalent and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 401,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "What was the total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest, and how did this affect their other income and interest expense?",
      "original_answer": "The total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest was $1.162 billion, which included a $1.1 billion benefit in other income and a $62 million reduction in interest expense.",
      "llm_answer": "\n\nThe reversal of the European Commission fine and associated interest in fiscal 2022 resulted in a total financial benefit of **$1.1 billion in other income** and a **$62 million reduction in interest expense** for Qualcomm. This reversal occurred in the third quarter of fiscal 2022 following the General Court of the European Union’s annulment of the EC’s decision, eliminating the previously accrued $1.2 billion fine and related interest. The benefit directly increased other income, while the elimination of future interest accruals reduced interest expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. It correctly identifies the $1.1 billion benefit in other income and the $62 million reduction in interest expense, which sum to the total financial impact of $1.162 billion, though the LLM does not explicitly state the total sum. This omission is minor, as both components are clearly presented and match the ground truth. The fiscal year (2022) and event (reversal due to General Court annulment) are correctly contextualized. The reasoning is sound, explaining the source of the benefit and its impact on financial statements. The only minor shortcoming is the lack of explicit summation to $1.162 billion, which slightly affects quantitative completeness but does not undermine the correctness of the individual figures or their implications. All entities, metrics, and timeframes are accurate. The answer is fully relevant and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 272,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "By how much did the fair value of Fixed Income Commingled Trusts held by MDT increase from fiscal year 2023 to fiscal year 2024, and what was the proportion of this increase relative to the total increase in fair value across all investment categories?",
      "original_answer": "The fair value of Fixed Income Commingled Trusts increased by $305 million (from $968 million in 2023 to $1,273 million in 2024). The total increase in fair value across all investment categories was $153 million (from $3,398 million in 2023 to $3,551 million in 2024). However, since the increase in Fixed Income Commingled Trusts alone ($305 million) exceeds the total portfolio increase ($153 million), it indicates that other investment categories collectively decreased in value over the same period.",
      "llm_answer": "\n\nThe fair value of Fixed Income Commingled Trusts held by MDT increased by **$305 million** from fiscal year 2023 ($968 million) to 2024 ($1,273 million). The total increase in fair value across all U.S. pension benefit investment categories was **$153 million** (from $3,398 million to $3,551 million). This means the Fixed Income Commingled Trusts increase accounted for **199% of the total increase** (i.e., $305M / $153M), driven by significant gains in this category offsetting declines in others like equity commingled trusts and short-term investments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the increase in fair value of Fixed Income Commingled Trusts is $305 million (from $968M in 2023 to $1,273M in 2024), and the total increase across all investment categories is $153 million (from $3,398M to $3,551M). These values match the ground truth exactly. (2) The calculation of the proportion ($305M / $153M ≈ 199%) is accurate and correctly interpreted to mean that this category's gain exceeded the total portfolio increase, implying losses in other categories—this aligns with the reasoning in the original answer. (3) The multi-hop reasoning is sound: the model synthesizes data across two fiscal years and two different aggregation levels (specific investment type vs. total portfolio), correctly comparing them and drawing a logical conclusion about the performance of other asset classes. (4) All entities—'Fixed Income Commingled Trusts', 'MDT', 'fiscal year 2023 to 2024', and 'total increase in fair value across all investment categories'—are accurately referenced. The answer is semantically equivalent to the ground truth, with added clarity in expressing the 199% ratio. No factual, numerical, or reasoning errors are present, justifying perfect scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 349,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does Morgan Stanley's SPOE strategy, as described in its resolution plan, specifically ensure adequate liquidity for its subsidiaries during a resolution scenario, and what role does Morgan Stanley Holdings LLC play in this process?",
      "original_answer": "Morgan Stanley's SPOE strategy ensures adequate liquidity for its subsidiaries during a resolution scenario by requiring the Parent Company to provide capital and liquidity through a secured amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as a resolution funding vehicle, receiving ongoing asset transfers from the Parent Company. In a resolution scenario, the Parent Company is obligated to contribute all of its material assets (excluding shares in subsidiaries and certain other assets) to the Funding IHC, which then provides capital and liquidity to supported subsidiaries under the terms of the agreement.",
      "llm_answer": "\n\nMorgan Stanley's SPOE (Single Point of Entry) strategy ensures adequate liquidity for its subsidiaries during a resolution scenario by structuring the Parent Company (Morgan Stanley) to provide capital and liquidity to designated subsidiaries through a **secured amended and restated support agreement**. This agreement obligates the Parent Company to transfer material non-subsidiary assets to a wholly owned subsidiary, **Morgan Stanley Holdings LLC (Funding IHC)**, which acts as a resolution funding vehicle. Funding IHC then distributes capital and liquidity to supported subsidiaries as needed, ensuring they have resources to implement the resolution strategy under the U.S. Bankruptcy Code or orderly liquidation authority. \n\nFunding IHC plays a critical role by receiving and holding the Parent Company’s assets (excluding shares in subsidiaries and certain other assets), which are secured to prioritize claims by supported subsidiaries over unsecured Parent Company obligations. This structure ensures subsidiaries can access liquidity during a resolution, while the Parent Company’s obligations under the support agreement are secured by its assets, enhancing the credibility of the SPOE strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: Morgan Stanley’s SPOE strategy relies on a secured amended and restated support agreement through which the Parent Company provides liquidity; Morgan Stanley Holdings LLC (Funding IHC) acts as the resolution funding vehicle; the Parent transfers material non-subsidiary assets to Funding IHC, which then supports subsidiaries. These points match the original answer exactly in substance. (2) There are no numeric values (e.g., dollar amounts, dates, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the roles of the Parent Company, Funding IHC, and the support agreement across resolution mechanics, demonstrating understanding of the structural flow of capital and obligations. (4) The only minor shortcoming is a slight expansion in the LLM answer about 'U.S. Bankruptcy Code or orderly liquidation authority' and 'priority over unsecured Parent Company obligations,' which, while contextually plausible and consistent with SPOE frameworks, are not explicitly stated in the ground truth. This adds minor interpretive detail but does not detract from factual correctness. Overall, the answer is semantically equivalent, complete, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 388,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Qualcomm's 2022 10-K projects that 60% of vehicles produced in 2028 will feature 5G connectivity, and also states that if Chinese OEMs shift away from using Qualcomm's integrated circuit products due to government actions, the company's revenues could be materially harmed. Given Qualcomm's dependency on Chinese markets and its strategic investments in 5G technologies, how does the company's growth strategy in automotive 5G adoption depend on maintaining access to Chinese OEMs?",
      "original_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs because the company projects that 60% of vehicles produced in 2028 will feature 5G connectivity, a market it aims to serve through its 5G technology investments. However, the 10-K explicitly states that if Chinese OEMs shift to using competitors' integrated circuit products or develop their own due to U.S. or Chinese government actions, Qualcomm's revenues could be materially harmed. Since China represents a major revenue source, any disruption in access to Chinese OEMs would directly undermine Qualcomm's ability to capitalize on the anticipated growth in 5G-enabled automotive platforms, thereby threatening its strategic expansion into this sector.",
      "llm_answer": "\n\nQualcomm's growth strategy in automotive 5G adoption is critically tied to maintaining access to Chinese OEMs, as the company projects 60% of vehicles produced by 2028 will feature 5G connectivity, a trend driven in part by Chinese market demand and adoption. However, the 10-K highlights significant risks: (1) Chinese OEMs may shift away from Qualcomm's integrated circuits due to government policies (e.g., China's \"Made in China 2025\" initiative promoting semiconductor self-sufficiency) or geopolitical tensions, which could materially harm revenues; (2) Qualcomm's business is already heavily concentrated in China, with revenue exposure to Chinese OEMs and supply chain dependencies, making it vulnerable to trade restrictions or national security policies. The automotive sector's long design cycles and high barriers to entry further amplify the need for sustained OEM partnerships. Thus, Qualcomm's ability to capitalize on 5G automotive growth hinges on navigating geopolitical risks, maintaining competitive advantage in 5G technologies, and ensuring continued access to Chinese OEMs amid regulatory and market dynamics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key factual elements from the ground truth: Qualcomm's projection that 60% of vehicles produced in 2028 will feature 5G connectivity, and the risk that a shift by Chinese OEMs away from Qualcomm's integrated circuits could materially harm revenues. All numeric values (60%, 2028) are accurate and match the original answer. (2) Quantitative accuracy is perfect—no calculations are required beyond the stated percentage and year, both of which are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes Qualcomm’s strategic investment in 5G, its dependence on Chinese OEMs, the geopolitical risks (e.g., 'Made in China 2025'), and the implications for automotive 5G growth. It adds contextual depth (e.g., long design cycles, supply chain dependencies) that enriches the ground truth without introducing inaccuracies. (4) The only reason for not scoring a 10 in correctness and qualitative accuracy is that the original answer emphasizes more directly the causal link between access to Chinese OEMs and the ability to capitalize on 5G-enabled automotive platforms as a core strategic dependency, while the LLM slightly reframes it with broader geopolitical context. However, the semantic meaning and factual content remain substantially equivalent and fully aligned with the ground truth. The added context improves relevance and depth without distorting facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 396,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the change in the total fair value of investments measured at net asset value for Medtronic (MDT) from fiscal year 2023 to 2024, and which category of investment contributed the most to this change?",
      "original_answer": "The total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024. The largest contributor to this change was the increase in equity commingled trusts, which rose by $269 million.",
      "llm_answer": "\n\nThe total fair value of investments measured at net asset value for Medtronic increased by **$1,187 million** from fiscal year 2023 ($2,179 million) to 2024 ($3,366 million). The **Partnership Units** category contributed the most to this change, increasing by $1,151 million (from $0 in 2023 Net Asset Value to $1,151 million in 2024), as they were reclassified into net asset value measurements during 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. While it correctly states the total increase in fair value of investments measured at net asset value ($1,187 million), this appears to be coincidental or copied without correct supporting data—the cited values of $2,179 million in 2023 and $3,366 million in 2024 do not align with the ground truth and are unsupported. (2) The key error lies in the attribution of the largest contributor: the LLM claims 'Partnership Units' increased by $1,151 million due to reclassification, but the ground truth identifies 'equity commingled trusts' as the largest contributor with a $269 million increase. This is a major factual discrepancy. No evidence in the ground truth supports the existence or reclassification of 'Partnership Units' in this context. (3) The multi-hop reasoning fails—the model incorrectly synthesizes non-existent or fabricated data rather than pulling accurate figures across years and categories. It invents a category ('Partnership Units') not mentioned in the original answer and assigns it a dominant role in the change, which contradicts the verified source. (4) Due to severe factual inaccuracies, especially in the core component (largest contributing category), the correctness score is very low. The quantitative accuracy is slightly above zero only because the total change figure matches, but the underlying numbers and calculation are wrong. Qualitative and contextual scores are low due to incorrect entities, flawed logic, and introduction of unsupported information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 436,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the valuation basis for Schwab's repurchase liabilities related to client-held fractional shares, and how does this valuation approach ensure no income statement impact despite market value fluctuations?",
      "original_answer": "Schwab values its repurchase liabilities related to client-held fractional shares based on quoted market prices or other observable market data consistent with the related client-held fractional shares. Unrealized gains and losses on these repurchase liabilities exactly offset the unrealized gains and losses on the corresponding client-held fractional shares, resulting in no net impact to the consolidated statements of income. This offset mechanism ensures that despite market value fluctuations, there is no income statement effect.",
      "llm_answer": "\n\nThe valuation basis for Schwab's repurchase liabilities related to client-held fractional shares is **fair value**, determined using quoted market prices or other observable market data consistent with the valuation of the related client-held fractional shares. Schwab applies the fair value option (ASC 825) to ensure the liabilities are measured similarly to the assets. This approach ensures no income statement impact because **unrealized gains and losses on the client-held fractional shares (assets) are offset by corresponding unrealized gains and losses on the repurchase liabilities**, resulting in a net zero effect on earnings. Additionally, since these liabilities carry no credit risk, no instrument-specific credit risk adjustments are recognized in income.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies the valuation basis as fair value using quoted market prices or observable market data, consistent with the related client-held fractional shares. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the conceptual financial mechanism is correctly described: unrealized gains and losses on the repurchase liabilities exactly offset those on the corresponding assets, resulting in no net income statement impact. (3) The multi-hop reasoning is sound—linking the valuation approach (fair value under ASC 825) to the offsetting effect on the income statement demonstrates synthesis across accounting treatment and financial statement impact. (4) The LLM adds contextual precision not in the original answer—mentioning the fair value option (ASC 825) and absence of credit risk adjustments—which aligns with Schwab's actual accounting policies and enhances accuracy without contradicting the ground truth. All entities (Schwab, repurchase liabilities, client-held fractional shares) are correctly identified and logically connected. The answer fully addresses both parts of the question: valuation basis and mechanism for no income impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 359,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, based on the disclosed annual expenses and deferred compensation liabilities?",
      "original_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan was $18 million, increasing from $176 million at December 31, 2020, to $194 million at December 31, 2021.",
      "llm_answer": "\n\nThe total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, was an **increase of $27 million**. This was calculated as the difference between the projected benefit obligation at the end of 2021 ($119 million) and the end of 2020 ($92 million), incorporating the 2021 benefit cost ($16 million) and actuarial loss ($11 million) disclosed in the table. Deferred compensation liabilities for officers and directors ($194 million in 2021 vs. $176 million in 2020) are unrelated to this specific plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states the projected benefit obligation increased from $176 million in 2020 to $194 million in 2021, a change of $18 million. The LLM incorrectly reports the 2020 obligation as $92 million and 2021 as $119 million, resulting in a calculated change of $27 million, which is wrong. These numbers do not match the disclosed data. (2) The quantitative inaccuracies are severe: both starting and ending values are incorrect, and the resulting $27 million increase is unsupported by the ground truth. The mention of a $16 million benefit cost and $11 million actuarial loss adding to $27 million appears to be a fabricated reconciliation not aligned with the actual data. Additionally, the deferred compensation liabilities ($194M in 2021, $176M in 2020) are incorrectly dismissed as unrelated — in fact, the ground truth explicitly ties the change in projected benefit obligation to these figures for this specific plan. (3) The multi-hop reasoning fails: the model misidentifies the relevant figures for the Financial Consultant Career Achievement Plan and incorrectly separates deferred compensation liabilities from the benefit obligation, when the ground truth uses those liabilities as the basis for the obligation amounts. (4) The contextual relevance is moderate because the answer addresses the right plan and attempts to use actuarial components and disclosures, but the incorrect data and flawed synthesis undermine the response. Due to major factual and calculation errors, the correctness score is low at 2, with similarly low quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 454,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What is the combined revenue contribution of the Beauty segment, where Pantene holds a 20% global market share in hair care, and the Fabric & Home Care segment, which contributes 36% of net sales, as a percentage of Procter & Gamble's total net sales for the fiscal year?",
      "original_answer": "The combined revenue contribution is 54% of Procter & Gamble's total net sales for the fiscal year.",
      "llm_answer": "\n\nThe combined revenue contribution of the Beauty segment (18% of net sales) and the Fabric & Home Care segment (36% of net sales) to Procter & Gamble's total net sales for the fiscal year is **54%**. The 20% global market share of Pantene in hair care is context for the Beauty segment but does not affect the calculation of net sales percentages provided in the segment breakdown.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the combined revenue contribution as 54%, which matches the ground truth. It accurately states that the Fabric & Home Care segment contributes 36% and infers the Beauty segment's contribution as 18% (though not explicitly stated in the question, it is consistent with known P&G segment data and results in the correct sum). The 20% global market share of Pantene is correctly treated as contextual information and not included in the net sales calculation, which is appropriate. (2) All numeric values and the final calculation (18% + 36% = 54%) are accurate. The format and reasoning are clear and mathematically sound. (3) The multi-hop reasoning is solid: the model distinguishes between market share (Pantene in hair care) and segment-level net sales contribution, correctly focusing on the latter for the revenue calculation. It synthesizes the relevant segment percentages without being misled by extraneous data. (4) The answer is semantically equivalent to the ground truth, with slightly more detail than the original answer. The only minor issue is the introduction of 18% for the Beauty segment, which was not provided in the question and not confirmed in the ground truth—however, since the sum (54%) is correct and aligns with the original answer, this does not constitute a factual error but rather a plausible inference. Thus, the answer is highly accurate and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 402,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis, and how does this connect to the separation event described?",
      "original_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $-410 million, which includes $187 million from Otis and $196 million from Carrier. This connects to the separation event described where, on April 3, 2020, UTC separated into three independent, publicly traded companies—UTC, Carrier, and Otis—and distributed all of the outstanding common stock of Carrier and Otis to UTC shareowners.",
      "llm_answer": "\n\nThe total income (loss) from discontinued operations attributable to common shareowners in 2020 related to Carrier and Otis was **$(410) million**. This includes **$187 million** from Otis and **$196 million** from Carrier, partially offset by **$(793) million** in separation-related costs (e.g., transaction expenses, debt extinguishment, and system separation costs). The separation event, which occurred on April 3, 2020, involved distributing Carrier and Otis to UTC shareholders, and the financial impact reflects their pre-separation operating results combined with the costs incurred during the separation process.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the total loss from discontinued operations as $(410) million and attributes $187 million to Otis and $196 million to Carrier, it introduces a new figure of $(793) million in separation-related costs that is not present in the ground truth. This changes the meaning and implies the total loss is a net result of operating income minus large separation costs, which is not supported by the original answer. The ground truth states the total is $-410 million composed of the two components ($187M + $196M = $383M), but does not mention any offsetting costs. The sum of $187M and $196M is $383M, not $410M, so there is also a discrepancy in internal calculation that is unexplained in either version. However, the LLM attempts to explain the difference with the $(793)M figure, which may be an inference from external knowledge but is not in the ground truth and thus incorrect in this evaluation context. (2) The date of the separation event (April 3, 2020) is correctly stated, and the description of the separation—distributing Carrier and Otis to UTC shareholders—is accurate and contextually appropriate. (3) The multi-hop reasoning is partially sound: the model connects financial results to the separation event and attempts to explain the components of discontinued operations. However, it adds unsupported financial detail (the $793M cost), which undermines the quantitative accuracy and suggests flawed synthesis. (4) The correctness score is 4 due to major quantitative errors and unsupported additions, despite correct entity identification and event description. Quantitative accuracy is low (3) because of the incorrect component sum and introduction of a non-ground-truth number. Qualitative accuracy is moderate (5) as the reasoning structure is logical but based on incorrect data. Contextual relevance is high (8) because the answer addresses the right companies, year, event, and financial concept.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 543,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "Given the Diabetes Pump Retainer Ring Litigation details, what is the total number of individual plaintiffs that have filed lawsuits against Medtronic's Diabetes operating unit as of May 14, 2024, and how does this litigation compare in terms of potential future claimants to the hernia mesh-related lawsuits mentioned in the document?",
      "original_answer": "As of May 14, 2024, a total of 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit related to the Series 600 insulin pumps with allegedly defective clear retainer rings. Additionally, law firms have indicated that they may file lawsuits on behalf of thousands of additional claimants in the future. In comparison, there are approximately 6,700 plaintiffs in Massachusetts state court, 500 in Minnesota state court, and 1,150 in a federal Multidistrict Litigation (MDL) related to hernia mesh products, with more cases potentially being filed. Both litigations involve allegations tied to Medtronic products, and the company has not recorded any expense for damages in either case due to the uncertainty of probable and estimable loss.",
      "llm_answer": "\n\nAs of May 14, 2024, **107 individual plaintiffs** have filed lawsuits against Medtronic's Diabetes operating unit related to the Diabetes Pump Retainer Ring Litigation. The document notes that plaintiffs' law firms may file additional lawsuits on behalf of **thousands of additional claimants** in the future. \n\nIn comparison, the hernia mesh-related lawsuits involve **8,350 individual plaintiffs** as of May 15, 2024, with the potential for further cases, though no specific estimate for future claimants is provided. While the diabetes pump litigation currently involves far fewer plaintiffs, its potential for **thousands of additional claims** suggests a similarly significant, though currently smaller, risk of expansion compared to the hernia mesh litigation. Both matters involve uncertain future claimant volumes, but the diabetes pump litigation’s growth potential is explicitly highlighted as substantial.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: 107 plaintiffs in the diabetes pump litigation is accurately reported. The hernia mesh litigation totals are correctly summed: 6,700 (Massachusetts) + 500 (Minnesota) + 1,150 (federal MDL) = 8,350 total plaintiffs, which the LLM correctly calculates. The date (May 14 vs May 15) is off by one day but is negligible given the context and likely reflects reporting lag or rounding. (2) The LLM correctly notes that thousands of additional claimants may be added in the diabetes pump litigation, while the hernia mesh litigation has ongoing potential but no specific estimate—this is consistent with the original. (3) The multi-hop reasoning is sound: the model synthesizes data across two different product litigations (diabetes pump and hernia mesh), compares current plaintiff counts, and evaluates future risk expansion potential. (4) The only minor shortcoming is that the original answer explicitly states Medtronic has not recorded any expense for damages in either case due to uncertainty—this risk accounting point is omitted in the LLM response, slightly reducing completeness. However, the core facts, numbers, and comparative analysis are all correct and well-reasoned, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 366,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the IDA agreement impact Schwab's capital management strategy, particularly in relation to off-balance sheet treatment of client deposits and Schwab's internal capital policy target range of 6.75%-7.00%?",
      "original_answer": "The IDA agreement requires that certain brokerage client deposits be swept off-balance sheet to TD Depository Institutions, reducing Schwab's on-balance sheet liabilities and affecting its capital utilization. Schwab manages capital to maintain a Tier 1 Leverage Ratio within a target range of 6.75%-7.00%, which is higher than the minimum regulatory requirement of 4%. The offloading of IDA balances helps Schwab optimize its balance sheet and maintain capital ratios above internal and regulatory thresholds, even during periods of balance sheet growth.",
      "llm_answer": "\n\nThe IDA agreement allows Schwab to hold certain client deposits (BDA balances) off-balance sheet at TD Depository Institutions, reducing the capital required to support these liabilities. This off-balance sheet treatment helps Schwab maintain its internal capital policy target range of 6.75%-7.00% by minimizing capital consumption from client deposits. However, Schwab has begun migrating IDA balances onto its balance sheet, which increases capital needs. To manage this, Schwab issues preferred stock and relies on earnings to sustain its Tier 1 Leverage Ratio (6.2% in 2021, below the target but above regulatory minimums). The pace of IDA migration is contingent on Schwab’s ability to maintain sufficient capital levels while balancing growth and regulatory requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core mechanism of the IDA agreement—sweeping client deposits off-balance sheet to TD Depository Institutions—which aligns with the ground truth and correctly identifies the impact on capital usage. It accurately references Schwab's internal capital target range of 6.75%-7.00% and the role of the Tier 1 Leverage Ratio. However, it introduces a specific quantitative claim not present in the ground truth: that Schwab’s Tier 1 Leverage Ratio was 6.2% in 2021. This figure is unsupported by the provided ground truth and may be factually incorrect or contextually misleading, especially as it states the ratio was 'below the target'—a detail not confirmed in the original answer. Additionally, the LLM mentions Schwab migrating IDA balances onto its balance sheet and issuing preferred stock, which adds operational detail beyond the scope of the ground truth. While plausible, these points are not part of the verified knowledge and introduce assumptions about strategic shifts and funding responses not corroborated in the original answer. The multi-hop reasoning is partially sound—linking off-balance sheet treatment to capital efficiency and internal targets—but extends beyond the evidence by inferring current strategic trade-offs and actions. The answer is contextually relevant and semantically aligned in direction, but the inclusion of unverified quantitative data and strategic developments reduces factual accuracy. Thus, while the conceptual framework is correct, the unsupported numbers and extrapolations limit correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 427,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "What was the total net cash inflow from RTX's disposition of the Forcepoint business and how did it contribute to the overall net cash provided by investing activities in 2021 compared to 2020?",
      "original_answer": "The disposition of the Forcepoint business contributed to the $1.9 billion in net cash inflows from dispositions of businesses in 2021. This was part of the $4.7 billion improvement in cash flows from investing activities in 2021 compared to 2020, which was primarily due to the absence of the Raytheon Merger cash acquisition of $3.2 billion in the prior year and the proceeds from the Forcepoint and other business dispositions.",
      "llm_answer": "\n\nThe total net cash inflow from RTX's disposition of the Forcepoint business in 2021 was **$1.9 billion**, as part of $1.9 billion in total dispositions of businesses (net of cash transferred) during the year. This contributed to the **overall net cash used in investing activities of $1.364 billion in 2021**, compared to **net cash provided of $3.343 billion in 2020**. The decline in 2021 was primarily driven by the absence of $3.2 billion in cash acquired from the Raytheon Merger in 2020, while the Forcepoint disposition partially offset the reduction in proceeds from other dispositions (e.g., $2.6 billion in 2020 from Collins Aerospace business sales).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.9 billion net cash inflow from the disposition of the Forcepoint business in 2021, which aligns with the ground truth. However, it incorrectly states that the overall net cash used in investing activities was $1.364 billion in 2021 and that there was net cash provided of $3.343 billion in 2020. The ground truth does not provide these exact figures for total investing activities, nor does it state that 2021 had net cash used — instead, it emphasizes a $4.7 billion improvement in cash flows from investing activities in 2021 vs. 2020. The $4.7 billion improvement is a key multi-hop fact that the LLM fails to report, instead introducing unsupported specific totals. (2) The $1.9 billion figure is accurate and correctly attributed. However, the $1.364 billion and $3.343 billion figures for net cash in investing activities appear to be fabricated or misattributed, as they are not in the original answer and contradict the narrative of a $4.7 billion improvement. The $3.2 billion from the Raytheon Merger in 2020 is correctly referenced as a comparative factor. (3) The reasoning partially captures the multi-hop logic — linking the Forcepoint sale to improved investing cash flows and contrasting it with the prior-year merger benefit — but fails to synthesize the correct net change ($4.7 billion improvement). Instead, it introduces incorrect base figures that undermine the calculation. (4) The contextual relevance is high because the answer addresses both parts of the question and discusses relevant entities and time periods. However, the quantitative inaccuracies and incorrect synthesis reduce correctness significantly. The answer is partially correct but contains critical errors in reported financial totals, leading to a score of 6 for correctness, with lower quantitative accuracy due to unsupported numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 508,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Oracle's reliance on third-party colocation suppliers for global data centers impact the financial risk associated with Oracle Cloud Services, especially considering the long-term lease commitments and potential contract termination fees?",
      "original_answer": "Oracle delivers Oracle Cloud Services through global data centers, substantially all of which are leased through third-party colocation suppliers. Oracle has entered into long-term operating lease commitments with these providers, which often include significant contract termination fees if Oracle needs to exit these obligations early due to strategic changes. This creates financial risk, as Oracle may be locked into costly lease agreements even if demand for Oracle Cloud Services does not meet expectations or if market conditions change unfavorably. Additionally, Oracle depreciates these leased assets over their estimated useful lives, which could be shortened if Oracle's cloud strategy shifts, further impacting profitability.",
      "llm_answer": "\n\nOracle's reliance on third-party colocation suppliers for global data centers introduces financial risks primarily through long-term lease commitments and potential termination fees. As disclosed in **Item 2 (Properties)**, Oracle leases \"substantially all\" of its cloud data centers from third parties. **Item 1A (Risk Factors)** highlights that these leases often require significant termination fees if Oracle needs to exit early due to strategic shifts, which could adversely impact profitability and cash flows. Additionally, Oracle faces risks from lack of control over third-party operations, including service interruptions, supply chain delays for data center equipment, and potential increases in infrastructure costs. These factors collectively heighten financial exposure, particularly if demand for cloud services fluctuates or operational disruptions arise, leading to higher costs, delayed revenue recognition, or reduced margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Oracle relies on third-party colocation suppliers for 'substantially all' of its global data centers, which matches the original answer's phrasing and factual content. It accurately highlights the financial risks stemming from long-term lease commitments and significant contract termination fees, referencing the correct SEC filing sections (Item 2 and Item 1A). (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—scored as 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes information about leasing structure, termination risks, and strategic implications across operational and financial dimensions. It adds contextual depth by mentioning service interruptions, supply chain delays, and cost increases, which are reasonable extensions of the risk profile and consistent with typical disclosures, though not explicitly in the ground truth. These additions do not contradict but enrich the answer, slightly exceeding the original without introducing error. (4) The core financial risk—being locked into costly leases if demand falls short—is clearly conveyed, satisfying the question's intent. The only minor gap is the omission of Oracle's depreciation of leased assets over useful lives and the risk of shortened depreciation periods affecting profitability, which is present in the original answer. This is a small but relevant detail in the financial impact discussion, preventing a perfect 10. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 466,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "What is the total number of shares available for future grants under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan as of December 31, 2021, and how does this availability support UnitedHealth Group's share-based compensation strategy?",
      "original_answer": "As of December 31, 2021, UnitedHealth Group had 64 million shares available under the 2020 Stock Incentive Plan and 18 million shares available under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available for future grants. This availability supports the company's share-based compensation strategy by ensuring sufficient shares are available for future stock options, restricted stock, and other equity awards, which are key tools in compensating employees and aligning their interests with shareholders.",
      "llm_answer": "\n\nAs of December 31, 2021, UnitedHealth Group had **64 million shares** available under the 2020 Stock Incentive Plan and **18 million shares** under the 1993 Employee Stock Purchase Plan (ESPP), totaling **82 million shares** for future grants. This availability supports the company’s share-based compensation strategy by providing flexibility to issue equity awards (e.g., stock options, restricted shares) to attract and retain talent while aligning employee incentives with shareholder interests. The reserved shares also enable the company to manage dilution through its share repurchase program, which offsets the dilutive impact of these grants and optimizes capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values from the ground truth: 64 million shares under the 2020 Stock Incentive Plan, 18 million under the 1993 Employee Stock Purchase Plan, and a total of 82 million shares available as of December 31, 2021. These figures match the original answer exactly and are presented clearly. (2) The calculation of the total (64M + 18M = 82M) is accurate and correctly implied. All dates and share plan names are factually correct, satisfying entity accuracy. (3) The multi-hop reasoning is sound—information from two separate plans is synthesized into a total and then used to explain strategic implications. The LLM extends the reasoning slightly by mentioning share repurchases and dilution management, which is a plausible and relevant addition consistent with corporate equity strategies, though not explicitly stated in the ground truth. This does not introduce error but adds context beyond the source. (4) The answer fully addresses both parts of the question: the quantitative total and the strategic rationale. While the original answer focuses on alignment with shareholders and compensation tools, the LLM enriches this with talent retention and capital structure optimization—reasonable inferences that do not detract from accuracy. The only reason for not scoring a 10 is that the added detail about repurchase programs, while contextually appropriate, is not present in the ground truth and slightly exceeds the provided information, though not inaccurately. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 440,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Schwab account for client-held fractional shares and their corresponding repurchase liabilities under GAAP, and where are these liabilities reflected on the consolidated balance sheet according to the 2022 10-K filing?",
      "original_answer": "Schwab accounts for client-held fractional shares as part of 'other securities owned' on the consolidated balance sheets, recording them at fair value based on quoted market prices or other observable market data. These shares are included in other assets, and unrealized gains and losses are recognized in earnings. For client-held fractional shares where off-balance sheet treatment under ASC 940 or derecognition criteria under ASC 860 are not met, Schwab recognizes related repurchase liabilities that are accounted for at fair value. These repurchase liabilities are reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet, as disclosed in the 2022 10-K filing.",
      "llm_answer": "\n\nSchwab accounts for client-held fractional shares as \"other securities owned at fair value\" in the consolidated balance sheets, with related repurchase liabilities also recorded at fair value. These liabilities, corresponding to the fractional shares held in client brokerage accounts, are included in **accrued expenses and other liabilities**. Unrealized gains and losses for both the securities and liabilities are recognized in earnings. This treatment is disclosed in Notes 2 and 8 of the 2022 10-K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Schwab accounts for client-held fractional shares as 'other securities owned' at fair value, included in other assets, with unrealized gains and losses recognized in earnings. The repurchase liabilities are properly stated to be recorded at fair value and reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet—this matches the original answer exactly. (2) There are no numeric values in the question or answer that require verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all referenced disclosures (Notes 2 and 8 of the 2022 10-K) are plausibly accurate and consistent with typical SEC filing structures. (3) The multi-hop reasoning is sound: the model correctly synthesizes accounting treatment (ASC 940/860 implications) and balance sheet presentation from the 2022 10-K, even if it doesn't explicitly mention the ASC standards by name—the omission is minor and does not detract from the core correctness. (4) The answer is semantically equivalent to the original, with slightly more concise wording and added reference to specific footnotes (Notes 2 and 8), which enhances credibility. The only minor shortcoming is the lack of explicit mention of the conditionality around off-balance sheet treatment under ASC 940 or derecognition under ASC 860, which is present in the ground truth and provides important context for when liabilities are recognized. However, the LLM captures the outcome (fair value recognition in liabilities) correctly. Thus, the answer is excellent but not perfect—hence a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 476,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Oracle's integration of Autonomous Database with OCI enable both cost reduction for customers and strategic growth in its cloud and license business?",
      "original_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by automating routine database administration tasks such as maintenance, tuning, patching, scaling, security, and backup, while also using machine learning-driven diagnostics to reduce human error and operational costs. This automation and efficiency lowers labor costs and allows for consumption-based pricing, where customers pay only for resources used. These cost-saving features directly support Oracle's strategic growth in its cloud and license business by encouraging customer migration to Oracle Cloud, particularly among existing Oracle customers using on-premise applications. The integration with other Oracle Cloud services like Java Cloud and Oracle APEX further enhances this migration by offering developers a modern, open platform for building cloud-native applications. As a result, Oracle can expand its cloud and license business by leveraging these technical capabilities to attract both new customers and a broader ecosystem of developers and partners.",
      "llm_answer": "\n\nOracle's integration of Autonomous Database with Oracle Cloud Infrastructure (OCI) enables cost reduction for customers through automated database operations, which lower labor costs and reduce human error, while consumption-based pricing ensures customers pay only for resources used. This integration also supports rapid deployment and reduces IT resource consumption compared to on-premise environments. Strategically, it drives growth in Oracle's cloud and license business by offering flexible deployment options (public cloud, on-premise via Exadata Cloud@Customer, or hybrid models), encouraging customers to adopt Oracle's cloud services. The seamless integration with OCI's scalable infrastructure and AI capabilities enhances Oracle's value proposition, fostering migration of existing workloads to the cloud and expanding revenue from cloud subscriptions and license sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: automation of database tasks (maintenance, tuning, patching, etc.) reduces labor costs and human error; consumption-based pricing is correctly identified as a cost-saving mechanism; strategic growth is supported through cloud migration, particularly leveraging flexible deployment models like Exadata Cloud@Customer and hybrid options. These points are consistent with the original answer’s emphasis on automation, cost efficiency, and migration incentives. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly links technical integration (Autonomous Database + OCI) to customer cost reduction, then connects that value proposition to Oracle’s strategic business growth in cloud and licensing. It appropriately infers that lower operational barriers encourage adoption, especially among existing Oracle customers, though it does not explicitly mention Oracle APEX or Java Cloud integration, which are part of the original answer’s ecosystem argument—this is a minor omission, not an error. (4) The answer is contextually fully relevant, directly addressing both cost reduction and strategic growth as required. Wording differs but semantic meaning matches. The only reason for not scoring a perfect 10 is the omission of specific developer platform integrations (APEX, Java Cloud), which are part of Oracle’s broader strategy to attract developers and partners. However, the LLM compensates by highlighting flexible deployment and AI integration, which are valid strategic growth drivers. Overall, the response is factually correct, well-reasoned, and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 493,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the financial implication for UnitedHealth Group if the AARP Program contract is transferred to another entity, considering the management and classification of AARP Program assets as described in the 10-K filing?",
      "original_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would be required to transfer cash equal to the fair value of the AARP Program assets at the date of transfer. These assets, which are managed separately from the company's general investment portfolio and used to fund medical costs payable and other related liabilities, are classified as current assets consistent with the liabilities they support. This would result in a direct reduction of both the company's current assets and the associated liabilities tied to the AARP Program, potentially impacting short-term liquidity depending on the fair value of the investments at the time of transfer.",
      "llm_answer": "\n\nIf the AARP Program contract is transferred to another entity, UnitedHealth Group would transfer cash equal to the **fair value of the AARP Program assets** (invested separately under AARP-approved guidelines) to the new entity. These assets, classified as **current assets** on the balance sheet, are specifically designated to fund medical costs payable, rate stabilization fund (RSF) liabilities, and other related obligations tied to the AARP Program. The transfer would not result in a gain or loss for UnitedHealth Group, as the assets are marked to fair value, and their purpose is directly linked to offsetting specific current liabilities. This transaction would reduce UnitedHealth Group’s cash and current assets while removing the associated liabilities, maintaining balance sheet alignment without significant financial disruption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the transfer of cash equal to the fair value of AARP Program assets, their classification as current assets, and their use in funding medical costs payable, RSF liabilities, and other related obligations are all consistent with the original answer. The statement that the transfer would not result in a gain or loss due to fair value accounting is a correct inference from the fact that assets are marked to market, which strengthens the reasoning. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in calculations or misstatements. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about asset classification, management, liability linkage, and the financial impact of a contract transfer. It goes slightly beyond the original by noting the absence of gain/loss, which is logically valid and consistent with accounting principles, though not explicitly stated in the ground truth. (4) The only reason for not awarding a full 10 is minor: the original emphasizes the potential impact on short-term liquidity depending on fair value at transfer, which the LLM omits. While the balance sheet alignment point is valid, the liquidity implication is a key qualitative nuance. Otherwise, the answer is contextually complete, precise, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 415,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the fair value of Card Member and Other Loans, and how does it compare to the carrying value in relation to the Level 3 fair value hierarchy classification?",
      "original_answer": "The fair value of Card Member and Other Loans is $113 billion, while the carrying value is $110 billion. This fair value is entirely classified under Level 3 of the fair value hierarchy, indicating that it is based on unobservable inputs rather than market data.",
      "llm_answer": "\n\nThe provided document pages do not explicitly disclose the fair value or carrying value of Card Member and Other Loans, nor do they specify their classification under the Level 3 fair value hierarchy. The pages focus on derivatives, hedging activities, legal proceedings, and lease commitments, with mentions of Card Member-related risks (e.g., foreign exchange exposure and receivables) but no quantified data for Card Member and Other Loans. To answer this question fully, additional sections of the 10-K (e.g., notes on loans or fair value disclosures) would be required.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is incorrect in substance. The ground truth states that the fair value of Card Member and Other Loans is $113 billion and the carrying value is $110 billion, with the entire fair value classified under Level 3 of the fair value hierarchy. The LLM claims this information is not disclosed in the provided document pages, which contradicts the existence of the ground truth. This indicates a failure to retrieve or recognize the correct data, resulting in a complete factual mismatch. There are no correct numbers or multi-hop synthesis. While the LLM correctly interprets the question and identifies relevant topics (e.g., fair value hierarchy, Card Member loans), its response is based on absence of data rather than accurate extraction, leading to very low scores in correctness and quantitative accuracy. Contextual relevance is moderate because the reasoning process aligns with typical 10-K structure, but it fails to deliver the actual facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 276,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How many shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan as of December 31, 2021, and what types of awards can these shares become the subject of?",
      "original_answer": "As of December 31, 2021, 64 million shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "\n\nAs of December 31, 2021, **64 million shares** were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares could be used for awards in the form of **stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards**. \n\n(Source: ITEM 12 - Equity Compensation Plan Information, Note (3) in the provided document.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of shares available for future issuance — 64 million — is accurate, and the date — December 31, 2021 — is correctly stated. (2) The answer completely addresses both parts of the question: the number of shares and the types of awards. The listed award types (stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards) are identical in meaning and scope to the original answer. (3) The entities — UnitedHealth Group, 2020 Stock Incentive Plan, and the correct fiscal date — are accurately identified. (4) The reasoning is sound, with no logical gaps or synthesis errors; the answer correctly draws from the relevant section of the filing (ITEM 12 - Equity Compensation Plan Information, Note 3). Minor wording differences (e.g., 'could be used for awards' vs. 'can become the subject of') do not affect semantic equivalence. The inclusion of a source reference further enhances contextual relevance and accuracy. All criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 318,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total estimated fair value of foreign government bonds and obligations held by the company in 2023, and how did this compare to the estimated fair value of the same category in 2022 for maturities of 12 months or more?",
      "original_answer": "The company held foreign government bonds and obligations with a total estimated fair value of $770 million in 2023. In comparison, the estimated fair value of the same category for maturities of 12 months or more in 2022 was $549 million, showing an increase of $221 million.",
      "llm_answer": "\n\nThe total estimated fair value of foreign government bonds and obligations held by the company in 2023 was **$770 million**. For maturities of 12 months or more, the fair value in 2023 was **$2 million** (based on the maturity breakdown in the provided tables). In 2022, the total estimated fair value was **$632 million**, with **$0** attributed to maturities of 12 months or more (as no securities in this category were classified under that maturity bucket in 2022). Thus, the 2023 total increased by $138 million compared to 2022, but the 12-month-or-more segment shifted from $0 to $2 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the estimated fair value of foreign government bonds and obligations with maturities of 12 months or more was $549 million in 2022, but the LLM claims it was $0, which is incorrect. Similarly, the LLM reports the 2023 total as $770 million (correct), but then incorrectly states that only $2 million of that amount was for maturities of 12 months or more, contradicting the ground truth which implies the full $770 million refers to that maturity bucket. (2) The calculation of the year-over-year increase is also wrong: the LLM computes a $138 million increase based on $770M - $632M, but the ground truth reports an increase of $221 million ($770M - $549M). Additionally, the LLM cites a 2022 total of $632 million, which does not match the ground truth value of $549 million. (3) The multi-hop reasoning is flawed—the question asks for a comparison of the same category (foreign government bonds with maturities ≥12 months) between 2023 and 2022. The LLM fails to correctly identify this category in both years, instead introducing incorrect maturity breakdowns not supported by the ground truth. It appears to misinterpret or misread the data tables, leading to incorrect synthesis. (4) The contextual relevance is moderate because the answer addresses the right topic and metric, but the severe quantitative and qualitative errors—especially in core numbers and comparisons—drastically reduce its correctness. The answer misrepresents the data and draws incorrect conclusions, warranting a low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 440,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total capital expenditure in the Africa/Eurasia region in 2021, and how does this compare to the capital expenditure in the same region in 2019?",
      "original_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019. This represents an increase of $25 million over the two-year period.",
      "llm_answer": "\n\nThe total capital expenditure in the Africa/Eurasia region was **$33 million in 2021** and **$8 million in 2019**. This represents a significant increase of **312.5%** in capital spending for the region from 2019 to 2021. \n\n(Source: Capital expenditures table in Note 14 of the Consolidated Financial Statements, pages 116–117.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the capital expenditures for the Africa/Eurasia region in both 2021 ($33 million) and 2019 ($8 million), matching the ground truth exactly. The dollar amounts and years are accurate. (2) The calculation of the percentage increase (from $8M to $33M) is mathematically correct: ((33 - 8) / 8) * 100 = 312.5%, which is accurate even though the ground truth emphasized the absolute increase of $25 million. Including a percentage increase adds analytical value and does not contradict the original answer. (3) The multi-hop reasoning is sound—information from two different years was correctly synthesized to make a comparison. The source citation (Note 14, pages 116–117) supports contextual grounding in the financial statements. (4) The only reason for not giving a perfect 10 is that the original answer focused on the $25 million increase rather than the percentage, so while the LLM provides more detail, it slightly shifts emphasis. However, this does not reduce factual accuracy. All entities, metrics, and years are correct. Thus, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 323,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the percentage change in Johnson & Johnson's worldwide sales of Contact Lenses/Other within the Vision segment from 2020 to 2021, and how did this performance compare to the overall growth rate of the broader Vision segment during the same period?",
      "original_answer": "The worldwide sales of Contact Lenses/Other grew by 14.9% from 2020 to 2021, while the broader Vision segment grew by 19.6% during the same period. This indicates that the Contact Lenses/Other category underperformed relative to the overall Vision segment's growth rate.",
      "llm_answer": "\n\nThe worldwide sales of Contact Lenses/Other within Johnson & Johnson's Vision segment increased by **14.9%** from 2020 to 2021. This growth was **slower than the broader Vision segment's overall growth rate of 19.6%** during the same period, which was driven by stronger performance in Surgical Vision and market recovery from pandemic-related disruptions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 14.9% growth in Contact Lenses/Other sales and the 19.6% growth in the broader Vision segment, both of which match the ground truth exactly. (2) All numeric values are accurate and properly formatted; no calculation errors are present. The percentage change values are consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly compares the performance of a sub-category (Contact Lenses/Other) to the overall segment (Vision), drawing the implicit conclusion that 14.9% growth is slower than 19.6%, hence underperformance—aligning with the ground truth's interpretation. (4) The answer is semantically equivalent to the original, with added context (e.g., mention of Surgical Vision and pandemic recovery) that is plausible and does not contradict the ground truth. All parts of the question are addressed: percentage change for Contact Lenses/Other and comparison to overall Vision segment growth. Scores are maximized due to full factual accuracy, correct synthesis, and clear, relevant communication.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 313,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the total weighted-average grant price for Service and Performance-Based RSUs that were outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year?",
      "original_answer": "$114.22 million for the outstanding shares as of December 31, 2021, which includes the impact of new grants at $125.02 million during the year.",
      "llm_answer": "\n\nThe total weighted-average grant price for Service and Performance-Based RSUs outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year, was **$114.22**. This figure is explicitly stated in the \"Service and Performance-Based RSUs\" section of the stock option and RSU activity table provided in Note 10 of the 10-K filing.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the final weighted-average grant price as $114.22, matching the ground truth value for the outstanding RSUs as of December 31, 2021. However, it omits the crucial context that this $114.22 million figure includes the impact of new grants valued at $125.02 million during the year, which is a key part of the original answer and necessary for full completeness. The LLM presents $114.22 as a standalone number without clarifying that it is a weighted average incorporating both beginning balances and new grants, thus missing a core multi-hop element. (2) Quantitatively, the $114.22 figure is accurate and correctly formatted (allowing for unit interpretation), but the absence of the $125.02 million new grant value — which is essential to explaining how the average was derived — constitutes a significant omission. There is no calculation error per se, but the lack of supporting data reduces quantitative completeness. (3) The reasoning is logically sound in citing Note 10 and the RSU activity table, and the entity (Service and Performance-Based RSUs), metric (weighted-average grant price), and date (December 31, 2021) are all correctly identified. However, the model fails to synthesize the two components (beginning balance and new grants) that contribute to the final average, indicating a gap in multi-hop reasoning. (4) The answer is highly contextually relevant, directly addressing the question and citing the correct source. The score of 7 reflects that the core number is correct but important explanatory detail from the ground truth is missing, reducing overall accuracy despite correct entity and metric identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 461,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "By how much did Boeing's outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decrease from 2023 to 2024, and what percentage did this tranche represent of the company's total debt in 2024?",
      "original_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million (from $10,135 million in 2023 to $6,159 million in 2024). In 2024, this tranche represented approximately 11.43% of Boeing's total debt of $53,864 million.",
      "llm_answer": "\n\nThe outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by **$3,976 million** (from $10,135 million in 2023 to $6,159 million in 2024). In 2024, this tranche represented **11.4%** of Boeing's total debt ($6,159 ÷ $53,864).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All numeric values are accurate: the decrease of $3,976 million is correctly calculated from $10,135 million (2023) to $6,159 million (2024). The percentage of 11.4% is a properly rounded version of the exact value (11.43%), which is acceptable and commonly used in financial reporting. (2) The calculation for the percentage is explicitly shown ($6,159 ÷ $53,864), and the total debt figure of $53,864 million matches the ground truth. (3) The multi-hop reasoning—linking the bond tranche balance in two years, computing the difference, and then determining its proportion of total debt in 2024—is sound and correctly executed. (4) All entities (Boeing, unsecured bonds with specified coupon and maturity, years 2023 and 2024) are correctly identified and used. The answer is complete, factually precise, and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 267,
        "total_tokens": 1414
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What was the combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021, and what percentage did this represent of the total Orthopaedics revenue for that year?",
      "original_answer": "The combined revenue from Knees and Hips in 2021 was $2,810 million ($1,325 million from Knees and $1,485 million from Hips). This represented 32.7% of the total Orthopaedics revenue of $8,588 million in 2021.",
      "llm_answer": "\n\nThe combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021 was $2.81 billion ($1.485 billion for Hips + $1.325 billion for Knees). This represented approximately 32.7% of the total Orthopaedics revenue of $8.588 billion for that year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: the combined revenue from Knees and Hips is correctly stated as $2.81 billion (sum of $1.325 billion for Knees and $1.485 billion for Hips), which aligns with the ground truth of $2,810 million. The total Orthopaedics revenue is accurately given as $8.588 billion ($8,588 million), and the percentage is correctly calculated as approximately 32.7%. (2) Quantitative accuracy is perfect: the numbers are presented in equivalent formats (billions vs. millions), and the sum ($1.325B + $1.485B = $2.81B) is mathematically accurate. The percentage (2,810 / 8,588 ≈ 32.7%) is also correct. (3) The multi-hop reasoning is sound—information from two product lines (Knees and Hips) is correctly aggregated and compared to total segment revenue, demonstrating proper synthesis across entities. (4) The answer is contextually complete and directly addresses both parts of the question: the combined revenue and its percentage of total Orthopaedics revenue in 2021. No errors in entities, years, or metrics. All components are accurate and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 328,
        "total_tokens": 1458
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What is the total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing, and why were these shares excluded?",
      "original_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 20.8 million. These shares were excluded because the effect would have been antidilutive due to Boeing incurring a net loss in those periods.",
      "llm_answer": "\n\nThe total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years (2024, 2023, and 2022) was **20.8 million shares** (11.6 million in 2024, 5.7 million in 2023, and 3.5 million in 2022). These shares were excluded because their inclusion would have been antidilutive due to Boeing incurring net losses in those periods, which would have reduced the loss per share when applying diluted calculations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the total number of excluded potential common shares as 20.8 million, matching the ground truth. It further breaks this down by year (11.6M in 2024, 5.7M in 2023, 3.5M in 2022), and the sum of these values (11.6 + 5.7 + 3.5 = 20.8 million) is accurate. (2) All numeric values are factually correct and consistent with the ground truth; minor formatting (e.g., 'million' vs 'M') is acceptable and does not affect accuracy. (3) The reasoning for exclusion—antidilutive effect due to net losses—is correctly explained and aligns with accounting principles and the original answer. The multi-hop synthesis across three fiscal years is properly executed, and the explanation of antidilution in the context of net losses is sound. (4) The answer is fully complete, addressing both the quantitative total and the qualitative reason for exclusion. All entities (Boeing, fiscal years 2024–2022, diluted loss per share) are correctly identified. Thus, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 293,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "By how much did the amendment to the Retirement Value formula in 2021 reduce the Projected Benefit Obligation as of January 3, 2021, and how does this change affect the calculation of pension benefits for U.S. non-union employees hired before 2015?",
      "original_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021 by approximately $1.8 billion. This change affects the calculation of pension benefits for U.S. non-union employees hired before 2015 by transitioning them from the Final Average Pay formula to the Retirement Value formula for benefits earned after January 1, 2026, while preserving the Final Average Pay formula for service before that date.",
      "llm_answer": "\n\nThe amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation (PBO) as of January 3, 2021, by approximately **$1.8 billion**. For U.S. non-union employees hired before 2015, this change means their future pension benefits (for service after January 1, 2026) will be calculated under the Retirement Value formula (based on compensation over total years of service), rather than the Final Average Pay formula (based on the last five years of compensation and service). However, benefits accrued under the Final Average Pay formula for service before 2026 remain unchanged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1.8 billion reduction in Projected Benefit Obligation as of January 3, 2021 is accurately reported. The date and dollar amount are correct and match the original answer exactly. (2) The explanation of the impact on U.S. non-union employees hired before 2015 is complete: it correctly states that benefits earned after January 1, 2026 will be calculated under the Retirement Value formula, while benefits for service before that date remain under the Final Average Pay formula. (3) The multi-hop reasoning is sound—synthesizing the financial impact (PBO reduction) with the change in benefit calculation methodology across time periods and employee groups. (4) The LLM adds slight clarification (e.g., explaining that Retirement Value is based on compensation over total years of service and Final Average Pay on last five years) which enhances understanding without introducing error. All entities—'Projected Benefit Obligation', 'Retirement Value formula', 'Final Average Pay formula', 'U.S. non-union employees hired before 2015', and the key date 'January 1, 2026'—are correctly identified and contextualized. The answer is semantically equivalent to the ground truth and fully addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 367,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "Given that American Express's financial assets and liabilities carried at amortized cost are based on market conditions and perceived risks as of specific dates, why does the filing state that the fair value of the company cannot be estimated by aggregating these figures?",
      "original_answer": "The filing explains that the fair value figures for financial assets and liabilities measured at amortized cost are estimates based on market conditions and perceived risks as of December 31, 2021 and 2020. These estimates require management judgment and are not indicative of future fair values. Furthermore, the filing explicitly states that the fair value of American Express as a whole cannot be estimated by aggregating the fair values of individual financial instruments because doing so would not capture the company's overall valuation, which includes non-financial factors and the complexities of the business as a whole.",
      "llm_answer": "\n\nThe filing states that aggregating the fair value estimates of financial assets and liabilities carried at amortized cost cannot determine American Express's overall fair value because:  \n1) These fair value estimates are based on **management judgment, market conditions, and model assumptions** (e.g., discounted cash flows, credit risk adjustments) as of specific dates, which may not reflect dynamic market realities or actual transaction prices.  \n2) The fair value measurements exclude **intangible assets** (e.g., brand equity, customer relationships) and operational value drivers not captured in financial statement line items.  \n3) Certain valuations (e.g., Card Member loans) omit economic value from future receivables or synergistic effects of the company’s business model, making aggregation incomplete and potentially misleading.  \n\nThus, the company’s total fair value requires a broader analysis beyond isolated instrument-level estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the answer correctly identifies that fair value estimates are based on management judgment, market conditions, and model assumptions as of specific dates (consistent with December 31, 2021 and 2020 in the original, though exact dates are omitted but implied). No numeric values are misstated, and there are no calculation errors—thus quantitative accuracy is perfect. (2) The answer addresses all key reasons why aggregation of individual financial instruments does not reflect the company's total fair value: reliance on estimates, exclusion of intangible assets (e.g., brand equity), and failure to capture synergies or operational value. These match the original answer’s emphasis on non-financial factors and business complexity. (3) Multi-hop reasoning is sound: the model synthesizes the limitations of amortized cost measurements, the role of judgment, and the broader business valuation context. (4) Minor deduction in qualitative accuracy due to not explicitly stating that the filing itself makes this point (i.e., slightly less emphasis on the source being the filing’s own disclaimer), but the substance is fully preserved. Semantic equivalence is strong. Contextual relevance is excellent—directly responsive to the question with appropriate depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 379,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How many amendments to the Benefits Plan for Members of the Board of Directors are explicitly listed in the exhibit index, and what were the effective dates of the original plan and its first amendment?",
      "original_answer": "There are two explicitly listed amendments to the Benefits Plan for Members of the Board of Directors. The original plan was effective on April 14, 2004, and the first amendment was dated December 16, 2005.",
      "llm_answer": "\n\nThe exhibit index explicitly lists **one amendment** to the Benefits Plan for Members of the Board of Directors (Amendment Number One, dated December 16, 2005). The original plan was effective as amended and restated through **April 14, 2004**, and its first amendment became effective on **December 16, 2005**.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical error in quantitative accuracy. It states that there is 'one amendment' explicitly listed, while the ground truth confirms there are two amendments. This undercounting significantly affects the correctness score. However, the effective dates provided are accurate: the original plan effective date is correctly identified as April 14, 2004, and the first amendment date is correctly given as December 16, 2005. The entity identification (Benefits Plan for Members of the Board of Directors) and context are correct, and the answer addresses all parts of the question, albeit with the key error in the amendment count. The reasoning appears sound in terms of extracting dates and linking the amendment to the original plan, but the failure to identify both amendments suggests incomplete synthesis from the exhibit index. While the wording is clear and semantically close, the factual inaccuracy in the number of amendments prevents a higher score. Minor phrasing like 'effective as amended and restated through April 14, 2004' is acceptable and aligns with the original plan's effective date.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 324,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Oracle's hybrid deployment model contribute to the cloud and license business representing 84% of total revenues in fiscal 2024?",
      "original_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based deployment options, provides customers with flexibility and choice, enabling them to select the deployment model that best suits their needs. This flexibility enhances customer retention and satisfaction, as evidenced by the high renewal rate of license support contracts. The cloud and license business, which includes these support contracts priced as a percentage of the net fees paid by customers, accounted for 84% of Oracle's total revenues in fiscal 2024. This indicates that the hybrid model not only supports customer adoption but also directly drives a significant portion of Oracle's revenue through recurring license support streams.",
      "llm_answer": "\n\nOracle's hybrid deployment model contributed to the cloud and license business representing 84% of total revenues in fiscal 2024 by providing customers with flexible deployment options (on-premise, cloud-based, or hybrid), enabling them to transition workloads to Oracle Cloud Services while retaining existing licenses. This flexibility increased customer adoption of Oracle's cloud offerings, as hybrid models allowed businesses to migrate incrementally, leveraging both cloud and on-premise environments. The document highlights that cloud services revenues grew to 37% of total revenues in fiscal 2024 (up from 32% in 2023), driven by programs enabling customers to pivot licenses to the cloud and expand existing workloads. This hybrid approach sustained demand for Oracle's cloud and license solutions, solidifying their dominance in revenue contribution.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's hybrid deployment model and its role in driving customer adoption and revenue, aligning with the core reasoning in the ground truth. It accurately notes that the cloud and license business represented 84% of total revenues in fiscal 2024, which matches the ground truth. However, it introduces a new figure—'cloud services revenues grew to 37% of total revenues'—which is not present in the original answer and cannot be verified from the provided ground truth. This number may be factually correct but lacks support in the reference and introduces unverified quantitative claims. (2) The 84% revenue figure is correct and properly attributed to fiscal 2024. The claim about cloud services being 37% of revenue (up from 32% in 2023) is specific and precise but absent from the ground truth, making it an unsupported addition. No calculations are performed, so no arithmetic errors exist, but the inclusion of unverified percentages reduces quantitative accuracy. (3) The multi-hop reasoning is sound: the model connects hybrid deployment → customer flexibility → increased cloud adoption → sustained revenue from cloud and license. It captures the essence of how hybrid deployment supports revenue dominance. However, it omits the key point about license support contracts being priced as a percentage of net fees and their role in generating recurring revenue, which is a significant element in the ground truth’s explanation of *how* the 84% is sustained. (4) The answer is contextually relevant and well-structured, addressing the question directly with logical flow. While it adds plausible details, the omission of the support contract pricing mechanism and introduction of unverified percentages prevent a higher score. The core factual claim (84% contribution) and strategic reasoning are correct, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 514,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How much of American Express's December 31, 2021 deferred fees are specifically tied to Membership Rewards program participants, and how does this relate to the methodology used to estimate the future redemption liability for these points?",
      "original_answer": "The deferred fees tied to Membership Rewards program participants are specifically called out in the $8,737 million total deferred card and other fees as of December 31, 2021. This connects to the methodology used to estimate the future redemption liability, which relies on statistical and actuarial models using the weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR) based on factors like redemption trends, card product type, and credit attributes.",
      "llm_answer": "\n\nThe deferred card and other fees, net, as of December 31, 2021, were $2.5 billion, which includes deferred fees for Membership Rewards program participants, though the exact amount specifically tied to the program is not disclosed in the provided data. The methodology for estimating the future redemption liability for Membership Rewards points involves using a **Weighted Average Cost (WAC) per point** and the **Ultimate Redemption Rate (URR)**. These are derived from statistical and actuarial models analyzing redemption trends, card product types, enrollment tenure, spend levels, and credit attributes. The WAC is adjusted for changes in redemption costs and patterns, ensuring the $11.4 billion Membership Rewards liability reflects management’s best estimate of future redemption costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the total deferred card and other fees as of December 31, 2021, were $8,737 million, with the Membership Rewards portion embedded within that figure. However, the LLM incorrectly reports this total as $2.5 billion, which is materially wrong. Additionally, the LLM introduces a $11.4 billion Membership Rewards liability, which is not mentioned in the original answer and cannot be verified against the provided ground truth. (2) The quantitative inaccuracies are severe: $2.5 billion vs. $8,737 million (over $8.7 billion) is off by more than 300%, and the $11.4 billion liability figure appears fabricated or misattributed. The only correct quantitative element is the mention of Weighted Average Cost (WAC) and Ultimate Redemption Rate (URR), though no numbers for these are provided. (3) The reasoning about the methodology—using statistical and actuarial models based on WAC, URR, redemption trends, card product type, and credit attributes—is semantically aligned with the original answer and shows correct multi-hop understanding of how the liability is estimated. However, this is undermined by the incorrect financial figures. (4) The contextual relevance is fair because the LLM addresses both parts of the question—amount of deferred fees tied to Membership Rewards and the estimation methodology—but fails on factual accuracy. Due to major errors in core financial data, the correctness score is low despite partially accurate reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 426,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How many different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021, based on filings listed in the 2024 10-K report?",
      "original_answer": "16 different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021.",
      "llm_answer": "\n\nThe Coca-Cola Company 2014 Equity Plan had **20 different forms of award agreements** documented between February 18, 2015, and February 17, 2021. These include Stock Option Agreements, Restricted Stock Unit Agreements, Performance Share Agreements, and a Retention Award Agreement, as detailed in filings referenced under Exhibits 10.5.1 through 10.5.21 (excluding the plan amendment at 10.5.17). Each form was adopted in the specified date range and corresponds to distinct award types or amendments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states 20 different forms of award agreements, while the ground truth is 16, making the core quantitative claim incorrect. This is a significant factual error that undermines the answer's correctness. (2) The date range (February 18, 2015, to February 17, 2021) is correctly interpreted and relevant filings are referenced (Exhibits 10.5.1 to 10.5.21), but the exclusion of Exhibit 10.5.17 does not justify reaching 20 forms—there are only 21 exhibits in total, and multiple are amendments or not award agreements. The count of 20 is not supported by the ground truth. (3) The reasoning appears multi-hop by referencing specific exhibits and categorizing agreement types, suggesting analysis of the 10-K's exhibit list, but it overcounts due to misclassification or inclusion of non-award-agreement documents. The synthesis is partially sound but flawed in execution. (4) Despite accurate context and relevant exhibit references, the answer fails on the primary fact—the number of award agreements—resulting in a low correctness and quantitative accuracy score. Qualitative accuracy is moderate due to correct identification of award types and structure. Contextual relevance is high as the response directly addresses the question framework and sources.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 359,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "Considering AMD's purchases from and equity gains with the ATMP JV in 2021, what was the total financial value of AMD's relationship with the ATMP JV that year, and how does this reflect the strategic importance of the joint venture?",
      "original_answer": "The total financial value of AMD's relationship with the ATMP JV in 2021 was $1.106 billion, combining $1.1 billion in purchases and a $6 million equity gain. This reflects the strategic importance of the joint venture as AMD relies on ATMP JV for critical assembly, test, mark, and packaging (ATMP) services, and maintains a 15% equity stake that gives it significant influence without the obligation to fund further investments.",
      "llm_answer": "\n\nThe total financial value of AMD's relationship with the ATMP JV in 2021 included **$1.1 billion in purchases** of assembly, test, mark, and packaging services and **$6 million in equity income** from the JV's performance. This reflects the strategic importance of the ATMP JV as a critical supplier for AMD’s manufacturing needs, enabling cost-efficient production while generating incremental returns through equity participation. The substantial transaction volume underscores the JV’s role in supporting AMD’s operational scale, while the equity gain highlights its financial contribution.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately reports $1.1 billion in purchases and $6 million in equity income, which sum to the correct total financial value of $1.106 billion (though the sum is not explicitly stated, the components are correct and sufficient for multi-hop understanding). (2) The entities—AMD, ATMP JV, and the year 2021—are correctly identified. (3) The reasoning is sound: the answer explains the strategic importance by referencing the JV's role in assembly, test, mark, and packaging services, AMD’s reliance on it for manufacturing scale, and the financial benefit via equity income. (4) It captures the essence of strategic importance—operational criticality and financial return—without needing to mention the 15% equity stake or funding obligations, which are contextually relevant but not essential to answering the core question about total value and strategic reflection. The answer is semantically equivalent to the ground truth, with no factual errors, omissions, or calculation issues.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 308,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Given that DARZALEX and DARZALEX FASPRO together accounted for 6.4% of Johnson & Johnson's total revenues in fiscal 2021 and their respective patent protections expire in 2029 (U.S.) and 2032 (Europe) for DARZALEX and are covered by a separate Janssen-owned portfolio for DARZALEX FASPRO, what is the earliest year that patent expiration could begin to materially impact this combined revenue stream?",
      "original_answer": "The earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is 2029, when the U.S. patents for DARZALEX expire, potentially allowing competitors to introduce biosimilars in the U.S. market, which accounts for a significant portion of Johnson & Johnson's global sales.",
      "llm_answer": "\n\nThe earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is **2029**, as this is when the U.S. patents for DARZALEX expire. While DARZALEX FASPRO is protected by a separate Janssen-owned portfolio (with unspecified expiration dates), the U.S. market’s significance and the 2029 expiration of DARZALEX’s U.S. patents represent the earliest potential catalyst for revenue impact. European patents for DARZALEX expire later (2032), making 2029 the earliest material risk year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurately stated: the U.S. patent expiration for DARZALEX occurs in 2029, European patents expire in 2032, and DARZALEX FASPRO is covered by a separate Janssen-owned portfolio. The answer correctly identifies 2029 as the earliest year for material impact. (2) Quantitative accuracy is perfect—dates (2029, 2032) are correct and match the original answer; no calculations were required, but temporal comparisons are sound. (3) Multi-hop reasoning is strong: the model synthesizes information about two drugs, their patent timelines in different geographies, the significance of the U.S. market, and the implications of biosimilar entry. It correctly infers that U.S. patent expiration in 2029 is the earliest material risk despite the separate protection for FASPRO. (4) The answer is contextually complete and relevant, addressing all aspects of the question with clear, logical flow and appropriate emphasis on market significance. Minor wording differences (e.g., 'catalyst for revenue impact' vs 'materially impact') do not affect semantic equivalence—both convey the same core conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 334,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "What is the total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018, as disclosed in the 2022 10-K filing?",
      "original_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in the 2022 10-K filing for the years 2015 and 2018 is two: one amendment effective June 30, 2015, and another effective November 1, 2018.",
      "llm_answer": "\n\nThe total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in 2015 and 2018, as disclosed in the 2022 10-K filing, is **two**. Specifically, there was one amendment effective June 30, 2015 (Exhibit 10.31) and one amendment effective November 1, 2018 (Exhibit 10.37).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of amendments is correctly stated as two, with accurate dates: one effective June 30, 2015, and another on November 1, 2018. These dates and counts align exactly with the original answer. (2) The answer is complete, addressing both the total count and the specific amendments per year as required by the multi-hop question. (3) Entity accuracy is correct—the plan name 'The Bank of New York Company, Inc. Excess Benefit Plan' is accurately referenced, and the years 2015 and 2018 are properly identified. (4) The reasoning is sound, demonstrating correct synthesis of information from the 2022 10-K filing across multiple years, as required. The inclusion of exhibit numbers (Exhibit 10.31 and 10.37) adds precision and supports the claim, even though not required for correctness. (5) The semantic meaning is equivalent to the ground truth, with clear, concise, and factually accurate communication. No errors in logic, calculation, or fact are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 302,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How do FedEx's Network 2.0 optimization expenditures and European workforce reduction costs relate to the company's overall 2025 capital expenditure plan and strategic DRIVE transformation program?",
      "original_answer": "FedEx's 2025 capital expenditure plan totals $5.2 billion, with a portion allocated to Network 2.0 optimization. Specifically, the company is investing in network optimization and facility modernization as part of this initiative. Additionally, FedEx Express announced a European workforce reduction plan tied to cost-cutting efforts, with expected cash expenditures ranging from $250 million to $375 million through fiscal 2026. These workforce reduction costs are classified as business optimization expenses and support the DRIVE transformation program, which aims to improve long-term profitability. The capital allocation for Network 2.0 and the European workforce reductions are strategic components of FedEx's broader efforts under the DRIVE initiative to enhance operational efficiency and reduce structural costs.",
      "llm_answer": "\n\nFedEx's Network 2.0 optimization expenditures are integral to its 2025 capital expenditure plan of approximately **$5.2 billion**, as they represent investments in network modernization and facility upgrades to enhance operational efficiency in the U.S. and Canada. These expenditures align with the **DRIVE transformation program**, which aims to improve long-term profitability through digital capabilities and end-to-end network optimization. \n\nConversely, the **European workforce reduction costs** (estimated at **$250–375 million in cash expenditures through fiscal 2026**) are part of DRIVE’s business optimization efforts to reduce structural costs, specifically targeting back-office and commercial functions in Europe. While these costs are classified separately as operational restructuring expenses, they complement the capital-intensive Network 2.0 initiatives by streamlining labor costs and improving overall operational efficiency under the broader DRIVE strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $5.2 billion 2025 capital expenditure plan, the $250–375 million European workforce reduction costs through fiscal 2026, and the classification of these expenditures under the DRIVE transformation program are all accurately reported. Number formats match or are acceptably varied (e.g., 'approximately $5.2 billion' = '$5.2 billion'). (2) Quantitative accuracy is perfect—both dollar amounts and timeframes (fiscal 2026) are correct. (3) The multi-hop reasoning is sound: the answer correctly synthesizes that Network 2.0 is a capital-intensive component of DRIVE focused on facility and network upgrades, while the European workforce reductions are operational restructuring costs (not capital expenditures) but still part of the same strategic initiative to improve profitability and efficiency. (4) The only minor shortcoming is a slight narrowing of Network 2.0's scope to 'U.S. and Canada'—while plausible, this geographic limitation is not in the original answer and slightly over-specifies without explicit support. However, this does not materially affect the correctness. The answer fully addresses the relationship between the expenditures, the capital plan, and the DRIVE program, with excellent contextual relevance and logical synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 376,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How does AMD's dependency on third-party suppliers for graphics cards and AIB partners affect its financial risk exposure in terms of inventory management and price protection obligations?",
      "original_answer": "AMD's dependency on third-party suppliers for graphics cards and its reliance on AIB partners exposes it to significant financial risk due to price protection obligations. If there is a significant decline in product prices, AMD must honor price protection rights for AIB partners' inventory, which can materially reduce revenue and gross margins. Additionally, AIB partners can return products removed from the price book within 12 months of manufacturing, further impacting financial stability during market fluctuations.",
      "llm_answer": "\n\nAMD's reliance on third-party suppliers and AIB partners increases financial risk exposure in two key areas:  \n1. **Inventory Management**: AMD bases inventory levels on customer demand estimates, which may be inaccurate, leading to excess or obsolete inventory requiring write-downs and reduced gross margins. Additionally, reliance on third-party suppliers for components (e.g., motherboards, graphics cards) creates risks of supply chain disruptions, further complicating inventory planning and potentially resulting in stockouts or overstocking.  \n2. **Price Protection Obligations**: Agreements with distributors and AIB partners include price protection rights, shielding their inventory from price reductions. A significant decline in AMD’s product prices would trigger these obligations, directly reducing revenue and gross margins. For example, price protection for products removed from AMD’s price book (within 12 months of manufacturing) could amplify financial pressure during market downturns.  \n\nThese risks are compounded by gray market activities, which distort demand visibility, and potential supplier or partner disruptions, all of which could materially impact AMD’s financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: AMD's reliance on AIB partners and third-party suppliers exposes it to inventory management risks and price protection obligations. The 12-month window for product returns after removal from the price book is correctly stated. There are no numerical inaccuracies—though no specific dollar amounts or percentages are mentioned in either answer, the qualitative financial impacts (reduced revenue, gross margins) are consistent. (2) Quantitative accuracy is perfect: the only time-specific detail (12 months) is correctly cited. (3) Reasoning is sound and multi-hop: the answer connects AMD’s business model (reliance on AIBs), contractual obligations (price protection), and financial consequences (margin pressure, revenue reduction), demonstrating proper synthesis. (4) The LLM adds contextual value (e.g., gray market risks, supply chain disruptions) not in the original but that are consistent with AMD’s risk disclosures, without introducing inaccuracies. The only reason for not scoring a 10 is that the original answer emphasizes the *materiality* of the risk more explicitly, while the LLM slightly broadens the scope to include distributor agreements and gray markets, which, while plausible, are not specified in the ground truth. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 395,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What is AbbVie's total cost of products sold related to Venclexta, considering both its shared U.S. profits with Genentech and the royalties paid on net revenues outside the United States?",
      "original_answer": "AbbVie's total cost of products sold related to Venclexta includes Genentech's 50% share of U.S. profits from Venclexta and the royalties paid on net revenues outside the United States. Both components are explicitly included in AbbVie's cost of products sold, as stated in the filing.",
      "llm_answer": "\n\nAbbVie's total cost of products sold related to Venclexta in 2023, considering shared U.S. profits with Genentech and royalties on international net revenues, was **$869 million**. This amount is explicitly stated in the \"Note 6 Collaborations\" section under the profit and cost-sharing table with Genentech, where Genentech's share of profits (including royalties) is included in AbbVie's cost of products sold.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer introduces a specific dollar amount ($869 million) and attributes it to a 'Note 6 Collaborations' section, which is not present in the original answer or supported by the provided ground truth. The ground truth does not specify any numerical value for AbbVie's total cost of products sold related to Venclexta—only the qualitative explanation that the cost includes Genentech's 50% share of U.S. profits and royalties on non-U.S. net revenues, both of which are included in cost of products sold per the filing. Therefore, the quantitative claim is unsupported and likely incorrect, significantly undermining factual accuracy. While the LLM correctly identifies the two components (shared U.S. profits with Genentech and international royalties), it falsely presents a precise figure without grounding in the source data. This reflects a failure in multi-hop synthesis: rather than acknowledging the absence of a specific number, it fabricates one. The reasoning structure is otherwise contextually relevant and aligns with the correct entities (AbbVie, Genentech, Venclexta, cost of products sold) and the right financial concepts. However, the inclusion of an unverified number reduces correctness substantially. The answer would have scored higher if it had mirrored the original answer’s qualitative explanation without introducing unsupported figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 378,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What specific governance document related to board members does BNY make publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and who is this document explicitly applicable to?",
      "original_answer": "BNY makes its Directors' Code of Conduct publicly available in addition to the Corporate Governance Guidelines and Committee Charters, and this document is explicitly applicable to all directors of BNY.",
      "llm_answer": "\n\nBNY makes its **Directors' Code of Conduct** publicly available, in addition to Committee Charters and Corporate Governance Guidelines. This document is explicitly applicable to **all directors of BNY**. The Directors' Code of Conduct is posted on the company’s website and outlines ethical standards and expectations for board members.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The document named, 'Directors' Code of Conduct,' is accurate and correctly identified as being publicly available in addition to Committee Charters and Corporate Governance Guidelines. The applicability to 'all directors of BNY' is explicitly stated, matching the original answer. (2) There are no numeric values, dates, or financial figures in this question, so quantitative accuracy is not applicable, but the absence of such data is handled correctly. (3) The multi-hop reasoning is sound: the model correctly synthesizes that BNY publishes multiple governance documents and identifies the specific additional one asked in the question, while correctly specifying the group to which it applies. (4) The answer is contextually relevant, complete, and adds minor but helpful contextual detail (e.g., the document is posted on the website and outlines ethical standards) without introducing inaccuracies. All components of the question are addressed with factual and semantic precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 304,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "Given AMD's 68% year-over-year revenue growth and 3 percentage-point gross margin improvement in 2021, how did the launch of the AMD Radeon RX 6600 XT and broader gaming-focused graphics strategy specifically contribute to these financial outcomes?",
      "original_answer": "The launch of the AMD Radeon RX 6600 XT in July 2021, designed for high-frame rate 1080p gaming, was part of a broader product strategy that contributed to AMD's 68% revenue growth from $9.8 billion in 2020 to $16.4 billion in 2021. This gaming-focused graphics strategy, which included the Radeon RX 6000M series for laptops and the AMD Advantage Design Framework, helped drive strong demand in the gaming segment. The improved gross margin from 45% to 48% reflects the company's success in scaling high-performance product lines like RDNA 2-based GPUs, which delivered both performance and power efficiency gains that enhanced AMD's competitive positioning and pricing power in the gaming market.",
      "llm_answer": "\n\nThe launch of the AMD Radeon RX 6600 XT and the broader gaming-focused graphics strategy significantly contributed to AMD's 2021 financial performance by driving robust demand in the high-growth gaming market. The RX 6600 XT, part of the RDNA 2 architecture, offered high-performance, power-efficient 1080p gaming capabilities, appealing to mainstream gamers and boosting discrete GPU sales. This, combined with the introduction of the AMD Advantage Design Framework (integrating RX 6000M mobile graphics and Ryzen processors in gaming laptops) and innovations like FidelityFX Super Resolution (FSR), enhanced product differentiation and customer adoption. These initiatives expanded AMD's market share in gaming, a segment with higher average selling prices, directly contributing to the 68% revenue growth. Additionally, the RDNA 2 architecture's efficiency and cost-optimized manufacturing likely improved gross margins, supported by strong demand and strategic pricing, helping achieve the 3 percentage-point margin expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All quantitative elements are correct: AMD's 68% year-over-year revenue growth, 3 percentage-point gross margin improvement (from 45% to 48%), and the July 2021 launch of the RX 6600 XT are all factually accurate and consistent with the original answer. No calculations are required beyond these figures, and all are correctly stated. (2) The answer addresses both parts of the question—how the RX 6600 XT and broader gaming strategy contributed to revenue growth and margin improvement. It correctly identifies the RDNA 2 architecture, the AMD Advantage Design Framework, and the RX 6000M series as key components of the strategy. (3) The multi-hop reasoning is sound: it connects product launches (RX 6600 XT, mobile GPUs) to increased demand, market share gains, higher average selling prices, and ultimately revenue and margin improvements. It also correctly infers that RDNA 2’s efficiency and manufacturing advantages contributed to gross margin expansion, which is logically consistent with the ground truth’s emphasis on performance and power efficiency enhancing pricing power. (4) While the LLM adds some plausible details not in the original (e.g., FidelityFX Super Resolution, 'cost-optimized manufacturing'), these do not contradict the ground truth and are contextually reasonable. The only minor gap is that the original explicitly cites the revenue increase from $9.8B to $16.4B, which the LLM omits—this is a small completeness issue but does not affect the core correctness. Overall, the answer is factually solid, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 447,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was AbbVie's net revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta sales in the United States did Genentech receive as part of their collaboration agreement?",
      "original_answer": "AbbVie reported total net revenue of $2,288 million from Venclexta in 2023. As part of the collaboration agreement with Genentech, the pre-tax profit from Venclexta sales in the United States is shared equally between AbbVie and Genentech. Therefore, Genentech received 50% of the United States pre-tax profit from Venclexta, which is included in AbbVie's cost of products sold.",
      "llm_answer": "\n\nAbbVie's net revenue from Venclexta in 2023 was **$2,288 million** (comprising $1,087 million in the United States and $1,201 million internationally). Under the collaboration agreement with Genentech, **Genentech received 50% of the pre-tax profit from U.S. sales**, which amounted to **$869 million** in 2023, as disclosed in the profit-sharing table under Note 6 of the 10-K. This reflects the 50-50 profit-sharing arrangement for U.S. commercialization of Venclexta.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies AbbVie's total net revenue from Venclexta in 2023 as $2,288 million, which matches the ground truth. However, it introduces a breakdown of $1,087 million (U.S.) and $1,201 million (international), which is not present in the original answer and cannot be verified from the provided ground truth. More critically, the LLM claims that Genentech received $869 million as its share of U.S. pre-tax profit, but this figure is not supported by the original answer, which only states that Genentech receives 50% of the U.S. pre-tax profit without specifying a dollar amount. There is no calculation or source in the ground truth to confirm $869 million, making this a significant factual overreach. (2) The quantitative accuracy is low because while the $2,288 million figure is correct, the $869 million figure is unsupported and potentially incorrect. The 50% profit-sharing is accurate, but attaching a specific dollar value not present in the ground truth undermines accuracy. (3) The reasoning partially reflects the collaboration structure but fails on multi-hop synthesis: the model assumes a calculation or disclosure (e.g., from Note 6) that is not validated by the ground truth. The original answer does not mention any specific dollar amount for Genentech’s share, so asserting $869 million represents a hallucination or incorrect inference. (4) Contextual relevance is high because the answer addresses both parts of the question and stays focused on Venclexta revenue and profit-sharing with Genentech, using appropriate financial terminology and referencing the collaboration agreement correctly in principle.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 453,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "Despite issuing 48 million new Class C common shares in the May 2024 exchange offer, why does Visa's 10-K report only 10 Class C common shares outstanding as of September 30, 2024?",
      "original_answer": "Visa issued 48 million new Class C common shares in the May 2024 exchange offer in connection with the exchange of 241 million Class B-1 shares. However, the 10-K filing shows only 10 Class C common shares outstanding as of September 30, 2024. This discrepancy is explained by the fact that the 10 shares figure in the equity section is presented in millions, as noted in the table's header (\"millions, except per share data\"). Therefore, the 10 shares reported actually represent 10 million shares outstanding. This means that although 48 million Class C shares were newly issued in May 2024, the total outstanding amount was subsequently reduced by 38 million shares, likely through share repurchases, retirements, or other corporate actions not detailed in the provided excerpts.",
      "llm_answer": "\n\nVisa's 10-K reports 10 million Class C common shares outstanding as of September 30, 2024, despite issuing 48 million new shares in the May 2024 exchange offer, because the newly issued shares were largely offset by share repurchases. The company repurchased 64 million shares in the open market during fiscal 2024, including the 48 million Class C shares issued in the exchange. These repurchased shares were retired, reducing the outstanding Class C shares back to the prior level of 10 million. This explains the discrepancy between the 48 million issued and the reported 10 million outstanding.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that 48 million Class C shares were issued in May 2024 and that only 10 million are reported outstanding as of September 30, 2024, aligning with the ground truth. It also correctly explains that the 10 in the 10-K represents 10 million shares, resolving the apparent discrepancy via subsequent corporate actions. However, it introduces a specific claim not present in the ground truth: that Visa repurchased 64 million shares in fiscal 2024, including the full 48 million Class C shares issued. This precise number (64 million) and the assertion that all 48 million were repurchased are not supported by the original answer, which only states that the reduction was 'likely through share repurchases, retirements, or other corporate actions' without specifying amounts or sources. (2) The quantitative accuracy is partially compromised: while 48 million issued and 10 million outstanding are correct, the 64 million repurchase figure is unverified and appears fabricated or inferred beyond available data. The original answer does not mention any repurchase volume, so this addition reduces factual precision. (3) The reasoning is logically sound and multi-hop—connecting the exchange offer, share issuance, and subsequent reduction in outstanding shares—but overreaches by asserting unconfirmed details. The synthesis across events is appropriate, but confidence in the mechanism (repurchases of exactly 64M) exceeds the evidence. (4) Contextual relevance is perfect: the answer directly addresses the core question about the discrepancy and provides a plausible, relevant explanation. Scores reflect high correctness but docked for unsupported numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 467,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How much total cost did FedEx incur in 2024 for both Network 2.0 implementation and DRIVE transformation-related business optimization activities, and what is the expected range of future costs for the European workforce reduction plan announced in June 2024?",
      "original_answer": "FedEx incurred $582 million in 2024 for business optimization activities related to Network 2.0 and the DRIVE transformation. The European workforce reduction plan announced in June 2024 is expected to cost between $250 million and $375 million in cash expenditures through fiscal 2026.",
      "llm_answer": "\n\nFedEx incurred total costs of **$582 million** in 2024 for Network 2.0 implementation and DRIVE transformation-related business optimization activities. The European workforce reduction plan announced in June 2024 is expected to incur **pre-tax costs ranging from $250 million to $375 million**, with expenses to be recognized through fiscal 2026. \n\n(Source: Notes to Consolidated Financial Statements, \"Business Optimization and Realignment Costs\" section.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $582 million cost incurred in 2024 for Network 2.0 and DRIVE transformation activities is accurately reported, and the expected future cost range of $250 million to $375 million for the European workforce reduction plan is correctly stated. The time frame 'through fiscal 2026' is also accurately reflected as 'expenses to be recognized through fiscal 2026'. (2) The answer addresses both parts of the multi-hop question completely: the historical cost in 2024 and the forward-looking cost estimate. (3) All entities—FedEx, Network 2.0, DRIVE transformation, European workforce reduction plan, and fiscal 2026—are correctly identified and contextually accurate. (4) The reasoning is sound, with proper synthesis of cost figures across different initiatives and time periods. The addition of a source reference enhances credibility and aligns with best practices, even if not required. Minor wording differences (e.g., 'pre-tax costs' vs. 'cash expenditures') do not affect semantic equivalence, as both refer to expected financial outlays. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 342,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was the total value of AMD's (AMD) unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021?",
      "original_answer": "$329 million was the total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021.",
      "llm_answer": "\n\nThe total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021 was **$329 million**. This amount is explicitly stated in the \"Accounts Receivable, net\" section of NOTE 3, which specifies that unbilled receivables primarily arise from development services and custom products where revenue has been recognized but not yet invoiced.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The quantitative value of $329 million is accurate and correctly attributed to AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021. The format ($329 million) matches the ground truth exactly. (2) The answer is complete, addressing the specific financial metric, the company (AMD), the fiscal year (2021), and the nature of the revenue (custom products and development services recognized over time). (3) Entity accuracy is correct: AMD is the right company, fiscal year 2021 is properly referenced, and the financial concept (unbilled accounts receivable) is accurately applied. (4) The reasoning is sound and includes contextual support by referencing NOTE 3 and explaining that unbilled receivables arise where revenue has been recognized but not yet invoiced, which demonstrates proper synthesis of financial reporting logic. The answer shows strong multi-hop understanding by linking revenue recognition practices to the specific line item. All components align perfectly with the original answer, with only minor, acceptable rewording for clarity and context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 344,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was AbbVie's total revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta's U.S. sales did AbbVie share with Genentech as part of their collaboration agreement?",
      "original_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million. As part of the collaboration agreement with Genentech, AbbVie shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech, which is included in AbbVie's cost of products sold.",
      "llm_answer": "\n\nAbbVie's total revenue from Venclexta in 2023 was **$2,288 million** (comprising $1,087 million in the U.S. and $1,201 million internationally). Under the collaboration agreement with Genentech, AbbVie shared **$869 million** of the pre-tax profit from Venclexta's U.S. sales, reflecting a 50% profit-sharing arrangement.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies AbbVie's total revenue from Venclexta in 2023 as $2,288 million, matching the ground truth. However, it introduces a specific dollar amount—$869 million—as the pre-tax profit shared with Genentech, which is not present in the original answer. The ground truth states that AbbVie shares 50% of the pre-tax profit from U.S. sales with Genentech but does not specify the dollar amount. Therefore, the inclusion of $869 million is an unsupported addition and likely incorrect or at minimum unverifiable from the provided truth. (2) While the total revenue figure is accurate, the $869 million figure cannot be confirmed and appears to be an inference or miscalculation (e.g., possibly derived from splitting U.S. revenue rather than U.S. pre-tax profit, which are not equivalent). Pre-tax profit is not the same as revenue, so sharing 50% of profit does not equate to $869 million unless profit margins are known and applied—this step is missing. (3) The multi-hop reasoning is partially sound: the model recognizes the collaboration with Genentech and the 50% profit-sharing structure, which is correct. However, it fails to clarify that the $869 million is not revenue but an inferred profit share, which reflects a flaw in quantitative reasoning. (4) The contextual relevance is perfect—it directly answers both parts of the question and adds geographic revenue breakdown, which is helpful but not required. The qualitative accuracy is high because the entities (AbbVie, Genentech, Venclexta, 2023, collaboration agreement) and the 50% sharing mechanism are correct. The quantitative accuracy is reduced due to the unsupported $869 million figure. Hence, correctness is 7: core facts are right, but a significant numerical claim is unverified and potentially misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 492,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was the change in the aggregate principal balance of the 3.650% notes due 2023 between December 31, 2022, and December 15, 2023, and how does this compare to the balance of the 3.700% notes due 2023 on December 15, 2023?",
      "original_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from December 31, 2022 ($171 million) to December 15, 2023 ($0). On the same date, the 3.700% notes due 2023 had an aggregate principal balance of $400 million.",
      "llm_answer": "\n\nThe aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million between December 31, 2022 ($171 million) and December 15, 2023 (fully repaid to $0). On December 15, 2023, the 3.700% notes due 2023 were also repaid in full ($400 million), resulting in a balance of $0. Thus, both note series were fully extinguished by their respective repayment dates, with the 3.700% notes repaid on December 15, 2023, and the 3.650% notes repaid earlier on August 16, 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $171 million decrease in the 3.650% notes due 2023, from $171 million on December 31, 2022, to $0 on December 15, 2023, which matches the ground truth. However, it incorrectly states that the 3.700% notes due 2023 were repaid in full on December 15, 2023, with a balance of $0, which contradicts the ground truth stating their balance was $400 million on that date. This is a critical factual error. (2) The quantitative values for the 3.650% notes are accurate (decrease of $171M, correct starting and ending balances), but the 3.700% note balance is wrong—the model reports $0 instead of $400 million. The calculation of the change for the 3.650% notes is correct. (3) The multi-hop reasoning fails because the model incorrectly synthesizes the repayment status of the 3.700% notes. It introduces an unsupported claim that they were 'repaid in full' and even specifies an earlier repayment date (August 16, 2023) for the 3.650% notes not present in the ground truth. There is no evidence in the original answer to support these dates or repayment events. (4) The contextual relevance is high because the answer addresses both parts of the question and attempts a comparison. However, due to the major factual error regarding the $400 million balance being misrepresented as $0, the correctness and qualitative accuracy scores are significantly reduced. Minor wording differences would be acceptable, but asserting a $400 million balance is $0 is a severe factual deviation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 419,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How could adverse litigation outcomes requiring Visa to modify its interchange reimbursement rates impact its transaction volumes and financial position, considering the protections provided by its U.S. and Europe retrospective responsibility plans and ongoing tax disputes?",
      "original_answer": "Adverse litigation outcomes could force Visa to reduce interchange reimbursement rates, which may lead some issuers to decrease promotion or use of Visa products, reduce cardholder benefits, or impose new fees, all of which could lower consumer usage and transaction volumes. This would directly harm Visa's net revenue. While Visa has U.S. and Europe retrospective responsibility plans that provide financial protections against certain litigation-related losses, these protections vary in scope and may not fully cover the financial impact of settlements, judgments, or changes in operating rules. At the same time, ongoing tax disputes with the IRS and foreign jurisdictions, combined with potential changes in global tax laws such as the OECD’s global minimum tax, could increase Visa’s effective tax rate and reduce cash flows. Therefore, even with partial mitigation from the retrospective plans, the combined effect of reduced interchange income and unfavorable tax outcomes could significantly harm Visa’s financial position.",
      "llm_answer": "\n\nAdverse litigation outcomes requiring Visa to modify interchange reimbursement rates could reduce its net revenue directly by lowering per-transaction fees. However, the U.S. and Europe retrospective responsibility plans (described in Note 5) may mitigate financial impacts by indemnifying Visa against certain litigation-related costs, though their effectiveness depends on coverage limits and terms. If interchange rate reductions persist, transaction volumes could decline as merchants or consumers shift to lower-cost alternatives (e.g., domestic RTP systems in India/Brazil or closed-loop platforms like Alipay), exacerbating revenue losses. Additionally, ongoing tax disputes (e.g., with the IRS or foreign authorities) could strain liquidity, as adverse tax rulings or settlements might further pressure cash flows and financial stability, compounding the impact of litigation-driven rate adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial and operational risks posed by adverse litigation outcomes on Visa's interchange rates, transaction volumes, and overall financial position. It correctly identifies that reduced interchange rates could lower net revenue and potentially reduce transaction volumes due to issuer behavior or consumer shifts to alternative payment systems. The mention of U.S. and Europe retrospective responsibility plans as partial mitigants is accurate and aligns with the ground truth, including the caveat about coverage limits. The LLM appropriately notes that these protections may not fully offset financial impacts, which matches the original answer's emphasis on incomplete coverage. The discussion of ongoing tax disputes with the IRS and foreign authorities is relevant and correctly framed as a compounding risk to liquidity and cash flows. While the original answer specifically references the OECD’s global minimum tax as a potential driver of higher effective tax rates, the LLM omits this detail but still conveys the essential risk of adverse tax outcomes affecting financial stability. The LLM introduces examples like 'domestic RTP systems in India/Brazil' and 'Alipay'—while illustrative and contextually reasonable—they are not present in the original answer and slightly extend beyond the source material, though they do not introduce factual errors. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Visa, IRS, retrospective responsibility plans) are correctly identified. The reasoning is logically sound and synthesizes multiple risk factors (litigation, interchange, volume, tax) across jurisdictions, satisfying the multi-hop requirement. The answer is semantically equivalent to the ground truth in all key aspects, with only minor contextual expansion. Thus, a correctness score of 9 is warranted due to high fidelity with one small omission (OECD tax initiative) and a slight addition of external examples.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 542,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "What are the effective dates of the Performance Share Unit award schedules under the United Technologies Corporation Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, and how do these dates reflect distinct governance updates to each plan as disclosed in the filings?",
      "original_answer": "The effective date of the Performance Share Unit award schedule under the United Technologies Corporation Long-Term Incentive Plan is January 1, 2020, while the effective date under the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan is March 31, 2021. These distinct effective dates reflect separate governance updates to each plan, with UTC’s update specifically tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, and Raytheon’s update tied to the amended Schedule of Terms filed on March 31, 2021, indicating discrete strategic and administrative adjustments within each company’s incentive structure.",
      "llm_answer": "\n\nThe Performance Share Unit (PSU) award schedules under the **United Technologies Corporation Long-Term Incentive Plan (UTC LTIP)** and the **Raytheon Technologies Corporation 2018 Long-Term Incentive Plan (RTX 2018 LTIP)** have distinct effective dates reflecting governance updates:  \n\n- For the **UTC LTIP**, the PSU schedule (Exhibit 10.15) was revised in **January 2016**, following the plan’s amendment and restatement in **April 2014** and a subsequent amendment in **February 2016**. This update aligns with broader governance adjustments to the plan’s structure and terms.  \n- For the **RTX 2018 LTIP**, the PSU schedule (Exhibit 10.25) was effective as of **March 2021**, after the plan’s initial adoption in **May 2018** and an amendment in **December 2020**. This reflects post-merger governance refinements to align incentives with Raytheon Technologies’ corporate strategy.  \n\nThese dates highlight periodic revisions to ensure compliance with regulatory requirements and strategic realignments post-merger (for RTX) or operational restructuring (for UTC).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dates. The ground truth states the effective date for UTC's PSU award schedule is January 1, 2020, but the LLM incorrectly states January 2016, citing amendments from 2014 and 2016. For Raytheon, the correct effective date is March 31, 2021, but the LLM only states 'March 2021', which is partially acceptable but lacks precision. More critically, the LLM misattributes the Raytheon update to an amendment in December 2020, whereas the ground truth ties it to the amended Schedule of Terms filed on March 31, 2021. (2) Quantitative accuracy is low: two key dates are wrong or imprecise, and no mention is made of the January 1, 2020 effective date for UTC being tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan, which is a central point in the original answer. (3) The multi-hop reasoning is partially sound—LLM recognizes that governance updates drive changes to PSU schedules and attempts to link amendments to effective dates—but fails to correctly synthesize the actual filings. It conflates prior plan amendments with the specific effective dates of the PSU award schedules, indicating a failure to distinguish between general plan amendments and the specific deferral or schedule updates. (4) Contextual relevance is fair: the answer addresses the right plans and the general idea of governance updates affecting PSU schedules, and correctly identifies the post-merger context for Raytheon. However, due to major factual errors in dates and misattribution of the basis for the effective dates, the overall correctness score is low despite some relevant context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 458,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "Which products were the primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022, and how did their performance compare to other product categories within the same segment?",
      "original_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were the Apple Watch and AirPods. These products contributed significantly to the segment's overall increase in net sales compared to 2021. In contrast, other categories such as HomePod mini and Beats products were not specifically cited as growth contributors, suggesting they either underperformed or remained flat relative to the strong performance of Apple Watch and AirPods. This indicates that the segment's growth was concentrated in two key product lines rather than being broadly distributed across all categories.",
      "llm_answer": "\n\nThe primary drivers of growth in Apple's Wearables, Home and Accessories segment in 2022 were **Apple Watch and AirPods**, which saw higher net sales compared to 2021. These products outperformed other items in the segment, such as Apple TV, Beats products, HomePod mini, and accessories, which were not explicitly cited as contributing significantly to the 7% year-over-year growth. The segment's performance was thus heavily reliant on the success of Apple Watch and AirPods, while other product categories within the segment either stagnated or had a smaller impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Apple Watch and AirPods as the primary growth drivers in Apple's Wearables, Home and Accessories segment in 2022, and notes that other categories like Beats products and HomePod mini did not significantly contribute—consistent with the original answer. The mention of Apple TV and accessories as underperforming or non-contributing is a slight expansion beyond the original, but does not contradict it and is contextually reasonable. (2) Quantitatively, the LLM correctly references a 7% year-over-year growth, which matches the known financial performance of the segment in 2022 (from external knowledge validation), and while the original answer does not include this percentage, its inclusion does not introduce error and adds relevant context. No incorrect numbers or miscalculations are present. (3) The multi-hop reasoning is sound: the model infers that because only Apple Watch and AirPods were highlighted, other categories likely underperformed or stagnated—this is a valid interpretation of the source data. (4) The answer is semantically equivalent to the ground truth, with slightly more detail but no factual deviation. The only reason for not scoring a 10 is the addition of Apple TV and accessories as explicit comparisons not mentioned in the original, which, while plausible, slightly extends beyond the provided truth. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 416,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does the impact of insurance reverification on Otezla's 2025 sales expectations compare with its effect on ENBREL's projected sales pattern, and what specific historical trend do both products follow?",
      "original_answer": "Both Otezla and ENBREL are expected to follow the historical trend of experiencing lower sales in the first quarter due to insurance reverification and increased co-pay expenses as U.S. patients work through deductibles. This pattern is specifically mentioned for both products in the context of their 2025 sales expectations.",
      "llm_answer": "\n\nThe impact of insurance reverification on Otezla's and ENBREL's 2025 sales expectations is similar in that both products are projected to follow the **historical pattern of lower first-quarter sales relative to subsequent quarters** due to benefit plan changes, insurance reverification, and increased co-pay expenses as U.S. patients work through deductibles. However, ENBREL's sales pattern also includes **continued declines in net selling price** starting in 2026 due to IRA Medicare Part D pricing, while Otezla faces potential price controls beginning in 2027. Both products thus share the quarterly seasonal trend but differ in timing of regulatory pricing impacts.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core historical trend shared by Otezla and ENBREL: lower first-quarter sales due to insurance reverification and patients working through deductibles, which aligns with the ground truth. This addresses the main comparison asked in the question. The qualitative description of the seasonal pattern is accurate and semantically equivalent to the original answer. However, the LLM introduces additional information not present in the ground truth—specifically, ENBREL's net selling price declines starting in 2026 due to IRA Medicare Part D pricing and Otezla's price controls in 2027. While potentially factually accurate in a broader context, these details were not part of the provided ground truth and go beyond the scope of the original answer, introducing a comparative element (regulatory timing differences) that wasn't asked for or supported by the source. This affects completeness and reasoning because the question only asked how the insurance reverification impact compares and what historical trend both follow—not about future regulatory pricing differences. Quantitatively, there are no numbers to verify, but the temporal references (first quarter, 2025 expectations) are consistent. Contextually, the answer remains highly relevant and well-structured. The core facts are correct, but the addition of unsupported comparative regulatory timelines prevents a higher score on qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 404,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "What is the total number of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K filing for both the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan?",
      "original_answer": "RTX disclosed 2 distinct exhibits related to stock appreciation rights awards: one for the United Technologies Corporation 2005 Long-Term Incentive Plan and one for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan.",
      "llm_answer": "\n\nThe total number of distinct stock appreciation rights (SAR)-related exhibits disclosed by RTX in its 2023 10-K filing for the two plans is **2**. For the **United Technologies Corporation 2005 Long-Term Incentive Plan**, Exhibit 10.16 (Schedule of Terms for SAR awards) is explicitly SAR-related. For the **Raytheon Technologies Corporation 2018 Long-Term Incentive Plan**, Exhibit 10.24 (Schedule of Terms for SAR awards) is disclosed. While Exhibit 10.17 (combined award agreement for RSU, PSU, and SAR) references SARs, it is not a distinct SAR-specific exhibit but a consolidated form, and thus not counted separately.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It correctly identifies the total number of distinct stock appreciation rights (SAR)-related exhibits as 2, matching the original answer. (2) The quantitative accuracy is precise: one SAR-specific exhibit for each of the two plans—United Technologies Corporation 2005 Long-Term Incentive Plan (Exhibit 10.16) and Raytheon Technologies Corporation 2018 Long-Term Incentive Plan (Exhibit 10.24). The LLM correctly excludes Exhibit 10.17 because it is a combined award agreement and not a distinct SAR-specific exhibit, demonstrating accurate interpretation of 'distinct' as per the question. (3) The multi-hop reasoning is sound: the model synthesizes information across two different incentive plans and correctly maps each to its respective SAR-related exhibit in the 2023 10-K, showing proper understanding of corporate structure and exhibit specificity. (4) The answer is contextually relevant, directly addressing the question with precise exhibit references and clear justification for inclusion/exclusion. Minor enhancements in detail (e.g., exhibit titles) improve clarity without deviating from the ground truth, and all entities (RTX, plan names, years) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 350,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How does the recurring impact of insurance reverification in the first quarter affect the combined sales performance of ENBREL and Otezla in 2025, based on their respective historical patterns and expected net selling price trends?",
      "original_answer": "The recurring impact of insurance reverification in the first quarter is expected to depress the combined sales performance of ENBREL and Otezla in 2025, following their historical pattern of lower sales during this period. For ENBREL, the expectation is for relatively flat volumes but continued declines in net selling price, which will contribute to reduced sales. Similarly, Otezla experienced an 8% decrease in net selling price in 2024, and it is expected to follow the same seasonal pattern in 2025. While Otezla saw 3% volume growth in 2024, this was not enough to offset the price declines, and a similar dynamic is expected in 2025, leading to a compounded negative impact on total sales for both drugs.",
      "llm_answer": "\n\nThe recurring impact of insurance reverification in the first quarter is expected to cause lower sales for both **ENBREL** and **Otezla** in Q1 2025, following their historical patterns. For **ENBREL**, Q1 sales typically decline due to benefit plan changes, insurance reverification, and higher co-pay expenses as U.S. patients work through deductibles, compounded by ongoing net selling price declines. Similarly, **Otezla** faces the same Q1 seasonal challenges, with lower net selling prices (8% decline in 2024) partially offset by modest volume growth. Collectively, these factors will likely result in reduced combined sales performance for ENBREL and Otezla in Q1 2025 compared to subsequent quarters, though full-year trends will depend on volume stability and pricing pressures, including the IRA’s Medicare Part D impact starting in 2026 for ENBREL.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: insurance reverification impacts Q1 sales for both ENBREL and Otezla, following historical patterns. The 8% decline in Otezla's net selling price in 2024 is accurately cited. ENBREL's ongoing net selling price declines are correctly noted. (2) Quantitative accuracy is perfect: the 8% price decline for Otezla in 2024 is correctly reported, and no incorrect numbers are introduced. The LLM does not fabricate any data. (3) Reasoning is sound: the model correctly synthesizes the multi-hop elements—seasonal insurance reverification effects, pricing trends, and volume dynamics—and applies them to forecast a combined negative impact on Q1 2025 sales. It appropriately notes that while Otezla had 3% volume growth in 2024 (implied from context), it didn't offset price declines, and a similar dynamic is expected. (4) The only minor gap is that the LLM mentions 'full-year trends will depend on...' and references the IRA’s 2026 impact, which, while contextually relevant, slightly extends beyond the scope of the question, which focuses on the Q1 reverification impact on 2025 performance. However, this does not detract from correctness. The core conclusion—that combined sales will be depressed in Q1 2025 due to reverification and pricing trends—is fully supported and semantically equivalent to the original answer. Wording differs slightly but meaning is preserved. Minor deduction in qualitative accuracy only for slight over-contextualization, but reasoning remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 432,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Considering the impact of increased co-pay expenses and Medicare price setting timelines, by how much could AMGN's revenue from Otezla and ENBREL be affected starting in 2025 and 2026 respectively, and how does this reflect a pattern in the company's revenue forecasting for its key drugs?",
      "original_answer": "AMGN's Otezla revenue is expected to face lower first-quarter sales in 2025 due to increased co-pay expenses and benefit plan changes, following a historical pattern. ENBREL will also see continued declines in net selling price starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act. These impacts reflect a pattern where AMGN's revenue forecasting for both drugs incorporates predictable first-quarter declines driven by insurance dynamics and co-pay expenses, followed by gradual recovery in subsequent quarters. The combined effect suggests a recurring revenue compression risk tied to U.S. patient deductibles and regulatory-driven pricing.",
      "llm_answer": "\n\nAMGN's revenue from **Otezla** could face a temporary decline in **2025**, primarily in Q1, due to increased co-pay expenses and benefit plan changes, as patients work through deductibles. However, Medicare price-setting impacts for Otezla (effective 2027) will not affect 2025. For **ENBREL**, revenue is expected to see continued net selling price declines starting in **2026** due to Medicare Part D price-setting under the IRA, with volumes projected to remain relatively flat. \n\nThis reflects a broader pattern in AMGN's revenue forecasting: **short-term quarterly volatility** from co-pay and plan changes (e.g., Q1 dips) and **longer-term pressure on net prices** from Medicare policies, which are factored into guidance for key drugs. Specific magnitude estimates for 2025/2026 are not quantified in the document but are described as following historical trends and regulatory timelines.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies that Otezla will face revenue pressure in 2025 due to increased co-pay expenses and benefit plan changes, primarily in Q1, which matches the original answer's emphasis on first-quarter declines driven by insurance dynamics. It correctly notes that ENBREL will see net selling price declines starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act (IRA), consistent with the ground truth. (2) Quantitatively, all dates (2025 for Otezla, 2026 for ENBREL) and policy references (Medicare Part D, IRA) are accurate. The LLM correctly clarifies that Otezla’s Medicare price-setting impact occurs in 2027, not 2025—this is a precise and relevant detail not in the original answer but factually correct, enhancing accuracy. However, the original answer emphasizes a *pattern* of recurring Q1 declines followed by recovery, which the LLM acknowledges but slightly underemphasizes. (3) The multi-hop reasoning is sound: the model synthesizes insurance dynamics (co-pays, deductibles) with regulatory timelines (IRA) and applies them to revenue forecasting patterns across two drugs. It correctly distinguishes between short-term volatility and long-term pricing pressure. (4) The only minor gap is that the LLM states 'specific magnitude estimates... are not quantified,' which is accurate, but the original answer goes further in characterizing the *combined effect* as a 'recurring revenue compression risk'—a synthesis the LLM implies but doesn’t fully articulate. Still, the core facts, entities, timelines, and reasoning are correct, warranting a high score. Minor deduction due to slightly less comprehensive synthesis of the overarching pattern.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 479,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What is the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, and how does Schwab account for the unrealized gains and losses associated with these liabilities in its consolidated statements of income?",
      "original_answer": "The total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is equal to the value of the corresponding client-held fractional shares, which Schwab includes in accrued expenses and other liabilities. Schwab accounts for the unrealized gains and losses on these repurchase liabilities by offsetting them against the unrealized gains and losses on the related client-held fractional shares, resulting in no net impact to the consolidated statements of income.",
      "llm_answer": "\n\nThe total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is not explicitly stated in the provided document pages. However, Schwab accounts for these liabilities by measuring them at fair value using quoted market prices or observable market data. Unrealized gains and losses associated with these repurchase liabilities are offset by corresponding unrealized gains and losses on the client-held fractional shares, resulting in **no impact to the consolidated statements of income**.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the accounting treatment for unrealized gains and losses—specifically, that they are offset against gains and losses on the related client-held fractional shares, resulting in no net impact to the consolidated statements of income. This part matches the ground truth exactly and is semantically equivalent. However, the LLM fails to provide the actual total fair value of the repurchase liabilities as of December 31, 2024, instead stating it is 'not explicitly stated in the provided document pages.' The ground truth indicates that the value is equal to the value of the corresponding client-held fractional shares, which implies it is determinable and accounted for in accrued expenses and other liabilities. Thus, the omission of a specific value (even if derived) is a significant gap. (2) Quantitative accuracy is low because no numerical value is provided for the fair value, despite the ground truth implying it is known and equal to the value of client-held fractional shares. The lack of any dollar amount or reference to its equivalence reduces factual precision. (3) The reasoning is partially sound: the model correctly synthesizes the offsetting mechanism between liabilities and assets, showing understanding of the economic hedge. However, it fails the multi-hop requirement to infer or report the fair value based on the relationship stated in the ground truth (i.e., fair value = value of client-held fractional shares). (4) Contextual relevance is high because the response stays focused on the question, uses correct terminology, and addresses both parts—though incompletely. The second part is fully accurate, but the first part lacks the necessary inference. Therefore, while the qualitative reasoning is mostly sound, the failure to report a quantifiable figure results in a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 507,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What was the total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares, and how does this compare to AspenTech's 2023 net sales?",
      "original_answer": "The implied fully diluted market capitalization of AspenTech was $15.3 billion according to Emerson's proposal. This is significantly higher than AspenTech's 2023 net sales of $1.04 billion, indicating a substantial valuation multiple of approximately 14.7x net sales.",
      "llm_answer": "\n\nThe total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares is **$15.3 billion**. This compares to AspenTech's 2023 net sales of **$1.04 billion**, resulting in a market capitalization approximately **14.7 times its 2023 net sales**. \n\n(Source: EMR_10k_2023.pdf, Page 5 and Page 71)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the implied fully diluted market capitalization of $15.3 billion and AspenTech's 2023 net sales of $1.04 billion are accurately reported. The resulting valuation multiple of 14.7x is correctly calculated ($15.3B / $1.04B ≈ 14.7). (2) The answer is complete, addressing both parts of the question: the market cap based on Emerson's proposal and its comparison to 2023 net sales. (3) Entities are accurate—AspenTech, Emerson, the correct fiscal year (2023), and financial metrics (fully diluted market capitalization, net sales) are all correctly identified. (4) The reasoning is sound: the LLM correctly synthesizes the acquisition proposal value and compares it to revenue, deriving the correct multiple. The inclusion of source documents adds contextual support. Semantic equivalence is maintained with precise factual alignment to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 273,
        "total_tokens": 1440
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "What is the total potential additional federal tax liability, including penalties, that AMGN faces from the IRS Notices for the years 2010-2012 and 2013-2015, and how would previously accrued repatriation taxes affect this amount?",
      "original_answer": "The total potential additional federal tax liability from the IRS Notices for the years 2010–2012 and 2013–2015 is $8.7 billion ($3.6 billion for 2010–2012 and $5.1 billion for 2013–2015), plus penalties of $2.0 billion, totaling $10.7 billion. However, this amount would be reduced by up to $3.1 billion in previously accrued repatriation taxes ($900 million for 2010–2012 and $2.2 billion for 2013–2015), resulting in a net potential liability of $7.6 billion before interest.",
      "llm_answer": "\n\nThe total potential additional federal tax liability, including penalties, from the IRS Notices for the years 2010-2012 and 2013-2015 is **$7.6 billion**. This includes **$3.6 billion** in additional taxes for 2010-2012 and **$5.1 billion in taxes plus $2.0 billion in penalties** for 2013-2015. Previously accrued repatriation taxes reduce this amount by **$900 million** for 2010-2012 and **$2.2 billion** for 2013-2015, lowering the net tax exposure but not affecting the asserted penalties.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the total potential additional federal tax liability including penalties as $7.6 billion, which is actually the *net* liability after reduction from previously accrued repatriation taxes. The correct total *before* reduction is $10.7 billion ($8.7 billion in taxes + $2.0 billion in penalties). The LLM conflates the net amount with the gross, which is a significant factual error. (2) Individual components are mostly accurate: $3.6 billion for 2010–2012 taxes, $5.1 billion for 2013–2015 taxes, $2.0 billion in penalties, and the repatriation tax reductions of $900 million and $2.2 billion are correct. However, the answer misattributes the $2.0 billion penalty only to 2013–2015 without specifying whether it applies to both periods — the original answer implies it's total across both periods. (3) The multi-hop reasoning is partially sound — the model identifies the two time periods, the tax and penalty components, and the offset from repatriation taxes. However, it fails to correctly structure the calculation: gross liability → reduction → net liability. Instead, it presents $7.6 billion as the total including penalties, which contradicts the correct sequence. (4) Despite accurate component numbers, the misrepresentation of the total and the flawed logic in combining them reduces correctness. The answer is contextually relevant and addresses all parts of the question, but the core quantitative claim is misleading. Hence, scores are moderate with deductions primarily on quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 432,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does the inclusion of ENBREL in the Medicare price setting program, as detailed in the 2024 10-K filing, affect Amgen's financial outlook, and what additional risk does the potential inclusion of Otezla pose in the future?",
      "original_answer": "Amgen expects the government-mandated price reduction for ENBREL, effective January 1, 2026, to negatively impact its profitability in Medicare. This is due to the significantly lower price set by CMS under Medicare Part D. Additionally, Otezla has been selected for Medicare price setting beginning January 1, 2027, which could further reduce revenues if Amgen is required to accept a government-determined price. The Inflation Reduction Act (IRA) allows for up to 100 drugs to be subject to price setting by 2031, and Amgen notes that other products may be selected in future cycles, compounding the material adverse effect on sales and operations.",
      "llm_answer": "\n\nThe inclusion of **ENBREL** in Medicare price setting under the Inflation Reduction Act (IRA) is expected to significantly reduce its profitability in Medicare starting January 1, 2026, as CMS set a price for ENBREL in Medicare Part D that is \"significantly lower than currently applicable.\" This directly impacts Amgen’s financial outlook by lowering revenue from one of its key products. The potential inclusion of **Otezla** in the 2027 Medicare price setting cycle (announced in January 2025) poses an additional risk, as it could trigger similar steep price reductions, further eroding margins. The cumulative effect of these measures, along with future selections of Amgen products for Medicare price setting, is projected to have a **material adverse effect** on sales and profitability, particularly as the program expands to 100 drugs by 2031.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: ENBREL's inclusion in Medicare price setting under the IRA with a significantly lower CMS price effective January 1, 2026, is accurately stated. Otezla's selection for price setting beginning January 1, 2027, is also correctly noted. (2) Quantitative accuracy is perfect: the dates (2026 and 2027) match the original answer, and while no specific dollar amounts or percentages are provided in either version, the characterization of the price reduction as 'significantly lower' is consistent. (3) Multi-hop reasoning is sound—the LLM correctly synthesizes the impact on Amgen’s financial outlook from both ENBREL and the future risk from Otezla, and extends the logic to the broader IRA framework allowing up to 100 drugs to be subject to price setting by 2031. (4) The answer conveys the same semantic meaning as the original: both emphasize the material adverse effect on sales, profitability, and operations due to government-mandated pricing. Wording differs slightly but meaning is preserved. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 321,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares impact the consolidated statements of income, given the company's election of the fair value option under ASC 825?",
      "original_answer": "Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares results in unrealized gains and losses on these liabilities, which are offset by unrealized gains and losses on the corresponding client-held fractional shares. This offsetting mechanism ensures there is no net impact on the consolidated statements of income. Additionally, since the repurchase liabilities do not carry credit risk, Schwab has not recognized any gains or losses attributable to instrument-specific credit risk in the consolidated statements of income or comprehensive income.",
      "llm_answer": "\n\nSchwab's election of the fair value option under ASC 825 for repurchase liabilities related to client-held fractional shares ensures that unrealized gains and losses on these liabilities are offset by corresponding unrealized gains and losses on the client-held fractional shares. This offset results in **no net impact to the consolidated statements of income**, as changes in fair value of both the assets and liabilities are recognized simultaneously and in equal magnitude. Additionally, since these repurchase liabilities carry no credit risk, Schwab does not recognize any instrument-specific credit risk gains or losses in earnings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies that Schwab's election of the fair value option under ASC 825 leads to recognition of unrealized gains and losses on repurchase liabilities based on quoted market prices, and that these are offset by corresponding gains and losses on client-held fractional shares, resulting in no net impact on the consolidated statements of income. (2) There are no numerical inaccuracies—while no specific dollar amounts or dates are present, the qualitative financial mechanics are correctly described, and the absence of credit risk is properly noted with the conclusion that no instrument-specific credit risk gains or losses are recognized. (3) The multi-hop reasoning is sound: the model correctly synthesizes the implications of ASC 825, fair value measurement, offsetting effects between liabilities and assets, and the treatment of credit risk. (4) All entities—Schwab, repurchase liabilities, client-held fractional shares, ASC 825, fair value option—are accurately referenced and logically connected. The answer is fully relevant and complete, matching the depth and scope of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 338,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the use of the market multiple method in conjunction with the discounted cash flow method contribute to the determination of the $431 million goodwill impairment charge for the LTC reporting unit in 2021, and what specific store closure strategy announced in 2021 impacted the Retail/LTC segment's long-lived asset impairment analysis?",
      "original_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using a combination of the discounted cash flow method and the market multiple method. These valuation techniques revealed that the LTC reporting unit's fair value was lower than its carrying value, primarily due to deteriorating financial forecasts driven by lower net facility admissions, customer losses, and the prolonged impact of the COVID-19 pandemic. Separately, in the Retail/LTC segment, the Company announced in November 2021 that it would close approximately 900 stores over three years (300 per year from 2022 to 2024), which triggered a long-lived asset impairment test. This led to a $1.4 billion store impairment charge in Q4 2021, including $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment, also within the Retail/LTC segment.",
      "llm_answer": "\n\nThe $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using the **discounted cash flow (DCF) method** and **market multiple method**, which collectively indicated that the LTC unit’s fair value fell below its carrying value. The DCF method incorporated updated projections reflecting challenges such as lower facility admissions, customer losses, and pandemic-driven occupancy declines, while the market multiple method compared the unit to peers, both showing diminished valuations.  \n\nThe **specific store closure strategy** impacting the Retail/LTC segment’s long-lived asset impairment analysis was the announcement in November 2021 to close approximately 900 stores over three years (300 annually from 2022–2024). This strategic decision triggered impairment indicators for affected stores’ asset groups, leading to a $1.4 billion long-lived asset impairment charge in Q4 2021, primarily due to reduced projected cash flows from closures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $431 million goodwill impairment for the LTC reporting unit in 2021, use of both the discounted cash flow and market multiple methods, the November 2021 announcement to close approximately 900 stores over three years (300 per year from 2022–2024), and the resulting $1.4 billion long-lived asset impairment charge in Q4 2021. The breakdown of the $1.4 billion charge into $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment is omitted, but the total amount and triggering event are correctly stated. (2) Quantitative accuracy is perfect: all dollar amounts ($431 million, 900 stores, 300 per year, $1.4 billion), dates (2021, Q4 2021, 2022–2024), and numerical details match the original. Format variations are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound—correctly linking the valuation methods to the goodwill impairment, identifying the store closure strategy as a separate but related event in the Retail/LTC segment, and explaining how it triggered long-lived asset impairments due to reduced cash flow projections. (4) The only minor omission is the detailed composition of the $1.4 billion impairment charge, which slightly reduces completeness but does not undermine the core accuracy. Wording differs but maintains semantic equivalence. Contextual relevance is excellent, directly addressing both parts of the question with appropriate financial and strategic context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 428,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "What is the dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, and what portion of this increase is attributable to Level 2 assets?",
      "original_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023 ($11,438 million) to December 31, 2024 ($12,416 million) is $978 million. Of this increase, Level 2 assets contributed $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024), indicating that the entire increase in this category came from growth in Level 2 assets.",
      "llm_answer": "\n\nThe dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, is **$978 million** ($12,416 million in 2024 - $11,438 million in 2023). Of this increase, **$1,205 million** is attributable to Level 2 assets, as the Level 2 portion rose from $8,810 million in 2023 to $10,015 million in 2024. The net increase accounts for a reduction in Level 1 assets ($2,628 million to $2,401 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the increase in Cash and investments segregated and on deposit is correctly calculated as $978 million ($12,416M - $11,438M), and the contribution from Level 2 assets is correctly identified as $1,205 million ($10,015M - $8,810M). These figures match the original answer exactly. (2) The answer addresses both parts of the multi-part question: the total dollar increase and the portion attributable to Level 2 assets. (3) Entity accuracy is correct—dates (December 31, 2023, and December 31, 2024), financial metric ('Cash and investments segregated and on deposit for regulatory purposes'), and asset classification (Level 1 and Level 2) are all properly identified. (4) The reasoning is sound and includes additional context (a decrease in Level 1 assets) that supports the conclusion that Level 2 assets not only account for the entire increase but more, which aligns with the original answer's implication. The multi-hop synthesis—linking changes in total segregated cash and investments to the component-level changes in Level 1 and Level 2 assets—is logically and factually correct. The answer is semantically equivalent to the ground truth and provides even slightly more contextual clarity. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 376,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How does Emerson allocate AspenTech's stock-based compensation expense between pre- and post-combination periods under ASC 805, and what specific valuation inputs and ownership figures from the acquisition are used in this allocation?",
      "original_answer": "Under ASC 805, Emerson allocates the fair value of AspenTech's stock-based compensation awards between pre- and post-combination service periods. The portion attributable to the pre-combination service period is included in the purchase price of the acquisition, while the post-combination portion is recognized as stock-based compensation expense over the remaining service period. This allocation uses the fair value of AspenTech stock at the time of the acquisition on May 16, 2022, determined using the closing market price per share, and Emerson's 55% ownership stake in AspenTech post-transaction.",
      "llm_answer": "\n\nEmerson allocated AspenTech's stock-based compensation expense under ASC 805 by determining the fair value of awards attributable to pre- and post-combination service periods. Specifically, the **$102 million** value of stock-based compensation awards tied to **pre-combination service** was included in the total purchase consideration for Heritage AspenTech (see Note 4). This amount was calculated using the **closing market price of $166.30 per share** of Heritage AspenTech on May 16, 2022 (the acquisition date), and the **66,662,482 shares outstanding** at that time. Emerson’s 55% ownership and the 45% non-controlling interest were also critical inputs, as the fair value of the non-controlling interest was determined using the same market price. Post-combination service-related expenses are recognized over the remaining vesting periods in Emerson’s consolidated financial statements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite addressing the correct conceptual framework under ASC 805. While it correctly describes the principle of allocating stock-based compensation between pre- and post-combination service periods, and notes that the pre-combination portion is included in purchase consideration, the specific quantitative inputs are incorrect. The ground truth does not mention a $102 million figure, nor does it reference 66,662,482 shares outstanding—these numbers are fabricated or hallucinated. The closing price of $166.30 per share on May 16, 2022, is plausible but not confirmed in the ground truth, which only states that the closing market price was used without specifying the exact amount. (2) The calculation of $166.30 × 66,662,482 would yield approximately $11.1 billion, not $102 million, indicating a severe internal inconsistency or miscalculation. This undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound—Emerson’s 55% ownership is correctly cited from the ground truth and relevant to the allocation, as is the use of the acquisition date (May 16, 2022). However, the inclusion of non-controlling interest valuation, while contextually related, goes beyond what was asked and introduces unverified details. (4) The answer is contextually relevant and structured well, showing understanding of ASC 805 mechanics, but the invention of precise figures like $102 million and share count severely damages factual correctness. Without corroboration from the knowledge graph, these specifics render the answer misleading. Thus, while the qualitative reasoning is moderately accurate and the structure relevant, the quantitative inaccuracies dominate the evaluation, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 488,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What was the percentage change in the value of CVS's investments in 'States, Municipalities and Political Subdivisions' from December 31, 2021, to December 31, 2022, and how did this shift affect the overall composition of CVS's debt securities portfolio?",
      "original_answer": "The value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million on December 31, 2021, to $170 million on December 31, 2022, representing a 94.5% decrease. This significant reduction altered the overall composition of CVS's debt securities portfolio, where in 2021 these securities accounted for approximately 13.3% of total debt securities ($3,091 million out of $23,240 million), compared to only 4.9% in 2022 ($170 million out of $3,462 million).",
      "llm_answer": "\n\nThe value of CVS's investments in 'States, Municipalities and Political Subdivisions' increased from $2,728 million in 2020 to $3,086 million in 2021, representing a **13.1% increase**. This growth contributed to a slight rise in the category's proportion within the overall debt securities portfolio, from 14.5% of total debt securities in 2020 to 14.8% in 2021, reflecting a marginal shift toward municipal securities in the portfolio's composition. Note that 2022 data for this specific investment category is not explicitly provided in the given pages.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It discusses a 13.1% increase from 2020 to 2021, but the question specifically asks for the percentage change from December 31, 2021, to December 31, 2022. The ground truth shows a 94.5% decrease during that period, whereas the LLM incorrectly reports an increase in the wrong time frame. Additionally, the LLM claims that 2022 data is not provided, which contradicts the original answer and implies a failure to access or interpret the correct data. (2) The numbers cited ($2,728 million in 2020, $3,086 million in 2021) do not match the ground truth values ($3,091 million in 2021, $170 million in 2022). The percentages (14.5% to 14.8%) are fabricated and unrelated to the correct portfolio composition figures (13.3% in 2021, 4.9% in 2022). Calculations are based on incorrect data and time periods. (3) The multi-hop reasoning failed completely: instead of comparing 2021 and 2022 values for the specified investment category and analyzing its impact on portfolio composition, the model used irrelevant 2020–2021 data and missed the core temporal comparison. (4) The answer receives a correctness score of 1 because it fundamentally misreads the question, uses incorrect years, fabricates trends, and omits the actual required analysis. Quantitative accuracy is 1 due to completely wrong numbers and calculations. Qualitative accuracy is 1 due to flawed logic and entity/timeframe misalignment. Contextual relevance is 2 because while it discusses CVS and debt securities, it addresses the wrong time period and omits the key 2021–2022 shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 440,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the potential conversion of class B common stock, tied to the final resolution of U.S. covered litigation under the U.S. retrospective responsibility plan, depend on the accrual activity related to that litigation, and what financial uncertainty does this create for Visa's class A common stockholders?",
      "original_answer": "Under the U.S. retrospective responsibility plan, class B common stock will become convertible into class A common stock upon the final resolution of U.S. covered litigation. However, the accrual activity for U.S. covered litigation, which includes a charge to the litigation provision when a loss is deemed probable and reasonably estimable, affects the timing and certainty of that resolution. The accrual could be higher or lower than the escrow account balance, introducing uncertainty about when the litigation will be resolved and thus when the conversion will occur. This uncertainty impacts the potential dilution for class A common stockholders, as the market price of class A stock could fall if the conversion happens at a higher valuation that later decreases. Therefore, the financial exposure and timing of litigation resolution directly influence the dilutive effect and stock value risk for existing class A shareholders.",
      "llm_answer": "\n\nThe conversion of Visa's Class B common stock into Class A common stock under the U.S. retrospective responsibility plan is contingent on the **final resolution of U.S. covered litigation**. The accrual activity for this litigation (e.g., $861 million added to the U.S. covered litigation accrual in fiscal 2022) reflects management’s estimate of probable and reasonably estimable losses. However, the actual outcome of the litigation remains uncertain, and future developments could materially alter these estimates. \n\nThis creates **financial uncertainty for Class A common stockholders** in two key ways:  \n1. **Dilution Risk**: Conversion of Class B shares increases the outstanding Class A shares, potentially reducing earnings per share (EPS) and diluting voting power.  \n2. **Earnings Volatility**: Unanticipated increases in litigation liabilities (e.g., higher accruals or unfavorable judgments) could reduce net income, directly impacting Class A stock value.  \n\nThe interplay between accrual adjustments and litigation resolution introduces uncertainty about both the timing and magnitude of conversion effects, exposing Class A stockholders to potential downside risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core mechanism: Class B stock conversion depends on the final resolution of U.S. covered litigation, and accrual activity introduces uncertainty affecting Class A shareholders. It accurately identifies dilution risk and earnings volatility as key impacts. However, the inclusion of a specific number—'$861 million added to the U.S. covered litigation accrual in fiscal 2022'—is problematic. The ground truth does not include this figure, and without confirmation from the knowledge graph that this exact amount is correct and relevant to the reasoning chain, its inclusion introduces unverified quantitative detail, reducing quantitative accuracy. While the conceptual link between accruals, litigation uncertainty, and shareholder risk is well-explained and semantically aligned with the original answer, the answer slightly misses the nuance that the *relationship between accrual levels and escrow account balance* creates uncertainty in resolution timing. This is implied but not explicitly stated. The reasoning is otherwise sound, logically connecting accrual uncertainty to conversion timing and shareholder risk. All entities (Class A/B stock, U.S. retrospective responsibility plan, covered litigation) are correctly identified and contextually used. The answer is highly relevant and addresses both parts of the multi-hop question: the dependency of conversion on litigation resolution (with accrual impact) and the resulting financial uncertainty for Class A holders.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 415,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what was the corresponding change in net losses on these investments year-over-year?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million in 2023 to $9,865 million in 2024), and the net losses on these investments increased by $46 million (from $21 million loss in 2023 to $67 million loss in 2024).",
      "llm_answer": "\n\nThe fair value of Cisco's available-for-sale debt investments decreased by **$5,727 million** (from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024). The corresponding net losses on these investments increased by **$46 million** year-over-year (from a $21 million loss in fiscal 2023 to a $67 million loss in fiscal 2024).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the decrease in fair value is accurately calculated as $5,727 million (from $15,592 million to $9,865 million), and the increase in net losses is correctly stated as $46 million (from $21 million loss to $67 million loss). These figures match the original answer exactly. (2) The answer is complete, addressing both parts of the question: the change in fair value and the year-over-year change in net losses. (3) Entity accuracy is correct—Cisco is the subject, the correct fiscal dates (July 29, 2023, and July 27, 2024) are used, and the financial metrics (available-for-sale debt investments, fair value, net losses) are properly identified. (4) The multi-hop reasoning—synthesizing data across two fiscal years for two different financial metrics—is sound and correctly executed. The wording differs slightly (e.g., 'fiscal 2023' vs specific dates) but maintains semantic equivalence. No errors in logic, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 293,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did the changes in ExtraBucks Rewards and gift card liabilities during 2021 impact CVS's revenue recognition, particularly in relation to breakage and redemption patterns?",
      "original_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 directly affected CVS's revenue recognition by reducing the contract liability balance as customers redeemed rewards and gift cards. Additionally, CVS recognized breakage revenue based on historical redemption patterns. As customers failed to redeem a portion of the issued rewards and gift cards, CVS reclassified these amounts from liabilities to revenue, reflecting the fulfillment of the obligation to provide goods or services. This process aligns with the company's accounting policy that recognizes breakage on unredeemed gift cards and expired rewards, which contributes to revenue as the likelihood of redemption diminishes over time.",
      "llm_answer": "\n\nThe changes in ExtraBucks Rewards and gift card liabilities during 2021 impacted CVS's revenue recognition through the timing of revenue recognition for unredeemed balances and breakage. For ExtraBucks Rewards, revenue is recognized as rewards are redeemed, with unredeemed balances reflected as contract liabilities. In 2021, $371 million in redemptions and breakage (vs. $359 million in 2020) contributed to revenue, driven by historical redemption patterns. Gift card breakage, also recognized based on historical redemption rates, further increased revenue as unused balances were derecognized. The net increase in contract liabilities from $71 million to $87 million (primarily from $387 million in new issuances/earnings) reflects deferred revenue that will be recognized upon future redemptions or as breakage. Thus, shifts in redemption behavior during 2021 directly influenced the timing and amount of revenue recognized from these programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth in terms of reasoning and key concepts. It correctly explains that changes in ExtraBucks Rewards and gift card liabilities impacted revenue recognition through redemption and breakage, and that breakage revenue is recognized based on historical redemption patterns. The answer includes specific quantitative data: $371 million in redemptions and breakage in 2021 (vs. $359 million in 2020), a rise in contract liabilities from $71M to $87M, and $387 million in new issuances/earnings. However, the ground truth does not include these specific numbers—such as the $371M or $359M figures or the $71M to $87M liability change—so their presence in the LLM answer cannot be verified as correct from the provided knowledge graph. This introduces unverifiable precision, which risks hallucination, though the directionality (increase in breakage-related revenue and liabilities) is consistent with the original answer. The qualitative reasoning is strong: it correctly identifies the accounting treatment (liabilities reduced upon redemption, breakage reclassified to revenue), links breakage to historical patterns, and explains deferred revenue recognition. The multi-hop synthesis—connecting liability changes, redemption behavior, and revenue recognition—is sound. Contextual relevance is excellent, directly addressing the question’s focus on revenue recognition, breakage, and redemption patterns. The only deduction is in quantitative accuracy due to the inclusion of unverified figures not present in the ground truth, though they are plausible and do not contradict it.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 447,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does the funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan affect the conversion rate of class B common stock into class A common stock, and what financial impact does this have on Visa Inc.'s litigation provision based on the fiscal 2022 accrual activity?",
      "original_answer": "Funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the conversion rate of class B common stock to class A common stock, diluting the value of class B shares. This dilution mechanism is directly tied to the Company’s funding actions. According to the fiscal 2022 data, there was a measurable reduction in the number of as-converted class B shares following escrow deposits, and concurrently, the litigation provision was charged based on the accrual activity for U.S. covered litigation, which was deemed probable and reasonably estimable.",
      "llm_answer": "\n\nThe funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan reduces the conversion rate of class B common stock into class A common stock through a downward adjustment. Specifically, deposits into the escrow account dilute the value of class B shares by lowering the number of class A shares they can convert into. In fiscal 2022, a $850 million deposit under this plan led to a reduction of 4 million equivalent class A shares. \n\nThis directly impacted Visa Inc.'s litigation provision, as the $850 million deposit was nearly fully offset by an $861 million accrual for interchange multidistrict litigation in fiscal 2022 (as detailed in Note 20). The accrual increased the litigation provision by $861 million, with the majority allocated to fund the escrow account to address claims from merchants who opted out of the Amended Settlement Agreement. Thus, the funding mechanism ties the litigation provision to both the estimated liability and the dilutive effect on class B common stock conversion rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the class B to class A stock conversion rate, resulting in dilution—this matches the core mechanism described in the original answer. (2) The LLM provides specific fiscal 2022 figures: an $850 million deposit leading to a reduction of 4 million equivalent class A shares, and an $861 million accrual for interchange multidistrict litigation. While the original answer does not include these exact numbers, they are consistent with the type of detailed accrual activity and share impact implied in the ground truth, and such specificity enhances rather than contradicts the original. The $861 million accrual being allocated to fund the escrow is logically sound and contextually appropriate. (3) The multi-hop reasoning is strong: the model correctly links escrow funding → conversion rate adjustment → dilution of class B shares → impact on litigation provision via accruals, which reflects the required synthesis across corporate governance and financial reporting domains. (4) Minor deduction in quantitative accuracy because the original answer does not specify the $850M or $861M figures or the 4 million share reduction—while plausible and internally consistent, they cannot be verified as ground truth. However, the qualitative and contextual accuracy remains high because the explanation mechanism is correct and the numbers serve as reasonable illustrations of the process. No factual contradictions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 449,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what would be the impact on total investments if a 100 basis point interest rate increase occurred in each of those years?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million, from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. If a 100 basis point interest rate increase had occurred in 2023, the valuation would have been $15,386 million, and in 2024 it would have been $9,736 million. The difference between these two adjusted values is $5,650 million, which reflects the same general trend of decline in investment value over the period even under interest rate stress.",
      "llm_answer": "\n\nThe fair value of Cisco's available-for-sale debt investments decreased by **$5,727 million** from July 29, 2023 ($15,592 million) to July 27, 2024 ($9,865 million).  \n\nA 100 basis point (1.00%) interest rate increase would have reduced the fair value of total investments by **$129 million** as of July 27, 2024 (from $9,865 million to $9,736 million) and by **$206 million** as of July 29, 2023 (from $15,592 million to $15,386 million).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key numerical aspects. (1) The decrease in fair value is correctly calculated as $5,727 million, from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. (2) The impact of a 100 basis point interest rate increase is accurately reported: $206 million reduction in 2023 (from $15,592M to $15,386M) and $129 million reduction in 2024 (from $9,865M to $9,736M). These values align exactly with the ground truth. (3) The multi-hop reasoning is sound—information is correctly synthesized across two fiscal years and two hypothetical interest rate scenarios. (4) While the original answer also notes that the adjusted values still show a decline of $5,650 million, this is contextual synthesis and not explicitly asked in the question. The LLM addresses the two explicit parts: the actual decrease and the impact of rate increases. The omission of the $5,650 comparison does not detract from correctness since the question does not ask for the difference under stress conditions, only the impact of the rate increase in each year. Wording differs slightly but maintains semantic equivalence. All entities (Cisco, available-for-sale debt investments, correct dates, and financial metrics) are accurate. Minor deduction in qualitative accuracy only because it doesn't explicitly connect the two stress-test values as part of a trend, but this is not required for full correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 401,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "What was the financial impact on Visa Inc.'s litigation provision as a result of the U.S. Covered Litigation, and how does the accrual activity relate to the mechanisms outlined in the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa Inc. records a charge to the litigation provision when a loss from U.S. Covered Litigation is deemed probable and reasonably estimable. The accrual activity related to this litigation is directly tied to the mechanisms within the U.S. Retrospective Responsibility Plan, such as the litigation escrow agreement and indemnification obligations from Visa U.S.A. members. These mechanisms are designed to address potential liabilities, and the total accrual could be either higher or lower than the escrow account balance, depending on the resolution of the litigation.",
      "llm_answer": "\n\nThe financial impact on Visa Inc.'s litigation provision from the U.S. Covered Litigation in fiscal 2022 was an **increase of $861 million**, primarily due to provisions for interchange multidistrict litigation. This amount aligns with the $850 million deposited into the U.S. litigation escrow account during the year to address claims from merchants who opted out of the Amended Settlement Agreement. The accrual activity directly relates to the mechanisms in the U.S. Retrospective Responsibility Plan, which includes the litigation escrow account, conversion rate adjustments for class B shares, indemnification obligations, and loss-sharing agreements. These mechanisms allocate and fund Visa’s liability for covered litigation, ensuring settlements and judgments are covered while mitigating financial exposure through structured risk-sharing arrangements with members and contractual partners.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—$861 million increase in litigation provision and $850 million escrow deposit in fiscal 2022—that are not present in the original ground truth answer. The ground truth does not provide any numerical values or specify a fiscal year (e.g., 2022), nor does it mention interchange multidistrict litigation as the driver. These numbers, while plausible, cannot be verified against the provided ground truth and appear to be hallucinated or drawn from external data not in the knowledge graph. (2) There is no verification possible for the calculation or alignment between $861M and $850M, as the original answer does not include such figures. The claim that the amounts 'align' introduces a quantitative comparison absent from the source, reducing quantitative accuracy. (3) Qualitatively, the LLM correctly identifies key mechanisms in the U.S. Retrospective Responsibility Plan—litigation escrow account, indemnification obligations, loss-sharing, and conversion rate adjustments—as relating to accrual activity. This reflects sound multi-hop reasoning in linking accruals to structural risk-sharing mechanisms. However, the original answer does not mention class B shares or conversion rates, so this detail exceeds the ground truth. (4) Contextually, the response is relevant and addresses both parts of the question: financial impact on litigation provision and relation to the U.S. Retrospective Responsibility Plan. But the inclusion of unverified numbers and specific events (fiscal 2022, interchange litigation) significantly undermines factual correctness. While the conceptual framework is aligned, the unsupported specifics result in a partially correct but materially inaccurate response. Thus, the correctness score is moderate due to major quantitative inaccuracies despite reasonable qualitative structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 510,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How much did the Heritage AspenTech acquisition contribute to the increase in Emerson's (EMR) gross margin percentage in 2023, and what was the total gross margin percentage for that year as a result of that contribution?",
      "original_answer": "The Heritage AspenTech acquisition contributed 0.6 percentage points to the increase in Emerson's gross margin in 2023. As a result, Emerson's gross margin for 2023 reached 49.0 percent.",
      "llm_answer": "\n\nThe Heritage AspenTech acquisition contributed **0.6 percentage points** to the increase in Emerson's gross margin percentage in 2023. The total gross margin percentage for 2023, as a result of this contribution and other factors, was **49.0%**. This is explicitly stated in the \"Cost of Sales\" section, which attributes the 3.3 percentage point year-over-year gross margin improvement to favorable pricing, the Heritage AspenTech acquisition, and favorable mix.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that the Heritage AspenTech acquisition contributed 0.6 percentage points to Emerson's gross margin increase in 2023, and that the total gross margin percentage for 2023 was 49.0%. (2) The numeric values (0.6 and 49.0%) are correct and match the original answer exactly; no calculations were required beyond what was provided in the source. (3) The reasoning is sound and reflects proper synthesis of the information, correctly identifying the contribution of the acquisition within the broader context of other factors (pricing, mix) that influenced gross margin. (4) The answer is contextually relevant, directly addressing both parts of the multi-part question and providing appropriate supporting detail from the source (e.g., mention of the 'Cost of Sales' section and other contributing factors), without introducing inaccuracies or irrelevant information. Minor additions for context (e.g., other factors in margin improvement) do not detract from accuracy and enhance clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 304,
        "total_tokens": 1486
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does Cisco's guarantee of channel partner financing arrangements potentially affect its credit loss exposure as described in the financing receivables section, given the risk of channel partner financial instability?",
      "original_answer": "Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because it could be required to make payments if channel partners default on short-term financing with third parties. According to the filing, Cisco facilitates revolving short-term financing for channel partners with payment terms ranging from 60 to 90 days and, in some cases, guarantees a portion of these arrangements. If channel partners face financial instability, Cisco may be obligated to cover unpaid amounts under these guarantees. This exposure is compounded by the fact that Cisco already records allowances for credit losses based on internal credit risk ratings, historical default rates, and macroeconomic conditions. If financial instability among channel partners rises, Cisco could experience higher credit losses tied to these financing guarantees, directly impacting its financial position.",
      "llm_answer": "\n\nCisco's guarantee of channel partner financing arrangements increases its credit loss exposure because if channel partners face financial instability and default on their obligations, Cisco may be required to make payments under these guarantees. As described in the financing receivables section (Note 1(g) to the Consolidated Financial Statements), Cisco facilitates third-party financing for channel partners and, in some cases, guarantees a portion of these arrangements. If partners fail to meet payment obligations due to financial distress, Cisco could incur losses by honoring these guarantees, thereby elevating its credit risk exposure. This risk is compounded by broader factors such as global credit market disruptions or economic downturns, which are highlighted in the Risk Factors section (Item 1A) as potential drivers of partner financial instability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Cisco's guarantee of channel partner financing increases credit loss exposure due to potential defaults, Cisco facilitates third-party financing with guarantees in some cases, and financial instability of partners could trigger Cisco's obligation to pay. These points are consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, time durations like 60–90 days) in the LLM answer, but the absence is not a deficiency since the LLM correctly reflects that such details exist in the filing without fabricating specifics. The original answer mentions 60–90 day payment terms, which the LLM omits, but this is a minor omission rather than an inaccuracy. (3) The multi-hop reasoning is sound: the LLM correctly links Cisco’s financing facilitation, its partial guarantees, partner financial instability, and the resulting credit risk, while also referencing relevant sections (Note 1(g) and Item 1A) to support the logic. (4) The answer is contextually fully relevant, directly addressing how guarantees affect credit loss exposure. The only reason for not scoring a 10 is the slight incompleteness in omitting the detail about Cisco’s existing allowance practices based on credit ratings and historical default rates, which adds depth to the risk assessment in the original. However, the core reasoning, entities, and implications are accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 414,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "Given Emerson's 55% ownership stake in AspenTech and the reported $1,093 million in total revenue from AspenTech for 2024, what portion of this revenue is proportionally attributable to Emerson's controlling interest, and how does this stake influence Emerson's overall software and control revenue of $5,399 million?",
      "original_answer": "Emerson's 55% ownership in AspenTech gives it control over a majority of AspenTech's revenue. With AspenTech generating $1,093 million in total revenue for 2024, Emerson's proportionally attributable share is $601.15 million (55% of $1,093 million). AspenTech's revenue is a component of Emerson’s broader 'Software and Control' segment, which reported $5,399 million in revenue for the year. This indicates that AspenTech contributes significantly to Emerson's software and control offerings, representing over 10% of that segment's revenue.",
      "llm_answer": "\n\nEmerson's 55% ownership stake in AspenTech entitles it to 55% of AspenTech's $1,093 million revenue, or **$591.15 million** (0.55 × $1,093 million). This stake influences Emerson's Software and Control revenue of $5,399 million because AspenTech is consolidated under Emerson's control, meaning the full $1,093 million is included in the Software and Control segment's total revenue. Thus, AspenTech's performance directly boosts the segment's reported revenue, with Emerson's proportional share reflected in consolidated earnings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a critical calculation error: 55% of $1,093 million is $601.15 million, not $591.15 million. This incorrect arithmetic undermines the quantitative accuracy. (2) The calculation should be: 0.55 × 1,093 = 601.15, but the model computes it as 591.15, which is off by $10 million. This is a significant factual error. (3) On reasoning: the model correctly identifies that Emerson's stake implies proportional economic interest and that AspenTech is part of the Software and Control segment. However, it incorrectly states that the *full* $1,093 million is included in Emerson's revenue due to consolidation, which contradicts the ground truth that only the proportional share is attributed in the context of the question. While consolidation practices may include full revenue in financial statements, the question specifically asks for the portion 'proportionally attributable' to Emerson's interest, which is 55%, not 100%. The model fails to align its explanation with the question’s focus on proportional attribution. (4) Despite the calculation error and flawed reasoning about consolidation, the model addresses all parts of the question and correctly contextualizes AspenTech within Emerson’s Software and Control segment. Hence, partial credit is given for structure and intent, but the factual and computational inaccuracies limit the score. Contextual relevance is high as the response stays focused on the entities and relationships in question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 406,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Pfizer's divestiture of Meridian and the Upjohn spin-off impact its overall cash position and financial restructuring in 2020 and 2021?",
      "original_answer": "Pfizer received $51 million in cash from the sale of Meridian in 2021 and recognized a $167 million loss from the transaction, which was recorded in Discontinued operations—net of tax. In contrast, the Upjohn spin-off in 2020 involved a much larger financial restructuring: Viatris paid Pfizer $12.0 billion in cash as part of the Reverse Morris Trust transaction, which Pfizer used to pay down commercial paper borrowings and redeem $1.492 billion in senior unsecured notes. The Upjohn transaction also resulted in Pfizer distributing $1.6 billion in net assets as part of the spin-off, including $412 million in cash transferred to the Upjohn Business. While the Meridian divestiture had a minimal cash inflow and a negative impact due to the loss, the Upjohn spin-off significantly affected Pfizer’s capital structure by reducing debt and providing a substantial cash infusion, illustrating a strategic shift toward focusing on core growth areas.",
      "llm_answer": "\n\nThe divestiture of Meridian and the Upjohn spin-off significantly impacted Pfizer's cash position and financial restructuring during 2020–2021. The **Upjohn spin-off in November 2020** generated **$12.0 billion in cash proceeds** from Viatris, which Pfizer used to pay down commercial paper borrowings and redeem $1.15 billion in 2021-due debt and $342 million in 2023-due debt, strengthening liquidity and reducing leverage. This transaction also resulted in a **$1.6 billion reduction in retained earnings** (non-cash) and eliminated Upjohn-related debt obligations. \n\nThe **Meridian sale in December 2021** contributed **$51 million in cash** but recognized a **$167 million after-tax loss**, reflecting a write-down of its carrying value. While the cash inflow was minor, the loss reduced 2021 net income. Collectively, these actions streamlined Pfizer’s portfolio, improved financial flexibility, and focused resources on core growth areas like innovation, with the Upjohn spin-off’s debt repayment directly enhancing the balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key financial impacts of both the Meridian divestiture and Upjohn spin-off, with accurate high-level synthesis and strategic context. However, there are minor quantitative inaccuracies that affect the quantitative accuracy score. Specifically: (1) The original answer states that Pfizer redeemed $1.492 billion in senior unsecured notes, but the LLM reports debt redemptions of $1.15 billion (2021-due) and $342 million (2023-due), summing to $1.492 billion—this total is correct, but the breakdown into maturities is not present in the ground truth and introduces unverified detail. (2) The LLM mentions a '$1.6 billion reduction in retained earnings' as a non-cash effect, while the ground truth states '$1.6 billion in net assets distributed', including $412 million in cash transferred—this is a material difference in interpretation: the original refers to asset distribution, not retained earnings impact, which is not explicitly mentioned in the ground truth. The cash amounts are correct: $12.0 billion from Viatris and $51 million from Meridian, and the $167 million after-tax loss from Meridian aligns with the original. The dates (November 2020 for Upjohn, December 2021 for Meridian) are accurate. The reasoning is sound in linking the Upjohn proceeds to debt reduction and improved liquidity, and the strategic focus on core growth areas is well-articulated. The answer addresses both transactions, their cash effects, and financial restructuring implications, satisfying completeness and contextual relevance. However, the mischaracterization of the $1.6 billion impact as a retained earnings reduction (rather than net assets distributed) is a notable qualitative deviation, though the overall direction of impact (balance sheet simplification, debt reduction) is correctly interpreted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 499,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022, combining both the Amended Settlement Agreement payment and the annual deposit, and how does this reflect the plan's role in managing litigation liabilities?",
      "original_answer": "Visa contributed a total of $1.45 billion under the U.S. Retrospective Responsibility Plan in 2022. This includes Visa's $600 million payment as part of the Amended Settlement Agreement and the company's annual deposit of $850 million under the plan. This demonstrates the plan's function in systematically funding potential litigation liabilities.",
      "llm_answer": "\n\nVisa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022 was **$983 million**, combining **$600 million** for the Amended Settlement Agreement (Visa's share of the $900 million total) and **$850 million** deposited into the U.S. litigation escrow account. After accounting for $467 million returned to the escrow account due to opt-out claims, the net contribution aligns with the $983 million provision for U.S. covered litigation. This reflects the plan's role in systematically funding settlements and maintaining escrow reserves to manage litigation liabilities, ensuring structured resolution of claims while mitigating the company's direct financial exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and calculation errors. The total contribution is stated as $983 million, but the ground truth is $1.45 billion. The LLM incorrectly introduces a 'net contribution' of $983 million after a $467 million return, which is not mentioned in the original answer and contradicts the total. The individual components—$600 million for the Amended Settlement Agreement and $850 million annual deposit—are correct, but their sum should be $1.45 billion, not $983 million. The subtraction of $467 million is unsupported and erroneous in this context. (2) Quantitative accuracy is severely compromised: $600M + $850M = $1.45B, not $983M. The introduction of an unverified 'return' amount distorts the calculation. (3) The reasoning is partially sound in identifying the two sources of contribution, but the synthesis fails due to the incorrect adjustment for opt-out claims, which is not part of the ground truth. The model adds extraneous, incorrect information that undermines the multi-hop logic. (4) Contextual relevance is fair because the answer addresses the U.S. Retrospective Responsibility Plan, litigation liabilities, and the two payment components, but the incorrect total and fabricated adjustment significantly reduce accuracy. The explanation of the plan’s role is reasonable but based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 378,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was the percentage change in the allocation to equity securities for the U.S. Retiree Health Care Plan between 2022 and 2023, and how did this shift affect the total value of equity securities in the plan by the end of 2023?",
      "original_answer": "The allocation to equity securities for the U.S. Retiree Health Care Plan decreased by 15 percentage points from 35% in 2022 to 20% in 2023. Despite this lower allocation percentage, the total value of equity securities in the plan increased slightly to $54 million by the end of 2023, as shown in the asset breakdown.",
      "llm_answer": "\n\nThe allocation to equity securities for the U.S. Retiree Health Care Plan decreased from 35% in 2022 to 20% in 2023, representing a **-42.86% change** (a 15 percentage point reduction). This shift reduced the total value of equity securities in the plan from **$98 million in 2022 to $54 million in 2023**, a decline of **$44 million**, as the lower allocation proportionally reduced equity holdings despite a slight decrease in total plan assets ($280 million to $264 million).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly identifies the percentage point decrease (from 35% to 20%, a 15 percentage point drop), it incorrectly calculates the percentage change as -42.86%, which is not what the question asks for—the question seeks the change in allocation percentage, not the relative percentage change in the allocation rate. More critically, the LLM claims the total value of equity securities decreased from $98 million in 2022 to $54 million in 2023, but the ground truth states that despite the lower allocation, the total value of equity securities *increased slightly* to $54 million by end of 2023. This implies the 2022 value was *less than $54 million*, contradicting the LLM's $98 million figure. The LLM also fabricates total plan asset values ($280M to $264M), which are not in the ground truth and lead to incorrect reasoning. (2) Number verification: Correct: 35% (2022), 20% (2023), $54M (2023 equity value). Incorrect: $98M (2022 equity value), $44M decline, total plan assets, and -42.86% relative change. (3) Multi-hop reasoning is flawed: The model incorrectly infers that a lower allocation must mean lower total value, failing to recognize that total plan assets could have changed in a way that still increased equity value even with lower allocation. The ground truth emphasizes this counterintuitive point, which the LLM misses entirely. (4) Scores are low due to major factual inaccuracies in key numbers and flawed logic, though the answer is contextually relevant in addressing the right plan and metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 437,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did the adoption of the CECL accounting standard influence the differences in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, and what specific capital component drove this difference?",
      "original_answer": "The adoption of the CECL accounting standard influenced the differences in total capital between the Advanced approaches and the Standardized approach due to variations in the amount permitted in Tier 2 capital related to the qualifying allowance for credit losses. Specifically, under the Standardized approach, total capital increased by $12.6 billion in 2023, partly due to an increase in the adjusted allowance for credit losses included in Tier 2 capital. This component is treated differently under the two approaches, contributing to the observed capital disparity.",
      "llm_answer": "\n\nThe adoption of the CECL accounting standard influenced the difference in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, by affecting the amount of **qualifying allowance for credit losses** permitted in Tier 2 capital. Under the Standardized approach, a larger portion of the allowance for credit losses ($12.92 billion) was included in Tier 2 capital compared to the Advanced approaches, which applied a reduction of $9.95 billion to this component. This discrepancy arose because CECL increased credit loss provisions, and regulatory rules allowed greater inclusion of these provisions in Tier 2 under the Standardized approach. The difference in permitted Tier 2 capital directly reduced total capital under the Advanced approaches by $9.95 billion relative to the Standardized approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core mechanism—the treatment of the qualifying allowance for credit losses in Tier 2 capital under CECL as the driver of capital differences between the Advanced and Standardized approaches. This aligns with the ground truth and shows accurate qualitative understanding. However, the quantitative details are inconsistent with the original answer. The ground truth states that total capital under the Standardized approach increased by $12.6 billion due to the adjusted allowance for credit losses, but does not specify the $12.92 billion figure for Standardized or $9.95 billion reduction for Advanced approaches. These precise numbers are not present in the ground truth and appear to be fabricated or misattributed. (2) The original answer does not provide a side-by-side comparison of $12.92B vs $9.95B or state a $9.95B reduction in Advanced approaches—these are specific inaccuracies. There is also no mention of a 'reduction' in the Advanced approaches, only that the Standardized approach saw an increase due to inclusion in Tier 2. The LLM introduces unsupported specifics. (3) The multi-hop reasoning is logically sound—connecting CECL adoption to differential regulatory treatment of allowances in Tier 2 capital across frameworks—but extends beyond the provided data with unverified figures. It synthesizes the concept correctly but adds granular data not present in the source. (4) The contextual relevance is high because the answer addresses both parts of the question: the influence of CECL and the specific capital component. The qualitative accuracy is good due to correct identification of Tier 2 and the allowance for credit losses as the key factor. However, the correctness score is reduced to 6 due to significant quantitative inaccuracies, which undermine trust in the financial analysis. Minor wording differences would be acceptable, but invented figures violate factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 529,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Using the midpoint of the stated percentage ranges for each plan, what weighted average percentage allocation to Fixed Income Securities and Cash Equivalents should be applied across all defined benefit and retiree health care plans based on their respective total asset values as reported?",
      "original_answer": "The weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all plans is approximately 72.3%, calculated using the midpoints of the percentage ranges and the total asset values for each plan.",
      "llm_answer": "\n\nThe weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all defined benefit and retiree health care plans, using the midpoint of the target ranges and total asset values as of December 31, 2023, is **78.8%**. This is calculated by applying the midpoint allocations (U.S. Defined Benefit: 72.5%, U.S. Retiree Health Care: 80%, Non-U.S. Defined Benefit: 80%) to their respective total assets ($418M, $264M, $1,866M) and weighting accordingly.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final calculated weighted average (78.8% vs. ground truth 72.3%), despite correctly identifying the need to use midpoints and weight by total asset values. The individual midpoint percentages provided (U.S. Defined Benefit: 72.5%, U.S. Retiree Health Care: 80%, Non-U.S. Defined Benefit: 80%) may be accurate, but the final weighted calculation does not match the correct result based on the asset weights. (2) The total asset values cited ($418M, $264M, $1,866M) appear to be consistent with the knowledge graph, but the weighted average computation is flawed. Correct calculation: (418*72.5 + 264*80 + 1866*80) / (418+264+1866) = (30305 + 21120 + 149280) / 2548 = 200705 / 2548 ≈ 78.77%, which matches the LLM's 78.8%. However, this contradicts the ground truth of 72.3%, suggesting either incorrect midpoints or asset values in the LLM response. Since the ground truth is 72.3%, the LLM's inputs or calculations must be wrong. (3) The multi-hop reasoning structure is sound—using midpoints, applying weights by asset value, and aggregating across plans—but the underlying data or arithmetic does not yield the correct result. (4) Scores reflect major quantitative inaccuracy (3/10), partially correct reasoning (4/10), and high relevance to the question (9/10), but the final answer is significantly off from the verified truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 386,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the implementation of Basel 3 capital calculations influence the composition and risk profile of Bank of America's covered trading positions as reflected in its Value at Risk (VaR) metrics?",
      "original_answer": "Basel 3 capital calculations require Bank of America to maintain specific capital ratios, including a capital conservation buffer of 2.5% and a stress capital buffer of 2.5% at December 31, 2023. These regulatory requirements influence the Corporation’s risk appetite and capital allocation decisions, particularly in its Global Markets segment, which holds the majority of the market-based portfolio. As a result, the Corporation manages its covered trading positions—such as foreign exchange and commodity positions—under Basel 3 guidelines, which directly affect the risk profile and VaR metrics of these positions. In 2023, the annual average of total covered positions and less liquid trading positions portfolio VaR decreased compared to 2022, primarily due to the roll off of March 2020 market volatility from the historical data window used in the VaR model calibration, aligning with the Basel 3 capital framework.",
      "llm_answer": "\n\nThe implementation of Basel 3 capital calculations influences Bank of America's covered trading positions and Value at Risk (VaR) metrics by shaping the composition and risk profile of its trading portfolio to meet regulatory capital adequacy requirements. As an Advanced approaches institution, the Corporation employs sophisticated models to calculate risk-weighted assets (RWAs), resulting in lower RWAs under the Advanced approach ($1,459 billion in 2023) compared to the Standardized approach ($1,651 billion). This allows for higher capital ratios (e.g., 13.4% CET1 under Advanced vs. 11.8% under Standardized), enabling the bank to maintain a more optimized portfolio structure. \n\nBasel 3's emphasis on liquidity and risk-based capital requirements likely drives Bank of America to prioritize liquid, short-term covered positions (e.g., foreign exchange and commodities, which are always classified as covered) and reduce exposure to less liquid or higher-risk assets. This aligns with the observed decrease in VaR for covered positions and less liquid trading portfolios in 2023 compared to 2022, partly due to reduced historical volatility from the March 2020 market stress period rolling out of the VaR model's historical data window. The bank’s VaR metrics reflect a lower-risk profile, as Basel 3 compliance incentivizes holding assets with lower risk weights and diversification benefits, thereby mitigating potential losses and ensuring capital adequacy under stress scenarios.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the influence of Basel 3 on Bank of America's capital structure and risk profile, particularly in the Global Markets segment, and links this to covered trading positions and VaR metrics. (2) Quantitatively, the LLM provides correct figures for risk-weighted assets under the Advanced ($1,459 billion) and Standardized ($1,651 billion) approaches in 2023, and accurately reports the CET1 ratios (13.4% vs 11.8%), which are consistent with the 2023 filing data. These numbers are not in the original answer but are factually correct and contextually relevant, enhancing the explanation without contradicting the ground truth. (3) The reasoning is sound: it correctly explains how Basel 3 incentivizes lower-risk, more liquid positions, and ties the decrease in VaR from 2022 to 2023 to the roll-off of March 2020 volatility in the historical window—this key point is present in both answers. (4) The LLM adds value by explaining the Advanced vs Standardized approach impact, which is not in the original answer but is a valid and important aspect of Basel 3 implementation. The only minor limitation is that it does not explicitly mention the 2.5% capital conservation buffer and 2.5% stress capital buffer at year-end 2023, which are part of the ground truth. However, the broader capital adequacy context is well-covered. Overall, the answer demonstrates strong multi-hop reasoning, correct entity identification (Bank of America, Basel 3, covered trading positions, VaR), and semantic equivalence with added depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1617,
        "completion_tokens": 440,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "What is the total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express, and how does this compare to the amount of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance?",
      "original_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is $1.8 billion. This compares to the $5.8 billion of outstanding debt eliminated through redemptions paid using proceeds from the $3.25 billion senior unsecured debt issuance, which also included $393 million in associated redemption premiums.",
      "llm_answer": "\n\nThe total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is **$1.8 billion** (as stated in Note 7 of the consolidated financial statements). This compares to **$5.8 billion** of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance in 2021 (also detailed in Note 7). Thus, the amount of debt eliminated ($5.8 billion) significantly exceeds the net book value of the aircraft ($1.8 billion).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects. The total net book value of the 19 Boeing aircraft is correctly stated as $1.8 billion, and the $5.8 billion debt eliminated through redemptions is also accurate. The mention of the senior unsecured debt issuance aligns with the context, though the LLM does not explicitly note the $3.25 billion issuance amount or the $393 million redemption premiums included in the $5.8 billion total. While this is a minor omission, it does not detract significantly from the correctness of the core comparison asked in the question. The reasoning is sound, clearly comparing the $5.8 billion debt eliminated to the $1.8 billion asset value, and the multi-hop synthesis (linking aircraft value to debt redemption via financing activities) is logically presented. The answer is contextually relevant and conveys the essential comparison accurately. The only reason for not awarding a perfect 10 is the omission of the redemption premium and issuance size details, which are part of the full picture but not central to the primary question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 316,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How much did TI contribute to U.S. defined contribution plans in 2023, and what is notable about the investment of plan assets in TI common stock for the retiree health care benefit plan?",
      "original_answer": "TI contributed $75 million to U.S. defined contribution plans in 2023. Notably, none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock.",
      "llm_answer": "\n\nTI contributed **$75 million** to its U.S. defined contribution plans in 2023. Notably, the document states that **none of the plan assets related to the U.S. retiree health care benefit plan are directly invested in TI common stock**, indicating a deliberate avoidance of such direct equity holdings in this specific retirement benefit plan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that TI contributed $75 million to U.S. defined contribution plans in 2023, which matches the ground truth exactly. The second part accurately notes that none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock, preserving the key factual nuance. (2) The dollar amount ($75 million) and year (2023) are factually correct with no calculation required. Format is consistent and clear. (3) The reasoning is sound and reflects proper synthesis: the answer distinguishes between the defined contribution plans (where the contribution is reported) and the retiree health care benefit plan (where investment in company stock is addressed), correctly attributing the lack of direct investment in TI stock to the latter. This shows accurate multi-hop understanding across different plan types. (4) All scores are 10 because the answer is factually precise, complete, contextually appropriate, and semantically equivalent to the ground truth, with no omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 307,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "Apple's 10-K filing emphasizes its strategic focus on services as a key growth area. Given that Services revenue increased from $85.2 billion in 2023 to $96.169 billion in 2024, and total net sales rose from $383.285 billion in 2023 to $391.035 billion in 2024, what percentage of the total net sales growth between 2023 and 2024 was attributable to the increase in Services revenue?",
      "original_answer": "The increase in Services revenue contributed approximately 121% of the total net sales growth between 2023 and 2024. This is calculated as follows: Services revenue increased by $10.969 billion ($96.169B - $85.2B), while total net sales increased by $7.75 billion ($391.035B - $383.285B). Therefore, the Services growth alone accounted for $10.969B / $7.75B = 121% of the total net sales growth.",
      "llm_answer": "\n\nThe increase in Services revenue contributed **141.5%** to Apple's total net sales growth between 2023 and 2024. This was calculated by dividing the $10.969 billion growth in Services revenue ($96.169B - $85.2B) by the $7.75 billion total net sales growth ($391.035B - $383.285B), resulting in a ratio of 1.415 (or 141.5%). Despite total sales growth being driven by Services, declines in other segments (e.g., iPad and Wearables) offset part of the Services expansion.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final percentage. The correct percentage is 121%, not 141.5%. The LLM incorrectly calculated $10.969B / $7.75B as 1.415 (141.5%), when the correct result is approximately 1.415 → 141.5% only if the division were $10.969 / $7.75 ≈ 1.415, but in reality, $10.969 / $7.75 = 1.415 → 141.5% is mathematically correct *if* those numbers were used, but the ground truth states the correct percentage is 121%, indicating a discrepancy in the source numbers. However, recalculating with the provided numbers: $96.169B - $85.2B = $10.969B (correct), $391.035B - $383.285B = $7.75B (correct), and $10.969 / $7.75 = 1.415 → 141.5%. This contradicts the original answer’s claim of 121%. Upon verification, 10.969 / 7.75 = 1.415 → 141.5% is mathematically accurate. Therefore, the original answer (ground truth) appears to be incorrect, but since the evaluation must be based on alignment with the provided ground truth, the LLM is marked wrong despite being mathematically correct. However, this creates a conflict. Rechecking: 10.969 / 7.75 = 1.415 → 141.5%, so the LLM's calculation is correct. The ground truth says '121%', which is wrong. But per evaluation instructions, the LLM must match the original answer (ground truth). Since it does not, it is scored as incorrect. (2) All input numbers are correctly used: $10.969B and $7.75B are accurate. The calculation is correct, but the expected answer is not. (3) The reasoning is sound: the LLM correctly identifies the Services growth, total sales growth, and computes the contribution ratio. It even adds contextual insight about declines in other segments, which explains why Services growth exceeds total growth. (4) Despite being mathematically correct and logically sound, the LLM does not match the ground truth percentage (121% vs 141.5%), so correctness and quantitative accuracy are severely penalized. However, this suggests a potential error in the ground truth. Given the instructions to align with the provided ground truth, the LLM is deemed incorrect. Final scores reflect this mismatch, though the LLM's answer is actually more accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 577,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "What is the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months, and how does the existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 contribute to the uncertainty surrounding these tax positions?",
      "original_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million. This uncertainty is influenced by the fact that the IRS has issued Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015, which Pfizer is currently appealing. These RARs represent formal audit findings that the company disputes, contributing to the ongoing uncertainty in tax positions and the potential for significant changes in unrecognized tax benefits.",
      "llm_answer": "\n\nThe estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is **$75 million**, primarily due to settlements with taxing authorities or expirations of statutes of limitations. The existence of IRS Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 contributes to uncertainty because Pfizer disputes these RARs and is appealing certain issues, while overlapping audits (e.g., 2016–2018 currently under audit) and complex legal proceedings make it difficult to predict outcomes or timing. These unresolved disputes increase the risk of significant adjustments to unrecognized tax benefits upon final resolution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits as $75 million, matching the ground truth exactly. All numeric values and time periods (tax years 2011–2013, 2014–2015) are accurate. (2) Quantitative accuracy is perfect—$75 million is correctly stated, and no calculations are required beyond this figure. Format is consistent and precise. (3) The reasoning is sound and adds contextual depth: the LLM accurately explains that the RARs contribute to uncertainty because Pfizer is appealing them, which aligns with the ground truth. It also enhances the explanation by noting overlapping audits (e.g., 2016–2018) and legal complexity, which, while not in the original answer, are plausible and contextually appropriate extensions that do not contradict the ground truth. (4) The answer is fully relevant and addresses both parts of the multi-hop question: the quantitative impact ($75M decrease) and the qualitative role of RARs in creating uncertainty. The only reason for not scoring a 10 is that the original answer emphasizes the RARs as the core source of uncertainty, while the LLM slightly broadens it with additional audit periods; this is not incorrect but represents a minor shift in emphasis. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 386,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the five-year transition period related to the adoption of the CECL accounting standard impact the calculation of BAC's TLAC ratios and CET1 capital as of December 31, 2023?",
      "original_answer": "The five-year transition period related to the adoption of the CECL accounting standard impacts the calculation of BAC's TLAC ratios by allowing the use of the regulatory capital rule that predates CECL, which affects how capital is measured and reported. As of December 31, 2023, BAC's CET1 capital was $194.9 billion, an increase of $14.9 billion from the prior year, influenced in part by the CECL transition's effect on capital calculations.",
      "llm_answer": "\n\nThe five-year transition period for CECL adoption impacts BAC's CET1 capital and TLAC ratios by gradually phasing out a transitional add-back to CET1 capital. As of December 31, 2023, the CECL transitional amount (a component of CET1) decreased to $1.25 billion from $1.88 billion in 2022, reflecting 50% and 75% of the transition provision's impact as of December 31, 2021, respectively. This reduction lowers CET1 capital, which directly affects CET1-based ratios (e.g., CET1 capital ratio of 11.8% under the Standardized approach in 2023). For TLAC ratios, which include Tier 1 capital (encompassing CET1), the phased reduction in CET1 slightly diminishes the numerator in TLAC calculations, though BAC’s TLAC ratios (29.0% of RWA in 2023) remained well above regulatory minima. The transition period thus softens the immediate CECL-related capital reduction, spreading its impact over five years.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer provides a generally accurate and well-reasoned explanation of how the CECL five-year transition impacts BAC's CET1 capital and TLAC ratios, with correct qualitative logic and contextual relevance. However, there are key quantitative discrepancies when compared to the ground truth. The original answer states that BAC's CET1 capital as of December 31, 2023, was $194.9 billion, an increase of $14.9 billion from the prior year, influenced by the CECL transition. The LLM answer does not mention this total CET1 capital figure or the year-over-year increase, instead focusing on the CECL transitional add-back decreasing from $1.88B to $1.25B. While this detail about the transitional amount may be factually accurate in context, it is not present in the ground truth and introduces specific numbers not supported by the provided answer. Additionally, the LLM cites a CET1 ratio of 11.8% and TLAC ratio of 29.0% of RWA in 2023—specific metrics absent from the original answer. These additions, while plausible, go beyond the verified facts. The reasoning about the phased impact of CECL on CET1 and its flow into TLAC is sound and correctly reflects the multi-hop nature of the question (linking CECL transition → CET1 → TLAC). The answer is semantically aligned in terms of mechanism but diverges in specific data points, reducing quantitative accuracy. The core impact—CECL transition softening capital reduction over five years—is correctly conveyed, warranting a solid score on qualitative and contextual dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 420,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How do the implementation dates and fuel surcharge adjustment mechanisms differ between FedEx Ground and FedEx Freight in response to fluctuating fuel prices?",
      "original_answer": "FedEx Ground adjusts its fuel surcharge on a weekly basis using fuel price data from two weeks prior, with updates to the fuel surcharge tables occurring on June 21, 2021, November 1, 2021, and April 4, 2022. FedEx Freight, on the other hand, adjusts its fuel surcharge weekly using fuel price data from two days prior, with updates to the fuel surcharge tables occurring on November 1, 2021, and April 4, 2022. These differences in timing and data lag reflect how each segment tailors its fuel surcharge mechanism to address fuel cost fluctuations.",
      "llm_answer": "\n\nFedEx Ground and FedEx Freight both use indexed fuel surcharges adjusted weekly, but differ in implementation dates and fuel price lag periods. **FedEx Ground** bases its surcharge on the fuel price from **two weeks prior** to the assessment week, with surcharge tables updated on **June 21, 2021, November 1, 2021, and April 4, 2022**. **FedEx Freight** uses a fuel price from **two days prior** to the assessment date, with surcharge tables updated only on **November 1, 2021, and April 4, 2022** (missing the June 21, 2021 update). This results in a longer lag for FedEx Ground (14 days vs. 2 days) and an earlier implementation of updated fuel surcharge tables for FedEx Ground in June 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: FedEx Ground uses a two-week (14-day) lag in fuel price data with surcharge updates on June 21, 2021, November 1, 2021, and April 4, 2022; FedEx Freight uses a two-day lag with updates only on November 1, 2021, and April 4, 2022. The statement that FedEx Ground had an earlier implementation (June 2021) is accurate and correctly contrasts the two. (2) All dates and time lags are factually correct and match the ground truth exactly. There are no calculation errors. Format variations are not an issue here as dates and time periods are clearly and correctly stated. (3) The multi-hop reasoning is sound—LLM correctly synthesizes timing differences and implementation dates across the two FedEx segments. The observation about the June 21, 2021 update being unique to FedEx Ground is accurate and adds useful comparative insight. (4) The only reason for not scoring a 10 is a minor omission in phrasing: the original answer notes that both companies update weekly, which the LLM mentions, but the emphasis on 'weekly' updates could have been more explicitly tied to both mechanisms. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent, highly accurate, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 364,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the reorganization of the Ventilator Product Line impact the reporting structure of MDT's Medical Surgical segment in fiscal year 2023, and what does this indicate about the strategic positioning of the retained Acute Care & Monitoring business?",
      "original_answer": "The Ventilator Product Line was moved out of the Medical Surgical segment and into the 'Other' line as part of a reorganization. This reorganization also involved the Renal Care Solutions business and led to the formation of a new unit called Acute Care & Monitoring within Medical Surgical, which combined retained PMRI businesses. This indicates a strategic refocusing of the Medical Surgical segment around core PMRI capabilities, while separating out businesses either being exited or transitioned.",
      "llm_answer": "\n\nThe reorganization of the Ventilator Product Line in fiscal year 2023 involved moving its operations out of the Medical Surgical segment into the \"Other\" category, alongside the Renal Care Solutions business. This adjustment, reflected in recast prior-period financials, streamlined the Medical Surgical segment’s reporting structure by excluding non-core businesses. The retained PMRI businesses were consolidated into a new Acute Care & Monitoring unit within Medical Surgical. This strategic move signals Medtronic’s focus on strengthening its core acute care offerings, emphasizing operational efficiency, and aligning resources with higher-growth or strategically critical areas, as evidenced by the deliberate restructuring to highlight Acute Care & Monitoring as a distinct, integrated business unit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the Ventilator Product Line was moved to the 'Other' category, along with Renal Care Solutions; the retained PMRI businesses were consolidated into a new Acute Care & Monitoring unit within the Medical Surgical segment. These changes occurred in fiscal year 2023, and prior periods were recast, which is consistent with the reorganization. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct mention of fiscal year 2023, which is accurate. (3) The multi-hop reasoning is sound: the model correctly infers that removing non-core businesses (ventilators, renal care) and forming a new unit indicates a strategic refocusing on core PMRI and acute care capabilities. The interpretation about operational efficiency and alignment with higher-growth areas is a reasonable extension of the ground truth's statement about strategic refocusing. (4) The only minor gap is that the LLM slightly expands on the implication by mentioning 'higher-growth or strategically critical areas' and 'operational efficiency'—while logically sound, these phrases go slightly beyond the original answer’s more conservative conclusion about refocusing around core PMRI and separating exited/transitioned businesses. However, this does not constitute an error, just a small interpretive addition. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 424,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "What was the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over the fiscal years 2022 and 2023, based on the amounts disclosed in both tables?",
      "original_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over fiscal years 2022 and 2023 was $252 million.",
      "llm_answer": "\n\nThe total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes for fiscal years 2022 and 2023 was **$252 million**. Specifically, the expenses were **$102 million in 2022** and **$150 million in 2023**, as disclosed in the \"Medical device regulations\" line item within the GAAP-to-Non-GAAP reconciliations and segment operating profit tables.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total financial impact of $252 million is correctly stated, with the breakdown of $102 million in 2022 and $150 million in 2023, which sum to the correct total. (2) Quantitative accuracy is perfect: both individual year amounts and the total are correct, and the calculation (102 + 150 = 252) is accurate. (3) The multi-hop reasoning is sound— the model correctly identified the relevant line item (Medical device regulations) across the specified tables (GAAP-to-Non-GAAP reconciliations and segment operating profit tables) and synthesized data from two fiscal years. (4) Entity accuracy is confirmed: Medtronic is the correct company, fiscal years 2022 and 2023 are correctly referenced, and the financial metric (impact on income before income taxes) is properly interpreted. The answer is semantically equivalent to the original and provides additional context without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 287,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How many different forms of Long-Term Incentive Restricted Stock Units, including both U.S. and International versions, are disclosed in Boeing's 2023 10-Q filings?",
      "original_answer": "Boeing disclosed four different forms of Long-Term Incentive Restricted Stock Units in their 2023 10-Q filings. These include: (1) U.S. Long-Term Incentive Restricted Stock Units (Exhibit 10.3), (2) U.S. Long-Term Incentive Performance Restricted Stock Units (Exhibit 10.5), (3) International Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.4), and (4) International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled) (Exhibit 10.6).",
      "llm_answer": "\n\nBoeing's 2023 10-Q filings disclose **six distinct forms** of Long-Term Incentive Restricted Stock Units (RSUs), including both U.S. and International versions. These include:  \n1. U.S. Long-Term Incentive RSUs (for CEO)  \n2. U.S. Long-Term Incentive Performance RSUs (for CEO)  \n3. U.S. Long-Term Incentive RSUs (general)  \n4. International Long-Term Incentive RSUs (Stock-Settled)  \n5. U.S. Long-Term Incentive Performance RSUs (general)  \n6. International Long-Term Incentive Performance RSUs (Stock-Settled).  \n\nThese forms are detailed in exhibits 10.32 through 10.37 of the 10-Q filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that Boeing disclosed six distinct forms of Long-Term Incentive Restricted Stock Units in its 2023 10-Q filings, but the ground truth confirms only four. This is a major factual error in both quantity and composition. The LLM incorrectly adds two extra forms: 'U.S. Long-Term Incentive RSUs (for CEO)' and 'U.S. Long-Term Incentive RSUs (general)', which are not listed in the ground truth. Additionally, the LLM references exhibits 10.32 through 10.37, which do not align with the actual exhibits cited in the original answer (Exhibits 10.3, 10.4, 10.5, and 10.6). (2) Quantitative accuracy is low: the number 'six' is incorrect versus the correct count of 'four'. The exhibit numbers are also factually wrong—10.32–10.37 are not valid in this context, especially for a 10-Q filing, which typically includes only a few key exhibits. (3) The reasoning is flawed: the model fails to correctly synthesize the disclosed forms from the actual filings. It introduces distinctions (e.g., 'for CEO' and 'general') that are not supported by the ground truth, suggesting a misinterpretation or fabrication of categories. The multi-hop requirement—identifying and categorizing disclosed RSU types from specific exhibits—was not met. (4) Contextual relevance is moderate because the answer addresses the right topic (types of RSUs in Boeing’s 10-Q) and correctly identifies some valid forms (e.g., International Stock-Settled variants), but the overall response is undermined by significant inaccuracies in count, naming, and exhibit references. Minor flexibility is allowed in naming, but not in inventing forms or exhibits.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 451,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "Given Apple's reliance on third-party developers and digital content providers for its product ecosystem, and considering the 12.9% year-over-year growth in Services revenue from 2022 to 2023, how might ongoing challenges in securing third-party software and content affect the sustainability of this growth trajectory for services like Apple Music?",
      "original_answer": "Apple's Services revenue grew from $78,129 million in 2022 to $85,200 million in 2023, representing a 12.9% increase. This growth includes revenue from services like Apple Music. However, the company's own disclosures indicate that its ability to maintain and grow this revenue depends on continued access to third-party software applications and digital content. Specifically, if developers choose not to maintain or update their applications due to Apple's minority market share or changes in App Store policies, or if content providers restrict access or raise costs, the attractiveness and functionality of Apple Music and other services could be compromised. This could lead to customer dissatisfaction and reduced demand, directly threatening the sustainability of the 12.9% growth rate seen in Services revenue.",
      "llm_answer": "\n\nOngoing challenges in securing third-party software and content could hinder the sustainability of Apple's Services revenue growth, including Apple Music, by reducing the availability and quality of digital offerings. The 10-K highlights that Apple relies on third-party developers and content providers for its ecosystem, and its minority market share in key hardware categories may incentivize developers to prioritize competitors like Android and Windows. This could lead to fewer or lower-quality apps and content for Apple platforms. Additionally, short-term licensing agreements for digital content (e.g., music, apps) may not be renewed on favorable terms, increasing costs or limiting access to critical content. Quality issues or outages in third-party software or content could also degrade user experiences, harming customer retention and subscription growth. These risks, combined with potential regulatory or operational disruptions in Apple's supply of digital services, could undermine the 12.9% year-over-year growth trajectory for Services revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Apple's Services revenue growth of 12.9% from 2022 to 2023 is correctly referenced in context, and while the exact dollar figures ($78,129M to $85,200M) are not quoted, the percentage growth is accurate and central to the analysis. No incorrect numbers or calculations are present. (2) The answer addresses all parts of the multi-hop question: it acknowledges Apple's reliance on third-party developers/content, the 12.9% growth in Services revenue, and evaluates how challenges in securing third-party software/content could threaten the sustainability of that growth, particularly for Apple Music. (3) Entity accuracy is strong: Apple, Apple Music, Services revenue, third-party developers, and content providers are all correctly identified and contextualized. The reasoning is sound and reflects multi-hop synthesis—linking ecosystem dependency, developer incentives (due to minority market share), licensing risks, and user experience impacts to the sustainability of revenue growth. (4) The LLM adds valuable context not explicitly in the ground truth, such as short-term licensing risks and platform competition (Android/Windows), which are reasonable inferences from Apple’s 10-K disclosures. The only minor gap is the absence of explicit mention that Apple’s own disclosures directly tie growth sustainability to third-party access—though this is implied. Overall, the answer is factually correct, logically structured, and semantically equivalent to the original, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 437,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do MetLife's cash buffer needs, as influenced by reinsurance and derivative counterparty risks, affect its ability to manage liquidity under stress scenarios, particularly in light of the $12.4 billion short-term liquidity position at the end of 2021?",
      "original_answer": "MetLife maintains a $12.4 billion short-term liquidity position as of December 31, 2021, to manage business requirements under current and stress market conditions. However, its cash buffer needs are influenced by exposure to reinsurance and derivative counterparties, where failure to pay guaranteed benefits could result in liquidity strain. Although these agreements are largely collateralized and subject to netting agreements, which reduce counterparty risk, the potential ineffectiveness of hedging strategies or unexpected policyholder behavior combined with market volatility could exceed the risk management framework. This dynamic directly ties MetLife's cash buffer needs (as a capital risk factor) to its liquidity management strategy, where the $12.4 billion short-term liquidity buffer serves as a safeguard against such risks.",
      "llm_answer": "\n\nMetLife's cash buffer needs, influenced by reinsurance and derivative counterparty risks, are mitigated by its robust $12.4 billion short-term liquidity position as of December 31, 2021. The company employs collateralized reinsurance agreements and derivative positions subject to master netting agreements, which reduce exposure to counterparty defaults. However, stress scenarios could necessitate increased cash buffers to cover potential liabilities if reinsurers or counterparties fail, potentially straining liquidity. MetLife's liquidity management strategies, including dynamic hedging and monitoring, aim to balance these risks while maintaining sufficient reserves to meet obligations under adverse conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $12.4 billion short-term liquidity position as of December 31, 2021, is correctly stated, matching the original answer exactly. No calculations are required, and the date and amount are precise. (2) The answer correctly identifies that reinsurance and derivative counterparty risks influence cash buffer needs and acknowledges that these exposures are mitigated through collateralization and netting agreements—key points from the ground truth. (3) The reasoning is sound: it explains that counterparty defaults under stress could increase cash buffer demands and potentially strain liquidity, which ties directly to MetLife’s liquidity management strategy. It also references dynamic hedging and monitoring as part of risk mitigation, consistent with the original answer’s emphasis on hedging effectiveness and stress resilience. (4) The only minor gap is that the LLM answer does not explicitly mention 'unexpected policyholder behavior' or the possibility that risks could 'exceed the risk management framework,' which are important nuances in the original answer regarding the limits of current controls. However, the core multi-hop synthesis—linking reinsurance/derivative risks to cash buffer needs, and evaluating them in the context of the $12.4B liquidity position under stress—is fully present and logically structured. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to the slight omission of edge-case vulnerabilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 457,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What is the total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, and how are these securities classified on the balance sheet according to the 2023 10-K filing?",
      "original_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is $33 million, and these securities are classified under 'Other Assets' on the balance sheet.",
      "llm_answer": "\n\nThe total fair value of Level 3 auction rate securities held by Medtronic (MDT) as of April 26, 2024, is **$33 million**. These securities are classified as **Other Assets** on the consolidated balance sheet, as disclosed in the \"Debt Securities\" section of the 2023 10-K filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total fair value of Level 3 auction rate securities as $33 million, which matches the ground truth. The classification of these securities under 'Other Assets' on the balance sheet is also accurate. (2) The numeric value ($33 million) and date (April 26, 2024) are factually correct and match the original answer; no calculations were required, but the value is precisely reported. (3) The reasoning is sound and reflects proper synthesis from the 2023 10-K filing, correctly linking MDT (Medtronic) to the disclosure in the 'Debt Securities' section, demonstrating accurate multi-hop understanding across entity, financial instrument, and balance sheet classification. (4) The answer is fully complete, addressing both parts of the question—value and classification—with correct entities, metrics, and context. Wording enhancements (e.g., bold formatting, mention of 'consolidated balance sheet') add clarity without altering meaning, maintaining semantic equivalence. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 311,
        "total_tokens": 1439
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact the recognition and measurement of credit losses on mortgage loans and fixed maturity securities AFS, based on the impairment losses reported for 2019 and the ACL methodologies described?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition and measurement of credit losses from an incurred loss model to an expected lifetime credit loss model. For fixed maturity securities AFS, the impairment (loss) for foreign government, consumer corporate, industrial corporate, RMBS, and finance corporate securities in 2019 were ($81) million, ($23) million, ($22) million, ($2) million, and ($1) million, respectively, under the prior OTTI model. After adoption, impairment (loss) was comprised of intent-to-sell and direct write-down losses, rather than OTTI and intent-to-sell losses. For mortgage loans, the ACL is now established based on expected lifetime credit losses over the contractual term, adjusted for expected prepayments and extensions, incorporating past events, current conditions, and forecasted economic conditions. This represents a shift from the previous model where credit loss was recognized only when it was probable that all amounts due would not be collected.",
      "llm_answer": "\n\nThe adoption of the credit loss guidance on January 1, 2020, shifted the recognition and measurement of credit losses from a reactive, event-driven model to a forward-looking, expected loss model for both mortgage loans and fixed maturity securities AFS. For **fixed maturity securities AFS**, prior to 2020, credit losses were recognized under the \"other-than-temporary impairment\" (OTTI) model only when recovery of amortized cost was unlikely (e.g., $129 million in 2019 impairment losses). Under the new guidance, credit losses are estimated using discounted cash flow analyses and recorded as an **allowance for credit losses (ACL)**, reflecting expected lifetime losses based on current and forecasted economic conditions. This resulted in a $91 million ACL release in 2020 (vs. no ACL in 2019), indicating earlier recognition of credit losses.  \n\nFor **mortgage loans**, the shift from the \"incurred loss\" model (recognizing losses when collection became probable) to the ACL model (estimating expected lifetime losses) led to a $213 million credit loss provision in 2020 (vs. $11 million impairment in 2019). The ACL methodology incorporates forecasts of prepayments, economic downturns, and collateral values, resulting in more proactive loss recognition. Both changes reflect a more conservative, forward-looking approach to credit risk, aligning with the guidance’s emphasis on anticipating losses rather than waiting for them to materialize.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct conceptual shift from an incurred loss model to an expected lifetime credit loss model for both fixed maturity securities AFS and mortgage loans, which aligns with the ground truth and shows good contextual understanding. However, there are significant quantitative inaccuracies that undermine the correctness. The original answer specifies exact 2019 impairment losses for fixed maturity securities AFS by category: ($81M, $23M, $22M, $2M, $1M), totaling $129M, which the LLM correctly sums as $129 million — this is accurate. However, the LLM introduces a '$91 million ACL release in 2020' and '$213 million credit loss provision in 2020' that are not present in the ground truth and cannot be verified from the provided data. The original answer does not report any ACL amounts or provisions for 2020, so these figures are fabricated or inferred incorrectly. Additionally, the ground truth explains a change in composition of impairment losses (intent-to-sell and direct write-down vs. OTTI), which the LLM omits. For mortgage loans, the shift in ACL methodology is correctly described in qualitative terms (incorporating forecasts, prepayments, economic conditions), but the $213M vs $11M comparison is unsupported by the original answer, which does not provide 2019 or 2020 loss amounts for mortgage loans. Thus, while the reasoning framework is sound and the direction of change is correctly interpreted, the inclusion of unverified numerical claims significantly reduces factual accuracy. The model synthesizes the multi-hop concept (change in accounting standard → impact on two asset types) well, but fails on precise data reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1648,
        "completion_tokens": 455,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does Lockheed Martin's obligation to provide consulting support under international offset agreements impact its ability to recover costs on U.S. government contractual commitments in 2024?",
      "original_answer": "Lockheed Martin's international offset agreements, which may include obligations to provide consulting support to in-country projects, require cash outlays and investments that are often outside the company’s control, such as those tied to joint ventures. These investments are only recoverable if the joint ventures operate successfully. Simultaneously, Lockheed Martin has $64.3 billion in purchase obligations related to U.S. government contracts, where cost recovery is only guaranteed if the government terminates the contract for convenience under the FAR. Therefore, if Lockheed Martin incurs significant costs fulfilling consulting support obligations under offset agreements but cannot recover those costs through successful joint ventures or offset reimbursements, it may not be able to recover those expenses under U.S. government contracts unless those contracts are terminated for convenience. This creates a financial risk in cost recovery when international obligations do not align with domestic reimbursement mechanisms.",
      "llm_answer": "\n\nLockheed Martin's obligations under international offset agreements, such as providing consulting support, may strain its financial and operational resources, potentially impacting its ability to recover costs on U.S. government contracts in 2024. These agreements require significant commitments (e.g., cash outlays, technology transfers, or in-country investments) that could divert resources from U.S. government programs. While U.S. government contracts generally allow cost recovery if terminated for convenience, offset obligations are separate and often involve non-recoverable expenses, particularly if joint ventures or third-party dependencies fail. Additionally, penalties for non-compliance with offset agreements (estimated at $2.1 billion in potential penalties as of 2024) could further reduce liquidity, indirectly affecting cost recovery on domestic contracts. The company’s ability to balance these international commitments with U.S. obligations depends on effective resource allocation and negotiation of offset terms to minimize financial drag.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core issue—Lockheed Martin's international offset obligations (including consulting support) may impair cost recovery on U.S. government contracts due to misaligned reimbursement mechanisms. It accurately notes that cost recovery on U.S. contracts is generally only guaranteed if terminated for convenience under the FAR, and that offset-related investments (e.g., joint ventures) are not automatically recoverable. However, the LLM introduces a specific figure—'$2.1 billion in potential penalties as of 2024'—that is not present in the original answer or supported by the ground truth. This number is factually unsupported in the provided context and constitutes a significant quantitative inaccuracy. (2) The original answer cites a $64.3 billion purchase obligation related to U.S. government contracts, which the LLM omits entirely. This is a key financial figure directly relevant to the question and its absence reduces completeness and quantitative accuracy. (3) The multi-hop reasoning is largely sound: the LLM correctly synthesizes the tension between non-recoverable international offset costs and constrained U.S. cost recovery mechanisms. It appropriately links resource diversion and financial risk across domains, demonstrating good qualitative understanding. (4) Despite the missing $64.3B figure and the unsupported $2.1B penalty claim, the answer remains contextually relevant and semantically aligned with the core financial risk argument. The reasoning is logical and covers the necessary entities (Lockheed Martin, offset agreements, U.S. government contracts, joint ventures, cost recovery limitations). The correctness score is 7 due to the mix of accurate conceptual synthesis and significant but not central numerical inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 491,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did TMO's pharma services business drive segment revenue and margin performance in 2021, considering both pandemic-related demand and the impact of inventory accounting changes?",
      "original_answer": "TMO's pharma services business significantly contributed to segment revenue and margin performance in 2021. The business experienced increased demand, particularly driven by its role in supporting customers with vaccine and therapy development during the ongoing COVID-19 pandemic. This led to strong sales growth and a positive sales mix, which boosted segment income margins. Additionally, a $20 million credit to cost of product revenue, resulting from a change in inventory accounting method, further improved margins. However, this positive impact was partially offset by strategic growth investments. Together, pandemic-related demand and the inventory accounting change were key contributors to the segment's financial performance.",
      "llm_answer": "\n\nTMO's pharma services business, part of the Laboratory Products and Biopharma Services segment, drove **21% revenue growth in 2021** due to pandemic-related demand for vaccine and therapy development services, as well as expanded capacity to meet biopharma customer needs. The segment’s **margin improved by 2.0 percentage points** (to 12.4%) from profit on higher sales, favorable sales mix, and a $20 million cost reduction from inventory accounting changes (FIFO to average cost method). Strategic acquisitions, such as PPD, Inc., further strengthened service offerings, while pandemic-driven demand amplified revenue and margin performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key drivers of TMO's pharma services business performance in 2021: pandemic-related demand for vaccine and therapy development, favorable sales mix, and a $20 million benefit from inventory accounting changes (FIFO to average cost method). It also notes strategic investments (acquisitions like PPD, Inc.) which, while not explicitly mentioned in the original answer, are contextually relevant and do not contradict it. (2) Quantitatively, the LLM states '21% revenue growth' and 'margin improved by 2.0 percentage points (to 12.4%)' — these specific figures are not present in the original answer, which only qualitatively describes 'strong sales growth' and 'boosted margins'. While the $20 million credit is correctly cited, the additional precision (growth rate, margin percentage) introduces data not confirmed by the ground truth, slightly reducing quantitative accuracy. However, since the direction and magnitude are plausible and consistent, this is a minor issue. (3) The reasoning is sound: it synthesizes pandemic demand and accounting changes as dual contributors to revenue and margin performance, fulfilling the multi-hop requirement. (4) The mention of PPD, Inc. acquisition adds context not in the original but is factually correct and relevant to biopharma services expansion, enhancing completeness without distorting the answer. Overall, the answer captures all critical elements, with only minor over-specification of metrics. Hence, high scores across all dimensions with a 9/10 on correctness due to unverified precise percentages.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 451,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does MetLife's participation in Supervisory Colleges, both in the U.S. and Europe, influence its regulatory oversight and risk profile given the involvement of NYDFS and EIOPA?",
      "original_answer": "MetLife's participation in Supervisory Colleges in both the U.S. and Europe enhances regulatory oversight and shapes its risk profile through coordinated supervision. In the U.S., the NYDFS annually chairs Supervisory College meetings attended by MetLife's key U.S. and non-U.S. regulators, facilitating cooperation and coordination among insurance supervisors to better understand the risk profile of MetLife's international operations. Similarly, in Europe, EIOPA requires European regulators, such as the Central Bank of Ireland, to establish Supervisory Colleges for EEA-based insurance groups with significant European operations like MetLife. These colleges enhance understanding of the group's risk profile through collaboration among European supervisors. This dual participation ensures that both U.S. and European regulators have a comprehensive view of MetLife's operations and risk exposures, thereby influencing its regulatory environment and risk management practices.",
      "llm_answer": "\n\nMetLife's participation in Supervisory Colleges, coordinated by the New York State Department of Financial Services (NYDFS) in the U.S. and the European Insurance and Occupational Pensions Authority (EIOPA) in Europe, enhances regulatory oversight by fostering collaboration among regulators to assess the company’s global risk profile. In the U.S., NYDFS chairs annual Supervisory College meetings involving key domestic and international regulators, enabling a holistic evaluation of MetLife’s operations, capital adequacy, and risk management practices. Similarly, in Europe, EIOPA mandates Supervisory Colleges for insurance groups with significant EEA operations, ensuring European regulators coordinate to monitor MetLife’s risk exposure and compliance with solvency standards. This collaborative framework likely increases transparency, harmonizes regulatory expectations, and may lead to more stringent capital or solvency requirements, as regulators gain deeper insights into interconnected risks across MetLife’s global operations. Consequently, MetLife’s risk profile is subject to heightened scrutiny, potentially influencing its capital allocation strategies and compliance measures to meet enhanced regulatory standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: MetLife's participation in Supervisory Colleges in both the U.S. and Europe is accurately described, with proper attribution to NYDFS and EIOPA. The role of NYDFS chairing annual meetings and EIOPA mandating colleges for EEA-based groups with significant operations (like MetLife) is correctly represented. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is 10 by default—no figures were introduced or misstated. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how coordinated supervision in both jurisdictions enhances regulatory oversight and impacts MetLife’s risk profile through increased transparency, harmonized expectations, and potential impacts on capital and compliance strategies. It appropriately infers that deeper regulatory insight may lead to more stringent requirements, which is a reasonable extension of the ground truth. (4) The only minor gap is that the LLM does not explicitly name the Central Bank of Ireland as an example of a European regulator involved, as stated in the original answer. However, this omission does not detract significantly from the overall accuracy or completeness. The answer remains semantically equivalent and contextually rich. Thus, correctness is scored 9 due to this slight omission, but contextual relevance and qualitative accuracy remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 409,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, impact Citi's Net Income in 2024, and what was the resulting percentage change in total Net Income?",
      "original_answer": "The reduction in the ACL build for transfer risk outside the U.S., driven by U.S. banking law, contributed to a lower provision expense of $295 million in 2024 compared to $406 million in the prior year. This $111 million decrease in provision expense positively impacted Net Income, which increased by 27% to $4.9 billion in 2024.",
      "llm_answer": "\n\nThe reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, lowered Citi's credit loss provisions in 2024. This contributed to a **$1.1 billion increase in Net Income** compared to 2023, as lower ACL provisions reduced expenses. Citi's total Net Income for 2024 was **$4.93 billion**, representing a **27% increase** from $3.87 billion in 2023. The ACL reduction was explicitly cited as a factor in the decreased provision for credit losses on other assets, particularly in the Markets and Banking segments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 27% increase in Net Income and the $4.9 billion (rounded from $4.93B) Net Income for 2024, which aligns with the ground truth. However, it incorrectly states a '$1.1 billion increase in Net Income'—the actual increase is $4.9B - $3.87B = $1.03B, not $1.1B. More critically, the ground truth attributes a $111 million decrease in provision expense (from $406M to $295M) as the driver, but the LLM implies this relatively small cost reduction led to a $1.1B net income increase, which overstates the impact and misaligns the magnitude. The answer fabricates precise prior-year net income ($3.87B) not in the original, though consistent with 27% growth. (2) Quantitative inaccuracies: the $1.1B income increase is incorrect (should be ~$1.03B); the $295M vs $406M provision figures are missing in the LLM answer, weakening precision. These are material omissions/alterations. (3) Reasoning is mostly sound—correctly links reduced ACL to lower provisions and higher net income, and correctly identifies U.S. banking law as a driver. The multi-hop logic (law → ACL reduction → lower expense → higher net income) is preserved. (4) Scores reflect mostly correct narrative and percentage with strong contextual and qualitative reasoning, but docked for significant quantitative inaccuracy in the dollar impact and omission of key figures from the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 389,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "Given that Lockheed Martin's FMS sales account for 73% of its international sales and the U.S. government may face funding disruptions due to the debt ceiling expiration in mid-January 2025, how might these potential disruptions specifically affect Lockheed Martin's Aeronautics segment, considering that international customers accounted for 32% of its net sales in 2024 and the F-35 program involves commitments from twelve FMS customers?",
      "original_answer": "Lockheed Martin's Aeronautics segment, which saw 32% of its 2024 net sales come from international customers, is significantly exposed to potential U.S. government funding disruptions due to the debt ceiling expiration. Since 73% of Lockheed Martin's international sales are conducted through FMS contracts with the U.S. government, any delay or reduction in U.S. defense funding could directly impact FMS orders for programs like the F-35, which has commitments from twelve FMS customers. This could result in delayed or reduced production schedules for the F-35, a key international platform, thereby affecting the Aeronautics segment’s revenue and margins. Given the long-cycle nature of defense contracts, such disruptions could have a prolonged effect on Lockheed Martin’s financial performance.",
      "llm_answer": "\n\nPotential U.S. government funding disruptions due to the debt ceiling expiration in mid-January 2025 could significantly impact Lockheed Martin's Aeronautics segment, which derives 32% of its net sales from international customers, primarily through Foreign Military Sales (FMS). Since 73% of Lockheed’s international sales are FMS contracts administered by the U.S. government, delays or disruptions in U.S. funding could slow or halt the approval, payment processing, and fulfillment of these international orders. This is particularly critical for the F-35 program, which involves 12 FMS customers and accounts for a substantial portion of Aeronautics’ international sales. If the U.S. government cannot timely authorize FMS-related expenditures, Lockheed may face deferred revenue recognition, production delays, and increased costs due to disrupted delivery schedules or contract holdups, directly affecting the segment’s financial performance. Additionally, uncertainty around funding could delay key F-35 production lots (e.g., Lot 18/19), further straining the segment’s cash flow and backlog conversion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: 32% of Aeronautics' 2024 net sales from international customers, 73% of international sales via FMS, and 12 FMS customers for the F-35 program. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—no calculations were required beyond correct interpretation of percentages and their implications, which were handled appropriately. (3) Multi-hop reasoning is sound: the model correctly links U.S. government funding disruptions (due to debt ceiling expiration in mid-January 2025) to FMS contract execution, then to F-35 production impacts, and finally to financial and operational consequences for the Aeronautics segment. It adds value by specifying potential effects like deferred revenue recognition, production delays, and impacts on specific production lots (e.g., Lot 18/19), which are plausible and contextually appropriate. (4) The answer is fully contextually relevant, addressing all parts of the question with precise, logically connected reasoning. Minor elaborations (e.g., backlog conversion, cash flow) enhance completeness without introducing inaccuracies. No factual, numerical, or logical errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 354,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How many shares of common stock were available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and its related plans as of December 31, 2023, and how does this compare to the number of shares underlying stock options assumed through acquisitions?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan for future awards. Additionally, 17 million shares were available for future issuance under the ESPP, bringing the total to 70 million shares. Separately, 191,000 shares were underlying stock options assumed through acquisitions. Therefore, the total shares available for future issuance under the active plans was significantly larger than the assumed stock options from acquisitions.",
      "llm_answer": "\n\nAs of December 31, 2023, **70 million shares** of common stock were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan and related plans (including 53 million under the 2020 Plan and 17 million under the Employee Stock Purchase Plan). This is significantly higher than the **191,000 shares** underlying stock options assumed through acquisitions, which are excluded from future issuance under the acquired plans.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 53 million shares under the 2020 Stock Incentive Plan and 17 million under the ESPP sum to 70 million total shares available for future issuance, which aligns with the original answer. The 191,000 shares underlying assumed stock options from acquisitions are also correctly reported. (2) The answer is complete, addressing both parts of the question: total shares available under the active plans and the comparison to assumed options from acquisitions. (3) Entity accuracy is correct—UnitedHealth Group, the 2020 Stock Incentive Plan, ESPP, and the date (December 31, 2023) are all properly identified. (4) The reasoning is sound: the LLM correctly synthesizes data across multiple components (incentive plan + ESPP) and makes a valid qualitative comparison, noting that 70 million is significantly higher than 191,000. The clarification that assumed options are excluded from future issuance under acquired plans adds contextual precision. All information is semantically equivalent to the ground truth, with no factual or calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 328,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What is the total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards, and how does this compare to the total unrecognized compensation cost as of November 3, 2024?",
      "original_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards is $1,746 million ($794 million in 2022 + $596 million in 2023 + $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was $11,259 million. This indicates that the majority of the compensation cost associated with these awards is yet to be recognized over the remaining weighted-average service period of 3.0 years.",
      "llm_answer": "\n\nThe total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards was **$1,746 million** ($794 million in 2022, $596 million in 2023, and $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was **$11,259 million**, which is significantly higher and represents the remaining cost expected to be recognized over the next 3.0 years on average.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $794 million (2022), $596 million (2023), and $356 million (2024) sum to the correct total of $1,746 million. The unrecognized compensation cost of $11,259 million as of November 3, 2024, is correctly reported. (2) The calculation of the total expense over the three years is accurate and explicitly broken down, demonstrating proper synthesis. (3) The qualitative reasoning is sound: the comparison between recognized expense and unrecognized cost is logically presented, and the mention of the 3.0-year weighted-average service period (implied from context) aligns with the original answer’s intent. (4) All entities—Multi-Year Equity Awards, fiscal years 2022–2024, and the relevant financial metrics—are correctly identified and used. The answer is semantically equivalent to the ground truth, with no omissions or inaccuracies. Minor wording differences (e.g., 'significantly higher' vs 'majority... yet to be recognized') do not affect factual correctness and are reasonable interpretations. All parts of the multi-hop question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 336,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total minimum LTD requirement for Citi in 2024 as a percentage of RWA, and how is this value calculated based on the components described in the TLAC section?",
      "original_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of RWA. This is calculated by adding Citi's capital surcharge under method 2 of the GSIB surcharge rule (3.5%) to the base minimum LTD requirement of 6% of RWA.",
      "llm_answer": "\n\nThe total minimum LTD requirement for Citi in 2024 is **9.5% of Risk-Weighted Assets (RWA)**. This is calculated as **6% of RWA plus a 3.5% capital surcharge** under Method 2 of the GSIB surcharge rule (as specified in the TLAC section). The 3.5% surcharge reflects Citi's systemic risk weighting, resulting in a binding requirement of 9.5% of RWA. This exceeds the alternative leverage-based threshold of 4.5% of total leverage exposure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages (9.5%, 6%, and 3.5%) are accurate and correctly attributed to the base LTD requirement and the GSIB capital surcharge under Method 2. The calculation (6% + 3.5% = 9.5%) is correctly described. (2) The answer is complete, addressing both the total minimum LTD requirement for Citi in 2024 and how it is calculated based on the components in the TLAC section. (3) Entity accuracy is correct: 'Citi', '2024', 'RWA', 'GSIB surcharge rule', and 'Method 2' are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it correctly links the base LTD requirement with the GSIB surcharge to derive the total binding requirement, and even adds contextual accuracy by noting that this exceeds the leverage-based threshold (which, while extra, does not detract from correctness). The semantic meaning is equivalent to the original answer, with slightly enhanced detail that remains factually consistent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 297,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade, and how does the pattern of annual increases from 2025 to 2029 inform the trend in pension obligations?",
      "original_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade is $19,510 million. This includes $1,800 million in 2025, increasing to $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, $1,990 million in 2029, and $9,990 million from 2030 to 2034. The annual increases from 2025 to 2029 show a consistent upward trend, indicating a growing financial obligation in the near term before a larger, cumulative payment in the final five years.",
      "llm_answer": "\n\nThe total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade (2025–2034) is **$19.5 billion**, calculated by summing the annual payments from 2025 to 2029 ($1,800 + $1,860 + $1,910 + $1,960 + $1,990 = $9.52 billion) and adding the 2030–2034 total of $9.99 billion. The pattern of annual increases from 2025 to 2029 (ranging from $60 million to $30 million per year) indicates a **gradual rise in pension obligations**, with the growth rate slowing over time. This suggests stabilizing or decelerating pressure on future funding needs, potentially reflecting improved plan funding status, actuarial assumptions, or investment performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the total projected funding requirement as $19.5 billion, which matches the ground truth of $19,510 million (rounded). The annual figures for 2025–2029 ($1,800M, $1,860M, $1,910M, $1,960M, $1,990M) are accurate, and their sum ($9,520M) is correctly calculated. The 2030–2034 amount is correctly stated as $9.99 billion ($9,990 million). The total sum is accurate: $9,520M + $9,990M = $19,510M. 2) Minor issue: the LLM writes '$19.5 billion' instead of '$19.51 billion' or '$19,510 million', which is a negligible rounding difference and acceptable under format variation. However, the sum of 2025–2029 is written as '$9.52 billion'—correct—but then referred to as part of the decade total without explicitly stating the full $19,510 million, which slightly reduces precision. 3) The reasoning about the increasing annual obligations from 2025 to 2029 is mostly sound, noting a gradual rise. However, the interpretation that the 'growth rate slowing over time' implies 'stabilizing or decelerating pressure' contradicts the ground truth's emphasis on 'growing financial obligation in the near term'. While the growth increments do decrease (from +$60M to +$30M), the obligations are still rising steadily, and the larger $9.99B payment in the final five years indicates continued significant pressure. Thus, the qualitative inference is partially misaligned. 4) All entities (Lockheed Martin, qualified defined benefit pension plans, years 2025–2034) are correct. The answer addresses both parts of the question: total funding and trend analysis. Contextual relevance is excellent. Final scores reflect high factual accuracy with a minor deduction in qualitative reasoning due to overinterpretation of deceleration as stabilization.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 478,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "What was the total combined value of Mortgage/Asset-backed securities held by Honeywell in both 2020 and 2021, and how did this investment category rank in terms of proportion to total fixed income investments in each year?",
      "original_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell in 2020 and 2021 was $1,072 million + $982 million = $2,054 million. In 2020, Mortgage/Asset-backed securities represented approximately 8.1% of total fixed income investments ($982 million / $12,106 million total fixed income). In 2021, this category represented approximately 8.9% of total fixed income investments ($1,072 million / $12,041 million total fixed income).",
      "llm_answer": "\n\nThe total combined value of Mortgage/Asset-backed securities held by Honeywell was **$1,151 million in 2021** (U.S.: $1,072 million + Non-U.S.: $79 million) and **$1,075 million in 2020** (U.S.: $982 million + Non-U.S.: $93 million). \n\nIn terms of proportion to total fixed income investments:  \n- **2021**: Mortgage/Asset-backed securities represented approximately **5.7%** of total fixed income ($1,151 / $20,155). This ranked as the **third-largest fixed income category**, following Corporate bonds (~56.1%) and Government securities (~26.1%).  \n- **2020**: The category represented **5.5%** of total fixed income ($1,075 / $19,598), also ranking **third**, behind Corporate bonds (~52.0%) and Government securities (~26.1%).  \n\nThe proportion and ranking remained consistent across both years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both values and calculations. The ground truth states that Honeywell held $1,072 million in 2021 and $982 million in 2020, totaling $2,054 million. However, the LLM incorrectly reports $1,151 million in 2021 and $1,075 million in 2020, adding non-U.S. amounts that are not present in the original data. These additions ($79M and $93M) are unsupported and lead to inflated totals. (2) The percentages are also incorrect: the LLM calculates 5.7% for 2021 ($1,151 / $20,155) and 5.5% for 2020 ($1,075 / $19,598), but the correct figures are 8.9% ($1,072 / $12,041) in 2021 and 8.1% ($982 / $12,106) in 2020. The total fixed income figures used by the LLM ($20.1B and $19.6B) are more than double the actual totals (~$12B), indicating a fundamental data error. (3) The multi-hop reasoning is flawed: the model fails to correctly identify and synthesize the correct values from the knowledge graph, instead introducing erroneous breakdowns (U.S./Non-U.S.) not present in the source. It also misidentifies the ranking—while it claims third place behind corporate and government bonds, the ground truth does not provide ranking information, so this assertion is unsupported. (4) Despite these major errors, the answer is contextually relevant—it addresses the required years, the investment category, and attempts proportion analysis and ranking. However, due to severe quantitative and qualitative inaccuracies, the correctness score is very low. Minor credit is given for attempting the right structure and calculation logic, albeit with wrong inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 444,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Broadcom's shift from annual equity awards to multi-year awards with 4-7 year vesting periods affect its stock-based compensation expense recognition pattern?",
      "original_answer": "Broadcom's shift from annual equity awards to multi-year equity awards changes the stock-based compensation expense recognition pattern by extending the recognition period from a 4-year vesting cycle per annual grant to a longer 7-year period in total for the multi-year awards. Previously, annual grants were issued each year and recognized over 4 years. Now, the Multi-Year Equity Awards encompass four annual grant cycles into one award, with compensation expense recognized from the grant date through the vesting date, which spans up to 7 years. This change results in a more prolonged and overlapping expense recognition timeline compared to the prior annual model.",
      "llm_answer": "\n\nBroadcom's shift to multi-year equity awards with 4-7 year vesting periods extends the recognition period for stock-based compensation expense. Previously, annual awards likely resulted in expense recognition each year. Under the new structure, compensation expense is recognized from the grant date over the longer vesting period (4–7 years), spreading the cost more gradually across multiple fiscal years. This change, implemented in fiscal year 2019, aligns expense recognition with the extended service period required for vesting, as reflected in the unrecognized compensation cost table showing expenses to be recognized through 2028 with a weighted-average service period of 3.0 years as of November 3, 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core impact of Broadcom's shift—extending the expense recognition period due to longer vesting cycles (4–7 years) and spreading costs over more years. It accurately notes the change from annual grants with 4-year vesting to multi-year awards with extended recognition. However, it introduces a specific date (fiscal year 2019) and a forward-looking detail about unrecognized compensation cost being recognized through 2028 with a weighted-average service period of 3.0 years as of November 3, 2024, which are not present in the original answer and cannot be verified against the ground truth. These additions may be factually correct but go beyond the provided knowledge graph and introduce unverified specifics. (2) The quantitative elements such as 'fiscal year 2019', 'through 2028', and 'weighted-average service period of 3.0 years' are not in the original answer and thus cannot be confirmed as accurate per the knowledge graph. The original answer does not specify implementation timing or future expense schedules, so these details reduce quantitative accuracy. (3) The reasoning is sound in understanding the shift from annual to multi-year awards and the resulting prolonged expense recognition. The model correctly infers that longer vesting leads to extended recognition, which shows good multi-hop synthesis. However, the inclusion of unsupported specifics suggests potential hallucination or reliance on external data not in the ground truth. (4) The answer is contextually relevant and captures the essence of the change in expense pattern. While the core qualitative reasoning is strong and semantically aligned, the unverified numbers and dates prevent a higher score. The correctness score is 7 because the main idea is correct, but the added details compromise full factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 503,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does the application of U.S. banking law specifically influence the credit loss provisions in both Legacy Franchises and the Markets segment, and what is the combined impact on Citi's total provision for credit losses in 2024?",
      "original_answer": "The application of U.S. banking law led to a smaller ACL build for transfer risk associated with exposures outside the U.S. in both Legacy Franchises and the Markets segment. In Legacy Franchises, this contributed to a decrease in provisions from $1.3 billion in 2023 to $1.1 billion in 2024. In the Markets segment, it contributed to a lower net ACL build of $295 million compared to $406 million in the prior year. The combined impact of these reductions under U.S. banking law contributed to a total provision decrease from $1.738 billion in 2023 ($1.3 billion + $438 million) to $1.563 billion in 2024 ($1.1 billion + $463 million), a reduction of $175 million.",
      "llm_answer": "\n\nThe application of U.S. banking law, specifically safety and soundness considerations, influenced credit loss provisions by reducing the allowance for credit losses (ACL) build for transfer risk associated with non-U.S. exposures in both Legacy Franchises and the Markets segment. For **Legacy Franchises**, this led to a smaller ACL build ($73 million vs. $127 million in 2023), contributing to a $1.1 billion provision for credit losses in 2024, down from $1.3 billion. For **Markets**, the ACL build decreased by $111 million (to $295 million from $406 million in 2023), but provisions rose to $463 million due to higher net credit losses on loans. **Combined**, these segments accounted for $1.56 billion in total credit loss provisions for Citi in 2024, reflecting reduced regulatory capital buffers for non-U.S. risks under U.S. banking law, partially offset by higher credit losses in Markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core influence of U.S. banking law on ACL builds for non-U.S. transfer risk in both Legacy Franchises and Markets, and correctly identifies the direction of changes in provisions. However, there are key quantitative inaccuracies. The LLM states that Legacy Franchises had an ACL build of $73 million vs. $127 million in 2023, but this specific ACL build data is not in the ground truth and appears fabricated. The ground truth does not provide ACL build amounts for Legacy Franchises—only total provisions. Similarly, while the $295 million and $406 million ACL build figures for Markets are correct, the LLM incorrectly attributes the increase in Markets provisions to 'higher net credit losses on loans'—the ground truth attributes the segment's provision change to a lower net ACL build, not higher credit losses. (2) The combined 2024 provision is stated as $1.56 billion, which matches the ground truth ($1.1B + $463M = $1.563B), so this is accurate within rounding. However, the 2023 combined provision is implied as $1.738B in the ground truth ($1.3B + $438M), but the LLM does not mention the $438M prior-year Markets provision, instead citing only the ACL build. The LLM also fails to compute or mention the $175 million total reduction, a key part of the original answer. (3) The multi-hop reasoning is partially sound—linking U.S. banking law to reduced ACL builds and lower provisions in both segments—but the explanation for Markets' rising provisions is factually incorrect, undermining the synthesis. (4) The correctness score is 7 due to accurate directional trends and correct total 2024 provision, but docked for fabricated ACL numbers and incorrect causal reasoning in Markets. Quantitative accuracy is 6 due to incorrect or unsupported numbers. Qualitative accuracy is 8 for generally sound logic and correct entities (segments, years, concepts). Contextual relevance is 9—answer stays focused and addresses all question parts, albeit with errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 541,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "What was the total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021, and what percentage of the total assets at fair value did this combined amount represent?",
      "original_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021 was $1,458 million ($767 million in 2020 + $691 million in 2021). This represented approximately 8.66% of the total assets at fair value across both years ($1,458 million ÷ ($8,450 million + $8,396 million)).",
      "llm_answer": "\n\nThe total value of Insurance buy-in contracts held by HON in Non-U.S. Plans was $767 million in 2020 and $691 million in 2021, summing to **$1,458 million**. This combined amount represented **8.6%** of the total assets at fair value for Non-U.S. Plans across both years ($1,458 ÷ ($8,450 + $8,396) = 8.6%).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively, all numbers are correct: $767 million in 2020 and $691 million in 2021 sum to $1,458 million, and total assets at fair value are correctly cited as $8,450 million (2020) and $8,396 million (2021). The calculation for the percentage is accurate: $1,458 ÷ ($8,450 + $8,396) = $1,458 ÷ $16,846 ≈ 8.655%, which rounds to 8.6% as reported—this is semantically equivalent to the ground truth's 8.66% when considering rounding conventions. (2) The answer is complete, addressing both parts of the question: the total value across two years and the percentage of total assets. (3) Entities are correct: HON, Non-U.S. Plans, Insurance buy-in contracts, and the years 2020 and 2021 are all properly identified. (4) The multi-hop reasoning is sound—information is synthesized across two years and two financial metrics (contract value and total assets), and the percentage is correctly derived from the sum of two-year totals. The only minor shortcoming is the rounding to 8.6% instead of reporting 8.66%, but this does not constitute a factual error given common rounding practices. Thus, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 350,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does Broadcom's (AVGO) emphasis on internal research and development, as part of its broader business strategy, influence its semiconductor segment's ability to maintain technology leadership in AI-related markets?",
      "original_answer": "Broadcom's focus on internal research and development plays a central role in maintaining its technology leadership in semiconductor markets, particularly in AI-related applications. The company explicitly states that its strategy involves 'extensive internal research and development' to ensure its products retain their technology market leadership. This R&D emphasis directly supports its semiconductor solutions segment, which includes products used in AI networking and connectivity. By investing in R&D, Broadcom is able to develop high-performance semiconductor devices such as complex digital and mixed-signal CMOS-based devices and analog III-V based products like gallium arsenide (GaAs) and indium phosphide (InP), which are critical for high-speed RF and optoelectronic applications in AI systems. This innovation enables Broadcom to deliver category-leading infrastructure technology products to major business and government customers, reinforcing its competitive edge in AI-driven markets.",
      "llm_answer": "\n\nBroadcom's emphasis on internal research and development (R&D) is a cornerstone of its strategy to maintain technology leadership in AI-related markets. The company directs significant R&D resources toward designing advanced semiconductor solutions, such as high-performance Ethernet switching silicon, custom silicon for AI and high-performance computing, and low-latency interconnect technologies critical for AI data centers. By investing in proprietary innovations like digital signal processing architectures and integration of AI-specific protocols, Broadcom ensures its semiconductor products address evolving AI workloads, enabling scalability and efficiency in data-intensive environments. This focus on internal R&D, combined with strategic acquisitions (e.g., VMware and Seagate’s SoC operations), strengthens its ability to deliver cutting-edge solutions that meet the demands of AI networking, storage, and compute applications, solidifying its competitive edge in these markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth in terms of factual content, reasoning, and relevance. (1) The answer correctly identifies Broadcom's emphasis on internal R&D as a strategic enabler of technology leadership in AI-related semiconductor markets. It accurately describes the role of R&D in developing advanced silicon solutions for AI networking, compute, and data center applications, which matches the original answer's focus on technology leadership through innovation. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly links Broadcom’s internal R&D investments to specific product innovations (e.g., high-performance Ethernet, custom AI silicon, low-latency interconnects) and ties them to AI infrastructure needs, demonstrating synthesis across technical and strategic domains. It also appropriately references strategic acquisitions (e.g., VMware, Seagate’s SoC operations) as complementary to R&D, though the original answer does not mention acquisitions—this is an addition, not a contradiction, and does not detract from accuracy. (4) The only minor gap is that the original answer specifies certain semiconductor technologies (e.g., CMOS-based devices, GaAs, InP) and their use in RF/optoelectronic applications, which the LLM omits. However, the LLM compensates by detailing other relevant technologies (e.g., DSP architectures, AI-specific protocols) that reflect similar technical depth. Overall, the semantic meaning, strategic insight, and technical grounding are equivalent. The answer is fully contextually relevant and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 478,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "What is the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements, and how does this compare to the total advance payments made under its multi-year capacity purchase commitments as of September 29, 2024?",
      "original_answer": "Qualcomm is expected to pay $9.6 billion in the next 12 months under its purchase agreements, which primarily relate to integrated circuit product inventory obligations. This amount is part of the total $12.8 billion in obligations under purchase agreements. The total advance payments made under multi-year capacity purchase commitments as of September 29, 2024, were $3.0 billion. Therefore, the amount expected to be paid in the next 12 months is significantly higher than the advance payments made, indicating a substantial upcoming cash outflow relative to the prepayments already made.",
      "llm_answer": "\n\nThe total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements is **$9.6 billion**, primarily related to integrated circuit product inventory obligations. As of September 29, 2024, the total advance payments made under its multi-year capacity purchase commitments were **$3.0 billion**. This means the expected near-term payments ($9.6 billion) significantly exceed the recorded advance payments ($3.0 billion), reflecting additional obligations beyond prior prepayments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key figures—$9.6 billion in expected payments over the next 12 months and $3.0 billion in advance payments as of September 29, 2024—are accurately reported with correct units and timeframes. There are no calculation errors. (2) The answer is complete, addressing both parts of the multi-part question: the near-term obligation amount and its comparison to advance payments. (3) Entity accuracy is correct: 'Qualcomm', 'purchase agreements', 'integrated circuit product inventory obligations', and 'multi-year capacity purchase commitments' are all properly identified and contextually used. (4) The reasoning is sound: the LLM correctly infers that the $9.6 billion in upcoming payments significantly exceeds the $3.0 billion already advanced, indicating additional obligations beyond prepayments—this reflects accurate multi-hop synthesis between payment commitments and prepayment balances. (5) The semantic meaning is equivalent to the original answer, with slightly more concise wording but no loss of key context or implication. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 331,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "By how much did the GTN adjustment reductions for 2024 differ from those of 2023, and what was the specific non-U.S. factor that contributed to this change?",
      "original_answer": "The GTN adjustment reductions for 2024 were $159 million, compared to $134 million for 2023, resulting in a $25 million difference. The specific non-U.S. factor that contributed to this change was revisions in clawback amounts driven by VAT recoverable estimates.",
      "llm_answer": "\n\nThe GTN adjustment reductions for 2024 were $159 million, compared to $134 million in 2023, resulting in a $25 million increase. The specific non-U.S. factor contributing to this change was revisions in clawback amounts driven by VAT (Value Added Tax) recoverable estimates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the GTN adjustment reductions for both 2024 ($159 million) and 2023 ($134 million), matching the ground truth exactly. The calculated difference of $25 million is accurate (159 - 134 = 25). (2) All numeric values are correct and properly formatted; the calculation is sound and matches the ground truth. (3) The non-U.S. factor—revisions in clawback amounts driven by VAT recoverable estimates—is accurately identified and phrased with equivalent meaning (VAT explicitly expanded to Value Added Tax, which is semantically acceptable). (4) The answer fully addresses both parts of the multi-hop question: the quantitative difference and the specific non-U.S. contributing factor. Reasoning and synthesis across time periods and causal factors are correct. All scores are maximized due to complete factual accuracy, correct calculations, proper entity and year identification, and clear, relevant response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 278,
        "total_tokens": 1415
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does Mastercard Send, as part of Mastercard's disbursements and remittances strategy, contribute to the company's broader objective of capturing new payment flows, and what specific partner ecosystems are leveraged to enable this capability according to the 2022 10-K filing?",
      "original_answer": "Mastercard Send contributes to the company's broader objective of capturing new payment flows by enabling consumers, businesses, governments, and nonprofits to send and receive money more efficiently, both domestically and across borders. This platform is a key component of Mastercard's disbursements and remittances strategy, which is explicitly tied to the company's goal of expanding multi-rail capabilities and applications to penetrate key flows. The platform leverages partnerships with central banks, fintechs, and financial institutions to help governments and nonprofits distribute social and economic assistance and facilitate business-to-consumer (B2C) disbursements, thereby enhancing the reach and utility of Mastercard's payment network.",
      "llm_answer": "\n\nMastercard Send contributes to Mastercard's objective of capturing new payment flows by enabling faster, more efficient cross-border and domestic disbursements and remittances through real-time payment capabilities. Specifically, it partners with **digital messaging/payment platforms, central banks, fintechs, and financial institutions** to facilitate B2C disbursements (e.g., social assistance, government programs) and person-to-person payments. These ecosystems expand Mastercard’s reach beyond traditional card networks, aligning with its strategy to penetrate high-growth payment segments like real-time transactions and digital-first use cases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Mastercard Send enables efficient domestic and cross-border disbursements and remittances, contributing to the company's objective of capturing new payment flows by expanding into real-time, multi-rail payment systems. The role in supporting government and nonprofit disbursements (e.g., social assistance) and B2C use cases is accurately described. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly links Mastercard Send to broader strategic goals (capturing new payment flows) and identifies the relevant partner ecosystems—central banks, fintechs, and financial institutions—as in the original. The addition of 'digital messaging/payment platforms' is a slight expansion not explicitly mentioned in the ground truth but is contextually plausible and consistent with Mastercard’s ecosystem strategy; it does not contradict the source and may reflect inference from 'multi-rail' capabilities. (4) The answer is semantically equivalent to the original, with slightly different phrasing (e.g., 'real-time payment capabilities', 'digital-first use cases') that enhance clarity without distorting facts. The core entities—Mastercard Send, disbursements/remittances strategy, partner types, and use cases—are all correctly identified and logically connected. Minor deduction in qualitative accuracy due to the slight over-extension of partner types, but overall reasoning and contextual relevance are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 448,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does Mastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, influence the composition and recognition timing of its 'Other revenues' category in 2022?",
      "original_answer": "Mastercard introduced Cyber and Intelligence Solutions as part of its value-added services, which directly contributes to the 'Other revenues' category. This category includes fees from cyber and intelligence solutions offered to prevent fraud and ensure transaction safety. These revenues are recognized in the period when the related services are performed or transactions occur, thereby affecting the timing and composition of 'Other revenues' within Mastercard’s net revenue structure.",
      "llm_answer": "\n\nMastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, contributes to the **composition** of its 'Other revenues' category by adding fees derived from fraud prevention, detection, and transaction safety services. These fees are recognized in the period services are performed or transactions occur, aligning with Mastercard’s revenue recognition policy for value-added products. In 2022, this likely increased the proportion of 'Other revenues' (which rose to $6.224 billion in 2021) by expanding service offerings under this category. The **recognition timing** remains tied to service delivery rather than transaction volume, as these solutions are billed and recognized contemporaneously with service provision, distinct from volume-based revenues like domestic assessments or cross-border fees. Acquisitions such as Ekata (enhancing digital identity verification) further integrated these services, solidifying their role in shaping the 'Other revenues' segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth in terms of both composition and recognition timing of Mastercard's 'Other revenues' in 2022. It correctly identifies that Cyber and Intelligence Solutions contribute to the composition of 'Other revenues' through fees for fraud prevention and transaction safety services, and that revenue recognition occurs when services are performed or transactions occur. The reasoning is sound and reflects proper multi-hop synthesis of how new service offerings impact revenue categorization and timing. The only minor issue is the reference to 'Other revenues' rising to $6.224 billion in 2021 — while this figure may be factually correct, it is not present in the ground truth and slightly misaligns with the question’s focus on 2022, potentially implying a projection not supported in the original answer. However, this does not undermine the core correctness. The mention of Ekata is contextually relevant and accurate, as it supports the expansion of cyber and intelligence capabilities. Wording differs but maintains semantic equivalence on key points. All entities (Mastercard, Cyber and Intelligence Solutions, 'Other revenues', 2022) are correct, and the distinction between service-based and volume-based revenue recognition is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 365,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What was the total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 and December 31, 2023, and how did this change compare to the change in unrealized losses on those securities over the same period?",
      "original_answer": "The total fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million at December 31, 2022 to $320 million at December 31, 2023, a decrease of $7 million. Meanwhile, unrealized losses on these securities increased from $31 million to $25 million, a decrease in unrealized losses of $6 million. This means that while the fair value slightly declined, the unrealized losses improved year-over-year.",
      "llm_answer": "\n\nThe total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022, and December 31, 2023, was an **increase of $88 million** (from $452 million to $540 million). Over the same period, the unrealized losses on these securities decreased by **$9 million**, from $(42 million) in 2022 to $(33 million) in 2023. This indicates that while the fair value of the securities rose, the magnitude of unrealized losses also reduced, reflecting improved valuation and market conditions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, the fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million to $320 million (a $7 million decrease), whereas the LLM claims an increase from $452 million to $540 million ($88 million increase). This represents a significant factual error in both the starting and ending values and the direction of change. Additionally, the ground truth states that unrealized losses increased from $31 million to $25 million — which is a decrease in losses of $6 million (i.e., improvement), but the LLM incorrectly reports unrealized losses decreasing from $42 million to $33 million (a $9 million reduction), using entirely wrong figures. (2) All calculations are based on incorrect inputs: the LLM’s claimed $88 million increase in fair value and $9 million reduction in unrealized losses do not match the ground truth data. The correct change in fair value is -$7 million; the correct change in unrealized losses is -$6 million (i.e., losses decreased by $6M). (3) The multi-hop reasoning is flawed because the model fails to retrieve or synthesize the correct data points across time periods and metrics. It appears to have either accessed incorrect documents or misattributed data to CAT. There is no evidence of correct entity-metric-time alignment. (4) The contextual relevance is low because the answer discusses the right type of securities and correct time frame (2022–2023), and attempts the correct comparison between fair value and unrealized losses, so some structural relevance remains. However, due to pervasive quantitative and qualitative inaccuracies, the answer is substantively wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 472,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What is the total fair value of Qualcomm's corporate bonds and notes, and how does this compare to the fair value of U.S. Treasury securities and government-related securities as a percentage of the total marketable securities?",
      "original_answer": "Qualcomm's corporate bonds and notes have a total fair value of $4,634 million, while the fair value of U.S. Treasury securities and government-related securities is $208 million. The total marketable securities amount to $5,451 million. Therefore, corporate bonds and notes represent approximately 85% of the total marketable securities, whereas U.S. Treasury securities and government-related securities account for about 3.8% of the total marketable securities.",
      "llm_answer": "\n\nThe total fair value of Qualcomm's corporate bonds and notes is **$4,634 million**. This represents approximately **84.9%** of the total fair value of marketable securities ($5,451 million). In comparison, the fair value of U.S. Treasury securities and government-related securities is **$208 million**, accounting for **3.8%** of total marketable securities. \n\nThese figures are derived from Note 9 of the 10-K, which breaks down marketable securities by security type and fair value hierarchy levels.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $4,634 million for corporate bonds and notes, $208 million for U.S. Treasury and government-related securities, and $5,451 million total marketable securities. Percentages are correctly calculated: 84.9% (which rounds to approximately 85%) for corporate bonds and 3.8% for government securities. (2) Calculations are precise: (4,634 / 5,451) ≈ 84.9%, and (208 / 5,451) ≈ 3.8%. (3) The multi-hop reasoning is sound—LLM correctly synthesized fair values from different categories and related them to the total marketable securities, as required by the question. (4) Entity identification is accurate (Qualcomm, correct security types), and the reference to Note 9 of the 10-K adds contextual support. Wording differs slightly (e.g., 'approximately 84.9%' vs 'approximately 85%'), but this is semantically equivalent and acceptable. All parts of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 289,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does MRK use pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, and what financial impact could this have on the company's oncology revenue stream?",
      "original_answer": "MRK leverages six months of pediatric market exclusivity (as stated in evidence_source_a) to extend market protection for Keytruda beyond the expiration of its compound patent. Additionally, evidence_source_b explains that for drug candidates like Keytruda, the company may benefit from a future Patent Term Extension (PTE) of up to five years and/or six months of pediatric market exclusivity, depending on regulatory approvals. Since Keytruda is part of a global strategic oncology collaboration (mentioned in evidence_source_a), any extension of exclusivity directly impacts revenue by delaying generic competition and preserving market share in the oncology segment. This regulatory strategy enhances revenue predictability and supports long-term financial planning around one of MRK's key oncology products.",
      "llm_answer": "\n\nMerck extends market protection for Keytruda beyond its compound patent expiration by leveraging **pediatric market exclusivity**, which adds **six months of exclusivity** in the U.S. and EU under regulatory frameworks (e.g., FDA Modernization Act and EU SPC rules). For Keytruda, this exclusivity is attached to its existing patent and data protection terms, delaying generic or biosimilar competition. In the U.S., Keytruda’s compound patent expires in 2028, but pediatric exclusivity and potential patent term extensions (e.g., pending PTEs) could push market exclusivity into 2028–2033, depending on jurisdiction. This extension sustains Merck’s oncology revenue by maintaining pricing power and market share in high-growth cancer indications, mitigating near-term revenue erosion from competition. The financial impact is significant, as Keytruda is a top oncology revenue driver, and prolonged exclusivity ensures continued cash flow during critical growth phases for newer therapies.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the use of pediatric market exclusivity (six months) to extend market protection for Keytruda, aligning with the ground truth. It also mentions the possibility of Patent Term Extension (PTE), which is consistent with evidence_source_b. However, the LLM introduces specific dates (e.g., 'compound patent expires in 2028', 'exclusivity into 2028–2033') that are not present in the original answer or cited evidence sources, making these additions speculative and factually unverified. The ground truth does not specify expiration dates or jurisdictional timelines, so these details reduce quantitative accuracy. (2) The financial impact is reasonably described—delaying generics, preserving market share, supporting revenue—but the original answer emphasizes the role of the global strategic oncology collaboration in amplifying this impact, which the LLM omits. This affects completeness in multi-hop synthesis. (3) The reasoning is logically sound and reflects an understanding of how regulatory exclusivity mechanisms work, including the combination of pediatric exclusivity and potential PTE. The model synthesizes concepts correctly, though it adds unsupported specifics. (4) Despite the overreach on dates, the core message about extending exclusivity to protect oncology revenue is semantically aligned and contextually relevant. The answer addresses both 'how' and 'financial impact' parts of the question, but with minor factual overreach and omission of the collaboration context, justifying a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 431,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the introduction of Mastercard Installments in 2022, as part of broader innovation efforts, support Mastercard's strategic goal of expanding digital payment services across multiple channels?",
      "original_answer": "The introduction of Mastercard Installments in 2022 directly supports Mastercard’s strategic goal of expanding digital payment services by offering a new open-loop buy-now-pay-later solution that connects lenders with merchants across the company's acceptance network. This aligns with Mastercard’s innovation focus on delivering better digital experiences everywhere, particularly through mobile and connected devices, as outlined in their 2022 10-K filing. Additionally, this initiative is part of a broader push to capture new payment flows and extend services, including multi-rail capabilities and digital currency solutions, which are key components of their strategy to diversify and strengthen their payments ecosystem.",
      "llm_answer": "\n\nThe introduction of Mastercard Installments in 2022 supports Mastercard's strategic goal of expanding digital payment services by introducing a **buy-now-pay-later (BNPL)** solution that enhances consumer payment flexibility and aligns with the company’s focus on multi-rail innovation. As outlined in the 10-K, this open-loop solution connects lenders with merchants across Mastercard’s network, enabling seamless, scalable BNPL options for consumers. This innovation directly supports Mastercard’s priority to \"expand in payments\" by capturing new digital payment flows, complementing existing rails (cards, real-time payments, ACH), and addressing evolving consumer demand for flexible, contactless, and digital-first payment methods. Additionally, it strengthens Mastercard’s ecosystem by integrating with its technology platforms (e.g., digital wallets, mobile apps) and reinforces its leadership in digitizing commerce across channels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: Mastercard Installments was introduced in 2022 as an open-loop buy-now-pay-later (BNPL) solution that connects lenders and merchants across Mastercard’s network. The reference to the 2022 10-K filing is correctly implied. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—date (2022) is correct. (3) The multi-hop reasoning is sound: the answer correctly links the introduction of Installments to Mastercard’s broader innovation strategy, multi-rail capabilities (cards, ACH, real-time payments), digital wallets, and mobile apps, demonstrating synthesis across strategic domains. (4) The LLM captures all core elements of the original answer—expansion of digital payment services, open-loop BNPL, network connectivity, innovation in digital experiences, and ecosystem diversification—though it omits explicit mention of 'digital currency solutions' and 'multi-rail capabilities' as named components of the broader push, which slightly reduces qualitative completeness. However, the mention of 'multi-rail innovation' and integration with digital platforms preserves semantic equivalence. Wording differs but meaning and factual content are consistent. Contextual relevance is excellent, directly addressing how the product supports strategic goals across channels.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 405,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "What portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP were recorded within Cost of sales in 2024, given that profits from the Lagevrio collaboration were split equally between the partners?",
      "original_answer": "Merck's profit-sharing payments to Ridgeback Biotherapeutics LP that were recorded within Cost of sales in 2024 corresponded to 50% of the profits generated from the Lagevrio collaboration, as the agreement stipulates that profits are split equally between Merck and Ridgeback.",
      "llm_answer": "\n\nThe portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP recorded within Cost of sales in 2024 was **$205 million**. This amount represents Ridgeback's 50% share of the collaboration's profits, calculated as half of the total profit from Lagevrio (molnupiravir) sales. Total profit was derived by subtracting Merck's actual costs (and Ridgeback's share) from net sales of $964 million, with the resulting $205 million included in Cost of sales as specified in the financial disclosures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($205 million and $964 million) and a calculation method not present in the original answer or supported by the provided ground truth. The ground truth states only that 50% of profits were recorded in Cost of sales due to equal profit sharing, with no mention of actual dollar figures, net sales, or cost calculations. These numerical values and the derived total profit are therefore unsupported and factually unverifiable from the given information. (2) The quantitative accuracy is low because the LLM fabricates precise financial figures and a profit calculation methodology that are not in the ground truth. Even if the 50% split aligns with the original answer, attaching $205 million as Ridgeback’s share introduces unverified data, making the response misleading. (3) The qualitative reasoning partially captures the multi-hop element—recognizing that profit-sharing with Ridgeback relates to Cost of sales and stems from an equal split—but overreaches by constructing a detailed financial model absent from the source. It correctly identifies the 50% split logic but fails to limit its response to the information available. (4) Contextual relevance is high because the answer addresses the correct entities (Merck, Ridgeback Biotherapeutics, Lagevrio), the correct year (2024), and the correct financial statement line (Cost of sales), and attempts to explain the accounting treatment. However, the addition of unsupported calculations significantly undermines factual correctness, warranting a moderate score overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 437,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the Overseas Fund Regime (OFR) interact with BlackRock's European domicile structures to affect its ability to market funds in the UK, and what equivalence requirements must be met under this regime?",
      "original_answer": "Under the Overseas Fund Regime (OFR), BlackRock must ensure that the consumer protection regimes in EU countries where its funds are domiciled are found equivalent to the UK's regime in order to market those funds to UK retail investors. This requirement directly affects BlackRock's ability to distribute its European-domiciled funds in the UK market and may necessitate adjustments to its fund structures or compliance frameworks to meet UK regulatory expectations.",
      "llm_answer": "\n\nThe Overseas Fund Regime (OFR) allows non-UK funds, including those domiciled in the EU, to register with the UK Financial Conduct Authority (FCA) for marketing to UK retail investors. For EU-domiciled BlackRock funds, the OFR requires that the consumer protection regimes of the EU countries where these funds are domiciled be deemed **equivalent to the UK’s regulatory standards**. This equivalence assessment ensures that UK investors receive protections comparable to those under UK law. If the UK determines that an EU country’s regime is not equivalent, BlackRock may face restrictions on marketing those funds in the UK, potentially limiting its product offerings. The equivalence requirement thus directly ties BlackRock’s European domicile structures to its ability to access the UK market under OFR, subject to ongoing regulatory alignment post-Brexit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that under the Overseas Fund Regime (OFR), EU-domiciled BlackRock funds can be marketed to UK retail investors only if the consumer protection regimes of the EU countries where the funds are domiciled are deemed equivalent to the UK’s standards. The answer accurately explains the regulatory mechanism (equivalence assessment by the UK), the consequence of non-equivalence (marketing restrictions), and the impact on BlackRock’s European structures and market access. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is 9 because while all key facts are correct, the original answer emphasizes that this may necessitate adjustments to fund structures or compliance frameworks, a point slightly underemphasized in the LLM response. However, the mention of potential restrictions and ongoing regulatory alignment captures the intent. Contextual relevance is perfect—the response directly addresses both parts of the multi-hop question: (1) how OFR interacts with European domicile structures and (2) what equivalence requirements apply.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 344,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does Broadcom's (AVGO) internal manufacturing strategy for FBAR filters, as part of its RF semiconductor devices, support its competitive advantage in the cellular handset market?",
      "original_answer": "Broadcom's internal manufacturing strategy for FBAR filters enables it to protect its intellectual property and accelerate time to market, which directly supports its competitive advantage in the cellular handset market where FBAR technology holds significant market share.",
      "llm_answer": "\n\nBroadcom's internal manufacturing strategy for FBAR filters, a key component of its RF semiconductor devices, strengthens its competitive advantage in the cellular handset market by enabling proprietary technology control, performance differentiation, and accelerated time-to-market. By fabricating FBAR filters in-house using specialized processes (primarily in the U.S. and Singapore), Broadcom protects its intellectual property (IP) and maintains leadership in filter technology, which is critical for efficient RF signal management in congested wireless spectra. This vertical integration allows the company to optimize FBAR performance, integrate advanced features (e.g., multi-band support), and deliver industry-leading RF front-end modules, differentiating its solutions in a crowded market. The strategy also supports close collaboration with customers like Apple, ensuring tailored, high-performance solutions that reinforce Broadcom's position as a key supplier in the cellular ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies Broadcom's internal manufacturing of FBAR filters as a strategic advantage that protects intellectual property and accelerates time to market—both key points in the original answer. The LLM expands on these with additional context (e.g., vertical integration, performance optimization, customer collaboration with Apple, multi-band support), which, while not in the original answer, are semantically consistent and plausibly derived from broader knowledge of Broadcom's business strategy. There are no numeric values in the question or answers, so quantitative accuracy is not applicable but assumed perfect. The reasoning is sound and reflects proper multi-hop synthesis: connecting internal manufacturing to IP protection, time-to-market advantages, and competitive positioning in the cellular handset market. The only reason for not scoring a 10 is that the LLM adds some elaboration beyond the core truth (e.g., locations like U.S. and Singapore, specific customer Apple) that were not in the original knowledge graph answer, slightly exceeding the supported evidence. However, these do not contradict the truth and are commonly known, so the answer remains substantially correct. Contextual relevance is excellent, fully addressing the question with focused, pertinent information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 382,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does Merck utilize both patent term extensions and regulatory exclusivity to maximize market protection for its biologic products, and what specific exclusivity durations are available in the U.S. for such products?",
      "original_answer": "Merck leverages both patent term extensions and regulatory exclusivity to extend market protection for its biologic products. In the U.S., regulatory data exclusivity for biologic products lasts 12 years from the date of first marketing approval. Additionally, if pediatric studies are completed, an extra six months of market exclusivity can be added. These mechanisms work together to provide extended market protection, allowing Merck to maintain exclusivity beyond the initial approval period and delay potential competition.",
      "llm_answer": "\n\nMerck maximizes market protection for its biologic products by combining **patent term extensions (PTE)** and **regulatory exclusivity** in the U.S. Specifically, it utilizes:  \n1. **Patent Term Restoration (PTE):** Up to **5 years** in the U.S. to offset time lost during clinical testing and regulatory review.  \n2. **Regulatory Data Exclusivity:** **12 years** from the first marketing approval of a biologic product, preventing FDA approval of biosimilars during this period.  \n3. **Pediatric Exclusivity:** An additional **6 months** of market exclusivity (added to the patent term or regulatory exclusivity) for completing required pediatric studies.  \n\nFor example, Merck’s Keytruda has a patent expiration in 2028 (with pending PTE) and U.S. data exclusivity expiring in 2033, demonstrating how layered protections extend market exclusivity beyond patent expiration. This strategy ensures prolonged market exclusivity by leveraging both patent and regulatory mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers are correct: 12 years of biologic data exclusivity, 6 months for pediatric exclusivity, and up to 5 years for patent term restoration (PTE) are all factually accurate and consistent with U.S. law (Hatch-Waxman and BPCIA). The example of Keytruda, while not part of the original answer, is plausible and contextually appropriate, though not verifiable from the provided ground truth—this adds value without introducing error. (2) The core mechanisms—patent term extensions and regulatory exclusivity—are correctly explained and differentiated. (3) The reasoning is sound: the LLM correctly synthesizes how Merck combines patent and regulatory tools for layered protection, demonstrating multi-hop understanding (e.g., PTE compensates for regulatory delay, exclusivity blocks biosimilars). (4) The only minor shortcoming is that the original answer does not mention the 5-year PTE limit, so including it represents a slight expansion rather than a discrepancy. However, this information is correct and enhances completeness. The LLM answer is semantically equivalent and more detailed than the ground truth, without introducing inaccuracies. Thus, it earns a 9/10 for correctness—excellent, but not perfectly minimal to the source truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 372,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How do the 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, potentially affect BlackRock's client engagement and compliance costs in its UK operations?",
      "original_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 10-K filing, introduce tailored reporting requirements for proxy advisers and investment consultants. These changes may increase BlackRock's compliance costs and necessitate adjustments to its stewardship activities on behalf of clients. Since BlackRock's UK subsidiaries are subject to rigorous conduct regulation, including the Consumer Duty rules, failure to meet the FCA's expectations regarding these new stewardship reporting obligations could expose BlackRock to regulatory sanctions, reputational risk, and potential client asset withdrawals, thereby impacting client engagement and operational efficiency.",
      "llm_answer": "\n\nThe 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, are expected to increase compliance costs and alter client engagement practices in BlackRock's UK operations. The reforms include **tailored reporting requirements for proxy advisers and investment consultants**, which may necessitate enhanced data collection, documentation, and disclosure processes for BlackRock’s stewardship activities on behalf of clients. These changes could raise operational complexity and compliance expenses, as BlackRock must adapt systems and procedures to meet stricter regulatory expectations. Additionally, the reforms may require **greater client communication and transparency** around voting strategies and engagement practices, potentially affecting how BlackRock interacts with institutional clients. While the reforms aim to improve accountability, they risk increasing costs and administrative burdens, which could indirectly impact BlackRock’s profitability and operational efficiency in the UK market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: the 2024 UK Stewardship Code reforms include 'tailored reporting requirements for proxy advisers and investment consultants,' which is explicitly mentioned in both answers. The LLM correctly identifies that these changes may increase compliance costs and affect stewardship activities, client engagement, and operational efficiency. (2) There are no numeric values, dates, or calculations in the question or answers beyond '2024,' which is correct in both cases—quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM synthesizes regulatory changes with their implications for BlackRock’s compliance, client communication, and operational processes. It correctly infers increased administrative burden and potential impact on profitability, which is consistent with the risk of regulatory sanctions and client asset withdrawals in the original. (4) The only minor gap is that the LLM does not explicitly mention the 'Consumer Duty rules' or 'FCA expectations' by name, which are part of the regulatory context in the original answer and contribute to the compliance pressure. However, it captures the essence of 'stricter regulatory expectations' and 'reputational risk' through related phrasing like 'regulatory expectations' and 'administrative burdens.' Overall, the answer is semantically equivalent, slightly less specific on the regulatory framework, but otherwise complete and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 423,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022, and how does the Heritage AspenTech acquisition directly factor into this change according to the evidence provided?",
      "original_answer": "The depreciation and amortization expenses for the AspenTech segment increased by $147 million (from $95 million in fiscal 2021 to $242 million in fiscal 2022). The Heritage AspenTech acquisition directly factors into this change because it is explicitly stated that the increase in backlog for the AspenTech segment in fiscal 2022 is related to this acquisition, which would lead to the recognition of additional intangible assets requiring amortization.",
      "llm_answer": "\n\nThe depreciation and amortization expenses for the AspenTech segment increased by **$147 million** (from $95 million in 2021 to $242 million in 2022). This increase is directly attributable to the **Heritage AspenTech acquisition**, which contributed **$148 million in amortization of intangibles** for fiscal 2022, as explicitly stated in the document. The acquisition added significant intangible assets (e.g., intellectual property, customer relationships) to the segment, driving the year-over-year rise in expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the dollar increase in depreciation and amortization expenses as $147 million, accurately calculated from $95 million in fiscal 2021 to $242 million in fiscal 2022. All numeric values match the ground truth, and the calculation is correct. (2) The quantitative accuracy is perfect—numbers, years, and the difference are all factually correct, with acceptable formatting. (3) The reasoning is strong and adds value by specifying that the Heritage AspenTech acquisition contributed $148 million in amortization of intangibles, which aligns closely with the $147 million increase. This minor $1 million discrepancy (likely due to rounding or reporting timing) does not undermine the overall correctness. The LLM correctly links the acquisition to the recognition of additional intangible assets requiring amortization, demonstrating sound multi-hop reasoning by connecting the acquisition to the expense increase. (4) The answer is contextually fully relevant, addressing both the quantitative change and the causal role of the acquisition. The only reason for not scoring a 10 is that the original answer does not explicitly state the $148 million figure—while plausible and consistent, it slightly exceeds the evidence provided in the ground truth, which attributes the increase to the acquisition via backlog and intangible asset recognition without citing a specific $148M amortization amount. Thus, qualitative accuracy is slightly reduced due to this unsupported precision, though the core logic remains sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 428,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and what percentage did this region contribute to the total global growth in this business segment?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million ($744 million in Fiscal Year 2022 from $720 million in Fiscal Year 2021). This regional increase contributed approximately 0.35% to the total global growth in the Subscriptions and Services segment, which grew by $362 million (from $6,564 million to $6,926 million).",
      "llm_answer": "\n\nThe year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was **$24 million** (from $720 million in FY2021 to $744 million in FY2022). This region contributed **6.6%** to the total global growth in the Subscriptions and Services segment, which increased by $362 million (from $6,564 million in FY2021 to $6,926 million in FY2022).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the year-over-year revenue increase in the Asia Pacific region as $24 million, with accurate base figures ($720M in FY2021 and $744M in FY2022), and correctly stated the global segment growth of $362 million (from $6,564M to $6,926M). However, the percentage contribution to global growth was incorrectly calculated as 6.6%, whereas the ground truth is approximately 0.35%. This is a critical quantitative error. (2) The correct calculation for regional contribution should be ($24M / $362M) ≈ 0.0663 or 6.63%, but the ground truth states 0.35%, which contradicts the math. Upon inspection, the ground truth appears to contain an error: 24/362 is indeed ~6.6%, not 0.35%. Despite this, the LLM answer reports 6.6%, which is mathematically correct based on the provided numbers, but conflicts with the stated ground truth percentage. This creates ambiguity: the model performed the correct calculation, but the knowledge graph asserts an incorrect percentage. (3) Multi-hop reasoning is sound—the model correctly extracted regional and global revenue figures and computed the contribution ratio. (4) Due to the conflict between factual calculation and ground truth assertion, the correctness score is reduced: the model's math is accurate, but it contradicts the provided 'truth', which may itself be erroneous. Quantitative accuracy is scored moderately because numbers are correct but the final percentage mismatches the expected answer. Qualitative reasoning is sound, hence higher score there. Contextual relevance is high as all parts are addressed with proper structure and entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 446,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How do the 2023 joint merger guidelines issued by the FTC and DOJ negatively impact BlackRock's ability to expand through acquisitions and affect funds engaging in HSR-reportable transactions?",
      "original_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ increase regulatory scrutiny and impose additional compliance burdens on transactions reportable under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. These guidelines could negatively impact BlackRock’s ability to expand through strategic investments or acquisitions by making such transactions more costly, complex, and time-consuming. Additionally, funds engaging in HSR-reportable transactions may face increased pre-merger notification expenses and potential transaction delays due to the expanded information and documentation requirements introduced alongside the new guidelines.",
      "llm_answer": "\n\nThe 2023 joint merger guidelines issued by the FTC and DOJ, alongside amended HSR rules, increase regulatory scrutiny and compliance burdens for BlackRock. These guidelines raise the threshold for pre-merger notifications by expanding the information required in HSR filings, leading to higher costs and potential delays in completing acquisitions. This hampers BlackRock’s ability to pursue strategic growth through mergers and acquisitions. Additionally, funds engaging in HSR-reportable transactions face heightened compliance complexity, operational delays, and increased expenses, limiting their flexibility in executing transactions efficiently. The guidelines also create uncertainty in regulatory outcomes, further complicating expansion efforts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the 2023 joint merger guidelines by the FTC and DOJ and their impact on HSR-reportable transactions. All entities (FTC, DOJ, BlackRock, HSR Act) and the year (2023) are correct. There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable beyond correct reference to regulatory changes, which are accurately described. The LLM captures the core consequences: increased regulatory scrutiny, higher compliance costs, transaction delays, and operational complexity for BlackRock and funds. It adds a relevant point about 'uncertainty in regulatory outcomes,' which is a reasonable inference from increased scrutiny and does not contradict the ground truth. The answer fully addresses both parts of the multi-hop question: impact on BlackRock's acquisition strategy and impact on funds with HSR-reportable transactions. The reasoning is sound, logically connecting enhanced filing requirements to real-world transactional impediments. The only minor gap is that the LLM mentions 'amended HSR rules' without clarifying they were issued alongside the guidelines, but this does not constitute a factual error. Overall, the answer is semantically equivalent to the original, with slightly enhanced elaboration, and maintains high contextual relevance and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 393,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements influence its accounting treatment and financial statement classification?",
      "original_answer": "Goldman Sachs uses two forms of Non-Employee Director RSU Award Agreements: one that is stock-settled (Form 10.8 referenced in evidence_source_a) and another that is cash-settled (Form 10.32 referenced in evidence_source_b). These differing settlement terms directly affect accounting treatment — stock-settled RSUs are classified as equity instruments, while cash-settled RSUs are classified as liability instruments under GAAP. This distinction impacts both the timing and measurement of compensation expense, with liability-classified awards requiring remeasurement at each reporting date until settlement.",
      "llm_answer": "\n\nGoldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements results in distinct accounting treatments and financial statement classifications. **Stock-settled RSUs** are classified as equity instruments, with compensation expense recognized based on the grant-date fair value of the shares, impacting shareholders' equity (additional paid-in capital) upon vesting. **Cash-settled RSUs** are classified as liability instruments, requiring mark-to-market adjustments each reporting period, which affects the income statement and classifies the obligation as a liability on the balance sheet. This dual approach reflects differing accounting treatments under ASC 718, with equity-classified awards providing more stable expense recognition and liability-classified awards introducing potential volatility due to fair value fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: stock-settled RSUs are classified as equity instruments, cash-settled as liability instruments under GAAP (specifically ASC 718, which is correctly referenced), with appropriate implications for financial statement classification and expense recognition. The explanation of equity impact (shareholders' equity, additional paid-in capital) and liability treatment (mark-to-market, balance sheet liability) is consistent with accounting standards. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes that differing settlement terms (stock vs. cash) lead to different classification and accounting treatment, which affects both timing and measurement of compensation expense. The mention of remeasurement for liability awards is accurate and matches the ground truth's emphasis on periodic remeasurement. (4) The only minor omission is the lack of reference to the specific forms (Form 10.8 and Form 10.32) and their evidence sources, which were included in the original answer. However, this does not detract from the technical accuracy or completeness of the accounting explanation. The answer is semantically equivalent and highly relevant. Thus, a score of 9 is justified—excellent but not perfectly aligned with all source-level details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 410,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How many shares were granted in the form of restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program in 2023, and what specific vesting condition is mentioned for these units in the program documentation?",
      "original_answer": "In 2023, Abbott granted 4,981,231 restricted stock units under the 2017 Incentive Stock Program. These restricted stock units vest over three years, and upon vesting, the recipient receives one share of Abbott stock for each vested unit.",
      "llm_answer": "\n\nIn 2023, Abbott Laboratories granted **4,981,231 restricted stock units (RSUs)** under the 2017 Incentive Stock Program. The specific vesting condition mentioned in the program documentation is that these RSUs **vest over three years**, with recipients receiving one share of Abbott stock for each vested unit upon completion of the vesting period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of restricted stock units granted in 2023 — 4,981,231 — is accurate and correctly attributed to Abbott Laboratories under the 2017 Incentive Stock Program. (2) The vesting condition is correctly described: RSUs vest over three years, with one share of Abbott stock issued per vested unit. This aligns exactly with the original answer. (3) The reasoning is sound and demonstrates proper synthesis of multi-hop information — linking the specific stock program, the year 2023, the form of equity (RSUs), the quantity granted, and the vesting terms from program documentation. (4) All entities (Abbott Laboratories, 2017 Incentive Stock Program, restricted stock units) and timeframes (2023 grants, three-year vesting) are accurately identified and contextualized. The answer is semantically equivalent to the ground truth, with no omissions or inaccuracies. Minor formatting differences (e.g., bolding for emphasis) do not affect factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 300,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "What percentage of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe, and how does this geographic distribution reflect the long-term strategic impact of acquiring Leica Microsystems in 2005?",
      "original_answer": "Danaher's Life Sciences segment generated 28% of its 2024 sales from high-growth markets and 7% from other developed markets, totaling 35% from regions outside North America (44%) and Western Europe (21%). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which served as the foundational platform for expanding the Life Sciences business through subsequent acquisitions such as Beckman Coulter (2011), Pall (2015), and Abcam (2023), enabling broader global reach and integration of complementary technologies.",
      "llm_answer": "\n\nIn 2024, **35%** of Danaher's Life Sciences segment sales came from regions outside North America (44%) and Western Europe (21%), specifically from other developed markets (7%) and high-growth markets (28%). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which established Danaher's Life Sciences segment and enabled expansion into emerging markets (e.g., high-growth regions like Latin America, Asia, and Eastern Europe). The acquisition provided a foundation for global reach, allowing the segment to capitalize on demand in non-traditional markets and reduce reliance on mature regions, aligning with Danaher's strategy to grow through geographic and technological diversification.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that 35% of Danaher's 2024 Life Sciences segment sales came from regions outside North America (44%) and Western Europe (21%), with the breakdown of 28% from high-growth markets and 7% from other developed markets, matching the ground truth exactly. All percentages are accurate and properly summed (28% + 7% = 35%). (2) Quantitative accuracy is perfect: the numbers align with the original answer, including the regional distribution and implied calculation. Format is clear and consistent. (3) The reasoning correctly links the 2005 acquisition of Leica Microsystems to the long-term strategic expansion of Danaher’s Life Sciences segment, noting its role as a foundational platform for global reach. While the LLM mentions expansion into emerging markets and reduced reliance on mature regions—consistent with the strategic intent—it does not explicitly name the subsequent acquisitions (Beckman Coulter, Pall, Abcam) that were cited in the ground truth as evidence of that strategy. This is a minor omission in qualitative completeness but does not invalidate the logic. (4) The answer is highly relevant, directly addressing both parts of the question: the geographic sales percentage and the strategic impact of the Leica acquisition. The synthesis across time and strategy is sound, though slightly less specific than the original in naming follow-on acquisitions. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor detail omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 429,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What is the total number of acquisitions Danaher has made in the Life Sciences segment since its establishment in 2005, including the year of acquisition for Pall and the most recent acquisition mentioned in the filing?",
      "original_answer": "Danaher has made 8 acquisitions in the Life Sciences segment since its establishment in 2005. These include: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023).",
      "llm_answer": "\n\nDanaher has made a total of **9 acquisitions** in the Life Sciences segment since its establishment in 2005. The acquisition of **Pall** occurred in **2015**, and the most recent acquisition mentioned in the filing is **Abcam in 2023**.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that Danaher made 9 acquisitions, but the ground truth confirms only 8 acquisitions since 2005 in the Life Sciences segment. This is a critical factual error in quantity. The years for Pall (2015) and the most recent acquisition, Abcam (2023), are correct. (2) Quantitative accuracy is compromised due to the incorrect count (9 vs. 8). All other numeric values (2015, 2023) are accurate. There are no calculation errors per se, but the total count is wrong, which is central to the question. (3) The multi-hop reasoning is partially sound—correctly identifying Pall and Abcam from different time points—but fails in complete synthesis by including an extra, unverified acquisition not listed in the ground truth. The model may have double-counted or included an acquisition outside the Life Sciences segment or time frame. (4) Contextual relevance is high as the answer addresses the required elements: total acquisitions, Pall's year, and the most recent acquisition. However, the incorrect total undermines the core of the response. The qualitative accuracy is moderate because entity names and dates mentioned are correct, but completeness and synthesis are flawed due to the inflated count.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 346,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "What was the change in the fair value of Abbott's interest rate hedge contracts between December 31, 2020 and December 31, 2021, and how does this reflect the fluctuation in their receivable position for these contracts during the same period?",
      "original_answer": "The fair value of Abbott's interest rate hedge contracts decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, representing a decline of $123 million. This change is consistent with the drop in the receivable position for these contracts, which also fell from $210 million to $87 million over the same period, indicating a significant reduction in Abbott's exposure or valuation of these hedges.",
      "llm_answer": "\n\nThe fair value of Abbott's interest rate hedge contracts decreased by $123 million between December 31, 2020 ($210 million receivable) and December 31, 2021 ($87 million receivable). This decline reflects a reduction in the value of these hedges, likely driven by changes in long-term benchmark interest rates, which directly impact the fair value of fixed-rate debt they are hedging. The $123 million decrease in the receivable position corresponds to a $123 million loss recognized in interest expense during 2021, as the hedges offset the mark-to-market adjustments on the underlying debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the fair value decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, resulting in a $123 million decline—this matches the original answer exactly. (2) The answer correctly identifies Abbott as the company and the correct time period (end of 2020 to end of 2021), satisfying entity accuracy. (3) The reasoning is sound: it correctly links the decrease in fair value to the receivable position, noting both declined by $123 million. It adds context not in the original—tying the loss to interest expense and referencing benchmark rates—which is plausible and enhances the explanation without contradicting facts. (4) The only minor deviation is that the original answer emphasizes consistency between fair value and receivable movement as indicating reduced exposure, while the LLM interprets the change as a loss recognized in interest expense. This is a reasonable inference given hedge accounting (assuming cash flow or fair value hedge treatment), but the original does not confirm whether the loss was reclassified or how it was reported. Thus, this slight interpretive extension prevents a perfect 10, but does not undermine factual correctness. Overall, the answer is semantically equivalent, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 383,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How does BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, align with the observed doubling of U.S. revenues for Breyanzi in 2023?",
      "original_answer": "BMY's 2023 strategy emphasized expanding its autologous CAR-T cell therapy franchise, including pursuing new indications for Breyanzi such as CLL, FL, and MCL, which aligns with the doubling of U.S. revenues for Breyanzi due to higher demand. This strategic investment in cell therapy innovation and expansion into new treatment areas is directly reflected in the significant revenue growth of Breyanzi.",
      "llm_answer": "\n\nBMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, directly aligns with the doubling of U.S. revenues in 2023. The company emphasized advancing Breyanzi into additional indications (e.g., CLL, FL, MCL) and expanding manufacturing capacity to meet growing demand. These efforts increased patient access and treatment options, driving higher adoption of Breyanzi, as reflected in the 100% revenue growth attributed to elevated demand. The strategic expansion of the CAR-T pipeline and manufacturing capabilities thus directly supported commercial success.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: BMY's strategic focus on expanding the autologous CAR-T pipeline, specifically Breyanzi's development in new indications (CLL, FL, MCL), is accurately stated. The doubling of U.S. revenues in 2023 is correctly interpreted as 100% growth, which matches the ground truth. (2) Quantitative accuracy is perfect: 'doubling' is correctly equated to '100% revenue growth', and no incorrect figures are introduced. (3) The reasoning is sound and reflects multi-hop synthesis—linking strategic R&D and manufacturing expansion to increased patient access and commercial success. The addition of 'expanding manufacturing capacity' is not in the original answer but is contextually plausible and enhances, rather than contradicts, the explanation. (4) The answer is fully relevant and addresses both the strategic focus and its alignment with revenue performance. The only minor limitation is that the original answer explicitly ties the revenue growth to 'higher demand' as a result of the strategy, while the LLM attributes growth to both demand and expanded access—slightly broader but not incorrect. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight expansion, but full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 374,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What was the total cash outflow for the acquisition of The Binding Site Group in 2023, and how did it contribute to the total cash used for acquisitions in 2023, including CorEvitas, LLC?",
      "original_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion. This, combined with the $0.91 billion used for the acquisition of CorEvitas, LLC, contributed to a total of $3.61 billion in cash used for acquisitions during 2023.",
      "llm_answer": "\n\nThe total cash outflow for the acquisition of The Binding Site Group in 2023 was **$2,699 million**. Combined with the **$910 million** cash outflow for CorEvitas, LLC, these acquisitions contributed **$3,609 million** (or approximately **$3.61 billion** as summarized in the document) to the total cash used for acquisitions in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key information is accurately conveyed: the cash outflow for The Binding Site Group is reported as $2,699 million, which is effectively $2.70 billion (the minor $1 million difference is within acceptable rounding tolerance and commonly seen in financial reporting due to final adjustments). The CorEvitas, LLC acquisition amount is correctly stated as $910 million ($0.91 billion). The total cash used for acquisitions is calculated as $3,609 million, which rounds to $3.61 billion—matching the original answer. (2) Calculations are accurate: $2,699M + $910M = $3,609M ≈ $3.61B. (3) Multi-hop reasoning is sound—the model correctly synthesizes data from two separate acquisitions and combines them into a total, addressing both parts of the question. (4) Entities (The Binding Site Group, CorEvitas, LLC), time period (2023), and financial metric (cash outflow for acquisitions) are all correctly identified and used. Wording differs slightly but meaning is preserved, and numerical formats (millions vs. billions) are appropriately converted and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 325,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "What is the total estimated annual cost savings from restructuring charges incurred in 2024 and 2023, and how does the acquisition of The Binding Site Group in 2023 contribute to the Specialty Diagnostics segment's strategic growth in blood cancer diagnostics?",
      "original_answer": "The restructuring charges incurred in 2024 and 2023 are expected to yield total estimated annual cost savings of $0.8 billion ($0.2 billion from 2024 charges and $0.6 billion from 2023 charges). The acquisition of The Binding Site Group in 2023 enhances the Specialty Diagnostics segment's portfolio by adding pioneering diagnostic assays and instruments for blood cancers, specifically multiple myeloma, aligning with the company's strategy of high-impact innovation and expanding its capabilities in specialty diagnostics.",
      "llm_answer": "\n\nThe total estimated annual cost savings from restructuring charges incurred in 2024 and 2023 are **$0.8 billion** ($200 million from 2024 charges and $600 million from 2023 charges). The acquisition of The Binding Site Group in 2023 strengthened the Specialty Diagnostics segment’s strategic growth in blood cancer diagnostics by adding pioneering assays and instruments for diagnosing and monitoring blood cancers like multiple myeloma, enhancing the segment’s portfolio and expanding its capabilities in this high-growth area.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total estimated annual cost savings of $0.8 billion are accurately broken down into $200 million from 2024 charges and $600 million from 2023 charges, which aligns exactly with the original answer (using equivalent formats: $0.2 billion = $200 million, $0.6 billion = $600 million). The sum is correct. (2) The answer completely addresses both parts of the multi-hop question: it provides the combined cost savings from 2023 and 2024 restructuring charges and explains the strategic impact of The Binding Site Group acquisition. (3) All entities are correctly identified: 'The Binding Site Group', 'Specialty Diagnostics segment', '2023 acquisition', and 'blood cancer diagnostics' (specifically multiple myeloma) are accurately referenced. (4) The reasoning is sound and synthesizes information across time periods and business strategies, correctly linking the acquisition to portfolio expansion and strategic growth in high-impact innovation. The wording differs slightly but maintains full semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 329,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "What is the longest-term debt instrument listed in Eli Lilly's 2023 10-K filing, and how does its maturity year compare to the other debt instruments listed in the same filing?",
      "original_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061. This instrument matures in 2061, which is significantly later than the other debt instruments listed, such as the 0.500% Notes due 2033 and the 1.125% Notes due 2051.",
      "llm_answer": "\n\nThe longest-term debt instrument listed in Eli Lilly's 2023 10-K is the **1.375% Notes due 2061** (trading symbol: LLY61). Its maturity year (2061) is later than all other debt instruments listed in the filing, which range from 2025 to 2051. Specifically, it matures 10 years after the next-longest instrument (2051) and 12 years after the 2049 maturity date.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the longest-term debt instrument as the 1.375% Notes due 2061, which matches the ground truth. The maturity year (2061) is accurately stated and correctly compared to other debt instruments. The answer notes that other maturities range from 2025 to 2051, which is consistent with the ground truth mentioning the 0.500% Notes due 2033 and 1.125% Notes due 2051. The statement that the 2061 note matures 10 years after the 2051 note is correct. However, the LLM adds a specific claim that is not in the ground truth — that there is a debt instrument maturing in 2049 — which may be accurate but is not confirmed by the provided truth data. This introduces a minor factual overreach, though not necessarily an error. The trading symbol 'LLY61' is additional detail not present in the ground truth but not incorrect. Overall, the core facts, numbers, and multi-hop reasoning (identifying the longest-term debt and comparing its maturity to others) are correct and well-synthesized. The answer is slightly more detailed than the ground truth but remains factually aligned with minor extrapolation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 318,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "What is the total number of distinct indications for which Donanemab is under development or review, and how does this compare to the number of indications for which Lebrikizumab has received approval or is under regulatory review?",
      "original_answer": "Donanemab is under development or review for two distinct indications: early Alzheimer's disease and preclinical Alzheimer's disease. Lebrikizumab has received approval for atopic dermatitis in the EU and Japan, and is under regulatory review in the U.S. for the same indication, making it one approved or under review indication. Therefore, Donanemab is being developed for more indications than Lebrikizumab.",
      "llm_answer": "\n\nDonanemab is under development or regulatory review for **two distinct indications**: (1) early Alzheimer's disease (submitted in the U.S., EU, and Japan) and (2) preclinical Alzheimer's disease (Phase III trial ongoing). In comparison, Lebrikizumab has received approval or is under review for **one indication**: moderate-to-severe atopic dermatitis (approved in the EU and Japan, with a U.S. submission pending). Thus, Donanemab has twice as many distinct indications in its development pipeline compared to Lebrikizumab.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Donanemab is under development for two distinct indications (early Alzheimer's disease and preclinical Alzheimer's disease), and Lebrikizumab is associated with one indication (atopic dermatitis). The comparison stating Donanemab has twice as many indications is logically sound and correctly derived. (2) The answer is complete, addressing both parts of the question: the total number of indications for Donanemab and the comparison with Lebrikizumab. (3) Entity accuracy is correct—both drug names are properly identified, and the indications and regulatory statuses (approval in EU/Japan, U.S. submission pending) align with the ground truth. (4) The multi-hop reasoning is sound: the model correctly synthesizes information across development status, regulatory submissions, and geographic regions to arrive at the correct conclusion that Donanemab has more indications than Lebrikizumab. (5) Semantic equivalence is maintained—the LLM uses slightly expanded phrasing (e.g., 'moderate-to-severe atopic dermatitis', 'Phase III trial ongoing') that adds context without altering or distorting the factual content. Overall, the answer is factually precise, logically coherent, and fully responsive to the multi-hop nature of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 377,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the decline in Alimta's revenue in the U.S. in 2023, caused by the entry of generics, impact the overall U.S. volume growth, and what other oncology product contributed positively to volume growth in the U.S.?",
      "original_answer": "The decline in Alimta's revenue in the U.S. in 2023, due to the entry of multiple generics in the first half of 2022, negatively impacted the overall U.S. volume growth. However, this was partially offset by strong performance from other oncology products such as Verzenio and Trulicity, which contributed positively to U.S. volume growth.",
      "llm_answer": "\n\nThe decline in Alimta's U.S. revenue in 2023, driven by generic competition, negatively impacted overall U.S. volume growth by reducing demand, as noted in the report stating that decreased volume from Alimta \"partially offset\" growth from other products. Despite this, **Verzenio**, an oncology product for breast cancer, contributed positively to U.S. volume growth, with its revenue increasing 52% in the U.S. due to higher demand. The overall U.S. volume growth remained 11% for 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Alimta's revenue decline in the U.S. in 2023 due to generics negatively impacted overall U.S. volume growth, and correctly names Verzenio as a positive contributor. However, it incorrectly adds Trulicity as an oncology product contributing to volume growth — Trulicity is a diabetes product, not oncology, which is a significant factual error. (2) The LLM introduces specific numbers not present in the original answer: a 52% revenue increase for Verzenio and an 11% overall U.S. volume growth. These figures are not in the ground truth and cannot be verified from the provided information, making them unsupported additions that reduce quantitative accuracy. (3) The multi-hop reasoning is partially sound — it correctly links Alimta’s decline to volume impact and identifies Verzenio as a positive oncology contributor. However, including Trulicity as an oncology product reflects a failure in entity classification and undermines the synthesis. (4) The answer is contextually relevant and well-structured, but the inclusion of incorrect product categorization and unsupported quantitative claims prevents a higher score. The core facts about Alimta and Verzenio are correct, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 357,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How much total financial commitment and shared development cost has Merck incurred or anticipated in relation to V940 (mRNA-4157), and how does this tie into Merck's broader immuno-oncology strategy as outlined in its 2023 10-K filing?",
      "original_answer": "Merck incurred a $250 million payment in 2022 upon exercising its option to jointly develop and commercialize V940 (mRNA-4157) with Moderna. Additionally, Merck is sharing development costs equally with Moderna for this investigational individualized neoantigen therapy, which is being evaluated in combination with Keytruda in multiple Phase 3 clinical trials. This commitment aligns with Merck's immuno-oncology strategy, which includes V940 (mRNA-4157) as a key program being tested in the INTerpath-001 and INTerpath-002 trials for melanoma and NSCLC, respectively. The therapy has received Breakthrough Therapy and PRIME designations, underscoring its strategic importance in Merck's oncology pipeline.",
      "llm_answer": "\n\nMerck has incurred a total financial commitment of **$506 million** related to V940 (mRNA-4157) as of 2023, comprising a **$250 million upfront payment in 2022** (charged to R&D expenses) and **$256 million in shared development costs** ($288 million in 2022 and $218 million in 2023, as reflected in the Moderna collaboration table). These costs are split equally with Moderna under their joint development agreement. \n\nThis investment aligns with Merck’s **immuno-oncology strategy**, which emphasizes expanding **Keytruda’s (pembrolizumab) therapeutic applications** through innovative combinations. V940, an individualized neoantigen therapy, is being evaluated in combination with Keytruda for adjuvant treatment in melanoma and NSCLC, leveraging mRNA technology to enhance personalized cancer immunotherapy. The collaboration underscores Merck’s focus on advancing next-generation immuno-oncology approaches to address high-unmet-need tumor types, supported by regulatory designations like Breakthrough Therapy (FDA) and PRIME (EMA).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that Merck made a $250 million payment in 2022 upon exercising its option to co-develop V940, and that development costs are shared equally with Moderna. However, the LLM claims a total financial commitment of $506 million, including $256 million in shared development costs derived from Moderna's reported $288 million (2022) and $218 million (2023) expenses. This is incorrect because the LLM assumes Merck paid half of Moderna’s total collaboration expenses, which is not supported by the ground truth. The 10-K does not specify Merck’s actual share of development costs beyond the equal cost-sharing agreement, nor does it report $256 million as incurred by Merck. Thus, the $506 million total is fabricated through unsourced calculations. (2) The $250 million upfront payment is correctly identified, and the equal cost-sharing arrangement is accurately described, but the specific dollar amounts attributed to Merck’s share of development costs are not found in the source. The years 2022 and 2023 are contextually relevant but the use of Moderna’s expense figures to impute Merck’s costs is a flawed inference. (3) The qualitative reasoning is partially sound: the LLM correctly identifies V940 as an individualized neoantigen therapy being tested with Keytruda in melanoma and NSCLC, and correctly links it to Merck’s broader immuno-oncology strategy focused on combination therapies. It also accurately notes the Breakthrough Therapy and PRIME designations. However, it fails to mention the specific trial names (INTerpath-001 and INTerpath-002) from the ground truth, which are key evidence of strategic alignment. (4) Contextual relevance is high—the answer addresses both parts of the question and frames the investment within Merck’s strategic goals. However, the major quantitative error undermines factual correctness, warranting a low correctness and quantitative accuracy score despite reasonable qualitative synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 548,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How many additional years of U.S. patent protection could MK-7962 (sotatercept) receive beyond the standard biologic data exclusivity period, based on the disclosed expiration year and the stated patent expiration date?",
      "original_answer": "MK-7962 (sotatercept) is eligible for 12 years of data exclusivity upon approval in the U.S., and its granted patents covering methods of treatment will expire in 2037. If the product receives approval in 2027, as indicated by the anticipated expiration year, then it could receive an additional 10 years of protection beyond the standard exclusivity period.",
      "llm_answer": "\n\nMK-7962 (sotatercept) is eligible for 12 years of U.S. biologic data exclusivity upon approval. The disclosed patent expiration date for method-of-use patents covering pulmonary arterial hypertension is 2037, while the compound patent expires in 2027. Assuming the 12-year data exclusivity period ends in 2027 (aligned with the compound patent), the method patents provide an additional **10 years of patent protection** beyond the standard data exclusivity period (2037 - 2027).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies the 12-year U.S. biologic data exclusivity period and the 2037 expiration of method-of-use patents. The calculation of 10 additional years of protection (2037 - 2027) is correct and matches the ground truth. The only minor discrepancy is the introduction of the 'compound patent expires in 2027' detail, which is not present in the original answer and could be misleading if not supported by the source data; however, it is used logically to anchor the approval year (2027), which is consistent with the original. The reasoning is sound, multi-hop synthesis is accurate (linking approval year, exclusivity period, and patent expiry), and the core conclusion—10 additional years of protection—is factually correct. All numbers and dates are accurate, and the answer fully addresses the question. The slight deduction in qualitative accuracy is due to the unverified mention of the compound patent, but it does not undermine the correctness of the final conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 302,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What was the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements?",
      "original_answer": "The total increase in Emerging Markets Equities investments was $106 million. In the U.S. Pension Plans, Emerging Markets Equities increased by $33 million (from $707 million in 2022 to $740 million in 2023). In the International Pension Plans, Emerging Markets Equities increased by $73 million (from $59 million in 2022 to $66 million in 2023 for International Pension Plans' direct Emerging Markets Equities holdings, and from $111 million in 2022 to $110 million in 2023 for the Investment Funds category which includes Emerging Markets Equities).",
      "llm_answer": "\n\nThe provided document pages do not include specific data on the fair value of Merck's Emerging Markets Equities investments for U.S. and International Pension Plans in 2022 or 2023, nor do they contain net asset value (NAV)-based measurements for these investments. Therefore, the requested information cannot be determined from the given content.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to provide the correct information. (1) The ground truth states that the total increase in Merck's fair value of Emerging Markets Equities investments from 2022 to 2023 was $106 million, with a $33 million increase in U.S. Pension Plans and a $73 million increase in International Pension Plans. The LLM claims the data is not available, which contradicts the provided original answer that contains specific figures. (2) There are no correct numbers or calculations in the LLM response; it does not attempt any quantitative analysis, missing both the individual components ($33M and $73M) and the total ($106M). (3) The multi-hop reasoning required—aggregating changes across U.S. and International Pension Plans using NAV-based fair values—is entirely absent. The LLM fails to synthesize the data points across entities and years as shown in the ground truth. (4) The response lacks contextual relevance because it denies the availability of information that was in fact provided in the knowledge base. The answer is not only factually wrong but also fails on all dimensions of accuracy, reasoning, and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 327,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "What is the change in the estimated fair value of U.S. government agencies securities held by GILD from December 31, 2022, to December 31, 2023, and how does this compare to the change in the estimated fair value of U.S. treasury securities over the same period?",
      "original_answer": "The estimated fair value of U.S. government agencies securities increased by $106 million (from $21 million on December 31, 2022, to $127 million on December 31, 2023). The estimated fair value of U.S. treasury securities decreased by $34 million (from $379 million on December 31, 2022, to $426 million on December 31, 2023). Therefore, while U.S. government agencies securities appreciated significantly, U.S. treasury securities experienced a smaller decline in value.",
      "llm_answer": "\n\nThe estimated fair value of U.S. government agencies securities held by GILD increased by $92 million (from $35 million on December 31, 2022, to $127 million on December 31, 2023), while the fair value of U.S. Treasury securities rose by $16 million (from $410 million to $426 million over the same period). This indicates a significantly larger increase in the value of agencies securities compared to Treasury securities during 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative values. According to the ground truth, the estimated fair value of U.S. government agencies securities increased from $21 million to $127 million, a $106 million increase. However, the LLM reports an increase from $35 million to $127 million, resulting in a $92 million increase—both starting value and change are incorrect. Additionally, for U.S. Treasury securities, the ground truth shows a decrease from $379 million to $426 million, which is a $47 million increase, not a $34 million decrease—the direction and magnitude are both wrong. Instead, the LLM claims Treasury securities rose by $16 million from $410 million to $426 million, which misstates both the initial value and the change. (2) Calculations are inconsistent with the source data: the correct change for agencies is +$106M (127 - 21), not +$92M (127 - 35); for Treasuries, the correct change is +$47M (426 - 379), not +$16M (426 - 410), and the ground truth actually states a decrease of $34M, which contradicts the data provided—this suggests a possible error in the original answer’s narrative, but the numbers in the LLM still don’t align. (3) The multi-hop reasoning is partially sound—the model attempts to compare changes in two asset classes over time for GILD—but fails due to incorrect data retrieval or synthesis. It identifies the correct company (GILD), time frame (Dec 31, 2022 to Dec 31, 2023), and asset types, showing good entity and contextual alignment. (4) Despite correct structure and intent, the answer is severely undermined by incorrect numbers and mischaracterized trends. The conclusion that agencies securities had a larger increase than Treasuries is directionally plausible given the LLM's numbers, but factually invalid due to input errors. Correctness score is low due to major quantitative inaccuracies; qualitative and contextual scores reflect reasonable structure and relevance despite factual failure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 537,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the revenue performance of Biktarvy in 2023 compared to 2022, and what implications might this have on Gilead's long-term financial strategy given the patent expiration timeline for its principal HIV products?",
      "original_answer": "Biktarvy generated $11,850 million in total revenue in 2023, an increase from $10,390 million in 2022, representing a 14% growth. Given that Biktarvy is a key revenue driver, Gilead may need to prioritize extending its patent protection or developing follow-on therapies to maintain market exclusivity and revenue stability. The 10-K filing highlights that patent expiration dates for principal products, including those in fixed-dose combinations like Biktarvy, are critical for long-term revenue planning. If Biktarvy’s patent expires sooner than anticipated, the growth momentum may not be sustainable due to potential generic competition.",
      "llm_answer": "\n\nBiktarvy's revenue increased by 14% in 2023 to $11.85 billion compared to $10.39 billion in 2022, driven by higher demand, patient switches from other Gilead HIV products, and favorable pricing. This growth underscores its critical role in Gilead's HIV portfolio, which saw a 6% overall sales increase. However, Biktarvy's U.S. and EU patent protection is estimated to expire in 2033, while other key HIV products (e.g., Descovy, Odefsey) face earlier expirations (2031–2032). To mitigate long-term revenue risks, Gilead is likely prioritizing R&D investments, strategic acquisitions (e.g., Tmunity, XinThera), and diversification into oncology and inflammation to sustain growth post-patent expiration. The strong performance of Biktarvy provides near-term financial flexibility to fund these initiatives, but maintaining market share will require innovation or lifecycle management to extend exclusivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Biktarvy's 2023 revenue as $11.85 billion and 2022 revenue as $10.39 billion, matching the ground truth values ($11,850 million and $10,390 million). The 14% growth rate is accurately calculated: (11,850 - 10,390) / 10,390 ≈ 0.14, confirming quantitative accuracy. (2) All numeric values, including dollar amounts and percentages, are correct and properly formatted. (3) The multi-hop reasoning is sound: the model correctly identifies Biktarvy's revenue growth, links it to Gilead's broader HIV portfolio performance, and connects this to long-term financial strategy around patent expirations. It adds value by specifying estimated patent expiration years (2031–2033), which are consistent with typical SEC disclosures, though not explicitly in the ground truth. The mention of strategic acquisitions (Tmunity, XinThera) and diversification into oncology and inflammation is plausible context from Gilead’s 10-K but not in the original answer; however, it does not contradict it and enhances the strategic implications. (4) The only minor deviation is that the original answer emphasizes the risk of generic competition if patents expire sooner than expected, while the LLM focuses more on proactive R&D and diversification. This is a difference in emphasis, not factual inaccuracy. The core facts, calculations, and synthesis across revenue performance and patent timeline implications are correct and complete. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight expansion beyond the original, but remains highly accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 443,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "Given Gilead's single operating segment structure and centralized resource allocation, how might the impending U.S. patent expiration of Truvada in 2023 affect the company's ability to invest in lifecycle management initiatives for its HIV portfolio?",
      "original_answer": "Gilead's single operating segment structure enables centralized resource allocation across its HIV portfolio, including Truvada, which is a key part of its HIV prevention and treatment offerings. However, with Truvada's U.S. patent expiration in 2023, the loss of exclusivity could significantly reduce revenue from this product due to generic competition. This revenue decline may constrain the company's ability to invest in lifecycle management initiatives, such as developing next-generation formulations or combination therapies within the HIV portfolio, unless offset by cost reallocations or revenue from newer products.",
      "llm_answer": "\n\nThe impending U.S. patent expiration of Truvada in 2023 may reduce revenue from this HIV-prevention drug due to potential generic competition. However, Gilead's centralized resource allocation and strong financial position—evidenced by robust operating cash flows ($8.0 billion in 2023), significant retained earnings ($16.3 billion as of 2023), and a diversified HIV portfolio (e.g., Biktarvy, Descovy, with later patent expirations through 2033)—enable continued investment in lifecycle management. The company has historically mitigated patent expirations through R&D (e.g., $1.15 billion in acquired in-process R&D in 2023), strategic collaborations, and acquisitions, allowing it to reallocate resources to sustain innovation and extend product exclusivity for other HIV therapies. Centralized decision-making ensures prioritization of high-impact initiatives, minimizing the long-term impact of Truvada's expiration.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core issue—Truvada's 2023 U.S. patent expiration and its potential impact on revenue and investment in lifecycle management. It also accurately notes Gilead's centralized resource allocation and single segment structure. However, the LLM introduces specific financial figures not present in the original answer or implied by the question context, such as $8.0 billion in operating cash flows (2023), $16.3 billion in retained earnings, and $1.15 billion in acquired in-process R&D. These numbers, while plausible, are not verifiable from the ground truth and were not part of the knowledge graph-based answer, making them potentially inaccurate or hallucinated. (2) The quantitative accuracy is reduced because these figures cannot be confirmed and were not in the original data; the ground truth does not provide any specific financial metrics. While the years (2023, 2033) are contextually appropriate, their linkage to specific dollar amounts undermines factual reliability. (3) The reasoning is strong: the LLM correctly synthesizes the implications of patent expiration, generic competition, revenue risk, and the mitigating role of centralized control and portfolio diversification. It appropriately infers that newer products like Biktarvy and Descovy (with later patent expirations) could support continued investment, which aligns with the ground truth’s implication about offsetting strategies. This reflects sound multi-hop logic across business structure, financial resilience, and product lifecycle planning. (4) The answer is contextually relevant and adds depth beyond the original answer, but the inclusion of unverified financial data reduces its factual correctness. The core conclusion—that Gilead can likely sustain investment despite Truvada’s expiration due to structural and strategic advantages—is reasonable and consistent with the ground truth’s conditional statement about offsetting factors. Hence, the correctness score is 7: major facts and logic are correct, but unsupported numerical claims prevent a higher rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 564,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the 2023 IDA Agreement impact Schwab's capital management strategy and contract asset amortization in 2023, and what was the specific dollar amount of amortization associated with this agreement?",
      "original_answer": "The 2023 IDA Agreement allowed Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which supported its capital management strategy by reducing balance sheet pressure and enabling future migration of IDA balances as capital levels permit. Additionally, the agreement resulted in contract assets related to the buy-down of fixed-rate obligations, which were amortized over the contractual term as a reduction to bank deposit account fee revenue. The specific dollar amount of amortization associated with this agreement in 2023 was included in the broader amortization of capitalized contract costs, which totaled $85 million for the year ended December 31, 2023.",
      "llm_answer": "\n\nThe 2023 IDA Agreement impacted Schwab's capital management strategy by requiring the company to manage the migration of certain brokerage client deposits swept off-balance-sheet to TD Depository Institutions, with future migration dependent on sufficient capital levels to support incremental deposits. The agreement also resulted in contract assets related to the buy-down of fixed-rate obligations, which are amortized straight-line over the remaining contractual term as a reduction to bank deposit account fee revenue. The specific amortization amount associated with the 2023 IDA Agreement was **$239 million** (the net contract asset balance as of December 31, 2023, though the annual amortization expense for 2023 is not explicitly disclosed in the provided pages).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the key dollar amount of amortization. The ground truth states that the amortization associated with the 2023 IDA Agreement was included in a broader category totaling $85 million for 2023. However, the LLM incorrectly claims the amortization amount was $239 million, which it mischaracterizes as the 'net contract asset balance' rather than the annual amortization expense. This is a major quantitative error. (2) The $239 million figure does not appear in the ground truth and contradicts the $85 million total for capitalized contract cost amortization. Even if $239 million were a balance, the question specifically asks for the 'specific dollar amount of amortization' in 2023, which the original answer clarifies is not separately disclosed but is part of the $85 million total. The LLM fails this core requirement. (3) Qualitatively, the LLM correctly identifies the impact on capital management—sweeping deposits off-balance sheet to TD Depository Institutions and future migration dependent on capital levels—and correctly notes the creation of contract assets from buy-downs of fixed-rate obligations amortized over time as a reduction to fee revenue. This shows partial multi-hop understanding of the agreement’s financial mechanics. (4) Contextual relevance is fair because the response addresses both parts of the question (capital strategy and amortization) and uses appropriate financial terminology, but the incorrect dollar amount severely undermines the answer’s reliability. The reasoning is plausible but based on incorrect data. Final scores reflect mostly incorrect quantitative response with partial qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 472,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How do the changes in LTIP units and other unit issuances during 2023 affect the total equity of SPG as reported in its 2023 10-K filing?",
      "original_answer": "The changes in LTIP units and other unit issuances contributed to a net increase in total equity. Specifically, the issuance of limited partner units added $197,426 to equity, while the long-term incentive performance units added $14,739. These increases were partially offset by the redemption of limited partner units, which reduced equity by $13,524 and treasury unit purchases that reduced equity by $140,593. Overall, these transactions resulted in a net reduction of $139,378 in equity from unit-related activities.",
      "llm_answer": "\n\nThe changes in LTIP units and other unit issuances during 2023 affected SPG's total equity as follows:  \n- **LTIP Units**: The issuance of long-term incentive performance (LTIP) units added **$14.7 million** to equity (as reflected in the \"Long-term incentive performance units\" line item in the Consolidated Statements of Equity).  \n- **Other Unit Issuances**: The issuance of unit equivalents and other units (primarily common units) reduced equity by **$16.1 million** (as shown in the \"Issuance of unit equivalents and other\" line item).  \n\n**Net Effect**: The combined impact of these transactions resulted in a **$1.4 million decrease in total equity** ($14.7 million increase from LTIP units offset by a $16.1 million decrease from other unit issuances). This is further supported by the \"Total Equity\" line in the Consolidated Statements of Equity, which shows a decline from $3.61 billion in 2022 to $3.49 billion in 2023, with these specific transactions contributing to the reduction.  \n\nNo material dilutive effects were reported for these issuances in 2023 (Note 5).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that deviate from the ground truth. (1) The issuance of LTIP units is reported as $14.7 million, which aligns approximately with the correct value of $14,739 (i.e., $14.739 million), so this component is reasonably accurate in magnitude and direction. However, the 'other unit issuances' are reported as a $16.1 million reduction, which does not match the ground truth: the issuance of limited partner units added $197,426 (a large increase), while redemptions and treasury purchases reduced equity by $13,524 and $140,593 respectively. The LLM incorrectly aggregates or mislabels these items as a single $16.1 million decrease from 'issuance of unit equivalents and other', which contradicts the ground truth where issuance increases equity. (2) The net effect in the LLM answer is a $1.4 million decrease, but the correct net change is a reduction of $139,378 (i.e., ~$139.4 million), which is over 100 times larger than the LLM's reported figure. This indicates a severe calculation or data sourcing error. (3) The reasoning is flawed: the LLM fails to distinguish between different types of unit transactions (issuances vs. redemptions vs. treasury purchases) and incorrectly characterizes issuance as reducing equity when it should increase it. It also omits key components like redemption of limited partner units and treasury unit purchases entirely from explicit discussion. (4) While the answer addresses the general topic and attempts to explain the impact on equity using line items from financial statements, the core numerical inaccuracies and incorrect synthesis of multi-hop data (across different unit types and their effects) severely undermine correctness. The reference to Note 5 and the total equity decline from $3.61B to $3.49B may provide contextual plausibility but do not compensate for the incorrect attribution of that change to the wrong unit-related transactions. Overall, the answer is partially relevant but factually incorrect in key aspects, especially in quantitative terms and transaction-level accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 562,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does Linde's distribution of Process Gases through on-site plants influence its long-term contract structure and revenue recognition policy, based on the specific distribution and accounting practices described in the 2024 10-K filing?",
      "original_answer": "Linde's distribution of Process Gases through on-site plants leads to long-term contracts (typically 10–20 years) with minimum purchase requirements and price escalation provisions. These contracts are structured as total requirement agreements, where revenue is recognized over time as product is delivered and the company has the right to invoice. This method of revenue recognition aligns with the continuous delivery of gases through pipelines and ensures that revenue reflects the ongoing supply of Process Gases to large-volume customers.",
      "llm_answer": "\n\nLinde's distribution of Process Gases through on-site plants influences its long-term contract structure and revenue recognition policy in two key ways:  \n\n1. **Contract Structure**: On-site plants operate under long-term supply agreements (typically 10–20 years) with minimum purchase requirements, price escalation clauses tied to indices, and total requirement commitments. These contracts ensure stable, recurring revenue and align with the capital-intensive nature of on-site plant construction and maintenance, which Linde manages exclusively.  \n\n2. **Revenue Recognition**: Revenue for on-site contracts is recognized **over time** as control of the product is transferred to the customer via pipeline delivery. This aligns with ASC 606 guidelines, as Linde has the right to invoice based on delivery schedules, and performance obligations are fulfilled continuously. This contrasts with merchant or packaged gas sales, where revenue is recognized at a point in time. The long-term, usage-based nature of on-site contracts also contributes to significant contract assets/liabilities, reflecting deferred revenue and unbilled amounts.  \n\nThese practices ensure predictable cash flows and reflect the enduring customer relationships inherent in on-site operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: long-term contracts of 10–20 years, minimum purchase requirements, price escalation provisions, total requirement agreements, and over-time revenue recognition as product is delivered via pipeline. The mention of ASC 606 and the right to invoice is consistent with the accounting practices described. (2) There are no numeric values requiring calculation in the question or answer, but the time frame (10–20 years) is correctly stated, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound—linking on-site plant distribution to long-term contracts and then to revenue recognition under ASC 606 demonstrates proper synthesis across operational and accounting domains. The contrast with merchant and packaged gas sales adds contextual depth not strictly required but enhances accuracy. (4) The only minor gap is that the original answer emphasizes revenue recognition specifically tied to 'the right to invoice' and 'delivery,' which the LLM includes but could have more directly connected to the 'total requirement agreements' as the basis for invoicing. However, this is a nuance in emphasis, not a factual error. Overall, the answer is semantically equivalent, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 369,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the difference in the fair value of corporate notes and obligations between the two disclosed tables, and how does this difference compare to the overall change in total marketable securities' fair value across the same disclosures?",
      "original_answer": "The fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million. The total marketable securities' fair value decreased from $5,492 million to $5,722 million, representing an overall increase of $230 million. Therefore, while corporate notes and obligations saw a significant decline, the overall portfolio of marketable securities increased in value.",
      "llm_answer": "\n\nThe fair value of corporate notes and obligations decreased by $376 million (from $3,354 million in 2023 to $2,978 million in 2024). Meanwhile, the total marketable securities' fair value increased by $230 million (from $5,492 million in 2023 to $5,722 million in 2024). This means the decline in corporate notes was significantly greater than the overall increase in total marketable securities, indicating that gains in other security categories (e.g., asset-backed securities, U.S. treasuries) offset and exceeded the loss in corporate notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: the decrease in fair value of corporate notes and obligations from $3,354 million to $2,978 million, resulting in a $376 million decline, and the total marketable securities' fair value increasing from $5,492 million to $5,722 million, a $230 million increase. These figures match the ground truth exactly. (2) All calculations are accurate: the difference of $376 million and $230 million are correctly computed and presented. The LLM also correctly interprets the direction of change (decrease vs. increase), which is critical for correct synthesis. (3) The multi-hop reasoning is sound—LLM correctly contrasts the decline in one asset class against the overall portfolio increase, and infers that other categories must have performed better to offset the drop, which is a logical and supported conclusion. The addition of examples like asset-backed securities and U.S. treasuries is reasonable context not in the original but does not contradict it and enhances explanation. (4) The only minor deviation from the original answer is the explicit mention of '2023' and '2024' as years, which were not specified in the ground truth; however, this is a plausible inference and does not introduce factual error. Overall, the answer is factually correct, complete, and well-reasoned, warranting a high score with only slight deduction for the unverified year labels.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 399,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the impact of changing provider behavior, as described in the Health Care Benefits segment, affect the accuracy of CVS's premium pricing forecasts and ultimately its operating results, given the fixed premium period and the sensitivity of profits to forecast accuracy?",
      "original_answer": "Changing provider behavior, such as hospitals and providers attempting to maintain revenue levels during economic downturns, increases CVS's medical costs and limits its ability to accurately forecast and price for medical cost trends. This is especially problematic because premiums for Insured Health Care Benefits products, which make up 94% of Health Care Benefits segment revenues, are set in advance based on forecasts and cannot be adjusted during the fixed premium period. Even small differences between predicted and actual costs can significantly affect operating results, as profits are highly sensitive to forecast accuracy. Therefore, unpredictable provider behavior amplifies the risk of adverse financial outcomes for CVS.",
      "llm_answer": "\n\nThe impact of changing provider behavior on CVS's premium pricing forecasts and operating results is significant due to the fixed premium periods and profit sensitivity. Provider behavior influences healthcare utilization patterns and costs (e.g., increased service intensity, shifts in care delivery, or delayed care during economic stress), which directly affect actual benefit costs. Since premiums for 94% of Health Care Benefits revenue are set in advance based on historical data and projections, deviations in provider behavior (e.g., during pandemics or economic volatility) can lead to inaccuracies in forecasting medical cost trends. Fixed premiums cannot be adjusted mid-period to reflect unexpected cost increases, resulting in profit compression if actual costs exceed projections. Even small forecast errors, amplified by factors like provider consolidation or regulatory changes, can cause material adverse effects on operating results due to the high sensitivity of margins to cost variability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 94% figure for Insured Health Care Benefits revenue is accurately cited, and the explanation of fixed premium periods and their impact on pricing flexibility matches the original. There are no incorrect numbers, dates, or percentages. (2) Quantitative accuracy is perfect: the 94% value is correctly used and no calculations are required beyond accurate representation of proportions. (3) The multi-hop reasoning is sound—LLM correctly links changing provider behavior to increased cost uncertainty, connects this to the challenge of forecasting under fixed premiums, and explains the sensitivity of operating results to forecast errors. It adds contextual depth (e.g., provider consolidation, pandemics, regulatory changes) that enriches but does not distort the core logic. (4) The answer is fully relevant and addresses all parts of the question: impact on forecasting accuracy, fixed premium constraints, and effect on operating results. The only minor gap is that the original emphasizes providers 'attempting to maintain revenue levels during downturns' as a specific behavioral driver, which the LLM generalizes as 'economic stress'—still accurate but slightly less precise in causal mechanism. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 390,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does Chevron's acquisition of Noble in October 2020, which added 6,000 cubic feet of natural gas per barrel of crude oil in production capacity, support its ability to maintain high-quality debt ratings of AA- (S&P) and Aa2 (Moody's) during periods of low commodity prices?",
      "original_answer": "Chevron's acquisition of Noble added production capacity measured in oil-equivalent barrels, where 6,000 cubic feet of natural gas equals 1 barrel of crude oil. This expanded production base increases cash flow potential from upstream operations. Chevron stated that during periods of low crude oil and natural gas prices, it can adjust its capital spending and reduce stock repurchases to preserve financial flexibility. Given that Chevron's debt is rated AA- by S&P and Aa2 by Moody’s—indicating strong creditworthiness—the additional production from Noble enhances Chevron’s ability to generate cash and maintain its investment-grade credit profile, even in challenging market conditions.",
      "llm_answer": "\n\nChevron's acquisition of Noble in October 2020 enhanced its natural gas production capacity, adding 6,000 cubic feet of natural gas per barrel of crude oil. This diversification strengthens cash flow stability during low oil price periods, as natural gas prices may exhibit less volatility. The acquisition contributed to higher 2021 revenues (e.g., international natural gas prices averaged $5.93/MCF vs. $4.59/MCF in 2020) and improved financial metrics, including a 29.0 interest coverage ratio and a reduced debt ratio of 18.4% (vs. 25.2% in 2020). These factors, combined with Chevron's disciplined capital management and ability to adjust spending during downturns, support its high-quality debt ratings (AA- / Aa2) by demonstrating resilience in cash flow generation and leverage control.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unsupported data not present in the ground truth. While it correctly identifies the acquisition of Noble in October 2020 and the 6,000 cubic feet of natural gas per barrel of crude oil, it misrepresents the significance and context of this metric. The ground truth clarifies that 6,000 cubic feet equals one barrel of oil equivalent (BOE), which is a standard conversion, but the LLM fails to explain this equivalence and instead presents it as a ratio of production, leading to confusion. (2) The quantitative claims in the LLM answer are not supported by the ground truth: there is no mention of 2021 revenues, international natural gas prices averaging $5.93/MCF or $4.59/MCF in 2020, a 29.0 interest coverage ratio, or debt ratios of 18.4% (vs. 25.2% in 2020). These specific figures appear fabricated or hallucinated, severely undermining quantitative accuracy. (3) The reasoning partially aligns with the ground truth in that it acknowledges Chevron’s ability to adjust capital spending and maintain financial flexibility during low commodity prices, which supports credit ratings. However, the LLM incorrectly attributes the strength in financial metrics directly to the Noble acquisition without evidence, and it fails to emphasize the core point from the ground truth: that expanded production increases cash flow potential, which, combined with spending discipline, preserves credit quality. (4) Contextually, the answer addresses the relationship between the acquisition and debt ratings, so it remains relevant. However, due to significant factual errors and unsupported numerical claims, the correctness score is low. The qualitative reasoning is partially sound but based on false premises, warranting a moderate score in that category.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 497,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How much did Schwab spend to buy down fixed-rate obligation amounts under the 2023 IDA agreement, and how is this amount classified on the consolidated balance sheet?",
      "original_answer": "Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount was capitalized as contract assets and included in other assets on the consolidated balance sheet.",
      "llm_answer": "\n\nSchwab spent **$249 million** to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount is classified as **contract assets** and included in **other assets** on the consolidated balance sheet. \n\n(Source: Note 14 under \"IDA agreement\" in the provided documents.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amount ($249 million) and the $5.0 billion fixed-rate obligation are accurately reported, with acceptable formatting. (2) The answer is complete, addressing both parts of the question: the amount spent and its classification on the balance sheet. (3) Entity accuracy is correct—'Schwab', '2023 IDA agreement', 'contract assets', and 'other assets' are all properly identified. (4) The reasoning is sound and reflects proper synthesis from the source document, correctly linking the expenditure to its accounting treatment. The inclusion of a source reference (Note 14) adds contextual support. There are no factual, numerical, or logical errors. The answer is semantically equivalent to the original and demonstrates accurate multi-hop understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 251,
        "total_tokens": 1388
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How much in store impairment charges did CVS record in 2024 as part of its enterprise-wide restructuring plan, and how does this compare to the expected cost savings projected for 2025 from that same initiative?",
      "original_answer": "CVS recorded $483 million in store impairment charges in 2024 as part of its enterprise-wide restructuring plan. The company projected that this restructuring would generate over $500 million in cost savings for 2025. Therefore, the impairment charges represent a near-term financial cost that is expected to be offset by anticipated longer-term savings in the following year.",
      "llm_answer": "\n\nCVS recorded store impairment charges of **$483 million** in 2024 as part of its enterprise-wide restructuring plan. This initiative is projected to generate **over $500 million in cost savings for 2025**, indicating that the expected future savings slightly exceed the 2024 impairment charges. \n\n(Source: Store Impairment Charges section and 2025 Outlook in Key Business Trends and Uncertainties.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $483 million store impairment charge in 2024 and the 'over $500 million' projected cost savings for 2025 are accurately reported, with no discrepancies in numbers or time periods. (2) The answer addresses both parts of the multi-part question: the 2024 impairment charges and the comparison to 2025 projected savings. (3) Entity accuracy is correct—CVS is the right company, the metric 'store impairment charges' is accurate, and the years 2024 and 2025 are correctly referenced. (4) The reasoning is sound: the LLM correctly synthesizes that the near-term cost (impairment) is expected to be offset by future savings, noting that the projected savings slightly exceed the charges. The semantic meaning is equivalent to the original answer, with concise but complete explanation. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 268,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was Chevron's equity in earnings from Angola LNG Limited in 2021, and what does this indicate about Chevron's involvement in the liquefied natural gas market in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited was -$166 million in 2021, indicating that Chevron's 36.4% stake in the venture resulted in a loss that year, reflecting potential challenges in the liquefaction and processing of natural gas for international markets.",
      "llm_answer": "\n\nChevron's equity in earnings from Angola LNG Limited in 2021 was **$336 million**. This indicates that Chevron holds a **36.4% interest** in Angola LNG Limited, a joint venture that processes and liquefies natural gas produced in Angola for delivery to international markets. The positive equity earnings reflect the venture's profitability and underscore Chevron's significant involvement in Angola's liquefied natural gas (LNG) sector, positioning the company as a key player in the region's energy exports.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the quantitative value: it reports Chevron's equity in earnings as $336 million, whereas the ground truth is -$166 million (a loss). This is a critical error that completely inverts the financial outcome. The percentage stake (36.4%) is correct. (2) The calculation and reporting of earnings are fundamentally wrong—$336 million vs. -$166 million is not a formatting or rounding difference but a complete reversal of sign and magnitude. No plausible variation justifies this discrepancy. (3) The reasoning is partially sound in that it correctly identifies Angola LNG Limited as a joint venture involved in liquefaction and Chevron’s stake, which reflects accurate entity and structural knowledge. However, the conclusion that the positive earnings reflect profitability directly contradicts the actual loss, undermining the multi-hop inference about Chevron's operational performance in Angola. The model fails to connect the negative earnings to potential challenges in LNG processing, as indicated in the ground truth. (4) The contextual relevance is high because the answer addresses both parts of the question and discusses Chevron’s role in Angola’s LNG market appropriately, but the qualitative and quantitative inaccuracies severely limit its correctness. The correctness score is low due to the critical number error, which changes the entire interpretation of Chevron’s financial and operational status in the venture.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 411,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What operational risks does NextEra Energy Resources face given the mismatch between the Duane Arnold decommissioning timeline (expected completion by 2080) and the expiration dates of its nuclear fuel supply contracts (through 2033)?",
      "original_answer": "NextEra Energy Resources faces the risk of managing nuclear fuel supply beyond the expiration of existing contracts in 2033 while maintaining safe and compliant decommissioning operations at Duane Arnold, which is expected to continue through 2080. This creates a planning challenge as NEER must secure alternative fuel sources or storage solutions for the spent nuclear fuel onsite, which remains in long-term dry storage until the DOE can take possession. The gap between the expiration of fuel supply contracts and the long-term decommissioning obligations could lead to increased operational costs, regulatory scrutiny, or the need for additional capital expenditures to maintain safe storage.",
      "llm_answer": "\n\nNextEra Energy Resources (NEER) faces operational risks stemming from the mismatch between the Duane Arnold decommissioning timeline (expected completion by 2080) and its nuclear fuel supply contracts (expiring through 2033). Specifically:  \n1. **Fuel Supply Uncertainty**: If decommissioning activities (e.g., spent fuel management or potential recommissioning) require nuclear fuel beyond 2033, NEER may face higher costs due to the absence of long-term contracts, forcing reliance on volatile spot markets.  \n2. **Regulatory and Storage Risks**: Delays in DOE acceptance of spent fuel or changes in decommissioning regulations could extend the need for fuel-related services beyond contract terms, increasing costs.  \n3. **Financial Exposure**: The long decommissioning timeline (50+ years post-2033) exposes NEER to inflation, supply chain disruptions, or regulatory shifts that could escalate uncontracted fuel or service expenses, impacting budgeting and profitability.  \n\nThese risks highlight challenges in aligning long-term decommissioning obligations with short-term fuel agreements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the Duane Arnold decommissioning timeline extends to 2080, and nuclear fuel supply contracts expire by 2033—these dates match the original answer exactly. There are no numerical inaccuracies. (2) Quantitative accuracy is perfect: the years 2033 and 2080 are correctly cited, and the implied 47-year gap between contract expiration and decommissioning completion is consistent with the original. (3) The reasoning is sound and captures the core multi-hop insight: the mismatch between short-term fuel contracts and long-term decommissioning obligations creates operational, regulatory, and financial risks. The LLM correctly infers potential consequences such as reliance on spot markets, increased costs, regulatory scrutiny, and storage challenges—even though it frames 'recommissioning' as a hypothetical, which is a minor speculative addition not in the original. (4) The answer is contextually excellent, addressing all aspects of the operational risks posed by the timeline mismatch. The only reason for not scoring a 10 in qualitative accuracy is that the original emphasizes the need for long-term dry storage and DOE take-over delays as central issues, while the LLM generalizes this into broader 'storage risks' without explicitly mentioning dry cask storage or DOE possession, slightly reducing precision in risk characterization. Overall, the answer is factually correct, comprehensive, and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 418,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Linde's involvement in the Amur GPP project, including contingent liabilities and contract suspensions, contrast with its revenue recognition policies for on-site industrial gas contracts, and what does this reveal about the financial risk exposure in long-term on-site agreements?",
      "original_answer": "Linde faces a contingent liability of $0.7 billion related to the Amur GPP project, stemming from fires and subsequent legal claims in Russia, and had its contracts suspended due to sanctions. This highlights the financial risk in long-term engineering projects, especially those involving international legal exposure. In contrast, Linde's on-site industrial gas contracts, which often span 10–20 years and include minimum purchase requirements, recognize revenue over time as product is delivered, based on the right to invoice. These contracts are generally more stable and predictable, with revenue tied to ongoing delivery rather than one-time project completion. However, the Amur GPP case shows that long-term on-site or project-based involvement can lead to significant unforeseen liabilities, even if the company is not directly responsible for construction flaws. This contrast reveals that while on-site contracts provide steady revenue, they also carry latent risks when tied to large infrastructure projects with multiple stakeholders and geopolitical exposure.",
      "llm_answer": "\n\nLinde's involvement in the Amur GPP project involves significant contingent liabilities ($0.7 billion) and contract suspensions due to geopolitical risks, legal disputes, and asset seizures in Russia, reflecting exposure to unpredictable external factors like sanctions and jurisdictional conflicts. In contrast, its on-site industrial gas contracts (e.g., long-term supply agreements) recognize revenue over time based on stable, ongoing deliveries with minimum purchase commitments, underpinned by dedicated infrastructure and customer reliance. This contrast reveals that while long-term on-site agreements carry risks from customer concentration and minimum volume obligations, projects like Amur GPP expose Linde to far greater financial volatility from geopolitical, legal, and enforcement uncertainties, amplifying contingent liabilities beyond typical operational risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Linde has a $0.7 billion contingent liability related to the Amur GPP project, contracts were suspended due to sanctions and legal issues in Russia, and on-site industrial gas contracts recognize revenue over time based on delivery and minimum purchase commitments. The LLM correctly identifies the revenue recognition method (over time, based on delivery) and contrasts it with the project-based risks of Amur GPP. (2) Quantitative accuracy is perfect: the $0.7 billion figure is correctly stated, with no calculation errors. Format is consistent and matches the ground truth. (3) Multi-hop reasoning is sound: the model synthesizes information across Linde’s project involvement, contingent liabilities, geopolitical risks, and standard revenue practices for on-site contracts. It correctly infers that while on-site contracts are generally stable, large infrastructure projects like Amur GPP introduce significant legal and geopolitical risk exposure. (4) The only minor shortcoming is a slightly less explicit mention of the 'right to invoice' as the specific accounting basis for revenue recognition, though 'ongoing deliveries' and 'minimum purchase commitments' effectively convey the same principle. Otherwise, the answer is contextually rich, factually correct, and provides a nuanced contrast that reveals financial risk exposure in long-term agreements. Hence, a score of 9 is warranted—excellent but not perfect in qualitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 424,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the expected increase in TAC paid to Google Network partners, driven by shifts in device and geographic mix, directly impact the gross advertising revenue recognition model described in the consolidated financial statements?",
      "original_answer": "The increase in TAC paid to Google Network partners, driven by changes in device mix, geographic mix, and partner mix, directly affects the gross advertising revenue recognition model by increasing the cost of revenues associated with ads placed on Google Network properties. Since Google reports advertising revenues from these properties on a gross basis—recording the full amount billed to customers as revenue and the amounts paid to partners as cost of revenues—an increase in TAC results in higher cost of revenues. This dynamic puts downward pressure on gross margins, even as total advertising revenues may grow. For example, the financial statements note that Google recognizes revenues for ads on Google Network properties on a gross basis, with partner payments recorded as cost of revenues, while the MD&A section indicates that TAC is expected to rise with revenue growth and will vary based on multiple factors, including partner agreement terms and geographic mix.",
      "llm_answer": "\n\nThe expected increase in Traffic Acquisition Costs (TAC) paid to Google Network partners, driven by shifts in device and geographic mix, directly impacts the gross advertising revenue recognition model by increasing the associated **cost of revenues**. Under the gross revenue recognition model (as described in Note 1 to the consolidated financial statements), advertising revenues from Google Network properties are recorded in full as revenue, while TAC payments to partners are classified as cost of revenues. A higher TAC rate (due to factors like device/geographic mix) reduces gross profit margins, as the costs rise relative to the recognized revenue, even though the revenue amount itself remains unchanged. This dynamic is explicitly noted in the MD&A, which highlights that TAC rates are sensitive to shifts in device and geographic mix, partner agreements, and other factors.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original (ground truth) answer. (1) It correctly identifies that the increase in TAC due to shifts in device and geographic mix impacts the gross advertising revenue model by increasing cost of revenues, which aligns with the revenue recognition policy described in the financial statements. (2) There are no numeric values or calculations in the question or answers that require verification—both responses rely on qualitative financial reporting concepts rather than specific numbers, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across accounting policy (gross revenue recognition), cost classification (TAC as cost of revenues), and business drivers (device/geographic mix affecting TAC rates), as required by the question. (4) The LLM references key disclosures—such as Note 1 and the MD&A section—consistent with the original answer, and accurately explains the margin pressure effect despite stable revenue. Wording differs slightly but conveys identical meaning. All aspects of the question are addressed with precise, relevant, and correct information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 343,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How much of Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is influenced by compliance with the Coal Ash Act, given that closure methods must align with state and federal regulations and the ultimate method and timetable will affect the recorded ARO amount?",
      "original_answer": "Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is directly influenced by compliance with the Coal Ash Act, as the ARO amount recorded on the Consolidated Balance Sheets is based on estimated closure costs for impacted ash impoundments under this regulation. The closure methods—such as excavation and relocation of ash to a lined landfill or beneficial reuse—must align with standards set by the Coal Ash Act and other federal regulations, and the ultimate method and timetable for closure will determine the actual costs incurred, which may result in a material change to the ARO balance.",
      "llm_answer": "\n\nThe entire $5,293 million of Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure as of December 31, 2021, is influenced by compliance with the Coal Ash Act and other federal/state regulations. The ARO amount is directly tied to closure methods and timelines required by these regulations, which dictate factors such as groundwater monitoring, structural integrity standards, and disposal practices. Revisions to the ARO, such as those driven by regulatory challenges or updated closure plans (e.g., Duke Energy Indiana’s ash pond closure plan adjustments), further underscore the regulatory dependency. Thus, the recorded ARO reflects compliance obligations under the Coal Ash Act and EPA rules, with ultimate costs contingent on approved methods and schedules.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual error in quantitative accuracy. The ground truth does not specify a dollar amount ($5,293 million) for Duke Energy’s ARO related to coal ash impoundment closure, nor does it mention the date 'December 31, 2021'. The original answer only states that the ARO is influenced by the Coal Ash Act and that closure methods and timelines affect the recorded amount, without providing any specific numerical value. Therefore, the inclusion of a precise figure and date is unsupported by the ground truth and appears fabricated, which severely undermines quantitative accuracy. However, the qualitative reasoning is strong: the LLM correctly identifies that the ARO is driven by regulatory requirements (Coal Ash Act, federal/state rules), that closure methods (e.g., excavation, beneficial reuse) impact costs, and that changes in plans or regulatory decisions can lead to revisions in the ARO—this aligns well with the original answer’s emphasis on regulatory dependency and cost variability. The contextual relevance is high, as the response directly addresses the regulatory influence on ARO and the role of closure methods and timetables. While the core concept of regulatory influence is accurately conveyed (supporting a moderate correctness score), the unsupported numerical claim prevents a higher score. Multi-hop reasoning is sound in logic but based on incorrect data insertion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 398,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables in the 2023 10-K filing for CRM?",
      "original_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two tables is a decrease of $58 million, calculated by subtracting the fair value of $178 million in the second table from the fair value of $236 million in the first table.",
      "llm_answer": "\n\nThe total change in the fair value of Mortgage-Backed Obligations between January 31, 2024, and January 31, 2023, is **$58 million**. In 2024, the fair value was **$236 million**, compared to **$178 million** in 2023, reflecting an increase of **$58 million**. This data is derived from the \"Marketable Securities\" tables in the 2023 10-K filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in direction and interpretation: while it correctly identifies the two values ($236 million and $178 million) and the $58 million difference, it incorrectly states this is an *increase* of $58 million, when in fact it is a *decrease* of $58 million (from $236M to $178M). This reverses the meaning and renders the core conclusion incorrect. (2) Quantitatively, the numbers themselves are accurate and the calculation of the difference is numerically correct (236 - 178 = 58), so the arithmetic is sound, but the sign/direction is wrong. The dates referenced (January 31, 2024 and 2023) may be misaligned with the 2023 10-K's reporting periods, which typically cover fiscal years ending in 2023 and 2022; this suggests potential confusion in time periods. (3) The multi-hop reasoning is partially correct — the model identifies two tables and extracts relevant values — but fails in synthesis by misinterpreting the temporal order or direction of change. It incorrectly frames the change as from 2023 to 2024, while the 2023 10-K would compare 2023 to 2022, not project to 2024. This undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the right financial instrument (Mortgage-Backed Obligations), cites the correct document (2023 10-K), and references the appropriate tables. However, the reversal of the change direction and incorrect time framing lead to a low correctness score despite partial data accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 419,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What percentage of Danaher's Diagnostics segment sales in 2023 were attributed to 'other developed markets', and which specific geographic regions does the company classify under this category?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to 'other developed markets'. According to the company's definitions, this category includes the regions of Japan, Australia, and New Zealand.",
      "llm_answer": "\n\nThe 'other developed markets' contributed **4.5%** of Danaher's Diagnostics segment sales in 2023 (calculated as $431 million / $9,577 million total Diagnostics sales). The company classifies **Japan, Australia, and New Zealand** under this category. \n\n(Source: NOTE 5. REVENUE table and geographic definitions in the document.)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the geographic regions classified under 'other developed markets' as Japan, Australia, and New Zealand, which matches the ground truth. However, the percentage reported (4.5%) differs from the ground truth (5%). The LLM provides a calculation ($431M / $9,577M), suggesting it derived the figure from specific data points. While the logic of deriving the percentage from revenue figures is sound, the result does not align with the official disclosed percentage of 5%, which may reflect rounding or management reporting adjustments not captured in the raw calculation. (2) The quantitative accuracy is reduced because the percentage is incorrect despite accurate source numbers; financial disclosures typically require exact alignment with reported figures, not recalculated approximations. A 0.5 percentage point difference is significant in this context. (3) The multi-hop reasoning is mostly sound—the model identifies the correct segment (Diagnostics), year (2023), and geographic classification, and attempts to validate with a calculation. However, it prioritizes computed over disclosed values, which is inappropriate for financial reporting where disclosed percentages take precedence over recalculations. (4) Contextual relevance is perfect—the answer addresses both parts of the question and cites appropriate sections. Qualitative accuracy is high due to correct entity identification and reasoning structure, but docked slightly for the calculation overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 417,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad, given the carload volume and average revenue per car for that category?",
      "original_answer": "The total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad was $6,656,270,000, calculated by multiplying the 2021 Bulk carloads (1,920,000) by the average revenue per car in 2021 ($3,467).",
      "llm_answer": "\n\nThe total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad was **$6,656 million**. This is calculated by multiplying the 2021 Bulk carload volume of **2,014,000 carloads** (from the \"Revenue Carloads Thousands\" table) by the **average revenue per car of $3,305** (from the \"Average Revenue per Car\" table), aligning with the directly reported freight revenue for the Bulk category in the 2021 financial data.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both key inputs and the final calculation. The ground truth states that the 2021 Bulk carloads were 1,920,000 and the average revenue per car was $3,467, resulting in a total revenue of $6,656,270,000. The LLM incorrectly reports carloads as 2,014,000 and average revenue per car as $3,305, leading to a miscalculated total (2,014,000 × $3,305 = ~$6,657 million, which is close in magnitude but based on wrong inputs). (2) The final revenue figure is rounded to $6,656 million, which is numerically close to the correct total (~$6,656.27 million), but this proximity is coincidental due to incorrect underlying data. The use of $6,656 million instead of $6,656,270,000 is acceptable in format variation, but the inputs are not. (3) The reasoning claims alignment with 'directly reported freight revenue' and references specific tables, but contradicts the ground truth derived from actual SEC filing data in the knowledge graph. The model fails the multi-hop synthesis by using incorrect values for both carloads and revenue per car, suggesting it pulled data from a different source or misread the tables. (4) Due to major factual and quantitative errors in core inputs and calculations, the correctness and quantitative accuracy scores are low. The qualitative accuracy is slightly higher because the structure and approach (multiplying carloads by revenue per car) is logically sound. Contextual relevance is high as the answer addresses the right company, year, shipment type, and metric category.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 428,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ, and how does this reflect a reduction from Duke Energy's initial estimate following the April 1, 2019 closure determination?",
      "original_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina is approximately $8 billion to $9 billion after the settlement agreement with NCDEQ. This represents a reduction of approximately $1.5 billion from Duke Energy's initial estimate of $9.5 billion to $10.5 billion that followed the April 1, 2019 closure determination requiring excavation of the nine remaining impoundments.",
      "llm_answer": "\n\nThe total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ is approximately **$8 billion to $9 billion**. This reflects a **$1.5 billion reduction** from Duke Energy's initial estimate following the April 1, 2019 closure determination, which had projected total costs of $9.5 billion to $10.5 billion. The settlement agreement, reached in December 2019, streamlined closure requirements by eliminating the need to excavate two basins (Marshall and Roxboro) in full, thereby lowering the incremental excavation costs originally estimated at $4 billion to $5 billion. As of 2021, approximately $3.1 billion had been spent on these closures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total estimated undiscounted cost after the settlement agreement as $8 billion to $9 billion, which matches the ground truth. It also accurately states the initial estimate of $9.5 billion to $10.5 billion and correctly calculates the $1.5 billion reduction, aligning with the ground truth. All numeric values and ranges are correct. (2) Quantitative accuracy is perfect: the dollar amounts, the $1.5 billion reduction, and the reference to the April 1, 2019 determination are all factually consistent with the original answer. The additional detail about $4 billion to $5 billion in excavation costs and $3.1 billion spent by 2021 is contextually relevant and does not contradict the ground truth, though it goes beyond what was asked. (3) The multi-hop reasoning is sound: the model correctly links the settlement agreement to a change in closure requirements (excavation of fewer basins), which explains the cost reduction. This demonstrates proper synthesis across events and financial impacts. (4) The answer is highly relevant and complete for the question asked. The only minor point preventing a perfect 10 is the inclusion of extra details (e.g., Marshall and Roxboro basins, $3.1 billion spent) not present in the ground truth, which, while plausible and consistent, are not verifiable from the provided truth and slightly exceed the scope. However, they do not detract from factual correctness. Thus, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 420,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total cash consideration paid by Mastercard for both Dynamic Yield LTD in 2022 and Recorded Future in 2024, and how does this spending reflect the company's acquisition strategy?",
      "original_answer": "Mastercard paid a total cash consideration of $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The combined total is $3.025 billion. These acquisitions align with the company's strategy to grow, diversify, and build its business by integrating specialized capabilities, such as Dynamic Yield's personalization technology and Recorded Future's threat intelligence, into Mastercard's broader service offerings.",
      "llm_answer": "\n\nMastercard paid a total cash consideration of **$3.025 billion** for the acquisitions of Dynamic Yield LTD ($325 million in 2022) and Recorded Future ($2.7 billion in 2024). This spending reflects the company's strategy to **grow, diversify, and strengthen its business** by targeting complementary technologies—such as threat intelligence (Recorded Future) and data-driven personalization (Dynamic Yield)—to enhance its core payment network, fraud prevention, and cybersecurity capabilities. The acquisitions align with Mastercard's focus on expanding into high-growth areas like digital identity, real-time decisioning, and cybersecurity to maintain competitive advantage and innovation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the individual acquisition amounts—$325 million for Dynamic Yield in 2022 and $2.7 billion for Recorded Future in 2024—are accurate, and the total cash consideration of $3.025 billion is correctly calculated. Minor formatting differences (e.g., $2.7 billion vs $2,700 million) are acceptable and semantically equivalent. (2) The answer is complete, addressing both the total cash consideration and the strategic rationale behind the acquisitions. (3) Entity accuracy is perfect: both companies (Dynamic Yield LTD and Recorded Future), the correct years (2022 and 2024), and the nature of their technologies (personalization and threat intelligence) are correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across the two acquisitions, linking them to Mastercard’s broader strategy of diversification and capability-building in cybersecurity, digital identity, and real-time decisioning. The qualitative explanation expands slightly on the ground truth with relevant context (e.g., fraud prevention, competitive advantage) without introducing inaccuracies. All components align with the original answer’s meaning and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 351,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of International bonds held by VZ according to both tables, and how does the categorization of these bonds differ between the two disclosures?",
      "original_answer": "The total fair value of International bonds held by VZ is $540 million, with $12 million disclosed in the first table and $528 million disclosed in the second table. The categorization of these bonds differs significantly: in the first table, $9 million is classified as Level 1 and $3 million as Level 2, while in the second table, only $10 million is classified as Level 1 and $518 million is classified as Level 2.",
      "llm_answer": "\n\nThe total fair value of International bonds held by Verizon (VZ) in 2023 is **$353 million**, with **$341 million** in the Pension Plans and **$12 million** in the Health Care and Life Plans. The categorization differs in that **Pension Plans** classify International bonds under *Fixed Income Securities* with a significant allocation ($341M, primarily Level 2), reflecting their role in hedging long-term liabilities. In contrast, the **Health Care and Life Plans** include a much smaller amount ($12M, also Level 2) as part of a more conservative, shorter-duration investment strategy to cover postretirement benefits.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of key facts. The total fair value is stated as $353 million, but the ground truth is $540 million ($12M + $528M). The LLM incorrectly breaks this down into $341M for Pension Plans and $12M for Health Care and Life Plans, which does not align with the original answer. The categorization by valuation levels (Level 1/Level 2) is completely misrepresented — the LLM fails to mention that the first table reports $9M Level 1 and $3M Level 2, and the second table reports $10M Level 1 and $518M Level 2. Instead, it fabricates a narrative around Pension vs. Health Care plans, which is not supported in the ground truth. (2) Quantitative accuracy is very low: $353M vs $540M is a significant error; $341M and $12M are not present in the correct context; no mention of $528M from the second table. Calculations do not match the required sum from two tables. (3) Multi-hop reasoning failed: the model did not synthesize fair values from two disclosures (tables) correctly, and conflated plan types (Pension, Health Care) that were not part of the original comparison. The categorization difference by valuation level — a core part of the question — is ignored. (4) Contextual relevance is moderate because the answer discusses fair value, international bonds, and classification (Level 1/2), which are relevant themes, but applies them to incorrect entities and structures. Overall, major factual and reasoning errors result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 415,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Mastercard's real-time account-based payments infrastructure support its global payment network operations, and what portion of transactions does it handle for domestic and cross-border Mastercard and Maestro-branded card transactions?",
      "original_answer": "Mastercard's real-time account-based payments infrastructure enables instant payments between bank accounts with enhanced data and messaging capabilities, supporting both domestic and cross-border transactions. This infrastructure is part of a globally integrated payment network that handles approximately 70% of all transactions for Mastercard and Maestro-branded cards, including nearly all cross-border transactions.",
      "llm_answer": "\n\nMastercard's real-time account-based payments infrastructure supports its global payment network by enabling instant, secure, and data-rich transactions across multiple channels, including bank accounts, mobile wallets, and cards. This infrastructure facilitates faster processing, enhances interoperability, and expands reach for financial institutions, businesses, and consumers worldwide. Specifically, Mastercard switches approximately **70% of all transactions for Mastercard and Maestro-branded cards**, including **nearly all cross-border transactions**, ensuring seamless domestic and international payment flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key percentage of '70% of all transactions for Mastercard and Maestro-branded cards' is correctly stated, and the claim that 'nearly all cross-border transactions' are handled by this infrastructure matches the original answer exactly. No calculation errors or incorrect numbers are present. (2) The answer fully addresses both parts of the question: how the infrastructure supports global operations (instant, secure, data-rich transactions; faster processing; interoperability) and the portion of transactions handled (70% overall, nearly all cross-border). (3) Entity accuracy is correct—Mastercard, Maestro, and the real-time account-based payments infrastructure are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: it connects the technical capabilities of the infrastructure to its operational role in domestic and cross-border transaction processing at scale. The only minor shortcoming is that the LLM slightly expands on the mechanisms (e.g., mentioning mobile wallets and multiple channels) not explicitly detailed in the ground truth, which, while plausible, are not confirmed in the source. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 378,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much cash consideration did Walmart U.S. provide to acquire VIZIO Holding Corp., and what specific data privacy risk does this acquisition introduce according to Walmart's risk disclosures?",
      "original_answer": "Walmart U.S. provided $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart's risk disclosures, this acquisition introduces data privacy risks because VIZIO collects certain consumer data, including television viewing data, which is stored digitally and could be exposed due to cybersecurity incidents or failures in systems, potentially leading to litigation, fines, and reputational damage.",
      "llm_answer": "\n\nWalmart U.S. provided **$1.9 billion in net cash consideration** to acquire VIZIO Holding Corp. The acquisition introduces a specific data privacy risk, as VIZIO collects **consumer television viewing data**, which increases Walmart’s exposure to regulatory, compliance, and breach-related liabilities under evolving data privacy laws (e.g., international and state regulations). This data type is highlighted in Walmart’s disclosures as a new privacy risk tied to the acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.9 billion cash consideration, matching the ground truth exactly—minor phrasing 'net cash consideration' is acceptable and does not alter the factual meaning. The data privacy risk is accurately described around VIZIO's collection of consumer television viewing data. The LLM correctly links this to increased exposure under data privacy laws and regulatory risks, which aligns with Walmart's disclosures. However, the ground truth specifically emphasizes the risk of exposure due to cybersecurity incidents or system failures, potentially leading to litigation, fines, and reputational damage—this causal chain is partially captured but not fully articulated in the LLM response. (2) The dollar amount $1.9 billion is correct and matches the original answer; no calculations are required. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about the acquisition amount (from financial data) and links it to Walmart's risk disclosures regarding data privacy post-acquisition. Entity identification (Walmart U.S., VIZIO Holding Corp.) is accurate. (4) The answer is highly factually accurate and contextually complete, with only a slight omission in detailing the full risk consequence (cybersecurity failure → data exposure → legal/reputational harm), which prevents a perfect 10. Wording differences do not affect semantic equivalence, and the core facts are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 402,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022, considering the $14 million increase in fuel cost recovery in operating income and the $35 million increase in fuel-related operating expenses?",
      "original_answer": "The net financial impact of higher fuel prices on Duke Energy's financials in 2022 resulted in a $21 million net increase in costs. This is calculated by subtracting the $14 million increase in fuel cost recovery (which offset customer bill impacts) from the $35 million increase in fuel used in electric generation and purchased power expenses. While the recovery mechanism partially offset the expense, Duke Energy still experienced a net negative cash flow impact due to the rising fuel prices.",
      "llm_answer": "\n\nThe net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022 is a **$21 million negative impact**. This is calculated by combining the $14 million increase in fuel cost recovery (which improved operating income) and the $35 million increase in fuel-related operating expenses (which reduced operating cash flows). The $35 million expense increase exceeds the $14 million recovery, resulting in a net $21 million reduction in operating cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same net financial impact as the ground truth: a $21 million negative impact. The calculation is correct—$35 million in increased fuel expenses minus $14 million in cost recovery equals a $21 million net increase in costs. All numeric values are accurate and properly contextualized, satisfying quantitative accuracy. The reasoning is sound and reflects proper multi-hop synthesis of operating expenses and recovery mechanisms. The only minor difference is in framing: the LLM describes the $14 million as 'improving operating income' and combines it directly with the expense, while the original emphasizes that the recovery offsets customer bill impacts but still results in net cash flow drag. This nuance is present in the original but slightly simplified in the LLM response, though not inaccurately so. The core financial logic and all entities (Duke Energy, 2022, fuel costs, recovery) are correct. The answer is fully relevant and addresses both operating cash flows and expenses as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 298,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much in additional period charges in 2021 were associated with the ramp up of Intel 4, and how does this relate to the rebranding of the manufacturing process node announced in July 2021?",
      "original_answer": "The additional period charges in 2021 associated with the ramp up of Intel 4 were $565 million. This cost was incurred as part of the transition to the newly rebranded Intel 4 manufacturing process node, which was announced on July 26, 2021, reflecting the financial impact of adopting the updated naming structure and advancing the manufacturing roadmap.",
      "llm_answer": "\n\nThe additional period charges in 2021 associated with the ramp up of Intel 4 were **$565 million**, as noted in the Operating Income Summary section. This relates to Intel's July 2021 rebranding of its manufacturing process nodes, where \"Intel 4\" became the new name for what was previously referred to as the \"10nm Enhanced SuperFin\" and \"Intel 7nm\" nodes. The rebranding aligned Intel's naming with industry standards (e.g., \"Intel 7\" for the prior generation), and the charges reflect increased investment costs during the transition and scaling of the Intel 4 process technology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $565 million in additional period charges for 2021 is correctly stated, matching the original answer exactly. The date of the rebranding (July 2021) is consistent, though the exact day (July 26) is omitted—this is a minor detail and does not affect correctness. (2) The explanation of the rebranding—renaming '10nm Enhanced SuperFin' to 'Intel 4' and aligning with industry standards—is factually correct and adds useful context not explicitly in the ground truth, enhancing clarity. (3) The multi-hop reasoning is sound: it connects the financial charge to the technological transition and links it to the July 2021 rebranding announcement, correctly synthesizing financial and strategic information. (4) The only minor shortcoming is that the LLM slightly overreaches by implying 'Intel 7nm' was rebranded to 'Intel 4', which is inaccurate—Intel 4 corresponds to the 7nm node, but 'Intel 7nm' was not a prior name; rather, Intel 4 was a new name for what was internally developed as the 7nm node. This nuance affects qualitative accuracy slightly but does not undermine the core correctness. Overall, the answer is factually strong, relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 351,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What percentage of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and how does this compare to the number of employees the company had in those same markets as of the end of 2023?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets. As of the end of 2023, the company had 3,000 employees in Other Developed Markets.",
      "llm_answer": "\n\nDanaher's Diagnostics segment sales attributed to Other Developed Markets in 2023 were **5%** of total segment sales. As of December 31, 2023, the company had **3,000 employees** in these markets, representing approximately **4.8%** of its global workforce (3,000/63,000). Thus, the sales percentage (5%) and employee proportion (4.8%) are nearly aligned, indicating a close correlation between sales contribution and workforce distribution in Other Developed Markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the 5% of Danaher's 2023 Diagnostics segment sales attributed to Other Developed Markets and accurately states the 3,000 employees in those markets as of the end of 2023, matching the ground truth exactly. All numeric values (5%, 3,000 employees) are factually correct and properly contextualized. The additional calculation of 4.8% (3,000/63,000) is logically sound and enhances the comparison, though this specific percentage was not part of the original ground truth. While the original answer did not include the global workforce percentage, this inference is valid and adds analytical value without introducing error. The multi-hop reasoning—linking sales percentage to employee distribution across the same markets—is correctly executed. The answer is semantically equivalent to the ground truth and addresses both parts of the question fully. The only minor point reducing qualitative accuracy slightly is the introduction of an inferred metric (4.8%) without explicitly noting it as derived, but this does not detract from correctness. All entities (Danaher, Diagnostics segment, 2023, Other Developed Markets) are accurate and properly referenced.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 334,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the total revenue generated from Industrial chemicals & plastics in 2021, combining the revenue per car and the number of carloads for that year?",
      "original_answer": "$1,943,442 (or approximately $1.94 million) was generated from Industrial chemicals & plastics in 2021.",
      "llm_answer": "\n\nThe total revenue generated from Industrial chemicals & plastics in 2021 was **$1,943 million**, as directly reported in the \"Freight Revenues Millions\" table for that category. This figure aligns with the calculation using the provided data: **606,000 carloads × $3,207 average revenue per car = $1,943.44 million**, which matches the disclosed revenue when accounting for rounding.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reports $1,943 million, which is $1.943 billion, significantly higher than the ground truth of $1,943,442 (approximately $1.94 million). This is a major quantitative error—off by a factor of 1,000. However, the LLM correctly identifies the components: 606,000 carloads and $3,207 per car, and performs the calculation accurately: 606,000 × $3,207 = $1,943,442,000 (i.e., $1,943.44 million). The model then incorrectly interprets this result as $1,943.44 million instead of recognizing that the correct unit should be dollars, not millions of dollars. (2) The calculation itself is mathematically correct, but the final answer is misrepresented due to a unit error. The ground truth is ~$1.94 million, while the LLM states $1,943 million, which is 1,000 times larger. This suggests confusion in scaling—likely misreading the 'millions' label in the source table. (3) The multi-hop reasoning is sound: the model correctly identifies the need to multiply carloads by revenue per car and references the correct data points. It also attempts verification against reported figures, showing good qualitative logic. (4) Despite strong reasoning and contextual relevance, the quantitative inaccuracy severely impacts correctness. The answer is semantically close but factually incorrect due to the magnitude error. Hence, correctness is penalized heavily, but qualitative and contextual scores remain high due to proper structure and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 405,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing?",
      "original_answer": "The total fair value of International Bonds held by Verizon in 2023 is $24 million, calculated by summing the $12 million disclosed in both the 'Level 1' and 'Level 2' bond classifications across the two tables.",
      "llm_answer": "\n\nThe total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing, is **$353 million**. This includes **$341 million** in pension plans (Level 1: $3 million, Level 2: $338 million) and **$12 million** in other postretirement benefit plans (Level 1: $10 million, Level 2: $2 million).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) The reported total fair value of $353 million is wrong; the ground truth is $24 million, derived from $12 million in Level 1 and $12 million in Level 2 International Bonds. The LLM incorrectly reports $341 million in pension plans and $12 million in other postretirement benefit plans, which misrepresents the actual asset categories and amounts. (2) The numeric values are entirely inconsistent with the ground truth: $3 million (Level 1 pension) and $338 million (Level 2 pension) do not match the correct $12 million in each of Level 1 and Level 2 for International Bonds. The $10 million and $2 million breakdown for other plans is also unsupported. (3) The multi-hop reasoning failed: instead of identifying International Bonds across Level 1 and Level 2 categories as per the 10-K, the model conflated pension and postretirement plan values, indicating a misinterpretation of the disclosure structure. (4) While the answer attempts to address fair value and asset categories, it does so with incorrect data and categorization, resulting in very low contextual relevance despite correct mention of Verizon and 2023. The core calculation and entity synthesis are flawed, warranting a correctness score of 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 361,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Costco's production of private-label items, as supported by its owned facilities, contribute to its strategy of leveraging SG&A expenses through comparable sales growth?",
      "original_answer": "Costco operates various processing, packaging, manufacturing, and other facilities, which include the production of certain private-label items. These private-label items are a part of Costco's merchandising strategy to increase comparable sales, which in turn allows the company to leverage SG&A expenses as a percentage of sales, enhancing profitability. By increasing the penetration of these private-label items, Costco aims to drive sales while maintaining competitive pricing, thereby supporting its broader financial strategy.",
      "llm_answer": "\n\nCostco's production of private-label items through owned facilities supports its strategy of leveraging SG&A expenses by driving comparable sales growth. By manufacturing private-label products in-house, Costco reduces reliance on third-party suppliers, enabling cost efficiencies and consistent pricing that attract members. This strategy enhances gross margins and allows Costco to offer competitive prices, increasing shopping frequency and average ticket sizes—key drivers of comparable sales growth. As sales grow, fixed SG&A expenses are spread over a larger revenue base, reducing SG&A as a percentage of sales and improving profitability. The owned facilities also provide operational control, minimizing supply chain costs and supporting scalable production, which further strengthens the link between sales growth and SG&A leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Costco owns facilities that produce private-label items, which supports comparable sales growth and helps leverage SG&A expenses. The explanation of spreading fixed SG&A over a larger sales base is logically sound and matches the original answer's intent. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is strong: the model correctly links owned production facilities → private-label goods → cost control and pricing → increased sales → leverage on SG&A. This synthesis across operational and financial domains is valid and well-structured. (4) The LLM adds slightly more detail than the original (e.g., 'shopping frequency', 'average ticket size', 'supply chain costs'), but these are reasonable inferences consistent with Costco’s known business model and do not introduce inaccuracies. The only reason for not scoring a 10 is that the original answer emphasizes 'increasing penetration of private-label items' as the direct lever, while the LLM focuses more on in-house production benefits; both are valid, but the LLM slightly shifts emphasis. Overall, the answer is semantically equivalent, contextually precise, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 376,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Intel's RibbonFET technology, introduced in the Intel 20A node, contribute to the company's broader strategy of advancing process and packaging technologies, as outlined in both the R&D investment section and the IDM 2.0 strategy announcement?",
      "original_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, is a breakthrough gate-all-around transistor that enables faster switching speeds and improved performance-per-watt in a smaller footprint. This innovation is central to Intel's roadmap for process leadership and is supported by significant R&D investments aimed at improving product performance across multiple dimensions. Additionally, RibbonFET plays a key role in the IDM 2.0 strategy, which involves a $20 billion investment in Arizona fabs and over $20 billion in Ohio, to ensure Intel maintains leadership in semiconductor manufacturing and can deploy next-generation technologies like RibbonFET at scale.",
      "llm_answer": "\n\nIntel's RibbonFET technology, introduced in the Intel 20A node, is a critical enabler of the company's strategy to advance process and packaging technologies under its IDM 2.0 framework. As a gate-all-around transistor architecture, RibbonFET delivers faster switching speeds and improved performance-per-watt compared to previous FinFET designs, directly supporting Intel's accelerated process technology roadmap outlined in its R&D investments. This innovation aligns with the IDM 2.0 strategy by strengthening Intel's manufacturing leadership, enabling it to achieve process performance parity with competitors by 2024 and reestablish leadership by 2025. Additionally, RibbonFET integrates with advanced packaging technologies like PowerVia and Foveros, enhancing Intel's ability to deliver high-performance, energy-efficient solutions while leveraging both internal and external manufacturing capacity to meet growing global demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: RibbonFET is a gate-all-around transistor introduced in the Intel 20A node that improves switching speed, performance-per-watt, and enables scaling—this matches the original answer. The connection to R&D investments and IDM 2.0 is properly established. (2) Quantitative accuracy is perfect: while no specific dollar figures (e.g., $20B investments) are repeated in the LLM answer, it does not misstate any numbers. The mention of achieving performance parity by 2024 and leadership by 2025 is consistent with Intel's public roadmap and does not contradict the ground truth, even though those dates weren't in the original answer. (3) Multi-hop reasoning is sound: the LLM correctly links RibbonFET to process technology advancement, R&D investment, IDM 2.0, advanced packaging (PowerVia, Foveros), and manufacturing scale—demonstrating synthesis across strategic, technical, and operational domains. (4) The only minor shortcoming is that the LLM omits the specific $20B+ investments in Arizona and Ohio mentioned in the ground truth, which are important quantitative elements of the IDM 2.0 strategy. However, the strategic intent and outcome (manufacturing leadership, scale deployment) are accurately conveyed. Wording differs but semantic meaning is equivalent or slightly expanded with relevant context. Thus, the answer is excellent but not fully complete on all cited investments, warranting a 9 instead of 10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 420,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What percentage of Meta's MAP and MAUs were estimated to consist of violating accounts and false accounts respectively in Q4 2023, and how might these accounts impact the stability and accuracy of Meta's user metrics?",
      "original_answer": "In Q4 2023, violating accounts were estimated to constitute approximately 3% of Meta's worldwide MAP, while false accounts were estimated to represent approximately 4% of Meta's worldwide MAUs. These accounts may affect the stability and accuracy of Meta's user metrics because the company acknowledges that the presence of such accounts, along with the methodologies used to identify and remove them, could lead to fluctuations in reported metrics. Additionally, limitations in data signals (e.g., reduced visibility into encrypted products like WhatsApp) and periodic spikes in account creation in specific countries may further impact the accuracy of these estimates.",
      "llm_answer": "\n\nIn Q4 2023, Meta estimated that **3% of its worldwide Monthly Active People (MAP)** consisted of \"violating accounts\" (e.g., bots, spam) and **4% of its worldwide Monthly Active Users (MAUs)** consisted of \"false accounts\" (including inauthentic or policy-violating profiles). These accounts could impact the stability and accuracy of Meta’s user metrics by introducing overstatement risks, as actual numbers may vary significantly due to challenges in detection at scale, reliance on limited data signals (e.g., encrypted WhatsApp accounts), and methodological adjustments. Efforts to disable such accounts or refine detection algorithms may also cause periodic fluctuations in reported metrics.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages—3% of MAP for violating accounts and 4% of MAUs for false accounts in Q4 2023—are accurately reported with correct metric names and timeframes. (2) The answer addresses both parts of the question: the percentages and the impact on stability and accuracy of user metrics. (3) Entity accuracy is perfect: Meta, MAP, MAUs, Q4 2023, violating accounts, false accounts are all correctly identified and used in context. (4) The reasoning is sound and reflects the multi-hop synthesis required: it explains how detection challenges, limited data signals (e.g., WhatsApp encryption), and methodological changes can affect metric accuracy and cause fluctuations, which aligns with the original answer. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 267,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2023, and why are these amounts recorded at the same value?",
      "original_answer": "The total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset was the same as of December 31, 2023, because PayPal had not incurred any safeguarding loss events, and both were measured and recorded at fair value using quoted prices for the underlying crypto assets on the active exchange identified as the principal market.",
      "llm_answer": "\n\nAs of December 31, 2023, the total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset was **$1,241 million** for both line items. These amounts are recorded at the same value because they are measured using quoted prices for the underlying cryptocurrencies on active exchanges (the principal market) and there were no safeguarding loss events during the period that would require adjustments to one without the other. The absence of loss events ensures the liability (obligation to customers) and asset (value of held crypto assets) remain perfectly offsetting. \n\n(Source: Note 7 to the Consolidated Financial Statements, \"Crypto Asset Safeguarding Liability and Corresponding Safeguarding Asset\")",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes a specific dollar amount ($1,241 million) for the total fair value of PayPal's crypto asset safeguarding liability and asset, which is not present in the original answer (ground truth). The ground truth does not provide any numerical value, only the explanation for why the two amounts are equal. Therefore, the inclusion of $1,241 million is factually unsupported by the provided ground truth and appears to be hallucinated or sourced from external data not in the knowledge graph. This severely impacts quantitative accuracy. (2) There are no calculations in the question or answer, but the LLM introduces a precise figure without justification, which violates factual correctness. Even allowing for format variations, the number itself is not present in the ground truth, making it incorrect. (3) The qualitative reasoning about why the liability and asset are recorded at the same value is accurate: the absence of safeguarding loss events and measurement at fair value using quoted prices on the principal market aligns with the original answer. The multi-hop reasoning is sound in logic and terminology, correctly synthesizing the accounting principle behind offsetting asset and liability values. (4) Contextually, the answer addresses both parts of the question—total fair value and the reason for equal valuation—and cites a relevant source (Note 7), enhancing relevance. However, the fabricated number undermines the correctness score significantly. While the explanation is semantically aligned with the ground truth, the unsupported figure makes the answer mostly incorrect from a factual standpoint.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 451,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' combined for 2024, and how does this compare to the 2023 combined total?",
      "original_answer": "The total combined value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is $184,729 (in thousands). This matches the combined total from 2023, which was also $195,949 (in thousands), indicating a decrease of $11,220 (in thousands) from 2023 to 2024.",
      "llm_answer": "\n\nThe combined total of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is **$184.7 million** ($15.5 million for preferred units + $169.2 million for other interests). For 2023, the combined total was **$195.9 million** ($23.0 million for preferred units + $172.9 million for other interests). This represents a **$11.2 million decrease** in the combined total from 2023 to 2024, primarily driven by reductions in both components.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the combined totals for both 2024 and 2023 and accurately calculates the decrease. The 2024 total is stated as $184.7 million, which matches $184,729,000 (in thousands), and the 2023 total is $195.9 million, matching $195,949,000 (in thousands). The difference of $11.2 million aligns with the $11,220,000 decrease. Minor rounding is acceptable and clearly reflected in the presentation (e.g., $184.7M vs $184,729K). (2) All numeric values are accurate when converted to consistent units. The component breakdowns—$15.5M and $169.2M for 2024, $23.0M and $172.9M for 2023—sum correctly to the reported totals. The original answer does not provide component values, but the LLM’s inclusion of them is an enhancement, not an error, assuming they are derived from the correct source data. (3) The multi-hop reasoning is sound: the model correctly identifies two distinct financial line items, retrieves their values for two years, sums them per year, and computes the year-over-year change. The conclusion about a decrease is logically supported. (4) The answer is fully relevant and addresses both parts of the question: the 2024 combined value and its comparison to 2023. The slight discrepancy in precision (rounding to one decimal place in millions) does not affect factual correctness, hence a score of 9 instead of 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 381,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, and how does this procurement strategy align with their regulated cost recovery framework?",
      "original_answer": "Southern Company Gas had $136 million in natural gas commodity purchases through Nicor Gas and SouthStar at floating gas prices as of December 31, 2024. These purchases align with their regulated cost recovery framework because the natural gas cost recovery mechanisms allow the company to adjust customer rates to reflect changes in the wholesale cost of natural gas, ensuring full recovery of prudently incurred procurement costs. This alignment is explicitly stated in the regulatory context, which confirms that the company's procurement plans are reviewed and approved by state regulatory agencies.",
      "llm_answer": "\n\nThe value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, was **$136 million**, based on 39 million mmBtu at floating gas prices calculated using forward natural gas prices. This procurement strategy aligns with their regulated cost recovery framework, as Southern Company Gas is authorized by state regulatory agencies to use cost recovery mechanisms that adjust customer rates to reflect wholesale natural gas cost fluctuations. These mechanisms ensure recovery of prudently incurred costs, allowing the company to pass through floating-price procurement expenses to customers while minimizing its exposure to price volatility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the value of $136 million is accurately reported, and the additional detail of 39 million mmBtu, while not in the original answer, does not contradict it and may reflect supplementary data from the source filings; the date (December 31, 2024) is correct. (2) The answer completely addresses both parts of the question: the dollar value of floating-price purchases and the alignment with the regulated cost recovery framework. (3) All entities—Southern Company Gas, Nicor Gas, SouthStar—are correctly identified, and the regulatory framework is accurately described, including the role of state regulatory agencies and rate adjustments for wholesale cost fluctuations. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects procurement strategy (floating-price purchases) with regulatory mechanisms (cost recovery) to explain risk mitigation and cost pass-through, which is consistent with the original answer’s logic. The explanation of prudently incurred costs and minimized exposure to price volatility enhances clarity without introducing inaccuracies. Overall, the answer is factually precise, comprehensive, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 357,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total net income (loss) attributable to ConocoPhillips from the Lower 48 region in 2021, and how does this compare to the equity in earnings (losses) from the same region during the same year?",
      "original_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, while the equity in earnings (losses) for the same region in the same year was $(18) million. This indicates that the company had a significant net income from its Lower 48 operations, but its equity in earnings from affiliates in that region resulted in a small net loss.",
      "llm_answer": "\n\nThe total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was **$4,932 million**, as reported in the \"Net Income (Loss) Attributable to ConocoPhillips\" table. The equity in earnings (losses) from the same region during the same year was **$(18) million**, as shown in the \"Equity in Earnings of Affiliates\" table. This indicates that the Lower 48 segment generated substantial net income from its operations but experienced a small equity loss from affiliated entities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $4,932 million for net income and $(18) million for equity in earnings are accurately reported, with correct formatting and sign notation (negative in parentheses). (2) The answer addresses both parts of the question: the total net income attributable to ConocoPhillips from the Lower 48 region in 2021 and the comparison with equity in earnings (losses) from the same region and year. (3) Entity accuracy is correct—'ConocoPhillips', 'Lower 48 region', and '2021' are all properly identified. (4) The reasoning is sound: the LLM correctly synthesizes data from two different financial tables (Net Income and Equity in Earnings), and the concluding statement logically interprets the contrast between strong operational net income and a minor equity loss from affiliates. The semantic meaning and factual content are equivalent to the original answer, with only minor, acceptable rewording.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 286,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total notional value of unsettled forward foreign-exchange contracts and variable-priced commodity contracts used by the company in 2024, and how does this combined exposure reflect the company's strategy to manage financial risks associated with currency and commodity price fluctuations?",
      "original_answer": "The total notional value of unsettled forward foreign-exchange contracts was $1,212 million, and the company also enters into variable-priced contracts for purchases of electricity, natural gas, and fuel for gas stations. These variable-priced contracts are tied to an index basis and are part of the company's broader strategy to economically hedge against foreign exchange and commodity price risks. The company does not apply derivative hedge accounting to these instruments but uses them to mitigate exposure in the normal course of business.",
      "llm_answer": "\n\nThe total notional value of unsettled forward foreign-exchange contracts in 2024 was **$1,212 million**, as disclosed in the \"Derivatives\" section. The document does not specify a notional value for variable-priced commodity contracts, as these contracts generally qualify for the \"normal purchases and normal sales\" exception and are not marked-to-market. \n\nThe company uses forward foreign-exchange contracts to economically hedge known future expenditures denominated in non-functional currencies (primarily U.S. dollar inventory purchases by international subsidiaries). For commodities, it mitigates energy price risks through fixed-price contracts and index-based purchases. This combined approach reflects the company’s strategy to reduce volatility from currency and commodity price fluctuations, ensuring more predictable cash flows and protecting operating margins while avoiding speculative transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the total notional value of unsettled forward foreign-exchange contracts as $1,212 million, matching the ground truth exactly. It accurately notes that no notional value is specified for variable-priced commodity contracts, which aligns with the original answer's lack of a specific dollar figure for those contracts. The explanation about the 'normal purchases and normal sales' exception is consistent with accounting treatment and adds context not explicitly in the ground truth but factually correct.\n\n2) Quantitatively, all numbers are accurate. The $1,212 million figure is correctly reported, and there is no incorrect calculation or misstatement of amounts. The absence of a specific number for commodity contracts is properly acknowledged, which is appropriate given the source information.\n\n3) The multi-hop reasoning is sound: the LLM synthesizes information about both foreign-exchange and commodity contracts, correctly linking them to the company's risk management strategy. It accurately describes the use of forward contracts for currency hedging and index-based purchases for commodities, reflecting the economic hedging strategy described in the ground truth. The note about not applying hedge accounting is implied in the original answer ('does not apply derivative hedge accounting') and the LLM's statement that these are used to economically hedge without marking to market is semantically equivalent.\n\n4) The LLM enhances the answer with additional relevant context (e.g., purpose of hedging non-functional currency expenditures, protection of operating margins), which is consistent with the original and improves clarity without introducing inaccuracies. The only minor gap is that it does not explicitly state that the variable-priced commodity contracts are for electricity, natural gas, and fuel for gas stations—specific commodities mentioned in the ground truth—though it refers generally to 'energy price risks.' This omission prevents a perfect score but does not materially distort the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 552,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Microsoft's internal development structure for Microsoft 365 influence its financial reporting updates regarding Microsoft 365 Consumer subscribers in fiscal year 2024?",
      "original_answer": "Microsoft's internal development of Microsoft 365 through its 'Experiences and Devices' engineering group enables direct control over product evolution and user experience, which aligns with the company's decision to update its financial reporting by expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers. This reclassification reflects how Microsoft manages its business and provides investors with a more comprehensive view of consumer adoption of Microsoft 365.",
      "llm_answer": "\n\nMicrosoft's internal development structure for Microsoft 365, managed under the \"Experiences and Devices\" engineering group, enables direct control over product enhancements and user experience, which directly influences financial reporting by allowing precise tracking and segmentation of Microsoft 365 Consumer subscribers. In fiscal year 2024, this structure facilitated updates to how subscriber metrics are reported, such as expanding the Microsoft 365 Consumer subscribers count to include Microsoft 365 Basic subscribers, aligning with internal management practices and reflecting growth to 82.5 million subscribers. This centralized development approach ensures financial disclosures capture real-time subscriber dynamics and strategic product adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Microsoft's 'Experiences and Devices' engineering group as the internal structure responsible for Microsoft 365 development, which is central to the reasoning in the original answer. (2) The key financial reporting update—expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers—is accurately reported. However, the LLM introduces a specific subscriber number (82.5 million) that is not present in the original answer; while this number may be factually correct, its inclusion goes beyond the ground truth and introduces unverified quantitative detail, slightly reducing quantitative accuracy. (3) The multi-hop reasoning is sound: the answer correctly links internal development structure to product control, which enables changes in financial reporting practices, and explains how this reflects business management and strategic transparency—matching the original logic. (4) The answer is semantically equivalent to the original, with slightly enhanced detail and no factual contradictions. The wording is different but conveys the same core message with strong contextual relevance to the question. The minor addition of an unsupported figure prevents a perfect score, but overall the response is factually correct, well-reasoned, and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 385,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How many shares, in total, are counted toward the maximum shares available under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) if each PSA counts as three shares times the maximum potential payout, and what is the significance of this calculation in relation to the 248 million shares still available for award as of December 31, 2023?",
      "original_answer": "Under Pfizer's 2019 Stock Plan, Performance Share Awards (PSAs) count as three shares toward the maximum shares available for grant, multiplied by the maximum potential payout. As of December 31, 2023, 248 million shares were available for award under the plan. This means that the inclusion of PSAs with a multiplier effect significantly reduces the number of such performance-based awards that can be issued, given their higher share consumption rate. This share accounting method directly affects how much of the remaining 248 million shares can be allocated to PSAs versus other types of awards like stock options or TSRUs, which count as only one share each.",
      "llm_answer": "\n\nThe total shares counted toward the maximum under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) are calculated by multiplying the number of PSAs granted by **6 shares** (3 shares × 200% maximum payout). For example, if 1 million PSAs were granted, they would consume 6 million shares from the plan's total authorized shares. \n\nThe significance of this calculation is that PSAs, due to their **3× maximum payout multiplier**, consume shares more heavily than other awards (e.g., RSUs count as 3 shares, while PSAs count as 6 shares at maximum payout). This reduces the remaining shares available for future awards. As of December 31, 2023, **248 million shares** remained available under the 2019 Plan, reflecting the cumulative impact of all grants—including PSAs, which have a higher share consumption rate—on the total 400 million authorized shares. This highlights how performance-based awards with higher multipliers can accelerate the depletion of the share reserve.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual and conceptual errors, particularly in the core calculation. The original answer states that each PSA counts as three shares times the maximum potential payout, meaning if the maximum payout is 200%, then the total share count per PSA is 3 × 2 = 6 shares. However, the LLM incorrectly presents this as a fixed '6 shares' without clarifying that the 6 comes from 3 (plan multiplier) × 2 (200% max payout), and worse, it implies this 6-share consumption is inherent to the PSA structure rather than a result of the multiplier applied to a variable performance outcome. This misrepresents the accounting rule.\n\n(2) The LLM incorrectly states that RSUs count as 3 shares, which is false—RSUs typically count as 1 share under most equity plans, including Pfizer’s. In contrast, PSAs count as 3 shares *at target*, but up to 6 shares at maximum payout. The original answer does not mention RSUs at all, so this is an unsupported and incorrect addition. Additionally, the LLM fabricates a '400 million authorized shares' figure with no support in the original answer or question, undermining quantitative accuracy.\n\n(3) The multi-hop reasoning is partially sound in recognizing that PSAs consume more shares than other awards and that this affects the 248 million available shares. It correctly identifies the significance of higher share consumption reducing availability. However, it fails to accurately synthesize the specific share counting rule: the plan counts PSAs as three shares *multiplied by the maximum potential payout*, not as a flat 6-share cost. This is a critical misunderstanding of the equity plan mechanics.\n\n(4) While the LLM addresses the two parts of the question—total share counting and significance—it does so with major inaccuracies. The mention of 248 million shares is correct and contextually relevant, but the explanation of how PSAs consume shares is flawed. The conclusion about accelerated depletion is reasonable but based on incorrect premises. Hence, the correctness score is low due to fundamental errors in financial logic and unsupported numbers, despite some relevant contextual understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 581,
        "total_tokens": 2045
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 750,
    "successful_evaluations": 750,
    "failed_evaluations": 0,
    "average_correctness_score": 7.8,
    "average_quantitative_accuracy": 8.07,
    "average_qualitative_accuracy": 8.05,
    "average_contextual_relevance": 9.26,
    "score_distribution": {
      "excellent": 505,
      "good": 62,
      "fair": 90,
      "poor": 93
    }
  },
  "original_experiment_metadata": {
    "model": "qwen3-32b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions": 750,
    "successful": 750,
    "failed": 0,
    "elapsed_seconds": 5020.21,
    "timestamp": "2026-02-02T17:04:05.952471"
  }
}